[
  {
    "applicants": {
      "value": [
        "American Therapeutics Inc",
        "Teva Pharmaceuticals Usa",
        "Pfizer Inc",
        "Dava Pharmaceuticals Inc",
        "Watson Laboratories Inc",
        "Pfizer Laboratories Div Pfizer Inc",
        "Purepac Pharmaceutical Co",
        "Idt Australia Ltd",
        "Mylan Pharmaceuticals Inc",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C02CA01",
        "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING: Alpha-adrenoreceptor antagonists"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1976,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL2",
    "molecule_properties": {
      "acd_logd": 2.08,
      "acd_logp": 2.14,
      "acd_most_bpka": 6.52,
      "alogp": 1.78,
      "aromatic_rings": 3,
      "full_molformula": "C19H21N5O4",
      "full_mwt": 383.41,
      "hba": 8,
      "hba_lipinski": 9,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 383.41,
      "mw_monoisotopic": 383.1594,
      "psa": 106.95,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4occc4",
      "standard_inchi": "InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)",
      "standard_inchi_key": "IENZQIKPVFGBNW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "CP-122991",
        "CP-12299",
        "CP-12299-1"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Prazosin HCl (FDA, JAN, USAN, USP)",
        "Prazosin (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-azosin",
    "usan_stem_definition": "antihypertensives (prazosin type)",
    "usan_stem_substem": "-azosin(-azosin)",
    "usan_year": 1968
  },
  {
    "applicants": {
      "value": [
        "Glaxosmithkline Consumer Healthcare",
        "Mcneil Consumer Healthcare",
        "Sanofi Aventis Us Llc",
        "Pfizer Inc",
        "Actavis Laboratories Ny Inc",
        "Watson Laboratories Inc",
        "Novartis Consumer Health Inc",
        "Perrigo R And D Co",
        "Pharmacia And Upjohn Co",
        "L Perrigo Co"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N07BA01",
        "description": "NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in nicotine dependence"
      }
    },
    "availability_type": 2,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1984,
    "indication_class": "Smoking Cessation Adjunct",
    "molecule_chembl_id": "CHEMBL3",
    "molecule_properties": {
      "acd_logd": -0.62,
      "acd_logp": 0.57,
      "acd_most_bpka": 8,
      "alogp": 1.85,
      "aromatic_rings": 1,
      "full_molformula": "C10H14N2",
      "full_mwt": 162.24,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 12,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 162.24,
      "mw_monoisotopic": 162.1157,
      "psa": 16.13,
      "qed_weighted": 0.63,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCC[C@H]1c2cccnc2",
      "standard_inchi": "InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",
      "standard_inchi_key": "SNICXCGAKADSCV-JTQLQIEISA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8323683,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-8323683-B2",
    "synonyms": {
      "value": [
        "Nicotine (FDA, MI, USP)",
        "Nicotine Polacrilex (FDA, USAN, USP)",
        "Nicotine Bitartrate (USAN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1985
  },
  {
    "applicants": {
      "value": [
        "Cadila Pharmaceuticals Ltd",
        "Akorn Inc",
        "Alvogen Group Holdings 2 Llc",
        "Bausch And Lomb Pharmaceuticals Inc",
        "Sandoz Inc",
        "Allergan Inc",
        "Apotex Inc",
        "Ranbaxy Laboratories Ltd",
        "Sandoz",
        "Hi Tech Pharmacal Co Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "J01MA01",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolone"
        },
        {
          "code": "S01AE01",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolone"
        },
        {
          "code": "S02AA16",
          "description": "SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1990,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL4",
    "molecule_properties": {
      "acd_logd": -0.39,
      "acd_logp": 1.85,
      "acd_most_apka": 5.19,
      "acd_most_bpka": 7.37,
      "alogp": 1.54,
      "aromatic_rings": 2,
      "full_molformula": "C18H20FN3O4",
      "full_mwt": 361.37,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 361.37,
      "mw_monoisotopic": 361.1438,
      "psa": 75.01,
      "qed_weighted": 0.87,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC1COc2c(N3CCN(C)CC3)c(F)cc4C(=O)C(=CN1c24)C(=O)O",
      "standard_inchi": "InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)",
      "standard_inchi_key": "GSDSWSVVBLHKDQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "HOE-280",
        "DL-8280"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ofloxacin (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1984
  },
  {
    "applicants": {
      "value": [
        "Sanofi Aventis Us Llc",
        "Watson Laboratories Inc",
        "Sun Pharmaceutical Industries Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01MB02",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Other quinolones"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1964,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL5",
    "molecule_properties": {
      "acd_logd": -1.54,
      "acd_logp": 0.03,
      "acd_most_apka": 3.45,
      "acd_most_bpka": 6.12,
      "alogp": 1.42,
      "aromatic_rings": 2,
      "full_molformula": "C12H12N2O3",
      "full_mwt": 232.24,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "ACID",
      "mw_freebase": 232.24,
      "mw_monoisotopic": 232.0848,
      "psa": 72.19,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1C=C(C(=O)O)C(=O)c2ccc(C)nc12",
      "standard_inchi": "InChI=1S/C12H12N2O3/c1-3-14-6-9(12(16)17)10(15)8-5-4-7(2)13-11(8)14/h4-6H,3H2,1-2H3,(H,16,17)",
      "standard_inchi_key": "MHWLWQUZZRMNGJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "WIN-18320",
        "WIN-183203"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nalidixate Sodium (USAN)",
        "Nalidixic Acid (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "nal-",
    "usan_stem_definition": "narcotic agonists/antagonists (normorphine type)",
    "usan_stem_substem": "nal-(nal-)",
    "usan_year": 1962
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL6246",
    "molecule_properties": {
      "acd_logd": -3.38,
      "acd_logp": 0.24,
      "acd_most_apka": 5.02,
      "alogp": 1.31,
      "aromatic_rings": 4,
      "full_molformula": "C14H6O8",
      "full_mwt": 302.19,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 22,
      "molecular_species": "ACID",
      "mw_freebase": 302.19,
      "mw_monoisotopic": 302.0063,
      "psa": 141.34,
      "qed_weighted": 0.22,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1cc2C(=O)Oc3c(O)c(O)cc4C(=O)Oc(c1O)c2c34",
      "standard_inchi": "InChI=1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7)9(5)17)2-6(16)10(18)12(8)21-13(3)19/h1-2,15-18H",
      "standard_inchi_key": "AFSDNFLWKVMVRB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ellagic Acid (DCF, INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL204021",
    "molecule_properties": {
      "acd_logd": 3.59,
      "acd_logp": 5.12,
      "acd_most_bpka": 9.03,
      "alogp": 7.22,
      "aromatic_rings": 4,
      "full_molformula": "C36H38F4N4O2S",
      "full_mwt": 666.79,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 47,
      "molecular_species": "BASE",
      "mw_freebase": 666.79,
      "mw_monoisotopic": 666.2652,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 58.44,
      "qed_weighted": 0.09,
      "ro3_pass": "N",
      "rtb": 13
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCN(Cc1ccc(cc1)c2ccc(cc2)C(F)(F)F)C(=O)CN3C4=C(CCC4)C(=O)N=C3SCc5ccc(F)cc5",
      "standard_inchi": "InChI=1S/C36H38F4N4O2S/c1-3-42(4-2)20-21-43(22-25-8-12-27(13-9-25)28-14-16-29(17-15-28)36(38,39)40)33(45)23-44-32-7-5-6-31(32)34(46)41-35(44)47-24-26-10-18-30(37)19-11-26/h8-19H,3-7,20-24H2,1-2H3",
      "standard_inchi_key": "WDPFJWLDPVQCAJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SB-480848"
    },
    "synonyms": {
      "value": [
        "Darapladib (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-pladib",
    "usan_stem_definition": "phospholipase A2 inhibitors",
    "usan_stem_substem": "-pladib(-pladib)",
    "usan_year": 2005
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Chartwell Rx Sciences Llc",
        "Chartwell Molecules Llc",
        "Novast Laboratories Ltd",
        "West-Ward Pharmaceuticals International Ltd",
        "Glenmark Pharmaceuticals Ltd",
        "Jubilant Generics Ltd",
        "Halsey Drug Co Inc",
        "Hospira Inc",
        "Glenmark Generics Ltd India"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01BC01",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroid"
        },
        {
          "code": "M02AA23",
          "description": "MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical us"
        },
        {
          "code": "C01EB03",
          "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: OTHER CARDIAC PREPARATIONS: Other cardiac preparation"
        },
        {
          "code": "M01AB51",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substance"
        },
        {
          "code": "M01AB01",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1965,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL6",
    "molecule_properties": {
      "acd_logd": 0.98,
      "acd_logp": 4.25,
      "acd_most_apka": 3.96,
      "alogp": 3.93,
      "aromatic_rings": 3,
      "full_molformula": "C19H16ClNO4",
      "full_mwt": 357.79,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 357.79,
      "mw_monoisotopic": 357.0768,
      "psa": 68.53,
      "qed_weighted": 0.77,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2c(c1)c(CC(=O)O)c(C)n2C(=O)c3ccc(Cl)cc3",
      "standard_inchi": "InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",
      "standard_inchi_key": "CGIGDMFJXJATDK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8734847,
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-8734847-B2",
    "synonyms": {
      "value": [
        "Indomethacin Sodium (FDA, USAN, USP)",
        "Indometacin (BAN, DCF, INN, JAN)",
        "Indometacin Farnesil (JAN)",
        "Indomethacin (FDA, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1963
  },
  {
    "applicants": {
      "value": [
        "Antibiotice Sa",
        "Istituto Biochimico Italiano Spa",
        "Pfizer Inc",
        "Sandoz Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Pfizer Laboratories Div Pfizer Inc",
        "Sagent Pharmaceuticals Inc",
        "Hospira Inc",
        "Aurobindo Pharma",
        "Mustafa Nevzat Ilac Sanayii As (Mn Pharmaceuticals)"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01CG01",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase inhibitors"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1986,
    "indication_class": "Inhibitor (beta-lactamase); Synergist (penicillin/cephalosporin),Synergist (penicillin/cephalosporin); Inhibitor (beta-lactamase)",
    "molecule_chembl_id": "CHEMBL403",
    "molecule_properties": {
      "acd_logd": -3.33,
      "acd_logp": 0.39,
      "acd_most_apka": 2.62,
      "alogp": -0.79,
      "full_molformula": "C8H11NO5S",
      "full_mwt": 233.24,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 15,
      "molecular_species": "ACID",
      "mw_freebase": 233.24,
      "mw_monoisotopic": 233.0358,
      "psa": 91.75,
      "qed_weighted": 0.6,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)[C@@H](N2[C@@H](CC2=O)S1(=O)=O)C(=O)O",
      "standard_inchi": "InChI=1S/C8H11NO5S/c1-8(2)6(7(11)12)9-4(10)3-5(9)15(8,13)14/h5-6H,3H2,1-2H3,(H,11,12)/t5-,6+/m1/s1",
      "standard_inchi_key": "FKENQMMABCRJMK-RITPCOANSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "CP-45899",
        "CP-45899-99",
        "CP-458992",
        "CP-45899-2"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulbactam Sodium (FDA, JAN, USAN, USP)",
        "Sulbactam (BAN, INN)",
        "Sulbactam Benzathine (USAN)",
        null
      ]
    },
    "usan_stem": "-bactam",
    "usan_stem_definition": "beta-lactamase inhibitors",
    "usan_stem_substem": "-bactam(-bactam)",
    "usan_year": 1980
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Infective (DNA gyrase inhibitor)",
    "molecule_chembl_id": "CHEMBL6259",
    "molecule_properties": {
      "acd_logd": -0.46,
      "acd_logp": 0.84,
      "acd_most_apka": 6.17,
      "acd_most_bpka": 7.41,
      "alogp": 2.72,
      "aromatic_rings": 3,
      "full_molformula": "C21H19F2N3O3",
      "full_mwt": 399.4,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "ACID",
      "mw_freebase": 399.4,
      "mw_monoisotopic": 399.1394,
      "psa": 65.78,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN(CC1)c2cc3N(C=C(C(=O)O)C(=O)c3cc2F)c4ccc(F)cc4",
      "standard_inchi": "InChI=1S/C21H19F2N3O3/c1-24-6-8-25(9-7-24)19-11-18-15(10-17(19)23)20(27)16(21(28)29)12-26(18)14-4-2-13(22)3-5-14/h2-5,10-12H,6-9H2,1H3,(H,28,29)",
      "standard_inchi_key": "NOCJXYPHIIZEHN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "ABBOTT-56619"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Difloxacin HCl (USAN)",
        "Difloxacin (INN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1986
  },
  {
    "applicants": {
      "value": [
        "Wockhardt Bio Ag",
        "Istituto Biochimico Italiano Spa",
        "Sandoz Inc",
        "Cubist Pharmaceuticals Llc",
        "Apollo Pharmaceuticals Inc",
        "Hospira Inc",
        "Mylan Laboratories Ltd",
        "Aurobindo Pharma Ltd",
        "Wyeth Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01CG02",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase inhibitors"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1993,
    "indication_class": "Inhibitor (beta-lactamase)",
    "molecule_chembl_id": "CHEMBL404",
    "molecule_properties": {
      "acd_logd": -3.13,
      "acd_logp": 0.6,
      "acd_most_apka": 2.33,
      "acd_most_bpka": 0.85,
      "alogp": -1.52,
      "aromatic_rings": 1,
      "full_molformula": "C10H12N4O5S",
      "full_mwt": 300.3,
      "hba": 7,
      "hba_lipinski": 9,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "ACID",
      "mw_freebase": 300.3,
      "mw_monoisotopic": 300.0528,
      "psa": 122.46,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@]1(Cn2ccnn2)[C@@H](N3[C@@H](CC3=O)S1(=O)=O)C(=O)O",
      "standard_inchi": "InChI=1S/C10H12N4O5S/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h2-3,7-8H,4-5H2,1H3,(H,16,17)/t7-,8+,10+/m1/s1",
      "standard_inchi_key": "LPQZKKCYTLCDGQ-WEDXCCLWSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6207661,
    "parenteral": true,
    "research_codes": {
      "value": [
        "CL-298741",
        "CL-307579",
        "YTR-830H"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6207661-B1",
    "synonyms": {
      "value": [
        "Tazobactam sodium (FDA, USAN)",
        "Tazobactam (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-bactam",
    "usan_stem_definition": "beta-lactamase inhibitors",
    "usan_stem_substem": "-bactam(-bactam)",
    "usan_year": 1989
  },
  {
    "atc_classification": {
      "drug": {
        "code": "J01MA08",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL6273",
    "molecule_properties": {
      "acd_logd": -0.27,
      "acd_logp": 1.84,
      "acd_most_apka": -0.54,
      "acd_most_bpka": 7.15,
      "alogp": 1.7,
      "aromatic_rings": 2,
      "full_molformula": "C17H18F3N3O3",
      "full_mwt": 369.34,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 369.34,
      "mw_monoisotopic": 369.13,
      "psa": 65.78,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN(CC1)c2c(F)cc3C(=O)C(=CN(CCF)c3c2F)C(=O)O",
      "standard_inchi": "InChI=1S/C17H18F3N3O3/c1-21-4-6-22(7-5-21)15-12(19)8-10-14(13(15)20)23(3-2-18)9-11(16(10)24)17(25)26/h8-9H,2-7H2,1H3,(H,25,26)",
      "standard_inchi_key": "XBJBPGROQZJDOJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "Ro-236240000",
        "AM-833",
        "Ro-236240"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fleroxacin (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1987
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL6209",
    "molecule_properties": {
      "acd_logd": 0.91,
      "acd_logp": 3.41,
      "acd_most_apka": 6.44,
      "acd_most_bpka": 10.45,
      "alogp": 2.43,
      "aromatic_rings": 2,
      "full_molformula": "C19H23F2N3O3",
      "full_mwt": 379.41,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 27,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 379.41,
      "mw_monoisotopic": 379.1707,
      "psa": 74.57,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCNCC1CCN(C1)c2c(F)cc3C(=O)C(=CN(CC)c3c2F)C(=O)O",
      "standard_inchi": "InChI=1S/C19H23F2N3O3/c1-3-22-8-11-5-6-24(9-11)17-14(20)7-12-16(15(17)21)23(4-2)10-13(18(12)25)19(26)27/h7,10-11,22H,3-6,8-9H2,1-2H3,(H,26,27)",
      "standard_inchi_key": "BAYYCLWCHFVRLV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CI-934"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Merafloxacin (INN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL6231",
    "molecule_properties": {
      "acd_logd": -0.68,
      "acd_logp": 0.19,
      "acd_most_apka": 6.17,
      "acd_most_bpka": 7.41,
      "alogp": 0.76,
      "aromatic_rings": 2,
      "full_molformula": "C16H19FN4O3",
      "full_mwt": 334.35,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 24,
      "molecular_species": "ACID",
      "mw_freebase": 334.35,
      "mw_monoisotopic": 334.1441,
      "psa": 77.81,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CNN1C=C(C(=O)O)C(=O)c2cc(F)c(cc12)N3CCN(C)CC3",
      "standard_inchi": "InChI=1S/C16H19FN4O3/c1-18-21-9-11(16(23)24)15(22)10-7-12(17)14(8-13(10)21)20-5-3-19(2)4-6-20/h7-9,18H,3-6H2,1-2H3,(H,23,24)",
      "standard_inchi_key": "RUXPNBWPIRDVTH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "WIN-493753",
        "WIN-49375"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Amifloxacin Mesylate (USAN)",
        "Amifloxacin (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1984
  },
  {
    "applicants": {
      "value": [
        "Rising Pharmaceuticals Inc",
        "Fresenius Kabi Usa Llc",
        "Wraser Pharmaceuticals Llc",
        "Amring Pharmaceuticals Inc",
        "Unique Pharmaceutical Laboratories A Division Of J.B. Chemicals And Pharmaceuticals Ltd",
        "Hospira Inc",
        "Bayer Healthcare Pharmaceuticals Inc",
        "Teligent Ou",
        "Pliva Inc",
        "Aurobindo Pharma Ltd"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "J01MA02",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolone"
        },
        {
          "code": "S01AE03",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolone"
        },
        {
          "code": "S03AA07",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: ANTIINFECTIVES: Antiinfective"
        },
        {
          "code": "S02AA15",
          "description": "SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1987,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL8",
    "molecule_properties": {
      "acd_logd": -0.29,
      "acd_logp": 1.62,
      "acd_most_apka": 6.43,
      "acd_most_bpka": 8.68,
      "alogp": 1.58,
      "aromatic_rings": 2,
      "full_molformula": "C17H18FN3O3",
      "full_mwt": 331.35,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 24,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 331.35,
      "mw_monoisotopic": 331.1332,
      "psa": 74.57,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)C1=CN(C2CC2)c3cc(N4CCNCC4)c(F)cc3C1=O",
      "standard_inchi": "InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)",
      "standard_inchi_key": "MYSWGUAQZAJSOK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5972389,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "BAY-Q-3939",
        "BAY-O-9867",
        "BAY-O-9867 Monohydrate"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5972389-A",
    "synonyms": {
      "value": [
        "Ciprofloxacin HCl (FDA, JAN, USAN, USP)",
        "Ciprofloxacin (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1987
  },
  {
    "applicants": {
      "value": "Merck Research Laboratories Div Merck Co Inc"
    },
    "atc_classification": {
      "drug": [
        {
          "code": "J01MA06",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolone"
        },
        {
          "code": "S01AE02",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1986,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL9",
    "molecule_properties": {
      "acd_logd": -0.66,
      "acd_logp": 1.74,
      "acd_most_apka": 0.16,
      "acd_most_bpka": 8.68,
      "alogp": 1.27,
      "aromatic_rings": 2,
      "full_molformula": "C16H18FN3O3",
      "full_mwt": 319.34,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 319.34,
      "mw_monoisotopic": 319.1332,
      "psa": 74.57,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1C=C(C(=O)O)C(=O)c2cc(F)c(cc12)N3CCNCC3",
      "standard_inchi": "InChI=1S/C16H18FN3O3/c1-2-19-9-11(16(22)23)15(21)10-7-12(17)14(8-13(10)19)20-5-3-18-4-6-20/h7-9,18H,2-6H2,1H3,(H,22,23)",
      "standard_inchi_key": "OGJPXUAPXNRGGI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "MK-366"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Norfloxacin (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1984
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL6615",
    "molecule_properties": {
      "acd_logd": 5.14,
      "acd_logp": 5.14,
      "acd_most_apka": 9.8,
      "alogp": 4.79,
      "aromatic_rings": 2,
      "full_molformula": "C18H22O2",
      "full_mwt": 270.37,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 270.37,
      "mw_monoisotopic": 270.162,
      "psa": 40.46,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(C(CC)c1ccc(O)cc1)c2ccc(O)cc2",
      "standard_inchi": "InChI=1S/C18H22O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,17-20H,3-4H2,1-2H3",
      "standard_inchi_key": "PBBGSZCBWVPOOL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Hexestrol (INN, MI, NF)",
        "Hexestrol Diphosphate Sodium (JAN)",
        null
      ]
    },
    "usan_stem": "-estr-",
    "usan_stem_definition": "estrogens",
    "usan_stem_substem": "-estr-(-estr-)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Hormone (replacement therapy, estrogen receptor antagonist); Osteoporosis Treatment And Prevention; Antineoplastic",
    "molecule_chembl_id": "CHEMBL6318",
    "molecule_properties": {
      "acd_logd": 4.88,
      "acd_logp": 7.04,
      "acd_most_bpka": 9.62,
      "alogp": 7.13,
      "aromatic_rings": 3,
      "full_molformula": "C28H30INO",
      "full_mwt": 523.46,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 31,
      "molecular_species": "BASE",
      "mw_freebase": 523.46,
      "mw_monoisotopic": 523.1372,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 12.47,
      "qed_weighted": 0.23,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC\\C(=C(/c1ccc(I)cc1)\\c2ccc(OCCN3CCCC3)cc2)\\c4ccccc4",
      "standard_inchi": "InChI=1S/C28H30INO/c1-2-27(22-8-4-3-5-9-22)28(23-10-14-25(29)15-11-23)24-12-16-26(17-13-24)31-21-20-30-18-6-7-19-30/h3-5,8-17H,2,6-7,18-21H2,1H3/b28-27-",
      "standard_inchi_key": "JJKOTMDDZAJTGQ-DQSJHHFOSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "CB-7432",
        "SB-223030"
      ]
    },
    "synonyms": {
      "value": [
        "Idoxifene (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ifene",
    "usan_stem_definition": "antiestrogens of the clomifene and tamoxifen groups",
    "usan_stem_substem": "-ifene(-ifene)",
    "usan_year": 1996
  },
  {
    "applicants": {
      "value": [
        "Mallinckrodt Inc",
        "Arbor Pharmaceuticals Llc",
        "Teva Womens Health Inc",
        "Teva Pharmaceuticals Usa",
        "Shire Development Inc",
        "Shire Development Llc",
        "Epic Pharma Llc",
        "Aurolife Pharma Llc",
        "Sun Pharmaceutical Industries Inc",
        "Ucb Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06BA01",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1955,
    "indication_class": "Stimulant (central)",
    "molecule_chembl_id": "CHEMBL405",
    "molecule_properties": {
      "acd_logd": -0.65,
      "acd_logp": 1.79,
      "acd_most_bpka": 9.94,
      "alogp": 1.58,
      "aromatic_rings": 1,
      "full_molformula": "C9H13N",
      "full_mwt": 135.21,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 10,
      "molecular_species": "BASE",
      "mw_freebase": 135.21,
      "mw_monoisotopic": 135.1048,
      "psa": 26.02,
      "qed_weighted": 0.65,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(N)Cc1ccccc1",
      "standard_inchi": "InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3",
      "standard_inchi_key": "KWTSXDURSIMDCE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6322819,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-6322819-B1",
    "synonyms": {
      "value": [
        "Amphetamine Aspartate (FDA)",
        "Amphetamine Adipate (FDA)",
        "Amphetamine sulfate (FDA, USP)",
        "Amfetamine (BAN, INN)",
        "Amphetamine (FDA)",
        "Amphetamine resin complex (FDA)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Valeant Pharmaceuticals North America Llc",
        "Arbor Pharmaceuticals Llc",
        "Sun Pharmaceutical Industries Inc",
        "Sandoz Inc",
        "Superpharm Corp",
        "Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Astrazeneca Pharmaceuticals Lp",
        "Par Pharmaceutical Inc",
        "Watson Laboratories Inc",
        "Biovail Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "C05AE02",
          "description": "CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Muscle relaxant"
        },
        {
          "code": "C01DA58",
          "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Organic nitrate"
        },
        {
          "code": "C01DA08",
          "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Organic nitrates"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1986,
    "indication_class": "Vasodilator (coronary)",
    "molecule_chembl_id": "CHEMBL6622",
    "molecule_properties": {
      "acd_logd": 0.95,
      "acd_logp": 0.95,
      "alogp": -1.06,
      "full_molformula": "C6H8N2O8",
      "full_mwt": 236.14,
      "hba": 8,
      "hba_lipinski": 10,
      "heavy_atoms": 16,
      "mw_freebase": 236.14,
      "mw_monoisotopic": 236.0281,
      "psa": 123.2,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "[O-][N+](=O)O[C@H]1CO[C@@H]2[C@@H](CO[C@H]12)O[N+](=O)[O-]",
      "standard_inchi": "InChI=1S/C6H8N2O8/c9-7(10)15-3-1-13-6-4(16-8(11)12)2-14-5(3)6/h3-6H,1-2H2/t3-,4+,5-,6-/m1/s1",
      "standard_inchi_key": "MOYKHGMNXAOIAT-JGWLITMVSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6465463,
    "oral": true,
    "prodrug": true,
    "rule_of_five": true,
    "sc_patent": "US-6465463-B1",
    "synonyms": {
      "value": [
        "Isosorbide Dinitrate (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1966
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N06AX03",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antihistaminic; Serotonin Inhibitor",
    "molecule_chembl_id": "CHEMBL6437",
    "molecule_properties": {
      "acd_logd": 0.77,
      "acd_logp": 1.14,
      "acd_most_bpka": 8.26,
      "alogp": 3.08,
      "aromatic_rings": 2,
      "full_molformula": "C18H20N2",
      "full_mwt": 264.37,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 264.37,
      "mw_monoisotopic": 264.1626,
      "psa": 6.48,
      "qed_weighted": 0.72,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN2C(C1)c3ccccc3Cc4ccccc24",
      "standard_inchi": "InChI=1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3",
      "standard_inchi_key": "UEQUQVLFIPOEMF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "ORG GB 94"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mianserin HCl (JAN, USAN)",
        "Mianserin (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-anserin",
    "usan_stem_definition": "serotonin 5-HT2 receptor antagonists",
    "usan_stem_substem": "-anserin(-anserin)",
    "usan_year": 1968
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL6731",
    "molecule_properties": {
      "acd_logd": -0.8,
      "acd_logp": 1.64,
      "acd_most_bpka": 9.94,
      "alogp": 1.31,
      "aromatic_rings": 1,
      "full_molformula": "C10H13NO2",
      "full_mwt": 179.22,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 13,
      "molecular_species": "BASE",
      "mw_freebase": 179.22,
      "mw_monoisotopic": 179.0946,
      "psa": 44.48,
      "qed_weighted": 0.74,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(N)Cc1ccc2OCOc2c1",
      "standard_inchi": "InChI=1S/C10H13NO2/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9/h2-3,5,7H,4,6,11H2,1H3",
      "standard_inchi_key": "NGBBVGZWCFBOGO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tenamfetamine (INN)",
        null
      ]
    },
    "usan_stem": "-fetamin(e)",
    "usan_stem_definition": "amfetamine derivatives",
    "usan_stem_substem": "-fetamin(e)(-fetamin(e))"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL263881",
    "molecule_properties": {
      "acd_logd": 2.37,
      "acd_logp": 2.71,
      "acd_most_bpka": 7.41,
      "alogp": 2.91,
      "aromatic_rings": 2,
      "full_molformula": "C20H25N3O",
      "full_mwt": 323.44,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 323.44,
      "mw_monoisotopic": 323.1998,
      "psa": 39.34,
      "qed_weighted": 0.94,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)C(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34",
      "standard_inchi": "InChI=1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1",
      "standard_inchi_key": "VAYOSLLFUXYJDT-RDTXWAMCSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "LSD"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lysergide (BAN, DCF, INN, MI)",
        null
      ]
    },
    "usan_stem": "-erg-",
    "usan_stem_definition": "ergot alkaloid derivatives",
    "usan_stem_substem": "-erg-(-erg-)"
  },
  {
    "applicants": {
      "value": [
        "Lupin Ltd",
        "Mallinckrodt Inc",
        "Sun Pharmaceutical Industries Inc",
        "Oxford Pharmaceuticals Llc",
        "Roxane Laboratories Inc",
        "Sanofi Aventis Us Llc",
        "Sandoz Inc",
        "Teva Pharmaceuticals Usa Inc",
        "Novartis Pharmaceuticals Corp",
        "Watson Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AA02",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1959,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL11",
    "molecule_properties": {
      "acd_logd": 2.35,
      "acd_logp": 4.36,
      "acd_most_bpka": 9.49,
      "alogp": 3.88,
      "aromatic_rings": 2,
      "full_molformula": "C19H24N2",
      "full_mwt": 280.42,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 280.42,
      "mw_monoisotopic": 280.1939,
      "psa": 6.48,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCCN1c2ccccc2CCc3ccccc13",
      "standard_inchi": "InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3",
      "standard_inchi_key": "BCGWQEUPMDMJNV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Imipramine HCl (FDA, JAN, USP)",
        "Imipramine (BAN, INN)",
        "Imipramine Pamoate (FDA)",
        null
      ]
    },
    "usan_stem": "-pramine",
    "usan_stem_definition": "antidepressants (imipramine type)",
    "usan_stem_substem": "-pramine(-pramine)"
  },
  {
    "applicants": {
      "value": [
        "Amerigen Pharmaceuticals Ltd",
        "Actavis Elizabeth Llc",
        "Sanofi Aventis Us Llc",
        "Sandoz Inc",
        "Watson Laboratories Inc",
        "Ani Pharmaceuticals Inc",
        "Mylan Pharmaceuticals Inc",
        "Teva Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C03BA11",
        "description": "CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, EXCL. THIAZIDES: Sulfonamides, plain"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1983,
    "indication_class": "Antihypertensive; Diuretic",
    "molecule_chembl_id": "CHEMBL406",
    "molecule_properties": {
      "acd_logd": 1.96,
      "acd_logp": 1.96,
      "acd_most_apka": 9.35,
      "acd_most_bpka": 1.87,
      "alogp": 2.08,
      "aromatic_rings": 2,
      "full_molformula": "C16H16ClN3O3S",
      "full_mwt": 365.84,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 365.84,
      "mw_monoisotopic": 365.0601,
      "psa": 92.5,
      "qed_weighted": 0.87,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC1Cc2ccccc2N1NC(=O)c3ccc(Cl)c(c3)S(=O)(=O)N",
      "standard_inchi": "InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)",
      "standard_inchi_key": "NDDAHWYSQHTHNT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Indapamide (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-pamide",
    "usan_stem_definition": "diuretics (sulfamoylbenzoic acid derivatives)",
    "usan_stem_substem": "-pamide(-pamide)",
    "usan_year": 1979
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Hoffmann La Roche Inc",
        "Teva Pharmaceuticals Usa",
        "Sandoz Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Sagent Pharmaceuticals Inc",
        "Baxter Healthcare Corp",
        "Hikma Farmaceutica (Portugal) Sa",
        "Mylan Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "V03AB25",
        "description": "VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1991,
    "indication_class": "Antagonist (to benzodiazepine)",
    "molecule_chembl_id": "CHEMBL407",
    "molecule_properties": {
      "acd_logd": 2.15,
      "acd_logp": 2.15,
      "acd_most_bpka": 0.86,
      "alogp": 1.77,
      "aromatic_rings": 2,
      "full_molformula": "C15H14FN3O3",
      "full_mwt": 303.29,
      "hba": 5,
      "hba_lipinski": 6,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 303.29,
      "mw_monoisotopic": 303.1019,
      "psa": 64.43,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)c1ncn2c1CN(C)C(=O)c3cc(F)ccc23",
      "standard_inchi": "InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3",
      "standard_inchi_key": "OFBIFZUFASYYRE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "Ro-151788",
        "Ro-151788000"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Flumazenil (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-azenil",
    "usan_stem_definition": "benzodiazepine receptor (agonists/antagonists)",
    "usan_stem_substem": "-azenil(-azenil)",
    "usan_year": 1987
  },
  {
    "applicants": {
      "value": [
        "Sankyo Usa Corp",
        "Pfizer Pharmaceuticals Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A10BG01",
        "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Thiazolidinediones"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1997,
    "indication_class": "Antidiabetic",
    "molecule_chembl_id": "CHEMBL408",
    "molecule_properties": {
      "acd_logd": 3.65,
      "acd_logp": 4.69,
      "acd_most_apka": 6.34,
      "alogp": 4.37,
      "aromatic_rings": 2,
      "full_molformula": "C24H27NO5S",
      "full_mwt": 441.55,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 31,
      "molecular_species": "ACID",
      "mw_freebase": 441.55,
      "mw_monoisotopic": 441.161,
      "psa": 84.86,
      "qed_weighted": 0.72,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1c(C)c2OC(C)(COc3ccc(CC4SC(=O)NC4=O)cc3)CCc2c(C)c1O",
      "standard_inchi": "InChI=1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H,25,27,28)",
      "standard_inchi_key": "GXPHKUHSUJUWKP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5859037,
    "oral": true,
    "research_codes": {
      "value": [
        "CS-045",
        "CI-991",
        "Gr92132X",
        "GR-92132X"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5859037-A",
    "synonyms": {
      "value": [
        "Troglitazone (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-glitazone",
    "usan_stem_definition": "PPST agonists (thiazolidene derivatives)",
    "usan_stem_substem": "-glitazone(-glitazone)",
    "usan_year": 1995,
    "withdrawn_class": "Hepatotoxicity",
    "withdrawn_country": "United States",
    "withdrawn_reason": "Hepatotoxicity",
    "withdrawn_year": 1997
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Roxane Laboratories Inc",
        "Apotex Inc",
        "Sandoz Inc",
        "Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Astrazeneca Pharmaceuticals Lp",
        "Sun Pharma Global Inc",
        "Teva Pharmaceuticals Usa Inc",
        "Santos Biotech Industries Inc",
        "Zydus Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L02BB03",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Anti-androgens"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1995,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL409",
    "molecule_properties": {
      "acd_logd": 4.13,
      "acd_logp": 4.13,
      "acd_most_apka": 11.49,
      "alogp": 2.88,
      "aromatic_rings": 2,
      "full_molformula": "C18H14F4N2O4S",
      "full_mwt": 430.38,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 29,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 430.38,
      "mw_monoisotopic": 430.061,
      "psa": 107.26,
      "qed_weighted": 0.56,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC(O)(CS(=O)(=O)c1ccc(F)cc1)C(=O)Nc2ccc(C#N)c(c2)C(F)(F)F",
      "standard_inchi": "InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)",
      "standard_inchi_key": "LKJPYSCBVHEWIU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "ICI-176334"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Bicalutamide (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-lutamide",
    "usan_stem_definition": "non-steroid antiandrogens",
    "usan_stem_substem": "-lutamide(-lutamide)",
    "usan_year": 1994
  },
  {
    "applicants": {
      "value": [
        "Marsam Pharmaceuticals Llc",
        "Valeant Pharmaceuticals North America Llc",
        "Lannett Holdings Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Dava Pharmaceuticals Inc",
        "Halsey Drug Co Inc",
        "Hospira Inc",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Mayne Pharma Llc",
        "Ferndale Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05BA01",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1963,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL12",
    "molecule_properties": {
      "acd_logd": 2.8,
      "acd_logp": 2.8,
      "acd_most_bpka": 3.4,
      "alogp": 3.15,
      "aromatic_rings": 2,
      "full_molformula": "C16H13ClN2O",
      "full_mwt": 284.75,
      "hba": 2,
      "hba_lipinski": 3,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 284.75,
      "mw_monoisotopic": 284.0716,
      "psa": 32.67,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13",
      "standard_inchi": "InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",
      "standard_inchi_key": "AAOVKJBEBIDNHE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "LA-III",
        "WY-3467",
        "Ro-52807"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Diazepam (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-azepam",
    "usan_stem_definition": "antianxiety agents (diazepam type)",
    "usan_stem_substem": "-azepam(-azepam)",
    "usan_year": 1963
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 7,
    "indication_class": "Anti-Ulcerative",
    "molecule_chembl_id": "CHEMBL266979",
    "molecule_properties": {
      "acd_logd": 3.29,
      "acd_logp": 3.29,
      "acd_most_apka": 13.89,
      "alogp": 3.73,
      "full_molformula": "C22H36O5",
      "full_mwt": 380.53,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 380.53,
      "mw_monoisotopic": 380.2563,
      "psa": 83.83,
      "qed_weighted": 0.4,
      "ro3_pass": "N",
      "rtb": 12
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCC(C)(O)C\\C=C\\[C@H]1[C@H](O)CC(=O)[C@@H]1CC\\C=C/CCC(=O)OC",
      "standard_inchi": "InChI=1S/C22H36O5/c1-4-5-14-22(2,26)15-10-12-18-17(19(23)16-20(18)24)11-8-6-7-9-13-21(25)27-3/h6-7,10,12,17-18,20,24,26H,4-5,8-9,11,13-16H2,1-3H3/b7-6-,12-10+/t17-,18-,20-,22?/m1/s1",
      "standard_inchi_key": "CIBHDGPIOICRGX-ZQCHCGQNSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SC-34301"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Enisoprost (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-prost",
    "usan_stem_definition": "prostaglandins",
    "usan_stem_substem": "-prost(-prost)",
    "usan_year": 1983
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Rubicon Research Pvt Ltd",
        "West-Ward Pharmaceuticals International Ltd",
        "Hospira Inc",
        "Concordia Pharmaceuticals Inc",
        "Aurobindo Pharma Ltd",
        "Ipca Laboratories Ltd",
        "Teva Pharmaceuticals Usa",
        "Sun Pharmaceutical Industries Inc",
        "Apothecon Inc Div Bristol Myers Squibb"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C07AB02",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1978,
    "indication_class": "Anti-Adrenergic (beta-receptor),Antihypertensive,Antihypertensive; Anti-Anginal",
    "molecule_chembl_id": "CHEMBL13",
    "molecule_properties": {
      "acd_logd": -0.47,
      "acd_logp": 1.63,
      "acd_most_apka": 13.89,
      "acd_most_bpka": 9.43,
      "alogp": 1.61,
      "aromatic_rings": 1,
      "full_molformula": "C15H25NO3",
      "full_mwt": 267.37,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 267.37,
      "mw_monoisotopic": 267.1834,
      "psa": 50.72,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "COCCc1ccc(OCC(O)CNC(C)C)cc1",
      "standard_inchi": "InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3",
      "standard_inchi_key": "IUBSYMUCCVWXPE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "H 93/26 Succinate",
        "H-93/26",
        "CGP-2175E",
        "CGP-2175C"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Metoprolol (BAN, INN, USAN)",
        "Metoprolol Tartrate (FDA, JAN, USAN, USP)",
        "Metoprolol Fumarate (FDA, USAN, USP)",
        "Metoprolol Succinate (FDA, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1976
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL6378",
    "molecule_properties": {
      "acd_logd": 1.55,
      "acd_logp": 1.56,
      "acd_most_apka": 9.37,
      "acd_most_bpka": 0.79,
      "alogp": 2.21,
      "aromatic_rings": 2,
      "full_molformula": "C16H16ClN3O3S",
      "full_mwt": 365.84,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 365.84,
      "mw_monoisotopic": 365.0601,
      "psa": 92.5,
      "qed_weighted": 0.87,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC1N(Cc2ccccc12)NC(=O)c3ccc(Cl)c(c3)S(=O)(=O)N",
      "standard_inchi": "InChI=1S/C16H16ClN3O3S/c1-10-13-5-3-2-4-12(13)9-20(10)19-16(21)11-6-7-14(17)15(8-11)24(18,22)23/h2-8,10H,9H2,1H3,(H,19,21)(H2,18,22,23)",
      "standard_inchi_key": "BHUKYXOYJMLRAK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Zidapamide (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-pamide",
    "usan_stem_definition": "diuretics (sulfamoylbenzoic acid derivatives)",
    "usan_stem_substem": "-pamide(-pamide)",
    "usan_year": 1983
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C07AA01",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Anti-Adrenergic (beta-receptor)",
    "molecule_chembl_id": "CHEMBL266195",
    "molecule_properties": {
      "acd_logd": 0.81,
      "acd_logp": 2.9,
      "acd_most_apka": 13.88,
      "acd_most_bpka": 9.43,
      "alogp": 2.15,
      "aromatic_rings": 1,
      "full_molformula": "C15H23NO2",
      "full_mwt": 249.35,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 18,
      "molecular_species": "BASE",
      "mw_freebase": 249.35,
      "mw_monoisotopic": 249.1729,
      "psa": 41.49,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)COc1ccccc1CC=C",
      "standard_inchi": "InChI=1S/C15H23NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h4-6,8-9,12,14,16-17H,1,7,10-11H2,2-3H3",
      "standard_inchi_key": "PAZJSJFMUHDSTF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "H 56/28"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Alprenolol (BAN, INN)",
        "Alprenolol HCl (JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1968
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL538393",
    "molecule_properties": {
      "acd_logd": 0.95,
      "acd_logp": 3.46,
      "acd_most_bpka": 10.04,
      "alogp": 2.76,
      "full_molformula": "C12H23N",
      "full_mwt": 181.32,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 13,
      "molecular_species": "BASE",
      "mw_freebase": 181.32,
      "mw_monoisotopic": 181.183,
      "psa": 3.24,
      "qed_weighted": 0.6,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)C1(C)C2CCC(C2)C1(C)C",
      "standard_inchi": "InChI=1S/C12H23N/c1-11(2)9-6-7-10(8-9)12(11,3)13(4)5/h9-10H,6-8H2,1-5H3",
      "standard_inchi_key": "QEYHZXNEIGHKAV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dimecamine (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 7,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL7301",
    "molecule_properties": {
      "acd_logd": 5.88,
      "acd_logp": 5.88,
      "acd_most_apka": 9.98,
      "acd_most_bpka": 1.55,
      "alogp": 6.86,
      "aromatic_rings": 1,
      "full_molformula": "C26H33NO2",
      "full_mwt": 391.56,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 29,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 391.56,
      "mw_monoisotopic": 391.2511,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 49.33,
      "qed_weighted": 0.32,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "C\\C(=C/C=C/C(=C/C(=O)Nc1ccc(O)cc1)/C)\\C=C\\C2=C(C)CCCC2(C)C",
      "standard_inchi": "InChI=1S/C26H33NO2/c1-19(11-16-24-21(3)10-7-17-26(24,4)5)8-6-9-20(2)18-25(29)27-22-12-14-23(28)15-13-22/h6,8-9,11-16,18,28H,7,10,17H2,1-5H3,(H,27,29)/b9-6+,16-11+,19-8+,20-18+",
      "standard_inchi_key": "AKJHMTWEGVYYSE-FXILSDISSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MCN-R-1967"
    },
    "synonyms": {
      "value": [
        "Fenretinide (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-retin-",
    "usan_stem_definition": "retinol derivatives",
    "usan_stem_substem": "-retin-(-retin-)",
    "usan_year": 1984
  },
  {
    "applicants": {
      "value": [
        "Eli Lilly And Co",
        "Bristol Myers Squibb",
        "Tablicaps Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "G03CC05",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Estrogens, combinations with other drug"
        },
        {
          "code": "L02AA01",
          "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONES AND RELATED AGENTS: Estrogen"
        },
        {
          "code": "G03CB02",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Synthetic estrogens, plain"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1973,
    "indication_class": "Estrogen",
    "molecule_chembl_id": "CHEMBL411",
    "molecule_properties": {
      "acd_logd": 5.33,
      "acd_logp": 5.33,
      "acd_most_apka": 10.19,
      "alogp": 4.83,
      "aromatic_rings": 2,
      "full_molformula": "C18H20O2",
      "full_mwt": 268.36,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 268.36,
      "mw_monoisotopic": 268.1463,
      "psa": 40.46,
      "qed_weighted": 0.78,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC\\C(=C(\\CC)/c1ccc(O)cc1)\\c2ccc(O)cc2",
      "standard_inchi": "InChI=1S/C18H20O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,19-20H,3-4H2,1-2H3/b18-17+",
      "standard_inchi_key": "RGLYKWWBQGJZGM-ISLYRVAYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Diethylstilbestrol (BAN, FDA, INN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-estr-",
    "usan_stem_definition": "estrogens",
    "usan_stem_substem": "-estr-(-estr-)",
    "withdrawn_country": "United States"
  },
  {
    "applicants": {
      "value": [
        "Nexgen Pharma Inc",
        "Targacept Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C02BB01",
        "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, GANGLION-BLOCKING: Secondary and tertiary amines"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1956,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL267936",
    "molecule_properties": {
      "acd_logd": -0.07,
      "acd_logp": 2.98,
      "acd_most_bpka": 11.35,
      "alogp": 2.42,
      "full_molformula": "C11H21N",
      "full_mwt": 167.3,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 12,
      "molecular_species": "BASE",
      "mw_freebase": 167.3,
      "mw_monoisotopic": 167.1674,
      "psa": 12.03,
      "qed_weighted": 0.63,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CNC1(C)C2CCC(C2)C1(C)C",
      "standard_inchi": "InChI=1S/C11H21N/c1-10(2)8-5-6-9(7-8)11(10,3)12-4/h8-9,12H,5-7H2,1-4H3",
      "standard_inchi_key": "IMYZQPCYWPFTAG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mecamylamine HCl (FDA, USP)",
        "Mecamylamine (BAN, INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Marsam Pharmaceuticals Llc",
        "Smith And Nephew Solopak Div Smith And Nephew",
        "West-Ward Pharmaceuticals International Ltd",
        "Hospira Inc",
        "Acella Pharmaceuticals Llc",
        "Aurobindo Pharma Ltd",
        "Taro Pharmaceutical Industries Ltd",
        "Pharmeral Inc",
        "Solopak Medical Products Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N03AB02",
          "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Hydantoin derivative"
        },
        {
          "code": "N03AB52",
          "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Hydantoin derivatives"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1953,
    "indication_class": "Anticonvulsant",
    "molecule_chembl_id": "CHEMBL16",
    "molecule_properties": {
      "acd_logd": -0.71,
      "acd_logp": 1.74,
      "acd_most_apka": 1.84,
      "acd_most_bpka": 10.79,
      "alogp": 1.97,
      "aromatic_rings": 2,
      "full_molformula": "C15H12N2O2",
      "full_mwt": 252.27,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 252.27,
      "mw_monoisotopic": 252.0899,
      "psa": 61.69,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "OC1=NC(=O)C(N1)(c2ccccc2)c3ccccc3",
      "standard_inchi": "InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)",
      "standard_inchi_key": "CXOFVDLJLONNDW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Phenytoin (BAN, FDA, INN, JAN, USAN, USP)",
        "Phenytoin Sodium (FDA, JAN, USP)",
        null
      ]
    },
    "usan_stem": "-toin",
    "usan_stem_definition": "antiepileptics (hydantoin derivatives)",
    "usan_stem_substem": "-toin(-toin)",
    "usan_year": 1975
  },
  {
    "applicants": {
      "value": [
        "Zydus Pharmaceuticals Usa Inc",
        "Dr Reddys Laboratories Ltd",
        "Pf Prism Cv"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "L04AA10",
          "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Selective immunosuppressant"
        },
        {
          "code": "S01XA23",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1999,
    "indication_class": "Immunosuppressant",
    "molecule_chembl_id": "CHEMBL413",
    "molecule_properties": {
      "acd_logd": 4.26,
      "acd_logp": 4.26,
      "acd_most_apka": 10.4,
      "alogp": 6.18,
      "full_molformula": "C51H79NO13",
      "full_mwt": 914.19,
      "hba": 13,
      "hba_lipinski": 14,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 65,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 914.19,
      "mw_monoisotopic": 913.5551,
      "num_lipinski_ro5_violations": 3,
      "num_ro5_violations": 3,
      "psa": 195.43,
      "qed_weighted": 0.16,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\\C=C(/C)\\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\\C=C\\C=C\\C=C(/C)\\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1O",
      "standard_inchi": "InChI=1S/C51H79NO13/c1-30-16-12-11-13-17-31(2)42(61-8)28-38-21-19-36(7)51(60,65-38)48(57)49(58)52-23-15-14-18-39(52)50(59)64-43(33(4)26-37-20-22-40(53)44(27-37)62-9)29-41(54)32(3)25-35(6)46(56)47(63-10)45(55)34(5)24-30/h11-13,16-17,25,30,32-34,36-40,42-44,46-47,53,56,60H,14-15,18-24,26-29H2,1-10H3/b13-11+,16-12+,31-17+,35-25+/t30-,32-,33-,34-,36-,37+,38+,39+,40-,42+,43+,44-,46-,47+,51-/m1/s1",
      "standard_inchi_key": "QFJCIRLUMZQUOT-HPLJOQBZSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5989591,
    "oral": true,
    "research_codes": {
      "value": [
        "AY-22989",
        "WY-090217"
      ]
    },
    "sc_patent": "US-5989591-A",
    "synonyms": {
      "value": [
        "Sirolimus (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-imus",
    "usan_stem_definition": "immunosuppressives: immunosuppressant, rapamycin derivatives",
    "usan_stem_substem": "-imus(-imus(-rolimus))",
    "usan_year": 1993
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Veloxis Pharmaceuticals Inc",
        "Astellas Pharma Us Inc",
        "Sandoz Inc",
        "Watson Laboratories Inc",
        "Leo Pharma As",
        "Belcher Pharmaceuticals Llc",
        "Dr Reddys Laboratories Ltd",
        "Hospira Inc",
        "Fougera Pharmaceuticals Inc"
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1994,
    "indication_class": "Immunosuppressant",
    "molecule_chembl_id": "CHEMBL269732",
    "molecule_properties": {
      "acd_logd": 4.78,
      "acd_logp": 4.79,
      "acd_most_apka": 9.96,
      "alogp": 4.64,
      "full_molformula": "C44H69NO12",
      "full_mwt": 804.03,
      "hba": 12,
      "hba_lipinski": 13,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 57,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 804.03,
      "mw_monoisotopic": 803.482,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 178.36,
      "qed_weighted": 0.18,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CO[C@@H]1C[C@@H](CC[C@H]1O)\\C=C(/C)\\[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@H]([C@H](C[C@@H](C)C\\C(=C\\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)\\C)OC)[C@H](C[C@H]4C)OC",
      "standard_inchi": "InChI=1S/C44H69NO12/c1-10-13-31-19-25(2)18-26(3)20-37(54-8)40-38(55-9)22-28(5)44(52,57-40)41(49)42(50)45-17-12-11-14-32(45)43(51)56-39(29(6)34(47)24-35(31)48)27(4)21-30-15-16-33(46)36(23-30)53-7/h10,19,21,26,28-34,36-40,46-47,52H,1,11-18,20,22-24H2,2-9H3/b25-19+,27-21+/t26-,28+,29+,30-,31+,32-,33+,34-,36+,37-,38-,39+,40+,44+/m0/s1",
      "standard_inchi_key": "QJJXYPPXXYFBGM-LFZNUXCKSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6440458,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "FK-506",
        "FR-900506"
      ]
    },
    "sc_patent": "US-6440458-B1",
    "synonyms": {
      "value": [
        "Tacrolimus (BAN, FDA, INN, USAN)",
        "Tacrolimus Hydrate (JAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-imus",
    "usan_stem_definition": "immunosuppressives: immunosuppressant, rapamycin derivatives",
    "usan_stem_substem": "-imus(-imus(-rolimus))",
    "usan_year": 1992
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL414",
    "molecule_properties": {
      "acd_logd": -2.56,
      "acd_logp": 0.5,
      "acd_most_apka": 3.6,
      "alogp": 0.03,
      "aromatic_rings": 1,
      "full_molformula": "C7H7NO4S",
      "full_mwt": 201.2,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 13,
      "molecular_species": "ACID",
      "mw_freebase": 201.2,
      "mw_monoisotopic": 201.0096,
      "psa": 97.46,
      "qed_weighted": 0.7,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NS(=O)(=O)c1ccc(cc1)C(=O)O",
      "standard_inchi": "InChI=1S/C7H7NO4S/c8-13(11,12)6-3-1-5(2-4-6)7(9)10/h1-4H,(H,9,10)(H2,8,11,12)",
      "standard_inchi_key": "UCAGLBKTLXCODC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Carzenide (INN, MI)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Mallinckrodt Llc",
        "Sandoz Inc",
        "Watson Laboratories Inc",
        "Mylan Pharmaceuticals Inc",
        "Teva Pharmaceuticals Usa Inc",
        "Taro Pharmaceutical Industries Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AA04",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1989,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL415",
    "molecule_properties": {
      "acd_logd": 2.95,
      "acd_logp": 4.94,
      "acd_most_bpka": 9.46,
      "alogp": 4.53,
      "aromatic_rings": 2,
      "full_molformula": "C19H23ClN2",
      "full_mwt": 314.86,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 314.86,
      "mw_monoisotopic": 314.155,
      "psa": 6.48,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13",
      "standard_inchi": "InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",
      "standard_inchi_key": "GDLIGKIOYRNHDA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "G-34586"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clomipramine HCl (FDA, JAN, USAN, USP)",
        "Clomipramine (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-pramine",
    "usan_stem_definition": "antidepressants (imipramine type)",
    "usan_stem_substem": "-pramine(-pramine)",
    "usan_year": 1970
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N06BA06",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL7010",
    "molecule_properties": {
      "acd_logd": 0.76,
      "acd_logp": 3.75,
      "acd_most_bpka": 11.01,
      "alogp": 3.18,
      "aromatic_rings": 1,
      "full_molformula": "C15H21N",
      "full_mwt": 215.34,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "BASE",
      "mw_freebase": 215.34,
      "mw_monoisotopic": 215.1674,
      "psa": 12.03,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCNC1C2CCC(C2)C1c3ccccc3",
      "standard_inchi": "InChI=1S/C15H21N/c1-2-16-15-13-9-8-12(10-13)14(15)11-6-4-3-5-7-11/h3-7,12-16H,2,8-10H2,1H3",
      "standard_inchi_key": "IKFBPFGUINLYQI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fencamfamin (BAN, INN)",
        "Fencamfamin HCl (MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL7303",
    "molecule_properties": {
      "acd_logd": -0.78,
      "acd_logp": -0.2,
      "acd_most_bpka": 7.84,
      "alogp": 0.42,
      "full_molformula": "C8H13NO2",
      "full_mwt": 155.2,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 11,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 155.2,
      "mw_monoisotopic": 155.0946,
      "psa": 29.54,
      "qed_weighted": 0.51,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "COC(=O)C1=CCCN(C)C1",
      "standard_inchi": "InChI=1S/C8H13NO2/c1-9-5-3-4-7(6-9)8(10)11-2/h4H,3,5-6H2,1-2H3",
      "standard_inchi_key": "HJJPJSXJAXAIPN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Arecoline Hydrobromide (MI, NF)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Mallinckrodt Hospital Products Ip Ltd",
        "Actavis Inc",
        "Dow Pharmaceutical Sciences",
        "Idt Australia Ltd",
        "Valeant Pharmaceuticals International",
        "Strides Pharma Global Pte Ltd"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D05AD02",
          "description": "DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR TOPICAL USE: Psoralens for topical us"
        },
        {
          "code": "D05BA02",
          "description": "DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR SYSTEMIC USE: Psoralens for systemic use"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1954,
    "indication_class": "Pigmentation Agent",
    "molecule_chembl_id": "CHEMBL416",
    "molecule_properties": {
      "acd_logd": 1.52,
      "acd_logp": 1.52,
      "alogp": 2.55,
      "aromatic_rings": 3,
      "full_molformula": "C12H8O4",
      "full_mwt": 216.19,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 16,
      "mw_freebase": 216.19,
      "mw_monoisotopic": 216.0423,
      "psa": 52.58,
      "qed_weighted": 0.59,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "COc1c2OC(=O)C=Cc2cc3ccoc13",
      "standard_inchi": "InChI=1S/C12H8O4/c1-14-12-10-8(4-5-15-10)6-7-2-3-9(13)16-11(7)12/h2-6H,1H3",
      "standard_inchi_key": "QXKHYNVANLEOEG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Methoxsalen (BAN, FDA, JAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-sal-",
    "usan_stem_definition": "anti-inflammatory agents (salicylic acid derivatives)",
    "usan_stem_substem": "-sal-(-sal-)"
  },
  {
    "applicants": {
      "value": "Strongbridge Us Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "S01EC02",
        "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1958,
    "indication_class": "Carbonic Anhydrase Inhibitor",
    "molecule_chembl_id": "CHEMBL17",
    "molecule_properties": {
      "acd_logd": 0.32,
      "acd_logp": 0.34,
      "acd_most_apka": 8.95,
      "alogp": 0.29,
      "aromatic_rings": 1,
      "full_molformula": "C6H6Cl2N2O4S2",
      "full_mwt": 305.16,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 305.16,
      "mw_monoisotopic": 303.9146,
      "psa": 120.32,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NS(=O)(=O)c1cc(Cl)c(Cl)c(c1)S(=O)(=O)N",
      "standard_inchi": "InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14)",
      "standard_inchi_key": "GJQPMPFPNINLKP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dichlorphenamide (FDA, USP)",
        "Diclofenamide (BAN, DCF, INN, JAN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL6607",
    "molecule_properties": {
      "acd_logd": 0.63,
      "acd_logp": 2.61,
      "acd_most_bpka": 9.41,
      "alogp": 2.36,
      "aromatic_rings": 1,
      "full_molformula": "C11H16BrNO2",
      "full_mwt": 274.16,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 15,
      "molecular_species": "BASE",
      "mw_freebase": 274.16,
      "mw_monoisotopic": 273.0364,
      "psa": 44.48,
      "qed_weighted": 0.92,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(CC(C)N)c(OC)cc1Br",
      "standard_inchi": "InChI=1S/C11H16BrNO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3",
      "standard_inchi_key": "FXMWUTGUCAKGQL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Brolamfetamine (INN)",
        null
      ]
    },
    "usan_stem": "-fetamin(e)",
    "usan_stem_definition": "amfetamine derivatives",
    "usan_stem_substem": "-fetamin(e)(-fetamin(e))"
  },
  {
    "applicants": {
      "value": [
        "Pharmacia And Upjohn Co",
        "Allergan Pharmaceutical"
      ]
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "molecule_chembl_id": "CHEMBL18",
    "molecule_properties": {
      "acd_logd": 2.12,
      "acd_logp": 2.14,
      "acd_most_apka": 8.41,
      "alogp": 1.34,
      "aromatic_rings": 2,
      "full_molformula": "C9H10N2O3S2",
      "full_mwt": 258.32,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 258.32,
      "mw_monoisotopic": 258.0133,
      "psa": 82.28,
      "qed_weighted": 0.9,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCOc1ccc2nc(sc2c1)S(=O)(=O)N",
      "standard_inchi": "InChI=1S/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13)",
      "standard_inchi_key": "OUZWUKMCLIBBOG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ethoxzolamide (FDA, MI, USP)",
        null
      ]
    },
    "usan_stem": "-zolamide",
    "usan_stem_definition": "carbonic anhydrase inhibitors",
    "usan_stem_substem": "-zolamide(-zolamide)"
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Fresenius Kabi Usa Llc",
        "Pfizer Inc",
        "Actavis Totowa Llc",
        "Ebewe Pharma Ges Mbh Nfg Kg",
        "West-Ward Pharmaceuticals International Ltd",
        "Hospira Inc",
        "Impax Laboratories Inc",
        "Mylan Institutional Llc",
        "Mylan Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01DB03",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1999,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL417",
    "molecule_properties": {
      "acd_logd": -1.47,
      "acd_logp": 0.24,
      "acd_most_apka": 7.35,
      "acd_most_bpka": 8.68,
      "alogp": 0,
      "aromatic_rings": 2,
      "full_molformula": "C27H29NO11",
      "full_mwt": 543.53,
      "hba": 12,
      "hba_lipinski": 12,
      "hbd": 6,
      "hbd_lipinski": 7,
      "heavy_atoms": 39,
      "molecular_species": "BASE",
      "mw_freebase": 543.53,
      "mw_monoisotopic": 543.1741,
      "num_lipinski_ro5_violations": 3,
      "num_ro5_violations": 3,
      "psa": 206.07,
      "qed_weighted": 0.24,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO",
      "standard_inchi": "InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22-,27-/m0/s1",
      "standard_inchi_key": "AOJJSUZBOXZQNB-VTZDEGQISA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "IMI-28"
    },
    "synonyms": {
      "value": [
        "Epirubicin HCl (FDA, JAN, USAN)",
        "Epirubicin (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-rubicin",
    "usan_stem_definition": "antineoplastic antibiotics (daunorubicin type)",
    "usan_stem_substem": "-rubicin(-rubicin)",
    "usan_year": 1984
  },
  {
    "applicants": {
      "value": [
        "Sandoz Inc",
        "Ani Pharmaceuticals Inc",
        "Mikart Inc",
        "Lederle Laboratories Div American Cyanamid Co",
        "Applied Analytical Industries"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "S01EC05",
        "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1959,
    "indication_class": "Carbonic Anhydrase Inhibitor",
    "molecule_chembl_id": "CHEMBL19",
    "molecule_properties": {
      "acd_logd": -0.21,
      "acd_logp": 0.13,
      "acd_most_apka": 7.31,
      "alogp": -1.42,
      "aromatic_rings": 1,
      "full_molformula": "C5H8N4O3S2",
      "full_mwt": 236.28,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 236.28,
      "mw_monoisotopic": 236.0038,
      "psa": 107.41,
      "qed_weighted": 0.64,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1N=C(S/C/1=N/C(=O)C)S(=O)(=O)N",
      "standard_inchi": "InChI=1S/C5H8N4O3S2/c1-3(10)7-4-9(2)8-5(13-4)14(6,11)12/h1-2H3,(H2,6,11,12)/b7-4+",
      "standard_inchi_key": "FLOSMHQXBMRNHR-QPJJXVBHSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Methazolamide (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "usan_stem": "-zolamide",
    "usan_stem_definition": "carbonic anhydrase inhibitors",
    "usan_stem_substem": "-zolamide(-zolamide)"
  },
  {
    "applicants": {
      "value": [
        "Sagent Agila Llc",
        "Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc",
        "Novast Laboratories Ltd",
        "West-Ward Pharmaceuticals International Ltd",
        "X Gen Pharmaceuticals Inc",
        "Hospira Inc",
        "Strides Pharma Global Pte Ltd",
        "Vangard Laboratories Inc Div Midway Medical Co",
        "Taro Pharmaceutical Industries Ltd",
        "Sun Pharmaceutical Industries Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "S01EC01",
        "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Carbonic anhydrase inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1953,
    "indication_class": "Carbonic Anhydrase Inhibitor",
    "molecule_chembl_id": "CHEMBL20",
    "molecule_properties": {
      "acd_logd": -0.69,
      "acd_logp": -0.26,
      "acd_most_apka": 7.44,
      "alogp": -0.86,
      "aromatic_rings": 1,
      "full_molformula": "C4H6N4O3S2",
      "full_mwt": 222.25,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 13,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 222.25,
      "mw_monoisotopic": 221.9881,
      "psa": 115.04,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)Nc1nnc(s1)S(=O)(=O)N",
      "standard_inchi": "InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)",
      "standard_inchi_key": "BZKPWHYZMXOIDC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Acetazolamide Sodium (FDA, JAN)",
        "Acetazolamide (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "usan_stem": "-zolamide",
    "usan_stem_definition": "carbonic anhydrase inhibitors",
    "usan_stem_substem": "-zolamide(-zolamide)"
  },
  {
    "applicants": {
      "value": [
        "Mylan Institutional Inc",
        "Novast Laboratories Ltd",
        "Par Formulations Private Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "D06BA03",
        "description": "DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Sulfonamides"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1969,
    "indication_class": "Anti-Infective, Topical,Antibacterial",
    "molecule_chembl_id": "CHEMBL419",
    "molecule_properties": {
      "acd_logd": -1.52,
      "acd_logp": -0.38,
      "acd_most_apka": 10.16,
      "acd_most_bpka": 8.52,
      "alogp": -0.21,
      "aromatic_rings": 1,
      "full_molformula": "C7H10N2O2S",
      "full_mwt": 186.24,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 12,
      "molecular_species": "BASE",
      "mw_freebase": 186.24,
      "mw_monoisotopic": 186.0463,
      "psa": 86.18,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NCc1ccc(cc1)S(=O)(=O)N",
      "standard_inchi": "InChI=1S/C7H10N2O2S/c8-5-6-1-3-7(4-2-6)12(9,10)11/h1-4H,5,8H2,(H2,9,10,11)",
      "standard_inchi_key": "TYMRLRRVMHJFTF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mafenide HCl (MI)",
        "Mafenide Acetate (FDA, JAN, USP)",
        "Mafenide (BAN, INN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1967
  },
  {
    "applicants": {
      "value": [
        "G And W Laboratories Inc",
        "Mylan Specialty Lp"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "J01EB06",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Short-acting sulfonamide"
        },
        {
          "code": "D06BA05",
          "description": "DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Sulfonamides"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1985,
    "molecule_chembl_id": "CHEMBL21",
    "molecule_properties": {
      "acd_logd": -0.67,
      "acd_logp": -0.67,
      "acd_most_apka": 10.1,
      "acd_most_bpka": 1.85,
      "alogp": -0.08,
      "aromatic_rings": 1,
      "full_molformula": "C6H8N2O2S",
      "full_mwt": 172.21,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 11,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 172.21,
      "mw_monoisotopic": 172.0306,
      "psa": 86.18,
      "qed_weighted": 0.58,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ccc(cc1)S(=O)(=O)N",
      "standard_inchi": "InChI=1S/C6H8N2O2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,7H2,(H2,8,9,10)",
      "standard_inchi_key": "FDDDEECHVMSUSB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulfanilamide (DCF, FDA, INN, MI, NF)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "sulfa-",
    "usan_stem_definition": "antimicrobials (sulfonamides derivatives)",
    "usan_stem_substem": "sulfa-(sulfa-)"
  },
  {
    "applicants": {
      "value": [
        "Watson Laboratories Inc",
        "Ani Pharmaceuticals Inc",
        "Wyeth Ayerst Laboratories",
        "Sandoz Inc"
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL420",
    "molecule_properties": {
      "acd_logd": 1.85,
      "acd_logp": 2.66,
      "acd_most_bpka": 8.17,
      "alogp": 1.81,
      "aromatic_rings": 1,
      "full_molformula": "C8H8Cl2N4",
      "full_mwt": 231.09,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 231.09,
      "mw_monoisotopic": 230.0126,
      "psa": 74.26,
      "qed_weighted": 0.41,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=N)N\\N=C\\c1c(Cl)cccc1Cl",
      "standard_inchi": "InChI=1S/C8H8Cl2N4/c9-6-2-1-3-7(10)5(6)4-13-14-8(11)12/h1-4H,(H4,11,12,14)/b13-4+",
      "standard_inchi_key": "WDZVGELJXXEGPV-YIXHJXPBSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "WY-8678",
        "WY-8678 Acetate"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Guanabenz Acetate (FDA, JAN, USAN, USP)",
        "Guanabenz (INN, USAN)",
        null
      ]
    },
    "usan_stem": "guan-",
    "usan_stem_definition": "antihypertensives (guanidine derivatives)",
    "usan_stem_substem": "guan-(guan-)",
    "usan_year": 1971
  },
  {
    "applicants": {
      "value": [
        "Chartwell Molecules Llc",
        "Naska Pharmacal Co Inc Div Rugby Darby Group Cosmetics",
        "West-Ward Pharmaceuticals International Ltd",
        "Hospira Inc",
        "Pliva Inc",
        "Aurobindo Pharma Ltd",
        "Allegis Holdings Llc",
        "Mayne Pharma Llc",
        "Bedford Laboratories Div Ben Venue Laboratories Inc",
        "Bausch And Lomb Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01EA01",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Trimethoprim and derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1973,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL22",
    "molecule_properties": {
      "acd_logd": 0.47,
      "acd_logp": 0.59,
      "acd_most_bpka": 6.9,
      "alogp": 1.26,
      "aromatic_rings": 2,
      "full_molformula": "C14H18N4O3",
      "full_mwt": 290.32,
      "hba": 7,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 290.32,
      "mw_monoisotopic": 290.1379,
      "psa": 105.51,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC",
      "standard_inchi": "InChI=1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18)",
      "standard_inchi_key": "IEDVJHCEMCRBQM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5763449,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "BW-5672",
        "TCMDC-125538",
        "BW-72U",
        "BW-56-72"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5763449-A",
    "synonyms": {
      "value": [
        "Trimethoprim HCl (FDA)",
        "Trimethoprim (BAN, FDA, INN, JAN, USAN, USP)",
        "Trimethoprim Sulfate (FDA, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-prim",
    "usan_stem_definition": "antibacterials (trimethoprim type)",
    "usan_stem_substem": "-prim(-prim)",
    "usan_year": 1964
  },
  {
    "applicants": {
      "value": [
        "Cadila Pharmaceuticals Ltd",
        "Marsam Pharmaceuticals Llc",
        "Smith And Nephew Solopak Div Smith And Nephew",
        "Exela Pharma Sciences Llc",
        "International Medication System",
        "Gd Searle Llc",
        "Hospira Inc",
        "Pliva Inc",
        "Par Pharmaceutical Inc",
        "Bedford Laboratories Div Ben Venue Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "C08DA01",
          "description": "CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS: Phenylalkylamine derivative"
        },
        {
          "code": "C08DA51",
          "description": "CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS: Phenylalkylamine derivatives"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1981,
    "indication_class": "Anti-Anginal; Cardiac Depressant (anti-arrhythmic),Vasodilator (coronary)",
    "molecule_chembl_id": "CHEMBL6966",
    "molecule_properties": {
      "acd_logd": 2.46,
      "acd_logp": 4.02,
      "acd_most_bpka": 8.97,
      "alogp": 5.09,
      "aromatic_rings": 2,
      "full_molformula": "C27H38N2O4",
      "full_mwt": 454.61,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 33,
      "molecular_species": "BASE",
      "mw_freebase": 454.61,
      "mw_monoisotopic": 454.2832,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 63.95,
      "qed_weighted": 0.42,
      "ro3_pass": "N",
      "rtb": 13
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC",
      "standard_inchi": "InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3",
      "standard_inchi_key": "SGTNSNPWRIOYBX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6096339,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "CP-16533-1",
        "CP-165331",
        "D-365"
      ]
    },
    "sc_patent": "US-6096339-A",
    "synonyms": {
      "value": [
        "Verapamil HCl (FDA, JAN, USAN, USP)",
        "Verapamil (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-pamil",
    "usan_stem_definition": "coronary vasodilators (verapamil type)",
    "usan_stem_substem": "-pamil(-pamil)",
    "usan_year": 1968
  },
  {
    "applicants": {
      "value": [
        "Solvay Pharmaceuticals",
        "Sun Pharmaceutical Industries Inc",
        "Sandoz Inc",
        "Superpharm Corp",
        "Watson Laboratories Inc",
        "Pharmacia And Upjohn Co",
        "Heritage Pharmaceuticals Inc",
        "Vintage Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A07EC01",
        "description": "ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1950,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL421",
    "molecule_properties": {
      "acd_logd": -0.1,
      "acd_logp": 3.05,
      "acd_most_apka": 2.88,
      "acd_most_bpka": 0.75,
      "alogp": 3.7,
      "aromatic_rings": 3,
      "full_molformula": "C18H14N4O5S",
      "full_mwt": 398.4,
      "hba": 7,
      "hba_lipinski": 9,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 28,
      "molecular_species": "ACID",
      "mw_freebase": 398.4,
      "mw_monoisotopic": 398.0685,
      "psa": 141.31,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)c1cc(ccc1O)N=Nc2ccc(cc2)S(=O)(=O)Nc3ccccn3",
      "standard_inchi": "InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+",
      "standard_inchi_key": "NCEXYHBECQHGNR-QZQOTICOSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "prodrug": true,
    "research_codes": {
      "value": "SAS-500"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Salazosulfapyridine (JAN)",
        "Sulfasalazine (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-sal-; sulfa-",
    "usan_stem_definition": "anti-inflammatory agents (salicylic acid derivatives); antimicrobials (sulfonamides derivatives)",
    "usan_stem_substem": "-sal-(-sal-); sulfa-(sulfa-)",
    "usan_year": 1975
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL6466",
    "molecule_properties": {
      "acd_logd": 1.39,
      "acd_logp": 1.39,
      "alogp": 1.79,
      "aromatic_rings": 2,
      "full_molformula": "C9H6O2",
      "full_mwt": 146.14,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 11,
      "mw_freebase": 146.14,
      "mw_monoisotopic": 146.0368,
      "psa": 30.21,
      "qed_weighted": 0.53,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1Oc2ccccc2C=C1",
      "standard_inchi": "InChI=1S/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6H",
      "standard_inchi_key": "ZYGHJZDHTFUPRJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Coumarin (MI, NF)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Valeant Pharmaceuticals North America Llc",
        "Chartwell Molecules Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Biovail Laboratories International Srl",
        "Allergan Sales Llc",
        "Hospira Inc",
        "Merck And Co Inc",
        "Par Pharmaceutical Inc",
        "Akorn Inc",
        "Teva Pharmaceuticals Usa"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "C08DB01",
          "description": "CARDIOVASCULAR SYSTEM: CALCIUM CHANNEL BLOCKERS: SELECTIVE CALCIUM CHANNEL BLOCKERS WITH DIRECT CARDIAC EFFECTS: Benzothiazepine derivative"
        },
        {
          "code": "C05AE03",
          "description": "CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Muscle relaxants"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Antihypertensive,Vasodilator (coronary)",
    "molecule_chembl_id": "CHEMBL23",
    "molecule_properties": {
      "acd_logd": 3.36,
      "acd_logp": 4.73,
      "acd_most_bpka": 8.94,
      "alogp": 3.37,
      "aromatic_rings": 2,
      "full_molformula": "C22H26N2O4S",
      "full_mwt": 414.53,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 29,
      "molecular_species": "BASE",
      "mw_freebase": 414.53,
      "mw_monoisotopic": 414.1613,
      "psa": 59.08,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(cc1)[C@@H]2Sc3ccccc3N(CCN(C)C)C(=O)[C@@H]2OC(=O)C",
      "standard_inchi": "InChI=1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/t20-,21+/m1/s1",
      "standard_inchi_key": "HSUGRBWQSSZJOP-RTWAWAEBSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6923984,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "RG-83606",
        "MK-793"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6923984-B1",
    "synonyms": {
      "value": [
        "Diltiazem Malate (FDA, USAN)",
        "Diltiazem HCl (FDA, JAN, USAN, USP)",
        "Diltiazem (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-tiazem",
    "usan_stem_definition": "calcium channel blockers (diltiazem type)",
    "usan_stem_substem": "-tiazem(-tiazem)",
    "usan_year": 1977
  },
  {
    "applicants": {
      "value": [
        "Dava Pharmaceuticals Inc",
        "Unique Pharmaceutical Laboratories A Division Of J.B. Chemicals And Pharmaceuticals Ltd",
        "Pliva Inc",
        "Aurobindo Pharma Ltd",
        "Ipca Laboratories Ltd",
        "Teva Pharmaceuticals Usa",
        "Sun Pharmaceutical Industries Inc",
        "Scs Pharmaceuticals",
        "Astrazeneca Pharmaceuticals Lp",
        "Zydus Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C07AB03",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1981,
    "indication_class": "Anti-Adrenergic (beta-receptor)",
    "molecule_chembl_id": "CHEMBL24",
    "molecule_properties": {
      "acd_logd": -1.76,
      "acd_logp": 0.34,
      "acd_most_apka": 13.88,
      "acd_most_bpka": 9.43,
      "alogp": 0.45,
      "aromatic_rings": 1,
      "full_molformula": "C14H22N2O3",
      "full_mwt": 266.34,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 266.34,
      "mw_monoisotopic": 266.163,
      "psa": 84.58,
      "qed_weighted": 0.64,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)COc1ccc(CC(=O)N)cc1",
      "standard_inchi": "InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)",
      "standard_inchi_key": "METKIMKYRPQLGS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "ICI-66082"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Atenolol (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1976
  },
  {
    "applicants": {
      "value": [
        "Novast Laboratories Ltd",
        "Sanofi Aventis Us Llc",
        "Allergan Sales Llc",
        "Bayer Healthcare Llc",
        "Halsey Drug Co Inc",
        "Bristol Myers Squibb Co",
        "Glaxosmithkline Consumer Healthcare",
        "Hikma International Pharmaceuticals Llc",
        "Meda Pharmaceuticals Meda Pharmaceuticals Inc",
        "Par Pharmaceutical Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N02BA01",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Salicylic acid and derivative"
        },
        {
          "code": "N02BA51",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Salicylic acid and derivative"
        },
        {
          "code": "N02BA71",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Salicylic acid and derivative"
        },
        {
          "code": "A01AD05",
          "description": "ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Other agents for local oral treatmen"
        },
        {
          "code": "B01AC06",
          "description": "BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1950,
    "indication_class": "Analgesic; Antirheumatic; Antipyretic",
    "molecule_chembl_id": "CHEMBL25",
    "molecule_properties": {
      "acd_logd": -1.68,
      "acd_logp": 1.4,
      "acd_most_apka": 3.48,
      "alogp": 1.31,
      "aromatic_rings": 1,
      "full_molformula": "C9H8O4",
      "full_mwt": 180.16,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 13,
      "molecular_species": "ACID",
      "mw_freebase": 180.16,
      "mw_monoisotopic": 180.0423,
      "psa": 63.6,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)Oc1ccccc1C(=O)O",
      "standard_inchi": "InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)",
      "standard_inchi_key": "BSYNRYMUTXBXSQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5972916,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-5972916-A",
    "synonyms": {
      "value": [
        "Aspirin (BAN, FDA, JAN, USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Sandoz Inc",
        "Watson Laboratories Inc",
        "Ivax Pharmaceuticals Inc",
        "Wockhardt Eu Operations (Swiss) Ag",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Mylan Pharmaceuticals Inc",
        "Glaxosmithkline"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AB06",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperazine structure"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1959,
    "indication_class": "Antipsychotic; Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL422",
    "molecule_properties": {
      "acd_logd": 4.02,
      "acd_logp": 4.62,
      "acd_most_bpka": 7.66,
      "alogp": 4.95,
      "aromatic_rings": 2,
      "full_molformula": "C21H24F3N3S",
      "full_mwt": 407.51,
      "hba": 4,
      "hba_lipinski": 3,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 407.51,
      "mw_monoisotopic": 407.1643,
      "psa": 9.72,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1",
      "standard_inchi": "InChI=1S/C21H24F3N3S/c1-25-11-13-26(14-12-25)9-4-10-27-17-5-2-3-6-19(17)28-20-8-7-16(15-18(20)27)21(22,23)24/h2-3,5-8,15H,4,9-14H2,1H3",
      "standard_inchi_key": "ZEWQUBUPAILYHI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Trifluoperazine HCl (FDA, JAN, USP)",
        "Trifluoperazine Maleate (JAN)",
        "Trifluoperazine (BAN, INN)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05AL01",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Benzamides"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL26",
    "molecule_properties": {
      "acd_logd": -1.07,
      "acd_logp": 0.78,
      "acd_most_apka": 9.98,
      "acd_most_bpka": 8.97,
      "alogp": 0.56,
      "aromatic_rings": 1,
      "full_molformula": "C15H23N3O4S",
      "full_mwt": 341.43,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 23,
      "molecular_species": "BASE",
      "mw_freebase": 341.43,
      "mw_monoisotopic": 341.1409,
      "psa": 101.73,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1CCCC1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N",
      "standard_inchi": "InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)",
      "standard_inchi_key": "BGRJTUBHPOOWDU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulpiride (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_year": 1968
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Epic Pharma Llc",
        "Wockhardt Ltd",
        "Sanofi Aventis Us Llc",
        "Apotex Inc",
        "Novartis Pharmaceuticals Corp",
        "Kvk Tech Inc",
        "Medimetriks Pharmaceuticals Inc",
        "Alcon Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01ED52",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1"
        },
        {
          "code": "C07AB05",
          "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selectiv"
        },
        {
          "code": "S01ED02",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1)"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1985,
    "indication_class": "Antihypertensive; Anti-Anginal",
    "molecule_chembl_id": "CHEMBL423",
    "molecule_properties": {
      "acd_logd": 0.43,
      "acd_logp": 2.53,
      "acd_most_apka": 13.89,
      "acd_most_bpka": 9.43,
      "alogp": 2.39,
      "aromatic_rings": 1,
      "full_molformula": "C18H29NO3",
      "full_mwt": 307.43,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 307.43,
      "mw_monoisotopic": 307.2147,
      "psa": 50.72,
      "qed_weighted": 0.62,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)COc1ccc(CCOCC2CC2)cc1",
      "standard_inchi": "InChI=1S/C18H29NO3/c1-14(2)19-11-17(20)13-22-18-7-5-15(6-8-18)9-10-21-12-16-3-4-16/h5-8,14,16-17,19-20H,3-4,9-13H2,1-2H3",
      "standard_inchi_key": "NWIUTZDMDHAVTP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "SL 75.212-10",
        "ALO-1401-02",
        "SL-75212-10"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Betaxolol (BAN, INN)",
        "Betaxolol HCl (FDA, JAN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1983
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "S01BC08",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroid"
        },
        {
          "code": "D01AE12",
          "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Keratolytic",
    "molecule_chembl_id": "CHEMBL424",
    "molecule_properties": {
      "acd_logd": -1.14,
      "acd_logp": 2.01,
      "acd_most_apka": 3.01,
      "alogp": 1.09,
      "aromatic_rings": 1,
      "full_molformula": "C7H6O3",
      "full_mwt": 138.12,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 10,
      "molecular_species": "ACID",
      "mw_freebase": 138.12,
      "mw_monoisotopic": 138.0317,
      "psa": 57.53,
      "qed_weighted": 0.61,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)c1ccccc1O",
      "standard_inchi": "InChI=1S/C7H6O3/c8-6-4-2-1-3-5(6)7(9)10/h1-4,8H,(H,9,10)",
      "standard_inchi_key": "YGSDEFSMJLZEOE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Salicylic Acid (JAN, USP)",
        null
      ]
    },
    "usan_stem": "sal-",
    "usan_stem_definition": "anti-inflammatory agents (salicylic acid derivatives)",
    "usan_stem_substem": "sal-(sal-)"
  },
  {
    "applicants": {
      "value": "Mylan Specialty Lp"
    },
    "atc_classification": {
      "drug": {
        "code": "A07EC03",
        "description": "ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1990,
    "indication_class": "Anti-Inflammatory (gastrointestinal)",
    "molecule_chembl_id": "CHEMBL425",
    "molecule_properties": {
      "acd_logd": -0.58,
      "acd_logp": 3.57,
      "acd_most_apka": 2.73,
      "alogp": 2.91,
      "aromatic_rings": 2,
      "full_molformula": "C14H10N2O6",
      "full_mwt": 302.24,
      "hba": 6,
      "hba_lipinski": 8,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 22,
      "molecular_species": "ACID",
      "mw_freebase": 302.24,
      "mw_monoisotopic": 302.0539,
      "psa": 139.78,
      "qed_weighted": 0.64,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)c1cc(ccc1O)N=Nc2ccc(O)c(c2)C(=O)O",
      "standard_inchi": "InChI=1S/C14H10N2O6/c17-11-3-1-7(5-9(11)13(19)20)15-16-8-2-4-12(18)10(6-8)14(21)22/h1-6,17-18H,(H,19,20)(H,21,22)/b16-15+",
      "standard_inchi_key": "QQBDLJCYGRGAKP-FOCLMDBBSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "prodrug": true,
    "research_codes": {
      "value": "CJ-91B"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Olsalazine Sodium (FDA, USAN)",
        "Olsalazine (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-sal-",
    "usan_stem_definition": "anti-inflammatory agents (salicylic acid derivatives)",
    "usan_stem_substem": "-sal-(-sal-)",
    "usan_year": 1987
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Pierre Fabre Dermatologie",
        "Smith And Nephew Solopak Div Smith And Nephew",
        "Anda Repository Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Dava Pharmaceuticals Inc",
        "Morton Grove Pharmaceuticals Inc",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Par Pharmaceutical Inc",
        "Ipca Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C07AA05",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1967,
    "indication_class": "Cardiac Depressant (anti-arrhythmic); Anti-Adrenergic (beta-receptor)",
    "molecule_chembl_id": "CHEMBL27",
    "molecule_properties": {
      "acd_logd": 0.79,
      "acd_logp": 2.9,
      "acd_most_apka": 13.84,
      "acd_most_bpka": 9.5,
      "alogp": 2.58,
      "aromatic_rings": 2,
      "full_molformula": "C16H21NO2",
      "full_mwt": 259.35,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 259.35,
      "mw_monoisotopic": 259.1572,
      "psa": 41.49,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)COc1cccc2ccccc12",
      "standard_inchi": "InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3",
      "standard_inchi_key": "AQHHHDLHHXJYJD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6500454,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "ICI-45520",
        "AY-64043"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6500454-B1",
    "synonyms": {
      "value": [
        "Propranolol HCl (FDA, JAN, USAN, USP)",
        "Propranolol (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1965
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C07AB01",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Anti-Adrenergic (beta-receptor)",
    "molecule_chembl_id": "CHEMBL6995",
    "molecule_properties": {
      "acd_logd": -1.5,
      "acd_logp": 0.59,
      "acd_most_apka": 13.88,
      "acd_most_bpka": 9.43,
      "alogp": 1.38,
      "aromatic_rings": 1,
      "full_molformula": "C14H22N2O3",
      "full_mwt": 266.34,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 266.34,
      "mw_monoisotopic": 266.163,
      "psa": 70.59,
      "qed_weighted": 0.7,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)COc1ccc(NC(=O)C)cc1",
      "standard_inchi": "InChI=1S/C14H22N2O3/c1-10(2)15-8-13(18)9-19-14-6-4-12(5-7-14)16-11(3)17/h4-7,10,13,15,18H,8-9H2,1-3H3,(H,16,17)",
      "standard_inchi_key": "DURULFYMVIFBIR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "AY-21011",
        "ICI-50172"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Practolol (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1969
  },
  {
    "applicants": {
      "value": [
        "Actelion Pharmaceuticals Ltd",
        "Recordati Rare Diseases Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01AA05",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrogen mustard analogues"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1949,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL427",
    "molecule_properties": {
      "acd_logd": 0.87,
      "acd_logp": 0.91,
      "acd_most_bpka": 6.4,
      "alogp": 1.4,
      "full_molformula": "C5H11Cl2N",
      "full_mwt": 156.06,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 8,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 156.06,
      "mw_monoisotopic": 155.0269,
      "psa": 3.24,
      "qed_weighted": 0.56,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN(CCCl)CCCl",
      "standard_inchi": "InChI=1S/C5H11Cl2N/c1-8(4-2-6)5-3-7/h2-5H2,1H3",
      "standard_inchi_key": "HAWPXGHAZFHHAD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7838564,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-7838564-B2",
    "synonyms": {
      "value": [
        "Mechlorethamine HCl (FDA, USP)",
        "Nitrogen Mustard N-Oxide HCl (JAN)",
        "Chlormethine (BAN, INN)",
        null
      ]
    },
    "topical": true
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antidiabetic",
    "molecule_chembl_id": "CHEMBL7002",
    "molecule_properties": {
      "acd_logd": 3.56,
      "acd_logp": 4.59,
      "acd_most_apka": 6.36,
      "alogp": 3.93,
      "aromatic_rings": 1,
      "full_molformula": "C18H23NO3S",
      "full_mwt": 333.45,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 333.45,
      "mw_monoisotopic": 333.1399,
      "psa": 55.4,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1",
      "standard_inchi": "InChI=1S/C18H23NO3S/c1-18(9-3-2-4-10-18)12-22-14-7-5-13(6-8-14)11-15-16(20)19-17(21)23-15/h5-8,15H,2-4,9-12H2,1H3,(H,19,20,21)",
      "standard_inchi_key": "YZFWTZACSRHJQD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "ADD-3878",
        "U-63287"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ciglitazone (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-glitazone",
    "usan_stem_definition": "PPST agonists (thiazolidene derivatives)",
    "usan_stem_substem": "-glitazone(-glitazone)",
    "usan_year": 1983
  },
  {
    "applicants": {
      "value": [
        "Consolidated Pharmaceutical Group Inc",
        "Eli Lilly And Co",
        "John D Copanos And Co Inc",
        "Casper Pharma Llc",
        "Apothecon Inc Div Bristol Myers Squibb",
        "Purepac Pharmaceutical Co",
        "Baxter Healthcare Corp",
        "King Pharmaceuticals Llc",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa",
        "Teva Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "J01CE01",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase sensitive penicillin"
        },
        {
          "code": "S01AA14",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1947,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL29",
    "molecule_properties": {
      "acd_logd": -1.81,
      "acd_logp": 1.92,
      "acd_most_apka": 2.45,
      "alogp": 0.86,
      "aromatic_rings": 1,
      "full_molformula": "C16H18N2O4S",
      "full_mwt": 334.4,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 334.4,
      "mw_monoisotopic": 334.0987,
      "psa": 86.71,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O",
      "standard_inchi": "InChI=1S/C16H18N2O4S/c1-16(2)12(15(21)22)18-13(20)11(14(18)23-16)17-10(19)8-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",
      "standard_inchi_key": "JGSARLDLIJGVTE-MBNYWOFBSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Benzylpenicillin Potassium (BAN, JAN)",
        "Penicillin G potassium (FDA, USP)",
        "Benzylpenicillin Sodium (BAN)",
        "Penicillin g sodium (FDA, USP)",
        "Benzylpenicillin (BAN, INN, MI)",
        "Benzathine Benzylpenicillin (BAN, INN)",
        "Benzathine Penicillin (BAN)",
        "Benzylpenicillin Benzathine (JAN)",
        "Penicillin G Benzathine (FDA, USP)",
        "Benethamine Penicillin (BAN, INN)",
        "Penicillin Calcium (USP)",
        null
      ]
    },
    "usan_stem": "-cillin",
    "usan_stem_definition": "penicillins",
    "usan_stem_substem": "-cillin(-cillin)"
  },
  {
    "applicants": {
      "value": [
        "Pfizer Pharmaceuticals Inc",
        "Pfizer Central Research"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01MA13",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones"
      }
    },
    "availability_type": -1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1997,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL428",
    "molecule_properties": {
      "acd_logd": -1.06,
      "acd_logp": 1,
      "acd_most_apka": 5.8,
      "acd_most_bpka": 7.92,
      "alogp": 1.89,
      "aromatic_rings": 3,
      "full_molformula": "C20H15F3N4O3",
      "full_mwt": 416.36,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 30,
      "molecular_species": "ACID",
      "mw_freebase": 416.36,
      "mw_monoisotopic": 416.1096,
      "psa": 101.45,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "N[C@@H]1[C@H]2CN(C[C@@H]12)c3nc4N(C=C(C(=O)O)C(=O)c4cc3F)c5ccc(F)cc5F",
      "standard_inchi": "InChI=1S/C20H15F3N4O3/c21-8-1-2-15(13(22)3-8)27-7-12(20(29)30)17(28)9-4-14(23)19(25-18(9)27)26-5-10-11(6-26)16(10)24/h1-4,7,10-11,16H,5-6,24H2,(H,29,30)/t10-,11+,16+",
      "standard_inchi_key": "WVPSKSLAZQPAKQ-CDMJZVDBSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "CP-99219-27",
        "CP-9921927"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Trovafloxacin Mesylate (FDA, USAN)",
        "Trovafloxacin (INN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1995,
    "withdrawn_class": "Hepatotoxicity",
    "withdrawn_country": "European Union; United States",
    "withdrawn_reason": "Hepatotoxicity",
    "withdrawn_year": 1999
  },
  {
    "applicants": {
      "value": [
        "Teva Parenteral Medicines Inc",
        "Chartwell Molecules Llc",
        "Dava Pharmaceuticals Inc",
        "Hospira Inc",
        "Contract Pharmacal Corp",
        "Pliva Inc",
        "Mylan Pharmaceuticals Inc",
        "Medtech Products Inc",
        "Luitpold Pharmaceuticals Inc",
        "Wockhardt Eu Operations (Swiss) Ag"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "A02BA51",
          "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): H2-receptor antagonist"
        },
        {
          "code": "A02BA01",
          "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): H2-receptor antagonists"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1977,
    "indication_class": "Antagonist (to histamine-H2 receptors)",
    "molecule_chembl_id": "CHEMBL30",
    "molecule_properties": {
      "acd_logd": -0.36,
      "acd_logp": -0.07,
      "acd_most_bpka": 7.07,
      "alogp": 0.6,
      "aromatic_rings": 1,
      "full_molformula": "C10H16N6S",
      "full_mwt": 252.35,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 252.35,
      "mw_monoisotopic": 252.1157,
      "psa": 88.89,
      "qed_weighted": 0.23,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CN\\C(=N/CCSCc1nc[nH]c1C)\\NC#N",
      "standard_inchi": "InChI=1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)",
      "standard_inchi_key": "AQIXAKUUQRKLND-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cimetidine HCl (FDA, USAN, USP)",
        "Cimetidine (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-tidine",
    "usan_stem_definition": "H2-receptor antagonists (cimetidine type)",
    "usan_stem_substem": "-tidine(-tidine)",
    "usan_year": 1975
  },
  {
    "applicants": {
      "value": [
        "Bristol Myers Squibb",
        "Lupin Ltd",
        "Bristol Myers Squibb Co Pharmaceutical Research Institute",
        "Hi-Tech Pharmacal Co Inc",
        "Apotex Inc",
        "Sandoz Inc",
        "Allergan Inc",
        "Allergan"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "J01MA16",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolone"
        },
        {
          "code": "S01AE06",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1999,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL31",
    "molecule_properties": {
      "acd_logd": -0.15,
      "acd_logp": 2.1,
      "acd_most_apka": 6.43,
      "acd_most_bpka": 8.71,
      "alogp": 1.98,
      "aromatic_rings": 2,
      "full_molformula": "C19H22FN3O4",
      "full_mwt": 375.4,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 27,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 375.4,
      "mw_monoisotopic": 375.1594,
      "psa": 83.8,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1c(N2CCNC(C)C2)c(F)cc3C(=O)C(=CN(C4CC4)c13)C(=O)O",
      "standard_inchi": "InChI=1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26)",
      "standard_inchi_key": "XUBOMFCQGDBHNK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6333045,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "AM-1155",
        "BMS-206584-01"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6333045-B1",
    "synonyms": {
      "value": [
        "Gatifloxacin (FDA, INN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1997,
    "withdrawn_class": "Gastrotoxicity",
    "withdrawn_country": "United States",
    "withdrawn_reason": "Increased risk of dysglycemia",
    "withdrawn_year": 2006
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Sagent Agila Llc",
        "County Line Pharmaceuticals Llc",
        "Apothecon Inc Div Bristol Myers Squibb",
        "West-Ward Pharmaceuticals International Ltd",
        "Schering Corp Sub Schering Plough Corp",
        "Sandoz Inc",
        "Watson Laboratories Inc",
        "Innogenix Llc",
        "Hospira Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C07AG01",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Alpha and beta blocking agents"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1984,
    "indication_class": "Anti-Adrenergic (beta-receptor); Anti-Adrenergic (alpha-receptor)",
    "molecule_chembl_id": "CHEMBL429",
    "molecule_properties": {
      "acd_logd": 0.83,
      "acd_logp": 2.72,
      "acd_most_apka": 8.21,
      "acd_most_bpka": 9.3,
      "alogp": 2.14,
      "aromatic_rings": 2,
      "full_molformula": "C19H24N2O3",
      "full_mwt": 328.41,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 328.41,
      "mw_monoisotopic": 328.1787,
      "psa": 95.58,
      "qed_weighted": 0.6,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N",
      "standard_inchi": "InChI=1S/C19H24N2O3/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24)",
      "standard_inchi_key": "SGUAFYQXFOLMHL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "SCH-15719W",
        "AH-5158A"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Labetalol HCl (FDA, JAN, USAN, USP)",
        "Labetalol (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-alol",
    "usan_stem_definition": "combined alpha and beta receptors",
    "usan_stem_substem": "-alol(-alol)",
    "usan_year": 1976
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Teva Pharmaceuticals Usa",
        "Lupin Ltd",
        "Fresenius Kabi Usa Llc",
        "Torrent Pharmaceuticals Ltd",
        "Apotex Inc",
        "Novartis Pharmaceuticals Corp",
        "Watson Laboratories Inc",
        "Msn Laboratories Private Ltd",
        "Crossmedika Sa"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "J01MA14",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolone"
        },
        {
          "code": "S01AE07",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolones"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1999,
    "molecule_chembl_id": "CHEMBL32",
    "molecule_properties": {
      "acd_logd": 0.31,
      "acd_logp": 2.83,
      "acd_most_apka": 6.43,
      "acd_most_bpka": 10.63,
      "alogp": 2.37,
      "aromatic_rings": 2,
      "full_molformula": "C21H24FN3O4",
      "full_mwt": 401.44,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 29,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 401.44,
      "mw_monoisotopic": 401.1751,
      "psa": 83.8,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1c(N2C[C@@H]3CCCN[C@@H]3C2)c(F)cc4C(=O)C(=CN(C5CC5)c14)C(=O)O",
      "standard_inchi": "InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1",
      "standard_inchi_key": "FABPRXSRWADJSP-MEDUHNTESA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5849752,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "BAY-12-8039",
        "BAY-128039"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5849752-A",
    "synonyms": {
      "value": [
        "Moxifloxacin HCl (FDA, USAN)",
        "Moxifloxacin (BAN, INN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1998
  },
  {
    "applicants": {
      "value": [
        "Rising Pharmaceuticals Inc",
        "Fresenius Kabi Usa Llc",
        "Sagent Agila Llc",
        "Jubilant Generics Ltd",
        "Hospira Inc",
        "Torrent Pharmaceuticals Limited",
        "Aurobindo Pharma Ltd",
        "Akorn Inc",
        "Lupin Ltd",
        "Acs Dobfar Info Sa"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01AE05",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolone"
        },
        {
          "code": "J01MA12",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1996,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL33",
    "molecule_properties": {
      "acd_logd": -0.39,
      "acd_logp": 1.85,
      "acd_most_apka": 5.19,
      "acd_most_bpka": 7.37,
      "alogp": 1.54,
      "aromatic_rings": 2,
      "full_molformula": "C18H20FN3O4",
      "full_mwt": 361.37,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 361.37,
      "mw_monoisotopic": 361.1438,
      "psa": 75.01,
      "qed_weighted": 0.87,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H]1COc2c(N3CCN(C)CC3)c(F)cc4C(=O)C(=CN1c24)C(=O)O",
      "standard_inchi": "InChI=1S/C18H20FN3O4/c1-10-9-26-17-14-11(16(23)12(18(24)25)8-22(10)14)7-13(19)15(17)21-5-3-20(2)4-6-21/h7-8,10H,3-6,9H2,1-2H3,(H,24,25)/t10-/m0/s1",
      "standard_inchi_key": "GSDSWSVVBLHKDQ-JTQLQIEISA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6806256,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "RWJ-25213",
        "DR-3355"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6806256-B2",
    "synonyms": {
      "value": [
        "Levofloxacin (BAN, FDA, INN, JAN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1996
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Anti-Adrenergic (beta-receptor)",
    "molecule_chembl_id": "CHEMBL7467",
    "molecule_properties": {
      "acd_logd": 0.17,
      "acd_logp": 0.91,
      "acd_most_apka": 13.37,
      "acd_most_bpka": 8.43,
      "alogp": 0.38,
      "aromatic_rings": 1,
      "full_molformula": "C15H22FN3O4",
      "full_mwt": 327.36,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 327.36,
      "mw_monoisotopic": 327.1594,
      "psa": 113.68,
      "qed_weighted": 0.52,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(CNC(=O)N)NCC(O)COC(=O)c1ccccc1F",
      "standard_inchi": "InChI=1S/C15H22FN3O4/c1-15(2,9-18-14(17)22)19-7-10(20)8-23-13(21)11-5-3-4-6-12(11)16/h3-6,10,19-20H,7-9H2,1-2H3,(H3,17,18,22)",
      "standard_inchi_key": "ZPLOQFLCMVIWRY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "ACC-9089"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Flestolol Sulfate (USAN)",
        "Flestolol (INN)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1985
  },
  {
    "applicants": {
      "value": [
        "Lg Chem Ltd",
        "Orchid Healthcare"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01MA15",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2003,
    "molecule_chembl_id": "CHEMBL430",
    "molecule_properties": {
      "acd_logd": -0.71,
      "acd_logp": 1.77,
      "acd_most_apka": 6.02,
      "acd_most_bpka": 9.15,
      "alogp": 0.97,
      "aromatic_rings": 2,
      "full_molformula": "C18H20FN5O4",
      "full_mwt": 389.39,
      "hba": 8,
      "hba_lipinski": 9,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 28,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 389.39,
      "mw_monoisotopic": 389.1499,
      "psa": 123.04,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CO\\N=C\\1/CN(CC1CN)c2nc3N(C=C(C(=O)O)C(=O)c3cc2F)C4CC4",
      "standard_inchi": "InChI=1S/C18H20FN5O4/c1-28-22-14-8-23(6-9(14)5-20)17-13(19)4-11-15(25)12(18(26)27)7-24(10-2-3-10)16(11)21-17/h4,7,9-10H,2-3,5-6,8,20H2,1H3,(H,26,27)/b22-14+",
      "standard_inchi_key": "ZRCVYEYHRGVLOC-HYARGMPZSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5776944,
    "oral": true,
    "research_codes": {
      "value": [
        "LB-20304a",
        "SB-265805-S"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5776944-A",
    "synonyms": {
      "value": [
        "Gemifloxacin (INN)",
        "Gemifloxacin Mesylate (FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1998
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antiproliferative Agent",
    "molecule_chembl_id": "CHEMBL7492",
    "molecule_properties": {
      "acd_logd": 1.93,
      "acd_logp": 1.97,
      "acd_most_bpka": 6.68,
      "alogp": 2.11,
      "aromatic_rings": 3,
      "full_molformula": "C17H19N5O2",
      "full_mwt": 325.37,
      "hba": 7,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 325.37,
      "mw_monoisotopic": 325.1539,
      "psa": 109.17,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(OC)c(Cc2cnc3nc(N)nc(N)c3c2C)c1",
      "standard_inchi": "InChI=1S/C17H19N5O2/c1-9-11(6-10-7-12(23-2)4-5-13(10)24-3)8-20-16-14(9)15(18)21-17(19)22-16/h4-5,7-8H,6H2,1-3H3,(H4,18,19,20,21,22)",
      "standard_inchi_key": "VJXSSYDSOJBUAV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "TCMDC-137235",
        "BW-301U Isethionate",
        "BW-301U"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Piritrexim (INN)",
        "Piritrexim Isethionate (USAN)",
        null
      ]
    },
    "usan_year": 1986
  },
  {
    "applicants": {
      "value": "Schering Corp"
    },
    "atc_classification": {
      "drug": {
        "code": "C09AA11",
        "description": "CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ACE INHIBITORS, PLAIN: ACE inhibitors, plain"
      }
    },
    "availability_type": 0,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1994,
    "indication_class": "Enzyme Inhibitor (angiotensin-converting)",
    "molecule_chembl_id": "CHEMBL431",
    "molecule_properties": {
      "acd_logd": 2.24,
      "acd_logp": 5.88,
      "acd_most_apka": 2.99,
      "acd_most_bpka": 5.29,
      "alogp": 2.39,
      "aromatic_rings": 1,
      "full_molformula": "C22H30N2O5S2",
      "full_mwt": 466.63,
      "hba": 7,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 31,
      "molecular_species": "ACID",
      "mw_freebase": 466.63,
      "mw_monoisotopic": 466.1596,
      "psa": 95.94,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2CC3(C[C@H]2C(=O)O)SCCS3",
      "standard_inchi": "InChI=1S/C22H30N2O5S2/c1-3-29-21(28)17(10-9-16-7-5-4-6-8-16)23-15(2)19(25)24-14-22(30-11-12-31-22)13-18(24)20(26)27/h4-8,15,17-18,23H,3,9-14H2,1-2H3,(H,26,27)/t15-,17-,18-/m0/s1",
      "standard_inchi_key": "HRWCVUIFMSZDJS-SZMVWBNQSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "prodrug": true,
    "research_codes": {
      "value": "SCH-33844"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Spirapril HCl (FDA, USAN)",
        "Spirapril (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-pril",
    "usan_stem_definition": "antihypertensives (ACE inhibitors)",
    "usan_stem_substem": "-pril(-pril)",
    "usan_year": 1987
  },
  {
    "applicants": {
      "value": [
        "Abraxis Pharmaceutical Products",
        "Baxter Healthcare Corp Anesthesia And Critical Care",
        "Nexus Pharmaceuticals Inc",
        "Armour Pharmaceutical Co",
        "Sanofi Aventis Us Llc",
        "Eli Lilly And Co",
        "Mead Johnson And Co Sub Bristol Myers Co",
        "Fisons Corp",
        "International Medication System",
        "Abbvie Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R03CB51",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS FOR SYSTEMIC USE: Non-selective beta-adrenoreceptor agonist"
        },
        {
          "code": "R03AB02",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Non-selective beta-adrenoreceptor agonist"
        },
        {
          "code": "C01CA02",
          "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agent"
        },
        {
          "code": "R03CB01",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS FOR SYSTEMIC USE: Non-selective beta-adrenoreceptor agonists"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1956,
    "indication_class": "Bronchodilator",
    "molecule_chembl_id": "CHEMBL434",
    "molecule_properties": {
      "acd_logd": -1.55,
      "acd_logp": 0.32,
      "acd_most_apka": 9.6,
      "acd_most_bpka": 9.26,
      "alogp": 1.13,
      "aromatic_rings": 1,
      "full_molformula": "C11H17NO3",
      "full_mwt": 211.26,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 15,
      "molecular_species": "BASE",
      "mw_freebase": 211.26,
      "mw_monoisotopic": 211.1208,
      "psa": 72.72,
      "qed_weighted": 0.56,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)c1ccc(O)c(O)c1",
      "standard_inchi": "InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3",
      "standard_inchi_key": "JWZZKOKVBUJMES-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Isoproterenol HCl (FDA, USP)",
        "l-Isoprenaline HCl (JAN)",
        "Isoprenaline (BAN, INN)",
        "Isoproterenol Sulfate (FDA, JAN, USP)",
        null
      ]
    },
    "topical": true
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Enzyme Inhibitor (aldose reductase)",
    "molecule_chembl_id": "CHEMBL266497",
    "molecule_properties": {
      "acd_logd": 0.48,
      "acd_logp": 0.49,
      "acd_most_apka": 8.91,
      "alogp": 0.64,
      "aromatic_rings": 1,
      "full_molformula": "C11H9FN2O3",
      "full_mwt": 236.2,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 236.2,
      "mw_monoisotopic": 236.0597,
      "psa": 67.43,
      "qed_weighted": 0.65,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "Fc1ccc2OCC[C@]3(NC(=O)NC3=O)c2c1",
      "standard_inchi": "InChI=1S/C11H9FN2O3/c12-6-1-2-8-7(5-6)11(3-4-17-8)9(15)13-10(16)14-11/h1-2,5H,3-4H2,(H2,13,14,15,16)/t11-/m0/s1",
      "standard_inchi_key": "LXANPKRCLVQAOG-NSHDSACASA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CP-45634"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sorbinil (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1979
  },
  {
    "applicants": {
      "value": [
        "Merck Research Laboratories Div Merck Co Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Dava Pharmaceuticals Inc",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Hikma International Pharmaceuticals Llc",
        "Par Pharmaceutical Inc",
        "Vangard Laboratories Inc Div Midway Medical Co",
        "Teva Pharmaceuticals Usa",
        "Aurolife Pharma Llc",
        "Lupin Ltd"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "C03AX01",
          "description": "CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, THIAZIDES: Thiazides, combinations with other drug"
        },
        {
          "code": "C03AA03",
          "description": "CARDIOVASCULAR SYSTEM: DIURETICS: LOW-CEILING DIURETICS, THIAZIDES: Thiazides, plain"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1959,
    "indication_class": "Diuretic",
    "molecule_chembl_id": "CHEMBL435",
    "molecule_properties": {
      "acd_logd": -0.04,
      "acd_logp": -0.02,
      "acd_most_apka": 8.95,
      "alogp": -0.35,
      "aromatic_rings": 1,
      "full_molformula": "C7H8ClN3O4S2",
      "full_mwt": 297.75,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 297.75,
      "mw_monoisotopic": 296.9645,
      "psa": 118.36,
      "qed_weighted": 0.65,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl",
      "standard_inchi": "InChI=1S/C7H8ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-2,10-11H,3H2,(H2,9,12,13)",
      "standard_inchi_key": "JZUFKLXOESDKRF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5559111,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-5559111-A",
    "synonyms": {
      "value": [
        "Hydrochlorothiazide (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "usan_stem": "-thiazide",
    "usan_stem_definition": "diuretics (thiazide derivatives)",
    "usan_stem_substem": "-thiazide(-thiazide)"
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Marsam Pharmaceuticals Llc",
        "Smith And Nephew Solopak Div Smith And Nephew",
        "Sanofi Aventis Us Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Astrazeneca Lp",
        "International Medication System",
        "Dava Pharmaceuticals Inc",
        "Hospira Inc",
        "Kalapharm Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C03CA01",
        "description": "CARDIOVASCULAR SYSTEM: DIURETICS: HIGH-CEILING DIURETICS: Sulfonamides, plain"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1966,
    "indication_class": "Diuretic",
    "molecule_chembl_id": "CHEMBL35",
    "molecule_properties": {
      "acd_logd": -0.82,
      "acd_logp": 2.3,
      "acd_most_apka": 3.04,
      "alogp": 1.89,
      "aromatic_rings": 2,
      "full_molformula": "C12H11ClN2O5S",
      "full_mwt": 330.75,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 21,
      "molecular_species": "ACID",
      "mw_freebase": 330.75,
      "mw_monoisotopic": 330.0077,
      "psa": 122.63,
      "qed_weighted": 0.77,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "NS(=O)(=O)c1cc(C(=O)O)c(NCc2occc2)cc1Cl",
      "standard_inchi": "InChI=1S/C12H11ClN2O5S/c13-9-5-10(15-6-7-2-1-3-20-7)8(12(16)17)4-11(9)21(14,18)19/h1-5,15H,6H2,(H,16,17)(H2,14,18,19)",
      "standard_inchi_key": "ZZUFCTLCJUWOSV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "LB-502"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Furosemide (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-semide",
    "usan_stem_definition": "diuretics (furosemide type)",
    "usan_stem_substem": "-semide(-semide)",
    "usan_year": 1964
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL404519",
    "molecule_properties": {
      "acd_logd": 4.85,
      "acd_logp": 9.55,
      "acd_most_apka": 4.48,
      "alogp": 8.14,
      "full_molformula": "C36H56O6",
      "full_mwt": 584.84,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 42,
      "molecular_species": "ACID",
      "mw_freebase": 584.84,
      "mw_monoisotopic": 584.4077,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 100.9,
      "qed_weighted": 0.24,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=C)[C@@H]1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](OC(=O)CC(C)(C)C(=O)O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O",
      "standard_inchi": "InChI=1S/C36H56O6/c1-21(2)22-12-17-36(30(40)41)19-18-34(8)23(28(22)36)10-11-25-33(7)15-14-26(42-27(37)20-31(3,4)29(38)39)32(5,6)24(33)13-16-35(25,34)9/h22-26,28H,1,10-20H2,2-9H3,(H,38,39)(H,40,41)/t22-,23+,24-,25+,26-,28+,33-,34+,35+,36-/m0/s1",
      "standard_inchi_key": "YJEJKUQEXFSVCJ-WRFMNRASSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "PA103001-04",
        "PA-457N",
        "PA103001-01",
        "PA-457 DI-NMG",
        "DSB*2NMG",
        "PA-103001",
        "PA-457"
      ]
    },
    "synonyms": {
      "value": [
        "Bevirimat (INN)",
        "Bevirimat Dimeglumine (USAN)",
        null
      ]
    },
    "usan_stem": "-virimat",
    "usan_stem_definition": "antiviral, disrupts viral maturation",
    "usan_stem_substem": "-virimat(-virimat)",
    "usan_year": 2006
  },
  {
    "applicants": {
      "value": [
        "Hoffmann La Roche Inc",
        "Turing Pharmaceuticals Llc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "P01BD01",
          "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Diaminopyrimidine"
        },
        {
          "code": "P01BD51",
          "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Diaminopyrimidines"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1953,
    "indication_class": "Antimalarial",
    "molecule_chembl_id": "CHEMBL36",
    "molecule_properties": {
      "acd_logd": 2.55,
      "acd_logp": 2.75,
      "acd_most_bpka": 7.17,
      "alogp": 2.52,
      "aromatic_rings": 2,
      "full_molformula": "C12H13ClN4",
      "full_mwt": 248.72,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 248.72,
      "mw_monoisotopic": 248.0829,
      "psa": 77.82,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCc1nc(N)nc(N)c1c2ccc(Cl)cc2",
      "standard_inchi": "InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17)",
      "standard_inchi_key": "WKSAUQYGYAYLPV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "TCMDC-123831",
        "GNF-Pf-5586",
        "TCMDC-125860"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pyrimethamine (BAN, FDA, INN, JAN, USP)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "A10XA01",
        "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: OTHER DRUGS USED IN DIABETES: Aldose reductase inhibitors"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Inhibitor (aldose reductase)",
    "molecule_chembl_id": "CHEMBL436",
    "molecule_properties": {
      "acd_logd": -0.07,
      "acd_logp": 3.59,
      "acd_most_apka": 3.49,
      "acd_most_bpka": 0.63,
      "alogp": 3.56,
      "aromatic_rings": 2,
      "full_molformula": "C16H14F3NO3S",
      "full_mwt": 357.35,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "ACID",
      "mw_freebase": 357.35,
      "mw_monoisotopic": 357.0646,
      "psa": 49.77,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2c(cccc2c1C(F)(F)F)C(=S)N(C)CC(=O)O",
      "standard_inchi": "InChI=1S/C16H14F3NO3S/c1-20(8-13(21)22)15(24)11-5-3-4-10-9(11)6-7-12(23-2)14(10)16(17,18)19/h3-7H,8H2,1-2H3,(H,21,22)",
      "standard_inchi_key": "LUBHDINQXIHVLS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AY-27773"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tolrestat (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors: aldose-reductase inhibitors",
    "usan_stem_substem": "-stat(-stat(-restat))",
    "usan_year": 1984,
    "withdrawn_class": "Hepatotoxicity",
    "withdrawn_country": "Canada; Italy; Argentina",
    "withdrawn_reason": "Hepatic necrosis",
    "withdrawn_year": 1996
  },
  {
    "applicants": {
      "value": [
        "E Fougera Div Altana Inc",
        "Pharmaderm Div Altana Inc",
        "G And W Laboratories Inc",
        "Ortho Mcneil Pharmaceutical Inc",
        "Perrigo New York Inc",
        "Savage Laboratories Inc Div Altana Inc",
        "Alpharma Us Pharmaceuticals Division"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D06BA02",
          "description": "DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Sulfonamide"
        },
        {
          "code": "J01EB07",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Short-acting sulfonamides"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1945,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL437",
    "molecule_properties": {
      "acd_logd": -0.34,
      "acd_logp": 0.05,
      "acd_most_apka": 7.24,
      "acd_most_bpka": 2.19,
      "alogp": 1.53,
      "aromatic_rings": 2,
      "full_molformula": "C9H9N3O2S2",
      "full_mwt": 255.32,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 255.32,
      "mw_monoisotopic": 255.0136,
      "psa": 85.08,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ccc(cc1)S(=O)(=O)Nc2nccs2",
      "standard_inchi": "InChI=1S/C9H9N3O2S2/c10-7-1-3-8(4-2-7)16(13,14)12-9-11-5-6-15-9/h1-6H,10H2,(H,11,12)",
      "standard_inchi_key": "JNMRHUJNCSQMMB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulfathiazole Sodium (MI, NF)",
        "Sulfathiazole (BAN, INN, USP)",
        "Sulfathiazole (Triple Sulfa) (FDA)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "sulfa-",
    "usan_stem_definition": "antimicrobials (sulfonamides derivatives)",
    "usan_stem_substem": "sulfa-(sulfa-)",
    "withdrawn_country": "United States"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Inhibitor (aldose reductase)",
    "molecule_chembl_id": "CHEMBL7679",
    "molecule_properties": {
      "acd_logd": -1.03,
      "acd_logp": 2.6,
      "acd_most_apka": 3.36,
      "alogp": 2.97,
      "aromatic_rings": 3,
      "full_molformula": "C17H12BrFN2O3",
      "full_mwt": 391.2,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "ACID",
      "mw_freebase": 391.2,
      "mw_monoisotopic": 390.0015,
      "psa": 72.19,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CC1=NN(Cc2ccc(Br)cc2F)C(=O)c3ccccc13",
      "standard_inchi": "InChI=1S/C17H12BrFN2O3/c18-11-6-5-10(14(19)7-11)9-21-17(24)13-4-2-1-3-12(13)15(20-21)8-16(22)23/h1-7H,8-9H2,(H,22,23)",
      "standard_inchi_key": "LKBFFDOJUKLQNY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "ICI-128436"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ponalrestat (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors: aldose-reductase inhibitors",
    "usan_stem_substem": "-stat(-stat(-restat))",
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": [
        "Lederle Laboratories Div American Cyanamid Co",
        "Lannett Co Inc",
        "Forest Pharmaceuticals Inc",
        "Eli Lilly And Co",
        "Pal Pak Inc",
        "Purepac Pharmaceutical Co",
        "Bristol Myers Squibb Co",
        "Impax Laboratories Inc",
        "Wyeth Ayerst Laboratories",
        "Alpharma Us Pharmaceuticals Division"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D06BA06",
          "description": "DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Sulfonamide"
        },
        {
          "code": "J01ED07",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Long-acting sulfonamides"
        }
      ]
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL438",
    "molecule_properties": {
      "acd_logd": -0.25,
      "acd_logp": 0.11,
      "acd_most_apka": 7.35,
      "acd_most_bpka": 1.58,
      "alogp": 1.17,
      "aromatic_rings": 2,
      "full_molformula": "C11H12N4O2S",
      "full_mwt": 264.31,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 264.31,
      "mw_monoisotopic": 264.0681,
      "psa": 97.97,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1",
      "standard_inchi": "InChI=1S/C11H12N4O2S/c1-8-6-7-13-11(14-8)15-18(16,17)10-4-2-9(12)3-5-10/h2-7H,12H2,1H3,(H,13,14,15)",
      "standard_inchi_key": "QPPBRPIAZZHUNT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulfamerazine (BAN, FDA, INN, USP)",
        "Sulfamerazine (Trisulfapyrimidines) (FDA)",
        "Sulfamerazine sodium (INN)",
        "Sulfamerazine Sodium [Injection] (INN, NF)",
        null
      ]
    },
    "usan_stem": "sulfa-",
    "usan_stem_definition": "antimicrobials (sulfonamides derivatives)",
    "usan_stem_substem": "sulfa-(sulfa-)"
  },
  {
    "applicants": {
      "value": [
        "Dr Reddys Laboratories Louisiana Llc",
        "Everylife",
        "Lannett Co Inc",
        "Forest Pharmaceuticals Inc",
        "Eli Lilly And Co",
        "Sandoz Inc",
        "Pal Pak Inc",
        "Purepac Pharmaceutical Co",
        "Thepharmanetwork Llc",
        "King Pharmaceuticals Llc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01EC02",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Intermediate-acting sulfonamides"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1941,
    "indication_class": "Anti-Infective, Topical,Antibacterial",
    "molecule_chembl_id": "CHEMBL439",
    "molecule_properties": {
      "acd_logd": -0.8,
      "acd_logp": -0.07,
      "acd_most_apka": 6.81,
      "acd_most_bpka": 1.57,
      "alogp": 0.86,
      "aromatic_rings": 2,
      "full_molformula": "C10H10N4O2S",
      "full_mwt": 250.28,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 250.28,
      "mw_monoisotopic": 250.0524,
      "psa": 97.97,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ccc(cc1)S(=O)(=O)Nc2ncccn2",
      "standard_inchi": "InChI=1S/C10H10N4O2S/c11-8-2-4-9(5-3-8)17(15,16)14-10-12-6-1-7-13-10/h1-7H,11H2,(H,12,13,14)",
      "standard_inchi_key": "SEEPANYCNGTZFQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulfadiazine Sodium (FDA, INN, USP)",
        "Silver Sulfadiazine (FDA)",
        "Sulfadiazine Silver (JAN)",
        "Sulfadiazine, Silver (USAN, USP)",
        "Sulfadiazine (BAN, FDA, INN, JAN, USP)",
        "Sulfadiazine (Trisulfapyrimidines) (FDA)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "sulfa-",
    "usan_stem_definition": "antimicrobials (sulfonamides derivatives)",
    "usan_stem_substem": "sulfa-(sulfa-)",
    "usan_year": 1975
  },
  {
    "applicants": {
      "value": "Parkedale Pharmaceuticals Inc"
    },
    "availability_type": 0,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Anesthetic (intravenous)",
    "molecule_chembl_id": "CHEMBL440",
    "molecule_properties": {
      "acd_logd": -1.11,
      "acd_logp": 2.39,
      "acd_most_apka": -3.28,
      "alogp": 1.93,
      "full_molformula": "C12H18N2O2S",
      "full_mwt": 254.35,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "ACID",
      "mw_freebase": 254.35,
      "mw_monoisotopic": 254.1089,
      "psa": 58.53,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCCC(C)C1(CC=C)C(=O)NC(=NC1=O)S",
      "standard_inchi": "InChI=1S/C12H18N2O2S/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)",
      "standard_inchi_key": "XLOMZPUITCYLMJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Thiamylal Sodium (FDA, JAN, USP)",
        "Thiamylal (USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": "Abbott Laboratories Hosp Products Div"
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N05CA19",
          "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plai"
        },
        {
          "code": "N01AF03",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Barbiturates, plain"
        }
      ]
    },
    "availability_type": 0,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Anesthetic (intravenous); Anticonvulsant",
    "molecule_chembl_id": "CHEMBL441",
    "molecule_properties": {
      "acd_logd": 2.59,
      "acd_logp": 3.05,
      "acd_most_apka": 7.11,
      "alogp": 1.35,
      "full_molformula": "C11H18N2O2S",
      "full_mwt": 242.34,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 242.34,
      "mw_monoisotopic": 242.1089,
      "psa": 58.2,
      "qed_weighted": 0.58,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCCC(C)C1(CC)C(=O)NC(=S)NC1=O",
      "standard_inchi": "InChI=1S/C11H18N2O2S/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)",
      "standard_inchi_key": "IUJDSEJGGMCXSG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Thiopental (BAN, BAN)",
        "Thiopental sodium (FDA, INN, JAN, USP)",
        null
      ]
    },
    "topical": true
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05CA10",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL268164",
    "molecule_properties": {
      "acd_logd": 1.41,
      "acd_logp": 1.5,
      "acd_most_apka": 8.03,
      "alogp": 1.25,
      "full_molformula": "C12H16N2O3",
      "full_mwt": 236.27,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 236.27,
      "mw_monoisotopic": 236.1161,
      "psa": 75.27,
      "qed_weighted": 0.56,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCC1(C(=O)NC(=O)NC1=O)C2=CCCCC2",
      "standard_inchi": "InChI=1S/C12H16N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h6H,2-5,7H2,1H3,(H2,13,14,15,16,17)",
      "standard_inchi_key": "WTYGAUXICFETTC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cyclobarbital (BAN, INN, MI, NF)",
        "Cyclobarbital Calcium (BAN, NF)",
        null
      ]
    },
    "usan_stem": "-barb-",
    "usan_stem_definition": "barbituric acid derivatives",
    "usan_stem_substem": "-barb-(-barb-)",
    "withdrawn_class": "Misuse",
    "withdrawn_country": "Norway",
    "withdrawn_reason": "Self-poisonings",
    "withdrawn_year": 1980
  },
  {
    "applicants": {
      "value": [
        "Tersera Therapeutics Llc",
        "Sandoz Inc",
        "Novartis Pharmaceuticals Corp",
        "Watson Laboratories Inc",
        "Mikart Inc",
        "Horizon Pharma Rheumatology Llc",
        "Organon Usa Inc",
        "Hikma International Pharmaceuticals Llc",
        "3M Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N02CA52",
          "description": "NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloid"
        },
        {
          "code": "N02CA72",
          "description": "NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloid"
        },
        {
          "code": "N02CA02",
          "description": "NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Ergot alkaloids"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1948,
    "indication_class": "Analgesic (specific in migraine)",
    "molecule_chembl_id": "CHEMBL442",
    "molecule_properties": {
      "acd_logd": 7.24,
      "acd_logp": 7.37,
      "acd_most_apka": 9.62,
      "acd_most_bpka": 6.94,
      "alogp": 1.99,
      "aromatic_rings": 3,
      "full_molformula": "C33H35N5O5",
      "full_mwt": 581.67,
      "hba": 6,
      "hba_lipinski": 10,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 43,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 581.67,
      "mw_monoisotopic": 581.2638,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 118.21,
      "qed_weighted": 0.43,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C[C@@H](C=C2[C@H]1Cc3c[nH]c4cccc2c34)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C5=O",
      "standard_inchi": "InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1",
      "standard_inchi_key": "XCGSFFUVFURLIX-VFGNJEKYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "synonyms": {
      "value": [
        "Ergotamine (BAN, INN)",
        "Ergotamine Tartrate (FDA, JAN, USP)",
        null
      ]
    },
    "topical": true
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Valeant International Barbados Srl",
        "Valeant Pharmaceuticals North America Llc",
        "Valeant International Bermuda",
        "Medicis Pharmaceutical Corp",
        "Perrigo Pharma International Dac",
        "Galderma Laboratories Lp",
        "Aqua Pharmaceuticals Llc",
        "Anchen Pharmaceuticals Inc",
        "Glenmark Pharmaceuticals Ltd"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "L01XX14",
          "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agent"
        },
        {
          "code": "D10AD01",
          "description": "DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Retinoids for topical use in acn"
        },
        {
          "code": "D10AD51",
          "description": "DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Retinoids for topical use in acne"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1971,
    "indication_class": "Keratolytic",
    "molecule_chembl_id": "CHEMBL38",
    "molecule_properties": {
      "acd_logd": 3.62,
      "acd_logp": 6.26,
      "acd_most_apka": 4.73,
      "alogp": 5.6,
      "full_molformula": "C20H28O2",
      "full_mwt": 300.44,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "ACID",
      "mw_freebase": 300.44,
      "mw_monoisotopic": 300.2089,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 37.3,
      "qed_weighted": 0.53,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "C\\C(=C/C=C/C(=C/C(=O)O)/C)\\C=C\\C1=C(C)CCCC1(C)C",
      "standard_inchi": "InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+",
      "standard_inchi_key": "SHGAZHPCJJPHSC-YCNIQYBTSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5955109,
    "oral": true,
    "sc_patent": "US-5955109-A",
    "synonyms": {
      "value": [
        "Tretinoin (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-retin-",
    "usan_stem_definition": "retinol derivatives",
    "usan_stem_substem": "-retin-(-retin-)",
    "usan_year": 1970
  },
  {
    "applicants": {
      "value": "Par Sterile Products Llc"
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N05CA15",
          "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plai"
        },
        {
          "code": "N01AF01",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Barbiturates, plain"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1960,
    "indication_class": "Anesthetic (intravenous)",
    "molecule_chembl_id": "CHEMBL7413",
    "molecule_properties": {
      "acd_logd": 1.88,
      "acd_logp": 2.01,
      "acd_most_apka": 7.82,
      "alogp": 1.31,
      "full_molformula": "C14H18N2O3",
      "full_mwt": 262.31,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 262.31,
      "mw_monoisotopic": 262.1317,
      "psa": 66.48,
      "qed_weighted": 0.47,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCC#CC(C)C1(CC=C)C(=O)NC(=O)N(C)C1=O",
      "standard_inchi": "InChI=1S/C14H18N2O3/c1-5-7-8-10(3)14(9-6-2)11(17)15-13(19)16(4)12(14)18/h6,10H,2,5,9H2,1,3-4H3,(H,15,17,19)",
      "standard_inchi_key": "NZXKDOXHBHYTKP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Methohexital (BAN, INN, USP)",
        "Methohexital sodium (FDA, USP)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N03AA02",
        "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Barbiturates and derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Anticonvulsant; Sedative-Hypnotic,Sedative-Hypnotic; Anticonvulsant",
    "molecule_chembl_id": "CHEMBL40",
    "molecule_properties": {
      "acd_logd": 0.31,
      "acd_logp": 0.53,
      "acd_most_apka": 7.58,
      "alogp": 0.7,
      "aromatic_rings": 1,
      "full_molformula": "C12H12N2O3",
      "full_mwt": 232.24,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 232.24,
      "mw_monoisotopic": 232.0848,
      "psa": 75.27,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCC1(C(=O)NC(=O)NC1=O)c2ccccc2",
      "standard_inchi": "InChI=1S/C12H12N2O3/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16/h3-7H,2H2,1H3,(H2,13,14,15,16,17)",
      "standard_inchi_key": "DDBREPKUVSBGFI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Phenobarbital Sodium (INN, JAN, USP)",
        "Phenobarbital (BAN, INN, JAN, USP)",
        null
      ]
    },
    "usan_stem": "-barb-",
    "usan_stem_definition": "barbituric acid derivatives",
    "usan_stem_substem": "-barb-(-barb-)"
  },
  {
    "applicants": {
      "value": [
        "Mallinckrodt Inc",
        "Lannett Holdings Inc",
        "Torrent Pharmaceuticals Ltd",
        "Allergan Pharmaceuticals International Ltd",
        "Eli Lilly And Co",
        "Aurobindo Pharma Ltd",
        "Par Pharmaceutical Inc",
        "China Resources Double Crane Pharmaceutical Co Ltd",
        "Teva Pharmaceuticals Usa",
        "Sun Pharmaceutical Industries Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AB03",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Selective serotonin reuptake inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1987,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL41",
    "molecule_properties": {
      "acd_logd": 1.41,
      "acd_logp": 3.93,
      "acd_most_bpka": 10.05,
      "alogp": 4.44,
      "aromatic_rings": 2,
      "full_molformula": "C17H18F3NO",
      "full_mwt": 309.33,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 309.33,
      "mw_monoisotopic": 309.134,
      "psa": 21.26,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CNCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2",
      "standard_inchi": "InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3",
      "standard_inchi_key": "RTHCYVBBDHJXIQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5910319,
    "oral": true,
    "research_codes": {
      "value": "LY-110140"
    },
    "rule_of_five": true,
    "sc_patent": "US-5910319-A",
    "synonyms": {
      "value": [
        "Fluoxetine HCl (FDA, USAN, USP)",
        "Fluoxetine (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-oxetine",
    "usan_stem_definition": "antidepressants (fluoxetine type)",
    "usan_stem_substem": "-oxetine(-oxetine)",
    "usan_year": 1975
  },
  {
    "applicants": {
      "value": [
        "Chartwell Molecules Llc",
        "Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc",
        "Naska Pharmacal Co Inc Div Rugby Darby Group Cosmetics",
        "West-Ward Pharmaceuticals International Ltd",
        "Hospira Inc",
        "Pliva Inc",
        "Aurobindo Pharma Ltd",
        "Bedford Laboratories Div Ben Venue Laboratories Inc",
        "Teva Pharmaceuticals Usa",
        "Hoffmann La Roche Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01EC01",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Intermediate-acting sulfonamides"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1973,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL443",
    "molecule_properties": {
      "acd_logd": -0.54,
      "acd_logp": 0.66,
      "acd_most_apka": 5.81,
      "acd_most_bpka": 1.39,
      "alogp": 1.37,
      "aromatic_rings": 2,
      "full_molformula": "C10H11N3O3S",
      "full_mwt": 253.28,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 17,
      "molecular_species": "ACID",
      "mw_freebase": 253.28,
      "mw_monoisotopic": 253.0521,
      "psa": 98.22,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1onc(NS(=O)(=O)c2ccc(N)cc2)c1",
      "standard_inchi": "InChI=1S/C10H11N3O3S/c1-7-6-10(12-16-7)13-17(14,15)9-4-2-8(11)3-5-9/h2-6H,11H2,1H3,(H,12,13)",
      "standard_inchi_key": "JLKIGFTWXXRPMT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "Ro-42130"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Acetylsulfamethoxazole (JAN)",
        "Sulfamethoxazole (BAN, FDA, INN, JAN, USAN, USP)",
        "Sulfamethoxazole Sodium (JAN)",
        null
      ]
    },
    "usan_stem": "sulfa-",
    "usan_stem_definition": "antimicrobials (sulfonamides derivatives)",
    "usan_stem_substem": "sulfa-(sulfa-)",
    "usan_year": 1962
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05CA04",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL444",
    "molecule_properties": {
      "acd_logd": 0.69,
      "acd_logp": 0.8,
      "acd_most_apka": 7.92,
      "alogp": 0.16,
      "full_molformula": "C8H12N2O3",
      "full_mwt": 184.19,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 13,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 184.19,
      "mw_monoisotopic": 184.0848,
      "psa": 75.27,
      "qed_weighted": 0.6,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCC1(CC)C(=O)NC(=O)NC1=O",
      "standard_inchi": "InChI=1S/C8H12N2O3/c1-3-8(4-2)5(11)9-7(13)10-6(8)12/h3-4H2,1-2H3,(H2,9,10,11,12,13)",
      "standard_inchi_key": "FTOAOBMCPZCFFF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Barbital Sodium (INN, MI, NF)",
        "Barbitone Sodium (BAN)",
        "Barbital (BAN, INN, JAN, MI, NF)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Teva Pharmaceuticals Usa",
        "Jazz Pharmaceuticals Iii International Ltd",
        "Sun Pharmaceutical Industries Inc",
        "Heritage Life Sciences Barbados Inc",
        "Tasman Pharma Inc",
        "Sandoz Inc",
        "Barr Laboratories Inc",
        "Zydus Pharmaceuticals Usa Inc",
        "Par Pharmaceutical"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AH02",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1989,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL42",
    "molecule_properties": {
      "acd_logd": 3.53,
      "acd_logp": 3.94,
      "acd_most_bpka": 7.33,
      "alogp": 3.72,
      "aromatic_rings": 2,
      "full_molformula": "C18H19ClN4",
      "full_mwt": 326.83,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 326.83,
      "mw_monoisotopic": 326.1298,
      "psa": 30.87,
      "qed_weighted": 0.8,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24",
      "standard_inchi": "InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3",
      "standard_inchi_key": "QZUDBNBUXVUHMW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6024981,
    "oral": true,
    "research_codes": {
      "value": "HF-1854"
    },
    "rule_of_five": true,
    "sc_patent": "US-6024981-A",
    "synonyms": {
      "value": [
        "Clozapine (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-pin(e)",
    "usan_stem_definition": "tricyclic compounds",
    "usan_stem_substem": "-pin(e)(-pin(e))",
    "usan_year": 1969
  },
  {
    "applicants": {
      "value": [
        "Mallinckrodt Llc",
        "Aurolife Pharma Llc",
        "Mayne Pharma Llc",
        "Mallinckrodt Inc",
        "Teva Pharmaceuticals Usa Inc",
        "Eli Lilly And Co",
        "Ranbaxy Pharmaceuticals Inc",
        "Idt Australia Ltd",
        "Mylan Pharmaceuticals Inc",
        "Pharmaceutical Associates Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AA10",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1964,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL445",
    "molecule_properties": {
      "acd_logd": 1.49,
      "acd_logp": 3.97,
      "acd_most_bpka": 10,
      "alogp": 3.83,
      "aromatic_rings": 2,
      "full_molformula": "C19H21N",
      "full_mwt": 263.38,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 263.38,
      "mw_monoisotopic": 263.1674,
      "psa": 12.03,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CNCCC=C1c2ccccc2CCc3ccccc13",
      "standard_inchi": "InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-11,20H,6,12-14H2,1H3",
      "standard_inchi_key": "PHVGLTMQBUFIQQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": 38489
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nortriptyline HCl (FDA, JAN, USAN, USP)",
        "Nortriptyline (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-triptyline",
    "usan_stem_definition": "antidepressants (dibenzo[a,d]cycloheptane derivatives)",
    "usan_stem_substem": "-triptyline(-triptyline)",
    "usan_year": 1963
  },
  {
    "applicants": {
      "value": [
        "Lederle Laboratories Div American Cyanamid Co",
        "Lannett Co Inc",
        "Forest Pharmaceuticals Inc",
        "Eli Lilly And Co",
        "Pal Pak Inc",
        "Purepac Pharmaceutical Co",
        "Bristol Myers Squibb Co",
        "Impax Laboratories Inc",
        "Wyeth Ayerst Laboratories",
        "Alpharma Us Pharmaceuticals Division"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01EB03",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Short-acting sulfonamides"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1949,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL446",
    "molecule_properties": {
      "acd_logd": 0.15,
      "acd_logp": 0.3,
      "acd_most_apka": 7.89,
      "acd_most_bpka": 1.08,
      "alogp": 1.48,
      "aromatic_rings": 2,
      "full_molformula": "C12H14N4O2S",
      "full_mwt": 278.34,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 278.34,
      "mw_monoisotopic": 278.0837,
      "psa": 97.97,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1",
      "standard_inchi": "InChI=1S/C12H14N4O2S/c1-8-7-9(2)15-12(14-8)16-19(17,18)11-5-3-10(13)4-6-11/h3-7H,13H2,1-2H3,(H,14,15,16)",
      "standard_inchi_key": "ASWVTGNCAZCNNR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulfadimidine (BAN, INN)",
        "Sulfamethazine (USP)",
        "Sulfamethazine (Trisulfapyrimidines) (FDA)",
        null
      ]
    },
    "usan_stem": "sulfa-",
    "usan_stem_definition": "antimicrobials (sulfonamides derivatives)",
    "usan_stem_substem": "sulfa-(sulfa-)"
  },
  {
    "applicants": {
      "value": [
        "Vitarine Pharmaceuticals Inc",
        "Everylife",
        "Anabolic Inc",
        "Whiteworth Towne Paulsen Inc",
        "Valeant Pharmaceuticals North America Llc",
        "Lannett Co Inc",
        "Eli Lilly And Co",
        "Watson Laboratories Inc",
        "West Ward Pharmaceutical Corp",
        "Ivax Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05CA06",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1950,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL447",
    "molecule_properties": {
      "acd_logd": 2.16,
      "acd_logp": 2.3,
      "acd_most_apka": 7.81,
      "alogp": 1.35,
      "full_molformula": "C12H18N2O3",
      "full_mwt": 238.29,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 238.29,
      "mw_monoisotopic": 238.1317,
      "psa": 75.27,
      "qed_weighted": 0.56,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCCC(C)C1(CC=C)C(=O)NC(=O)NC1=O",
      "standard_inchi": "InChI=1S/C12H18N2O3/c1-4-6-8(3)12(7-5-2)9(15)13-11(17)14-10(12)16/h5,8H,2,4,6-7H2,1,3H3,(H2,13,14,15,16,17)",
      "standard_inchi_key": "KQPKPCNLIDLUMF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Secobarbital Sodium (BAN, FDA, JAN, USP)",
        "Secobarbital (INN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-barb-",
    "usan_stem_definition": "barbituric acid derivatives",
    "usan_stem_substem": "-barb-(-barb-)",
    "withdrawn_class": "Misuse",
    "withdrawn_country": "France; Norway",
    "withdrawn_reason": "Self-poisoning",
    "withdrawn_year": 1980
  },
  {
    "applicants": {
      "value": [
        "Vitarine Pharmaceuticals Inc",
        "Everylife",
        "Anabolic Inc",
        "Whiteworth Towne Paulsen Inc",
        "Nexgen Pharma Inc",
        "Oak Pharmaceuticals Inc",
        "Lannett Co Inc",
        "Renaissance Ssa Llc",
        "Watson Laboratories Inc",
        "Custopharm Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05CA01",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1973,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL448",
    "molecule_properties": {
      "acd_logd": 2.06,
      "acd_logp": 2.18,
      "acd_most_apka": 7.93,
      "alogp": 1.18,
      "full_molformula": "C11H18N2O3",
      "full_mwt": 226.28,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 226.28,
      "mw_monoisotopic": 226.1317,
      "psa": 75.27,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCCC(C)C1(CC)C(=O)NC(=O)NC1=O",
      "standard_inchi": "InChI=1S/C11H18N2O3/c1-4-6-7(3)11(5-2)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)",
      "standard_inchi_key": "WEXRUCMBJFQVBZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pentobarbital Sodium (FDA, JAN, USP)",
        "Pentobarbital (BAN, FDA, INN, USP)",
        "Pentobarbital Calcium (JAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-barb-",
    "usan_stem_definition": "barbituric acid derivatives",
    "usan_stem_substem": "-barb-(-barb-)",
    "withdrawn_class": "Misuse",
    "withdrawn_country": "Norway",
    "withdrawn_reason": "Self-Poisonings",
    "withdrawn_year": 1980
  },
  {
    "atc_classification": {
      "drug": {
        "code": "P01AX05",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Other agents against amoebiasis and other protozoal diseases"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL7568",
    "molecule_properties": {
      "acd_logd": 2.29,
      "acd_logp": 5.59,
      "acd_most_bpka": 10.47,
      "alogp": 5.97,
      "aromatic_rings": 3,
      "full_molformula": "C23H30ClN3O",
      "full_mwt": 399.97,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 28,
      "molecular_species": "BASE",
      "mw_freebase": 399.97,
      "mw_monoisotopic": 399.2077,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 37.39,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc3ccc(OC)cc13",
      "standard_inchi": "InChI=1S/C23H30ClN3O/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26)",
      "standard_inchi_key": "GPKJTRJOBQGKQK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "GNF-Pf-5448",
        "TCMDC-125480"
      ]
    },
    "synonyms": {
      "value": [
        "Mepacrine (BAN, INN)",
        "Quinacrine HCl (USP)",
        null
      ]
    },
    "usan_stem": "-crine",
    "usan_stem_definition": "acridine derivatives",
    "usan_stem_substem": "-crine(-crine)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05CA02",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL267894",
    "molecule_properties": {
      "acd_logd": 0.14,
      "acd_logp": 2.01,
      "acd_most_apka": 7.69,
      "alogp": 1.39,
      "full_molformula": "C11H18N2O3",
      "full_mwt": 226.28,
      "hba": 2,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 226.28,
      "mw_monoisotopic": 226.1317,
      "psa": 78.76,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCC1(CCC(C)C)C(=O)NC(=NC1=O)O",
      "standard_inchi": "InChI=1S/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)",
      "standard_inchi_key": "VIROVYVQCGLCII-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Amobarbital (BAN, INN, JAN, USP)",
        "Amobarbital Sodium (USP)",
        "Amobarbital Sodium For Injection (JAN)",
        null
      ]
    },
    "usan_stem": "-barb-",
    "usan_stem_definition": "barbituric acid derivatives",
    "usan_stem_substem": "-barb-(-barb-)",
    "withdrawn_class": "Misuse",
    "withdrawn_country": "Norway",
    "withdrawn_reason": "Self-Poisonings",
    "withdrawn_year": 1980
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "N05CA16",
          "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plai"
        },
        {
          "code": "N01AF02",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Barbiturates, plain"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL7728",
    "molecule_properties": {
      "acd_logd": 1.36,
      "acd_logp": 1.46,
      "acd_most_apka": 7.99,
      "alogp": 1.2,
      "full_molformula": "C12H16N2O3",
      "full_mwt": 236.27,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 236.27,
      "mw_monoisotopic": 236.1161,
      "psa": 66.48,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)NC(=O)C(C)(C2=CCCCC2)C1=O",
      "standard_inchi": "InChI=1S/C12H16N2O3/c1-12(8-6-4-3-5-7-8)9(15)13-11(17)14(2)10(12)16/h6H,3-5,7H2,1-2H3,(H,13,15,17)",
      "standard_inchi_key": "UYXAWHWODHRRMR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Hexobarbital (BAN, INN, JAN, MI, USP)",
        "Hexobarbital Sodium (NF)",
        null
      ]
    },
    "usan_stem": "-barb-",
    "usan_stem_definition": "barbituric acid derivatives",
    "usan_stem_substem": "-barb-(-barb-)"
  },
  {
    "applicants": {
      "value": [
        "Solvay Pharmaceuticals",
        "Whiteworth Towne Paulsen Inc",
        "Hikma Pharmaceuticals Llc",
        "Medpointe Pharmaceuticals Medpointe Healthcare Inc",
        "Mylan Specialty Lp",
        "Lannett Co Inc",
        "Sandoz Inc",
        "Watson Laboratories Inc",
        "Wockhardt Eu Operations (Swiss) Ag",
        "Halsey Drug Co Inc"
      ]
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1939,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL449",
    "molecule_properties": {
      "acd_logd": 1.56,
      "acd_logp": 1.67,
      "acd_most_apka": 7.93,
      "alogp": 0.79,
      "full_molformula": "C10H16N2O3",
      "full_mwt": 212.25,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 212.25,
      "mw_monoisotopic": 212.1161,
      "psa": 75.27,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(C)C1(CC)C(=O)NC(=O)NC1=O",
      "standard_inchi": "InChI=1S/C10H16N2O3/c1-4-6(3)10(5-2)7(13)11-9(15)12-8(10)14/h6H,4-5H2,1-3H3,(H2,11,12,13,14,15)",
      "standard_inchi_key": "ZRIHAIZYIMGOAB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Butabarbital Sodium (FDA, USP)",
        "Secbutabarbital Sodium (INN)",
        "Butabarbital (USP)",
        "Secbutabarbital (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-barb-",
    "usan_stem_definition": "barbituric acid derivatives",
    "usan_stem_substem": "-barb-(-barb-)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05CA05",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL7863",
    "molecule_properties": {
      "acd_logd": 1.14,
      "acd_logp": 1.28,
      "acd_most_apka": 7.81,
      "alogp": 0.57,
      "full_molformula": "C10H14N2O3",
      "full_mwt": 210.23,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 210.23,
      "mw_monoisotopic": 210.1004,
      "psa": 75.27,
      "qed_weighted": 0.53,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)C1(CC=C)C(=O)NC(=O)NC1=O",
      "standard_inchi": "InChI=1S/C10H14N2O3/c1-4-5-10(6(2)3)7(13)11-9(15)12-8(10)14/h4,6H,1,5H2,2-3H3,(H2,11,12,13,14,15)",
      "standard_inchi_key": "UORJNBVJVRLXMQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Aprobarbital (DCF, INN, MI, NF)",
        null
      ]
    },
    "usan_stem": "-barb-",
    "usan_stem_definition": "barbituric acid derivatives",
    "usan_stem_substem": "-barb-(-barb-)"
  },
  {
    "applicants": {
      "value": "Abbvie Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "N03AA30",
        "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Barbiturates and derivatives"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "molecule_chembl_id": "CHEMBL450",
    "molecule_properties": {
      "acd_logd": 1.45,
      "acd_logp": 1.5,
      "acd_most_apka": 8.27,
      "alogp": 0.5,
      "full_molformula": "C9H14N2O3",
      "full_mwt": 198.22,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 198.22,
      "mw_monoisotopic": 198.1004,
      "psa": 66.48,
      "qed_weighted": 0.66,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCC1(CC)C(=O)NC(=O)N(C)C1=O",
      "standard_inchi": "InChI=1S/C9H14N2O3/c1-4-9(5-2)6(12)10-8(14)11(3)7(9)13/h4-5H2,1-3H3,(H,10,12,14)",
      "standard_inchi_key": "FWJKNZONDWOGMI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Metharbital (BAN, FDA, INN, JAN, USP)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05CA21",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Barbiturates, plain"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL267719",
    "molecule_properties": {
      "acd_logd": 0.73,
      "acd_logp": 0.92,
      "acd_most_apka": 7.67,
      "alogp": 0.49,
      "full_molformula": "C10H12N2O3",
      "full_mwt": 208.22,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 208.22,
      "mw_monoisotopic": 208.0848,
      "psa": 75.27,
      "qed_weighted": 0.52,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "C=CCC1(CC=C)C(=O)NC(=O)NC1=O",
      "standard_inchi": "InChI=1S/C10H12N2O3/c1-3-5-10(6-4-2)7(13)11-9(15)12-8(10)14/h3-4H,1-2,5-6H2,(H2,11,12,13,14,15)",
      "standard_inchi_key": "FDQGNLOWMMVRQL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Allobarbital (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-barb-",
    "usan_stem_definition": "barbituric acid derivatives",
    "usan_stem_substem": "-barb-(-barb-)",
    "usan_year": 1966
  },
  {
    "applicants": {
      "value": [
        "Rachelle Laboratories Inc",
        "Valeant Pharmaceuticals North America Llc",
        "Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc",
        "Anda Repository Llc",
        "Halsey Drug Co Inc",
        "Par Pharmaceutical Inc",
        "Mylan Pharmaceuticals Inc",
        "Vangard Laboratories Inc Div Midway Medical Co",
        "Hoffmann La Roche Inc",
        "Roxane Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05BA02",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1960,
    "first_in_class": true,
    "indication_class": "Sedative-Hypnotic,Tranquilizer (minor)",
    "molecule_chembl_id": "CHEMBL451",
    "molecule_properties": {
      "acd_logd": 2.49,
      "acd_logp": 2.49,
      "acd_most_bpka": 2.38,
      "alogp": 2.95,
      "aromatic_rings": 2,
      "full_molformula": "C16H14ClN3O",
      "full_mwt": 299.76,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 299.76,
      "mw_monoisotopic": 299.0825,
      "psa": 50.46,
      "qed_weighted": 0.65,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3",
      "standard_inchi": "InChI=1S/C16H14ClN3O/c1-18-15-10-20(21)16(11-5-3-2-4-6-11)13-9-12(17)7-8-14(13)19-15/h2-9H,10H2,1H3,(H,18,19)",
      "standard_inchi_key": "ANTSCNMPPGJYLG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "Ro-5-0690",
        "Ro-50690"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Chlordiazepoxide HCl (BAN, FDA, JAN, USAN, USP)",
        "Chlordiazepoxide (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "usan_year": 1963
  },
  {
    "atc_classification": {
      "drug": {
        "code": "B01AE04",
        "description": "BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Direct thrombin inhibitors"
      }
    },
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL266349",
    "molecule_properties": {
      "acd_logd": -0.51,
      "acd_logp": 2.42,
      "acd_most_apka": 2.12,
      "acd_most_bpka": 11.62,
      "alogp": 0.81,
      "aromatic_rings": 1,
      "full_molformula": "C22H31N5O4",
      "full_mwt": 429.52,
      "hba": 5,
      "hba_lipinski": 9,
      "hbd": 5,
      "hbd_lipinski": 6,
      "heavy_atoms": 31,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 429.52,
      "mw_monoisotopic": 429.2376,
      "num_lipinski_ro5_violations": 1,
      "psa": 148.61,
      "qed_weighted": 0.29,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=N)c1ccc(CNC(=O)[C@@H]2CCN2C(=O)[C@H](NCC(=O)O)C3CCCCC3)cc1",
      "standard_inchi": "InChI=1S/C22H31N5O4/c23-20(24)16-8-6-14(7-9-16)12-26-21(30)17-10-11-27(17)22(31)19(25-13-18(28)29)15-4-2-1-3-5-15/h6-9,15,17,19,25H,1-5,10-13H2,(H3,23,24)(H,26,30)(H,28,29)/t17-,19+/m0/s1",
      "standard_inchi_key": "DKWNMCUOEDMMIN-PKOBYXMFSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Melagatran (INN)",
        null
      ]
    },
    "usan_stem": "-gatran",
    "usan_stem_definition": "thrombin inhibitors (argatroban type)",
    "usan_stem_substem": "-gatran(-gatran)"
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Hoffmann La Roche Inc",
        "Actavis Elizabeth Llc",
        "Sun Pharmaceutical Industries Inc",
        "Apotex Inc",
        "Sandoz Inc",
        "Watson Laboratories Inc",
        "Par Pharmaceutical Inc",
        "Prinston Pharmaceutical Inc",
        "Barr Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N03AE01",
        "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Benzodiazepine derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1975,
    "indication_class": "Anticonvulsant",
    "molecule_chembl_id": "CHEMBL452",
    "molecule_properties": {
      "acd_logd": 2.52,
      "acd_logp": 2.52,
      "acd_most_apka": 11.21,
      "acd_most_bpka": 1.55,
      "alogp": 3.04,
      "aromatic_rings": 2,
      "full_molformula": "C15H10ClN3O3",
      "full_mwt": 315.72,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 315.72,
      "mw_monoisotopic": 315.0411,
      "psa": 84.6,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1",
      "standard_inchi": "InChI=1S/C15H10ClN3O3/c16-12-4-2-1-3-10(12)15-11-7-9(19(21)22)5-6-13(11)18-14(20)8-17-15/h1-7H,8H2,(H,18,20)",
      "standard_inchi_key": "DGBIGWXXNGSACT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "Ro-5-4023",
        "Ro-54023"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clonazepam (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-azepam",
    "usan_stem_definition": "antianxiety agents (diazepam type)",
    "usan_stem_substem": "-azepam(-azepam)",
    "usan_year": 1969
  },
  {
    "applicants": {
      "value": [
        "Vitarine Pharmaceuticals Inc",
        "Hoffmann La Roche Inc",
        "Aurolife Pharma Llc",
        "Lederle Laboratories Div American Cyanamid Co",
        "Roxane Laboratories Inc",
        "Sola Barnes Hind",
        "Lannett Co Inc",
        "Solvay Pharmaceuticals",
        "Mk Laboratories Inc",
        "Watson Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01AB02",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Sulfonamide"
        },
        {
          "code": "J01EB05",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Short-acting sulfonamides"
        }
      ]
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1971,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL453",
    "molecule_properties": {
      "acd_logd": -0.55,
      "acd_logp": 1.01,
      "acd_most_apka": 4.83,
      "acd_most_bpka": 1.52,
      "alogp": 1.67,
      "aromatic_rings": 2,
      "full_molformula": "C11H13N3O3S",
      "full_mwt": 267.31,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 18,
      "molecular_species": "ACID",
      "mw_freebase": 267.31,
      "mw_monoisotopic": 267.0678,
      "psa": 98.22,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C",
      "standard_inchi": "InChI=1S/C11H13N3O3S/c1-7-8(2)13-17-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6,14H,12H2,1-2H3",
      "standard_inchi_key": "NHUHCSRWZMLRLA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "NU-445"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulfisoxazole Diolamine (FDA, USAN, USP)",
        "Sulfafurazole (BAN, INN)",
        "Sulfisoxazole (FDA, JAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1966
  },
  {
    "atc_classification": {
      "drug": {
        "code": "J01ED05",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Long-acting sulfonamides"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL268869",
    "molecule_properties": {
      "acd_logd": -0.45,
      "acd_logp": 0.32,
      "acd_most_apka": 7.19,
      "acd_most_bpka": 3.54,
      "alogp": 0.87,
      "aromatic_rings": 2,
      "full_molformula": "C11H12N4O3S",
      "full_mwt": 280.31,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 280.31,
      "mw_monoisotopic": 280.063,
      "psa": 107.2,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1",
      "standard_inchi": "InChI=1S/C11H12N4O3S/c1-18-11-7-6-10(13-14-11)15-19(16,17)9-4-2-8(12)3-5-9/h2-7H,12H2,1H3,(H,13,15)",
      "standard_inchi_key": "VLYWMPOKSSWJAL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulfamethoxypyridazine (BAN, INN, MI, USP)",
        null
      ]
    },
    "usan_stem": "sulfa-",
    "usan_stem_definition": "antimicrobials (sulfonamides derivatives)",
    "usan_stem_substem": "sulfa-(sulfa-)",
    "withdrawn_country": "United Kingdom",
    "withdrawn_year": 1986
  },
  {
    "applicants": {
      "value": [
        "Gilbert Laboratories",
        "Novast Laboratories Ltd",
        "Mallinckrodt Chemical Inc",
        "Mallinckrodt Inc",
        "Mayrand Inc",
        "Forest Pharmaceuticals Inc",
        "Lannett Holdings Inc",
        "Allergan Sales Llc",
        "Halsey Drug Co Inc",
        "Hikma International Pharmaceuticals Llc"
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1983,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL454",
    "molecule_properties": {
      "acd_logd": 1.64,
      "acd_logp": 1.79,
      "acd_most_apka": 7.78,
      "alogp": 0.96,
      "full_molformula": "C11H16N2O3",
      "full_mwt": 224.26,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 224.26,
      "mw_monoisotopic": 224.1161,
      "psa": 75.27,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O",
      "standard_inchi": "InChI=1S/C11H16N2O3/c1-4-5-11(6-7(2)3)8(14)12-10(16)13-9(11)15/h4,7H,1,5-6H2,2-3H3,(H2,12,13,14,15,16)",
      "standard_inchi_key": "UZVHFVZFNXBMQJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Butalbital (FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1966
  },
  {
    "applicants": {
      "value": [
        "Valeant Pharmaceuticals North America Llc",
        "E Fougera Div Altana Inc",
        "Sola Barnes Hind",
        "Pharmafair Inc",
        "Optopics Laboratories Corp",
        "Bausch And Lomb Pharmaceuticals Inc",
        "Alcon Pharmaceuticals Ltd",
        "Akorn Inc",
        "Schering Corp Sub Schering Plough Corp",
        "Taro Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D10AF06",
          "description": "DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Antiinfectives for treatment of acn"
        },
        {
          "code": "S01AB04",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Sulfonamides"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1945,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL455",
    "molecule_properties": {
      "acd_logd": -2.52,
      "acd_logp": -0.96,
      "acd_most_apka": 5.43,
      "acd_most_bpka": 0.93,
      "alogp": 0.09,
      "aromatic_rings": 1,
      "full_molformula": "C8H10N2O3S",
      "full_mwt": 214.25,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 14,
      "molecular_species": "ACID",
      "mw_freebase": 214.25,
      "mw_monoisotopic": 214.0412,
      "psa": 89.26,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)NS(=O)(=O)c1ccc(N)cc1",
      "standard_inchi": "InChI=1S/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11)",
      "standard_inchi_key": "SKIVFJLNDNKQPD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulfacetamide (BAN, INN, USP)",
        "Sulfacetamide (Triple Sulfa) (FDA)",
        "Sulfacetamide sodium (FDA, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "sulfa-",
    "usan_stem_definition": "antimicrobials (sulfonamides derivatives)",
    "usan_stem_substem": "sulfa-(sulfa-)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "L01XX01",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL43",
    "molecule_properties": {
      "acd_logd": 3.22,
      "acd_logp": 3.32,
      "acd_most_apka": 8.55,
      "acd_most_bpka": 7.89,
      "alogp": 4.51,
      "aromatic_rings": 4,
      "full_molformula": "C21H19N3O3S",
      "full_mwt": 393.47,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 393.47,
      "mw_monoisotopic": 393.1147,
      "psa": 80.32,
      "qed_weighted": 0.49,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(NS(=O)(=O)C)ccc1Nc2c3ccccc3nc4ccccc24",
      "standard_inchi": "InChI=1S/C21H19N3O3S/c1-27-20-13-14(24-28(2,25)26)11-12-19(20)23-21-15-7-3-5-9-17(15)22-18-10-6-4-8-16(18)21/h3-13,24H,1-2H3,(H,22,23)",
      "standard_inchi_key": "XCPGHVQEEXUHNC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "CI-880",
        "NCI-249992",
        "M-AMSA"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Amsacrine (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-crine",
    "usan_stem_definition": "acridine derivatives",
    "usan_stem_substem": "-crine(-crine)",
    "usan_year": 1980
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antihypertensive; Diuretic",
    "molecule_chembl_id": "CHEMBL7797",
    "molecule_properties": {
      "acd_logd": -0.46,
      "acd_logp": 3.23,
      "acd_most_apka": 2.8,
      "alogp": 4.15,
      "aromatic_rings": 2,
      "full_molformula": "C18H14Cl2O4",
      "full_mwt": 365.21,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "ACID",
      "mw_freebase": 365.21,
      "mw_monoisotopic": 364.0269,
      "psa": 63.6,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)c3ccccc3",
      "standard_inchi": "InChI=1S/C18H14Cl2O4/c1-18(11-5-3-2-4-6-11)8-10-7-12(24-9-13(21)22)15(19)16(20)14(10)17(18)23/h2-7H,8-9H2,1H3,(H,21,22)",
      "standard_inchi_key": "PRKWVSHZYDOZLP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MK-196"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Indacrinone (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-rinone",
    "usan_stem_definition": "cardiotonics (amrinone type)",
    "usan_stem_substem": "-rinone(-rinone)",
    "usan_year": 1979
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL429405",
    "molecule_properties": {
      "acd_logd": -1.97,
      "acd_logp": 0.54,
      "acd_most_apka": 2.12,
      "acd_most_bpka": 9.54,
      "alogp": 1.93,
      "aromatic_rings": 1,
      "full_molformula": "C13H18Cl2N2O2",
      "full_mwt": 305.21,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 19,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 305.21,
      "mw_monoisotopic": 304.0745,
      "psa": 66.56,
      "qed_weighted": 0.72,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "NC(Cc1ccc(cc1)N(CCCl)CCCl)C(=O)O",
      "standard_inchi": "InChI=1S/C13H18Cl2N2O2/c14-5-7-17(8-6-15)11-3-1-10(2-4-11)9-12(16)13(18)19/h1-4,12H,5-9,16H2,(H,18,19)",
      "standard_inchi_key": "SGDBTWWWUNNDEQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sarcolysin (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "West-Ward Pharmaceuticals International Ltd",
        "Par Sterile Products Llc",
        "Aton Pharma Inc",
        "Edenbridge Pharmaceuticals Llc",
        "Zydus Pharmaceuticals Usa Inc",
        "Mylan Institutional Llc",
        "Par Pharmaceutical Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C03CC01",
        "description": "CARDIOVASCULAR SYSTEM: DIURETICS: HIGH-CEILING DIURETICS: Aryloxyacetic acid derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1967,
    "indication_class": "Diuretic",
    "molecule_chembl_id": "CHEMBL456",
    "molecule_properties": {
      "acd_logd": -0.85,
      "acd_logp": 2.84,
      "acd_most_apka": 2.81,
      "alogp": 3.61,
      "aromatic_rings": 1,
      "full_molformula": "C13H12Cl2O4",
      "full_mwt": 303.14,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "ACID",
      "mw_freebase": 303.14,
      "mw_monoisotopic": 302.0113,
      "psa": 63.6,
      "qed_weighted": 0.64,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(=C)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl",
      "standard_inchi": "InChI=1S/C13H12Cl2O4/c1-3-7(2)13(18)8-4-5-9(12(15)11(8)14)19-6-10(16)17/h4-5H,2-3,6H2,1H3,(H,16,17)",
      "standard_inchi_key": "AVOLMBLBETYQHX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "MK-595"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Etacrynic Acid (DCF, INN, JAN)",
        "Ethacrynic acid (BAN, FDA, USAN, USP)",
        "Ethacrynate Sodium (FDA, USAN, USP)",
        null
      ]
    },
    "usan_year": 1963
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL7549",
    "molecule_properties": {
      "acd_logd": 0.73,
      "acd_logp": 2.74,
      "acd_most_apka": 9.95,
      "acd_most_bpka": 9.44,
      "alogp": 2.98,
      "aromatic_rings": 1,
      "full_molformula": "C14H21NO",
      "full_mwt": 219.33,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "BASE",
      "mw_freebase": 219.33,
      "mw_monoisotopic": 219.1623,
      "psa": 23.47,
      "qed_weighted": 0.84,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCCN1CCC[C@H](C1)c2cccc(O)c2",
      "standard_inchi": "InChI=1S/C14H21NO/c1-2-8-15-9-4-6-13(11-15)12-5-3-7-14(16)10-12/h3,5,7,10,13,16H,2,4,6,8-9,11H2,1H3/t13-/m1/s1",
      "standard_inchi_key": "HTSNFXAICLXZMA-CYBMUJFWSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Preclamol (INN)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C03CC02",
        "description": "CARDIOVASCULAR SYSTEM: DIURETICS: HIGH-CEILING DIURETICS: Aryloxyacetic acid derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1979,
    "indication_class": "Diuretic; Uricosuric; Antihypertensive",
    "molecule_chembl_id": "CHEMBL267744",
    "molecule_properties": {
      "acd_logd": -0.65,
      "acd_logp": 3.04,
      "acd_most_apka": 2.79,
      "alogp": 3.75,
      "aromatic_rings": 2,
      "full_molformula": "C13H8Cl2O4S",
      "full_mwt": 331.18,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "ACID",
      "mw_freebase": 331.18,
      "mw_monoisotopic": 329.952,
      "psa": 63.6,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)COc1ccc(C(=O)c2cccs2)c(Cl)c1Cl",
      "standard_inchi": "InChI=1S/C13H8Cl2O4S/c14-11-7(13(18)9-2-1-5-20-9)3-4-8(12(11)15)19-6-10(16)17/h1-5H,6H2,(H,16,17)",
      "standard_inchi_key": "AGHANLSBXUWXTB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SK&F-62698"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ticrynafen (USAN)",
        "Tienilic Acid (BAN, DCF, INN)",
        null
      ]
    },
    "usan_year": 1975,
    "withdrawn_class": "Hepatotoxicity",
    "withdrawn_country": "United Kingdom; United States; Germany; France",
    "withdrawn_reason": "Liver Toxicity and Death",
    "withdrawn_year": 1980
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL7643",
    "molecule_properties": {
      "acd_logd": 2.2,
      "acd_logp": 4.17,
      "acd_most_apka": 4.96,
      "alogp": 3.34,
      "aromatic_rings": 2,
      "full_molformula": "C16H15ClN2O3S",
      "full_mwt": 350.83,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 350.83,
      "mw_monoisotopic": 350.0492,
      "psa": 75.27,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1ccc(NC(=O)NS(=O)(=O)c2ccc3CCCc3c2)cc1",
      "standard_inchi": "InChI=1S/C16H15ClN2O3S/c17-13-5-7-14(8-6-13)18-16(20)19-23(21,22)15-9-4-11-2-1-3-12(11)10-15/h4-10H,1-3H2,(H2,18,19,20)",
      "standard_inchi_key": "JQJSFAJISYZPER-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "LY-186641"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulofenur (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1990
  },
  {
    "applicants": {
      "value": [
        "Cadila Pharmaceuticals Ltd",
        "Northstar Healthcare Holdings Ltd",
        "Chartwell Molecules Llc",
        "Sun Pharmaceutical Industries Inc",
        "Apotex Inc",
        "Caribe Holdings Cayman Co Ltd Dba Puracap Caribe",
        "Sandoz Inc",
        "Invagen Pharmaceuticals Inc",
        "Teva Pharmaceuticals Usa Inc",
        "Watson Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C10AB04",
        "description": "CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Fibrates"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1981,
    "indication_class": "Antihyperlipidemic",
    "molecule_chembl_id": "CHEMBL457",
    "molecule_properties": {
      "acd_logd": 1.69,
      "acd_logp": 4.3,
      "acd_most_apka": 4.75,
      "alogp": 3.57,
      "aromatic_rings": 1,
      "full_molformula": "C15H22O3",
      "full_mwt": 250.34,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 18,
      "molecular_species": "ACID",
      "mw_freebase": 250.34,
      "mw_monoisotopic": 250.1569,
      "psa": 46.53,
      "qed_weighted": 0.78,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1",
      "standard_inchi": "InChI=1S/C15H22O3/c1-11-6-7-12(2)13(10-11)18-9-5-8-15(3,4)14(16)17/h6-7,10H,5,8-9H2,1-4H3,(H,16,17)",
      "standard_inchi_key": "HEMJJKBWTPKOJG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "CI-719"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Gemfibrozil (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1980
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05CH01",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Melatonin receptor agonists"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL45",
    "molecule_properties": {
      "acd_logd": 1.04,
      "acd_logp": 1.04,
      "alogp": 1.86,
      "aromatic_rings": 2,
      "full_molformula": "C13H16N2O2",
      "full_mwt": 232.28,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 232.28,
      "mw_monoisotopic": 232.1212,
      "psa": 54.12,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2[nH]cc(CCNC(=O)C)c2c1",
      "standard_inchi": "InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",
      "standard_inchi_key": "DRLFMBDRBRZALE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": "Melatonin"
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "B05XB03",
        "description": "BLOOD AND BLOOD FORMING ORGANS: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS: I.V. SOLUTION ADDITIVES: Amino acids"
      }
    },
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Amino Acid",
    "molecule_chembl_id": "CHEMBL8085",
    "molecule_properties": {
      "acd_logd": -4.2,
      "acd_logp": -0.73,
      "acd_most_apka": 2.49,
      "acd_most_bpka": 10.64,
      "alogp": -0.47,
      "full_molformula": "C6H14N2O2",
      "full_mwt": 146.19,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 3,
      "hbd_lipinski": 5,
      "heavy_atoms": 10,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 146.19,
      "mw_monoisotopic": 146.1055,
      "psa": 89.34,
      "qed_weighted": 0.46,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "NCCCC[C@H](N)C(=O)O",
      "standard_inchi": "InChI=1S/C6H14N2O2/c7-4-2-1-3-5(8)6(9)10/h5H,1-4,7-8H2,(H,9,10)/t5-/m0/s1",
      "standard_inchi_key": "KDXKERNSBIXSRK-YFKPBYRVSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lysine (INN, USAN)",
        null
      ]
    },
    "usan_year": 1979
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL266510",
    "molecule_properties": {
      "acd_logd": 2.97,
      "acd_logp": 2.97,
      "acd_most_apka": 10.43,
      "alogp": 4.53,
      "aromatic_rings": 2,
      "full_molformula": "C16H10ClF4NO2",
      "full_mwt": 359.71,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 359.71,
      "mw_monoisotopic": 359.0336,
      "psa": 38.33,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(Cl)cc1[C@]2(F)C(=O)Nc3cc(ccc23)C(F)(F)F",
      "standard_inchi": "InChI=1S/C16H10ClF4NO2/c1-24-13-5-3-9(17)7-11(13)15(18)10-4-2-8(16(19,20)21)6-12(10)22-14(15)23/h2-7H,1H3,(H,22,23)/t15-/m0/s1",
      "standard_inchi_key": "ULYONBAOIMCNEH-HNNXBMFYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BMS-204352"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Flindokalner (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-kalner",
    "usan_stem_definition": "opener of large conductance calcium-activated (maxi-k) K+ channels",
    "usan_stem_substem": "-kalner(-kalner)",
    "usan_year": 2002
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL8184",
    "molecule_properties": {
      "acd_logd": 6.58,
      "acd_logp": 6.58,
      "acd_most_bpka": 4.08,
      "alogp": 2.84,
      "aromatic_rings": 2,
      "full_molformula": "C15H22N4O2",
      "full_mwt": 290.37,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 290.37,
      "mw_monoisotopic": 290.1743,
      "psa": 69.04,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCNc1c(cnc2c1cnn2CC)C(=O)OCC",
      "standard_inchi": "InChI=1S/C15H22N4O2/c1-4-7-8-16-13-11-10-18-19(5-2)14(11)17-9-12(13)15(20)21-6-3/h9-10H,4-8H2,1-3H3,(H,16,17)",
      "standard_inchi_key": "IQNQAOGGWGCROX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SQ-65396"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cartazolate (INN, USAN)",
        null
      ]
    },
    "usan_year": 1975
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Chartwell Molecules Llc",
        "Lannett Holdings Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Hospira Inc",
        "Hikma International Pharmaceuticals Llc",
        "Aurobindo Pharma Ltd",
        "Taro Pharmaceutical Industries Ltd",
        "Natco Pharma Ltd",
        "Ipca Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A04AA01",
        "description": "ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Serotonin (5HT3) antagonists"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1991,
    "indication_class": "Anti-Anxiety Agent; Anti-Emetic; Antischizophrenic",
    "molecule_chembl_id": "CHEMBL46",
    "molecule_properties": {
      "acd_logd": 1.2,
      "acd_logp": 1.55,
      "acd_most_bpka": 7.5,
      "alogp": 3.13,
      "aromatic_rings": 3,
      "full_molformula": "C18H19N3O",
      "full_mwt": 293.37,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 293.37,
      "mw_monoisotopic": 293.1528,
      "psa": 39.82,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1nccn1CC2CCc3c(C2=O)c4ccccc4n3C",
      "standard_inchi": "InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3",
      "standard_inchi_key": "FELGMEQIXOGIFQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8580830,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "GR-38032",
        "GR-38032F"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-8580830-B2",
    "synonyms": {
      "value": [
        "Ondansetron HCl (FDA, JAN, USAN, USP)",
        "Ondansetron (BAN, FDA, INN, USP)",
        null
      ]
    },
    "usan_stem": "-setron",
    "usan_stem_definition": "serotonin 5-HT3 antagonists",
    "usan_stem_substem": "-setron(-setron)",
    "usan_year": 1989
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 1,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (antioxidant)",
    "molecule_chembl_id": "CHEMBL7983",
    "molecule_properties": {
      "acd_logd": 1.64,
      "acd_logp": 1.78,
      "acd_most_apka": 7.94,
      "alogp": 1.37,
      "aromatic_rings": 1,
      "full_molformula": "C10H12O5",
      "full_mwt": 212.2,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 212.2,
      "mw_monoisotopic": 212.0685,
      "psa": 86.99,
      "qed_weighted": 0.52,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCCOC(=O)c1cc(O)c(O)c(O)c1",
      "standard_inchi": "InChI=1S/C10H12O5/c1-2-3-15-10(14)6-4-7(11)9(13)8(12)5-6/h4-5,11-13H,2-3H2,1H3",
      "standard_inchi_key": "ZTHYODDOHIVTJV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Propyl Gallate (NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL8148",
    "molecule_properties": {
      "acd_logd": 0.77,
      "acd_logp": 2.9,
      "acd_most_apka": 11.64,
      "acd_most_bpka": 9.48,
      "alogp": 3.3,
      "aromatic_rings": 2,
      "full_molformula": "C21H28N2O5S",
      "full_mwt": 420.53,
      "hba": 7,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 29,
      "molecular_species": "BASE",
      "mw_freebase": 420.53,
      "mw_monoisotopic": 420.1719,
      "psa": 96.89,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)c1cc(NC(=O)c2cccs2)ccc1OCC(O)CNC(C)(C)C",
      "standard_inchi": "InChI=1S/C21H28N2O5S/c1-5-27-20(26)16-11-14(23-19(25)18-7-6-10-29-18)8-9-17(16)28-13-15(24)12-22-21(2,3)4/h6-11,15,22,24H,5,12-13H2,1-4H3,(H,23,25)",
      "standard_inchi_key": "PHMRLCQEIQGCHH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tienoxolol (INN)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Ulcerative",
    "molecule_chembl_id": "CHEMBL8030",
    "molecule_properties": {
      "acd_logd": 1.85,
      "acd_logp": 2.1,
      "acd_most_bpka": 8.09,
      "alogp": 2.28,
      "aromatic_rings": 2,
      "full_molformula": "C11H10N2O2",
      "full_mwt": 202.21,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 202.21,
      "mw_monoisotopic": 202.0742,
      "psa": 55.24,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cccc(Oc2cnc(O)nc2)c1",
      "standard_inchi": "InChI=1S/C11H10N2O2/c1-8-3-2-4-9(5-8)15-10-6-12-11(14)13-7-10/h2-7H,1H3,(H,12,13,14)",
      "standard_inchi_key": "HJQILFPVRNHTIG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CP-26154"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tolimidone (INN, USAN)",
        null
      ]
    },
    "usan_year": 1978
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Anxiety Agent",
    "molecule_chembl_id": "CHEMBL8412",
    "molecule_properties": {
      "acd_logd": 0.58,
      "acd_logp": 0.97,
      "acd_most_bpka": 7.69,
      "alogp": 1.22,
      "aromatic_rings": 2,
      "full_molformula": "C19H23N5O3S",
      "full_mwt": 401.49,
      "hba": 7,
      "hba_lipinski": 8,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 401.49,
      "mw_monoisotopic": 401.1522,
      "psa": 86.71,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1N(CCCCN2CCN(CC2)c3ncccn3)S(=O)(=O)c4ccccc14",
      "standard_inchi": "InChI=1S/C19H23N5O3S/c25-18-16-6-1-2-7-17(16)28(26,27)24(18)11-4-3-10-22-12-14-23(15-13-22)19-20-8-5-9-21-19/h1-2,5-9H,3-4,10-15H2",
      "standard_inchi_key": "TZJUVVIWVWFLCD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BAY-Q-7821"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ipsapirone (BAN, INN)",
        "Ipsapirone HCl (USAN)",
        null
      ]
    },
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Amneal Pharmaceuticals Co Gmbh",
        "Bristol Myers Squibb Co Pharmaceutical Research Institute",
        "Orion Corp Orion Pharma",
        "Oxford Pharmaceuticals Llc",
        "Apotex Inc",
        "Egis Plc",
        "Sandoz Inc",
        "Nesher Pharmaceuticals Usa Llc",
        "Zydus Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05BE01",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Azaspirodecanedione derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1986,
    "indication_class": "Tranquilizer (minor)",
    "molecule_chembl_id": "CHEMBL49",
    "molecule_properties": {
      "acd_logd": 1.24,
      "acd_logp": 1.59,
      "acd_most_bpka": 7.72,
      "alogp": 2.09,
      "aromatic_rings": 1,
      "full_molformula": "C21H31N5O2",
      "full_mwt": 385.51,
      "hba": 6,
      "hba_lipinski": 7,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 385.51,
      "mw_monoisotopic": 385.2478,
      "psa": 69.64,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4",
      "standard_inchi": "InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",
      "standard_inchi_key": "QWCRAEMEVRGPNT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "MJ-9022-1"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Buspirone HCl (FDA, USAN, USP)",
        "Buspirone (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-spirone",
    "usan_stem_definition": "anxiolytics (buspirone type)",
    "usan_stem_substem": "-spirone(-spirone)",
    "usan_year": 1973
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C02KD01",
        "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: OTHER ANTIHYPERTENSIVES: Serotonin antagonists"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Serotonin Antagonist",
    "molecule_chembl_id": "CHEMBL51",
    "molecule_properties": {
      "acd_logd": 3.05,
      "acd_logp": 3.56,
      "acd_most_apka": 12.83,
      "acd_most_bpka": 7.8,
      "alogp": 2.42,
      "aromatic_rings": 3,
      "full_molformula": "C22H22FN3O3",
      "full_mwt": 395.43,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 395.43,
      "mw_monoisotopic": 395.1645,
      "psa": 75.17,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "Fc1ccc(cc1)C(=O)C2CCN(CCN3C(=O)Nc4ccccc4C3=O)CC2",
      "standard_inchi": "InChI=1S/C22H22FN3O3/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29)",
      "standard_inchi_key": "FPCCSQOGAWCVBH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "R-41468"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ketanserin (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-anserin",
    "usan_stem_definition": "serotonin 5-HT2 receptor antagonists",
    "usan_stem_substem": "-anserin(-anserin)",
    "usan_year": 1981
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Glomerulonephritis Treatment",
    "molecule_chembl_id": "CHEMBL8273",
    "molecule_properties": {
      "acd_logd": -2.25,
      "acd_logp": 1.38,
      "acd_most_apka": 3.19,
      "alogp": 1.67,
      "aromatic_rings": 2,
      "full_molformula": "C16H17NO5S",
      "full_mwt": 335.38,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 335.38,
      "mw_monoisotopic": 335.0827,
      "psa": 92.7,
      "qed_weighted": 0.77,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)COc1ccc(CCNS(=O)(=O)c2ccccc2)cc1",
      "standard_inchi": "InChI=1S/C16H17NO5S/c18-16(19)12-22-14-8-6-13(7-9-14)10-11-17-23(20,21)15-4-2-1-3-5-15/h1-9,17H,10-12H2,(H,18,19)",
      "standard_inchi_key": "XTNWJMVJVSGKLR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "BM 13.177",
        "BM-13177",
        "SK&F-95587"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulotroban (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-troban",
    "usan_stem_definition": "antithrombotics (thromboxane A2 receptor antagonists)",
    "usan_stem_substem": "-troban(-troban)",
    "usan_year": 1989
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Roxane Laboratories Inc",
        "Sun Pharmaceutical Industries Inc",
        "Merck Research Laboratories Div Merck Co Inc",
        "Merck And Co Inc",
        "Sandoz Inc",
        "Superpharm Corp",
        "Teva Pharmaceuticals Usa Inc",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Watson Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C02AB01",
        "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Methyldopa"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1962,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL459",
    "molecule_properties": {
      "acd_logd": -3.26,
      "acd_logp": -0.74,
      "acd_most_apka": 2.28,
      "acd_most_bpka": 8.85,
      "alogp": 0.44,
      "aromatic_rings": 1,
      "full_molformula": "C10H13NO4",
      "full_mwt": 211.22,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 15,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 211.22,
      "mw_monoisotopic": 211.0845,
      "psa": 103.78,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O",
      "standard_inchi": "InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1",
      "standard_inchi_key": "CJCSPKMFHVPWAR-JTQLQIEISA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "MK-351"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Methyldopa (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-dopa",
    "usan_stem_definition": "dopamine receptor agonists",
    "usan_stem_substem": "-dopa(-dopa)",
    "usan_year": 1962
  },
  {
    "applicants": {
      "value": [
        "Epic Pharma Llc",
        "Endo Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AE02",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Indole derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1974,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL460",
    "molecule_properties": {
      "acd_logd": -1.38,
      "acd_logp": -1.32,
      "acd_most_bpka": 6.57,
      "alogp": 1.96,
      "aromatic_rings": 1,
      "full_molformula": "C16H24N2O2",
      "full_mwt": 276.38,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 276.38,
      "mw_monoisotopic": 276.1838,
      "psa": 45.33,
      "qed_weighted": 0.92,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCc1c(C)[nH]c2CCC(CN3CCOCC3)C(=O)c12",
      "standard_inchi": "InChI=1S/C16H24N2O2/c1-3-13-11(2)17-14-5-4-12(16(19)15(13)14)10-18-6-8-20-9-7-18/h12,17H,3-10H2,1-2H3",
      "standard_inchi_key": "KLPWJLBORRMFGK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "EN-1733A"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Molindone (BAN, INN)",
        "Molindone HCl (FDA, USAN, USP)",
        null
      ]
    },
    "usan_year": 1967
  },
  {
    "applicants": {
      "value": "Us Worldmeds Llc"
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N04BC07",
          "description": "NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Dopamine agonist"
        },
        {
          "code": "G04BE07",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunction"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 2004,
    "indication_class": "Emetic",
    "molecule_chembl_id": "CHEMBL53",
    "molecule_properties": {
      "acd_logd": 1.16,
      "acd_logp": 1.7,
      "acd_most_apka": 9.43,
      "acd_most_bpka": 7.88,
      "alogp": 2.85,
      "aromatic_rings": 2,
      "full_molformula": "C17H17NO2",
      "full_mwt": 267.33,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 267.33,
      "mw_monoisotopic": 267.1259,
      "psa": 43.7,
      "qed_weighted": 0.72,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCc2cccc3c2[C@H]1Cc4ccc(O)c(O)c34",
      "standard_inchi": "InChI=1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/t13-/m1/s1",
      "standard_inchi_key": "VMWNQDUVQKEIOC-CYBMUJFWSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Apomorphine (BAN, BAN)",
        "Apomorphine HCl (FDA, USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Marsam Pharmaceuticals Llc",
        "Smith And Nephew Solopak Div Smith And Nephew",
        "Anda Repository Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Morton Grove Pharmaceuticals Inc",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Par Pharmaceutical Inc",
        "Mylan Pharmaceuticals Inc",
        "Akorn Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AD01",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Butyrophenone derivatives"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1967,
    "indication_class": "Antidyskinetic (in gilles de la tourette's disease); Antipsychotic",
    "molecule_chembl_id": "CHEMBL54",
    "molecule_properties": {
      "acd_logd": 2.93,
      "acd_logp": 3.76,
      "acd_most_apka": 13.86,
      "acd_most_bpka": 8.04,
      "alogp": 4.43,
      "aromatic_rings": 2,
      "full_molformula": "C21H23ClFNO2",
      "full_mwt": 375.87,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 375.87,
      "mw_monoisotopic": 375.1401,
      "psa": 40.54,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3",
      "standard_inchi": "InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",
      "standard_inchi_key": "LNEPOXFFQSENCJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "MCN-JR-1625",
        "R-1625"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Haloperidol Lactate (FDA)",
        "Haloperidol (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-peridol",
    "usan_stem_definition": "antipsychotics (haloperidol type)",
    "usan_stem_substem": "-peridol(-peridol)",
    "usan_year": 1965
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL8425",
    "molecule_properties": {
      "acd_logd": 2.74,
      "acd_logp": 2.74,
      "acd_most_bpka": 3.21,
      "alogp": 2.83,
      "aromatic_rings": 2,
      "full_molformula": "C16H16N2O2",
      "full_mwt": 268.32,
      "hba": 3,
      "hba_lipinski": 4,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 268.32,
      "mw_monoisotopic": 268.1212,
      "psa": 41.9,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC1=NN(CCOc2ccc3ccccc3c2)C(=O)C1",
      "standard_inchi": "InChI=1S/C16H16N2O2/c1-12-10-16(19)18(17-12)8-9-20-15-7-6-13-4-2-3-5-14(13)11-15/h2-7,11H,8-10H2,1H3",
      "standard_inchi_key": "ISBUYSPRIJRBKX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BAY-G-6575"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nafazatrom (BAN, INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Baxter Healthcare Corp Anesthesia And Critical Care",
        "Armour Pharmaceutical Co",
        "Watson Laboratories Inc",
        "Hospira Inc",
        "Seton Pharmaceuticals Llc"
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1984,
    "molecule_chembl_id": "CHEMBL55",
    "molecule_properties": {
      "acd_logd": -0.15,
      "acd_logp": 2.85,
      "acd_most_bpka": 12.5,
      "alogp": 2.88,
      "aromatic_rings": 2,
      "full_molformula": "C19H24N4O2",
      "full_mwt": 340.43,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 4,
      "hbd_lipinski": 6,
      "heavy_atoms": 25,
      "molecular_species": "BASE",
      "mw_freebase": 340.43,
      "mw_monoisotopic": 340.1899,
      "num_lipinski_ro5_violations": 1,
      "psa": 118.2,
      "qed_weighted": 0.3,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(=N)N)cc1",
      "standard_inchi": "InChI=1S/C19H24N4O2/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23)",
      "standard_inchi_key": "XDRYMKDFEDOLFX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "MB-800 [as isethionate]",
        "TCMDC-125857",
        "GNF-Pf-3680",
        "RP-2512 [as isethionate]",
        "MB-800",
        "RP-2512"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pentamidine Isethionate (FDA, USAN)",
        "Pentamidine (BAN, DCF, INN, MI)",
        "Pentamidine Isetionate (JAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-amidine",
    "usan_stem_definition": "pentamidine derivatives/analogues",
    "usan_stem_substem": "-amidine(-amidine)",
    "usan_year": 2007
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Acidifier (urlnary)",
    "molecule_chembl_id": "CHEMBL274119",
    "molecule_properties": {
      "acd_logd": -2.29,
      "acd_logp": 0.22,
      "acd_most_apka": 2.23,
      "acd_most_bpka": 9.4,
      "alogp": 0.15,
      "full_molformula": "C5H11NO2S",
      "full_mwt": 149.22,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 9,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 149.22,
      "mw_monoisotopic": 149.051,
      "psa": 63.32,
      "qed_weighted": 0.6,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CSCCC(N)C(=O)O",
      "standard_inchi": "InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)",
      "standard_inchi_key": "FFEARJCKVFRZRR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "DL-Methionine (JAN)",
        "Methionine (INN, NF)",
        "Racemethionine (USAN, USP)",
        null
      ]
    },
    "usan_year": 1980
  },
  {
    "applicants": {
      "value": "Merck And Co Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "V04CH30",
        "description": "VARIOUS: DIAGNOSTIC AGENTS: OTHER DIAGNOSTIC AGENTS: Tests for renal function and ureteral injuries"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Diagnostic Aid (renal function determination)",
    "molecule_chembl_id": "CHEMBL463",
    "molecule_properties": {
      "acd_logd": -3.69,
      "acd_logp": -0.12,
      "acd_most_apka": 3.61,
      "acd_most_bpka": 2.53,
      "alogp": 0.08,
      "aromatic_rings": 1,
      "full_molformula": "C9H10N2O3",
      "full_mwt": 194.19,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 14,
      "molecular_species": "ACID",
      "mw_freebase": 194.19,
      "mw_monoisotopic": 194.0691,
      "psa": 92.42,
      "qed_weighted": 0.59,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ccc(cc1)C(=O)NCC(=O)O",
      "standard_inchi": "InChI=1S/C9H10N2O3/c10-7-3-1-6(2-4-7)9(14)11-5-8(12)13/h1-4H,5,10H2,(H,11,14)(H,12,13)",
      "standard_inchi_key": "HSMNQINEKMPTIC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Aminohippurate Sodium (FDA, USP)",
        "p-Aminohippurate Sodium (JAN)",
        "Aminohippuric Acid (USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": "Hoffmann La Roche Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "D05BB01",
        "description": "DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR SYSTEMIC USE: Retinoids for treatment of psoriasis"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1986,
    "indication_class": "Antipsoriatic",
    "molecule_chembl_id": "CHEMBL464",
    "molecule_properties": {
      "acd_logd": 7.15,
      "acd_logp": 7.15,
      "alogp": 5.65,
      "aromatic_rings": 1,
      "full_molformula": "C23H30O3",
      "full_mwt": 354.49,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 26,
      "mw_freebase": 354.49,
      "mw_monoisotopic": 354.2195,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 35.53,
      "qed_weighted": 0.36,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)\\C=C(/C)\\C=C\\C=C(/C)\\C=C\\c1c(C)cc(OC)c(C)c1C",
      "standard_inchi": "InChI=1S/C23H30O3/c1-8-26-23(24)14-17(3)11-9-10-16(2)12-13-21-18(4)15-22(25-7)20(6)19(21)5/h9-15H,8H2,1-7H3/b11-9+,13-12+,16-10+,17-14+",
      "standard_inchi_key": "HQMNCQVAMBCHCO-DJRRULDNSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "Ro-109359"
    },
    "synonyms": {
      "value": [
        "Etretinate (BAN, FDA, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-retin-",
    "usan_stem_definition": "retinol derivatives",
    "usan_stem_substem": "-retin-(-retin-)",
    "usan_year": 1979,
    "withdrawn_class": "Teratogenicity",
    "withdrawn_country": "France; United States",
    "withdrawn_reason": "Risk for birth defects",
    "withdrawn_year": 1989
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL8514",
    "molecule_properties": {
      "acd_logd": 3.21,
      "acd_logp": 3.81,
      "acd_most_bpka": 7.77,
      "alogp": 4.84,
      "aromatic_rings": 2,
      "full_molformula": "C25H31NO",
      "full_mwt": 361.53,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 361.53,
      "mw_monoisotopic": 361.2406,
      "psa": 23.47,
      "qed_weighted": 0.73,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)[C@]1(O)CCN2C[C@H]3c4ccccc4CCc5cccc([C@@H]2C1)c35",
      "standard_inchi": "InChI=1S/C25H31NO/c1-24(2,3)25(27)13-14-26-16-21-19-9-5-4-7-17(19)11-12-18-8-6-10-20(23(18)21)22(26)15-25/h4-10,21-22,27H,11-16H2,1-3H3/t21-,22-,25-/m0/s1",
      "standard_inchi_key": "ZZJYIKPMDIWRSN-HWBMXIPRSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AY-23028"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Butaclamol HCl (USAN)",
        "Butaclamol (INN)",
        null
      ]
    },
    "usan_year": 1973
  },
  {
    "applicants": {
      "value": [
        "Macleods Pharmaceuticals Ltd",
        "Boehringer Ingelheim Pharmaceuticals Inc",
        "Apotex Inc",
        "Hetero Labs Ltd Unit Iii",
        "Alvogen Malta Operations Ltd",
        "Sandoz Inc",
        "Technology Organized Llc",
        "Prinston Pharmaceutical Inc",
        "Micro Labs Ltd",
        "Strides Pharma Global Pte Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J05AG01",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Non-nucleoside reverse transcriptase inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1996,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL57",
    "molecule_properties": {
      "acd_logd": 2.64,
      "acd_logp": 2.64,
      "acd_most_apka": 12.05,
      "acd_most_bpka": 4.25,
      "alogp": 2.65,
      "aromatic_rings": 2,
      "full_molformula": "C15H14N4O",
      "full_mwt": 266.3,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 266.3,
      "mw_monoisotopic": 266.1168,
      "psa": 58.12,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccnc2N(C3CC3)c4ncccc4C(=O)Nc12",
      "standard_inchi": "InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",
      "standard_inchi_key": "NQDJXKOVJZTUJA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8460704,
    "oral": true,
    "research_codes": {
      "value": "BIRG-0587"
    },
    "rule_of_five": true,
    "sc_patent": "US-8460704-B2",
    "synonyms": {
      "value": [
        "Nevirapine (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-pin(e); -vir-",
    "usan_stem_definition": "tricyclic compounds; antivirals",
    "usan_stem_substem": "-pin(e)(-pin(e)); -vir-(-vir-)",
    "usan_year": 1991
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (emulsion adjunct)",
    "molecule_chembl_id": "CHEMBL8659",
    "molecule_properties": {
      "acd_logd": 4.83,
      "acd_logp": 7.42,
      "acd_most_apka": 4.78,
      "alogp": 6.11,
      "full_molformula": "C18H34O2",
      "full_mwt": 282.47,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "ACID",
      "mw_freebase": 282.47,
      "mw_monoisotopic": 282.2559,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 37.3,
      "qed_weighted": 0.29,
      "ro3_pass": "N",
      "rtb": 15
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCC\\C=C/CCCCCCCC(=O)O",
      "standard_inchi": "InChI=1S/C18H34O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h9-10H,2-8,11-17H2,1H3,(H,19,20)/b10-9-",
      "standard_inchi_key": "ZQPPMHVWECSIRJ-KTKRTIGZSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Oleic Acid (NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL8706",
    "molecule_properties": {
      "acd_logd": 3.51,
      "acd_logp": 3.65,
      "acd_most_bpka": 6.98,
      "alogp": 3.33,
      "aromatic_rings": 1,
      "full_molformula": "C13H15Cl2NO",
      "full_mwt": 272.18,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 272.18,
      "mw_monoisotopic": 271.0531,
      "psa": 12.47,
      "qed_weighted": 0.58,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CN(CCCOc1ccc(Cl)cc1Cl)CC#C",
      "standard_inchi": "InChI=1S/C13H15Cl2NO/c1-3-7-16(2)8-4-9-17-13-6-5-11(14)10-12(13)15/h1,5-6,10H,4,7-9H2,2H3",
      "standard_inchi_key": "BTFHLQRNAMSNLC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "M&B-9302"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clorgiline (BAN, INN)",
        "Clorgyline (BAN)",
        null
      ]
    },
    "usan_stem": "-giline",
    "usan_stem_definition": "MAO inhibitors, type B",
    "usan_stem_substem": "-giline(-giline)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Inflammatory (dermatologic)",
    "molecule_chembl_id": "CHEMBL8846",
    "molecule_properties": {
      "acd_logd": 6.56,
      "acd_logp": 6.7,
      "acd_most_apka": 7.82,
      "alogp": 5.28,
      "aromatic_rings": 2,
      "full_molformula": "C19H24O2S",
      "full_mwt": 316.47,
      "hba": 3,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 316.47,
      "mw_monoisotopic": 316.1497,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 37.3,
      "qed_weighted": 0.77,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)c1cc(cc(c1O)C(C)(C)C)C(=O)c2cccs2",
      "standard_inchi": "InChI=1S/C19H24O2S/c1-18(2,3)13-10-12(16(20)15-8-7-9-22-15)11-14(17(13)21)19(4,5)6/h7-11,21H,1-6H3",
      "standard_inchi_key": "WAAVMZLJRXYRMA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "R-830",
        "R-830T",
        "S-16820"
      ]
    },
    "synonyms": {
      "value": [
        "Prifelone (INN, USAN)",
        null
      ]
    },
    "usan_year": 1988
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL8759",
    "molecule_properties": {
      "acd_logd": -4.13,
      "acd_logp": -0.64,
      "acd_most_apka": 2.06,
      "acd_most_bpka": 9.75,
      "alogp": -0.49,
      "full_molformula": "C8H11NO4",
      "full_mwt": 185.18,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 13,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 185.18,
      "mw_monoisotopic": 185.0688,
      "psa": 100.62,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "N[C@]1(CC[C@H]2[C@@H]([C@@H]12)C(=O)O)C(=O)O",
      "standard_inchi": "InChI=1S/C8H11NO4/c9-8(7(12)13)2-1-3-4(5(3)8)6(10)11/h3-5H,1-2,9H2,(H,10,11)(H,12,13)/t3-,4-,5-,8-/m0/s1",
      "standard_inchi_key": "VTAARTQTOOYTES-RGDLXGNYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "LY-354740"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Eglumegad (INN, USAN)",
        "Eglumetad (INN, USAN)",
        null
      ]
    },
    "usan_year": 2000
  },
  {
    "applicants": {
      "value": [
        "Svc Pharma Lp",
        "Akorn Inc",
        "Insys Therapeutics Inc",
        "Abbvie Inc",
        "Insys Development Co Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A04AD10",
        "description": "ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Other antiemetics"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1985,
    "indication_class": "Anti-Emetic",
    "molecule_chembl_id": "CHEMBL465",
    "molecule_properties": {
      "acd_logd": 6.84,
      "acd_logp": 6.84,
      "acd_most_apka": 9.81,
      "alogp": 5.74,
      "aromatic_rings": 1,
      "full_molformula": "C21H30O2",
      "full_mwt": 314.47,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 314.47,
      "mw_monoisotopic": 314.2246,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 29.46,
      "qed_weighted": 0.57,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCc1cc(O)c2[C@@H]3C=C(C)CC[C@H]3C(C)(C)Oc2c1",
      "standard_inchi": "InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1",
      "standard_inchi_key": "CYQFCXCEBYINGO-IAGOWNOFSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8222292,
    "oral": true,
    "sc_patent": "US-8222292-B2",
    "synonyms": {
      "value": [
        "Dronabinol (FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-nab-",
    "usan_stem_definition": "cannabinol derivatives",
    "usan_stem_substem": "-nab-(-nab-)",
    "usan_year": 1984
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Teva Pharmaceuticals Usa",
        "Emd Serono Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Fresenius Kabi Oncology Plc",
        "Mylan Laboratories Ltd",
        "Mylan Institutional Llc",
        "Hospira Worldwide, Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01DB07",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Anthracyclines and related substances"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1987,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL58",
    "molecule_properties": {
      "acd_logd": -1.58,
      "acd_logp": 1.55,
      "acd_most_apka": 7.08,
      "acd_most_bpka": 9.27,
      "alogp": -0.14,
      "aromatic_rings": 2,
      "full_molformula": "C22H28N4O6",
      "full_mwt": 444.49,
      "hba": 10,
      "hba_lipinski": 10,
      "hbd": 8,
      "hbd_lipinski": 8,
      "heavy_atoms": 32,
      "molecular_species": "BASE",
      "mw_freebase": 444.49,
      "mw_monoisotopic": 444.2009,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 163.18,
      "qed_weighted": 0.14,
      "ro3_pass": "N",
      "rtb": 12
    },
    "molecule_structures": {
      "canonical_smiles": "OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12",
      "standard_inchi": "InChI=1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-4,23-30H,5-12H2",
      "standard_inchi_key": "KKZJGLLVHKMTCM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "CL-232315"
    },
    "synonyms": {
      "value": [
        "Mitoxantrone HCl (FDA, JAN, USAN, USP)",
        "Mitozantrone (BAN)",
        "Mitoxantrone (INN)",
        null
      ]
    },
    "usan_stem": "-antrone",
    "usan_stem_definition": "antineoplastics, anthraquinone derivatives",
    "usan_stem_substem": "-antrone(-antrone)",
    "usan_year": 1980
  },
  {
    "applicants": {
      "value": [
        "Teva Parenteral Medicines Inc",
        "Baxter Healthcare Corp Anesthesia And Critical Care",
        "Smith And Nephew Solopak Div Smith And Nephew",
        "Teligent Ou",
        "International Medication System",
        "Abbott Laboratories Hosp Products Div",
        "Luitpold Pharmaceuticals Inc",
        "Hospira Inc",
        "Baxter Healthcare Corp",
        "B Braun Medical Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C01CA04",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1974,
    "indication_class": "Adrenergic",
    "molecule_chembl_id": "CHEMBL59",
    "molecule_properties": {
      "acd_logd": -2.21,
      "acd_logp": 0.05,
      "acd_most_apka": 9.39,
      "acd_most_bpka": 10.11,
      "alogp": 0.6,
      "aromatic_rings": 1,
      "full_molformula": "C8H11NO2",
      "full_mwt": 153.18,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 11,
      "molecular_species": "BASE",
      "mw_freebase": 153.18,
      "mw_monoisotopic": 153.079,
      "psa": 66.48,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NCCc1ccc(O)c(O)c1",
      "standard_inchi": "InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",
      "standard_inchi_key": "VYFYYTLLBUKUHU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "ASL-279"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dopamine HCl (FDA, JAN, USAN, USP)",
        "Dopamine (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-pamine",
    "usan_stem_definition": "dopaminergics (butopamine type)",
    "usan_stem_substem": "-pamine(-pamine)",
    "usan_year": 1969
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL267930",
    "molecule_properties": {
      "acd_logd": 1.76,
      "acd_logp": 3.25,
      "acd_most_bpka": 8.89,
      "alogp": 3.22,
      "aromatic_rings": 2,
      "full_molformula": "C23H26FN3O2",
      "full_mwt": 395.48,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "BASE",
      "mw_freebase": 395.48,
      "mw_monoisotopic": 395.2009,
      "psa": 52.65,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4",
      "standard_inchi": "InChI=1S/C23H26FN3O2/c24-19-10-8-18(9-11-19)21(28)7-4-14-26-15-12-23(13-16-26)22(29)25-17-27(23)20-5-2-1-3-6-20/h1-3,5-6,8-11H,4,7,12-17H2,(H,25,29)",
      "standard_inchi_key": "DKGZKTPJOSAWFA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "R-5147"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Spiperone (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-perone",
    "usan_stem_definition": "antianxiety agents/neuroleptics (4-fluoro-4-piperidinobutyrophenone derivatives)",
    "usan_stem_substem": "-perone(-perone)",
    "usan_year": 1966
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antithrombotic",
    "molecule_chembl_id": "CHEMBL267473",
    "molecule_properties": {
      "acd_logd": -1.43,
      "acd_logp": 1.28,
      "acd_most_apka": 4.41,
      "acd_most_bpka": 6.71,
      "alogp": 1.66,
      "aromatic_rings": 2,
      "full_molformula": "C12H12N2O3",
      "full_mwt": 232.24,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "ACID",
      "mw_freebase": 232.24,
      "mw_monoisotopic": 232.0848,
      "psa": 64.35,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)c1ccc(OCCn2ccnc2)cc1",
      "standard_inchi": "InChI=1S/C12H12N2O3/c15-12(16)10-1-3-11(4-2-10)17-8-7-14-6-5-13-9-14/h1-6,9H,7-8H2,(H,15,16)",
      "standard_inchi_key": "XQGZSYKGWHUSDH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "UK-37248",
        "UK-37248-01"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dazoxiben (BAN, INN)",
        "Dazoxiben HCl (USAN)",
        null
      ]
    },
    "usan_year": 1981
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05AL07",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Benzamides"
      }
    },
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL267044",
    "molecule_properties": {
      "acd_logd": -1.07,
      "acd_logp": 0.78,
      "acd_most_apka": 9.98,
      "acd_most_bpka": 8.97,
      "alogp": 0.56,
      "aromatic_rings": 1,
      "full_molformula": "C15H23N3O4S",
      "full_mwt": 341.43,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 23,
      "molecular_species": "BASE",
      "mw_freebase": 341.43,
      "mw_monoisotopic": 341.1409,
      "psa": 101.73,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1CCC[C@H]1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N",
      "standard_inchi": "InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)/t11-/m0/s1",
      "standard_inchi_key": "BGRJTUBHPOOWDU-NSHDSACASA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Levosulpiride (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 1,
    "drug_type": 1,
    "indication_class": "Radioactive Agent",
    "molecule_chembl_id": "CHEMBL8809",
    "molecule_properties": {
      "acd_logd": 1.12,
      "acd_logp": 3.58,
      "acd_most_apka": 5.93,
      "acd_most_bpka": 8.97,
      "alogp": 2.92,
      "aromatic_rings": 1,
      "full_molformula": "C15H20Cl2N2O3",
      "full_mwt": 347.24,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 347.24,
      "mw_monoisotopic": 346.0851,
      "psa": 61.8,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1CCC[C@H]1CNC(=O)c2c(O)c(Cl)cc(Cl)c2OC",
      "standard_inchi": "InChI=1S/C15H20Cl2N2O3/c1-3-19-6-4-5-9(19)8-18-15(21)12-13(20)10(16)7-11(17)14(12)22-2/h7,9,20H,3-6,8H2,1-2H3,(H,18,21)/t9-/m0/s1",
      "standard_inchi_key": "WAOQONBSWFLFPE-VIFPVBQESA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Raclopride (INN, BAN)",
        "Raclopride (11C) (USAN, USP)",
        null
      ]
    },
    "usan_stem": "-pride",
    "usan_stem_definition": "sulpiride derivatives",
    "usan_stem_substem": "-pride(-pride)",
    "usan_year": 1997
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL8946",
    "molecule_properties": {
      "acd_logd": 1.49,
      "acd_logp": 3.45,
      "acd_most_apka": 7.71,
      "acd_most_bpka": 8.97,
      "alogp": 2.83,
      "aromatic_rings": 1,
      "full_molformula": "C17H25ClN2O3",
      "full_mwt": 340.85,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "BASE",
      "mw_freebase": 340.85,
      "mw_monoisotopic": 340.1554,
      "psa": 61.8,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1CCC[C@H]1CNC(=O)c2c(O)c(CC)cc(Cl)c2OC",
      "standard_inchi": "InChI=1S/C17H25ClN2O3/c1-4-11-9-13(18)16(23-3)14(15(11)21)17(22)19-10-12-7-6-8-20(12)5-2/h9,12,21H,4-8,10H2,1-3H3,(H,19,22)/t12-/m0/s1",
      "standard_inchi_key": "AADCDMQTJNYOSS-LBPRGKRZSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Eticlopride (INN)",
        null
      ]
    },
    "usan_stem": "-pride",
    "usan_stem_definition": "sulpiride derivatives",
    "usan_stem_substem": "-pride(-pride)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL267723",
    "molecule_properties": {
      "acd_logd": 0.63,
      "acd_logp": 3.02,
      "acd_most_apka": 6.4,
      "acd_most_bpka": 8.97,
      "alogp": 2.22,
      "aromatic_rings": 1,
      "full_molformula": "C15H21IN2O3",
      "full_mwt": 404.25,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 404.25,
      "mw_monoisotopic": 404.0597,
      "psa": 61.8,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1CCC[C@H]1CNC(=O)c2c(O)c(I)ccc2OC",
      "standard_inchi": "InChI=1S/C15H21IN2O3/c1-3-18-8-4-5-10(18)9-17-15(20)13-12(21-2)7-6-11(16)14(13)19/h6-7,10,19H,3-5,8-9H2,1-2H3,(H,17,20)/t10-/m0/s1",
      "standard_inchi_key": "CANPFCFJURGKAX-JTQLQIEISA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Iolopride (123I) (INN)",
        null
      ]
    },
    "usan_stem": "io-; -pride",
    "usan_stem_definition": "iodine-containing contrast media; sulpiride derivatives",
    "usan_stem_substem": "io-(io-); -pride(-pride)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Diagnostic Aid; Radioactive Agent",
    "molecule_chembl_id": "CHEMBL267932",
    "molecule_properties": {
      "acd_logd": 2.39,
      "acd_logp": 3.98,
      "acd_most_bpka": 9.03,
      "alogp": 3.56,
      "aromatic_rings": 2,
      "full_molformula": "C24H28FN3O2",
      "full_mwt": 409.51,
      "hba": 4,
      "hba_lipinski": 5,
      "heavy_atoms": 30,
      "molecular_species": "BASE",
      "mw_freebase": 409.51,
      "mw_monoisotopic": 409.2166,
      "psa": 43.86,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CN(c2ccccc2)C3(CCN(CCCC(=O)c4ccc(F)cc4)CC3)C1=O",
      "standard_inchi": "InChI=1S/C24H28FN3O2/c1-26-18-28(21-6-3-2-4-7-21)24(23(26)30)13-16-27(17-14-24)15-5-8-22(29)19-9-11-20(25)12-10-19/h2-4,6-7,9-12H,5,8,13-18H2,1H3",
      "standard_inchi_key": "QHJLPOSPWKZACG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mespiperone (11C) (INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-perone",
    "usan_stem_definition": "antianxiety agents/neuroleptics (4-fluoro-4-piperidinobutyrophenone derivatives)",
    "usan_stem_substem": "-perone(-perone)",
    "usan_year": 1997
  },
  {
    "applicants": {
      "value": [
        "Barr Laboratories Inc",
        "Bristol Myers Squibb Co",
        "Par Pharmaceutical Inc",
        "Roxane Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01XX05",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1967,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL467",
    "molecule_properties": {
      "acd_logd": -1.8,
      "acd_logp": -1.8,
      "acd_most_apka": 10.56,
      "alogp": -0.96,
      "full_molformula": "CH4N2O2",
      "full_mwt": 76.05,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 5,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 76.05,
      "mw_monoisotopic": 76.0273,
      "psa": 75.35,
      "qed_weighted": 0.26,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=O)NO",
      "standard_inchi": "InChI=1S/CH4N2O2/c2-1(4)3-5/h5H,(H3,2,3,4)",
      "standard_inchi_key": "VSNHCAURESNICA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "SQ-1089"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Hydroxycarbamide (INN)",
        "Hydroxyurea (BAN, FDA, USAN, USP)",
        null
      ]
    },
    "usan_year": 1965
  },
  {
    "applicants": {
      "value": [
        "Paddock Laboratories Llc",
        "Allergan Sales Llc",
        "Bausch And Lomb Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "D06BB04",
        "description": "DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Antivirals"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1990,
    "indication_class": "Antimitotic",
    "molecule_chembl_id": "CHEMBL61",
    "molecule_properties": {
      "acd_logd": 2.35,
      "acd_logp": 2.35,
      "acd_most_apka": 13.26,
      "alogp": 2.41,
      "aromatic_rings": 2,
      "full_molformula": "C22H22O8",
      "full_mwt": 414.41,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 30,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 414.41,
      "mw_monoisotopic": 414.1315,
      "psa": 92.68,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(cc(OC)c1OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](O)c4cc5OCOc5cc24",
      "standard_inchi": "InChI=1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19-,20-/m0/s1",
      "standard_inchi_key": "YJGVMLPVUAXIQN-XVVDYKMHSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Podofilox (FDA, USAN)",
        "Podophyllotoxin (BAN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1989
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 7,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL8965",
    "molecule_properties": {
      "acd_logd": 0.38,
      "acd_logp": 1.13,
      "acd_most_apka": 13.49,
      "acd_most_bpka": 8.16,
      "alogp": 2.67,
      "full_molformula": "C31H51NO9",
      "full_mwt": 581.75,
      "hba": 10,
      "hba_lipinski": 10,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 41,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 581.75,
      "mw_monoisotopic": 581.3564,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 135.13,
      "qed_weighted": 0.27,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC[C@H]1OC(=O)C[C@@H](O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@@H]([C@H]2O)N(C)C)[C@@H](CC=O)C[C@@H](C)C(=O)\\C=C\\[C@]3(C)O[C@H]3[C@@H]1C",
      "standard_inchi": "InChI=1S/C31H51NO9/c1-9-25-20(5)29-31(6,41-29)12-10-23(34)17(2)14-21(11-13-33)28(19(4)24(35)16-26(36)39-25)40-30-27(37)22(32(7)8)15-18(3)38-30/h10,12-13,17-22,24-25,27-30,35,37H,9,11,14-16H2,1-8H3/b12-10+/t17-,18-,19+,20-,21+,22+,24-,25-,27-,28-,29+,30+,31+/m1/s1",
      "standard_inchi_key": "IUPCWCLVECYZRV-JZMZINANSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "SCH-14947",
        "SCH-14947 Stearate"
      ]
    },
    "synonyms": {
      "value": [
        "Rosaramicin Stearate (USAN)",
        "Rosaramicin (BAN, INN, USAN)",
        "Rosaramicin Sodium Phosphate (USAN)",
        null
      ]
    },
    "usan_stem": "-micin",
    "usan_stem_definition": "antibiotics (Micromonospora strains)",
    "usan_stem_substem": "-micin(-micin)",
    "usan_year": 1973
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Tranquilizer",
    "molecule_chembl_id": "CHEMBL63",
    "molecule_properties": {
      "acd_logd": 2,
      "acd_logp": 2,
      "alogp": 2.62,
      "aromatic_rings": 1,
      "full_molformula": "C16H21NO3",
      "full_mwt": 275.35,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 275.35,
      "mw_monoisotopic": 275.1521,
      "psa": 47.56,
      "qed_weighted": 0.92,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(cc1OC2CCCC2)C3CNC(=O)C3",
      "standard_inchi": "InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)",
      "standard_inchi_key": "HJORMJIFDVBMOB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "ZK-62771",
        "ZK-62711"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Rolipram (INN, USAN)",
        null
      ]
    },
    "usan_year": 1980
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL9298",
    "molecule_properties": {
      "acd_logd": 1.29,
      "acd_logp": 1.48,
      "acd_most_bpka": 7.16,
      "alogp": 2.68,
      "aromatic_rings": 2,
      "full_molformula": "C14H13N3",
      "full_mwt": 223.28,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 223.28,
      "mw_monoisotopic": 223.1109,
      "psa": 41.61,
      "qed_weighted": 0.75,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "N#Cc1ccc(cc1)C2CCCc3cncn23",
      "standard_inchi": "InChI=1S/C14H13N3/c15-8-11-4-6-12(7-5-11)14-3-1-2-13-9-16-10-17(13)14/h4-7,9-10,14H,1-3H2",
      "standard_inchi_key": "CLPFFLWZZBQMAO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CGS-16949A"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fadrozole (INN)",
        "Fadrozole HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-rozole",
    "usan_stem_definition": "aromatase inhibitors (imidazole/triazole derivatives)",
    "usan_stem_substem": "-rozole(-rozole)",
    "usan_year": 1990
  },
  {
    "applicants": {
      "value": [
        "Sanofi Aventis Us Llc",
        "Eli Lilly And Co",
        "Panray Corp Sub Ormont Drug And Chemical Co Inc",
        "Halsey Drug Co Inc",
        "Bristol Myers Squibb Co",
        "Dow Pharmaceutical Corp Sub Dow Chemical Co",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Hikma International Pharmaceuticals Llc",
        "Cmp Pharma Inc",
        "Hoffmann La Roche Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "J04AC51",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Hydrazide"
        },
        {
          "code": "J04AC01",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Hydrazides"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1952,
    "indication_class": "Antibacterial (tuberculostatic)",
    "molecule_chembl_id": "CHEMBL64",
    "molecule_properties": {
      "acd_logd": -0.77,
      "acd_logp": -0.77,
      "acd_most_apka": 11.4,
      "acd_most_bpka": 3.79,
      "alogp": -0.31,
      "aromatic_rings": 1,
      "full_molformula": "C6H7N3O",
      "full_mwt": 137.14,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 10,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 137.14,
      "mw_monoisotopic": 137.0589,
      "psa": 68.01,
      "qed_weighted": 0.32,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "NNC(=O)c1ccncc1",
      "standard_inchi": "InChI=1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10)",
      "standard_inchi_key": "QRXWMOHMRWLFEY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "prodrug": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Isoniazid (BAN, FDA, INN, JAN, USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": "Celgene Corp"
    },
    "atc_classification": {
      "drug": {
        "code": "L04AX02",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressants"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1998,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL468",
    "molecule_properties": {
      "acd_logd": 0.33,
      "acd_logp": 0.33,
      "acd_most_apka": 10.7,
      "alogp": 0.09,
      "aromatic_rings": 1,
      "full_molformula": "C13H10N2O4",
      "full_mwt": 258.23,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 258.23,
      "mw_monoisotopic": 258.0641,
      "psa": 83.55,
      "qed_weighted": 0.72,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1",
      "standard_inchi": "InChI=1S/C13H10N2O4/c16-10-6-5-9(11(17)14-10)15-12(18)7-3-1-2-4-8(7)13(15)19/h1-4,9H,5-6H2,(H,14,16,17)",
      "standard_inchi_key": "UEJJHQNACJXSKW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6045501,
    "oral": true,
    "research_codes": {
      "value": "K-17"
    },
    "rule_of_five": true,
    "sc_patent": "US-6045501-A",
    "synonyms": {
      "value": [
        "Thalidomide (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-domide",
    "usan_stem_definition": "thalidomide derivatives",
    "usan_stem_substem": "-domide(-domide)",
    "usan_year": 1961
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Amphastar Pharmaceutical Inc",
        "Hospira Inc",
        "Pliva Inc",
        "Alcon Pharmaceuticals Ltd",
        "Bedford Laboratories Div Ben Venue Laboratories Inc",
        "Mylan Pharmaceuticals Inc",
        "Akorn Inc",
        "Apotex Inc Richmond Hill"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01BC05",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroid"
        },
        {
          "code": "M01AB15",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1989,
    "indication_class": "Analgesic",
    "molecule_chembl_id": "CHEMBL469",
    "molecule_properties": {
      "acd_logd": -0.34,
      "acd_logp": 2.68,
      "acd_most_apka": 4.29,
      "alogp": 2.29,
      "aromatic_rings": 2,
      "full_molformula": "C15H13NO3",
      "full_mwt": 255.27,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "ACID",
      "mw_freebase": 255.27,
      "mw_monoisotopic": 255.0895,
      "psa": 59.3,
      "qed_weighted": 0.86,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)C1CCn2c1ccc2C(=O)c3ccccc3",
      "standard_inchi": "InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)",
      "standard_inchi_key": "OZWKMVRBQXNZKK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6333044,
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-6333044-B1",
    "synonyms": {
      "value": [
        "Ketorolac (BAN, INN)",
        "Ketorolac Tromethamine (FDA, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-ac",
    "usan_stem_definition": "anti-inflammatory agents (acetic acid derivatives)",
    "usan_stem_substem": "-ac(-ac)",
    "usan_year": 1984
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL9194",
    "molecule_properties": {
      "acd_logd": 2.16,
      "acd_logp": 5.15,
      "acd_most_apka": 3.49,
      "acd_most_bpka": 6.89,
      "alogp": 4.69,
      "aromatic_rings": 2,
      "full_molformula": "C29H38N2O6",
      "full_mwt": 510.63,
      "hba": 6,
      "hba_lipinski": 8,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 37,
      "molecular_species": "ACID",
      "mw_freebase": 510.63,
      "mw_monoisotopic": 510.273,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 88.54,
      "qed_weighted": 0.44,
      "ro3_pass": "N",
      "rtb": 12
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCN(CCCC)C(=O)CN1C[C@@H]([C@H]([C@@H]1c2ccc(OC)cc2)C(=O)O)c3ccc4OCOc4c3",
      "standard_inchi": "InChI=1S/C29H38N2O6/c1-4-6-14-30(15-7-5-2)26(32)18-31-17-23(21-10-13-24-25(16-21)37-19-36-24)27(29(33)34)28(31)20-8-11-22(35-3)12-9-20/h8-13,16,23,27-28H,4-7,14-15,17-19H2,1-3H3,(H,33,34)/t23-,27-,28+/m1/s1",
      "standard_inchi_key": "MOTJMGVDPWRKOC-QPVYNBJUSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "ABT-627",
        "A-127722",
        "ABBOT-147627",
        "A-147627.1"
      ]
    },
    "synonyms": {
      "value": [
        "Atrasentan (INN)",
        "Atrasentan HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-entan",
    "usan_stem_definition": "endothelin receptor antagonists",
    "usan_stem_substem": "-entan(-entan)",
    "usan_year": 2000
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL274826",
    "molecule_properties": {
      "acd_logd": 2.72,
      "acd_logp": 2.72,
      "alogp": 4.09,
      "full_molformula": "C19H26O2",
      "full_mwt": 286.42,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 21,
      "mw_freebase": 286.42,
      "mw_monoisotopic": 286.1933,
      "psa": 34.14,
      "qed_weighted": 0.67,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@]12CC[C@H]3[C@@H](CCC4=CC(=O)CC[C@]34C)[C@@H]1CCC2=O",
      "standard_inchi": "InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",
      "standard_inchi_key": "AEMFNILZOJDQLW-QAGGRKNESA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Androstenedione (JAN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Anti-Inflammatory; Analgesic",
    "molecule_chembl_id": "CHEMBL428479",
    "molecule_properties": {
      "acd_logd": -0.19,
      "acd_logp": 2.85,
      "acd_most_apka": 4.27,
      "alogp": 2.3,
      "aromatic_rings": 2,
      "full_molformula": "C16H15NO4",
      "full_mwt": 285.3,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "ACID",
      "mw_freebase": 285.3,
      "mw_monoisotopic": 285.1001,
      "psa": 68.53,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(cc1)C(=O)c2ccc3C(CCn23)C(=O)O",
      "standard_inchi": "InChI=1S/C16H15NO4/c1-21-11-4-2-10(3-5-11)15(18)14-7-6-13-12(16(19)20)8-9-17(13)14/h2-7,12H,8-9H2,1H3,(H,19,20)",
      "standard_inchi_key": "HEOZYYOUKGGSBJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "RS-37326"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Anirolac (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ac",
    "usan_stem_definition": "anti-inflammatory agents (acetic acid derivatives)",
    "usan_stem_substem": "-ac(-ac)",
    "usan_year": 1985
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL9116",
    "molecule_properties": {
      "acd_logd": -0.94,
      "acd_logp": -0.94,
      "acd_most_apka": 11.18,
      "alogp": -0.55,
      "full_molformula": "C6H11N3O4",
      "full_mwt": 189.17,
      "hba": 4,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 13,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 189.17,
      "mw_monoisotopic": 189.075,
      "psa": 87.74,
      "qed_weighted": 0.5,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "CNC(=O)ON(C(=O)C)C(=O)NC",
      "standard_inchi": "InChI=1S/C6H11N3O4/c1-4(10)9(5(11)7-2)13-6(12)8-3/h1-3H3,(H,7,11)(H,8,12)",
      "standard_inchi_key": "JURAJLFHWXNPHG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Caracemide (INN, USAN)",
        null
      ]
    },
    "usan_year": 1983
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL9324",
    "molecule_properties": {
      "acd_logd": -3.26,
      "acd_logp": -3.26,
      "alogp": 1.88,
      "full_molformula": "C8H20N+",
      "full_mwt": 130.25,
      "hba_lipinski": 1,
      "heavy_atoms": 9,
      "mw_freebase": 130.25,
      "mw_monoisotopic": 130.159,
      "psa": 0,
      "qed_weighted": 0.51,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC[N+](CC)(CC)CC",
      "standard_inchi": "InChI=1S/C8H20N/c1-5-9(6-2,7-3)8-4/h5-8H2,1-4H3/q+1",
      "standard_inchi_key": "CBXCPBUEXACCNR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "TEAB"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tetraethylammonium Chloride (MI)",
        "Tetrylammonium Bromide (INN)",
        null
      ]
    },
    "usan_stem": "-ium",
    "usan_stem_definition": "quaternary ammonium derivatives",
    "usan_stem_substem": "-ium(-ium)"
  },
  {
    "applicants": {
      "value": [
        "Apotex Inc Etobicoke Site",
        "Sun Pharmaceutical Industries Inc",
        "Arbor Pharmaceuticals Llc",
        "Upsher-Smith Laboratories Llc",
        "Apotex Inc",
        "Vintage Pharmaceuticals Inc",
        "Watson Laboratories Inc",
        "Epic Pharma Inc",
        "Beximco Pharmaceuticals Usa Inc",
        "Covis Pharma Bv"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C07AA07",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1992,
    "indication_class": "Anti-Adrenergic (beta-receptor)",
    "molecule_chembl_id": "CHEMBL471",
    "molecule_properties": {
      "acd_logd": -1.68,
      "acd_logp": 0.24,
      "acd_most_apka": 8.28,
      "acd_most_bpka": 9.31,
      "alogp": 1.09,
      "aromatic_rings": 1,
      "full_molformula": "C12H20N2O3S",
      "full_mwt": 272.37,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 18,
      "molecular_species": "BASE",
      "mw_freebase": 272.37,
      "mw_monoisotopic": 272.1195,
      "psa": 78.43,
      "qed_weighted": 0.72,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)c1ccc(NS(=O)(=O)C)cc1",
      "standard_inchi": "InChI=1S/C12H20N2O3S/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17/h4-7,9,12-15H,8H2,1-3H3",
      "standard_inchi_key": "ZBMZVLHSJCTVON-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 9724297,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "MJ-1999"
    },
    "rule_of_five": true,
    "sc_patent": "US-9724297-B2",
    "synonyms": {
      "value": [
        "Sotalol (BAN, INN)",
        "Sotalol HCl (FDA, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-alol",
    "usan_stem_definition": "combined alpha and beta receptors",
    "usan_stem_substem": "-alol(-alol)",
    "usan_year": 1967
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Antagonist (cholecystokinin)",
    "molecule_chembl_id": "CHEMBL9506",
    "molecule_properties": {
      "acd_logd": 4.74,
      "acd_logp": 4.74,
      "acd_most_apka": 13.25,
      "acd_most_bpka": 3.18,
      "alogp": 3.74,
      "aromatic_rings": 4,
      "full_molformula": "C25H20N4O2",
      "full_mwt": 408.46,
      "hba": 3,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 31,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 408.46,
      "mw_monoisotopic": 408.1586,
      "psa": 77.56,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)[C@@H](NC(=O)c2cc3ccccc3[nH]2)N=C(c4ccccc4)c5ccccc15",
      "standard_inchi": "InChI=1S/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30)/t23-/m1/s1",
      "standard_inchi_key": "NFHRQQKPEBFUJK-HSZRJFAPSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "L-364718",
        "MK-329"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Devazepide (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-azepide",
    "usan_stem_definition": "cholecystokinin receptor antagonists",
    "usan_stem_substem": "-azepide(-azepide)",
    "usan_year": 1989
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL9419",
    "molecule_properties": {
      "acd_logd": 0.69,
      "acd_logp": 0.69,
      "acd_most_apka": 9.5,
      "acd_most_bpka": 0.25,
      "alogp": 1.35,
      "aromatic_rings": 1,
      "full_molformula": "C8H9NO2",
      "full_mwt": 151.16,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 11,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 151.16,
      "mw_monoisotopic": 151.0633,
      "psa": 49.33,
      "qed_weighted": 0.64,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)Nc1cccc(O)c1",
      "standard_inchi": "InChI=1S/C8H9NO2/c1-6(10)9-7-3-2-4-8(11)5-7/h2-5,11H,1H3,(H,9,10)",
      "standard_inchi_key": "QLNWXBAGRTUKKI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BS-749"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Metacetamol (BAN, INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL9514",
    "molecule_properties": {
      "acd_logd": 2.62,
      "acd_logp": 2.63,
      "acd_most_apka": 10.33,
      "acd_most_bpka": 4.47,
      "alogp": 3.03,
      "aromatic_rings": 3,
      "full_molformula": "C14H11N3O3S",
      "full_mwt": 301.33,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 301.33,
      "mw_monoisotopic": 301.0521,
      "psa": 84.08,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "COC(=O)Nc1nc2ccc(cc2[nH]1)C(=O)c3cccs3",
      "standard_inchi": "InChI=1S/C14H11N3O3S/c1-20-14(19)17-13-15-9-5-4-8(7-10(9)16-13)12(18)11-3-2-6-21-11/h2-7H,1H3,(H2,15,16,17,19)",
      "standard_inchi_key": "KYRVNWMVYQXFEU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "R-17934"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nocodazole (INN, USAN)",
        null
      ]
    },
    "usan_year": 1976
  },
  {
    "applicants": {
      "value": [
        "Bristol Myers Squibb",
        "Epic Pharma Llc",
        "Pharmadax Inc",
        "Actavis Elizabeth Llc",
        "Sanofi Aventis Us Llc",
        "Teva Pharmaceuticals Usa Inc",
        "Dava Pharmaceuticals Inc",
        "Sandoz Inc",
        "Pharmacia And Upjohn Co",
        "Heritage Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A10BB01",
        "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Sulfonylureas"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1984,
    "indication_class": "Antidiabetic",
    "molecule_chembl_id": "CHEMBL472",
    "molecule_properties": {
      "acd_logd": 1.14,
      "acd_logp": 3.08,
      "acd_most_apka": 5.11,
      "alogp": 3.64,
      "aromatic_rings": 2,
      "full_molformula": "C23H28ClN3O5S",
      "full_mwt": 494.01,
      "hba": 5,
      "hba_lipinski": 8,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 33,
      "molecular_species": "ACID",
      "mw_freebase": 494.01,
      "mw_monoisotopic": 493.1438,
      "psa": 113.6,
      "qed_weighted": 0.52,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3",
      "standard_inchi": "InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)",
      "standard_inchi_key": "ZNNLBTZKUZBEKO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6303146,
    "oral": true,
    "research_codes": {
      "value": [
        "HB 419",
        "U-26452",
        "HB-419"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6303146-B1",
    "synonyms": {
      "value": [
        "Glibenclamide (BAN, DCF, INN, JAN)",
        "Glyburide (FDA, USAN, USP)",
        null
      ]
    },
    "usan_year": 1969
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Cardiac Depressant (anti-arrhythmic)",
    "molecule_chembl_id": "CHEMBL9484",
    "molecule_properties": {
      "acd_logd": 0.32,
      "acd_logp": 0.32,
      "alogp": 6.49,
      "aromatic_rings": 1,
      "full_molformula": "C21H37ClN+",
      "full_mwt": 338.99,
      "hba_lipinski": 1,
      "heavy_atoms": 23,
      "mw_freebase": 338.99,
      "mw_monoisotopic": 338.2609,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 0,
      "qed_weighted": 0.28,
      "ro3_pass": "N",
      "rtb": 13
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCC[N+](CC)(CC)CCCCc1ccc(Cl)cc1",
      "standard_inchi": "InChI=1S/C21H37ClN/c1-4-7-8-9-11-18-23(5-2,6-3)19-12-10-13-20-14-16-21(22)17-15-20/h14-17H,4-13,18-19H2,1-3H3/q+1",
      "standard_inchi_key": "WPSYTTKBGAZSCX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "GNF-Pf-3889"
    },
    "synonyms": {
      "value": [
        "Clofilium phosphate (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ium",
    "usan_stem_definition": "quaternary ammonium derivatives",
    "usan_stem_substem": "-ium(-ium)",
    "usan_year": 1979
  },
  {
    "applicants": {
      "value": [
        "Mayne Pharma Inc",
        "Pfizer Pharmaceuticals Production Corp Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C01BD04",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1999,
    "indication_class": "Cardiac Depressant (anti-arrhythmic)",
    "molecule_chembl_id": "CHEMBL473",
    "molecule_properties": {
      "acd_logd": 0.52,
      "acd_logp": 1.38,
      "acd_most_apka": 8.98,
      "acd_most_bpka": 8.28,
      "alogp": 1.98,
      "aromatic_rings": 2,
      "full_molformula": "C19H27N3O5S2",
      "full_mwt": 441.58,
      "hba": 6,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 29,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 441.58,
      "mw_monoisotopic": 441.1392,
      "psa": 104.81,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CN(CCOc1ccc(NS(=O)(=O)C)cc1)CCc2ccc(NS(=O)(=O)C)cc2",
      "standard_inchi": "InChI=1S/C19H27N3O5S2/c1-22(13-12-16-4-6-17(7-5-16)20-28(2,23)24)14-15-27-19-10-8-18(9-11-19)21-29(3,25)26/h4-11,20-21H,12-15H2,1-3H3",
      "standard_inchi_key": "IXTMWRCNAAVVAI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6124363,
    "oral": true,
    "research_codes": {
      "value": "UK-68798"
    },
    "rule_of_five": true,
    "sc_patent": "US-6124363-A",
    "synonyms": {
      "value": [
        "Dofetilide (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ilide",
    "usan_stem_definition": "class III antiarrhythmic agents",
    "usan_stem_substem": "-ilide(-ilide)",
    "usan_year": 1993
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Carbonic Anhydrase Inhibitor",
    "molecule_chembl_id": "CHEMBL417975",
    "molecule_properties": {
      "acd_logd": 1.86,
      "acd_logp": 2,
      "acd_most_apka": 9.42,
      "acd_most_bpka": 6.91,
      "alogp": 0.86,
      "aromatic_rings": 1,
      "full_molformula": "C11H18N2O4S3",
      "full_mwt": 338.48,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 338.48,
      "mw_monoisotopic": 338.0429,
      "psa": 106.33,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)CN[C@H]1CCS(=O)(=O)c2sc(cc12)S(=O)(=O)N",
      "standard_inchi": "InChI=1S/C11H18N2O4S3/c1-7(2)6-13-9-3-4-19(14,15)11-8(9)5-10(18-11)20(12,16)17/h5,7,9,13H,3-4,6H2,1-2H3,(H2,12,16,17)/t9-/m0/s1",
      "standard_inchi_key": "JFLUCCKXAYBETQ-VIFPVBQESA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MK-417"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sezolamide HCl (USAN)",
        "Sezolamide (INN)",
        null
      ]
    },
    "usan_stem": "-zolamide",
    "usan_stem_definition": "carbonic anhydrase inhibitors",
    "usan_stem_substem": "-zolamide(-zolamide)",
    "usan_year": 1990
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anesthetic",
    "molecule_chembl_id": "CHEMBL275528",
    "molecule_properties": {
      "acd_logd": 3.38,
      "acd_logp": 4.25,
      "acd_most_bpka": 8.21,
      "alogp": 4.33,
      "aromatic_rings": 1,
      "full_molformula": "C17H25N",
      "full_mwt": 243.39,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 243.39,
      "mw_monoisotopic": 243.1987,
      "psa": 3.24,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C1CCN(CC1)C2(CCCCC2)c3ccccc3",
      "standard_inchi": "InChI=1S/C17H25N/c1-4-10-16(11-5-1)17(12-6-2-7-13-17)18-14-8-3-9-15-18/h1,4-5,10-11H,2-3,6-9,12-15H2",
      "standard_inchi_key": "JTJMJGYZQZDUJJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "CN-25253-2",
        "GP-121",
        "CI-395"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Phencyclidine HCl (USAN)",
        "Phencyclidine (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-clidine",
    "usan_stem_definition": "muscarinic receptor agonists",
    "usan_stem_substem": "-clidine(-clidine)",
    "usan_year": 1963
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL268254",
    "molecule_properties": {
      "acd_logd": 2.94,
      "acd_logp": 2.94,
      "acd_most_apka": 11.58,
      "acd_most_bpka": 2.22,
      "alogp": 3.78,
      "aromatic_rings": 2,
      "full_molformula": "C15H10Cl2N2O",
      "full_mwt": 305.16,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 305.16,
      "mw_monoisotopic": 304.017,
      "psa": 41.46,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1",
      "standard_inchi": "InChI=1S/C15H10Cl2N2O/c16-9-5-6-13-11(7-9)15(18-8-14(20)19-13)10-3-1-2-4-12(10)17/h1-7H,8H2,(H,19,20)",
      "standard_inchi_key": "CHIFCDOIPRCHCF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Delorazepam (INN)",
        null
      ]
    },
    "usan_stem": "-azepam",
    "usan_stem_definition": "antianxiety agents (diazepam type)",
    "usan_stem_substem": "-azepam(-azepam)"
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Fresenius Kabi Usa Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Hospira Inc",
        "Bayer Healthcare Pharmaceuticals Inc",
        "Abraxis Pharmaceutical Products"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01AX04",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Other alkylating agents"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1975,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL476",
    "molecule_properties": {
      "acd_logd": 0.03,
      "acd_logp": 0.03,
      "acd_most_apka": 11.45,
      "acd_most_bpka": 3.93,
      "alogp": 0.07,
      "aromatic_rings": 1,
      "full_molformula": "C6H10N6O",
      "full_mwt": 182.19,
      "hba": 4,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 13,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 182.19,
      "mw_monoisotopic": 182.0916,
      "psa": 99.73,
      "qed_weighted": 0.51,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)N=Nc1[nH]cnc1C(=O)N",
      "standard_inchi": "InChI=1S/C6H10N6O/c1-12(2)11-10-6-4(5(7)13)8-3-9-6/h3H,1-2H3,(H2,7,13)(H,8,9)/b11-10+",
      "standard_inchi_key": "FDKXTQMXEQVLRF-ZHACJKMWSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "DIC",
        "DTIC"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dacarbazine (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1972
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Akorn Inc",
        "Teva Pharmaceuticals Usa",
        "Sagent Strides Llc",
        "Astellas Pharma Us Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Luitpold Pharmaceuticals Inc",
        "Hospira Inc",
        "Emcure Pharmaceuticals Ltd",
        "Mylan Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C01EB10",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: OTHER CARDIAC PREPARATIONS: Other cardiac preparations"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1989,
    "indication_class": "Cardiac Depressant (anti-arrhythmic)",
    "molecule_chembl_id": "CHEMBL477",
    "molecule_properties": {
      "acd_logd": -0.76,
      "acd_logp": -0.76,
      "acd_most_apka": 13.11,
      "acd_most_bpka": 3.82,
      "alogp": -1.98,
      "aromatic_rings": 2,
      "full_molformula": "C10H13N5O4",
      "full_mwt": 267.25,
      "hba": 9,
      "hba_lipinski": 9,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 267.25,
      "mw_monoisotopic": 267.0968,
      "psa": 139.54,
      "qed_weighted": 0.49,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ncnc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O",
      "standard_inchi": "InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",
      "standard_inchi_key": "OIRDTQYFTABQOQ-KQYNXXCUSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "SR-96225"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Adenosine (BAN, FDA, USAN, USP)",
        null
      ]
    },
    "usan_year": 1988
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic (specific thymidylate synthase inhibitor)",
    "molecule_chembl_id": "CHEMBL9440",
    "molecule_properties": {
      "acd_logp": 2.23,
      "acd_most_bpka": 5.38,
      "alogp": 2.85,
      "aromatic_rings": 3,
      "full_molformula": "C23H24N4O3S",
      "full_mwt": 436.54,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 31,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 436.54,
      "mw_monoisotopic": 436.1569,
      "psa": 88.23,
      "qed_weighted": 0.66,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CN(Cc1ccc(cc1)S(=O)(=O)N2CCOCC2)c3ccc4N=C(N)c5cccc3c45",
      "standard_inchi": "InChI=1S/C23H24N4O3S/c1-26(21-10-9-20-22-18(21)3-2-4-19(22)23(24)25-20)15-16-5-7-17(8-6-16)31(28,29)27-11-13-30-14-12-27/h2-10H,11-15H2,1H3,(H2,24,25)",
      "standard_inchi_key": "CVEGTZWWWRJCFK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AG-331"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Metesind (INN)",
        "Metesind Glucuronate (USAN)",
        null
      ]
    },
    "usan_stem": "-tesind",
    "usan_stem_definition": "thymidilate synthetase inhibitors (benzindole derivatives)",
    "usan_stem_substem": "-tesind(-tesind)",
    "usan_year": 1996
  },
  {
    "applicants": {
      "value": [
        "Alpharma Us Pharmaceuticals Division",
        "Roxane Laboratories Inc",
        "Sun Pharmaceutical Industries Inc",
        "Sandoz Inc",
        "Novartis Pharmaceuticals Corp",
        "Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Par Pharmaceutical Inc",
        "Superpharm Corp",
        "Watson Laboratories Inc",
        "West Ward Pharmaceutical Corp"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AC02",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperidine structure"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1962,
    "indication_class": "Antipsychotic; Sedative-Hypnotic,Sedative-Hypnotic; Antipsychotic",
    "molecule_chembl_id": "CHEMBL479",
    "molecule_properties": {
      "acd_logd": 3.5,
      "acd_logp": 5.9,
      "acd_most_bpka": 9.84,
      "alogp": 5.89,
      "aromatic_rings": 2,
      "full_molformula": "C21H26N2S2",
      "full_mwt": 370.59,
      "hba": 4,
      "hba_lipinski": 2,
      "heavy_atoms": 25,
      "molecular_species": "BASE",
      "mw_freebase": 370.59,
      "mw_monoisotopic": 370.1537,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 6.48,
      "qed_weighted": 0.62,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1",
      "standard_inchi": "InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3",
      "standard_inchi_key": "KLBQZWRITKRQQV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "TP-21"
    },
    "synonyms": {
      "value": [
        "Thioridazine HCl (FDA, JAN, USP)",
        "Thioridazine (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1962,
    "withdrawn_class": "Cardiotoxicity",
    "withdrawn_country": "United Kingdom; Worldwide",
    "withdrawn_reason": "Cardiac arrythmias",
    "withdrawn_year": 2005
  },
  {
    "applicants": {
      "value": [
        "Rising Pharmaceuticals Inc",
        "Krka Tovarna Zdravil Dd Novo Mesto",
        "Ajanta Pharma Ltd",
        "Glaxosmithkline Consumer Healthcare",
        "Natco Pharma Ltd",
        "Teva Pharmaceuticals Usa",
        "Perrigo R And D Co",
        "Dr Reddys Laboratories Ltd",
        "Inventia Healthcare Private Ltd",
        "Takeda Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "A02BC03",
          "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitor"
        },
        {
          "code": "A02BC53",
          "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Proton pump inhibitors"
        }
      ]
    },
    "availability_type": 2,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1995,
    "indication_class": "Anti-Ulcerative",
    "molecule_chembl_id": "CHEMBL480",
    "molecule_properties": {
      "acd_logd": 2.58,
      "acd_logp": 2.58,
      "acd_most_apka": 9.56,
      "acd_most_bpka": 3.65,
      "alogp": 3.52,
      "aromatic_rings": 3,
      "full_molformula": "C16H14F3N3O2S",
      "full_mwt": 369.37,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 369.37,
      "mw_monoisotopic": 369.0759,
      "psa": 67.87,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1c(OCC(F)(F)F)ccnc1C[S+]([O-])c2nc3ccccc3[nH]2",
      "standard_inchi": "InChI=1S/C16H14F3N3O2S/c1-10-13(20-7-6-14(10)24-9-16(17,18)19)8-25(23)15-21-11-4-2-3-5-12(11)22-15/h2-7H,8-9H2,1H3,(H,21,22)",
      "standard_inchi_key": "MJIHNNLFOKEZEW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6328994,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "AG-1749",
        "A-65006"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6328994-B1",
    "synonyms": {
      "value": [
        "Lansoprazole (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-prazole",
    "usan_stem_definition": "antiulcer agents (benzimidazole derivatives)",
    "usan_stem_substem": "-prazole(-prazole)",
    "usan_year": 1989
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Teva Parenteral Medicines Inc",
        "Actavis Totowa Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Intas Pharmaceuticals Usa",
        "Pliva Lachema As",
        "Hospira Inc",
        "Fresenius Kabi Oncology Plc",
        "Ipsen Biopharmaceuticals Inc",
        "Akorn Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01XX19",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1996,
    "indication_class": "Antineoplastic (DNA topoisomerase I Inhibitor)",
    "molecule_chembl_id": "CHEMBL481",
    "molecule_properties": {
      "acd_logd": 2.08,
      "acd_logp": 3.73,
      "acd_most_apka": 11.2,
      "acd_most_bpka": 9.33,
      "alogp": 4.09,
      "aromatic_rings": 3,
      "full_molformula": "C33H38N4O6",
      "full_mwt": 586.69,
      "hba": 9,
      "hba_lipinski": 10,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 43,
      "molecular_species": "BASE",
      "mw_freebase": 586.69,
      "mw_monoisotopic": 586.2791,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 114.2,
      "qed_weighted": 0.36,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(OC(=O)N6CCC(CC6)N7CCCCC7)cc15)[C@@](O)(CC)C(=O)OC4",
      "standard_inchi": "InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1",
      "standard_inchi_key": "UWKQSNNFCGGAFS-XIFFEERXSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6403569,
    "parenteral": true,
    "prodrug": true,
    "research_codes": {
      "value": "U-101440E"
    },
    "sc_patent": "US-6403569-B1",
    "synonyms": {
      "value": [
        "Irinotecan (BAN, INN)",
        "Irinotecan HCl (FDA, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-tecan",
    "usan_stem_definition": "antineoplastics (camptothecine derivatives)",
    "usan_stem_substem": "-tecan(-tecan)",
    "usan_year": 1995
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Mallinckrodt Inc",
        "Lannett Holdings Inc",
        "Hi-Tech Pharmacal Co Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Dava Pharmaceuticals Inc",
        "Allergan Sales Llc",
        "Hospira Inc",
        "Purdue Pharma Lp",
        "Actavis Elizabeth Llc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N02AA01",
          "description": "NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Natural opium alkaloid"
        },
        {
          "code": "A07DA52",
          "description": "ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: ANTIPROPULSIVES: Antipropulsive"
        },
        {
          "code": "N02AA51",
          "description": "NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Natural opium alkaloids"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1984,
    "indication_class": "Analgesic (narcotic)",
    "molecule_chembl_id": "CHEMBL70",
    "molecule_properties": {
      "acd_logd": 0.04,
      "acd_logp": 0.87,
      "acd_most_apka": 9.48,
      "acd_most_bpka": 8.25,
      "alogp": 1.2,
      "aromatic_rings": 1,
      "full_molformula": "C17H19NO3",
      "full_mwt": 285.34,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 285.34,
      "mw_monoisotopic": 285.1365,
      "psa": 52.93,
      "qed_weighted": 0.7,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@@H]2C=C[C@@H]4O)c35",
      "standard_inchi": "InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",
      "standard_inchi_key": "BQJCRHHNABKAKU-KBQPJGBKSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5891467,
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-5891467-A",
    "synonyms": {
      "value": [
        "Morphine (BAN, BAN)",
        "Morphine Sulfate (FDA, JAN, USP)",
        "Morphine HCl (JAN, MI, USP)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL483",
    "molecule_properties": {
      "acd_logd": -4.06,
      "acd_logp": -0.14,
      "acd_most_apka": 1.61,
      "acd_most_bpka": 4.22,
      "alogp": -0.05,
      "aromatic_rings": 2,
      "full_molformula": "C9H14N5O4P",
      "full_mwt": 287.22,
      "hba": 7,
      "hba_lipinski": 9,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 19,
      "molecular_species": "ACID",
      "mw_freebase": 287.22,
      "mw_monoisotopic": 287.0783,
      "psa": 136.38,
      "qed_weighted": 0.65,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H](Cn1cnc2c(N)ncnc12)OCP(=O)(O)O",
      "standard_inchi": "InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1",
      "standard_inchi_key": "SGOIRFVFHAKUTI-ZCFIWIBFSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "GS-1278",
        "PMPA"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tenofovir (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-vir",
    "usan_stem_definition": "antivirals",
    "usan_stem_substem": "-vir(-vir)",
    "usan_year": 1999
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 7,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL484",
    "molecule_properties": {
      "acd_logd": -4.4,
      "acd_logp": -0.49,
      "acd_most_apka": 1.63,
      "acd_most_bpka": 4.19,
      "alogp": -0.44,
      "aromatic_rings": 2,
      "full_molformula": "C8H12N5O4P",
      "full_mwt": 273.19,
      "hba": 7,
      "hba_lipinski": 9,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 18,
      "molecular_species": "ACID",
      "mw_freebase": 273.19,
      "mw_monoisotopic": 273.0627,
      "psa": 136.38,
      "qed_weighted": 0.49,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ncnc2c1ncn2CCOCP(=O)(O)O",
      "standard_inchi": "InChI=1S/C8H12N5O4P/c9-7-6-8(11-3-10-7)13(4-12-6)1-2-17-5-18(14,15)16/h3-4H,1-2,5H2,(H2,9,10,11)(H2,14,15,16)",
      "standard_inchi_key": "SUPKOOSCJHTBAH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "GS-0393"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Adefovir (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-vir",
    "usan_stem_definition": "antivirals",
    "usan_stem_substem": "-vir(-vir)",
    "usan_year": 1994
  },
  {
    "applicants": {
      "value": [
        "Valeant Pharmaceuticals North America Llc",
        "Mallinckrodt Inc",
        "Lannett Holdings Inc",
        "Watson Laboratories Inc Florida",
        "Anda Repository Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Hi-Tech Pharmacal Co Inc",
        "Carnrick Laboratories Inc Div Gw Carnrick Co",
        "Dava Pharmaceuticals Inc",
        "Allergan Sales Llc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R05DA04",
          "description": "RESPIRATORY SYSTEM: COUGH AND COLD PREPARATIONS: COUGH SUPPRESSANTS, EXCL. COMBINATIONS WITH EXPECTORANTS: Opium alkaloids and derivative"
        },
        {
          "code": "N02AA59",
          "description": "NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Natural opium alkaloid"
        },
        {
          "code": "N02AA79",
          "description": "NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Natural opium alkaloids"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1952,
    "indication_class": "Analgesic (narcotic); Antitussive,Antitussive,Antitussive; Analgesic (narcotic)",
    "molecule_chembl_id": "CHEMBL485",
    "molecule_properties": {
      "acd_logd": 0.46,
      "acd_logp": 1.39,
      "acd_most_apka": 13.4,
      "acd_most_bpka": 8.23,
      "alogp": 1.5,
      "aromatic_rings": 1,
      "full_molformula": "C18H21NO3",
      "full_mwt": 299.37,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 299.37,
      "mw_monoisotopic": 299.1521,
      "psa": 41.93,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2C[C@@H]3[C@@H]4C=C[C@H](O)[C@@H]5Oc1c2[C@]45CCN3C",
      "standard_inchi": "InChI=1S/C18H21NO3/c1-19-8-7-18-11-4-5-13(20)17(18)22-16-14(21-2)6-3-10(15(16)18)9-12(11)19/h3-6,11-13,17,20H,7-9H2,1-2H3/t11-,12+,13-,17-,18-/m0/s1",
      "standard_inchi_key": "OROGSEYTTFOCAN-DNJOTXNNSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6248363,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-6248363-B1",
    "synonyms": {
      "value": [
        "Codeine sulfate (FDA, USP)",
        "Codeine (BAN, BAN, USP)",
        "Codeine Phosphate (BAN, FDA, JAN, USP)",
        "Codeine Polistirex (FDA, USAN)",
        null
      ]
    },
    "usan_year": 1987
  },
  {
    "applicants": {
      "value": [
        "Marsam Pharmaceuticals Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Kv Pharmaceutical Co",
        "Usl Pharma Llc",
        "Vangard Laboratories Inc Div Midway Medical Co",
        "Purepac Pharmaceutical Co",
        "Wockhardt Eu Operations (Swiss) Ag",
        "Pharmaceutical Assoc Inc Div Beach Products",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa",
        "Private Formulations Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AA01",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with aliphatic side-chain"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1957,
    "indication_class": "Antipsychotic; Anti-Emetic",
    "molecule_chembl_id": "CHEMBL71",
    "molecule_properties": {
      "acd_logd": 3.24,
      "acd_logp": 5.18,
      "acd_most_bpka": 9.41,
      "alogp": 4.89,
      "aromatic_rings": 2,
      "full_molformula": "C17H19ClN2S",
      "full_mwt": 318.87,
      "hba": 3,
      "hba_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 318.87,
      "mw_monoisotopic": 318.0957,
      "psa": 6.48,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13",
      "standard_inchi": "InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",
      "standard_inchi_key": "ZPEIMTDSQAKGNT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Chlorpromazine HCl (BAN, FDA, JAN, USP)",
        "Chlorpromazine (BAN, FDA, INN, USP)",
        "Chlorpromazine Hibenzate (JAN)",
        "Chlorpromazine Phenolphthalinate (JAN)",
        "Chlorpromazine Tannate (JAN)",
        null
      ]
    },
    "topical": true
  },
  {
    "applicants": {
      "value": [
        "Amneal Pharmaceuticals Co Gmbh",
        "Sanofi Aventis Us Llc",
        "Actavis Totowa Llc",
        "Us Pharmaceutical Holdings Ii Llc",
        "Sandoz Inc",
        "Ani Pharmaceuticals Inc",
        "Heritage Pharmaceuticals Inc",
        "Usl Pharma Inc",
        "Impax Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AA01",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1964,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL72",
    "molecule_properties": {
      "acd_logd": 1.27,
      "acd_logp": 3.97,
      "acd_most_bpka": 10.4,
      "alogp": 3.53,
      "aromatic_rings": 2,
      "full_molformula": "C18H22N2",
      "full_mwt": 266.39,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 266.39,
      "mw_monoisotopic": 266.1783,
      "psa": 15.27,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CNCCCN1c2ccccc2CCc3ccccc13",
      "standard_inchi": "InChI=1S/C18H22N2/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3",
      "standard_inchi_key": "HCYAFALTSJYZDH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "EX 4355",
        "18-8181",
        "EX-4355",
        "DMI",
        "JB-8181",
        "RMI-9384A",
        "G-35020"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Desipramine HCl (FDA, JAN, USAN, USP)",
        "Desipramine (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-pramine",
    "usan_stem_definition": "antidepressants (imipramine type)",
    "usan_stem_substem": "-pramine(-pramine)",
    "usan_year": 1962
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL487",
    "molecule_properties": {
      "acd_logd": 3.55,
      "acd_logp": 4.85,
      "acd_most_apka": 9.82,
      "acd_most_bpka": 8.69,
      "alogp": 5.7,
      "aromatic_rings": 3,
      "full_molformula": "C26H29NO2",
      "full_mwt": 387.52,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "BASE",
      "mw_freebase": 387.52,
      "mw_monoisotopic": 387.2198,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 32.7,
      "qed_weighted": 0.5,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC\\C(=C(\\c1ccc(OCCN(C)C)cc1)/c2cccc(O)c2)\\c3ccccc3",
      "standard_inchi": "InChI=1S/C26H29NO2/c1-4-25(20-9-6-5-7-10-20)26(22-11-8-12-23(28)19-22)21-13-15-24(16-14-21)29-18-17-27(2)3/h5-16,19,28H,4,17-18H2,1-3H3/b26-25+",
      "standard_inchi_key": "ZQZFYGIXNQKOAV-OCEACIFDSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "K-060E",
        "K-21060E",
        "FK-435",
        "K-060"
      ]
    },
    "synonyms": {
      "value": [
        "Droloxifene (INN, USAN)",
        "Droloxifene Citrate (USAN)",
        null
      ]
    },
    "usan_stem": "-ifene",
    "usan_stem_definition": "antiestrogens of the clomifene and tamoxifen groups",
    "usan_stem_substem": "-ifene(-ifene)",
    "usan_year": 1994
  },
  {
    "applicants": {
      "value": "Novartis Pharmaceuticals Corp"
    },
    "atc_classification": {
      "drug": {
        "code": "L02BG01",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Aromatase inhibitors"
      }
    },
    "availability_type": 0,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1980,
    "indication_class": "Adrenocortical Suppressant; Antineoplastic",
    "molecule_chembl_id": "CHEMBL488",
    "molecule_properties": {
      "acd_logd": 0.54,
      "acd_logp": 0.54,
      "acd_most_apka": 11.6,
      "acd_most_bpka": 4.41,
      "alogp": 1.35,
      "aromatic_rings": 1,
      "full_molformula": "C13H16N2O2",
      "full_mwt": 232.28,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 232.28,
      "mw_monoisotopic": 232.1212,
      "psa": 72.19,
      "qed_weighted": 0.6,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCC1(CCC(=O)NC1=O)c2ccc(N)cc2",
      "standard_inchi": "InChI=1S/C13H16N2O2/c1-2-13(8-7-11(16)15-12(13)17)9-3-5-10(14)6-4-9/h3-6H,2,7-8,14H2,1H3,(H,15,16,17)",
      "standard_inchi_key": "ROBVIMPUHSLWNV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Aminoglutethimide (BAN, FDA, INN, USP)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL10041",
    "molecule_properties": {
      "acd_logd": 3.63,
      "acd_logp": 4.93,
      "acd_most_apka": 10.32,
      "acd_most_bpka": 8.69,
      "alogp": 5.7,
      "aromatic_rings": 3,
      "full_molformula": "C26H29NO2",
      "full_mwt": 387.52,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "BASE",
      "mw_freebase": 387.52,
      "mw_monoisotopic": 387.2198,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 32.7,
      "qed_weighted": 0.5,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccc(O)cc3",
      "standard_inchi": "InChI=1S/C26H29NO2/c1-4-25(20-10-14-23(28)15-11-20)26(21-8-6-5-7-9-21)22-12-16-24(17-13-22)29-19-18-27(2)3/h5-17,28H,4,18-19H2,1-3H3/b26-25-",
      "standard_inchi_key": "DODQJNMQWMSYGS-QPLCGJKRSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "4-OHT"
    },
    "synonyms": {
      "value": [
        "Afimoxifene (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ifene",
    "usan_stem_definition": "antiestrogens of the clomifene and tamoxifen groups",
    "usan_stem_substem": "-ifene(-ifene)",
    "usan_year": 2006
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL264214",
    "molecule_properties": {
      "acd_logd": 3.1,
      "acd_logp": 3.1,
      "acd_most_apka": 9.58,
      "acd_most_bpka": 3.46,
      "alogp": 3.69,
      "aromatic_rings": 3,
      "full_molformula": "C16H17N3OS2",
      "full_mwt": 331.47,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 331.47,
      "mw_monoisotopic": 331.0813,
      "psa": 58.64,
      "qed_weighted": 0.72,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCSc1ccnc(C[S+]([O-])c2nc3ccccc3[nH]2)c1C",
      "standard_inchi": "InChI=1S/C16H17N3OS2/c1-3-21-15-8-9-17-14(11(15)2)10-22(20)16-18-12-6-4-5-7-13(12)19-16/h4-9H,3,10H2,1-2H3,(H,18,19)",
      "standard_inchi_key": "YWQUFKJVMWHDSN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Disuprazole (INN)",
        null
      ]
    },
    "usan_stem": "-prazole",
    "usan_stem_definition": "antiulcer agents (benzimidazole derivatives)",
    "usan_stem_substem": "-prazole(-prazole)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL9861",
    "molecule_properties": {
      "acd_logd": 1.22,
      "acd_logp": 1.22,
      "acd_most_apka": 9.61,
      "acd_most_bpka": 3,
      "alogp": 2.27,
      "aromatic_rings": 3,
      "full_molformula": "C13H11N3OS",
      "full_mwt": 257.32,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 257.32,
      "mw_monoisotopic": 257.0623,
      "psa": 58.64,
      "qed_weighted": 0.78,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "[O-][S+](Cc1ccccn1)c2nc3ccccc3[nH]2",
      "standard_inchi": "InChI=1S/C13H11N3OS/c17-18(9-10-5-3-4-8-14-10)13-15-11-6-1-2-7-12(11)16-13/h1-8H,9H2,(H,15,16)",
      "standard_inchi_key": "HBDKFZNDMVLSHM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Timoprazole (INN)",
        null
      ]
    },
    "usan_stem": "-prazole",
    "usan_stem_definition": "antiulcer agents (benzimidazole derivatives)",
    "usan_stem_substem": "-prazole(-prazole)"
  },
  {
    "applicants": {
      "value": [
        "Ipca Laboratories Ltd",
        "Hikma Pharmaceuticals Llc",
        "Sanofi Aventis Us Llc",
        "Natco Pharma Limited",
        "Watson Laboratories Inc",
        "Purepac Pharmaceutical Co",
        "Md Pharmaceutical Inc",
        "Impax Laboratories Inc",
        "Teva Pharmaceuticals Usa Inc",
        "Natco Pharma Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "P01BA01",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Aminoquinolines"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1949,
    "indication_class": "Anti-Amebic; Antimalarial,Anti-Amebic; Suppressant (lupus erythematosus); Antimalarial",
    "molecule_chembl_id": "CHEMBL76",
    "molecule_properties": {
      "acd_logd": 1.59,
      "acd_logp": 4.41,
      "acd_most_bpka": 10.47,
      "alogp": 4.81,
      "aromatic_rings": 2,
      "full_molformula": "C18H26ClN3",
      "full_mwt": 319.88,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 319.88,
      "mw_monoisotopic": 319.1815,
      "psa": 28.16,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12",
      "standard_inchi": "InChI=1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21)",
      "standard_inchi_key": "WHTVZRBIWZFKQO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "NSC-187208"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Chloroquine HCl (FDA, USP)",
        "Chloroquine Phosphate (BAN, FDA, USP)",
        "Chloroquine (BAN, INN, USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Lupin Ltd",
        "Roxane Laboratories Inc",
        "Sun Pharmaceutical Industries Inc",
        "Oxford Pharmaceuticals Llc",
        "Actavis Laboratories Fl Inc",
        "Upsher-Smith Laboratories Llc",
        "Apotex Inc",
        "Jubilant Generics Ltd",
        "Teva Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AB05",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Selective serotonin reuptake inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1992,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL490",
    "molecule_properties": {
      "acd_logd": 1.48,
      "acd_logp": 3.7,
      "acd_most_bpka": 9.68,
      "alogp": 3.33,
      "aromatic_rings": 2,
      "full_molformula": "C19H20FNO3",
      "full_mwt": 329.37,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 329.37,
      "mw_monoisotopic": 329.1427,
      "psa": 39.72,
      "qed_weighted": 0.93,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc3ccc4OCOc4c3",
      "standard_inchi": "InChI=1S/C19H20FNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14-,17-/m0/s1",
      "standard_inchi_key": "AHOUBRCZNHFOSL-YOEHRIQHSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5874447,
    "oral": true,
    "research_codes": {
      "value": [
        "BRL-29060",
        "POT.MES"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5874447-A",
    "synonyms": {
      "value": [
        "Paroxetine mesylate (FDA, USAN)",
        "Paroxetine HCl (FDA, USP)",
        "Paroxetine (BAN, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-oxetine",
    "usan_stem_definition": "antidepressants (fluoxetine type)",
    "usan_stem_substem": "-oxetine(-oxetine)",
    "usan_year": 1989
  },
  {
    "atc_classification": {
      "drug": {
        "code": "M01AH05",
        "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Coxibs"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL416146",
    "molecule_properties": {
      "acd_logd": 2.46,
      "acd_logp": 2.46,
      "acd_most_bpka": 3.68,
      "alogp": 4.18,
      "aromatic_rings": 3,
      "full_molformula": "C18H15ClN2O2S",
      "full_mwt": 358.85,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 358.85,
      "mw_monoisotopic": 358.0543,
      "psa": 59.92,
      "qed_weighted": 0.7,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccc(cn1)c2ncc(Cl)cc2c3ccc(cc3)S(=O)(=O)C",
      "standard_inchi": "InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",
      "standard_inchi_key": "MNJVRJDLRVPLFE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MK-0663"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Etoricoxib (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-coxib",
    "usan_stem_definition": "cyclooxygenase-2 inhibitors",
    "usan_stem_substem": "-coxib(-coxib)",
    "usan_year": 2000
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL10085",
    "molecule_properties": {
      "acd_logd": 3.43,
      "acd_logp": 3.79,
      "acd_most_bpka": 7.23,
      "alogp": 4.42,
      "aromatic_rings": 2,
      "full_molformula": "C26H35N3O2",
      "full_mwt": 421.59,
      "hba": 4,
      "hba_lipinski": 5,
      "heavy_atoms": 31,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 421.59,
      "mw_monoisotopic": 421.2729,
      "psa": 36.02,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)Oc1ccccc1N2CCN(Cc3cccc(c3)C(=O)N4CCCCC4)CC2",
      "standard_inchi": "InChI=1S/C26H35N3O2/c1-21(2)31-25-12-5-4-11-24(25)28-17-15-27(16-18-28)20-22-9-8-10-23(19-22)26(30)29-13-6-3-7-14-29/h4-5,8-12,19,21H,3,6-7,13-18,20H2,1-2H3",
      "standard_inchi_key": "ZKZFPRUSWCYSGT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "RWJ-37796",
        "RWJ-377796"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mazapertine Succinate (USAN)",
        "Mazapertine (INN)",
        null
      ]
    },
    "usan_year": 1994
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Miles Laboratories Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Astrazeneca Lp",
        "International Medication System",
        "Combe Inc",
        "Gd Searle Llc",
        "Glenmark Pharmaceuticals Ltd",
        "Taro Pharmaceuticals Usa Inc",
        "Hospira Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R02AD02",
          "description": "RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Anesthetics, loca"
        },
        {
          "code": "S02DA01",
          "description": "SENSORY ORGANS: OTOLOGICALS: OTHER OTOLOGICALS: Analgesics and anesthetic"
        },
        {
          "code": "C05AD01",
          "description": "CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Local anesthetic"
        },
        {
          "code": "N01BB02",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amide"
        },
        {
          "code": "D04AB01",
          "description": "DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Anesthetics for topical us"
        },
        {
          "code": "C01BB01",
          "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class I"
        },
        {
          "code": "S01HA07",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: LOCAL ANESTHETICS: Local anesthetic"
        },
        {
          "code": "N01BB52",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1948,
    "indication_class": "Anesthetic (local),Anesthetic (topical)",
    "molecule_chembl_id": "CHEMBL79",
    "molecule_properties": {
      "acd_logd": 1.67,
      "acd_logp": 2.2,
      "acd_most_bpka": 7.96,
      "alogp": 2.58,
      "aromatic_rings": 1,
      "full_molformula": "C14H22N2O",
      "full_mwt": 234.34,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 234.34,
      "mw_monoisotopic": 234.1732,
      "psa": 32.34,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CC(=O)Nc1c(C)cccc1C",
      "standard_inchi": "InChI=1S/C14H22N2O/c1-5-16(6-2)10-13(17)15-14-11(3)8-7-9-12(14)4/h7-9H,5-6,10H2,1-4H3,(H,15,17)",
      "standard_inchi_key": "NNJVILVZKWQKPM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6004286,
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-6004286-A",
    "synonyms": {
      "value": [
        "Lidocaine HCl (FDA, JAN, USP)",
        "Lignocaine HCl (BAN)",
        "Lidocaine (FDA, INN, JAN, USP)",
        "Lignocaine (BAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-caine",
    "usan_stem_definition": "local anesthetics",
    "usan_stem_substem": "-caine(-caine)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL10188",
    "molecule_properties": {
      "acd_logd": 4.63,
      "acd_logp": 5.8,
      "acd_most_apka": 6.7,
      "acd_most_bpka": 2.95,
      "alogp": 5.49,
      "aromatic_rings": 4,
      "full_molformula": "C25H22N2O2",
      "full_mwt": 382.46,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 29,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 382.46,
      "mw_monoisotopic": 382.1681,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 62.22,
      "qed_weighted": 0.48,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC[C@H](NC(=O)c1c(O)c(nc2ccccc12)c3ccccc3)c4ccccc4",
      "standard_inchi": "InChI=1S/C25H22N2O2/c1-2-20(17-11-5-3-6-12-17)27-25(29)22-19-15-9-10-16-21(19)26-23(24(22)28)18-13-7-4-8-14-18/h3-16,20,28H,2H2,1H3,(H,27,29)/t20-/m0/s1",
      "standard_inchi_key": "BIAVGWDGIJKWRM-FQEVSTJZSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "SB-223412-A",
        "SB-2234",
        "SB-223412"
      ]
    },
    "synonyms": {
      "value": [
        "Talnetant (INN)",
        "Talnetant HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-tant",
    "usan_stem_definition": "tachykinin (neurokinin) receptor antagonists: NK3 receptor antagonists",
    "usan_stem_substem": "-tant(-tant(-netant))",
    "usan_year": 1998
  },
  {
    "atc_classification": {
      "drug": {
        "code": "A02BX03",
        "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Other drugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Anti-Ulcerative",
    "molecule_chembl_id": "CHEMBL9967",
    "molecule_properties": {
      "acd_logd": -0.07,
      "acd_logp": 0.21,
      "acd_most_apka": 11.29,
      "acd_most_bpka": 7.39,
      "alogp": 1.56,
      "aromatic_rings": 2,
      "full_molformula": "C19H21N5O2",
      "full_mwt": 351.41,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 351.41,
      "mw_monoisotopic": 351.1695,
      "psa": 68.78,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc4cccnc24)CC1",
      "standard_inchi": "InChI=1S/C19H21N5O2/c1-22-9-11-23(12-10-22)13-17(25)24-16-7-3-2-5-14(16)19(26)21-15-6-4-8-20-18(15)24/h2-8H,9-13H2,1H3,(H,21,26)",
      "standard_inchi_key": "RMHMFHUVIITRHF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "LS-519-C12"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pirenzepine HCl (JAN, USAN)",
        "Pirenzepine (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-pin(e)",
    "usan_stem_definition": "tricyclic compounds",
    "usan_stem_substem": "-pin(e)(-pin(e))",
    "usan_year": 1986
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL10316",
    "molecule_properties": {
      "acd_logd": 0.55,
      "acd_logp": 2.31,
      "acd_most_bpka": 9.52,
      "alogp": 0.83,
      "aromatic_rings": 1,
      "full_molformula": "C11H12N2O2",
      "full_mwt": 204.23,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 15,
      "molecular_species": "BASE",
      "mw_freebase": 204.23,
      "mw_monoisotopic": 204.0899,
      "psa": 42.85,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "C1CN=C(N1)C2COc3ccccc3O2",
      "standard_inchi": "InChI=1S/C11H12N2O2/c1-2-4-9-8(3-1)14-7-10(15-9)11-12-5-6-13-11/h1-4,10H,5-7H2,(H,12,13)",
      "standard_inchi_key": "HPMRFMKYPGXPEP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "RX-781094"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Idazoxan (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-oxan(e)",
    "usan_stem_definition": "alpha-adrenoceptor antagonists (benzodioxane derivatives)",
    "usan_stem_substem": "-oxan(e)(-oxan(e))"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL9960",
    "molecule_properties": {
      "acd_logd": 5.33,
      "acd_logp": 5.33,
      "acd_most_apka": 12.82,
      "acd_most_bpka": 3.63,
      "alogp": 5.78,
      "aromatic_rings": 4,
      "full_molformula": "C25H22N2O",
      "full_mwt": 366.46,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 366.46,
      "mw_monoisotopic": 366.1732,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 41.99,
      "qed_weighted": 0.49,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC[C@H](NC(=O)c1cc(nc2ccccc12)c3ccccc3)c4ccccc4",
      "standard_inchi": "InChI=1S/C25H22N2O/c1-2-22(18-11-5-3-6-12-18)27-25(28)21-17-24(19-13-7-4-8-14-19)26-23-16-10-9-15-20(21)23/h3-17,22H,2H2,1H3,(H,27,28)/t22-/m0/s1",
      "standard_inchi_key": "MXNGYQJJYRVGGJ-QFIPXVFZSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AZD-7624"
    },
    "synonyms": {
      "value": "AZD-7624"
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Anticholinergic",
    "molecule_chembl_id": "CHEMBL10272",
    "molecule_properties": {
      "acd_logd": 1.7,
      "acd_logp": 2.83,
      "acd_most_apka": 11.2,
      "acd_most_bpka": 8.5,
      "alogp": 3.27,
      "aromatic_rings": 2,
      "full_molformula": "C23H26N2O2",
      "full_mwt": 362.47,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 362.47,
      "mw_monoisotopic": 362.1994,
      "psa": 49.41,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1CCC(C2CCN(Cc3ccccc3)CC2)(C(=O)N1)c4ccccc4",
      "standard_inchi": "InChI=1S/C23H26N2O2/c26-21-11-14-23(22(27)24-21,19-9-5-2-6-10-19)20-12-15-25(16-13-20)17-18-7-3-1-4-8-18/h1-10,20H,11-17H2,(H,24,26,27)",
      "standard_inchi_key": "LQQIVYSCPWCSSD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "Janssen R-4929",
        "MCN-JR-4929-11"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Benzetimide HCl (USAN)",
        "Benzetimide (INN)",
        null
      ]
    },
    "usan_year": 1969
  },
  {
    "applicants": {
      "value": [
        "Dentsply Pharmaceutical",
        "Astrazeneca Lp"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N01BB57",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amide"
        },
        {
          "code": "N01BB07",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Amides"
        }
      ]
    },
    "availability_type": 0,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1976,
    "indication_class": "Anesthetic (local)",
    "molecule_chembl_id": "CHEMBL492",
    "molecule_properties": {
      "acd_logd": 3.16,
      "acd_logp": 3.57,
      "acd_most_bpka": 8.07,
      "alogp": 3.75,
      "aromatic_rings": 1,
      "full_molformula": "C17H28N2O",
      "full_mwt": 276.42,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 276.42,
      "mw_monoisotopic": 276.2202,
      "psa": 32.34,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCCN(CC)C(CC)C(=O)Nc1c(C)cccc1C",
      "standard_inchi": "InChI=1S/C17H28N2O/c1-6-12-19(8-3)15(7-2)17(20)18-16-13(4)10-9-11-14(16)5/h9-11,15H,6-8,12H2,1-5H3,(H,18,20)",
      "standard_inchi_key": "VTUSIVBDOCDNHS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "W-19053"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Etidocaine (BAN, INN, USAN)",
        "Etidocaine HCl (FDA)",
        null
      ]
    },
    "usan_stem": "-caine",
    "usan_stem_definition": "local anesthetics",
    "usan_stem_substem": "-caine(-caine)",
    "usan_year": 1973
  },
  {
    "applicants": {
      "value": [
        "Marsam Pharmaceuticals Llc",
        "Indivior Inc",
        "Smith And Nephew Solopak Div Smith And Nephew",
        "Sanofi Aventis Us Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Kaleo Inc",
        "International Medication System",
        "Astrazeneca Lp",
        "Orexo Us Inc",
        "Hospira Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "A06AH04",
          "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Peripheral opioid receptor antagonist"
        },
        {
          "code": "V03AB15",
          "description": "VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1971,
    "indication_class": "Antagonist (to narcotics)",
    "molecule_chembl_id": "CHEMBL80",
    "molecule_properties": {
      "acd_logd": 1.66,
      "acd_logp": 1.77,
      "acd_most_apka": 9.16,
      "acd_most_bpka": 6.71,
      "alogp": 1.3,
      "aromatic_rings": 1,
      "full_molformula": "C19H21NO4",
      "full_mwt": 327.38,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 327.38,
      "mw_monoisotopic": 327.1471,
      "psa": 70,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1ccc2C[C@H]3N(CC=C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O",
      "standard_inchi": "InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1",
      "standard_inchi_key": "UZHSEJADLWPNLE-GRGSLBFTSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6159498,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "EN-15304"
    },
    "rule_of_five": true,
    "sc_patent": "US-6159498-A",
    "synonyms": {
      "value": [
        "Naloxone HCl (FDA, JAN, USAN, USP)",
        "Naloxone (BAN, INN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "nal-",
    "usan_stem_definition": "narcotic agonists/antagonists (normorphine type)",
    "usan_stem_substem": "nal-(nal-)",
    "usan_year": 1963
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Eli Lilly And Co",
        "Glenmark Pharmaceuticals Ltd",
        "Invagen Pharmaceuticals Inc",
        "Watson Laboratories Inc",
        "Sciegen Pharmaceuticals Inc",
        "Amneal Pharmaceuticals",
        "Aurobindo Pharma Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "G03XC01",
        "description": "GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: OTHER SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: Selective estrogen receptor modulators"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1997,
    "indication_class": "Anti-Estrogen",
    "molecule_chembl_id": "CHEMBL81",
    "molecule_properties": {
      "acd_logd": 3.4,
      "acd_logp": 4.57,
      "acd_most_apka": 8.83,
      "acd_most_bpka": 8.52,
      "alogp": 6.08,
      "aromatic_rings": 4,
      "full_molformula": "C28H27NO4S",
      "full_mwt": 473.59,
      "hba": 6,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 34,
      "molecular_species": "BASE",
      "mw_freebase": 473.59,
      "mw_monoisotopic": 473.1661,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 70,
      "qed_weighted": 0.32,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4",
      "standard_inchi": "InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2",
      "standard_inchi_key": "GZUITABIAKMVPG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6458811,
    "oral": true,
    "research_codes": {
      "value": "LY-156758"
    },
    "sc_patent": "US-6458811-B1",
    "synonyms": {
      "value": [
        "Raloxifene HCl (FDA, USAN)",
        "Raloxifene (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-ifene",
    "usan_stem_definition": "antiestrogens of the clomifene and tamoxifen groups",
    "usan_stem_substem": "-ifene(-ifene)",
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": [
        "Roxane Laboratories Inc",
        "Actavis Laboratories Fl Inc",
        "Apotex Inc",
        "Astrazeneca Pharmaceuticals Lp",
        "Pharmachemie Bv",
        "Midatech Pharma Us Inc",
        "Zydus Pharmaceuticals Usa Inc",
        "Aegis Pharmaceuticals Inc",
        "Mylan Pharmaceuticals Inc",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L02BA01",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Anti-estrogens"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1977,
    "indication_class": "Anti-Estrogen",
    "molecule_chembl_id": "CHEMBL83",
    "molecule_properties": {
      "acd_logd": 3.83,
      "acd_logp": 5.13,
      "acd_most_bpka": 8.69,
      "alogp": 6,
      "aromatic_rings": 3,
      "full_molformula": "C26H29NO",
      "full_mwt": 371.52,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 28,
      "molecular_species": "BASE",
      "mw_freebase": 371.52,
      "mw_monoisotopic": 371.2249,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 12.47,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC\\C(=C(/c1ccccc1)\\c2ccc(OCCN(C)C)cc2)\\c3ccccc3",
      "standard_inchi": "InChI=1S/C26H29NO/c1-4-25(21-11-7-5-8-12-21)26(22-13-9-6-10-14-22)23-15-17-24(18-16-23)28-20-19-27(2)3/h5-18H,4,19-20H2,1-3H3/b26-25-",
      "standard_inchi_key": "NKANXQFJJICGDU-QPLCGJKRSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6127425,
    "oral": true,
    "prodrug": true,
    "research_codes": {
      "value": "ICI-46474"
    },
    "sc_patent": "US-6127425-A",
    "synonyms": {
      "value": [
        "Tamoxifen (BAN, INN)",
        "Tamoxifen citrate (FDA, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1976
  },
  {
    "applicants": {
      "value": [
        "Us Pharmaceuticals Holdings I Llc",
        "Veroscience Llc",
        "Sandoz Inc",
        "Paddock Laboratories Llc",
        "Zydus Pharmaceuticals Usa Inc",
        "Mylan Pharmaceuticals Inc",
        "Lek Pharmaceutical And Chemical Co Dd"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N04BC01",
          "description": "NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Dopamine agonist"
        },
        {
          "code": "G02CB01",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: OTHER GYNECOLOGICALS: Prolactine inhibitors"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1978,
    "indication_class": "Enzyme Inhibitor (prolactin)",
    "molecule_chembl_id": "CHEMBL493",
    "molecule_properties": {
      "acd_logd": 8.55,
      "acd_logp": 8.6,
      "acd_most_apka": 9.6,
      "acd_most_bpka": 6.44,
      "alogp": 3.19,
      "aromatic_rings": 2,
      "full_molformula": "C32H40BrN5O5",
      "full_mwt": 654.61,
      "hba": 6,
      "hba_lipinski": 10,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 43,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 654.61,
      "mw_monoisotopic": 653.2213,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 118.21,
      "qed_weighted": 0.46,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)C[C@@H]1N2C(=O)[C@](NC(=O)[C@H]3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(O[C@@]2(O)[C@@H]7CCCN7C1=O)C(C)C",
      "standard_inchi": "InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1",
      "standard_inchi_key": "OZVBMTJYIDMWIL-AYFBDAFISA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7888310,
    "oral": true,
    "research_codes": {
      "value": [
        "CB-154",
        "CB-154 Mesylate"
      ]
    },
    "sc_patent": "US-7888310-B2",
    "synonyms": {
      "value": [
        "Bromocriptine Mesilate (JAN)",
        "Bromocriptine Mesylate (FDA, USAN, USP)",
        "Bromocriptine (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1976
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Antifihrinolytic; Anticoagulant",
    "molecule_chembl_id": "CHEMBL273264",
    "molecule_properties": {
      "acd_logd": -0.92,
      "acd_logp": 2.06,
      "acd_most_bpka": 11,
      "alogp": 2.65,
      "aromatic_rings": 3,
      "full_molformula": "C19H17N5O2",
      "full_mwt": 347.38,
      "hba": 4,
      "hba_lipinski": 7,
      "hbd": 5,
      "hbd_lipinski": 7,
      "heavy_atoms": 26,
      "molecular_species": "BASE",
      "mw_freebase": 347.38,
      "mw_monoisotopic": 347.1382,
      "num_lipinski_ro5_violations": 1,
      "psa": 138.07,
      "qed_weighted": 0.21,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=N)Nc1ccc(cc1)C(=O)Oc2ccc3cc(ccc3c2)C(=N)N",
      "standard_inchi": "InChI=1S/C19H17N5O2/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23/h1-10H,(H3,20,21)(H4,22,23,24)",
      "standard_inchi_key": "MQQNFDZXWVTQEH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "FUT-175"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nafamostat (INN)",
        "Nafamostat Mesilate (JAN)",
        "Nafamostat Mesylate (USAN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors: proteolytic enzyme inhibitors",
    "usan_stem_substem": "-stat(-stat(-mostat))",
    "usan_year": 1992
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL269455",
    "molecule_properties": {
      "acd_logd": 1.14,
      "acd_logp": 1.16,
      "acd_most_apka": 8.17,
      "alogp": 2.03,
      "aromatic_rings": 2,
      "full_molformula": "C15H8F2N2O2",
      "full_mwt": 286.24,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 286.24,
      "mw_monoisotopic": 286.0554,
      "psa": 58.2,
      "qed_weighted": 0.73,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "Fc1ccc2c3ccc(F)cc3C4(NC(=O)NC4=O)c2c1",
      "standard_inchi": "InChI=1S/C15H8F2N2O2/c16-7-1-3-9-10-4-2-8(17)6-12(10)15(11(9)5-7)13(20)18-14(21)19-15/h1-6H,(H2,18,19,20,21)",
      "standard_inchi_key": "QCCHBHSAIQIQGO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Imirestat (INN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors: aldose-reductase inhibitors",
    "usan_stem_substem": "-stat(-stat(-restat))"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL10445",
    "molecule_properties": {
      "acd_logd": 2.25,
      "acd_logp": 4.04,
      "acd_most_apka": 11.31,
      "acd_most_bpka": 9.08,
      "alogp": 4.09,
      "aromatic_rings": 2,
      "full_molformula": "C22H27Cl2N3O4",
      "full_mwt": 468.38,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 31,
      "molecular_species": "BASE",
      "mw_freebase": 468.38,
      "mw_monoisotopic": 467.1379,
      "psa": 79.9,
      "qed_weighted": 0.52,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCNC(=O)c1cc(Cl)c(NC(=O)COc2ccc(Cl)cc2)cc1OC",
      "standard_inchi": "InChI=1S/C22H27Cl2N3O4/c1-4-27(5-2)11-10-25-22(29)17-12-18(24)19(13-20(17)30-3)26-21(28)14-31-16-8-6-15(23)7-9-16/h6-9,12-13H,4-5,10-11,14H2,1-3H3,(H,25,29)(H,26,28)",
      "standard_inchi_key": "VZNJZQAFQDEJOO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cloxacepride (INN)",
        null
      ]
    },
    "usan_stem": "-pride",
    "usan_stem_definition": "sulpiride derivatives",
    "usan_stem_substem": "-pride(-pride)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL10413",
    "molecule_properties": {
      "acd_logd": 1.09,
      "acd_logp": 4.48,
      "acd_most_apka": 3.76,
      "alogp": 2.85,
      "aromatic_rings": 3,
      "full_molformula": "C17H11BrClFN2O4",
      "full_mwt": 441.64,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 441.64,
      "mw_monoisotopic": 439.9575,
      "psa": 81.3,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CN1C(=O)N(Cc2ccc(Br)cc2F)C(=O)c3ccc(Cl)cc13",
      "standard_inchi": "InChI=1S/C17H11BrClFN2O4/c18-10-2-1-9(13(20)5-10)7-22-16(25)12-4-3-11(19)6-14(12)21(17(22)26)8-15(23)24/h1-6H,7-8H2,(H,23,24)",
      "standard_inchi_key": "SXONDGSPUVNZLO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "FR-74366",
        "CI-1014",
        "FK-366"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Zenarestat (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors: aldose-reductase inhibitors",
    "usan_stem_substem": "-stat(-stat(-restat))",
    "usan_year": 1998
  },
  {
    "applicants": {
      "value": "Actelion Pharmaceuticals Ltd"
    },
    "atc_classification": {
      "drug": {
        "code": "B01AC11",
        "description": "BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 2004,
    "molecule_chembl_id": "CHEMBL494",
    "molecule_properties": {
      "acd_logd": 0.68,
      "acd_logp": 3.28,
      "acd_most_apka": 4.77,
      "alogp": 3.54,
      "full_molformula": "C22H32O4",
      "full_mwt": 360.49,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 360.49,
      "mw_monoisotopic": 360.2301,
      "psa": 77.76,
      "qed_weighted": 0.35,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC#CCC(C)[C@H](O)\\C=C\\[C@H]1[C@H](O)C[C@@H]2C\\C(=C/CCCC(=O)O)\\C[C@H]12",
      "standard_inchi": "InChI=1S/C22H32O4/c1-3-4-7-15(2)20(23)11-10-18-19-13-16(8-5-6-9-22(25)26)12-17(19)14-21(18)24/h8,10-11,15,17-21,23-24H,5-7,9,12-14H2,1-2H3,(H,25,26)/b11-10+,16-8+/t15?,17-,18+,19-,20+,21+/m0/s1",
      "standard_inchi_key": "HIFJCPQKFCZDDL-ACWOEMLNSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "ZK-00036374"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Iloprost (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-prost",
    "usan_stem_definition": "prostaglandins",
    "usan_stem_substem": "-prost(-prost)",
    "usan_year": 2004
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Fresenius Kabi Usa Llc",
        "Teva Pharmaceuticals Usa",
        "Novast Laboratories Ltd",
        "Mylan Laboratories Ltd",
        "Actavis Totowa Llc",
        "Novartis Pharmaceuticals Corp",
        "Sandoz Inc",
        "Hospira Inc",
        "Dr Reddys Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01XX17",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1996,
    "indication_class": "Antineoplastic (DNA topoisomerase I Inhibitor)",
    "molecule_chembl_id": "CHEMBL84",
    "molecule_properties": {
      "acd_logd": -0.32,
      "acd_logp": 0.32,
      "acd_most_apka": 8.92,
      "acd_most_bpka": 7.65,
      "alogp": 1.85,
      "aromatic_rings": 3,
      "full_molformula": "C23H23N3O5",
      "full_mwt": 421.45,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 31,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 421.45,
      "mw_monoisotopic": 421.1638,
      "psa": 104.89,
      "qed_weighted": 0.49,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5c(CN(C)C)c(O)ccc5nc34)C2=O",
      "standard_inchi": "InChI=1S/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8,27,30H,4,9-11H2,1-3H3/t23-/m0/s1",
      "standard_inchi_key": "UCFGDBYHRUNTLO-QHCPKHFHSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8158645,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "SK&F-S-104864A",
        "SK-S-104864-A"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-8158645-B2",
    "synonyms": {
      "value": [
        "Topotecan (BAN, INN)",
        "Topotecan HCl (FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-tecan",
    "usan_stem_definition": "antineoplastics (camptothecine derivatives)",
    "usan_stem_substem": "-tecan(-tecan)",
    "usan_year": 1990
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Inhibitor (aldose reductase); Antidiabetic",
    "molecule_chembl_id": "CHEMBL10372",
    "molecule_properties": {
      "acd_logd": -1.18,
      "acd_logp": 2.44,
      "acd_most_apka": 3.36,
      "alogp": 3.7,
      "aromatic_rings": 4,
      "full_molformula": "C19H12F3N3O3S",
      "full_mwt": 419.38,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "ACID",
      "mw_freebase": 419.38,
      "mw_monoisotopic": 419.0551,
      "psa": 85.08,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CC1=NN(Cc2nc3cc(ccc3s2)C(F)(F)F)C(=O)c4ccccc14",
      "standard_inchi": "InChI=1S/C19H12F3N3O3S/c20-19(21,22)10-5-6-15-14(7-10)23-16(29-15)9-25-18(28)12-4-2-1-3-11(12)13(24-25)8-17(26)27/h1-7H,8-9H2,(H,26,27)",
      "standard_inchi_key": "BCSVCWVQNOXFGL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CP-73850"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Zopolrestat (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors: aldose-reductase inhibitors",
    "usan_stem_substem": "-stat(-stat(-restat))",
    "usan_year": 1990
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Inhibitor (aldose reductase)",
    "molecule_chembl_id": "CHEMBL273910",
    "molecule_properties": {
      "acd_logd": 1.38,
      "acd_logp": 1.38,
      "acd_most_apka": 10.99,
      "alogp": 2.19,
      "aromatic_rings": 2,
      "full_molformula": "C19H11BrF2N2O4",
      "full_mwt": 449.21,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 449.21,
      "mw_monoisotopic": 447.987,
      "psa": 83.55,
      "qed_weighted": 0.56,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Fc1ccc2C(=O)N(Cc3ccc(Br)cc3F)C(=O)C4(CC(=O)NC4=O)c2c1",
      "standard_inchi": "InChI=1S/C19H11BrF2N2O4/c20-10-2-1-9(14(22)5-10)8-24-16(26)12-4-3-11(21)6-13(12)19(18(24)28)7-15(25)23-17(19)27/h1-6H,7-8H2,(H,23,25,27)",
      "standard_inchi_key": "BMHZAHGTGIZZCT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "WAY-ARI-509"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Minalrestat (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors: aldose-reductase inhibitors",
    "usan_stem_substem": "-stat(-stat(-restat))",
    "usan_year": 1996
  },
  {
    "applicants": {
      "value": [
        "Torrent Pharmaceuticals Ltd",
        "West-Ward Pharmaceuticals International Ltd",
        "Jubilant Generics Ltd",
        "Ajanta Pharma Ltd",
        "Par Pharmaceutical Inc",
        "Aurobindo Pharma Ltd",
        "Apotex Inc Richmond Hill",
        "Sun Pharmaceutical Industries Inc",
        "Oxford Pharmaceuticals Llc",
        "Lifestar Pharma Llc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AX08",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1993,
    "indication_class": "Neuroleptic",
    "molecule_chembl_id": "CHEMBL85",
    "molecule_properties": {
      "acd_logd": 1.89,
      "acd_logp": 2.68,
      "acd_most_bpka": 8.07,
      "alogp": 3.59,
      "aromatic_rings": 3,
      "full_molformula": "C23H27FN4O2",
      "full_mwt": 410.49,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 30,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 410.49,
      "mw_monoisotopic": 410.2118,
      "psa": 64.16,
      "qed_weighted": 0.66,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1",
      "standard_inchi": "InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3",
      "standard_inchi_key": "RAPZEAPATHNIPO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5792477,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "R-64-766",
        "R-64766"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5792477-A",
    "synonyms": {
      "value": [
        "Risperidone (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-peridone",
    "usan_stem_definition": "antipsychotics (risperidone type)",
    "usan_stem_substem": "-peridone(-peridone)",
    "usan_year": 1989
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL10758",
    "molecule_properties": {
      "acd_logd": 0,
      "acd_logp": 2.94,
      "acd_most_bpka": 10.85,
      "alogp": 2.13,
      "aromatic_rings": 2,
      "full_molformula": "C12H14N2",
      "full_mwt": 186.26,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 14,
      "molecular_species": "BASE",
      "mw_freebase": 186.26,
      "mw_monoisotopic": 186.1157,
      "psa": 16.96,
      "qed_weighted": 0.67,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "C1CNCc2cc3ccccc3n2C1",
      "standard_inchi": "InChI=1S/C12H14N2/c1-2-5-12-10(4-1)8-11-9-13-6-3-7-14(11)12/h1-2,4-5,8,13H,3,6-7,9H2",
      "standard_inchi_key": "FEJCIXJKPISCJV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MCN-2453"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Azepindole (INN, USAN)",
        null
      ]
    },
    "usan_year": 1978
  },
  {
    "applicants": {
      "value": [
        "Rising Pharmaceuticals Inc",
        "Hh And P Llc",
        "Sanofi Aventis Us Llc",
        "Blacksmith Brands Inc",
        "Bausch And Lomb Pharmaceuticals Inc",
        "King Pharmaceuticals Inc",
        "Akorn Inc",
        "Teva Pharmaceuticals Usa",
        "Roxane Laboratories Inc",
        "Micro Labs Ltd India"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01GX51",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergic"
        },
        {
          "code": "R01AC51",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Antiallergic agents, excl. corticosteroid"
        },
        {
          "code": "D11AH03",
          "description": "DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Agents for dermatitis, excluding corticosteroid"
        },
        {
          "code": "S01GX01",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergic"
        },
        {
          "code": "R01AC01",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Antiallergic agents, excl. corticosteroid"
        },
        {
          "code": "R03BC01",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Antiallergic agents, excl. corticosteroid"
        },
        {
          "code": "A07EB01",
          "description": "ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Antiallergic agents, excl. corticosteroids"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Anti-Asthmatic (prophylactic)",
    "molecule_chembl_id": "CHEMBL428880",
    "molecule_properties": {
      "acd_logd": -2.75,
      "acd_logp": 2,
      "acd_most_apka": 1.94,
      "alogp": 2.11,
      "aromatic_rings": 4,
      "full_molformula": "C23H16O11",
      "full_mwt": 468.37,
      "hba": 9,
      "hba_lipinski": 11,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 34,
      "molecular_species": "ACID",
      "mw_freebase": 468.37,
      "mw_monoisotopic": 468.0693,
      "num_lipinski_ro5_violations": 1,
      "psa": 173.71,
      "qed_weighted": 0.35,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "OC(COc1cccc2OC(=CC(=O)c12)C(=O)O)COc3cccc4OC(=CC(=O)c34)C(=O)O",
      "standard_inchi": "InChI=1S/C23H16O11/c24-11(9-31-14-3-1-5-16-20(14)12(25)7-18(33-16)22(27)28)10-32-15-4-2-6-17-21(15)13(26)8-19(34-17)23(29)30/h1-8,11,24H,9-10H2,(H,27,28)(H,29,30)",
      "standard_inchi_key": "IMZMKUWMOSJXDT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "FPL-670"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cromoglycic Acid (BAN)",
        "Cromolyn sodium (FDA, USAN, USP)",
        "Sodium Cromoglicate (JAN)",
        "Cromoglicic Acid (INN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1968
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Smith And Nephew Solopak Div Smith And Nephew",
        "West-Ward Pharmaceuticals International Ltd",
        "Halsey Drug Co Inc",
        "Hospira Inc",
        "Morton Grove Pharmaceuticals Inc",
        "Clonmel Healthcare",
        "Par Pharmaceutical Inc",
        "Bedford Laboratories Div Ben Venue Laboratories Inc",
        "King Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A03FA01",
        "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: PROPULSIVES: Propulsives"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1979,
    "indication_class": "Anti-Emetic",
    "molecule_chembl_id": "CHEMBL86",
    "molecule_properties": {
      "acd_logd": 0.3,
      "acd_logp": 2.16,
      "acd_most_apka": 13.84,
      "acd_most_bpka": 9.08,
      "alogp": 2,
      "aromatic_rings": 1,
      "full_molformula": "C14H22ClN3O2",
      "full_mwt": 299.8,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 299.8,
      "mw_monoisotopic": 299.1401,
      "psa": 67.59,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC",
      "standard_inchi": "InChI=1S/C14H22ClN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19)",
      "standard_inchi_key": "TTWJBBZEZQICBI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6024981,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "AHR-3070-C"
    },
    "rule_of_five": true,
    "sc_patent": "US-6024981-A",
    "synonyms": {
      "value": [
        "Metoclopramide (JAN, BAN, INN, JAN)",
        "Metoclopramide HCl (FDA, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1964
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL10634",
    "molecule_properties": {
      "acd_logd": -0.21,
      "acd_logp": 2.87,
      "acd_most_apka": 4.21,
      "alogp": 3.71,
      "aromatic_rings": 2,
      "full_molformula": "C18H16O4",
      "full_mwt": 296.32,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "ACID",
      "mw_freebase": 296.32,
      "mw_monoisotopic": 296.1049,
      "psa": 63.6,
      "qed_weighted": 0.92,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C(=O)O)c1ccc2Oc3ccc(C)cc3CC(=O)c2c1",
      "standard_inchi": "InChI=1S/C18H16O4/c1-10-3-5-16-13(7-10)9-15(19)14-8-12(11(2)18(20)21)4-6-17(14)22-16/h3-8,11H,9H2,1-2H3,(H,20,21)",
      "standard_inchi_key": "REHLODZXMGOGQP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Bermoprofen (INN)",
        null
      ]
    },
    "usan_stem": "-profen",
    "usan_stem_definition": "anti-inflammatory/analgesic agents (ibuprofen type)",
    "usan_stem_substem": "-profen(-profen)"
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Hq Specialty Pharma Corp",
        "Teva Pharmaceuticals Usa",
        "Actavis Totowa Llc",
        "Sandoz Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Abraxis Bioscience Llc",
        "Pliva Lachema As",
        "Hospira Inc",
        "Mylan Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01CD01",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS: Taxanes"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1992,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL428647",
    "molecule_properties": {
      "acd_logd": 3.95,
      "acd_logp": 3.95,
      "acd_most_apka": 11.9,
      "alogp": 3.74,
      "aromatic_rings": 3,
      "full_molformula": "C47H51NO14",
      "full_mwt": 853.92,
      "hba": 14,
      "hba_lipinski": 15,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 62,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 853.92,
      "mw_monoisotopic": 853.331,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 221.29,
      "qed_weighted": 0.13,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(=O)C)[C@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7)C(=C1C5(C)C)C",
      "standard_inchi": "InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1",
      "standard_inchi_key": "RCINICONZNJXQF-MZXODVADSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7758891,
    "parenteral": true,
    "research_codes": {
      "value": "BMS-181339-01"
    },
    "sc_patent": "US-7758891-B2",
    "synonyms": {
      "value": [
        "Paclitaxel (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-taxel",
    "usan_stem_definition": "antineoplastics, taxane derivatives",
    "usan_stem_substem": "-taxel(-taxel)",
    "usan_year": 1993
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Mylan Specialty Lp",
        "Pfizer Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Auxilium Pharmaceuticals Llc",
        "Pharmacia And Upjohn Co"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "C01EA01",
          "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: OTHER CARDIAC PREPARATIONS: Prostaglandin"
        },
        {
          "code": "G04BE01",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunction"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1981,
    "indication_class": "Vasodilator",
    "molecule_chembl_id": "CHEMBL495",
    "molecule_properties": {
      "acd_logd": 0.16,
      "acd_logp": 2.75,
      "acd_most_apka": 4.77,
      "alogp": 3.48,
      "full_molformula": "C20H34O5",
      "full_mwt": 354.49,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 354.49,
      "mw_monoisotopic": 354.2406,
      "psa": 94.83,
      "qed_weighted": 0.35,
      "ro3_pass": "N",
      "rtb": 13
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCC[C@H](O)\\C=C\\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O",
      "standard_inchi": "InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h12-13,15-17,19,21,23H,2-11,14H2,1H3,(H,24,25)/b13-12+/t15-,16+,17+,19+/m0/s1",
      "standard_inchi_key": "GMVPRGQOIOIIMI-DWKJAMRDSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "U-10136"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Alprostadil (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-dil; -prost-",
    "usan_stem_definition": "vasodilators (undefined group); prostaglandins",
    "usan_stem_substem": "-dil(-dil); -prost-(-prost-)",
    "usan_year": 1977
  },
  {
    "applicants": {
      "value": [
        "Davis And Geck Div American Cyanamid Co",
        "Bayer Pharmaceuticals Corp",
        "Sanofi Aventis Us Llc",
        "Arbrook Inc",
        "Xttrium Laboratories Inc",
        "Professional Disposables Inc",
        "Vestal Laboratories Div Chemed Corp",
        "Dial Corp Div Greyhound Co",
        "Huntington Laboratories Inc",
        "3M Co"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "D08AE01",
        "description": "DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Phenol and derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1949,
    "indication_class": "Anti-Infective, Topical; Detergent",
    "molecule_chembl_id": "CHEMBL496",
    "molecule_properties": {
      "acd_logd": 5.81,
      "acd_logp": 7.17,
      "acd_most_apka": 6.49,
      "alogp": 6.61,
      "aromatic_rings": 2,
      "full_molformula": "C13H6Cl6O2",
      "full_mwt": 406.91,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "ACID",
      "mw_freebase": 406.91,
      "mw_monoisotopic": 403.8499,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 40.46,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1c(Cl)cc(Cl)c(Cl)c1Cc2c(O)c(Cl)cc(Cl)c2Cl",
      "standard_inchi": "InChI=1S/C13H6Cl6O2/c14-6-2-8(16)12(20)4(10(6)18)1-5-11(19)7(15)3-9(17)13(5)21/h2-3,20-21H,1H2",
      "standard_inchi_key": "ACGUYXCXAPNIKK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Hexachlorophene (BAN, FDA, INN, USP)",
        null
      ]
    },
    "topical": true
  },
  {
    "applicants": {
      "value": "Bayer Pharmaceuticals Corp"
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D09AA10",
          "description": "DERMATOLOGICALS: MEDICATED DRESSINGS: MEDICATED DRESSINGS: Medicated dressings with antiinfective"
        },
        {
          "code": "S02AA05",
          "description": "SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfective"
        },
        {
          "code": "D08AH30",
          "description": "DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Quinoline derivative"
        },
        {
          "code": "G01AC02",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Quinoline derivative"
        },
        {
          "code": "P01AA52",
          "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Hydroxyquinoline derivative"
        },
        {
          "code": "P01AA02",
          "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Hydroxyquinoline derivatives"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Anti-Amebic; Anti-Infective, Topical",
    "molecule_chembl_id": "CHEMBL497",
    "molecule_properties": {
      "acd_logd": 2.47,
      "acd_logp": 4.17,
      "acd_most_apka": 2.32,
      "acd_most_bpka": 7.23,
      "alogp": 3.2,
      "aromatic_rings": 2,
      "full_molformula": "C9H5ClINO",
      "full_mwt": 305.5,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 13,
      "molecular_species": "ACID",
      "mw_freebase": 305.5,
      "mw_monoisotopic": 304.9104,
      "psa": 33.12,
      "qed_weighted": 0.76,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1c(I)cc(Cl)c2cccnc12",
      "standard_inchi": "InChI=1S/C9H5ClINO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H",
      "standard_inchi_key": "QCDFBFJGMNKBDO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clioquinol (BAN, FDA, INN, USP)",
        null
      ]
    },
    "topical": true,
    "withdrawn_class": "Neurotoxicity",
    "withdrawn_country": "United Kingdom; United States; Germany; France; Japan",
    "withdrawn_reason": "Neurotoxicity",
    "withdrawn_year": 1973
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N06AX22",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL10878",
    "molecule_properties": {
      "acd_logd": 2.46,
      "acd_logp": 2.46,
      "alogp": 2.53,
      "aromatic_rings": 2,
      "full_molformula": "C15H17NO2",
      "full_mwt": 243.31,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 243.31,
      "mw_monoisotopic": 243.1259,
      "psa": 38.33,
      "qed_weighted": 0.9,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2cccc(CCNC(=O)C)c2c1",
      "standard_inchi": "InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)",
      "standard_inchi_key": "YJYPHIXNFHFHND-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Agomelatine (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Teva Parenteral Medicines Inc",
        "Roxane Laboratories Inc",
        "Jiangsu Hengrui Medicine Co Ltd",
        "West-Ward Pharmaceuticals International Ltd",
        "Baxter Healthcare Corp",
        "Bedford Laboratories Div Ben Venue Laboratories Inc"
      ]
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1959,
    "indication_class": "Immunosuppressant; Antineoplastic",
    "molecule_chembl_id": "CHEMBL88",
    "molecule_properties": {
      "acd_logd": 0.73,
      "acd_logp": 0.73,
      "acd_most_bpka": 2.84,
      "alogp": 1.88,
      "full_molformula": "C7H15Cl2N2O2P",
      "full_mwt": 261.09,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 261.09,
      "mw_monoisotopic": 260.0248,
      "psa": 41.57,
      "qed_weighted": 0.61,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "ClCCN(CCCl)P1(=O)NCCCO1",
      "standard_inchi": "InChI=1S/C7H15Cl2N2O2P/c8-2-5-11(6-3-9)14(12)10-4-1-7-13-14/h1-7H2,(H,10,12)",
      "standard_inchi_key": "CMSMOCZEIVJLDB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "prodrug": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cyclophosphamide (BAN, JAN, USP, BAN, FDA, INN, JAN, USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Aurolife Pharma Llc",
        "Dava Pharmaceuticals Inc",
        "Sandoz Inc",
        "Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Superpharm Corp",
        "Watson Laboratories Inc",
        "Pfizer Laboratories Div Pfizer Inc",
        "Ani Pharmaceuticals Inc",
        "Halsey Drug Co Inc",
        "Usl Pharma Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A10BB02",
        "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Sulfonylureas"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1958,
    "indication_class": "Antidiabetic",
    "molecule_chembl_id": "CHEMBL498",
    "molecule_properties": {
      "acd_logd": 0.32,
      "acd_logp": 2.29,
      "acd_most_apka": 4.71,
      "alogp": 1.74,
      "aromatic_rings": 1,
      "full_molformula": "C10H13ClN2O3S",
      "full_mwt": 276.75,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "ACID",
      "mw_freebase": 276.75,
      "mw_monoisotopic": 276.0335,
      "psa": 75.27,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1",
      "standard_inchi": "InChI=1S/C10H13ClN2O3S/c1-2-7-12-10(14)13-17(15,16)9-5-3-8(11)4-6-9/h3-6H,2,7H2,1H3,(H2,12,13,14)",
      "standard_inchi_key": "RKWGIWYCVPQPMF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Chlorpropamide (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "usan_stem": "-pamide",
    "usan_stem_definition": "diuretics (sulfamoylbenzoic acid derivatives)",
    "usan_stem_substem": "-pamide(-pamide)"
  },
  {
    "applicants": {
      "value": [
        "Valeant Pharmaceuticals North America Llc",
        "E Fougera Div Altana Inc",
        "Lannett Holdings Inc",
        "Merck Research Laboratories Div Merck Co Inc",
        "Merck And Co Inc",
        "Bausch And Lomb Pharmaceuticals Inc",
        "Akorn Inc",
        "Teva Pharmaceuticals Usa",
        "Quantum Pharmics Ltd",
        "Teva Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01ED51",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1"
        },
        {
          "code": "S01ED01",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Beta blocking agents 1"
        },
        {
          "code": "C07AA06",
          "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1978,
    "indication_class": "Anti-Adrenergic (beta-receptor)",
    "molecule_chembl_id": "CHEMBL499",
    "molecule_properties": {
      "acd_logd": -0.6,
      "acd_logp": 1.28,
      "acd_most_apka": 13.38,
      "acd_most_bpka": 9.35,
      "alogp": 0.5,
      "aromatic_rings": 1,
      "full_molformula": "C13H24N4O3S",
      "full_mwt": 316.43,
      "hba": 8,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 316.43,
      "mw_monoisotopic": 316.1569,
      "psa": 79.74,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)NC[C@H](O)COc1nsnc1N2CCOCC2",
      "standard_inchi": "InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1",
      "standard_inchi_key": "BLJRIMJGRPQVNF-JTQLQIEISA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6174524,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-6174524-B1",
    "synonyms": {
      "value": [
        "Timolol Maleate (FDA, JAN, USAN, USP)",
        "Timolol (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1973
  },
  {
    "applicants": {
      "value": [
        "Sun Pharmaceutical Industries Inc",
        "Nostrum Laboratories Inc",
        "Novartis Pharmaceuticals Corp",
        "Watson Laboratories Inc",
        "Purepac Pharmaceutical Co",
        "Idt Australia Ltd",
        "G And W Laboratories Inc",
        "Zydus Pharmaceuticals Usa Inc",
        "Mylan Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C07AA03",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Vasodilator",
    "molecule_chembl_id": "CHEMBL500",
    "molecule_properties": {
      "acd_logd": -0.5,
      "acd_logp": 1.68,
      "acd_most_apka": 13.94,
      "acd_most_bpka": 9.54,
      "alogp": 1.91,
      "aromatic_rings": 2,
      "full_molformula": "C14H20N2O2",
      "full_mwt": 248.33,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 18,
      "molecular_species": "BASE",
      "mw_freebase": 248.33,
      "mw_monoisotopic": 248.1525,
      "psa": 57.28,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)COc1cccc2[nH]ccc12",
      "standard_inchi": "InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3",
      "standard_inchi_key": "JZQKKSLKJUAGIC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "LB-46"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pindolol (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1970
  },
  {
    "availability_type": -1,
    "chirality": -1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL273977",
    "molecule_properties": {
      "full_molformula": "C6H12NNaO3S",
      "full_mwt": 201.22,
      "mw_freebase": 201.22,
      "mw_monoisotopic": 201.0436
    },
    "molecule_structures": {
      "canonical_smiles": "[Na+].[O-]S(=O)(=O)NC1CCCCC1",
      "standard_inchi": "InChI=1S/C6H13NO3S.Na/c8-11(9,10)7-6-4-2-1-3-5-6;/h6-7H,1-5H2,(H,8,9,10);/q;+1/p-1",
      "standard_inchi_key": "UDIPTWFVPPPURJ-UHFFFAOYSA-M"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Sodium Cyclamate (BAN, INN, MI, NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL11417",
    "molecule_properties": {
      "acd_logd": -3.19,
      "acd_logp": 0.09,
      "acd_most_apka": 3.64,
      "acd_most_bpka": 0.35,
      "alogp": 2.32,
      "aromatic_rings": 3,
      "full_molformula": "C25H22N4O8",
      "full_mwt": 506.47,
      "hba": 11,
      "hba_lipinski": 12,
      "hbd": 4,
      "hbd_lipinski": 6,
      "heavy_atoms": 37,
      "molecular_species": "ACID",
      "mw_freebase": 506.47,
      "mw_monoisotopic": 506.1438,
      "num_lipinski_ro5_violations": 3,
      "num_ro5_violations": 2,
      "psa": 197.18,
      "qed_weighted": 0.38,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "COC1=C(N)C(=O)c2nc(ccc2C1=O)c3nc(C(=O)O)c(C)c(c3N)c4ccc(OC)c(OC)c4O",
      "standard_inchi": "InChI=1S/C25H22N4O8/c1-9-14(10-6-8-13(35-2)23(36-3)20(10)30)15(26)19(29-17(9)25(33)34)12-7-5-11-18(28-12)22(32)16(27)24(37-4)21(11)31/h5-8,30H,26-27H2,1-4H3,(H,33,34)",
      "standard_inchi_key": "PVYJZLYGTZKPJE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "NSC-45383"
    },
    "synonyms": {
      "value": [
        "Rufocromomycin (BAN, DCF, INN)",
        "Streptonigrin (USAN)",
        null
      ]
    },
    "usan_year": 1962
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Hq Specialty Pharma Corp",
        "Fresenius Kabi Usa Llc",
        "Teva Pharmaceuticals Usa",
        "Gland Pharma Ltd",
        "West-Ward Pharmaceuticals International Ltd",
        "Pharmachemie Bv",
        "Mylan Laboratories Ltd",
        "Bedford Laboratories Div Ben Venue Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01XA01",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Platinum compounds"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 10,
    "first_approval": 1978,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL11359",
    "molecule_properties": {
      "full_molformula": "H6Cl2N2Pt+2",
      "full_mwt": 300.05,
      "mw_freebase": 300.05,
      "mw_monoisotopic": 298.9545
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "CIS-DDP"
    },
    "synonyms": {
      "value": [
        "Cisplatin (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1977
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL11252",
    "molecule_properties": {
      "acd_logd": -1.34,
      "acd_logp": 0.66,
      "acd_most_bpka": 11.73,
      "alogp": 0.83,
      "aromatic_rings": 3,
      "full_molformula": "C22H27N9O4",
      "full_mwt": 481.52,
      "hba": 8,
      "hba_lipinski": 13,
      "hbd": 6,
      "hbd_lipinski": 7,
      "heavy_atoms": 35,
      "molecular_species": "BASE",
      "mw_freebase": 481.52,
      "mw_monoisotopic": 481.2186,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 1,
      "psa": 181.06,
      "qed_weighted": 0.14,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "Cn1cc(NC(=O)c2cc(NC(=O)c3cc(NC=O)cn3C)cn2C)cc1C(=O)NCCC(=N)N",
      "standard_inchi": "InChI=1S/C22H27N9O4/c1-29-9-13(26-12-32)6-17(29)21(34)28-15-8-18(31(3)11-15)22(35)27-14-7-16(30(2)10-14)20(33)25-5-4-19(23)24/h6-12H,4-5H2,1-3H3,(H3,23,24)(H,25,33)(H,26,32)(H,27,35)(H,28,34)",
      "standard_inchi_key": "UPBAOYRENQEPJO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "F.I. 6426"
    },
    "synonyms": {
      "value": [
        "Stallimycin HCl (USAN)",
        "Stallimycin (INN)",
        null
      ]
    },
    "usan_stem": "-mycin",
    "usan_stem_definition": "antibiotics (Streptomyces strains)",
    "usan_stem_substem": "-mycin(-mycin)",
    "usan_year": 1976
  },
  {
    "applicants": {
      "value": [
        "Cadila Pharmaceuticals Ltd",
        "Fresenius Kabi Usa Llc",
        "Chartwell Rx Sciences Llc",
        "Teva Parenteral Medicines Inc",
        "Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc",
        "Arbor Pharmaceuticals Llc",
        "Smith And Nephew Solopak Div Smith And Nephew",
        "Anda Repository Llc",
        "Glenmark Pharmaceuticals Ltd",
        "Invagen Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C02DB02",
        "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON: Hydrazinophthalazine derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1953,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL276832",
    "molecule_properties": {
      "acd_logd": 0.99,
      "acd_logp": 1,
      "acd_most_bpka": 6.25,
      "alogp": 0.92,
      "aromatic_rings": 2,
      "full_molformula": "C8H8N4",
      "full_mwt": 160.18,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 12,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 160.18,
      "mw_monoisotopic": 160.0749,
      "psa": 63.83,
      "qed_weighted": 0.48,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "NNc1nncc2ccccc12",
      "standard_inchi": "InChI=1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)",
      "standard_inchi_key": "RPTUSVTUFVMDQK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6465463,
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-6465463-B1",
    "synonyms": {
      "value": [
        "Hydralazine (BAN, INN)",
        "Hydralazine HCl (FDA, JAN, USP)",
        null
      ]
    },
    "usan_stem": "-dralazine",
    "usan_stem_definition": "antihypertensives (hydrazine-phthalazines)",
    "usan_stem_substem": "-dralazine(-dralazine)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antihyperlipidemic",
    "molecule_chembl_id": "CHEMBL274185",
    "molecule_properties": {
      "acd_logd": 8.76,
      "acd_logp": 8.76,
      "acd_most_apka": 11.8,
      "acd_most_bpka": 4.07,
      "alogp": 9.79,
      "aromatic_rings": 4,
      "full_molformula": "C34H40F2N4OS",
      "full_mwt": 590.78,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 42,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 590.78,
      "mw_monoisotopic": 590.2891,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 61.02,
      "qed_weighted": 0.1,
      "ro3_pass": "N",
      "rtb": 16
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCN(CCCCCSc1nc(c2ccccc2)c([nH]1)c3ccccc3)C(=O)Nc4ccc(F)cc4F",
      "standard_inchi": "InChI=1S/C34H40F2N4OS/c1-2-3-4-5-13-22-40(34(41)37-30-21-20-28(35)25-29(30)36)23-14-8-15-24-42-33-38-31(26-16-9-6-10-17-26)32(39-33)27-18-11-7-12-19-27/h6-7,9-12,16-21,25H,2-5,8,13-15,22-24H2,1H3,(H,37,41)(H,38,39)",
      "standard_inchi_key": "TVXOXGBTADZYCZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "DUP-128"
    },
    "synonyms": {
      "value": [
        "Lecimibide (INN, USAN)",
        null
      ]
    },
    "usan_year": 1994
  },
  {
    "atc_classification": {
      "drug": {
        "code": "L03AX02",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Other immunostimulants"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Biological Response Modifier; Immunomodulator",
    "molecule_chembl_id": "CHEMBL11672",
    "molecule_properties": {
      "acd_logd": -1.5,
      "acd_logp": 1.03,
      "acd_most_apka": 4.5,
      "acd_most_bpka": 0.58,
      "alogp": 2.52,
      "aromatic_rings": 3,
      "full_molformula": "C18H16N2O3",
      "full_mwt": 308.34,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 308.34,
      "mw_monoisotopic": 308.1161,
      "psa": 62.54,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C(=O)C1=C(O)c2ccccc2N(C)C1=O)c3ccccc3",
      "standard_inchi": "InChI=1S/C18H16N2O3/c1-19(12-8-4-3-5-9-12)17(22)15-16(21)13-10-6-7-11-14(13)20(2)18(15)23/h3-11,21H,1-2H3",
      "standard_inchi_key": "SGOOQMRIPALTEL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "LS-2616",
        "FCF-89"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Roquinimex (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-imex",
    "usan_stem_definition": "immunostimulants",
    "usan_stem_substem": "-imex(-imex)",
    "usan_year": 1995
  },
  {
    "applicants": {
      "value": [
        "Leadiant Biosciences Inc",
        "Teva Parenteral Medicines Inc",
        "Alkopharma Usa Inc",
        "Apothecon Inc Div Bristol Myers Squibb",
        "Astellas Pharma Us Inc",
        "X Gen Pharmaceuticals Inc",
        "Abbott Laboratories",
        "Bristol Myers Squibb Co",
        "Abraxis Pharmaceutical Products"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "A07AA07",
          "description": "ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Antibiotic"
        },
        {
          "code": "J02AA01",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Antibiotic"
        },
        {
          "code": "G01AA03",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Antibiotic"
        },
        {
          "code": "A01AB04",
          "description": "ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatment"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1964,
    "indication_class": "Antifungal",
    "molecule_chembl_id": "CHEMBL267345",
    "molecule_properties": {
      "acd_logd": -0.28,
      "acd_logp": 2.3,
      "acd_most_apka": 3.72,
      "acd_most_bpka": 8.12,
      "alogp": 0.71,
      "full_molformula": "C47H73NO17",
      "full_mwt": 924.09,
      "hba": 17,
      "hba_lipinski": 18,
      "hbd": 12,
      "hbd_lipinski": 13,
      "heavy_atoms": 65,
      "molecular_species": "ACID",
      "mw_freebase": 924.09,
      "mw_monoisotopic": 923.4878,
      "num_lipinski_ro5_violations": 3,
      "num_ro5_violations": 3,
      "psa": 319.61,
      "qed_weighted": 0.17,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@@H]1OC(=O)C[C@H](O)C[C@H](O)CC[C@@H](O)[C@H](O)C[C@H](O)C[C@]2(O)C[C@H](O)[C@H]([C@H](C[C@@H](O[C@@H]3O[C@H](C)[C@@H](O)[C@H](N)[C@@H]3O)\\C=C\\C=C\\C=C\\C=C\\C=C\\C=C\\C=C\\[C@H](C)[C@@H](O)[C@H]1C)O2)C(=O)O",
      "standard_inchi": "InChI=1S/C47H73NO17/c1-27-17-15-13-11-9-7-5-6-8-10-12-14-16-18-34(64-46-44(58)41(48)43(57)30(4)63-46)24-38-40(45(59)60)37(54)26-47(61,65-38)25-33(51)22-36(53)35(52)20-19-31(49)21-32(50)23-39(55)62-29(3)28(2)42(27)56/h5-18,27-38,40-44,46,49-54,56-58,61H,19-26,48H2,1-4H3,(H,59,60)/b6-5+,9-7+,10-8+,13-11+,14-12+,17-15+,18-16+/t27-,28-,29-,30+,31+,32+,33-,34-,35+,36+,37-,38-,40+,41-,42+,43+,44-,46-,47+/m0/s1",
      "standard_inchi_key": "APKFDSVGJQXUKY-INPOYWNPSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5965156,
    "oral": true,
    "parenteral": true,
    "sc_patent": "US-5965156-A",
    "synonyms": {
      "value": [
        "Amphotericin (BAN)",
        "Amphotericin B (FDA, INN, JAN, USP)",
        null
      ]
    },
    "topical": true
  },
  {
    "applicants": {
      "value": "Eli Lilly And Co"
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1939,
    "indication_class": "Stimulant (gastric secretory)",
    "molecule_chembl_id": "CHEMBL90",
    "molecule_properties": {
      "acd_logd": -2.7,
      "acd_logp": -0.7,
      "acd_most_bpka": 9.26,
      "alogp": -0.09,
      "aromatic_rings": 1,
      "full_molformula": "C5H9N3",
      "full_mwt": 111.15,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 8,
      "molecular_species": "BASE",
      "mw_freebase": 111.15,
      "mw_monoisotopic": 111.0796,
      "psa": 54.7,
      "qed_weighted": 0.56,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NCCc1c[nH]cn1",
      "standard_inchi": "InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",
      "standard_inchi_key": "NTYJJOPFIAHURM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Histamine Dihydrochloride (USAN)",
        "Histamine Phosphate (FDA, USP)",
        null
      ]
    },
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": [
        "Actavis Pharma Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Teva Pharmaceuticals Usa",
        "Personal Products Co",
        "Janssen Pharmaceutica Products Lp",
        "Perrigo Co",
        "Actavis Mid Atlantic Llc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Midatech Pharma Us Inc",
        "Perrigo R And D Co",
        "Taro Pharmaceuticals Usa Inc",
        "L Perrigo Co"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "A01AB09",
          "description": "ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatmen"
        },
        {
          "code": "J02AB01",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Imidazole derivative"
        },
        {
          "code": "D01AC52",
          "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivative"
        },
        {
          "code": "D01AC02",
          "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivative"
        },
        {
          "code": "A07AC01",
          "description": "ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFECTIVES: Imidazole derivative"
        },
        {
          "code": "S02AA13",
          "description": "SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfective"
        },
        {
          "code": "G01AF04",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Imidazole derivatives"
        }
      ]
    },
    "availability_type": 2,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1974,
    "indication_class": "Antifungal",
    "molecule_chembl_id": "CHEMBL91",
    "molecule_properties": {
      "acd_logd": 4.9,
      "acd_logp": 4.97,
      "acd_most_bpka": 6.64,
      "alogp": 6.45,
      "aromatic_rings": 3,
      "full_molformula": "C18H14Cl4N2O",
      "full_mwt": 416.14,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 416.14,
      "mw_monoisotopic": 413.986,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 27.05,
      "qed_weighted": 0.46,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)c(Cl)c1",
      "standard_inchi": "InChI=1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2",
      "standard_inchi_key": "BYBLEWFAAKGYCD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6153635,
    "parenteral": true,
    "research_codes": {
      "value": "R-14889"
    },
    "sc_patent": "US-6153635-A",
    "synonyms": {
      "value": [
        "Miconazole nitrate (FDA, JAN, USAN, USP)",
        "Miconazole (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-conazole",
    "usan_stem_definition": "systemic antifungals (miconazole type)",
    "usan_stem_substem": "-conazole(-conazole)",
    "usan_year": 1970
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL275739",
    "molecule_properties": {
      "acd_logd": 1.52,
      "acd_logp": 1.52,
      "acd_most_bpka": 4.61,
      "alogp": 1.61,
      "aromatic_rings": 2,
      "full_molformula": "C14H19N5O",
      "full_mwt": 273.34,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 273.34,
      "mw_monoisotopic": 273.159,
      "psa": 55.21,
      "qed_weighted": 0.92,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccc(C)n1Nc2ccc(nn2)N3CCOCC3",
      "standard_inchi": "InChI=1S/C14H19N5O/c1-11-3-4-12(2)19(11)17-13-5-6-14(16-15-13)18-7-9-20-10-8-18/h3-6H,7-10H2,1-2H3,(H,15,17)",
      "standard_inchi_key": "JBVCSNJKVNKDHK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mopidralazine (INN)",
        null
      ]
    },
    "usan_stem": "-dralazine",
    "usan_stem_definition": "antihypertensives (hydrazine-phthalazines)",
    "usan_stem_substem": "-dralazine(-dralazine)"
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Teva Pharmaceuticals Usa",
        "Eagle Pharmaceuticals Inc",
        "Ingenus Pharmaceuticals Llc",
        "Jiangsu Hengrui Medicine Co Ltd",
        "Actavis Llc An Indirect Wholly-Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Apotex Inc",
        "Sanofi Aventis Us Llc",
        "Sandoz",
        "Pfizer Labs"
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1996,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL92",
    "molecule_properties": {
      "acd_logd": 2.46,
      "acd_logp": 2.46,
      "acd_most_apka": 11.2,
      "alogp": 3.26,
      "aromatic_rings": 2,
      "full_molformula": "C43H53NO14",
      "full_mwt": 807.89,
      "hba": 14,
      "hba_lipinski": 15,
      "hbd": 5,
      "hbd_lipinski": 5,
      "heavy_atoms": 58,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 807.89,
      "mw_monoisotopic": 807.3466,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 224.45,
      "qed_weighted": 0.15,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](O)C3=O)C5(C)C)C",
      "standard_inchi": "InChI=1S/C43H53NO14/c1-22-26(55-37(51)32(48)30(24-15-11-9-12-16-24)44-38(52)58-39(3,4)5)20-43(53)35(56-36(50)25-17-13-10-14-18-25)33-41(8,34(49)31(47)29(22)40(43,6)7)27(46)19-28-42(33,21-54-28)57-23(2)45/h9-18,26-28,30-33,35,46-48,53H,19-21H2,1-8H3,(H,44,52)/t26-,27-,28+,30-,31+,32+,33-,35-,41+,42-,43+/m0/s1",
      "standard_inchi_key": "ZDZOTLJHXYCWBA-VCVYQWHSSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8940786,
    "parenteral": true,
    "research_codes": {
      "value": "RP-56976"
    },
    "sc_patent": "US-8940786-B2",
    "synonyms": {
      "value": [
        "Docetaxel (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-taxel",
    "usan_stem_definition": "antineoplastics, taxane derivatives",
    "usan_stem_substem": "-taxel(-taxel)",
    "usan_year": 1994
  },
  {
    "applicants": {
      "value": [
        "Rising Pharmaceuticals Inc",
        "Chiesi Usa Inc"
      ]
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1996,
    "indication_class": "Inhibitor (5-lipoxygenase)",
    "molecule_chembl_id": "CHEMBL93",
    "molecule_properties": {
      "acd_logd": 2.7,
      "acd_logp": 2.7,
      "acd_most_apka": 9.97,
      "alogp": 2.73,
      "aromatic_rings": 2,
      "full_molformula": "C11H12N2O2S",
      "full_mwt": 236.3,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 236.3,
      "mw_monoisotopic": 236.0619,
      "psa": 66.56,
      "qed_weighted": 0.62,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(N(O)C(=O)N)c1cc2ccccc2s1",
      "standard_inchi": "InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",
      "standard_inchi_key": "MWLSOWXNZPKENC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "A-64077",
        "ABBOTT-64077"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Zileuton (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-leuton",
    "usan_stem_definition": "5-lipoxgenase inhibitors",
    "usan_stem_substem": "-leuton(-leuton)",
    "usan_year": 1990
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "V03AB19",
          "description": "VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidote"
        },
        {
          "code": "S01EB05",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Cholinergic (ophthalmic)",
    "molecule_chembl_id": "CHEMBL94",
    "molecule_properties": {
      "acd_logd": 0.54,
      "acd_logp": 1.27,
      "acd_most_apka": 12.23,
      "acd_most_bpka": 8.31,
      "alogp": 1.77,
      "aromatic_rings": 1,
      "full_molformula": "C15H21N3O2",
      "full_mwt": 275.35,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 275.35,
      "mw_monoisotopic": 275.1634,
      "psa": 44.81,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1",
      "standard_inchi": "InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15+/m1/s1",
      "standard_inchi_key": "PIJVFDBKTWXHHD-HIFRSBDPSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Physostigmine (BAN, USP)",
        "Physostigmine Salicylate (JAN, USP)",
        "Physostigmine Sulfate (USP)",
        null
      ]
    },
    "usan_stem": "-stigmine",
    "usan_stem_definition": "cholinesterase inhibitors (physostigmine type)",
    "usan_stem_substem": "-stigmine(-stigmine)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Amino Acid",
    "molecule_chembl_id": "CHEMBL274323",
    "molecule_properties": {
      "acd_logd": -4.58,
      "acd_logp": -1.07,
      "acd_most_apka": 2.28,
      "acd_most_bpka": 9.95,
      "alogp": -1.13,
      "full_molformula": "C4H7NO4",
      "full_mwt": 133.1,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 9,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 133.1,
      "mw_monoisotopic": 133.0375,
      "psa": 100.62,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "N[C@@H](CC(=O)O)C(=O)O",
      "standard_inchi": "InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1",
      "standard_inchi_key": "CKLJMWTZIZZHCS-REOHCLBHSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Aspartic Acid (INN, MI, USAN, USP)",
        "L-Aspartic acid (JAN)",
        null
      ]
    },
    "usan_year": 1979
  },
  {
    "applicants": {
      "value": "Shionogi Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "N06DA01",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTI-DEMENTIA DRUGS: Anticholinesterases"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1993,
    "indication_class": "Cognition Adjuvant; Dementia Symptoms Treatment Adjunct",
    "molecule_chembl_id": "CHEMBL95",
    "molecule_properties": {
      "acd_logd": 0.51,
      "acd_logp": 2.56,
      "acd_most_bpka": 9.64,
      "alogp": 2.7,
      "aromatic_rings": 2,
      "full_molformula": "C13H14N2",
      "full_mwt": 198.27,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 15,
      "molecular_species": "BASE",
      "mw_freebase": 198.27,
      "mw_monoisotopic": 198.1157,
      "psa": 38.91,
      "qed_weighted": 0.71,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1c2CCCCc2nc3ccccc13",
      "standard_inchi": "InChI=1S/C13H14N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1,3,5,7H,2,4,6,8H2,(H2,14,15)",
      "standard_inchi_key": "YLJREFDVOIBQDA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "CI-970"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tacrine HCl (FDA, USAN, USP)",
        "Tacrine (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-crine",
    "usan_stem_definition": "acridine derivatives",
    "usan_stem_substem": "-crine(-crine)",
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": [
        "Cadila Pharmaceuticals Ltd",
        "Torrent Pharmaceuticals Ltd",
        "Osmotica Pharmaceutical Us Llc",
        "Jubilant Generics Ltd",
        "Forest Laboratories Llc",
        "Aurobindo Pharma Ltd",
        "Par Pharmaceutical Inc",
        "Lupin Ltd",
        "Sun Pharmaceutical Industries Inc",
        "Alembic Pharmaceuticals Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06DA02",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTI-DEMENTIA DRUGS: Anticholinesterases"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1996,
    "indication_class": "Dementia Symptoms Treatment Adjunct; Inhibitor (acetylcholinesterase); Cognition Adjuvant; Alzheimer's Disease Treatment (adjunct)",
    "molecule_chembl_id": "CHEMBL502",
    "molecule_properties": {
      "acd_logd": 2.47,
      "acd_logp": 3.91,
      "acd_most_bpka": 8.84,
      "alogp": 4.36,
      "aromatic_rings": 2,
      "full_molformula": "C24H29NO3",
      "full_mwt": 379.5,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 28,
      "molecular_species": "BASE",
      "mw_freebase": 379.5,
      "mw_monoisotopic": 379.2147,
      "psa": 38.77,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc2CC(CC3CCN(Cc4ccccc4)CC3)C(=O)c2cc1OC",
      "standard_inchi": "InChI=1S/C24H29NO3/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18/h3-7,14-15,17,20H,8-13,16H2,1-2H3",
      "standard_inchi_key": "ADEBPBSSDYVVLD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8039009,
    "oral": true,
    "research_codes": {
      "value": [
        "E-2020",
        "E2020",
        "BNAG"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-8039009-B2",
    "synonyms": {
      "value": [
        "Donepezil HCl (FDA, USAN)",
        "Donepezil (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-pezil",
    "usan_stem_definition": "acetylcholinesterase inhibitors used in the treatment of Alzheimer's disease",
    "usan_stem_substem": "-pezil(-pezil)",
    "usan_year": 1997
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Amino Acid",
    "molecule_chembl_id": "CHEMBL12198",
    "molecule_properties": {
      "acd_logd": -3.08,
      "acd_logp": -0.57,
      "acd_most_apka": 2.31,
      "acd_most_bpka": 9.61,
      "alogp": -0.58,
      "full_molformula": "C3H7NO2",
      "full_mwt": 89.09,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 6,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 89.09,
      "mw_monoisotopic": 89.0477,
      "psa": 63.32,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC(N)C(=O)O",
      "standard_inchi": "InChI=1S/C3H7NO2/c1-2(4)3(5)6/h2H,4H2,1H3,(H,5,6)",
      "standard_inchi_key": "QNAYBMKLOCPYGJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Alanine (INN, USAN, USP)",
        "L-Alanine (JAN)",
        null
      ]
    },
    "usan_year": 1979
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Amino Acid",
    "molecule_chembl_id": "CHEMBL11298",
    "molecule_properties": {
      "acd_logd": -3.99,
      "acd_logp": -1.49,
      "acd_most_apka": 2.16,
      "acd_most_bpka": 9.1,
      "alogp": -1.61,
      "full_molformula": "C3H7NO3",
      "full_mwt": 105.09,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 7,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 105.09,
      "mw_monoisotopic": 105.0426,
      "psa": 83.55,
      "qed_weighted": 0.39,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "N[C@@H](CO)C(=O)O",
      "standard_inchi": "InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m0/s1",
      "standard_inchi_key": "MTCFGRXMJLQNBG-REOHCLBHSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Serine (INN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1979
  },
  {
    "applicants": {
      "value": [
        "Lupin Ltd",
        "Sun Pharmaceutical Industries Inc",
        "Merck Research Laboratories Div Merck Co Inc",
        "Actavis Elizabeth Llc",
        "Apotex Inc",
        "Sandoz Inc",
        "Carlsbad Technology Inc",
        "Abbvie Inc",
        "Mylan Pharmaceuticals Inc",
        "Covis Pharma Bv"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C10AA02",
        "description": "CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: HMG CoA reductase inhibitors"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1987,
    "indication_class": "Inhibitor (HMG-CoA reductase); Antihyperlipidemic",
    "molecule_chembl_id": "CHEMBL503",
    "molecule_properties": {
      "acd_logd": 4.31,
      "acd_logp": 4.31,
      "acd_most_apka": 13.49,
      "alogp": 4.2,
      "full_molformula": "C24H36O5",
      "full_mwt": 404.55,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 404.55,
      "mw_monoisotopic": 404.2563,
      "psa": 72.83,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12",
      "standard_inchi": "InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1",
      "standard_inchi_key": "PCZOHLXUXFIOCF-BXMDZJJMSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5916595,
    "oral": true,
    "prodrug": true,
    "research_codes": {
      "value": "MK-803"
    },
    "rule_of_five": true,
    "sc_patent": "US-5916595-A",
    "synonyms": {
      "value": [
        "Lovastatin (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-stat-",
    "usan_stem_definition": "enzyme inhibitors: antihyperlipidemics (HMG-CoA inhibitors)",
    "usan_stem_substem": "-stat-(-stat-(-vastatin))",
    "usan_year": 1987
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL12213",
    "molecule_properties": {
      "acd_logd": -3,
      "acd_logp": 0.5,
      "acd_most_apka": 3.52,
      "acd_most_bpka": 9.36,
      "alogp": 0.13,
      "aromatic_rings": 2,
      "full_molformula": "C21H27N7O6",
      "full_mwt": 473.49,
      "hba": 9,
      "hba_lipinski": 13,
      "hbd": 7,
      "hbd_lipinski": 8,
      "heavy_atoms": 34,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 473.49,
      "mw_monoisotopic": 473.2023,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 1,
      "psa": 202.77,
      "qed_weighted": 0.25,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(CCNc2ccc(cc2)C(=O)N[C@@H](CCC(=O)O)C(=O)O)CNC3=C1C(=O)N=C(N)N3",
      "standard_inchi": "InChI=1S/C21H27N7O6/c1-28-13(10-24-17-16(28)19(32)27-21(22)26-17)8-9-23-12-4-2-11(3-5-12)18(31)25-14(20(33)34)6-7-15(29)30/h2-5,13-14,23H,6-10H2,1H3,(H,25,31)(H,29,30)(H,33,34)(H4,22,24,26,27,32)/t13?,14-/m0/s1",
      "standard_inchi_key": "KCPBTDJBDDCNQE-KZUDCZAMSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Ketotrexate (INN)",
        null
      ]
    },
    "usan_stem": "-trexate",
    "usan_stem_definition": "antimetabolites (folic acid derivatives)",
    "usan_stem_substem": "-trexate(-trexate)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL11662",
    "molecule_properties": {
      "acd_logd": -2.21,
      "acd_logp": 0.53,
      "acd_most_apka": 4.43,
      "acd_most_bpka": 6.87,
      "alogp": 2.03,
      "aromatic_rings": 2,
      "full_molformula": "C13H12N2O2",
      "full_mwt": 228.25,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "ACID",
      "mw_freebase": 228.25,
      "mw_monoisotopic": 228.0899,
      "psa": 55.12,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)\\C=C\\c1ccc(Cn2ccnc2)cc1",
      "standard_inchi": "InChI=1S/C13H12N2O2/c16-13(17)6-5-11-1-3-12(4-2-11)9-15-8-7-14-10-15/h1-8,10H,9H2,(H,16,17)/b6-5+",
      "standard_inchi_key": "SHZKQBHERIJWAO-AATRIKPKSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ozagrel (INN, MI)",
        "Ozagrel Sodium (JAN)",
        null
      ]
    },
    "usan_stem": "-grel",
    "usan_stem_definition": "platelet aggregation inhibitors",
    "usan_stem_substem": "-grel(-grel)"
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL267770",
    "molecule_properties": {
      "acd_logd": 1.09,
      "acd_logp": 4.83,
      "acd_most_apka": 2.08,
      "alogp": 3.32,
      "aromatic_rings": 2,
      "full_molformula": "C18H15ClO4S",
      "full_mwt": 362.83,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "ACID",
      "mw_freebase": 362.83,
      "mw_monoisotopic": 362.038,
      "psa": 71.44,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccc(cc1)S(=O)(=O)C(CC#Cc2ccc(Cl)cc2)C(=O)O",
      "standard_inchi": "InChI=1S/C18H15ClO4S/c1-13-5-11-16(12-6-13)24(22,23)17(18(20)21)4-2-3-14-7-9-15(19)10-8-14/h5-12,17H,4H2,1H3,(H,20,21)",
      "standard_inchi_key": "PZCCKADCRMBHIC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tibeglisene (INN)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "M02AA05",
          "description": "MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical us"
        },
        {
          "code": "R02AX03",
          "description": "RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Other throat preparation"
        },
        {
          "code": "G02CC03",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: OTHER GYNECOLOGICALS: Antiinflammatory products for vaginal administratio"
        },
        {
          "code": "M01AX07",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Other antiinflammatory and antirheumatic agents, non-steroid"
        },
        {
          "code": "A01AD02",
          "description": "ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Other agents for local oral treatment"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Anti-Inflammatory; Antipyretic; Analgesic",
    "molecule_chembl_id": "CHEMBL12610",
    "molecule_properties": {
      "acd_logd": 1.65,
      "acd_logp": 3.56,
      "acd_most_bpka": 9.25,
      "alogp": 3.42,
      "aromatic_rings": 3,
      "full_molformula": "C19H23N3O",
      "full_mwt": 309.41,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 23,
      "molecular_species": "BASE",
      "mw_freebase": 309.41,
      "mw_monoisotopic": 309.1841,
      "psa": 30.29,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCCOc1nn(Cc2ccccc2)c3ccccc13",
      "standard_inchi": "InChI=1S/C19H23N3O/c1-21(2)13-8-14-23-19-17-11-6-7-12-18(17)22(20-19)15-16-9-4-3-5-10-16/h3-7,9-12H,8,13-15H2,1-2H3",
      "standard_inchi_key": "CNBGNNVCVSKAQZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AF-864"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Benzydamine HCl (JAN, USAN)",
        "Benzydamine (BAN, INN)",
        null
      ]
    },
    "usan_year": 1965
  },
  {
    "atc_classification": {
      "drug": {
        "code": "A05AB01",
        "description": "ALIMENTARY TRACT AND METABOLISM: BILE AND LIVER THERAPY: BILE THERAPY: Preparations for biliary tract therapy"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL11978",
    "molecule_properties": {
      "acd_logd": -0.22,
      "acd_logp": -0.22,
      "acd_most_apka": 13.97,
      "acd_most_bpka": 3.13,
      "alogp": 0.44,
      "aromatic_rings": 1,
      "full_molformula": "C7H8N2O",
      "full_mwt": 136.15,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 10,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 136.15,
      "mw_monoisotopic": 136.0637,
      "psa": 41.99,
      "qed_weighted": 0.61,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CNC(=O)c1cccnc1",
      "standard_inchi": "InChI=1S/C7H8N2O/c1-8-7(10)6-3-2-4-9-5-6/h2-5H,1H3,(H,8,10)",
      "standard_inchi_key": "ZYVXHFWBYUDDBM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": "Nicotinyl methylamide"
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL269644",
    "molecule_properties": {
      "acd_logd": 1.24,
      "acd_logp": 1.24,
      "acd_most_bpka": 0.51,
      "alogp": 1.64,
      "aromatic_rings": 1,
      "full_molformula": "C8H9NO",
      "full_mwt": 135.17,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 10,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 135.17,
      "mw_monoisotopic": 135.0684,
      "psa": 29.1,
      "qed_weighted": 0.62,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)Nc1ccccc1",
      "standard_inchi": "InChI=1S/C8H9NO/c1-7(10)9-8-5-3-2-4-6-8/h2-6H,1H3,(H,9,10)",
      "standard_inchi_key": "FZERHIULMFGESH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Acetanilide (MI, NF)",
        null
      ]
    },
    "usan_stem": "-ilide",
    "usan_stem_definition": "class III antiarrhythmic agents",
    "usan_stem_substem": "-ilide(-ilide)"
  },
  {
    "applicants": {
      "value": "Mylan Institutional Llc"
    },
    "atc_classification": {
      "drug": [
        {
          "code": "M02AX03",
          "description": "MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Other topical products for joint and muscular pai"
        },
        {
          "code": "G04BX13",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Other urologicals"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1978,
    "indication_class": "Anti-Inflammatory (topical)",
    "molecule_chembl_id": "CHEMBL504",
    "molecule_properties": {
      "acd_logd": -1.41,
      "acd_logp": -1.41,
      "alogp": -0.01,
      "full_molformula": "C2H6OS",
      "full_mwt": 78.14,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 4,
      "mw_freebase": 78.14,
      "mw_monoisotopic": 78.0139,
      "psa": 17.07,
      "qed_weighted": 0.4,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "C[S+](C)[O-]",
      "standard_inchi": "InChI=1S/C2H6OS/c1-4(2)3/h1-2H3",
      "standard_inchi_key": "IAZDPXIOMUYVGZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "DMSO",
        "SQ-9453"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dimethyl Sulfoxide (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1965
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Cardiac Depressant (anti-arrhythmic); Anti-Adrenergic (beta-receptor)",
    "molecule_chembl_id": "CHEMBL275742",
    "molecule_properties": {
      "acd_logd": 0.79,
      "acd_logp": 2.9,
      "acd_most_apka": 13.84,
      "acd_most_bpka": 9.5,
      "alogp": 2.58,
      "aromatic_rings": 2,
      "full_molformula": "C16H21NO2",
      "full_mwt": 259.35,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 259.35,
      "mw_monoisotopic": 259.1572,
      "psa": 41.49,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NC[C@@H](O)COc1cccc2ccccc12",
      "standard_inchi": "InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3/t14-/m1/s1",
      "standard_inchi_key": "AQHHHDLHHXJYJD-CQSZACIVSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "AY-20694",
        "ICI-47319"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dexpropranolol HCl (USAN)",
        "Dexpropranolol (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1969
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Anthelmintic",
    "molecule_chembl_id": "CHEMBL12131",
    "molecule_properties": {
      "acd_logd": 6.96,
      "acd_logp": 8.29,
      "acd_most_apka": 5.99,
      "alogp": 7.12,
      "aromatic_rings": 3,
      "full_molformula": "C22H14Cl2I2N2O2",
      "full_mwt": 663.08,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 30,
      "molecular_species": "ACID",
      "mw_freebase": 663.08,
      "mw_monoisotopic": 661.8522,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 73.12,
      "qed_weighted": 0.29,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cc(C(C#N)c2ccc(Cl)cc2)c(Cl)cc1NC(=O)c3cc(I)cc(I)c3O",
      "standard_inchi": "InChI=1S/C22H14Cl2I2N2O2/c1-11-6-15(17(10-27)12-2-4-13(23)5-3-12)18(24)9-20(11)28-22(30)16-7-14(25)8-19(26)21(16)29/h2-9,17,29H,1H3,(H,28,30)",
      "standard_inchi_key": "JMPFSEBWVLAJKM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "R-31520"
    },
    "synonyms": {
      "value": [
        "Closantel (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-antel",
    "usan_stem_definition": "anthelmintics (undefined group)",
    "usan_stem_substem": "-antel(-antel)",
    "usan_year": 1976
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL12806",
    "molecule_properties": {
      "acd_logd": -0.81,
      "acd_logp": 1.1,
      "acd_most_apka": 5.13,
      "alogp": 1.94,
      "aromatic_rings": 2,
      "full_molformula": "C18H20ClN3O5S",
      "full_mwt": 425.89,
      "hba": 5,
      "hba_lipinski": 8,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 28,
      "molecular_species": "ACID",
      "mw_freebase": 425.89,
      "mw_monoisotopic": 425.0812,
      "psa": 113.6,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CNC(=O)NS(=O)(=O)c1ccc(CCNC(=O)c2cc(Cl)ccc2OC)cc1",
      "standard_inchi": "InChI=1S/C18H20ClN3O5S/c1-20-18(24)22-28(25,26)14-6-3-12(4-7-14)9-10-21-17(23)15-11-13(19)5-8-16(15)27-2/h3-8,11H,9-10H2,1-2H3,(H,21,23)(H2,20,22,24)",
      "standard_inchi_key": "RXOBKRPNVDTZQF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Glicondamide (INN)",
        null
      ]
    },
    "usan_stem": "gli-",
    "usan_stem_definition": "antihyperglycemics",
    "usan_stem_substem": "gli-(gli-)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL275758",
    "molecule_properties": {
      "acd_logd": 2.97,
      "acd_logp": 2.97,
      "acd_most_apka": 13.07,
      "alogp": 2.71,
      "aromatic_rings": 2,
      "full_molformula": "C21H23NO5S",
      "full_mwt": 401.48,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 401.48,
      "mw_monoisotopic": 401.1297,
      "psa": 83.91,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)Oc2ccc(cc2[C@H]([C@@H]1O)N3CCCC3=O)S(=O)(=O)c4ccccc4",
      "standard_inchi": "InChI=1S/C21H23NO5S/c1-21(2)20(24)19(22-12-6-9-18(22)23)16-13-15(10-11-17(16)27-21)28(25,26)14-7-4-3-5-8-14/h3-5,7-8,10-11,13,19-20,24H,6,9,12H2,1-2H3/t19-,20+/m1/s1",
      "standard_inchi_key": "LKAQWOWWTKFLNX-UXHICEINSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Rilmakalim (INN)",
        null
      ]
    },
    "usan_stem": "-kalim",
    "usan_stem_definition": "potassium channel agonists",
    "usan_stem_substem": "-kalim(-kalim)"
  },
  {
    "applicants": {
      "value": [
        "Schering Plough Healthcare Products Inc",
        "Bayer Healthcare Llc",
        "Panray Corp Sub Ormont Drug And Chemical Co Inc",
        "Halsey Drug Co Inc",
        "Kv Pharmaceutical Co",
        "Acella Pharmaceuticals Llc",
        "Elkins Sinn Div Ah Robins Co Inc",
        "Pharmeral Inc",
        "Bio-Pharm Inc",
        "Lederle Laboratories Div American Cyanamid Co"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R06AB54",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamine"
        },
        {
          "code": "R06AB04",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamines"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1950,
    "indication_class": "Antihistaminic",
    "molecule_chembl_id": "CHEMBL505",
    "molecule_properties": {
      "acd_logd": 1.03,
      "acd_logp": 2.97,
      "acd_most_bpka": 9.33,
      "alogp": 3.82,
      "aromatic_rings": 2,
      "full_molformula": "C16H19ClN2",
      "full_mwt": 274.8,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 274.8,
      "mw_monoisotopic": 274.1237,
      "psa": 16.13,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCC(c1ccc(Cl)cc1)c2ccccn2",
      "standard_inchi": "InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3",
      "standard_inchi_key": "SOYKEARSMXGVTM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6248363,
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-6248363-B1",
    "synonyms": {
      "value": [
        "Chlorpheniramine (BAN, BAN)",
        "Chlorpheniramine maleate (FDA, JAN, USP)",
        "Chlorpheniramine Polistirex (FDA, USAN)",
        "Chlorphenamine (INN)",
        null
      ]
    },
    "usan_year": 1987
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL12531",
    "molecule_properties": {
      "acd_logd": -1.58,
      "acd_logp": 1.91,
      "acd_most_bpka": 3.71,
      "alogp": 2.52,
      "aromatic_rings": 2,
      "full_molformula": "C19H22ClN3O5S2",
      "full_mwt": 471.99,
      "hba": 5,
      "hba_lipinski": 8,
      "hbd": 3,
      "hbd_lipinski": 2,
      "heavy_atoms": 30,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 471.99,
      "mw_monoisotopic": 471.0689,
      "psa": 106.09,
      "qed_weighted": 0.31,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CN\\C(=N\\S(=O)(=O)c1cc(CCNC(=O)c2cc(Cl)ccc2OC)ccc1OC)\\S",
      "standard_inchi": "InChI=1S/C19H22ClN3O5S2/c1-21-19(29)23-30(25,26)17-10-12(4-6-16(17)28-3)8-9-22-18(24)14-11-13(20)5-7-15(14)27-2/h4-7,10-11H,8-9H2,1-3H3,(H,22,24)(H2,21,23,29)",
      "standard_inchi_key": "VXTKXGKPBOLHRY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "HMR-1883"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clamikalant (INN)",
        null
      ]
    },
    "usan_stem": "-kalant",
    "usan_stem_definition": "potassium channel antagonists",
    "usan_stem_substem": "-kalant(-kalant)"
  },
  {
    "applicants": {
      "value": [
        "Sanofi Aventis Us Llc",
        "Alvogen Inc",
        "Bayshore Pharmaceuticals Llc",
        "Ingenus Pharmaceuticals Nj Llc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "P01BA03",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Aminoquinolines"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1952,
    "indication_class": "Antimalarial",
    "molecule_chembl_id": "CHEMBL506",
    "molecule_properties": {
      "acd_logd": 0.01,
      "acd_logp": 2.74,
      "acd_most_bpka": 10.38,
      "alogp": 2.78,
      "aromatic_rings": 2,
      "full_molformula": "C15H21N3O",
      "full_mwt": 259.35,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 259.35,
      "mw_monoisotopic": 259.1685,
      "psa": 60.17,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(NC(C)CCCN)c2ncccc2c1",
      "standard_inchi": "InChI=1S/C15H21N3O/c1-11(5-3-7-16)18-14-10-13(19-2)9-12-6-4-8-17-15(12)14/h4,6,8-11,18H,3,5,7,16H2,1-2H3",
      "standard_inchi_key": "INDBQLZJXZLFIT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Primaquine Phosphate (FDA, USP)",
        "Primaquine (BAN, INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL12552",
    "molecule_properties": {
      "acd_logd": 3.53,
      "acd_logp": 3.53,
      "alogp": 2.78,
      "aromatic_rings": 2,
      "full_molformula": "C17H14N2O2",
      "full_mwt": 278.31,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 278.31,
      "mw_monoisotopic": 278.1055,
      "psa": 55.02,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)Oc2ccc(cc2C(=C1)N3C=CC=CC3=O)C#N",
      "standard_inchi": "InChI=1S/C17H14N2O2/c1-17(2)10-14(19-8-4-3-5-16(19)20)13-9-12(11-18)6-7-15(13)21-17/h3-10H,1-2H3",
      "standard_inchi_key": "JTVSKASWNROQQF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Bimakalim (INN)",
        null
      ]
    },
    "usan_stem": "-kalim",
    "usan_stem_definition": "potassium channel agonists",
    "usan_stem_substem": "-kalim(-kalim)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "M05BA02",
        "description": "MUSCULO-SKELETAL SYSTEM: DRUGS FOR TREATMENT OF BONE DISEASES: DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION: Bisphosphonates"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Regulator (calcium)",
    "molecule_chembl_id": "CHEMBL12318",
    "molecule_properties": {
      "acd_logd": -4.38,
      "acd_logp": 1.11,
      "acd_most_apka": 0.75,
      "alogp": 0.43,
      "full_molformula": "CH4Cl2O6P2",
      "full_mwt": 244.89,
      "hba": 2,
      "hba_lipinski": 6,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 11,
      "molecular_species": "ACID",
      "mw_freebase": 244.89,
      "mw_monoisotopic": 243.886,
      "psa": 115.06,
      "qed_weighted": 0.41,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "OP(=O)(O)C(Cl)(Cl)P(=O)(O)O",
      "standard_inchi": "InChI=1S/CH4Cl2O6P2/c2-1(3,10(4,5)6)11(7,8)9/h(H2,4,5,6)(H2,7,8,9)",
      "standard_inchi_key": "ACSIXWWBWUQEHA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        177501,
        "ZK-00091106"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clodronate Disodium (USAN)",
        "Clodronic Acid (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-dronate",
    "usan_stem_definition": "calcium metabolism regulators",
    "usan_stem_substem": "-dronate(-dronate)",
    "usan_year": 1977
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antidiabetic",
    "molecule_chembl_id": "CHEMBL12261",
    "molecule_properties": {
      "acd_logd": 6.24,
      "acd_logp": 6.24,
      "alogp": 5.02,
      "full_molformula": "C18H34O3",
      "full_mwt": 298.47,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 21,
      "mw_freebase": 298.47,
      "mw_monoisotopic": 298.2508,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 38.83,
      "qed_weighted": 0.26,
      "ro3_pass": "N",
      "rtb": 14
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCCCCCCCCC1(CO1)C(=O)OC",
      "standard_inchi": "InChI=1S/C18H34O3/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-18(16-21-18)17(19)20-2/h3-16H2,1-2H3",
      "standard_inchi_key": "RSSDZUNGAWCFPT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MCN-3716"
    },
    "synonyms": {
      "value": [
        "Methyl palmoxirate (USAN)",
        null
      ]
    },
    "usan_year": 1982
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antidiabetic",
    "molecule_chembl_id": "CHEMBL12394",
    "molecule_properties": {
      "acd_logd": 2.61,
      "acd_logp": 6.06,
      "acd_most_apka": 3.66,
      "alogp": 4.93,
      "full_molformula": "C17H32O3",
      "full_mwt": 284.44,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "ACID",
      "mw_freebase": 284.44,
      "mw_monoisotopic": 284.2351,
      "psa": 49.83,
      "qed_weighted": 0.36,
      "ro3_pass": "N",
      "rtb": 14
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCCCCCCCCC1(CO1)C(=O)O",
      "standard_inchi": "InChI=1S/C17H32O3/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-17(15-20-17)16(18)19/h2-15H2,1H3,(H,18,19)",
      "standard_inchi_key": "FGIJQXGDQVNWKH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "MCN-3802 [Anhydrous free acid]",
        "MCN-3802-21-98"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Palmoxirate sodium (USAN)",
        "Palmoxiric Acid (INN)",
        null
      ]
    },
    "usan_year": 1982
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL275803",
    "molecule_properties": {
      "acd_logd": -1.64,
      "acd_logp": 0.76,
      "acd_most_bpka": 11.7,
      "alogp": 1.21,
      "aromatic_rings": 2,
      "full_molformula": "C14H23N7S",
      "full_mwt": 321.45,
      "hba": 4,
      "hba_lipinski": 7,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 321.45,
      "mw_monoisotopic": 321.1736,
      "psa": 107.77,
      "qed_weighted": 0.33,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H](Cc1c[nH]cn1)\\N=C(/N)\\NCCSCc2[nH]cnc2C",
      "standard_inchi": "InChI=1S/C14H23N7S/c1-10(5-12-6-16-8-19-12)21-14(15)17-3-4-22-7-13-11(2)18-9-20-13/h6,8-10H,3-5,7H2,1-2H3,(H,16,19)(H,18,20)(H3,15,17,21)/t10-/m1/s1",
      "standard_inchi_key": "JXJRIXGXPTZOCF-SNVBAGLBSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sopromidine (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Vitarine Pharmaceuticals Inc",
        "American Therapeutics Inc",
        "Sandoz Inc",
        "Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Quantum Pharmics Ltd",
        "Watson Laboratories Inc",
        "Parke Davis Div Warner Lambert Co",
        "Barr Laboratories Inc",
        "Usl Pharma Inc",
        "Mylan Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "M01AG04",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Fenamate"
        },
        {
          "code": "M02AA18",
          "description": "MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1980,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL509",
    "molecule_properties": {
      "acd_logd": 2.37,
      "acd_logp": 5.44,
      "acd_most_apka": 3.59,
      "alogp": 4.74,
      "aromatic_rings": 2,
      "full_molformula": "C14H11Cl2NO2",
      "full_mwt": 296.15,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "ACID",
      "mw_freebase": 296.15,
      "mw_monoisotopic": 295.0167,
      "psa": 49.33,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl",
      "standard_inchi": "InChI=1S/C14H11Cl2NO2/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19/h2-7,17H,1H3,(H,18,19)",
      "standard_inchi_key": "SBDNJUWAMKYJOX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "CI-583",
        "CL-583.NA SALT",
        "CL-583",
        "INF-4668"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Meclofenamate sodium (FDA, USAN, USP)",
        "Meclofenamic Acid (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-fenamate",
    "usan_stem_definition": "anti-inflammatory agents (anthranilic acid derivatives) and their salts or esters",
    "usan_stem_substem": "-fenamate(-fenamate)",
    "usan_year": 1976
  },
  {
    "atc_classification": {
      "drug": {
        "code": "A05AX02",
        "description": "ALIMENTARY TRACT AND METABOLISM: BILE AND LIVER THERAPY: BILE THERAPY: Other drugs for bile therapy"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 1,
    "drug_type": 1,
    "indication_class": "Choleretic",
    "molecule_chembl_id": "CHEMBL12208",
    "molecule_properties": {
      "acd_logd": 2.33,
      "acd_logp": 2.43,
      "acd_most_apka": 8,
      "alogp": 1.81,
      "aromatic_rings": 2,
      "full_molformula": "C10H8O3",
      "full_mwt": 176.17,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 13,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 176.17,
      "mw_monoisotopic": 176.0473,
      "psa": 50.44,
      "qed_weighted": 0.62,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CC1=CC(=O)Oc2cc(O)ccc12",
      "standard_inchi": "InChI=1S/C10H8O3/c1-6-4-10(12)13-9-5-7(11)2-3-8(6)9/h2-5,11H,1H3",
      "standard_inchi_key": "HSHNITRMYYLLCV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "LM-94"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Hymecromone (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_year": 1978
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Diagnostic Aid (gastric secretion indicator)",
    "molecule_chembl_id": "CHEMBL12608",
    "molecule_properties": {
      "acd_logd": -1.47,
      "acd_logp": 1.23,
      "acd_most_bpka": 12.62,
      "alogp": 1.42,
      "aromatic_rings": 2,
      "full_molformula": "C14H23N7S",
      "full_mwt": 321.45,
      "hba": 4,
      "hba_lipinski": 7,
      "hbd": 5,
      "hbd_lipinski": 5,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 321.45,
      "mw_monoisotopic": 321.1736,
      "psa": 105.27,
      "qed_weighted": 0.27,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1[nH]cnc1CSCCNC(=N)NCCCc2c[nH]cn2",
      "standard_inchi": "InChI=1S/C14H23N7S/c1-11-13(21-10-19-11)8-22-6-5-18-14(15)17-4-2-3-12-7-16-9-20-12/h7,9-10H,2-6,8H2,1H3,(H,16,20)(H,19,21)(H3,15,17,18)",
      "standard_inchi_key": "MURRAGMMNAYLNA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SK&F-92676-A3"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Impromidine (BAN, INN)",
        "Impromidine HCl (USAN)",
        null
      ]
    },
    "usan_year": 1979
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antagonist (to histamine-H2 receptors)",
    "molecule_chembl_id": "CHEMBL269646",
    "molecule_properties": {
      "acd_logd": -0.9,
      "acd_logp": -0.27,
      "acd_most_bpka": 7.93,
      "alogp": -0.07,
      "aromatic_rings": 1,
      "full_molformula": "C10H16N8S2",
      "full_mwt": 312.43,
      "hba": 6,
      "hba_lipinski": 8,
      "hbd": 4,
      "hbd_lipinski": 6,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 312.43,
      "mw_monoisotopic": 312.0939,
      "num_lipinski_ro5_violations": 1,
      "psa": 137.5,
      "qed_weighted": 0.19,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "C\\N=C(\\NCCSCc1csc(N=C(N)N)n1)/NC#N",
      "standard_inchi": "InChI=1S/C10H16N8S2/c1-14-9(16-6-11)15-2-3-19-4-7-5-20-10(17-7)18-8(12)13/h5H,2-4H2,1H3,(H2,14,15,16)(H4,12,13,17,18)",
      "standard_inchi_key": "YDDXVAXDYKBWDX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "ICI-125211"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tiotidine (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-tidine",
    "usan_stem_definition": "H2-receptor antagonists (cimetidine type)",
    "usan_stem_substem": "-tidine(-tidine)",
    "usan_year": 1980
  },
  {
    "atc_classification": {
      "drug": {
        "code": "A08AA06",
        "description": "ALIMENTARY TRACT AND METABOLISM: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: Centrally acting antiobesity products"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL276443",
    "molecule_properties": {
      "acd_logd": -0.03,
      "acd_logp": 2.71,
      "acd_most_bpka": 10.38,
      "alogp": 2.23,
      "aromatic_rings": 1,
      "full_molformula": "C11H17N",
      "full_mwt": 163.26,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 12,
      "molecular_species": "BASE",
      "mw_freebase": 163.26,
      "mw_monoisotopic": 163.1361,
      "psa": 12.03,
      "qed_weighted": 0.72,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCNC(C)Cc1ccccc1",
      "standard_inchi": "InChI=1S/C11H17N/c1-3-12-10(2)9-11-7-5-4-6-8-11/h4-8,10,12H,3,9H2,1-2H3",
      "standard_inchi_key": "YAGBSNMZQKEFCO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Etilamfetamine (INN)",
        null
      ]
    },
    "usan_stem": "-fetamin(e)",
    "usan_stem_definition": "amfetamine derivatives",
    "usan_stem_substem": "-fetamin(e)(-fetamin(e))"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antagonist (to histamine-H2 receptors)",
    "molecule_chembl_id": "CHEMBL275446",
    "molecule_properties": {
      "acd_logd": -1.67,
      "acd_logp": 1.07,
      "acd_most_bpka": 15.68,
      "alogp": 1.46,
      "aromatic_rings": 1,
      "full_molformula": "C9H16N4S2",
      "full_mwt": 244.39,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 3,
      "hbd_lipinski": 2,
      "heavy_atoms": 15,
      "molecular_species": "BASE",
      "mw_freebase": 244.39,
      "mw_monoisotopic": 244.0816,
      "psa": 53.07,
      "qed_weighted": 0.32,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "C\\N=C(/S)\\NCCSCc1[nH]cnc1C",
      "standard_inchi": "InChI=1S/C9H16N4S2/c1-7-8(13-6-12-7)5-15-4-3-11-9(14)10-2/h6H,3-5H2,1-2H3,(H,12,13)(H2,10,11,14)",
      "standard_inchi_key": "FPBPLBWLMYGIQR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SK&F-92058"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Metiamide (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1973
  },
  {
    "applicants": {
      "value": [
        "Impax Laboratories Inc",
        "Watson Laboratories Inc",
        "Allergan Pharmaceutical"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R06AC01",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted ethylene diamine"
        },
        {
          "code": "D04AA02",
          "description": "DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Antihistamines for topical use"
        }
      ]
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1973,
    "indication_class": "Antihistaminic",
    "molecule_chembl_id": "CHEMBL511",
    "molecule_properties": {
      "acd_logd": 0.76,
      "acd_logp": 2.67,
      "acd_most_bpka": 9.02,
      "alogp": 2.66,
      "aromatic_rings": 2,
      "full_molformula": "C17H23N3O",
      "full_mwt": 285.39,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 285.39,
      "mw_monoisotopic": 285.1841,
      "psa": 28.6,
      "qed_weighted": 0.78,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(CN(CCN(C)C)c2ccccn2)cc1",
      "standard_inchi": "InChI=1S/C17H23N3O/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15/h4-11H,12-14H2,1-3H3",
      "standard_inchi_key": "YECBIJXISLIIDS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pyrilamine Maleate (FDA, USP)",
        "Mepyramine (BAN, INN)",
        null
      ]
    },
    "topical": true
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Serotonin Antagonist",
    "molecule_chembl_id": "CHEMBL267777",
    "molecule_properties": {
      "acd_logd": 4.71,
      "acd_logp": 5.2,
      "acd_most_bpka": 7.74,
      "alogp": 5.48,
      "aromatic_rings": 4,
      "full_molformula": "C27H25F2N3OS",
      "full_mwt": 477.58,
      "hba": 5,
      "hba_lipinski": 4,
      "heavy_atoms": 34,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 477.58,
      "mw_monoisotopic": 477.1686,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 37.61,
      "qed_weighted": 0.38,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC1=C(CCN2CCC(=C(c3ccc(F)cc3)c4ccc(F)cc4)CC2)C(=O)N5C=CSC5=N1",
      "standard_inchi": "InChI=1S/C27H25F2N3OS/c1-18-24(26(33)32-16-17-34-27(32)30-18)12-15-31-13-10-21(11-14-31)25(19-2-6-22(28)7-3-19)20-4-8-23(29)9-5-20/h2-9,16-17H,10-15H2,1H3",
      "standard_inchi_key": "JUQLTPCYUFPYKE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "R-55667"
    },
    "synonyms": {
      "value": [
        "Ritanserin (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-anserin",
    "usan_stem_definition": "serotonin 5-HT2 receptor antagonists",
    "usan_stem_substem": "-anserin(-anserin)",
    "usan_year": 1985
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05AE03",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Indole derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antipsychotic; Neuroleptic",
    "molecule_chembl_id": "CHEMBL12713",
    "molecule_properties": {
      "acd_logd": 2.46,
      "acd_logp": 3.67,
      "acd_most_bpka": 8.97,
      "alogp": 4.63,
      "aromatic_rings": 3,
      "full_molformula": "C24H26ClFN4O",
      "full_mwt": 440.95,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 31,
      "molecular_species": "BASE",
      "mw_freebase": 440.95,
      "mw_monoisotopic": 440.1779,
      "psa": 40.51,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "Fc1ccc(cc1)n2cc(C3CCN(CCN4CCNC4=O)CC3)c5cc(Cl)ccc25",
      "standard_inchi": "InChI=1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)",
      "standard_inchi_key": "GZKLJWGUPQBVJQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sertindole (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1992,
    "withdrawn_class": "Cardiotoxicity",
    "withdrawn_country": "United Kingdom; Germany; Italy; Ireland; Netherlands; European Union",
    "withdrawn_reason": "Arrhythmias and Sudden Cardiac Death (Arrhythmias and Sudden)",
    "withdrawn_year": 1998
  },
  {
    "applicants": {
      "value": [
        "Arbor Pharmaceuticals Llc",
        "Emcure Pharmaceuticals Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01AD01",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrosoureas"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1977,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL513",
    "molecule_properties": {
      "acd_logd": 1.37,
      "acd_logp": 1.38,
      "acd_most_apka": 10.19,
      "alogp": 1.16,
      "full_molformula": "C5H9Cl2N3O2",
      "full_mwt": 214.05,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 12,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 214.05,
      "mw_monoisotopic": 213.0072,
      "psa": 61.77,
      "qed_weighted": 0.42,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "ClCCNC(=O)N(CCCl)N=O",
      "standard_inchi": "InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2,(H,8,11)",
      "standard_inchi_key": "DLGOEMSEDOSKAD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "BCNU"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Carmustine (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-mustine",
    "usan_stem_definition": "antineoplastics (chloroethylamine derivatives)",
    "usan_stem_substem": "-mustine(-mustine)",
    "usan_year": 1970
  },
  {
    "atc_classification": {
      "drug": {
        "code": "L01AD03",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrosoureas"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL12948",
    "molecule_properties": {
      "acd_logd": 3.26,
      "acd_logp": 3.26,
      "acd_most_apka": 10.89,
      "alogp": 2.5,
      "full_molformula": "C10H18ClN3O2",
      "full_mwt": 247.73,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 247.73,
      "mw_monoisotopic": 247.1088,
      "psa": 61.77,
      "qed_weighted": 0.47,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC1CCC(CC1)NC(=O)N(CCCl)N=O",
      "standard_inchi": "InChI=1S/C10H18ClN3O2/c1-8-2-4-9(5-3-8)12-10(15)14(13-16)7-6-11/h8-9H,2-7H2,1H3,(H,12,15)",
      "standard_inchi_key": "FVLVBPDQNARYJU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "Methyl-Ccnu"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Semustine (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-mustine",
    "usan_stem_definition": "antineoplastics (chloroethylamine derivatives)",
    "usan_stem_substem": "-mustine(-mustine)",
    "usan_year": 1972
  },
  {
    "applicants": {
      "value": "Corden Pharma Latina Spa"
    },
    "atc_classification": {
      "drug": {
        "code": "L01AD02",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrosoureas"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1976,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL514",
    "molecule_properties": {
      "acd_logd": 2.72,
      "acd_logp": 2.72,
      "acd_most_apka": 10.88,
      "alogp": 2.25,
      "full_molformula": "C9H16ClN3O2",
      "full_mwt": 233.7,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 233.7,
      "mw_monoisotopic": 233.0931,
      "psa": 61.77,
      "qed_weighted": 0.46,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "ClCCN(N=O)C(=O)NC1CCCCC1",
      "standard_inchi": "InChI=1S/C9H16ClN3O2/c10-6-7-13(12-15)9(14)11-8-4-2-1-3-5-8/h8H,1-7H2,(H,11,14)",
      "standard_inchi_key": "GQYIWUVLTXOXAJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "CCNU"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lomustine (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-mustine",
    "usan_stem_definition": "antineoplastics (chloroethylamine derivatives)",
    "usan_stem_substem": "-mustine(-mustine)",
    "usan_year": 1972
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N03AG03",
        "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Fatty acid derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL96",
    "molecule_properties": {
      "acd_logd": -3.14,
      "acd_logp": -0.64,
      "acd_most_apka": 4.44,
      "acd_most_bpka": 11.25,
      "alogp": -0.19,
      "full_molformula": "C4H9NO2",
      "full_mwt": 103.12,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 7,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 103.12,
      "mw_monoisotopic": 103.0633,
      "psa": 63.32,
      "qed_weighted": 0.52,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "NCCCC(=O)O",
      "standard_inchi": "InChI=1S/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7)",
      "standard_inchi_key": "BTCSSZJGUNDROE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Gamma-Aminobutyric Acid (JAN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL12314",
    "molecule_properties": {
      "acd_logd": 1.77,
      "acd_logp": 2.07,
      "acd_most_apka": 11.34,
      "acd_most_bpka": 7.26,
      "alogp": 1.29,
      "aromatic_rings": 2,
      "full_molformula": "C18H26N4O2S",
      "full_mwt": 362.5,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 362.5,
      "mw_monoisotopic": 362.1776,
      "psa": 57.58,
      "qed_weighted": 0.9,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)S(=O)(=O)N[C@H]1C[C@H]2[C@@H](Cc3cn(C)c4cccc2c34)N(C)C1",
      "standard_inchi": "InChI=1S/C18H26N4O2S/c1-20(2)25(23,24)19-13-9-15-14-6-5-7-16-18(14)12(10-21(16)3)8-17(15)22(4)11-13/h5-7,10,13,15,17,19H,8-9,11H2,1-4H3/t13-,15+,17+/m0/s1",
      "standard_inchi_key": "JLVHTNZNKOSCNB-YSVLISHTSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mesulergine (INN, MI)",
        null
      ]
    },
    "usan_stem": "-erg-",
    "usan_stem_definition": "ergot alkaloid derivatives",
    "usan_stem_substem": "-erg-(-erg-)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL275707",
    "molecule_properties": {
      "acd_logd": 2.82,
      "acd_logp": 4.72,
      "acd_most_bpka": 9.32,
      "alogp": 3.87,
      "aromatic_rings": 3,
      "full_molformula": "C21H27N3",
      "full_mwt": 321.47,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 321.47,
      "mw_monoisotopic": 321.2205,
      "psa": 20.2,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@@H]1CN(CCCn2c3ccccc3c4ccccc24)C[C@H](C)N1",
      "standard_inchi": "InChI=1S/C21H27N3/c1-16-14-23(15-17(2)22-16)12-7-13-24-20-10-5-3-8-18(20)19-9-4-6-11-21(19)24/h3-6,8-11,16-17,22H,7,12-15H2,1-2H3/t16-,17+",
      "standard_inchi_key": "GUDVQJXODNJRIJ-CALCHBBNSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BW-234U Dihydrochloride"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Rimcazole (INN)",
        "Rimcazole HCl (USAN)",
        null
      ]
    },
    "usan_year": 1986
  },
  {
    "applicants": {
      "value": "Aspen Global Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "L01AA02",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Nitrogen mustard analogues"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1957,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL515",
    "molecule_properties": {
      "acd_logd": 0.06,
      "acd_logp": 2.61,
      "acd_most_apka": 4.82,
      "acd_most_bpka": 4.62,
      "alogp": 3.38,
      "aromatic_rings": 1,
      "full_molformula": "C14H19Cl2NO2",
      "full_mwt": 304.22,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "ACID",
      "mw_freebase": 304.22,
      "mw_monoisotopic": 303.0793,
      "psa": 40.54,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CCCc1ccc(cc1)N(CCCl)CCCl",
      "standard_inchi": "InChI=1S/C14H19Cl2NO2/c15-8-10-17(11-9-16)13-6-4-12(5-7-13)2-1-3-14(18)19/h4-7H,1-3,8-11H2,(H,18,19)",
      "standard_inchi_key": "JCKYGMPEJWAADB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Chlorambucil (BAN, FDA, INN, USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Chartwell Rx Sciences Llc",
        "Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc",
        "Pharmaceutical Assoc Inc",
        "Lyne Laboratories Inc",
        "Halsey Drug Co Inc",
        "Morton Grove Pharmaceuticals Inc",
        "Kv Pharmaceutical Co",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Pliva Inc",
        "Merck And Co Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "R06AX02",
        "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1961,
    "indication_class": "Antihistaminic; Antipruritic",
    "molecule_chembl_id": "CHEMBL516",
    "molecule_properties": {
      "acd_logd": 4.27,
      "acd_logp": 5.82,
      "acd_most_bpka": 8.95,
      "alogp": 4.7,
      "aromatic_rings": 2,
      "full_molformula": "C21H21N",
      "full_mwt": 287.41,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 287.41,
      "mw_monoisotopic": 287.1674,
      "psa": 3.24,
      "qed_weighted": 0.58,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCC(=C2c3ccccc3C=Cc4ccccc24)CC1",
      "standard_inchi": "InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3",
      "standard_inchi_key": "JJCFRYNCJDLXIK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cyproheptadine HCl (FDA, JAN, USP)",
        "Cyproheptadine (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-(a)tadine",
    "usan_stem_definition": "tricyclic histaminic-H1 receptor antagonists, loratadine derivatives",
    "usan_stem_substem": "-(a)tadine(-(a)tadine)"
  },
  {
    "applicants": {
      "value": [
        "Sanofi Aventis Us Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Hospira Inc",
        "Baxter Healthcare Corp Anesthesia Critical Care"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C01CE01",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Phosphodiesterase inhibitors"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1984,
    "indication_class": "Cardiotonic",
    "molecule_chembl_id": "CHEMBL12856",
    "molecule_properties": {
      "acd_logd": -0.22,
      "acd_logp": -0.21,
      "acd_most_apka": 12.05,
      "acd_most_bpka": 5.72,
      "alogp": 1.02,
      "aromatic_rings": 2,
      "full_molformula": "C10H9N3O",
      "full_mwt": 187.2,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 187.2,
      "mw_monoisotopic": 187.0746,
      "psa": 71.77,
      "qed_weighted": 0.7,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "NC1=CC(=CNC1=O)c2ccncc2",
      "standard_inchi": "InChI=1S/C10H9N3O/c11-9-5-8(6-13-10(9)14)7-1-3-12-4-2-7/h1-6H,11H2,(H,13,14)",
      "standard_inchi_key": "RNLQIBCLLYYYFJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "WIN-40680"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Inamrinone Lactate (FDA)",
        "Amrinone (BAN, INN, JAN)",
        "Inamrinone (USAN, USP)",
        null
      ]
    },
    "usan_stem": "-rinone",
    "usan_stem_definition": "cardiotonics (amrinone type)",
    "usan_stem_substem": "-rinone(-rinone)",
    "usan_year": 1999
  },
  {
    "applicants": {
      "value": [
        "Aurolife Pharma Llc",
        "Sun Pharmaceutical Industries Inc",
        "Superpharm Corp",
        "Teva Pharmaceuticals Usa Inc",
        "Watson Laboratories Inc",
        "Nesher Pharmaceuticals Usa Llc",
        "Gd Searle Llc",
        "Mylan Pharmaceuticals Inc",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa",
        "Interpharm Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C01BA03",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ia"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1977,
    "indication_class": "Cardiac Depressant (anti-arrhythmic)",
    "molecule_chembl_id": "CHEMBL517",
    "molecule_properties": {
      "acd_logd": -0.07,
      "acd_logp": 2.33,
      "acd_most_bpka": 10.1,
      "alogp": 3.36,
      "aromatic_rings": 2,
      "full_molformula": "C21H29N3O",
      "full_mwt": 339.48,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 25,
      "molecular_species": "BASE",
      "mw_freebase": 339.48,
      "mw_monoisotopic": 339.2311,
      "psa": 59.22,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)N(CCC(C(=O)N)(c1ccccc1)c2ccccn2)C(C)C",
      "standard_inchi": "InChI=1S/C21H29N3O/c1-16(2)24(17(3)4)15-13-21(20(22)25,18-10-6-5-7-11-18)19-12-8-9-14-23-19/h5-12,14,16-17H,13,15H2,1-4H3,(H2,22,25)",
      "standard_inchi_key": "UVTNFZQICZKOEM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "SC-7031",
        "SC-13957"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Disopyramide Phosphate (BAN, FDA, JAN, USAN, USP)",
        "Disopyramide (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_year": 1970
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 7,
    "indication_class": "Antifungal; Anti-Inflammatory; Antimicrobial",
    "molecule_chembl_id": "CHEMBL417799",
    "molecule_properties": {
      "acd_logd": -0.65,
      "acd_logp": -0.65,
      "alogp": 3.43,
      "aromatic_rings": 4,
      "full_molformula": "C20H14NO4+",
      "full_mwt": 332.34,
      "hba": 4,
      "hba_lipinski": 5,
      "heavy_atoms": 25,
      "mw_freebase": 332.34,
      "mw_monoisotopic": 332.0917,
      "psa": 40.8,
      "qed_weighted": 0.37,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "C[n+]1cc2c3OCOc3ccc2c4ccc5cc6OCOc6cc5c14",
      "standard_inchi": "InChI=1S/C20H14NO4/c1-21-8-15-12(4-5-16-20(15)25-10-22-16)13-3-2-11-6-17-18(24-9-23-17)7-14(11)19(13)21/h2-8H,9-10H2,1H3/q+1",
      "standard_inchi_key": "INVGWHRKADIJHF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sanguinarium Chloride (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ium",
    "usan_stem_definition": "quaternary ammonium derivatives",
    "usan_stem_substem": "-ium(-ium)",
    "usan_year": 1992
  },
  {
    "atc_classification": {
      "drug": {
        "code": "H02AA01",
        "description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Mineralocorticoids"
      }
    },
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 1,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL273453",
    "molecule_properties": {
      "acd_logd": 0.71,
      "acd_logp": 0.71,
      "acd_most_apka": 12.98,
      "alogp": 1.85,
      "full_molformula": "C21H28O5",
      "full_mwt": 360.45,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 360.45,
      "mw_monoisotopic": 360.1937,
      "psa": 91.67,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@]12CCC(=O)C=C1CC[C@H]3[C@@H]4CC[C@H](C(=O)CO)[C@]4(C[C@H](O)[C@H]23)C=O",
      "standard_inchi": "InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",
      "standard_inchi_key": "PQSUYGKTWSAVDQ-ZVIOFETBSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Aldosterone (BAN, DCF, INN, MI)",
        null
      ]
    },
    "usan_stem": "-ster-",
    "usan_stem_definition": "steroids (androgens, anabolics)",
    "usan_stem_substem": "-ster-(-ster-)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL13134",
    "molecule_properties": {
      "acd_logd": 4.22,
      "acd_logp": 4.24,
      "acd_most_apka": 11.26,
      "acd_most_bpka": 5.95,
      "alogp": 4.44,
      "aromatic_rings": 4,
      "full_molformula": "C41H52N6O5",
      "full_mwt": 708.9,
      "hba": 8,
      "hba_lipinski": 11,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 52,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 708.9,
      "mw_monoisotopic": 708.3999,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 1,
      "psa": 145.78,
      "qed_weighted": 0.15,
      "ro3_pass": "N",
      "rtb": 14
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)[C@H](NC(=O)c1ccc2ccccc2n1)C(=O)N[C@@H](Cc3ccccc3)[C@H](O)CN4CC[C@H](C[C@H]4C(=O)NC(C)(C)C)OCc5ccncc5",
      "standard_inchi": "InChI=1S/C41H52N6O5/c1-27(2)37(45-38(49)33-16-15-30-13-9-10-14-32(30)43-33)40(51)44-34(23-28-11-7-6-8-12-28)36(48)25-47-22-19-31(52-26-29-17-20-42-21-18-29)24-35(47)39(50)46-41(3,4)5/h6-18,20-21,27,31,34-37,48H,19,22-26H2,1-5H3,(H,44,51)(H,45,49)(H,46,50)/t31-,34+,35+,36-,37+/m1/s1",
      "standard_inchi_key": "RXBWRFDZXRAEJT-SZNOJMITSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BILA-2011-BS"
    },
    "synonyms": {
      "value": [
        "Palinavir (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-vir",
    "usan_stem_definition": "antivirals: HIV protease inhibitors (saquinavir type)",
    "usan_stem_substem": "-vir(-vir(-navir))",
    "usan_year": 1995
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Cardiotonic",
    "molecule_chembl_id": "CHEMBL12831",
    "molecule_properties": {
      "acd_logd": 0.02,
      "acd_logp": 0.02,
      "acd_most_apka": 13.48,
      "acd_most_bpka": 5.14,
      "alogp": 1.49,
      "aromatic_rings": 2,
      "full_molformula": "C13H12N4O",
      "full_mwt": 240.27,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 240.27,
      "mw_monoisotopic": 240.1011,
      "psa": 59.28,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1CCC(=NN1)c2ccc(cc2)n3ccnc3",
      "standard_inchi": "InChI=1S/C13H12N4O/c18-13-6-5-12(15-16-13)10-1-3-11(4-2-10)17-8-7-14-9-17/h1-4,7-9H,5-6H2,(H,16,18)",
      "standard_inchi_key": "VXMYWVMXSWJFCV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CI-914"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Imazodan (INN)",
        "Imazodan HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-dan",
    "usan_stem_definition": "positive inotropic agents (pimobendan type)",
    "usan_stem_substem": "-dan(-dan)",
    "usan_year": 1986
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C01BA04",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ia"
      }
    },
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Oxytocic",
    "molecule_chembl_id": "CHEMBL412873",
    "molecule_properties": {
      "acd_logd": -0.02,
      "acd_logp": 2.84,
      "acd_most_bpka": 10.08,
      "alogp": 2.35,
      "full_molformula": "C15H26N2",
      "full_mwt": 234.39,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "BASE",
      "mw_freebase": 234.39,
      "mw_monoisotopic": 234.2096,
      "psa": 6.48,
      "qed_weighted": 0.63,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "C1CCN2C[C@H]3C[C@H](CN4CCCC[C@@H]34)[C@H]2C1",
      "standard_inchi": "InChI=1S/C15H26N2/c1-3-7-16-11-13-9-12(14(16)5-1)10-17-8-4-2-6-15(13)17/h12-15H,1-11H2/t12-,13-,14-,15+/m1/s1",
      "standard_inchi_key": "SLRCCWJSBJZJBV-TUVASFSCSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sparteine (INN)",
        "Sparteine Sulfate (JAN, USAN)",
        null
      ]
    },
    "usan_year": 1962,
    "withdrawn_country": "United States"
  },
  {
    "applicants": {
      "value": "Merck And Co Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "L01XX38",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2006,
    "molecule_chembl_id": "CHEMBL98",
    "molecule_properties": {
      "acd_logd": 2.34,
      "acd_logp": 2.34,
      "acd_most_apka": 9.48,
      "acd_most_bpka": 0.5,
      "alogp": 2.47,
      "aromatic_rings": 1,
      "full_molformula": "C14H20N2O3",
      "full_mwt": 264.32,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 264.32,
      "mw_monoisotopic": 264.1474,
      "psa": 78.43,
      "qed_weighted": 0.38,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "ONC(=O)CCCCCCC(=O)Nc1ccccc1",
      "standard_inchi": "InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)",
      "standard_inchi_key": "WAEXFXRVDQXREF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7399787,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-7399787-B2",
    "synonyms": {
      "value": [
        "Vorinostat (FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors: inhibitors of histone deacetylase",
    "usan_stem_substem": "-stat(-stat(-inostat))",
    "usan_year": 2005
  },
  {
    "atc_classification": {
      "drug": {
        "code": "J01MA03",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL267648",
    "molecule_properties": {
      "acd_logd": -0.17,
      "acd_logp": 1.92,
      "acd_most_apka": 0.16,
      "acd_most_bpka": 7.41,
      "alogp": 1.61,
      "aromatic_rings": 2,
      "full_molformula": "C17H20FN3O3",
      "full_mwt": 333.36,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "ACID",
      "mw_freebase": 333.36,
      "mw_monoisotopic": 333.1489,
      "psa": 65.78,
      "qed_weighted": 0.92,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1C=C(C(=O)O)C(=O)c2cc(F)c(cc12)N3CCN(C)CC3",
      "standard_inchi": "InChI=1S/C17H20FN3O3/c1-3-20-10-12(17(23)24)16(22)11-8-13(18)15(9-14(11)20)21-6-4-19(2)5-7-21/h8-10H,3-7H2,1-2H3,(H,23,24)",
      "standard_inchi_key": "FHFYDNQZQSQIAI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "1589 RB",
        "41 982 RP",
        "EU-5306"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pefloxacin Mesylate (USAN)",
        "Pefloxacin (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1981
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Cardiac Depressant (anti-arrhythmic)",
    "molecule_chembl_id": "CHEMBL276177",
    "molecule_properties": {
      "acd_logd": 0.38,
      "acd_logp": 4.31,
      "acd_most_bpka": 10.52,
      "alogp": 4.45,
      "aromatic_rings": 1,
      "full_molformula": "C23H38ClN3O",
      "full_mwt": 408.03,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 28,
      "molecular_species": "BASE",
      "mw_freebase": 408.03,
      "mw_monoisotopic": 407.2703,
      "psa": 49.57,
      "qed_weighted": 0.62,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)N(CCC(CCN1CCCCC1)(C(=O)N)c2ccccc2Cl)C(C)C",
      "standard_inchi": "InChI=1S/C23H38ClN3O/c1-18(2)27(19(3)4)17-13-23(22(25)28,20-10-6-7-11-21(20)24)12-16-26-14-8-5-9-15-26/h6-7,10-11,18-19H,5,8-9,12-17H2,1-4H3,(H2,25,28)",
      "standard_inchi_key": "YKFWMDHZMQLWBO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SC-31828"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Disobutamide (INN, USAN)",
        null
      ]
    },
    "usan_year": 1980
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Analgesic",
    "molecule_chembl_id": "CHEMBL13178",
    "molecule_properties": {
      "acd_logd": 4.66,
      "acd_logp": 4.82,
      "acd_most_bpka": 7.07,
      "alogp": 3.52,
      "aromatic_rings": 3,
      "full_molformula": "C23H26N2O3",
      "full_mwt": 378.47,
      "hba": 5,
      "hba_lipinski": 5,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 378.47,
      "mw_monoisotopic": 378.1943,
      "psa": 43.7,
      "qed_weighted": 0.62,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(cc1)C(=O)c2c(C)n(CCN3CCOCC3)c4ccccc24",
      "standard_inchi": "InChI=1S/C23H26N2O3/c1-17-22(23(26)18-7-9-19(27-2)10-8-18)20-5-3-4-6-21(20)25(17)12-11-24-13-15-28-16-14-24/h3-10H,11-16H2,1-2H3",
      "standard_inchi_key": "MEUQWHZOUDZXHH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "WIN-480986"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pravadoline (INN)",
        "Pravadoline Maleate (USAN)",
        null
      ]
    },
    "usan_stem": "-adol-",
    "usan_stem_definition": "analgesics (mixed opiate receptor agonists/antagonists)",
    "usan_stem_substem": "-adol-(-adol-)",
    "usan_year": 1989
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL275040",
    "molecule_properties": {
      "acd_logd": -2.86,
      "acd_logp": 0.64,
      "acd_most_apka": 2.03,
      "acd_most_bpka": 10.7,
      "alogp": 0.33,
      "full_molformula": "C10H15NO4",
      "full_mwt": 213.23,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 15,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 213.23,
      "mw_monoisotopic": 213.1001,
      "psa": 86.63,
      "qed_weighted": 0.59,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=C)[C@H]1CN[C@@H]([C@H]1CC(=O)O)C(=O)O",
      "standard_inchi": "InChI=1S/C10H15NO4/c1-5(2)7-4-11-9(10(14)15)6(7)3-8(12)13/h6-7,9,11H,1,3-4H2,2H3,(H,12,13)(H,14,15)/t6-,7+,9-/m0/s1",
      "standard_inchi_key": "VLSMHEGGTFMBBZ-OOZYFLPDSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Kainic Acid (INN, JAN, MI)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Pliva Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Marksans Pharma Ltd",
        "Aiping Pharmaceutical Inc",
        "Moberg Pharma North America Llc",
        "Ohm Corp",
        "Hi-Tech Pharmacal Co Inc",
        "P And L Development Llc Dba Pld Developments Llc",
        "Bayer Healthcare Llc",
        "Halsey Drug Co Inc",
        "Contract Pharmacal Corp"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "M02AA13",
          "description": "MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical us"
        },
        {
          "code": "M01AE51",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivative"
        },
        {
          "code": "M01AE01",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivative"
        },
        {
          "code": "G02CC01",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: OTHER GYNECOLOGICALS: Antiinflammatory products for vaginal administratio"
        },
        {
          "code": "C01EB16",
          "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: OTHER CARDIAC PREPARATIONS: Other cardiac preparation"
        },
        {
          "code": "R02AX02",
          "description": "RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Other throat preparations"
        }
      ]
    },
    "availability_type": 2,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1974,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL521",
    "molecule_properties": {
      "acd_logd": 0.58,
      "acd_logp": 3.5,
      "acd_most_apka": 4.41,
      "alogp": 3.07,
      "aromatic_rings": 1,
      "full_molformula": "C13H18O2",
      "full_mwt": 206.28,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 15,
      "molecular_species": "ACID",
      "mw_freebase": 206.28,
      "mw_monoisotopic": 206.1307,
      "psa": 37.3,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)Cc1ccc(cc1)C(C)C(=O)O",
      "standard_inchi": "InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)",
      "standard_inchi_key": "HEFNNWSXXWATRW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6211246,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "U-18573"
    },
    "rule_of_five": true,
    "sc_patent": "US-6211246-B1",
    "synonyms": {
      "value": [
        "Ibuprofen (BAN, FDA, INN, JAN, USAN, USP)",
        "Ibuprofen Lysine (FDA, USAN)",
        "Ibuprofen Sodium (FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-profen",
    "usan_stem_definition": "anti-inflammatory/analgesic agents (ibuprofen type)",
    "usan_stem_substem": "-profen(-profen)",
    "usan_year": 1968
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL13376",
    "molecule_properties": {
      "acd_logd": 1.22,
      "acd_logp": 4.43,
      "acd_most_apka": 4.04,
      "alogp": 3.93,
      "aromatic_rings": 3,
      "full_molformula": "C19H16ClNO4",
      "full_mwt": 357.79,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 357.79,
      "mw_monoisotopic": 357.0768,
      "psa": 68.53,
      "qed_weighted": 0.7,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2c(C(=O)c3ccc(Cl)cc3)c(C)n(CC(=O)O)c2c1",
      "standard_inchi": "InChI=1S/C19H16ClNO4/c1-11-18(19(24)12-3-5-13(20)6-4-12)15-8-7-14(25-2)9-16(15)21(11)10-17(22)23/h3-9H,10H2,1-2H3,(H,22,23)",
      "standard_inchi_key": "DGMZLCLHHVYDIS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "R-3959",
        "C-1656"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clometacin (DCF, INN, MI)",
        null
      ]
    },
    "usan_stem": "-metacin",
    "usan_stem_definition": "anti-inflammatory agents (indomethacin type)",
    "usan_stem_substem": "-metacin(-metacin)",
    "withdrawn_class": "Hepatotoxicity",
    "withdrawn_country": "France",
    "withdrawn_reason": "Hepatotoxicity",
    "withdrawn_year": 1987
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL13341",
    "molecule_properties": {
      "acd_logd": 2.31,
      "acd_logp": 2.31,
      "acd_most_bpka": 3.19,
      "alogp": 2.41,
      "aromatic_rings": 2,
      "full_molformula": "C16H13N3O3",
      "full_mwt": 295.3,
      "hba": 4,
      "hba_lipinski": 6,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 295.3,
      "mw_monoisotopic": 295.0957,
      "psa": 75.81,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)CN=C(c2ccccc2)c3cc(ccc13)[N+](=O)[O-]",
      "standard_inchi": "InChI=1S/C16H13N3O3/c1-18-14-8-7-12(19(21)22)9-13(14)16(17-10-15(18)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",
      "standard_inchi_key": "GWUSZQUVEVMBPI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "S-1530"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nimetazepam (INN, JAN, MI)",
        null
      ]
    },
    "usan_stem": "-azepam",
    "usan_stem_definition": "antianxiety agents (diazepam type)",
    "usan_stem_substem": "-azepam(-azepam)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05CD03",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL13280",
    "molecule_properties": {
      "acd_logd": 2.13,
      "acd_logp": 2.13,
      "acd_most_bpka": 1.68,
      "alogp": 2.55,
      "aromatic_rings": 2,
      "full_molformula": "C16H12FN3O3",
      "full_mwt": 313.29,
      "hba": 4,
      "hba_lipinski": 6,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 313.29,
      "mw_monoisotopic": 313.0863,
      "psa": 75.81,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)CN=C(c2ccccc2F)c3cc(ccc13)[N+](=O)[O-]",
      "standard_inchi": "InChI=1S/C16H12FN3O3/c1-19-14-7-6-10(20(22)23)8-12(14)16(18-9-15(19)21)11-4-2-3-5-13(11)17/h2-8H,9H2,1H3",
      "standard_inchi_key": "PPTYJKAXVCCBDU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "Ro-54200"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Flunitrazepam (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-azepam",
    "usan_stem_definition": "antianxiety agents (diazepam type)",
    "usan_stem_substem": "-azepam(-azepam)",
    "usan_year": 1976,
    "withdrawn_class": "Misuse",
    "withdrawn_country": "France; unapproved in United States",
    "withdrawn_reason": "Abuse",
    "withdrawn_year": 1996
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05CD02",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Anticonvulsant; Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL13209",
    "molecule_properties": {
      "acd_logd": 2.35,
      "acd_logp": 2.35,
      "acd_most_apka": 11.35,
      "acd_most_bpka": 2.55,
      "alogp": 2.38,
      "aromatic_rings": 2,
      "full_molformula": "C15H11N3O3",
      "full_mwt": 281.27,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 281.27,
      "mw_monoisotopic": 281.08,
      "psa": 84.6,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "[O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3)c2c1",
      "standard_inchi": "InChI=1S/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19)",
      "standard_inchi_key": "KJONHKAYOJNZEC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "Ro-45360",
        "Ro-53059"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nitrazepam (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-azepam",
    "usan_stem_definition": "antianxiety agents (diazepam type)",
    "usan_stem_substem": "-azepam(-azepam)",
    "usan_year": 1966
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05BA16",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL523",
    "molecule_properties": {
      "acd_logd": 2.78,
      "acd_logp": 2.78,
      "acd_most_apka": 11.72,
      "acd_most_bpka": 3.22,
      "alogp": 3.13,
      "aromatic_rings": 2,
      "full_molformula": "C15H11ClN2O",
      "full_mwt": 270.72,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 270.72,
      "mw_monoisotopic": 270.056,
      "psa": 41.46,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1ccc2NC(=O)CN=C(c3ccccc3)c2c1",
      "standard_inchi": "InChI=1S/C15H11ClN2O/c16-11-6-7-13-12(8-11)15(17-9-14(19)18-13)10-4-2-1-3-5-10/h1-8H,9H2,(H,18,19)",
      "standard_inchi_key": "AKPLHCDWDRPJGD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nordazepam (INN, MI)",
        null
      ]
    },
    "usan_stem": "-azepam",
    "usan_stem_definition": "antianxiety agents (diazepam type)",
    "usan_stem_substem": "-azepam(-azepam)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05BA17",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL13291",
    "molecule_properties": {
      "acd_logd": 2.62,
      "acd_logp": 2.62,
      "acd_most_bpka": 1.89,
      "alogp": 3.29,
      "aromatic_rings": 2,
      "full_molformula": "C16H12ClFN2O",
      "full_mwt": 302.74,
      "hba": 2,
      "hba_lipinski": 3,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 302.74,
      "mw_monoisotopic": 302.0622,
      "psa": 32.67,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)CN=C(c2ccccc2F)c3cc(Cl)ccc13",
      "standard_inchi": "InChI=1S/C16H12ClFN2O/c1-20-14-7-6-10(17)8-12(14)16(19-9-15(20)21)11-4-2-3-5-13(11)18/h2-8H,9H2,1H3",
      "standard_inchi_key": "ROYOYTLGDLIGBX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fludiazepam (INN, JAN, MI)",
        null
      ]
    },
    "usan_stem": "-azepam",
    "usan_stem_definition": "antianxiety agents (diazepam type)",
    "usan_stem_substem": "-azepam(-azepam)"
  },
  {
    "applicants": {
      "value": "Glaxosmithkline"
    },
    "atc_classification": {
      "drug": {
        "code": "C01CA10",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents"
      }
    },
    "availability_type": 0,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "molecule_chembl_id": "CHEMBL524",
    "molecule_properties": {
      "acd_logd": -1.1,
      "acd_logp": 0.61,
      "acd_most_apka": 11.87,
      "acd_most_bpka": 8.29,
      "alogp": 1.08,
      "aromatic_rings": 1,
      "full_molformula": "C11H17NO3",
      "full_mwt": 211.26,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 211.26,
      "mw_monoisotopic": 211.1208,
      "psa": 64.71,
      "qed_weighted": 0.78,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(OC)c(c1)C(O)C(C)N",
      "standard_inchi": "InChI=1S/C11H17NO3/c1-7(12)11(13)9-6-8(14-2)4-5-10(9)15-3/h4-7,11,13H,12H2,1-3H3",
      "standard_inchi_key": "WJAJPNHVVFWKKL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Methoxamine (BAN, INN)",
        "Methoxamine HCl (FDA, JAN, USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Teva Parenteral Medicines Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Watson Laboratories Inc",
        "Hospira Inc",
        "Sagent Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N01AX10",
        "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Other general anesthetics"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1989,
    "indication_class": "Anesthetic (intravenous)",
    "molecule_chembl_id": "CHEMBL526",
    "molecule_properties": {
      "acd_logd": 3.66,
      "acd_logp": 3.66,
      "acd_most_apka": 11,
      "alogp": 3.64,
      "aromatic_rings": 1,
      "full_molformula": "C12H18O",
      "full_mwt": 178.27,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 13,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 178.27,
      "mw_monoisotopic": 178.1358,
      "psa": 20.23,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)c1cccc(C(C)C)c1O",
      "standard_inchi": "InChI=1S/C12H18O/c1-8(2)10-6-5-7-11(9(3)4)12(10)13/h5-9,13H,1-4H3",
      "standard_inchi_key": "OLBCVFGFOZPWHH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8476010,
    "parenteral": true,
    "research_codes": {
      "value": "ICI-35868"
    },
    "rule_of_five": true,
    "sc_patent": "US-8476010-B2",
    "synonyms": {
      "value": [
        "Propofol (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-fo-",
    "usan_stem_definition": "phosphoro-derivatives",
    "usan_stem_substem": "-fo-(-fo-)",
    "usan_year": 1984
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Hikma Pharmaceuticals Llc",
        "Sun Pharmaceutical Industries Inc",
        "Scs Pharmaceuticals",
        "Egis Pharmaceuticals",
        "Watson Laboratories Inc",
        "Pfizer Laboratories Div Pfizer Inc",
        "Flamingo Pharmaceuticals Ltd",
        "Mylan Ireland Ltd",
        "Pharmaceutics International Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "M01AC01",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Oxicam"
        },
        {
          "code": "S01BC06",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroid"
        },
        {
          "code": "M02AA07",
          "description": "MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Anti-Inflammatory,Anti-Inflammatory; Analgesic",
    "molecule_chembl_id": "CHEMBL527",
    "molecule_properties": {
      "acd_logd": -2.27,
      "acd_logp": 0.59,
      "acd_most_apka": 4.5,
      "acd_most_bpka": 3.54,
      "alogp": 1.58,
      "aromatic_rings": 2,
      "full_molformula": "C15H13N3O4S",
      "full_mwt": 331.35,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 331.35,
      "mw_monoisotopic": 331.0627,
      "psa": 99.6,
      "qed_weighted": 0.87,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ccccn3",
      "standard_inchi": "InChI=1S/C15H13N3O4S/c1-18-13(15(20)17-12-8-4-5-9-16-12)14(19)10-6-2-3-7-11(10)23(18,21)22/h2-9,19H,1H3,(H,16,17,20)",
      "standard_inchi_key": "QYSPLQLAKJAUJT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "CP-16171",
        "CP-16171-85"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Piroxicam Olamine (USAN)",
        "Piroxicam (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-icam",
    "usan_stem_definition": "anti-inflammatory agents (isoxicam type)",
    "usan_stem_substem": "-icam(-icam)",
    "usan_year": 1974
  },
  {
    "applicants": {
      "value": "Astellas Pharma Us Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "J01DD07",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Third-generation cephalosporins"
      }
    },
    "availability_type": 0,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1983,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL528",
    "molecule_properties": {
      "acd_logd": -4.35,
      "acd_logp": -0.65,
      "acd_most_apka": 2.99,
      "acd_most_bpka": 1.7,
      "alogp": -0.56,
      "aromatic_rings": 1,
      "full_molformula": "C13H13N5O5S2",
      "full_mwt": 383.41,
      "hba": 9,
      "hba_lipinski": 10,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 383.41,
      "mw_monoisotopic": 383.0358,
      "psa": 147.21,
      "qed_weighted": 0.35,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CO\\N=C(/C(=O)N[C@H]1[C@H]2SCC=C(N2C1=O)C(=O)O)\\c3csc(N)n3",
      "standard_inchi": "InChI=1S/C13H13N5O5S2/c1-23-17-7(5-4-25-13(14)15-5)9(19)16-8-10(20)18-6(12(21)22)2-3-24-11(8)18/h2,4,8,11H,3H2,1H3,(H2,14,15)(H,16,19)(H,21,22)/b17-7-/t8-,11-/m1/s1",
      "standard_inchi_key": "NNULBSISHYWZJU-LLKWHZGFSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "SK&F-88373-Z",
        "SK&F-88373Z",
        "FK-749",
        "FR-13749"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ceftizoxime (BAN, INN)",
        "Ceftizoxime Sodium (FDA, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "cef-",
    "usan_stem_definition": "cephalosporins",
    "usan_stem_substem": "cef-(cef-)",
    "usan_year": 1980
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL13324",
    "molecule_properties": {
      "acd_logd": -1.76,
      "acd_logp": 1.39,
      "acd_most_apka": -2.03,
      "acd_most_bpka": 2.78,
      "alogp": 1.58,
      "aromatic_rings": 3,
      "full_molformula": "C11H7N3O2",
      "full_mwt": 213.2,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "ACID",
      "mw_freebase": 213.2,
      "mw_monoisotopic": 213.0538,
      "psa": 67.49,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)c1cn2c(cnc3ccccc23)n1",
      "standard_inchi": "InChI=1S/C11H7N3O2/c15-11(16)8-6-14-9-4-2-1-3-7(9)12-5-10(14)13-8/h1-6H,(H,15,16)",
      "standard_inchi_key": "JVKYTWZLUFMIKS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dazoquinast (INN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics (not acting primarily as antihistamines,leukotriene biosynthesis inhibitors)",
    "usan_stem_substem": "-ast(-ast)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL275459",
    "molecule_properties": {
      "acd_logd": -1.73,
      "acd_logp": 0.14,
      "acd_most_apka": -4.66,
      "acd_most_bpka": 7.94,
      "alogp": 2.17,
      "aromatic_rings": 1,
      "full_molformula": "C12H16N2OS2",
      "full_mwt": 268.41,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "heavy_atoms": 17,
      "molecular_species": "ACID",
      "mw_freebase": 268.41,
      "mw_monoisotopic": 268.0704,
      "psa": 42.32,
      "qed_weighted": 0.51,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C\\N=C(\\S)/[C@@]1(CCCC[S+]1[O-])c2cccnc2",
      "standard_inchi": "InChI=1S/C12H16N2OS2/c1-13-11(16)12(6-2-3-8-17(12)15)10-5-4-7-14-9-10/h4-5,7,9H,2-3,6,8H2,1H3,(H,13,16)/t12-,17-/m1/s1",
      "standard_inchi_key": "GKEMHVLBZNVZOI-SJKOYZFVSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Aprikalim (INN)",
        null
      ]
    },
    "usan_stem": "-kalim",
    "usan_stem_definition": "potassium channel agonists",
    "usan_stem_substem": "-kalim(-kalim)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Anti-Asthmatic; Antihypertensive",
    "molecule_chembl_id": "CHEMBL100",
    "molecule_properties": {
      "acd_logd": 2.12,
      "acd_logp": 2.12,
      "acd_most_apka": 13.18,
      "alogp": 1.75,
      "aromatic_rings": 1,
      "full_molformula": "C16H18N2O3",
      "full_mwt": 286.33,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 286.33,
      "mw_monoisotopic": 286.1317,
      "psa": 73.56,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)Oc2ccc(cc2[C@H]([C@@H]1O)N3CCCC3=O)C#N",
      "standard_inchi": "InChI=1S/C16H18N2O3/c1-16(2)15(20)14(18-7-3-4-13(18)19)11-8-10(9-17)5-6-12(11)21-16/h5-6,8,14-15,20H,3-4,7H2,1-2H3/t14-,15+/m1/s1",
      "standard_inchi_key": "TVZCRIROJQEVOT-CABCVRRESA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BRL-38227"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Levcromakalim (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-kalim",
    "usan_stem_definition": "potassium channel agonists",
    "usan_stem_substem": "-kalim(-kalim)",
    "usan_year": 1993
  },
  {
    "applicants": {
      "value": [
        "Sun Pharmaceutical Industries Inc",
        "Sanofi Aventis Us Llc",
        "Sandoz Inc",
        "Novartis Pharmaceuticals Corp",
        "Watson Laboratories Inc",
        "Ivax Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "M02AA01",
          "description": "MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical us"
        },
        {
          "code": "M01AA01",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Butylpyrazolidines"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1980,
    "indication_class": "Antirheumatic",
    "molecule_chembl_id": "CHEMBL101",
    "molecule_properties": {
      "acd_logd": 1.07,
      "acd_logp": 3.38,
      "acd_most_apka": 4.64,
      "alogp": 3.79,
      "aromatic_rings": 2,
      "full_molformula": "C19H20N2O2",
      "full_mwt": 308.38,
      "hba": 2,
      "hba_lipinski": 4,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 308.38,
      "mw_monoisotopic": 308.1525,
      "psa": 40.62,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3",
      "standard_inchi": "InChI=1S/C19H20N2O2/c1-2-3-14-17-18(22)20(15-10-6-4-7-11-15)21(19(17)23)16-12-8-5-9-13-16/h4-13,17H,2-3,14H2,1H3",
      "standard_inchi_key": "VYMDGNCVAMGZFE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Phenylbutazone (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "usan_stem": "-butazone",
    "usan_stem_definition": "anti-inflammatory analgesics (phenylbutazone type)",
    "usan_stem_substem": "-butazone(-butazone)",
    "withdrawn_class": "Hematological toxicity; Misuse",
    "withdrawn_country": "Germany",
    "withdrawn_reason": "Off-Label Abuse; Hematologic Toxicity",
    "withdrawn_year": 1985
  },
  {
    "atc_classification": {
      "drug": {
        "code": "M01AX13",
        "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Other antiinflammatory and antirheumatic agents, non-steroids"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL268501",
    "molecule_properties": {
      "acd_logd": 3.16,
      "acd_logp": 3.16,
      "acd_most_bpka": 0.74,
      "alogp": 3.95,
      "aromatic_rings": 3,
      "full_molformula": "C18H18N2O",
      "full_mwt": 278.36,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 278.36,
      "mw_monoisotopic": 278.1419,
      "psa": 34.89,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)N1C(=O)N=C(c2ccccc2)c3ccc(C)cc13",
      "standard_inchi": "InChI=1S/C18H18N2O/c1-12(2)20-16-11-13(3)9-10-15(16)17(19-18(20)21)14-7-5-4-6-8-14/h4-12H,1-3H3",
      "standard_inchi_key": "JTIGKVIOEQASGT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "43-715"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Proquazone (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1971
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Teva Parenteral Medicines Inc",
        "Hospira Inc",
        "Pliva Inc",
        "Aurobindo Pharma Ltd",
        "Teva Pharmaceuticals Usa",
        "Lupin Ltd",
        "Pfizer Inc",
        "Pfizer Central Research",
        "Teva Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "J01FA10",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS: Macrolide"
        },
        {
          "code": "S01AA26",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotics"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1991,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL529",
    "molecule_properties": {
      "acd_logd": 0.66,
      "acd_logp": 2.58,
      "acd_most_apka": 13.28,
      "acd_most_bpka": 8.59,
      "alogp": 1.9,
      "full_molformula": "C38H72N2O12",
      "full_mwt": 749,
      "hba": 14,
      "hba_lipinski": 14,
      "hbd": 5,
      "hbd_lipinski": 5,
      "heavy_atoms": 52,
      "molecular_species": "BASE",
      "mw_freebase": 749,
      "mw_monoisotopic": 748.5085,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 180.08,
      "qed_weighted": 0.24,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O",
      "standard_inchi": "InChI=1S/C38H72N2O12/c1-15-27-38(10,46)31(42)24(6)40(13)19-20(2)17-36(8,45)33(52-35-29(41)26(39(11)12)16-21(3)48-35)22(4)30(23(5)34(44)50-27)51-28-18-37(9,47-14)32(43)25(7)49-28/h20-33,35,41-43,45-46H,15-19H2,1-14H3/t20-,21-,22+,23-,24-,25+,26+,27-,28+,29-,30+,31-,32+,33-,35+,36-,37-,38-/m1/s1",
      "standard_inchi_key": "MQTOSJVFKKJCRP-BICOPXKESA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6068859,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "XZ-450",
        "CP-62993"
      ]
    },
    "sc_patent": "US-6068859-A",
    "synonyms": {
      "value": [
        "Azithromycin (BAN, FDA, INN, USAN, USP)",
        "Azithromycin Dihydrate (FDA)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-mycin",
    "usan_stem_definition": "antibiotics (Streptomyces strains)",
    "usan_stem_substem": "-mycin(-mycin)",
    "usan_year": 1987
  },
  {
    "applicants": {
      "value": "Hoffmann La Roche Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "J01CA11",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum"
      }
    },
    "availability_type": 0,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1984,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL530",
    "molecule_properties": {
      "acd_logd": -0.2,
      "acd_logp": 2.33,
      "acd_most_bpka": 9.04,
      "alogp": 1.41,
      "full_molformula": "C15H23N3O3S",
      "full_mwt": 325.43,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 325.43,
      "mw_monoisotopic": 325.146,
      "psa": 73.21,
      "qed_weighted": 0.48,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)S[C@@H]2[C@H](\\N=C\\N3CCCCCC3)C(=O)N2[C@H]1C(=O)O",
      "standard_inchi": "InChI=1S/C15H23N3O3S/c1-15(2)11(14(20)21)18-12(19)10(13(18)22-15)16-9-17-7-5-3-4-6-8-17/h9-11,13H,3-8H2,1-2H3,(H,20,21)/b16-9+/t10-,11+,13-/m1/s1",
      "standard_inchi_key": "BWWVAEOLVKTZFQ-ISVUSNJMSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "Ro-109070"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Amdinocillin (FDA, USAN, USP)",
        "Mecillinam (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-cillin",
    "usan_stem_definition": "penicillins",
    "usan_stem_substem": "-cillin(-cillin)",
    "usan_year": 1981
  },
  {
    "applicants": {
      "value": [
        "Par Pharmaceutical",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa",
        "Valeant Pharmaceuticals International"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N04BC02",
        "description": "NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Dopamine agonists"
      }
    },
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1988,
    "indication_class": "Dopamine Agonist",
    "molecule_chembl_id": "CHEMBL531",
    "molecule_properties": {
      "acd_logd": 2.5,
      "acd_logp": 3.9,
      "acd_most_bpka": 7.98,
      "alogp": 4.27,
      "aromatic_rings": 2,
      "full_molformula": "C19H26N2S",
      "full_mwt": 314.5,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 314.5,
      "mw_monoisotopic": 314.1817,
      "psa": 19.03,
      "qed_weighted": 0.91,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34",
      "standard_inchi": "InChI=1S/C19H26N2S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3/t13-,16-,18-/m1/s1",
      "standard_inchi_key": "YEHCICAEULNIGD-MZMPZRCHSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "LY-127809"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pergolide Mesylate (FDA, USAN, USP)",
        "Pergolide (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-erg-",
    "usan_stem_definition": "ergot alkaloid derivatives",
    "usan_stem_substem": "-erg-(-erg-)",
    "usan_year": 1979,
    "withdrawn_class": "Cardiotoxicity",
    "withdrawn_country": "United States",
    "withdrawn_reason": "Risk for heart valve damage",
    "withdrawn_year": 2007
  },
  {
    "applicants": {
      "value": [
        "Syosset Laboratories Inc",
        "Teva Parenteral Medicines Inc",
        "Arbor Pharmaceuticals Llc",
        "Pharmafair Inc",
        "Eli Lilly And Co",
        "Dow Pharmaceutical Sciences",
        "Lyne Laboratories Inc",
        "Hospira Inc",
        "Bristol Myers Squibb Co",
        "Perrigo Co Of Tenessee Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "J01FA01",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS: Macrolide"
        },
        {
          "code": "S01AA17",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotic"
        },
        {
          "code": "D10AF02",
          "description": "DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Antiinfectives for treatment of acn"
        },
        {
          "code": "D10AF52",
          "description": "DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Antiinfectives for treatment of acne"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1964,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL532",
    "molecule_properties": {
      "acd_logd": 1.16,
      "acd_logp": 1.91,
      "acd_most_apka": 13.09,
      "acd_most_bpka": 8.16,
      "alogp": 1.79,
      "full_molformula": "C37H67NO13",
      "full_mwt": 733.94,
      "hba": 14,
      "hba_lipinski": 14,
      "hbd": 5,
      "hbd_lipinski": 5,
      "heavy_atoms": 51,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 733.94,
      "mw_monoisotopic": 733.4612,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 193.91,
      "qed_weighted": 0.24,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O",
      "standard_inchi": "InChI=1S/C37H67NO13/c1-14-25-37(10,45)30(41)20(4)27(39)18(2)16-35(8,44)32(51-34-28(40)24(38(11)12)15-19(3)47-34)21(5)29(22(6)33(43)49-25)50-26-17-36(9,46-13)31(42)23(7)48-26/h18-26,28-32,34,40-42,44-45H,14-17H2,1-13H3/t18-,19-,20+,21+,22-,23+,24+,25-,26+,28-,29+,30-,31+,32-,34+,35-,36-,37-/m1/s1",
      "standard_inchi_key": "ULGZDMOVFRHVEP-RWJQBGPGSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "synonyms": {
      "value": [
        "Erythromycin Lactobionate (BAN, FDA, JAN, USP)",
        "Erythromycin (BAN, FDA, INN, JAN, USP)",
        "Erythromycin gluceptate (FDA, USP)",
        "Erythromycin Stearate (BAN, FDA, JAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-mycin",
    "usan_stem_definition": "antibiotics (Streptomyces strains)",
    "usan_stem_substem": "-mycin(-mycin)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL269446",
    "molecule_properties": {
      "acd_logd": 1.21,
      "acd_logp": 3.45,
      "acd_most_apka": 8.54,
      "acd_most_bpka": 9.72,
      "alogp": 4.5,
      "aromatic_rings": 1,
      "full_molformula": "C21H37FN2O3S",
      "full_mwt": 416.6,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 28,
      "molecular_species": "BASE",
      "mw_freebase": 416.6,
      "mw_monoisotopic": 416.2509,
      "psa": 69.64,
      "qed_weighted": 0.44,
      "ro3_pass": "N",
      "rtb": 14
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CCCCCC(C)(C)F)CCC[C@H](O)c1ccc(NS(=O)(=O)C)cc1",
      "standard_inchi": "InChI=1S/C21H37FN2O3S/c1-5-24(16-8-6-7-15-21(2,3)22)17-9-10-20(25)18-11-13-19(14-12-18)23-28(4,26)27/h11-14,20,23,25H,5-10,15-17H2,1-4H3/t20-/m0/s1",
      "standard_inchi_key": "RPQUKWBLAHJOPX-FQEVSTJZSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "U-108342E"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Trecetilide (INN)",
        "Trecetilide fumarate (USAN)",
        null
      ]
    },
    "usan_stem": "-ilide",
    "usan_stem_definition": "class III antiarrhythmic agents",
    "usan_stem_substem": "-ilide(-ilide)",
    "usan_year": 1997
  },
  {
    "applicants": {
      "value": [
        "Pharmacia And Upjohn Co",
        "Mylan Institutional Llc",
        "Luitpold Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C01BD05",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1995,
    "indication_class": "Cardiac Depressant (anti-arrhythmic)",
    "molecule_chembl_id": "CHEMBL533",
    "molecule_properties": {
      "acd_logd": 1.3,
      "acd_logp": 3.72,
      "acd_most_apka": 8.54,
      "acd_most_bpka": 9.95,
      "alogp": 4.16,
      "aromatic_rings": 1,
      "full_molformula": "C20H36N2O3S",
      "full_mwt": 384.59,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "BASE",
      "mw_freebase": 384.59,
      "mw_monoisotopic": 384.2447,
      "psa": 69.64,
      "qed_weighted": 0.47,
      "ro3_pass": "N",
      "rtb": 14
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCN(CC)CCCC(O)c1ccc(NS(=O)(=O)C)cc1",
      "standard_inchi": "InChI=1S/C20H36N2O3S/c1-4-6-7-8-9-16-22(5-2)17-10-11-20(23)18-12-14-19(15-13-18)21-26(3,24)25/h12-15,20-21,23H,4-11,16-17H2,1-3H3",
      "standard_inchi_key": "ALOBUEHUHMBRLE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "U-70226E"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ibutilide (BAN, INN)",
        "Ibutilide Fumarate (FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-ilide",
    "usan_stem_definition": "class III antiarrhythmic agents",
    "usan_stem_substem": "-ilide(-ilide)",
    "usan_year": 1990
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Fresenius Kabi Usa Llc",
        "Sofgen Pharmaceuticals Llc",
        "Amneal Pharmaceuticals Of Ny Llc",
        "Ferring Pharmaceuticals Inc",
        "Eli Lilly And Co",
        "Actavis Laboratories Ut Inc",
        "Sandoz Inc",
        "Allergan Sales Llc",
        "Luitpold Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "G03DA04",
        "description": "GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: PROGESTOGENS: Pregnen (4) derivatives"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1976,
    "indication_class": "Progestin",
    "molecule_chembl_id": "CHEMBL103",
    "molecule_properties": {
      "acd_logd": 3.83,
      "acd_logp": 3.83,
      "alogp": 4.72,
      "full_molformula": "C21H30O2",
      "full_mwt": 314.47,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 23,
      "mw_freebase": 314.47,
      "mw_monoisotopic": 314.2246,
      "psa": 34.14,
      "qed_weighted": 0.7,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)[C@H]1CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C",
      "standard_inchi": "InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1",
      "standard_inchi_key": "RJKFOVLPORLFTN-LEKSSAKUSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7300664,
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-7300664-B1",
    "synonyms": {
      "value": [
        "Progesterone (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-gest-",
    "usan_stem_definition": "progestins",
    "usan_stem_substem": "-gest-(-gest-)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "R01AA12",
        "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, plain"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL14012",
    "molecule_properties": {
      "acd_logd": 1.58,
      "acd_logp": 3.45,
      "acd_most_bpka": 9.84,
      "alogp": 2.19,
      "aromatic_rings": 1,
      "full_molformula": "C13H18N2O",
      "full_mwt": 218.3,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "BASE",
      "mw_freebase": 218.3,
      "mw_monoisotopic": 218.1419,
      "psa": 33.62,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)c1ccccc1OCC2=NCCN2",
      "standard_inchi": "InChI=1S/C13H18N2O/c1-10(2)11-5-3-4-6-12(11)16-9-13-14-7-8-15-13/h3-6,10H,7-9H2,1-2H3,(H,14,15)",
      "standard_inchi_key": "GFYSWQDCHLWRMQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fenoxazoline (INN)",
        "Fenoxazoline HCl (MI)",
        null
      ]
    },
    "usan_stem": "-azoline",
    "usan_stem_definition": "antihistamines/local vasoconstrictors (antazoline type)",
    "usan_stem_substem": "-azoline(-azoline)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Growth Hormone Releasing Factor",
    "molecule_chembl_id": "CHEMBL13817",
    "molecule_properties": {
      "acd_logd": 2.42,
      "acd_logp": 2.84,
      "acd_most_bpka": 8.23,
      "alogp": 1.77,
      "aromatic_rings": 2,
      "full_molformula": "C27H36N4O5S",
      "full_mwt": 528.68,
      "hba": 6,
      "hba_lipinski": 9,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 37,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 528.68,
      "mw_monoisotopic": 528.2406,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 122.04,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(N)C(=O)N[C@H](COCc1ccccc1)C(=O)N2CCC3(CC2)CN(c4ccccc34)S(=O)(=O)C",
      "standard_inchi": "InChI=1S/C27H36N4O5S/c1-26(2,28)25(33)29-22(18-36-17-20-9-5-4-6-10-20)24(32)30-15-13-27(14-16-30)19-31(37(3,34)35)23-12-8-7-11-21(23)27/h4-12,22H,13-19,28H2,1-3H3,(H,29,33)/t22-/m1/s1",
      "standard_inchi_key": "UMUPQWIGCOZEOY-JOCHJYFZSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "MK-677",
        "MK-0677"
      ]
    },
    "synonyms": {
      "value": [
        "Ibutamoren (INN)",
        "Ibutamoren Mesylate (USAN)",
        null
      ]
    },
    "usan_stem": "-moren",
    "usan_stem_definition": "non-peptidic growth hormone secretagogues",
    "usan_stem_substem": "-moren(-moren)",
    "usan_year": 1997
  },
  {
    "atc_classification": {
      "drug": {
        "code": "R06AE06",
        "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Piperazine derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Anti-Allergic; Anti-Asthmatic",
    "molecule_chembl_id": "CHEMBL13828",
    "molecule_properties": {
      "acd_logd": 4.06,
      "acd_logp": 4.34,
      "acd_most_apka": 12.2,
      "acd_most_bpka": 7.5,
      "alogp": 4.13,
      "aromatic_rings": 4,
      "full_molformula": "C27H30N4O",
      "full_mwt": 426.56,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 32,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 426.56,
      "mw_monoisotopic": 426.242,
      "psa": 44.27,
      "qed_weighted": 0.48,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1Nc2ccccc2N1CCCN3CCN(CC3)C(c4ccccc4)c5ccccc5",
      "standard_inchi": "InChI=1S/C27H30N4O/c32-27-28-24-14-7-8-15-25(24)31(27)17-9-16-29-18-20-30(21-19-29)26(22-10-3-1-4-11-22)23-12-5-2-6-13-23/h1-8,10-15,26H,9,16-21H2,(H,28,32)",
      "standard_inchi_key": "BAINIUMDFURPJM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "R-35443"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Oxatomide (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_year": 1977
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL276711",
    "molecule_properties": {
      "acd_logd": 3.09,
      "acd_logp": 3.09,
      "acd_most_apka": 13.18,
      "acd_most_bpka": 1.53,
      "alogp": 3.12,
      "aromatic_rings": 2,
      "full_molformula": "C15H14N2O",
      "full_mwt": 238.29,
      "hba": 1,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 238.29,
      "mw_monoisotopic": 238.1106,
      "psa": 44.89,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cc(C)c(\\C=C\\2/C(=O)Nc3ccccc23)[nH]1",
      "standard_inchi": "InChI=1S/C15H14N2O/c1-9-7-10(2)16-14(9)8-12-11-5-3-4-6-13(11)17-15(12)18/h3-8,16H,1-2H3,(H,17,18)/b12-8-",
      "standard_inchi_key": "WUWDLXZGHZSWQZ-WQLSENKSSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SU-5416"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Semaxanib (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-anib",
    "usan_stem_definition": "angiogenesis inhibitors",
    "usan_stem_substem": "-anib(-anib)",
    "usan_year": 2000
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL274654",
    "molecule_properties": {
      "acd_logd": -0.66,
      "acd_logp": 1.95,
      "acd_most_apka": 4.62,
      "acd_most_bpka": 2.37,
      "alogp": 3.14,
      "aromatic_rings": 2,
      "full_molformula": "C18H18N2O3",
      "full_mwt": 310.35,
      "hba": 2,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 310.35,
      "mw_monoisotopic": 310.1317,
      "psa": 82.19,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1[nH]c(\\C=C\\2/C(=O)Nc3ccccc23)c(C)c1CCC(=O)O",
      "standard_inchi": "InChI=1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)/b14-9-",
      "standard_inchi_key": "NHFDRBXTEDBWCZ-ZROIWOOFSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "TSU-68",
        "SU-6668"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Orantinib (INN)",
        null
      ]
    },
    "usan_stem": "-tinib",
    "usan_stem_definition": "tyrosine kinase inhibitors",
    "usan_stem_substem": "-tinib(-tinib)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL13608",
    "molecule_properties": {
      "acd_logd": -0.02,
      "acd_logp": 1.8,
      "acd_most_apka": 11.7,
      "acd_most_bpka": 9.09,
      "alogp": 3.09,
      "aromatic_rings": 2,
      "full_molformula": "C22H25FN4O2",
      "full_mwt": 396.47,
      "hba": 3,
      "hba_lipinski": 6,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 29,
      "molecular_species": "BASE",
      "mw_freebase": 396.47,
      "mw_monoisotopic": 396.1962,
      "psa": 77.23,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1[nH]c(\\C=C\\2/C(=O)Nc3ccc(F)cc23)c(C)c1C(=O)NCCN4CCCC4",
      "standard_inchi": "InChI=1S/C22H25FN4O2/c1-13-19(12-17-16-11-15(23)5-6-18(16)26-21(17)28)25-14(2)20(13)22(29)24-7-10-27-8-3-4-9-27/h5-6,11-12,25H,3-4,7-10H2,1-2H3,(H,24,29)(H,26,28)/b17-12-",
      "standard_inchi_key": "SRSGVKWWVXWSJT-ATVHPVEESA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "PHA-291639E",
        "PHA-291639"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Toceranib (INN, USAN)",
        "Toceranib Phosphate (USAN)",
        null
      ]
    },
    "usan_stem": "-anib",
    "usan_stem_definition": "angiogenesis inhibitors",
    "usan_stem_substem": "-anib(-anib)",
    "usan_year": 2008
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Alcon Research Ltd",
        "Apotex Inc",
        "Alcon Pharmaceuticals Ltd",
        "Bausch And Lomb Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R06AX17",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic us"
        },
        {
          "code": "S01GX08",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergics"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1999,
    "indication_class": "Anti-Asthmatic",
    "molecule_chembl_id": "CHEMBL534",
    "molecule_properties": {
      "acd_logd": 0.74,
      "acd_logp": 2.19,
      "acd_most_bpka": 8.84,
      "alogp": 4.01,
      "aromatic_rings": 2,
      "full_molformula": "C19H19NOS",
      "full_mwt": 309.43,
      "hba": 3,
      "hba_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 309.43,
      "mw_monoisotopic": 309.1187,
      "psa": 20.31,
      "qed_weighted": 0.73,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCC(=C2c3ccccc3CC(=O)c4sccc24)CC1",
      "standard_inchi": "InChI=1S/C19H19NOS/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19/h2-5,8,11H,6-7,9-10,12H2,1H3",
      "standard_inchi_key": "ZCVMWBYGMWKGHF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "HC-20511 fumarate",
        "HC-20511"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ketotifen (BAN, INN)",
        "Ketotifen fumarate (FDA, JAN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1979
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL13852",
    "molecule_properties": {
      "acd_logd": 0.83,
      "acd_logp": 2.7,
      "acd_most_bpka": 9.84,
      "alogp": 1.94,
      "aromatic_rings": 1,
      "full_molformula": "C13H16N2O",
      "full_mwt": 216.28,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "BASE",
      "mw_freebase": 216.28,
      "mw_monoisotopic": 216.1263,
      "psa": 33.62,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "C(Oc1ccccc1C2CC2)C3=NCCN3",
      "standard_inchi": "InChI=1S/C13H16N2O/c1-2-4-12(11(3-1)10-5-6-10)16-9-13-14-7-8-15-13/h1-4,10H,5-9H2,(H,14,15)",
      "standard_inchi_key": "YAORIDZYZDUZCM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cirazoline (INN)",
        null
      ]
    },
    "usan_stem": "-azoline",
    "usan_stem_definition": "antihistamines/local vasoconstrictors (antazoline type)",
    "usan_stem_substem": "-azoline(-azoline)"
  },
  {
    "applicants": {
      "value": [
        "Cp Pharmaceuticals International Cv",
        "Mylan Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01XE04",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2006,
    "molecule_chembl_id": "CHEMBL535",
    "molecule_properties": {
      "acd_logd": 0.44,
      "acd_logp": 2.27,
      "acd_most_apka": 11.7,
      "acd_most_bpka": 9.09,
      "alogp": 3.33,
      "aromatic_rings": 2,
      "full_molformula": "C22H27FN4O2",
      "full_mwt": 398.48,
      "hba": 3,
      "hba_lipinski": 6,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 29,
      "molecular_species": "BASE",
      "mw_freebase": 398.48,
      "mw_monoisotopic": 398.2118,
      "psa": 77.23,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCNC(=O)c1c(C)[nH]c(\\C=C\\2/C(=O)Nc3ccc(F)cc23)c1C",
      "standard_inchi": "InChI=1S/C22H27FN4O2/c1-5-27(6-2)10-9-24-22(29)20-13(3)19(25-14(20)4)12-17-16-11-15(23)7-8-18(16)26-21(17)28/h7-8,11-12,25H,5-6,9-10H2,1-4H3,(H,24,29)(H,26,28)/b17-12-",
      "standard_inchi_key": "WINHZLLDWRZWRT-ATVHPVEESA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6573293,
    "oral": true,
    "research_codes": {
      "value": "SU-11248"
    },
    "rule_of_five": true,
    "sc_patent": "US-6573293-B2",
    "synonyms": {
      "value": [
        "Sunitinib (INN)",
        "Sunitinib Malate (FDA)",
        null
      ]
    },
    "usan_stem": "-tinib",
    "usan_stem_definition": "tyrosine kinase inhibitors",
    "usan_stem_substem": "-tinib(-tinib)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Analgesic; Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL13878",
    "molecule_properties": {
      "acd_logd": 5.2,
      "acd_logp": 5.21,
      "acd_most_apka": 8.83,
      "alogp": 4.97,
      "aromatic_rings": 1,
      "full_molformula": "C20H28O2",
      "full_mwt": 300.44,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 300.44,
      "mw_monoisotopic": 300.2089,
      "psa": 37.3,
      "qed_weighted": 0.48,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)c1cc(cc(c1O)C(C)(C)C)C(=O)CCCC#C",
      "standard_inchi": "InChI=1S/C20H28O2/c1-8-9-10-11-17(21)14-12-15(19(2,3)4)18(22)16(13-14)20(5,6)7/h1,12-13,22H,9-11H2,2-7H3",
      "standard_inchi_key": "ZHXUEUKVDMWSKV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "NE-11740"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tebufelone (INN, USAN)",
        null
      ]
    },
    "usan_year": 1990
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL13881",
    "molecule_properties": {
      "acd_logd": -0.65,
      "acd_logp": 1.28,
      "acd_most_bpka": 9.98,
      "alogp": 1.1,
      "aromatic_rings": 1,
      "full_molformula": "C10H13N3",
      "full_mwt": 175.24,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 13,
      "molecular_species": "BASE",
      "mw_freebase": 175.24,
      "mw_monoisotopic": 175.1109,
      "psa": 36.42,
      "qed_weighted": 0.72,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "C(Nc1ccccc1)C2=NCCN2",
      "standard_inchi": "InChI=1S/C10H13N3/c1-2-4-9(5-3-1)13-8-10-11-6-7-12-10/h1-5,13H,6-8H2,(H,11,12)",
      "standard_inchi_key": "FPZTYKLEJPXTKD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Phenamazoline (INN)",
        null
      ]
    },
    "usan_stem": "-azoline",
    "usan_stem_definition": "antihistamines/local vasoconstrictors (antazoline type)",
    "usan_stem_substem": "-azoline(-azoline)"
  },
  {
    "applicants": {
      "value": "Galderma Laboratories Lp"
    },
    "atc_classification": {
      "drug": {
        "code": "D11AX11",
        "description": "DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatologicals"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2002,
    "indication_class": "Depigmentor",
    "molecule_chembl_id": "CHEMBL537",
    "molecule_properties": {
      "acd_logd": 0.62,
      "acd_logp": 0.62,
      "acd_most_apka": 10.33,
      "alogp": 1.1,
      "aromatic_rings": 1,
      "full_molformula": "C6H6O2",
      "full_mwt": 110.11,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 8,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 110.11,
      "mw_monoisotopic": 110.0368,
      "psa": 40.46,
      "qed_weighted": 0.49,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1ccc(O)cc1",
      "standard_inchi": "InChI=1S/C6H6O2/c7-5-1-2-6(8)4-3-5/h1-4,7-8H",
      "standard_inchi_key": "QIGBRXMKCJKVMJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7915243,
    "rule_of_five": true,
    "sc_patent": "US-7915243-B2",
    "synonyms": {
      "value": [
        "Hydroquinone (FDA, USP)",
        null
      ]
    },
    "topical": true
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL14126",
    "molecule_properties": {
      "acd_logd": 2.72,
      "acd_logp": 2.72,
      "acd_most_apka": 9.57,
      "alogp": 2.55,
      "aromatic_rings": 2,
      "full_molformula": "C10H8O",
      "full_mwt": 144.17,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 11,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 144.17,
      "mw_monoisotopic": 144.0575,
      "psa": 20.23,
      "qed_weighted": 0.6,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1ccc2ccccc2c1",
      "standard_inchi": "InChI=1S/C10H8O/c11-10-6-5-8-3-1-2-4-9(8)7-10/h1-7,11H",
      "standard_inchi_key": "JWAZRIHNYRIHIV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Betanaphthol (NF)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Icu Medical Inc",
        "Pharmafair Inc",
        "Bayer Pharmaceuticals Corp",
        "Warner Chilcott Co Llc",
        "Vintage Pharmaceuticals Llc",
        "Taro Pharmaceuticals Usa Inc",
        "Wockhardt Eu Operations (Swiss) Ag",
        "Hi Tech Pharmacal Co Inc",
        "Kv Pharmaceutical Co",
        "B Braun Medical Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "G01AD02",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Organic acid"
        },
        {
          "code": "S02AA10",
          "description": "SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfectives"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (acidifying agent)",
    "molecule_chembl_id": "CHEMBL539",
    "molecule_properties": {
      "acd_logd": -2.9,
      "acd_logp": -0.32,
      "acd_most_apka": 4.79,
      "alogp": 0.09,
      "full_molformula": "C2H4O2",
      "full_mwt": 60.05,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 4,
      "molecular_species": "ACID",
      "mw_freebase": 60.05,
      "mw_monoisotopic": 60.0211,
      "psa": 37.3,
      "qed_weighted": 0.43,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)O",
      "standard_inchi": "InChI=1S/C2H4O2/c1-2(3)4/h1H3,(H,3,4)",
      "standard_inchi_key": "QTBSBXVTEAMEQO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Acetic Acid (JAN, NF)",
        "Acetic acid, glacial (FDA, JAN)",
        null
      ]
    },
    "topical": true
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (solvent)",
    "molecule_chembl_id": "CHEMBL14152",
    "molecule_properties": {
      "acd_logd": 0.79,
      "acd_logp": 0.79,
      "alogp": 0.57,
      "full_molformula": "C4H8O2",
      "full_mwt": 88.11,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 6,
      "mw_freebase": 88.11,
      "mw_monoisotopic": 88.0524,
      "psa": 26.3,
      "qed_weighted": 0.44,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)C",
      "standard_inchi": "InChI=1S/C4H8O2/c1-3-6-4(2)5/h3H2,1-2H3",
      "standard_inchi_key": "XEKOWRVHYACXOJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ethyl acetate (NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (flavor)",
    "molecule_chembl_id": "CHEMBL13883",
    "molecule_properties": {
      "acd_logd": 1.06,
      "acd_logp": 1.21,
      "acd_most_apka": 7.78,
      "alogp": 1.21,
      "aromatic_rings": 1,
      "full_molformula": "C8H8O3",
      "full_mwt": 152.15,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 11,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 152.15,
      "mw_monoisotopic": 152.0473,
      "psa": 46.53,
      "qed_weighted": 0.65,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(C=O)ccc1O",
      "standard_inchi": "InChI=1S/C8H8O3/c1-11-8-4-6(5-9)2-3-7(8)10/h2-5,10H,1H3",
      "standard_inchi_key": "MWOOGOJBHIARFG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Vanillin (NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (antifungal agent)",
    "molecule_chembl_id": "CHEMBL541",
    "molecule_properties": {
      "acd_logd": -1.31,
      "acd_logp": 1.56,
      "acd_most_apka": 4.2,
      "alogp": 1.38,
      "aromatic_rings": 1,
      "full_molformula": "C7H6O2",
      "full_mwt": 122.12,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 9,
      "molecular_species": "ACID",
      "mw_freebase": 122.12,
      "mw_monoisotopic": 122.0368,
      "psa": 37.3,
      "qed_weighted": 0.61,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)c1ccccc1",
      "standard_inchi": "InChI=1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9)",
      "standard_inchi_key": "WPYMKLBDIGXBTP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Benzoic Acid (JAN, USP)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "D02BA01",
        "description": "DERMATOLOGICALS: EMOLLIENTS AND PROTECTIVES: PROTECTIVES AGAINST UV-RADIATION: Protectives against UV-radiation for topical use"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Analgesic,Ultraviolet Screen",
    "molecule_chembl_id": "CHEMBL542",
    "molecule_properties": {
      "acd_logd": -1.76,
      "acd_logp": 0.68,
      "acd_most_apka": 4.86,
      "acd_most_bpka": 2.51,
      "alogp": 0.97,
      "aromatic_rings": 1,
      "full_molformula": "C7H7NO2",
      "full_mwt": 137.14,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 10,
      "molecular_species": "ACID",
      "mw_freebase": 137.14,
      "mw_monoisotopic": 137.0477,
      "psa": 63.32,
      "qed_weighted": 0.57,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ccc(cc1)C(=O)O",
      "standard_inchi": "InChI=1S/C7H7NO2/c8-6-3-1-5(2-4-6)7(9)10/h1-4H,8H2,(H,9,10)",
      "standard_inchi_key": "ALYNCZNDIQEVRV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Aminobenzoate Sodium (USP)",
        "Aminobenzoate Potassium (USP)",
        "Aminobenzoic Acid (USP)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (solvent)",
    "molecule_chembl_id": "CHEMBL14253",
    "molecule_properties": {
      "acd_logd": -0.04,
      "acd_logp": -0.04,
      "alogp": 0.6,
      "full_molformula": "C3H6O",
      "full_mwt": 58.08,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 4,
      "mw_freebase": 58.08,
      "mw_monoisotopic": 58.0419,
      "psa": 17.07,
      "qed_weighted": 0.4,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)C",
      "standard_inchi": "InChI=1S/C3H6O/c1-3(2)4/h1-2H3",
      "standard_inchi_key": "CSCPPACGZOOCGX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Acetone (NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL13589",
    "molecule_properties": {
      "acd_logd": 1.16,
      "acd_logp": 1.16,
      "acd_most_bpka": 3.79,
      "alogp": 1.2,
      "aromatic_rings": 2,
      "full_molformula": "C9H9N5",
      "full_mwt": 187.21,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 187.21,
      "mw_monoisotopic": 187.0858,
      "psa": 76.72,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ncnc(Nc2ccccc2)n1",
      "standard_inchi": "InChI=1S/C9H9N5/c10-8-11-6-12-9(14-8)13-7-4-2-1-3-5-7/h1-6H,(H3,10,11,12,13,14)",
      "standard_inchi_key": "YMFGJWGABDOFID-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Amanozine (INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL14053",
    "molecule_properties": {
      "acd_logd": -2.02,
      "acd_logp": 1.73,
      "acd_most_apka": 0.09,
      "alogp": 1.44,
      "full_molformula": "C2HCl3O2",
      "full_mwt": 163.39,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 7,
      "molecular_species": "ACID",
      "mw_freebase": 163.39,
      "mw_monoisotopic": 161.9042,
      "psa": 37.3,
      "qed_weighted": 0.55,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)C(Cl)(Cl)Cl",
      "standard_inchi": "InChI=1S/C2HCl3O2/c3-2(4,5)1(6)7/h(H,6,7)",
      "standard_inchi_key": "YNJBWRMUSHSURL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Trichloroacetic Acid (MI, USP)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (solvent)",
    "molecule_chembl_id": "CHEMBL14245",
    "molecule_properties": {
      "acd_logd": 0.84,
      "acd_logp": 0.84,
      "alogp": 0.78,
      "full_molformula": "C4H10O",
      "full_mwt": 74.12,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 5,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 74.12,
      "mw_monoisotopic": 74.0732,
      "psa": 20.23,
      "qed_weighted": 0.51,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCO",
      "standard_inchi": "InChI=1S/C4H10O/c1-2-3-4-5/h5H,2-4H2,1H3",
      "standard_inchi_key": "LRHPLDYGYMQRHN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Butyl alcohol (NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Antimicrobial; Pharmaceutic Aid (acidifying agent)",
    "molecule_chembl_id": "CHEMBL14021",
    "molecule_properties": {
      "acd_logd": -2.39,
      "acd_logp": 0.19,
      "acd_most_apka": 4.79,
      "alogp": 0.48,
      "full_molformula": "C3H6O2",
      "full_mwt": 74.08,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 5,
      "molecular_species": "ACID",
      "mw_freebase": 74.08,
      "mw_monoisotopic": 74.0368,
      "psa": 37.3,
      "qed_weighted": 0.49,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(=O)O",
      "standard_inchi": "InChI=1S/C3H6O2/c1-2-3(4)5/h2H2,1H3,(H,4,5)",
      "standard_inchi_key": "XBDQKXXYIPTUBI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Propionic acid (NF)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "C05BB05",
          "description": "CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: ANTIVARICOSE THERAPY: Sclerosing agents for local injectio"
        },
        {
          "code": "R02AA19",
          "description": "RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Antiseptic"
        },
        {
          "code": "N01BX03",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Other local anesthetic"
        },
        {
          "code": "D08AE03",
          "description": "DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Phenol and derivatives"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Disinfectant,Pharmaceutic Aid (preservative)",
    "molecule_chembl_id": "CHEMBL14060",
    "molecule_properties": {
      "acd_logd": 1.54,
      "acd_logp": 1.54,
      "acd_most_apka": 9.86,
      "alogp": 1.39,
      "aromatic_rings": 1,
      "full_molformula": "C6H6O",
      "full_mwt": 94.11,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 7,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 94.11,
      "mw_monoisotopic": 94.0419,
      "psa": 20.23,
      "qed_weighted": 0.51,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1ccccc1",
      "standard_inchi": "InChI=1S/C6H6O/c7-6-4-2-1-3-5-6/h1-5,7H",
      "standard_inchi_key": "ISWSIDIOOBJBQZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Phenol (JAN, USP)",
        "Phenolate Sodium (USAN)",
        null
      ]
    },
    "usan_year": 1978
  },
  {
    "applicants": {
      "value": "Aqua Pharmaceuticals Llc"
    },
    "atc_classification": {
      "drug": {
        "code": "D11AX06",
        "description": "DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatologicals"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1999,
    "molecule_chembl_id": "CHEMBL544",
    "molecule_properties": {
      "acd_logd": 1.35,
      "acd_logp": 1.35,
      "acd_most_apka": 10.4,
      "alogp": 1.4,
      "aromatic_rings": 1,
      "full_molformula": "C7H8O2",
      "full_mwt": 124.14,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 9,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 124.14,
      "mw_monoisotopic": 124.0524,
      "psa": 29.46,
      "qed_weighted": 0.61,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(O)cc1",
      "standard_inchi": "InChI=1S/C7H8O2/c1-9-7-4-2-6(8)3-5-7/h2-5,8H,1H3",
      "standard_inchi_key": "NWVVVBRKAWDGAB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6353029,
    "research_codes": {
      "value": "BMS-181158"
    },
    "rule_of_five": true,
    "sc_patent": "US-6353029-B1",
    "synonyms": {
      "value": [
        "Mequinol (DCF, FDA, INN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1999
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL13766",
    "molecule_properties": {
      "acd_logd": 1.34,
      "acd_logp": 1.34,
      "acd_most_apka": 9.97,
      "alogp": 1.4,
      "aromatic_rings": 1,
      "full_molformula": "C7H8O2",
      "full_mwt": 124.14,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 9,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 124.14,
      "mw_monoisotopic": 124.0524,
      "psa": 29.46,
      "qed_weighted": 0.61,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccccc1O",
      "standard_inchi": "InChI=1S/C7H8O2/c1-9-7-5-3-2-4-6(7)8/h2-5,8H,1H3",
      "standard_inchi_key": "LHGVFZTZFXWLCP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Guaiacol (JAN, MI, NF)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Bayer Pharmaceuticals Corp",
        "Schering Corp Sub Schering Plough Corp",
        "Schering Plough Healthcare Products Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Paddock Laboratories Llc",
        "Bayer Healthcare Llc",
        "Glenmark Pharmaceuticals Sa",
        "Taro Pharmaceuticals Usa Inc",
        "Bayer Healthcare Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "A01AB18",
          "description": "ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatmen"
        },
        {
          "code": "G01AF02",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Imidazole derivative"
        },
        {
          "code": "D01AC01",
          "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1975,
    "indication_class": "Antifungal",
    "molecule_chembl_id": "CHEMBL104",
    "molecule_properties": {
      "acd_logd": 4.9,
      "acd_logp": 4.92,
      "acd_most_bpka": 6.12,
      "alogp": 5.38,
      "aromatic_rings": 4,
      "full_molformula": "C22H17ClN2",
      "full_mwt": 344.85,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 344.85,
      "mw_monoisotopic": 344.108,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 17.82,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4",
      "standard_inchi": "InChI=1S/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H",
      "standard_inchi_key": "VNFPBHJOKIVQEB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "BAY-5097",
        "GNF-Pf-3499"
      ]
    },
    "synonyms": {
      "value": [
        "Clotrimazole (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1970
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL13779",
    "molecule_properties": {
      "acd_logd": -1.41,
      "acd_logp": -1.41,
      "acd_most_apka": 10.51,
      "acd_most_bpka": 1.98,
      "alogp": -0.2,
      "aromatic_rings": 2,
      "full_molformula": "C11H10N4O4",
      "full_mwt": 262.23,
      "hba": 5,
      "hba_lipinski": 8,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 262.23,
      "mw_monoisotopic": 262.0702,
      "psa": 104.57,
      "qed_weighted": 0.35,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "COC(=O)N\\N=C\\c1c[n+]([O-])c2ccccc2[n+]1[O-]",
      "standard_inchi": "InChI=1S/C11H10N4O4/c1-19-11(16)13-12-6-8-7-14(17)9-4-2-3-5-10(9)15(8)18/h2-7H,1H3,(H,13,16)/b12-6+",
      "standard_inchi_key": "OVGGLBAWFMIPPY-WUXMJOGZSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "GS-6244"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Carbadox (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-adox",
    "usan_stem_definition": "antibacterials (quinoline dioxide derivatives)",
    "usan_stem_substem": "-adox(-adox)",
    "usan_year": 1968
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Bristol Myers Co",
        "West-Ward Pharmaceuticals International Ltd",
        "Bristol Laboratories Inc Div Bristol Myers Co",
        "Mobius Therapeutics Llc",
        "Hospira Inc",
        "Mylan Laboratories Ltd",
        "Supergen Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01DC03",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES: Other cytotoxic antibiotics"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1981,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL105",
    "molecule_properties": {
      "acd_logd": -0.3,
      "acd_logp": -0.3,
      "acd_most_apka": 13.27,
      "acd_most_bpka": 5.08,
      "alogp": -1.65,
      "full_molformula": "C15H18N4O5",
      "full_mwt": 334.33,
      "hba": 8,
      "hba_lipinski": 9,
      "hbd": 3,
      "hbd_lipinski": 5,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 334.33,
      "mw_monoisotopic": 334.1277,
      "psa": 146.89,
      "qed_weighted": 0.41,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CO[C@]12[C@H]3N[C@H]3CN1C4=C([C@H]2COC(=O)N)C(=O)C(=C(C)C4=O)N",
      "standard_inchi": "InChI=1S/C15H18N4O5/c1-5-9(16)12(21)8-6(4-24-14(17)22)15(23-2)13-7(18-13)3-19(15)10(8)11(5)20/h6-7,13,18H,3-4,16H2,1-2H3,(H2,17,22)/t6-,7+,13+,15-/m1/s1",
      "standard_inchi_key": "NWIBSHFKIJFRCO-WUDYKRTCSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7806265,
    "parenteral": true,
    "research_codes": {
      "value": "NSC-26980"
    },
    "rule_of_five": true,
    "sc_patent": "US-7806265-B2",
    "synonyms": {
      "value": [
        "Mitomycin (BAN, FDA, INN, USAN, USP)",
        "Mitomycin C (JAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-mycin",
    "usan_stem_definition": "antibiotics (Streptomyces strains)",
    "usan_stem_substem": "-mycin(-mycin)",
    "usan_year": 1972
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "D08AX53",
          "description": "DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Other antiseptics and disinfectant"
        },
        {
          "code": "D08AX03",
          "description": "DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Other antiseptics and disinfectants"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL14687",
    "molecule_properties": {
      "acd_logd": 0.33,
      "acd_logp": 0.33,
      "alogp": 0.39,
      "full_molformula": "C3H8O",
      "full_mwt": 60.1,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 4,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 60.1,
      "mw_monoisotopic": 60.0575,
      "psa": 20.23,
      "qed_weighted": 0.46,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CCCO",
      "standard_inchi": "InChI=1S/C3H8O/c1-2-3-4/h4H,2-3H2,1H3",
      "standard_inchi_key": "BDERNNFJNOPAEC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": "Propanol"
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (solvent)",
    "molecule_chembl_id": "CHEMBL14688",
    "molecule_properties": {
      "acd_logd": -0.69,
      "acd_logp": -0.69,
      "alogp": -0.39,
      "full_molformula": "CH4O",
      "full_mwt": 32.04,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 2,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 32.04,
      "mw_monoisotopic": 32.0262,
      "psa": 20.23,
      "qed_weighted": 0.39,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CO",
      "standard_inchi": "InChI=1S/CH4O/c1-2/h2H,1H3",
      "standard_inchi_key": "OKKJLVBELUTLKV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Methyl alcohol (NF)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Miles Laboratories Inc",
        "Baxter Healthcare Corp",
        "B Braun Medical Inc",
        "Hospira Worldwide, Inc",
        "3M Health Care Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "V03AZ01",
          "description": "VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Nerve depressant"
        },
        {
          "code": "D08AX08",
          "description": "DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Other antiseptics and disinfectant"
        },
        {
          "code": "V03AB16",
          "description": "VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (solvent); Anti-Infective, Topical",
    "molecule_chembl_id": "CHEMBL545",
    "molecule_properties": {
      "acd_logd": -0.18,
      "acd_logp": -0.18,
      "alogp": 0,
      "full_molformula": "C2H6O",
      "full_mwt": 46.07,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 3,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 46.07,
      "mw_monoisotopic": 46.0419,
      "psa": 20.23,
      "qed_weighted": 0.41,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CCO",
      "standard_inchi": "InChI=1S/C2H6O/c1-2-3/h3H,2H2,1H3",
      "standard_inchi_key": "LFQSCWFLJHTTHZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7081246,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-7081246-B2",
    "synonyms": {
      "value": [
        "Alcohol (FDA, USP)",
        "Alcohol, Diluted (NF)",
        "Alcohol, Rubbing (INN)",
        "Ethanol (JAN)",
        null
      ]
    },
    "topical": true
  },
  {
    "applicants": {
      "value": "Novartis Pharmaceuticals Corp"
    },
    "atc_classification": {
      "drug": {
        "code": "C07AA02",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective"
      }
    },
    "availability_type": 0,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1983,
    "indication_class": "Vasodilator (coronary)",
    "molecule_chembl_id": "CHEMBL546",
    "molecule_properties": {
      "acd_logd": 0.04,
      "acd_logp": 2.15,
      "acd_most_apka": 13.89,
      "acd_most_bpka": 9.44,
      "alogp": 1.99,
      "aromatic_rings": 1,
      "full_molformula": "C15H23NO3",
      "full_mwt": 265.35,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 265.35,
      "mw_monoisotopic": 265.1678,
      "psa": 50.72,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)COc1ccccc1OCC=C",
      "standard_inchi": "InChI=1S/C15H23NO3/c1-4-9-18-14-7-5-6-8-15(14)19-11-13(17)10-16-12(2)3/h4-8,12-13,16-17H,1,9-11H2,2-3H3",
      "standard_inchi_key": "CEMAWMOMDPGJMB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "BA-39089"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Oxprenolol HCl (FDA, JAN, USAN, USP)",
        "Oxprenolol (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1968
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Unique Pharmaceutical Laboratories A Division Of J.B. Chemicals And Pharmaceuticals Ltd",
        "Hospira Inc",
        "Pliva Inc",
        "Aurobindo Pharma Ltd",
        "Taro Pharmaceutical Industries Ltd",
        "Teva Pharmaceuticals Usa",
        "Roxane Laboratories Inc",
        "Pfizer Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D01AC15",
          "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivative"
        },
        {
          "code": "J02AC01",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Triazole derivatives"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1990,
    "indication_class": "Antifungal",
    "molecule_chembl_id": "CHEMBL106",
    "molecule_properties": {
      "acd_logd": 0.45,
      "acd_logp": 0.45,
      "acd_most_apka": 11.01,
      "acd_most_bpka": 2.94,
      "alogp": 0.74,
      "aromatic_rings": 3,
      "full_molformula": "C13H12F2N6O",
      "full_mwt": 306.28,
      "hba": 7,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 306.28,
      "mw_monoisotopic": 306.1041,
      "psa": 81.65,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F",
      "standard_inchi": "InChI=1S/C13H12F2N6O/c14-10-1-2-11(12(15)3-10)13(22,4-20-8-16-6-18-20)5-21-9-17-7-19-21/h1-3,6-9,22H,4-5H2",
      "standard_inchi_key": "RFHAOTPXVQNOHP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "UK-49858"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fluconazole (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-conazole",
    "usan_stem_definition": "systemic antifungals (miconazole type)",
    "usan_stem_substem": "-conazole(-conazole)",
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Hoffmann La Roche Inc",
        "Amneal Pharmaceuticals Of Ny Llc",
        "Sun Pharmaceutical Industries Inc",
        "Douglas Pharmaceuticals America Ltd",
        "Dr Reddys Laboratories Ltd",
        "Mylan Pharmaceuticals Inc",
        "Sun Pharmaceutical Industries Ltd"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D10BA01",
          "description": "DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR SYSTEMIC USE: Retinoids for treatment of acn"
        },
        {
          "code": "D10AD54",
          "description": "DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Retinoids for topical use in acn"
        },
        {
          "code": "D10AD04",
          "description": "DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Retinoids for topical use in acne"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1982,
    "indication_class": "Keratolytic",
    "molecule_chembl_id": "CHEMBL547",
    "molecule_properties": {
      "acd_logd": 3.66,
      "acd_logp": 6.26,
      "acd_most_apka": 4.76,
      "alogp": 5.6,
      "full_molformula": "C20H28O2",
      "full_mwt": 300.44,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "ACID",
      "mw_freebase": 300.44,
      "mw_monoisotopic": 300.2089,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 37.3,
      "qed_weighted": 0.53,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "C\\C(=C\\C(=O)O)\\C=C\\C=C(/C)\\C=C\\C1=C(C)CCCC1(C)C",
      "standard_inchi": "InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14-",
      "standard_inchi_key": "SHGAZHPCJJPHSC-XFYACQKRSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7435427,
    "oral": true,
    "prodrug": true,
    "research_codes": {
      "value": "Ro-43780"
    },
    "sc_patent": "US-7435427-B2",
    "synonyms": {
      "value": [
        "Isotretinoin (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-retin-",
    "usan_stem_definition": "retinol derivatives",
    "usan_stem_substem": "-retin-(-retin-)",
    "usan_year": 1979
  },
  {
    "applicants": {
      "value": [
        "Vanda Pharmaceuticals Inc",
        "Inventia Healthcare Private Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AX14",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2009,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL14376",
    "molecule_properties": {
      "acd_logd": 2.31,
      "acd_logp": 3.38,
      "acd_most_bpka": 8.43,
      "alogp": 4.83,
      "aromatic_rings": 3,
      "full_molformula": "C24H27FN2O4",
      "full_mwt": 426.49,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 31,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 426.49,
      "mw_monoisotopic": 426.1955,
      "psa": 64.8,
      "qed_weighted": 0.38,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(ccc1OCCCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)C",
      "standard_inchi": "InChI=1S/C24H27FN2O4/c1-16(28)18-4-7-21(23(14-18)29-2)30-13-3-10-27-11-8-17(9-12-27)24-20-6-5-19(25)15-22(20)31-26-24/h4-7,14-15,17H,3,8-13H2,1-2H3",
      "standard_inchi_key": "XMXHEBAFVSFQEX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": "RE39198",
    "oral": true,
    "research_codes": {
      "value": "HP-873"
    },
    "rule_of_five": true,
    "sc_patent": "US-RE39198-E1",
    "synonyms": {
      "value": [
        "Iloperidone (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-peridone",
    "usan_stem_definition": "antipsychotics (risperidone type)",
    "usan_stem_substem": "-peridone(-peridone)",
    "usan_year": 1993
  },
  {
    "applicants": {
      "value": [
        "Pharmacia And Upjohn Co",
        "Ferring Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "G02AD02",
        "description": "GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: UTEROTONICS: Prostaglandins"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1977,
    "indication_class": "Oxytocic; Prostaglandin",
    "molecule_chembl_id": "CHEMBL548",
    "molecule_properties": {
      "acd_logd": 0.36,
      "acd_logp": 2.97,
      "acd_most_apka": 4.75,
      "alogp": 3.25,
      "full_molformula": "C20H32O5",
      "full_mwt": 352.47,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 352.47,
      "mw_monoisotopic": 352.225,
      "psa": 94.83,
      "qed_weighted": 0.37,
      "ro3_pass": "N",
      "rtb": 12
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCC[C@H](O)\\C=C\\[C@H]1[C@H](O)CC(=O)[C@@H]1C\\C=C/CCCC(=O)O",
      "standard_inchi": "InChI=1S/C20H32O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-17,19,21,23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,19+/m0/s1",
      "standard_inchi_key": "XEYBRNLFEZDVAW-ARSRFYASSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "U-12062"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dinoprostone (BAN, FDA, INN, JAN, USAN, USP)",
        "Dinoprostone beta-Cyclodextrin Clathrate (JAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-prost-",
    "usan_stem_definition": "prostaglandins",
    "usan_stem_substem": "-prost-(-prost-)",
    "usan_year": 1971
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Eurohealth International Sarl",
        "Par Sterile Products Llc",
        "Amphastar Pharmaceuticals Inc",
        "Eclat Pharmaceuticals Llc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N07AA01",
          "description": "NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: PARASYMPATHOMIMETICS: Anticholinesterase"
        },
        {
          "code": "S01EB06",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetic"
        },
        {
          "code": "N07AA51",
          "description": "NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: PARASYMPATHOMIMETICS: Anticholinesterases"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2013,
    "indication_class": "Cholinergic",
    "molecule_chembl_id": "CHEMBL278020",
    "molecule_properties": {
      "acd_logd": -2.09,
      "acd_logp": -2.09,
      "alogp": 1.94,
      "aromatic_rings": 1,
      "full_molformula": "C12H19N2O2+",
      "full_mwt": 223.3,
      "hba": 2,
      "hba_lipinski": 4,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 223.3,
      "mw_monoisotopic": 223.1441,
      "psa": 29.54,
      "qed_weighted": 0.72,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C",
      "standard_inchi": "InChI=1S/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1",
      "standard_inchi_key": "ALWKGYPQUAPLQC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Neostigmine Methylsulfate (FDA, JAN, USP)",
        "Neostigmine (BAN, BAN)",
        "Neostigmine Bromide (BAN, INN, JAN, USP)",
        null
      ]
    },
    "usan_stem": "-stigmine",
    "usan_stem_definition": "cholinesterase inhibitors (physostigmine type)",
    "usan_stem_substem": "-stigmine(-stigmine)"
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL14429",
    "molecule_properties": {
      "acd_logd": 2.22,
      "acd_logp": 2.49,
      "acd_most_bpka": 7.34,
      "alogp": 2.81,
      "aromatic_rings": 1,
      "full_molformula": "C16H23NO2",
      "full_mwt": 261.37,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 261.37,
      "mw_monoisotopic": 261.1729,
      "psa": 29.54,
      "qed_weighted": 0.78,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(=O)O[C@]1(CCN(C)C[C@@H]1C)c2ccccc2",
      "standard_inchi": "InChI=1S/C16H23NO2/c1-4-15(18)19-16(14-8-6-5-7-9-14)10-11-17(3)12-13(16)2/h5-9,13H,4,10-12H2,1-3H3/t13-,16-/m0/s1",
      "standard_inchi_key": "UVAZQQHAVMNMHE-BBRMVZONSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "NU-1779"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Betaprodine (BAN, DCF, INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL14762",
    "molecule_properties": {
      "acd_logd": 1.52,
      "acd_logp": 1.52,
      "acd_most_bpka": 4.77,
      "alogp": 3.2,
      "aromatic_rings": 3,
      "full_molformula": "C19H26N6O",
      "full_mwt": 354.46,
      "hba": 7,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 354.46,
      "mw_monoisotopic": 354.2168,
      "psa": 87.89,
      "qed_weighted": 0.58,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1",
      "standard_inchi": "InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1",
      "standard_inchi_key": "BTIHMVBBUGXLCJ-OAHLLOKOSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "CYC-202",
        "AL-39256"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Seliciclib (INN)",
        null
      ]
    },
    "usan_stem": "-ciclib",
    "usan_stem_definition": "cyclin dependent kinase inhibitors",
    "usan_stem_substem": "-ciclib(-ciclib)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N06AX18",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL14370",
    "molecule_properties": {
      "acd_logd": 1.44,
      "acd_logp": 2.45,
      "acd_most_bpka": 8.38,
      "alogp": 3.19,
      "aromatic_rings": 2,
      "full_molformula": "C19H23NO3",
      "full_mwt": 313.4,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 313.4,
      "mw_monoisotopic": 313.1678,
      "psa": 39.72,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCOc1ccccc1OC(C2CNCCO2)c3ccccc3",
      "standard_inchi": "InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3",
      "standard_inchi_key": "CBQGYUDMJHNJBX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "PNU-155950E",
        "FCE-20124"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Reboxetine (BAN, INN)",
        "Reboxetine Mesylate (USAN)",
        null
      ]
    },
    "usan_stem": "-oxetine",
    "usan_stem_definition": "antidepressants (fluoxetine type)",
    "usan_stem_substem": "-oxetine(-oxetine)",
    "usan_year": 1997
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL14249",
    "molecule_properties": {
      "acd_logd": -9.66,
      "acd_logp": -3.65,
      "acd_most_apka": 0.97,
      "acd_most_bpka": 3.82,
      "alogp": -1.63,
      "aromatic_rings": 2,
      "full_molformula": "C10H16N5O13P3",
      "full_mwt": 507.18,
      "hba": 14,
      "hba_lipinski": 18,
      "hbd": 7,
      "hbd_lipinski": 8,
      "heavy_atoms": 31,
      "molecular_species": "ACID",
      "mw_freebase": 507.18,
      "mw_monoisotopic": 506.9957,
      "num_lipinski_ro5_violations": 3,
      "num_ro5_violations": 3,
      "psa": 279.13,
      "qed_weighted": 0.2,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]3O",
      "standard_inchi": "InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",
      "standard_inchi_key": "ZKHQWZAMYRWXGA-KQYNXXCUSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Adenosine Triphosphate Disodium (JAN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL428690",
    "molecule_properties": {
      "acd_logd": 0.74,
      "acd_logp": 3.27,
      "acd_most_apka": 6.16,
      "acd_most_bpka": 9.28,
      "alogp": 3.3,
      "aromatic_rings": 3,
      "full_molformula": "C21H20ClNO5",
      "full_mwt": 401.85,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 28,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 401.85,
      "mw_monoisotopic": 401.103,
      "psa": 94.14,
      "qed_weighted": 0.61,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CC[C@@H]([C@H](O)C1)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccccc4Cl",
      "standard_inchi": "InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1",
      "standard_inchi_key": "BIIVYFLTOXDAOV-YVEFUNNKSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "HL-275",
        "L-868275",
        "HMR-1275",
        "L-86-8275",
        "MDL-107826A",
        "NSC-649890"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Alvocidib (INN, USAN)",
        "Alvocidib HCl (USAN)",
        null
      ]
    },
    "usan_year": 2010
  },
  {
    "applicants": {
      "value": [
        "Torrent Pharmaceuticals Ltd",
        "Jubilant Generics Ltd",
        "West-Ward Pharmaceuticals International Ltd",
        "Biovail Laboratories International Srl",
        "Invagen Pharmaceuticals Inc",
        "Torpharm Inc",
        "Pliva Inc",
        "Aurobindo Pharma Ltd",
        "Natco Pharma Ltd",
        "Teva Pharmaceuticals Usa"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AB04",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Selective serotonin reuptake inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1998,
    "molecule_chembl_id": "CHEMBL549",
    "molecule_properties": {
      "acd_logd": 1.35,
      "acd_logp": 3.48,
      "acd_most_bpka": 9.57,
      "alogp": 3.81,
      "aromatic_rings": 2,
      "full_molformula": "C20H21FN2O",
      "full_mwt": 324.4,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 324.4,
      "mw_monoisotopic": 324.1638,
      "psa": 36.26,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCCC1(OCc2cc(ccc12)C#N)c3ccc(F)cc3",
      "standard_inchi": "InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3",
      "standard_inchi_key": "WSEQXVZVJXJVFP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "LU-10171B"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Citalopram Hydrobromide (FDA, USAN)",
        "Citalopram (BAN, INN, MI)",
        null
      ]
    },
    "usan_year": 1998
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Perrigo Pharma International Dac",
        "Lannett Holdings Inc",
        "Novartis Pharmaceuticals Corp",
        "Innogenix Llc",
        "Eisai Inc",
        "Impax Laboratories Inc",
        "Alcon Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01EB51",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetic"
        },
        {
          "code": "S01EB01",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetic"
        },
        {
          "code": "N07AX01",
          "description": "NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: PARASYMPATHOMIMETICS: Other parasympathomimetics"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1974,
    "indication_class": "Antiglaucoma Agent; Cholinergic (ophthalmic),Cholinergic (ophthalmic)",
    "molecule_chembl_id": "CHEMBL550",
    "molecule_properties": {
      "acd_logd": -0.39,
      "acd_logp": -0.24,
      "acd_most_bpka": 7.01,
      "alogp": 1.16,
      "aromatic_rings": 1,
      "full_molformula": "C11H16N2O2",
      "full_mwt": 208.26,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 208.26,
      "mw_monoisotopic": 208.1212,
      "psa": 44.12,
      "qed_weighted": 0.7,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC[C@H]1[C@@H](Cc2cncn2C)COC1=O",
      "standard_inchi": "InChI=1S/C11H16N2O2/c1-3-10-8(6-15-11(10)14)4-9-5-12-7-13(9)2/h5,7-8,10H,3-4,6H2,1-2H3/t8-,10-/m0/s1",
      "standard_inchi_key": "QCHFTSOMWOSFHM-WPRPVWTQSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pilocarpine Nitrate (USP)",
        "Pilocarpine HCl (FDA, JAN, USP)",
        "Pilocarpine (BAN, FDA, JAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-pin(e)",
    "usan_stem_definition": "tricyclic compounds",
    "usan_stem_substem": "-pin(e)(-pin(e))"
  },
  {
    "applicants": {
      "value": [
        "Takeda Pharmaceuticals Usa Inc",
        "Lederle Laboratories Div American Cyanamid Co",
        "Beecham Laboratories Div Beecham Inc",
        "Ingenus Pharmaceuticals Nj Llc",
        "Merck And Co Inc",
        "Sandoz Inc",
        "Watson Laboratories Inc",
        "Ani Pharmaceuticals Inc",
        "Hikma International Pharmaceuticals Llc",
        "Impax Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "M04AC01",
        "description": "MUSCULO-SKELETAL SYSTEM: ANTIGOUT PREPARATIONS: ANTIGOUT PREPARATIONS: Preparations with no effect on uric acid metabolism"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1961,
    "indication_class": "Suppressant (gout)",
    "molecule_chembl_id": "CHEMBL107",
    "molecule_properties": {
      "acd_logd": 1.07,
      "acd_logp": 1.07,
      "alogp": 2.87,
      "aromatic_rings": 2,
      "full_molformula": "C22H25NO6",
      "full_mwt": 399.44,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 399.44,
      "mw_monoisotopic": 399.1682,
      "psa": 83.09,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "COC1=CC=C2C(=CC1=O)[C@H](CCc3cc(OC)c(OC)c(OC)c23)NC(=O)C",
      "standard_inchi": "InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1",
      "standard_inchi_key": "IAKHMKGGTNLKSZ-INIZCTEOSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7601758,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-7601758-B1",
    "synonyms": {
      "value": [
        "Colchicine (FDA, JAN, USP)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Asthmatic",
    "molecule_chembl_id": "CHEMBL274239",
    "molecule_properties": {
      "acd_logd": 1.17,
      "acd_logp": 1.18,
      "acd_most_bpka": 6.28,
      "alogp": 0.85,
      "aromatic_rings": 2,
      "full_molformula": "C15H18ClN3O3S",
      "full_mwt": 355.85,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 355.85,
      "mw_monoisotopic": 355.0757,
      "psa": 65.78,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "OCCN1CCN(CC1)C(=O)CN2C(=O)Sc3ccc(Cl)cc23",
      "standard_inchi": "InChI=1S/C15H18ClN3O3S/c16-11-1-2-13-12(9-11)19(15(22)23-13)10-14(21)18-5-3-17(4-6-18)7-8-20/h1-2,9,20H,3-8,10H2",
      "standard_inchi_key": "HTJXMOGUGMSZOG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tiaramide HCl (JAN, USAN)",
        "Tiaramide (BAN, INN)",
        null
      ]
    },
    "usan_year": 1981
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL14935",
    "molecule_properties": {
      "acd_logd": -2.21,
      "acd_logp": 1.27,
      "acd_most_apka": 2.46,
      "acd_most_bpka": 10.94,
      "alogp": 0.61,
      "aromatic_rings": 1,
      "full_molformula": "C13H21N5O2",
      "full_mwt": 279.34,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 20,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 279.34,
      "mw_monoisotopic": 279.1695,
      "psa": 103.79,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)[C@@H]1C[C@H]2C[C@@H](CCc3nnn[nH]3)CC[C@H]2CN1",
      "standard_inchi": "InChI=1S/C13H21N5O2/c19-13(20)11-6-10-5-8(1-3-9(10)7-14-11)2-4-12-15-17-18-16-12/h8-11,14H,1-7H2,(H,19,20)(H,15,16,17,18)/t8-,9+,10-,11+/m1/s1",
      "standard_inchi_key": "ZXFRFPSZAKNPQQ-YTWAJWBKSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "NGX424",
        "LY-293558"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tezampanel (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ampa",
    "usan_stem_definition": "ionotropic non-NMDA glutamate receptors (AMPA and/or KA receptors): antagonists",
    "usan_stem_substem": "-ampa(-ampa(-ampanel))",
    "usan_year": 2006
  },
  {
    "applicants": {
      "value": [
        "Mylan Pharmaceuticals Inc",
        "Osi Pharmaceuticals Inc",
        "Teva Pharmaceuticals Usa"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01XE03",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2004,
    "molecule_chembl_id": "CHEMBL553",
    "molecule_properties": {
      "acd_logd": 3.03,
      "acd_logp": 3.03,
      "acd_most_bpka": 5.32,
      "alogp": 3.41,
      "aromatic_rings": 3,
      "full_molformula": "C22H23N3O4",
      "full_mwt": 393.44,
      "hba": 7,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 393.44,
      "mw_monoisotopic": 393.1689,
      "psa": 74.73,
      "qed_weighted": 0.42,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC",
      "standard_inchi": "InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)",
      "standard_inchi_key": "AAKJLRGGTJKAMG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5747498,
    "oral": true,
    "research_codes": {
      "value": [
        "Ro-508231",
        "OSI-774",
        "RG-1415",
        "R-1415",
        "CP-358774-01",
        "CP-35877401",
        "CP-358774"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5747498-A",
    "synonyms": {
      "value": [
        "Erlotinib HCl (FDA, INN, USAN)",
        "Erlotinib (INN)",
        null
      ]
    },
    "usan_stem": "-tinib",
    "usan_stem_definition": "tyrosine kinase inhibitors",
    "usan_stem_substem": "-tinib(-tinib)",
    "usan_year": 2001
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antipsychotic; Neuroleptic",
    "molecule_chembl_id": "CHEMBL273786",
    "molecule_properties": {
      "acd_logd": 3.06,
      "acd_logp": 3.5,
      "acd_most_bpka": 7.35,
      "alogp": 3.58,
      "aromatic_rings": 2,
      "full_molformula": "C17H19FN4S",
      "full_mwt": 330.43,
      "hba": 5,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 330.43,
      "mw_monoisotopic": 330.1314,
      "psa": 30.87,
      "qed_weighted": 0.8,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN(CC1)C2=Nc3cc(F)ccc3Nc4sc(C)cc24",
      "standard_inchi": "InChI=1S/C17H19FN4S/c1-11-9-13-16(22-7-5-21(2)6-8-22)19-15-10-12(18)3-4-14(15)20-17(13)23-11/h3-4,9-10,20H,5-8H2,1-2H3",
      "standard_inchi_key": "JBHUBOISLBWHAR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Flumezapine (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-pin(e)",
    "usan_stem_definition": "tricyclic compounds",
    "usan_stem_substem": "-pin(e)(-pin(e))",
    "usan_year": 1981
  },
  {
    "applicants": {
      "value": "Novartis Pharmaceuticals Corp"
    },
    "atc_classification": {
      "drug": {
        "code": "L01XE07",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2007,
    "molecule_chembl_id": "CHEMBL554",
    "molecule_properties": {
      "acd_logd": 6.26,
      "acd_logp": 6.3,
      "acd_most_bpka": 6.34,
      "alogp": 6.14,
      "aromatic_rings": 5,
      "full_molformula": "C29H26ClFN4O4S",
      "full_mwt": 581.07,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 40,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 581.07,
      "mw_monoisotopic": 580.1347,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 106.35,
      "qed_weighted": 0.18,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2",
      "standard_inchi": "InChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)",
      "standard_inchi_key": "BCFGMOOMADDAQU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6391874,
    "oral": true,
    "research_codes": {
      "value": [
        "GW-572016",
        "GW572016F",
        "GW-2016"
      ]
    },
    "sc_patent": "US-6391874-B1",
    "synonyms": {
      "value": [
        "Lapatinib Ditosylate (FDA, USAN)",
        "Lapatinib (INN)",
        null
      ]
    },
    "usan_stem": "-tinib",
    "usan_stem_definition": "tyrosine kinase inhibitors",
    "usan_stem_substem": "-tinib(-tinib)",
    "usan_year": 2003
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL277382",
    "molecule_properties": {
      "acd_logd": 2.3,
      "acd_logp": 4.57,
      "acd_most_bpka": 9.74,
      "alogp": 4.48,
      "aromatic_rings": 2,
      "full_molformula": "C20H25N",
      "full_mwt": 279.43,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 279.43,
      "mw_monoisotopic": 279.1987,
      "psa": 3.24,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)N1CCC(CC1)(c2ccccc2)c3ccccc3",
      "standard_inchi": "InChI=1S/C20H25N/c1-17(2)21-15-13-20(14-16-21,18-9-5-3-6-10-18)19-11-7-4-8-12-19/h3-12,17H,13-16H2,1-2H3",
      "standard_inchi_key": "CFOOTBBXHJHHMT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Prodipine (INN, MI)",
        null
      ]
    },
    "usan_stem": "-dipine",
    "usan_stem_definition": "phenylpyridine vasodilators (nifedipine type)",
    "usan_stem_substem": "-dipine(-dipine)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05AD02",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Butyrophenone derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL15023",
    "molecule_properties": {
      "acd_logd": 3.09,
      "acd_logp": 3.79,
      "acd_most_apka": 13.87,
      "acd_most_bpka": 7.88,
      "alogp": 4.79,
      "aromatic_rings": 2,
      "full_molformula": "C22H23F4NO2",
      "full_mwt": 409.42,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 409.42,
      "mw_monoisotopic": 409.1665,
      "psa": 40.54,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3cccc(c3)C(F)(F)F",
      "standard_inchi": "InChI=1S/C22H23F4NO2/c23-19-8-6-16(7-9-19)20(28)5-2-12-27-13-10-21(29,11-14-27)17-3-1-4-18(15-17)22(24,25)26/h1,3-4,6-9,15,29H,2,5,10-14H2",
      "standard_inchi_key": "GPMXUUPHFNMNDH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "R-2498",
        "MCN-JR-2498"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Trifluperidol (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-peridol",
    "usan_stem_definition": "antipsychotics (haloperidol type)",
    "usan_stem_substem": "-peridol(-peridol)",
    "usan_year": 1965
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Anxiety Agent",
    "molecule_chembl_id": "CHEMBL279867",
    "molecule_properties": {
      "acd_logd": 2.76,
      "acd_logp": 2.76,
      "alogp": 3.16,
      "aromatic_rings": 4,
      "full_molformula": "C18H17N5O2",
      "full_mwt": 335.37,
      "hba": 7,
      "hba_lipinski": 7,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 335.37,
      "mw_monoisotopic": 335.1382,
      "psa": 78.22,
      "qed_weighted": 0.57,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)N1C(=O)c2c(ncn2c3ccccc13)c4noc(n4)C5CC5",
      "standard_inchi": "InChI=1S/C18H17N5O2/c1-10(2)23-13-6-4-3-5-12(13)22-9-19-14(15(22)18(23)24)16-20-17(25-21-16)11-7-8-11/h3-6,9-11H,7-8H2,1-2H3",
      "standard_inchi_key": "ZGEGOFCLSWVVKG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "FG-10571",
        "U-78875"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Panadiplon (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-plon",
    "usan_stem_definition": "non-benzodiazepine anxiolytics, sedatives, hypnotics",
    "usan_stem_substem": "-plon(-plon)",
    "usan_year": 1990
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL279605",
    "molecule_properties": {
      "acd_logd": 6.14,
      "acd_logp": 6.14,
      "acd_most_apka": 10.18,
      "alogp": 5.4,
      "aromatic_rings": 2,
      "full_molformula": "C20H26O2",
      "full_mwt": 298.43,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 298.43,
      "mw_monoisotopic": 298.1933,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 40.46,
      "qed_weighted": 0.78,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(C(CC)c1ccc(O)c(C)c1)c2ccc(O)c(C)c2",
      "standard_inchi": "InChI=1S/C20H26O2/c1-5-17(15-7-9-19(21)13(3)11-15)18(6-2)16-8-10-20(22)14(4)12-16/h7-12,17-18,21-22H,5-6H2,1-4H3",
      "standard_inchi_key": "PYWBJEDBESDHNP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Methestrol (BAN, DCF, INN, MI)",
        null
      ]
    },
    "usan_stem": "-estr-",
    "usan_stem_definition": "estrogens",
    "usan_stem_substem": "-estr-(-estr-)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Anti-Anxiety Agent",
    "molecule_chembl_id": "CHEMBL274047",
    "molecule_properties": {
      "acd_logd": 0.73,
      "acd_logp": 1.09,
      "acd_most_bpka": 7.71,
      "alogp": 1.41,
      "aromatic_rings": 1,
      "full_molformula": "C21H29N5O2",
      "full_mwt": 383.5,
      "hba": 6,
      "hba_lipinski": 7,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 383.5,
      "mw_monoisotopic": 383.2321,
      "psa": 69.64,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1[C@@H]2[C@H]3CC[C@H](C3)[C@@H]2C(=O)N1CCCCN4CCN(CC4)c5ncccn5",
      "standard_inchi": "InChI=1S/C21H29N5O2/c27-19-17-15-4-5-16(14-15)18(17)20(28)26(19)9-2-1-8-24-10-12-25(13-11-24)21-22-6-3-7-23-21/h3,6-7,15-18H,1-2,4-5,8-14H2/t15-,16+,17+,18-",
      "standard_inchi_key": "CEIJFEGBUDEYSX-FZDBZEDMSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SM-3997"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tandospirone Citrate (USAN)",
        "Tandospirone (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-spirone",
    "usan_stem_definition": "anxiolytics (buspirone type)",
    "usan_stem_substem": "-spirone(-spirone)",
    "usan_year": 1990
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL407641",
    "molecule_properties": {
      "acd_logd": 1.7,
      "acd_logp": 1.77,
      "acd_most_bpka": 6.86,
      "alogp": 1.65,
      "aromatic_rings": 1,
      "full_molformula": "C11H18ClN5S",
      "full_mwt": 287.82,
      "hba": 6,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 287.82,
      "mw_monoisotopic": 287.0971,
      "psa": 44.29,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CNc1nc(Cl)c(SC)c(n1)N2CCN(C)CC2",
      "standard_inchi": "InChI=1S/C11H18ClN5S/c1-13-11-14-9(12)8(18-3)10(15-11)17-6-4-16(2)5-7-17/h4-7H2,1-3H3,(H,13,14,15)",
      "standard_inchi_key": "ITYXRJDDBZMFAY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mezilamine (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Shire Development Inc",
        "Validus Pharmaceuticals Llc",
        "Jubilant Cadista Pharmaceuticals Inc",
        "Torrent Pharmaceuticals Ltd",
        "Actavis Elizabeth Llc",
        "Apotex Inc Etobicoke Site",
        "Apotex Inc",
        "Novartis Pharmaceuticals Corp",
        "Mylan Ireland Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N03AF01",
        "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Carboxamide derivatives"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1968,
    "indication_class": "Analgesic; Anticonvulsant",
    "molecule_chembl_id": "CHEMBL108",
    "molecule_properties": {
      "acd_logd": 1.9,
      "acd_logp": 1.9,
      "acd_most_apka": 13.94,
      "alogp": 3.39,
      "aromatic_rings": 2,
      "full_molformula": "C15H12N2O",
      "full_mwt": 236.27,
      "hba": 1,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 236.27,
      "mw_monoisotopic": 236.095,
      "psa": 46.33,
      "qed_weighted": 0.75,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=O)N1c2ccccc2C=Cc3ccccc13",
      "standard_inchi": "InChI=1S/C15H12N2O/c16-15(18)17-13-7-3-1-5-11(13)9-10-12-6-2-4-8-14(12)17/h1-10H,(H2,16,18)",
      "standard_inchi_key": "FFGPTBGBLSHEPO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6977253,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "G-32883"
    },
    "rule_of_five": true,
    "sc_patent": "US-6977253-B2",
    "synonyms": {
      "value": [
        "Carbamazepine (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-pin(e)",
    "usan_stem_definition": "tricyclic compounds",
    "usan_stem_substem": "-pin(e)(-pin(e))",
    "usan_year": 1965
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Anti-Asthmatic (leukotriene antagonist)",
    "molecule_chembl_id": "CHEMBL280481",
    "molecule_properties": {
      "acd_logd": 0.37,
      "acd_logp": 3.41,
      "acd_most_apka": 4.27,
      "acd_most_bpka": 2.18,
      "alogp": 6.48,
      "aromatic_rings": 3,
      "full_molformula": "C26H27ClN2O3S2",
      "full_mwt": 515.1,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 34,
      "molecular_species": "ACID",
      "mw_freebase": 515.1,
      "mw_monoisotopic": 514.1152,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 70.5,
      "qed_weighted": 0.3,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)C(=O)CCS[C@H](SCCC(=O)O)c1cccc(\\C=C\\c2ccc3ccc(Cl)cc3n2)c1",
      "standard_inchi": "InChI=1S/C26H27ClN2O3S2/c1-29(2)24(30)12-14-33-26(34-15-13-25(31)32)20-5-3-4-18(16-20)6-10-22-11-8-19-7-9-21(27)17-23(19)28-22/h3-11,16-17,26H,12-15H2,1-2H3,(H,31,32)/b10-6+/t26-/m1/s1",
      "standard_inchi_key": "AXUZQJFHDNNPFG-LHAVAQOQSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "MK-679",
        "L-668019"
      ]
    },
    "synonyms": {
      "value": [
        "Verlukast (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics: leukotriene receptor antagonists",
    "usan_stem_substem": "-ast(-ast(-lukast))",
    "usan_year": 1990
  },
  {
    "atc_classification": {
      "drug": {
        "code": "G04BE04",
        "description": "GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunction"
      }
    },
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL15245",
    "molecule_properties": {
      "acd_logd": 1.72,
      "acd_logp": 2.87,
      "acd_most_bpka": 8.44,
      "alogp": 2.65,
      "aromatic_rings": 2,
      "full_molformula": "C21H26N2O3",
      "full_mwt": 354.45,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 354.45,
      "mw_monoisotopic": 354.1943,
      "psa": 65.56,
      "qed_weighted": 0.77,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12",
      "standard_inchi": "InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1",
      "standard_inchi_key": "BLGXFZZNTVWLAY-SCYLSFHTSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Yohimbine HCl (USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Eci Pharmaceuticals Llc",
        "Rp Scherer North America Div Rp Scherer Corp",
        "Par Pharmaceutical Inc",
        "Usl Pharma Llc",
        "Aurobindo Pharma Ltd",
        "Unichem Laboratories Limited",
        "Apotex Inc Richmond Hill",
        "Lupin Ltd",
        "Actavis Laboratories Fl Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N03AG01",
        "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Fatty acid derivatives"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1978,
    "indication_class": "Anticonvulsant",
    "molecule_chembl_id": "CHEMBL109",
    "molecule_properties": {
      "acd_logd": 0.02,
      "acd_logp": 2.58,
      "acd_most_apka": 4.82,
      "alogp": 2.29,
      "full_molformula": "C8H16O2",
      "full_mwt": 144.21,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 10,
      "molecular_species": "ACID",
      "mw_freebase": 144.21,
      "mw_monoisotopic": 144.115,
      "psa": 37.3,
      "qed_weighted": 0.64,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCCC(CCC)C(=O)O",
      "standard_inchi": "InChI=1S/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)",
      "standard_inchi_key": "NIJJYAXOARWZEE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6419953,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "A-44090",
        "ABBOTT 44090",
        "ABBOTT-50711",
        44089
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6419953-B1",
    "synonyms": {
      "value": [
        "Valproic acid (BAN, FDA, INN, USAN, USP)",
        "Sodium Valproate (JAN)",
        "Valproate Sodium (FDA, USAN)",
        "Divalproex Sodium (FDA, USAN, USP)",
        "Semisodium Valproate (BAN)",
        "Valproate Semisodium (INN)",
        null
      ]
    },
    "usan_year": 1975
  },
  {
    "atc_classification": {
      "drug": {
        "code": "J01MA05",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1992,
    "indication_class": "Antibacterial (microbial DNA topoisomerase inhibitor)",
    "molecule_chembl_id": "CHEMBL277100",
    "molecule_properties": {
      "acd_logd": -0.88,
      "acd_logp": 1.27,
      "acd_most_apka": 6.02,
      "acd_most_bpka": 8.74,
      "alogp": 2.9,
      "aromatic_rings": 3,
      "full_molformula": "C21H18F3N3O3",
      "full_mwt": 417.39,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 30,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 417.39,
      "mw_monoisotopic": 417.13,
      "psa": 74.57,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC1CN(CCN1)c2cc3N(C=C(C(=O)O)C(=O)c3cc2F)c4ccc(F)cc4F",
      "standard_inchi": "InChI=1S/C21H18F3N3O3/c1-11-9-26(5-4-25-11)19-8-18-13(7-16(19)24)20(28)14(21(29)30)10-27(18)17-3-2-12(22)6-15(17)23/h2-3,6-8,10-11,25H,4-5,9H2,1H3,(H,29,30)",
      "standard_inchi_key": "QKDHBVNJCZBTMR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "ABBOTT-62254"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Temafloxacin (BAN, INN)",
        "Temafloxacin HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1988,
    "withdrawn_class": "Hematological toxicity; Hepatotoxicity; Immune system toxicity; Nephrotoxicity",
    "withdrawn_country": "United States; United Kingdom; Germany",
    "withdrawn_reason": "Low blood sugar; hemolytic anemia; kidney, liver dysfunction; allergic reactions",
    "withdrawn_year": 1992
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL273348",
    "molecule_properties": {
      "acd_logd": -1.27,
      "acd_logp": 1.01,
      "acd_most_apka": 5.79,
      "acd_most_bpka": 8.76,
      "alogp": 2.04,
      "aromatic_rings": 3,
      "full_molformula": "C19H15F3N4O3",
      "full_mwt": 404.35,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 29,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 404.35,
      "mw_monoisotopic": 404.1096,
      "psa": 101.45,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "NC1CCN(C1)c2nc3N(C=C(C(=O)O)C(=O)c3cc2F)c4ccc(F)cc4F",
      "standard_inchi": "InChI=1S/C19H15F3N4O3/c20-9-1-2-15(13(21)5-9)26-8-12(19(28)29)16(27)11-6-14(22)18(24-17(11)26)25-4-3-10(23)7-25/h1-2,5-6,8,10H,3-4,7,23H2,(H,28,29)",
      "standard_inchi_key": "WUWFMDMBOJLQIV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "ABBOTT-61827"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tosufloxacin (INN, USAN)",
        "Tosufloxacin Tosilate (JAN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1989
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL278255",
    "molecule_properties": {
      "acd_logd": 0.5,
      "acd_logp": 2.45,
      "acd_most_apka": 6.39,
      "acd_most_bpka": 9.1,
      "alogp": 2.36,
      "aromatic_rings": 2,
      "full_molformula": "C17H17ClFN3O3",
      "full_mwt": 365.79,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 25,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 365.79,
      "mw_monoisotopic": 365.0942,
      "psa": 88.56,
      "qed_weighted": 0.87,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "NC1CCN(C1)c2c(F)cc3C(=O)C(=CN(C4CC4)c3c2Cl)C(=O)O",
      "standard_inchi": "InChI=1S/C17H17ClFN3O3/c18-13-14-10(5-12(19)15(13)21-4-3-8(20)6-21)16(23)11(17(24)25)7-22(14)9-1-2-9/h5,7-9H,1-4,6,20H2,(H,24,25)",
      "standard_inchi_key": "QGPKADBNRMWEQR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CI-960 HCl"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clinafloxacin (INN)",
        "Clinafloxacin HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1992
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antibacterial (veterinary)",
    "molecule_chembl_id": "CHEMBL15511",
    "molecule_properties": {
      "acd_logd": 1.08,
      "acd_logp": 2.31,
      "acd_most_apka": 6.43,
      "acd_most_bpka": 7.75,
      "alogp": 2.32,
      "aromatic_rings": 2,
      "full_molformula": "C19H22FN3O3",
      "full_mwt": 359.4,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 359.4,
      "mw_monoisotopic": 359.1645,
      "psa": 65.78,
      "qed_weighted": 0.91,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1CCN(CC1)c2cc3N(C=C(C(=O)O)C(=O)c3cc2F)C4CC4",
      "standard_inchi": "InChI=1S/C19H22FN3O3/c1-2-21-5-7-22(8-6-21)17-10-16-13(9-15(17)20)18(24)14(19(25)26)11-23(16)12-3-4-12/h9-12H,2-8H2,1H3,(H,25,26)",
      "standard_inchi_key": "SPFYMRJSYKOXGV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BAY-VP-2674"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Enrofloxacin (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": "Chemo Research Sl"
    },
    "atc_classification": {
      "drug": {
        "code": "P01CA02",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS: Nitroimidazole derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2017,
    "molecule_chembl_id": "CHEMBL110",
    "molecule_properties": {
      "acd_logd": 0.91,
      "acd_logp": 0.91,
      "acd_most_bpka": 0.45,
      "alogp": 1.11,
      "aromatic_rings": 2,
      "full_molformula": "C12H12N4O3",
      "full_mwt": 260.25,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 260.25,
      "mw_monoisotopic": 260.0909,
      "psa": 90.06,
      "qed_weighted": 0.64,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "[O-][N+](=O)c1nccn1CC(=O)NCc2ccccc2",
      "standard_inchi": "InChI=1S/C12H12N4O3/c17-11(14-8-10-4-2-1-3-5-10)9-15-7-6-13-12(15)16(18)19/h1-7H,8-9H2,(H,14,17)",
      "standard_inchi_key": "CULUWZNBISUWAS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Benznidazole (FDA, INN, MI, USAN)",
        null
      ]
    },
    "usan_stem": "-nidazole",
    "usan_stem_definition": "antiprotozoal substances (metronidazole type)",
    "usan_stem_substem": "-nidazole(-nidazole)",
    "usan_year": 2016
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Novartis Pharmaceuticals Corp",
        "Watson Laboratories Inc",
        "Hospira Inc",
        "Gland Pharma Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "V03AC01",
        "description": "VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Iron chelating agents"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1968,
    "indication_class": "Antidote (to iron poisoning); Chelating Agent,Chelating Agent (iron)",
    "molecule_chembl_id": "CHEMBL556",
    "molecule_properties": {
      "acd_logd": -3.4,
      "acd_logp": -0.61,
      "acd_most_apka": 9.08,
      "acd_most_bpka": 10.56,
      "alogp": 0.92,
      "full_molformula": "C25H48N6O8",
      "full_mwt": 560.69,
      "hba": 9,
      "hba_lipinski": 14,
      "hbd": 6,
      "hbd_lipinski": 7,
      "heavy_atoms": 39,
      "molecular_species": "BASE",
      "mw_freebase": 560.69,
      "mw_monoisotopic": 560.3534,
      "num_lipinski_ro5_violations": 3,
      "num_ro5_violations": 2,
      "psa": 205.84,
      "qed_weighted": 0.06,
      "ro3_pass": "N",
      "rtb": 23
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN",
      "standard_inchi": "InChI=1S/C25H48N6O8/c1-21(32)29(37)18-9-3-6-16-27-22(33)12-14-25(36)31(39)20-10-4-7-17-28-23(34)11-13-24(35)30(38)19-8-2-5-15-26/h37-39H,2-20,26H2,1H3,(H,27,33)(H,28,34)",
      "standard_inchi_key": "UBQYURCVBFRUQT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "BA-29837",
        "BA-33112"
      ]
    },
    "synonyms": {
      "value": [
        "Deferoxamine HCl (USAN)",
        "Deferoxamine Mesilate (JAN)",
        "Deferoxamine Mesylate (FDA, USAN, USP)",
        "Desferrioxamine Mesilate (BAN)",
        "Deferoxamine (INN, USAN)",
        "Desferrioxamine (BAN)",
        null
      ]
    },
    "usan_year": 1964
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL557",
    "molecule_properties": {
      "acd_logd": 1.32,
      "acd_logp": 3.91,
      "acd_most_apka": 2.13,
      "acd_most_bpka": 8.27,
      "alogp": 3.95,
      "aromatic_rings": 2,
      "full_molformula": "C15H12I3NO4",
      "full_mwt": 650.98,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 650.98,
      "mw_monoisotopic": 650.7901,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 92.78,
      "qed_weighted": 0.43,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "N[C@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O",
      "standard_inchi": "InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m1/s1",
      "standard_inchi_key": "AUYYCJSJGJYCDS-GFCCVEGCSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "DT-3"
    },
    "synonyms": {
      "value": [
        "Detrothyronine (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Idt Australia Ltd",
        "Teva Pharmaceuticals Usa Inc",
        "Watson Laboratories Inc",
        "Boehringer Ingelheim"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C01BB02",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ib"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1985,
    "indication_class": "Cardiac Depressant (anti-arrhythmic)",
    "molecule_chembl_id": "CHEMBL558",
    "molecule_properties": {
      "acd_logd": 0.92,
      "acd_logp": 2.12,
      "acd_most_bpka": 8.58,
      "alogp": 2.03,
      "aromatic_rings": 1,
      "full_molformula": "C11H17NO",
      "full_mwt": 179.26,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 13,
      "molecular_species": "BASE",
      "mw_freebase": 179.26,
      "mw_monoisotopic": 179.131,
      "psa": 35.25,
      "qed_weighted": 0.77,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(N)COc1c(C)cccc1C",
      "standard_inchi": "InChI=1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3",
      "standard_inchi_key": "VLPIATFUUWWMKC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "KO-1173 CL",
        "KO-1173-Cl"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mexiletine (BAN, INN)",
        "Mexiletine HCl (FDA, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1986
  },
  {
    "applicants": {
      "value": "Abbvie Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "C10AX01",
        "description": "CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Other lipid modifying agents"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1967,
    "indication_class": "Antihyperlipidemic",
    "molecule_chembl_id": "CHEMBL559",
    "molecule_properties": {
      "acd_logd": 1.68,
      "acd_logp": 4.72,
      "acd_most_apka": 2.12,
      "acd_most_bpka": 8.27,
      "alogp": 4.56,
      "aromatic_rings": 2,
      "full_molformula": "C15H11I4NO4",
      "full_mwt": 776.87,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 24,
      "molecular_species": "ACID",
      "mw_freebase": 776.87,
      "mw_monoisotopic": 776.6867,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 92.78,
      "qed_weighted": 0.39,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "N[C@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O",
      "standard_inchi": "InChI=1S/C15H11I4NO4/c16-8-4-7(5-9(17)13(8)21)24-14-10(18)1-6(2-11(14)19)3-12(20)15(22)23/h1-2,4-5,12,21H,3,20H2,(H,22,23)/t12-/m1/s1",
      "standard_inchi_key": "XUIIKFGFIJCVMT-GFCCVEGCSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "synonyms": {
      "value": [
        "Dextrothyroxine (BAN, BAN)",
        "Dextrothyroxine Sodium (FDA, INN, USAN, USP)",
        "T4 (Liotrix) (FDA)",
        null
      ]
    },
    "usan_year": 1962
  },
  {
    "atc_classification": {
      "drug": {
        "code": "A08AX01",
        "description": "ALIMENTARY TRACT AND METABOLISM: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: Other antiobesity drugs"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2006,
    "molecule_chembl_id": "CHEMBL111",
    "molecule_properties": {
      "acd_logd": 4.84,
      "acd_logp": 4.84,
      "acd_most_apka": 11.31,
      "acd_most_bpka": 3.22,
      "alogp": 5.94,
      "aromatic_rings": 3,
      "full_molformula": "C22H21Cl3N4O",
      "full_mwt": 463.8,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 30,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 463.8,
      "mw_monoisotopic": 462.0781,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 50.16,
      "qed_weighted": 0.52,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1c(nn(c2ccc(Cl)cc2Cl)c1c3ccc(Cl)cc3)C(=O)NN4CCCCC4",
      "standard_inchi": "InChI=1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)",
      "standard_inchi_key": "JZCPYUJPEARBJL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "SR-14171",
        "SR-141716A",
        "SR-141716"
      ]
    },
    "synonyms": {
      "value": [
        "Rimonabant (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-nab-",
    "usan_stem_definition": "cannabinol derivatives: CB cannabinoid receptor antagonists",
    "usan_stem_substem": "-nab-(-nab-(-nabant))",
    "usan_year": 2005,
    "withdrawn_class": "Psychiatric toxicity",
    "withdrawn_country": "European Union; Never approved in the United States",
    "withdrawn_reason": "Psychiatric effects, especially depression",
    "withdrawn_year": 2008
  },
  {
    "atc_classification": {
      "drug": {
        "code": "J01DC14",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Second-generation cephalosporins"
      }
    },
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL15413",
    "molecule_properties": {
      "acd_logd": -6.03,
      "acd_logp": -2.43,
      "acd_most_apka": 3.25,
      "acd_most_bpka": 0.3,
      "alogp": -1.29,
      "aromatic_rings": 1,
      "full_molformula": "C15H18F2N6O7S2",
      "full_mwt": 496.47,
      "hba": 12,
      "hba_lipinski": 13,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 32,
      "molecular_species": "ACID",
      "mw_freebase": 496.47,
      "mw_monoisotopic": 496.0646,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 169,
      "qed_weighted": 0.19,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CO[C@]1(NC(=O)CSC(F)F)[C@H]2OCC(=C(N2C1=O)C(=O)O)CSc3nnnn3CCO",
      "standard_inchi": "InChI=1S/C15H18F2N6O7S2/c1-29-15(18-8(25)6-31-13(16)17)11(28)23-9(10(26)27)7(4-30-12(15)23)5-32-14-19-20-21-22(14)2-3-24/h12-13,24H,2-6H2,1H3,(H,18,25)(H,26,27)/t12-,15+/m1/s1",
      "standard_inchi_key": "UHRBTBZOWWGKMK-DOMZBBRYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Flomoxef (INN, MI)",
        "Flomoxef Sodium (JAN)",
        null
      ]
    },
    "usan_stem": "-oxef",
    "usan_stem_definition": "antibiotics (oxacefalosporanic acid derivatives)",
    "usan_stem_substem": "-oxef(-oxef)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N06AX04",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1984,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL273575",
    "molecule_properties": {
      "acd_logd": 0.32,
      "acd_logp": 1.01,
      "acd_most_bpka": 7.85,
      "alogp": 2.85,
      "aromatic_rings": 2,
      "full_molformula": "C16H18N2",
      "full_mwt": 238.33,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 238.33,
      "mw_monoisotopic": 238.147,
      "psa": 29.26,
      "qed_weighted": 0.77,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CC(c2ccccc2)c3cccc(N)c3C1",
      "standard_inchi": "InChI=1S/C16H18N2/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18/h2-9,14H,10-11,17H2,1H3",
      "standard_inchi_key": "XXPANQJNYNUNES-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "HOE-984"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nomifensine (BAN, INN)",
        "Nomifensine Maleate (USAN)",
        null
      ]
    },
    "usan_stem": "-fensine",
    "usan_stem_definition": "norepinephrine, serotonin, dopamine reuptake inhibitor",
    "usan_stem_substem": "-fensine(-fensine)",
    "usan_year": 1975,
    "withdrawn_class": "Hematological toxicity; Hepatotoxicity",
    "withdrawn_country": "United States; United Kingdom; United States; Spain; Germany; France",
    "withdrawn_reason": "Serious hypersensitive reactions; Hemolytic Anemia; Hepatotoxicity",
    "withdrawn_year": 1986
  },
  {
    "applicants": {
      "value": "Pharmacia Corp"
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01AE04",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Fluoroquinolone"
        },
        {
          "code": "J01MA07",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones"
        }
      ]
    },
    "availability_type": 0,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1992,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL561",
    "molecule_properties": {
      "acd_logd": 0.04,
      "acd_logp": 2.46,
      "acd_most_apka": -0.25,
      "acd_most_bpka": 8.57,
      "alogp": 1.8,
      "aromatic_rings": 2,
      "full_molformula": "C17H19F2N3O3",
      "full_mwt": 351.35,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 25,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 351.35,
      "mw_monoisotopic": 351.1394,
      "psa": 74.57,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1C=C(C(=O)O)C(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c12",
      "standard_inchi": "InChI=1S/C17H19F2N3O3/c1-3-21-8-11(17(24)25)16(23)10-6-12(18)15(13(19)14(10)21)22-5-4-20-9(2)7-22/h6,8-9,20H,3-5,7H2,1-2H3,(H,24,25)",
      "standard_inchi_key": "ZEKZLJVOYLTDKK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "SC-47111B",
        "SC-47111",
        "NY-198",
        "SC-47111A"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lomefloxacin HCl (FDA, JAN, USAN)",
        "Lomefloxacin (BAN, INN, USAN)",
        "Lomefloxacin Mesylate (USAN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": [
        "Cipla Ltd",
        "Chartwell Rx Sciences Llc",
        "Sandoz Inc",
        "Pliva Inc",
        "Valeant Pharmaceuticals International Inc",
        "Valeant Pharmaceuticals Luxembourg Sarl",
        "Sigmapharm Laboratories Llc",
        "Johnson And Johnson Consumer Products Inc",
        "Johnson And Johnson Consumer Companies Inc",
        "Vintage Pharmaceuticals"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D01BA01",
          "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR SYSTEMIC USE: Antifungals for systemic us"
        },
        {
          "code": "D01AA08",
          "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Antibiotics"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1962,
    "indication_class": "Antifungal",
    "molecule_chembl_id": "CHEMBL562",
    "molecule_properties": {
      "acd_logd": 2.01,
      "acd_logp": 2.01,
      "alogp": 2.81,
      "aromatic_rings": 1,
      "full_molformula": "C17H17ClO6",
      "full_mwt": 352.77,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 24,
      "mw_freebase": 352.77,
      "mw_monoisotopic": 352.0714,
      "psa": 71.06,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "COC1=CC(=O)C[C@@H](C)[C@]12Oc3c(Cl)c(OC)cc(OC)c3C2=O",
      "standard_inchi": "InChI=1S/C17H17ClO6/c1-8-5-9(19)6-12(23-4)17(8)16(20)13-10(21-2)7-11(22-3)14(18)15(13)24-17/h6-8H,5H2,1-4H3/t8-,17+/m1/s1",
      "standard_inchi_key": "DDUHZTYCFQRHIY-RBHXEPJQSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Griseofulvin (BAN, INN, JAN, USP)",
        "Griseofulvin, microcrystalline (FDA)",
        "Griseofulvin, Microsize (FDA)",
        "Griseofulvin, ultramicrocrystalline (FDA)",
        "Griseofulvin, Ultramicrosize (FDA)",
        null
      ]
    },
    "usan_stem": "-vin-",
    "usan_stem_definition": "vinca alkaloids",
    "usan_stem_substem": "-vin-(-vin-)"
  },
  {
    "applicants": {
      "value": [
        "Aurolife Pharma Llc",
        "Sun Pharmaceutical Industries Inc",
        "Allergan Pharmaceutical",
        "Pharmacia And Upjohn Co",
        "Theragen Inc",
        "Mylan Pharmaceuticals Inc",
        "Pliva Inc",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa",
        "Teva Pharmaceuticals Usa Inc",
        "Bausch And Lomb Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R02AX01",
          "description": "RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Other throat preparation"
        },
        {
          "code": "M01AE09",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivative"
        },
        {
          "code": "S01BC04",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroid"
        },
        {
          "code": "M02AA19",
          "description": "MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1986,
    "indication_class": "Anti-Inflammatory; Analgesic,Inhibitor (prostaglandin synthesis)",
    "molecule_chembl_id": "CHEMBL563",
    "molecule_properties": {
      "acd_logd": 0.52,
      "acd_logp": 3.66,
      "acd_most_apka": 4.14,
      "alogp": 3.68,
      "aromatic_rings": 2,
      "full_molformula": "C15H13FO2",
      "full_mwt": 244.26,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 18,
      "molecular_species": "ACID",
      "mw_freebase": 244.26,
      "mw_monoisotopic": 244.09,
      "psa": 37.3,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C(=O)O)c1ccc(c(F)c1)c2ccccc2",
      "standard_inchi": "InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)",
      "standard_inchi_key": "SYTBZMRGLBWNTM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "BTS-18322",
        "BTS 18322",
        "U-27182"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Flurbiprofen (BAN, FDA, INN, JAN, USAN, USP)",
        "Flurbiprofen sodium (FDA, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-profen",
    "usan_stem_definition": "anti-inflammatory/analgesic agents (ibuprofen type)",
    "usan_stem_substem": "-profen(-profen)",
    "usan_year": 1976
  },
  {
    "applicants": {
      "value": [
        "Wyeth Ayerst Laboratories",
        "Watson Laboratories Inc",
        "Baxter Healthcare Corp Anesthesia Critical Care"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AA03",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with aliphatic side-chain"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1956,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL564",
    "molecule_properties": {
      "acd_logd": 2.73,
      "acd_logp": 4.69,
      "acd_most_bpka": 9.43,
      "alogp": 4.24,
      "aromatic_rings": 2,
      "full_molformula": "C17H20N2S",
      "full_mwt": 284.43,
      "hba": 3,
      "hba_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 284.43,
      "mw_monoisotopic": 284.1347,
      "psa": 6.48,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCCN1c2ccccc2Sc3ccccc13",
      "standard_inchi": "InChI=1S/C17H20N2S/c1-18(2)12-7-13-19-14-8-3-5-10-16(14)20-17-11-6-4-9-15(17)19/h3-6,8-11H,7,12-13H2,1-2H3",
      "standard_inchi_key": "ZGUGWUXLJSTTMA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Promazine HCl (FDA, USP)",
        "Promazine (BAN, INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Usl Pharma Llc",
        "Sandoz Inc",
        "Watson Laboratories Inc",
        "Banner Pharmacaps Inc",
        "Wyeth Ayerst Laboratories",
        "Teva Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C10AB01",
        "description": "CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Fibrates"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1967,
    "indication_class": "Antihyperlipidemic",
    "molecule_chembl_id": "CHEMBL565",
    "molecule_properties": {
      "acd_logd": 3.88,
      "acd_logp": 3.88,
      "alogp": 3.06,
      "aromatic_rings": 1,
      "full_molformula": "C12H15ClO3",
      "full_mwt": 242.7,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 16,
      "mw_freebase": 242.7,
      "mw_monoisotopic": 242.071,
      "psa": 35.53,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1",
      "standard_inchi": "InChI=1S/C12H15ClO3/c1-4-15-11(14)12(2,3)16-10-7-5-9(13)6-8-10/h5-8H,4H2,1-3H3",
      "standard_inchi_key": "KNHUKKLJHYUCFP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "prodrug": true,
    "research_codes": {
      "value": [
        "AY-61123",
        "ICI-28257"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clofibrate (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-fibrate",
    "usan_stem_definition": "antihyperlipidemics (clofibrate type)",
    "usan_stem_substem": "-fibrate(-fibrate)",
    "usan_year": 1963
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antihyperlipoproteinemic",
    "molecule_chembl_id": "CHEMBL278488",
    "molecule_properties": {
      "acd_logd": -1.69,
      "acd_logp": 2.04,
      "acd_most_apka": 2.25,
      "alogp": 1.47,
      "aromatic_rings": 1,
      "full_molformula": "C12H10O4",
      "full_mwt": 218.21,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "ACID",
      "mw_freebase": 218.21,
      "mw_monoisotopic": 218.0579,
      "psa": 63.6,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(OC(=CC1=O)C(=O)O)c2ccccc2",
      "standard_inchi": "InChI=1S/C12H10O4/c1-12(8-5-3-2-4-6-8)10(13)7-9(16-12)11(14)15/h2-7H,1H3,(H,14,15)",
      "standard_inchi_key": "DFDGRKNOFOJBAJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AY-25712"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Acifran (INN, USAN)",
        null
      ]
    },
    "usan_year": 1984
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 7,
    "indication_class": "Antineoplastic (adjunct)",
    "molecule_chembl_id": "CHEMBL566",
    "molecule_properties": {
      "acd_logd": -1.08,
      "acd_logp": -1.04,
      "acd_most_apka": 8.95,
      "alogp": -0.94,
      "aromatic_rings": 1,
      "full_molformula": "C4H4N2O2",
      "full_mwt": 112.09,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 8,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 112.09,
      "mw_monoisotopic": 112.0273,
      "psa": 65.72,
      "qed_weighted": 0.45,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1NC=CC(=O)N1",
      "standard_inchi": "InChI=1S/C4H4N2O2/c7-3-1-2-5-4(8)6-3/h1-2H,(H2,5,6,7,8)",
      "standard_inchi_key": "ISAKRJDGNUQOIC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "SQ-7726",
        "SQ-6201",
        "SQ-8493",
        "BMS-205603-01"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Uracil (JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-racil",
    "usan_stem_definition": "uracil type antineoplastics",
    "usan_stem_substem": "-racil(-racil)",
    "usan_year": 1997
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL15487",
    "molecule_properties": {
      "acd_logd": -2.16,
      "acd_logp": 0.61,
      "acd_most_bpka": 10.45,
      "alogp": 0.76,
      "full_molformula": "C5H11N",
      "full_mwt": 85.15,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 6,
      "molecular_species": "BASE",
      "mw_freebase": 85.15,
      "mw_monoisotopic": 85.0891,
      "psa": 12.03,
      "qed_weighted": 0.46,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "C1CCNCC1",
      "standard_inchi": "InChI=1S/C5H11N/c1-2-4-6-5-3-1/h6H,1-5H2",
      "standard_inchi_key": "NQRYJNQNLNOLGT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Piperidine Phosphate (MI)",
        null
      ]
    },
    "usan_stem": "-eridine",
    "usan_stem_definition": "analgesics (meperidine type)",
    "usan_stem_substem": "-eridine(-eridine)"
  },
  {
    "applicants": {
      "value": [
        "Wes Pharma Inc",
        "Valeant Pharmaceuticals North America Llc",
        "Mallinckrodt Chemical Inc",
        "Novast Laboratories Ltd",
        "Watson Laboratories Inc Florida",
        "Mayrand Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Schering Plough Healthcare Products Inc",
        "Dava Pharmaceuticals Inc",
        "Hikma International Pharmaceuticals Llc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N02BE51",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilide"
        },
        {
          "code": "N02BE71",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilide"
        },
        {
          "code": "N02BE01",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilides"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1968,
    "indication_class": "Analgesic; Antipyretic",
    "molecule_chembl_id": "CHEMBL112",
    "molecule_properties": {
      "acd_logd": 0.47,
      "acd_logp": 0.47,
      "acd_most_apka": 9.86,
      "acd_most_bpka": 1.72,
      "alogp": 1.35,
      "aromatic_rings": 1,
      "full_molformula": "C8H9NO2",
      "full_mwt": 151.16,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 11,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 151.16,
      "mw_monoisotopic": 151.0633,
      "psa": 49.33,
      "qed_weighted": 0.6,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)Nc1ccc(O)cc1",
      "standard_inchi": "InChI=1S/C8H9NO2/c1-6(10)9-7-2-4-8(11)5-3-7/h2-5,11H,1H3,(H,9,10)",
      "standard_inchi_key": "RZVAJINKPMORJF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5972916,
    "oral": true,
    "parenteral": true,
    "prodrug": true,
    "rule_of_five": true,
    "sc_patent": "US-5972916-A",
    "synonyms": {
      "value": [
        "Acetaminophen (FDA, JAN, USP)",
        "Paracetamol (BAN, DCF, INN)",
        null
      ]
    },
    "topical": true
  },
  {
    "atc_classification": {
      "drug": {
        "code": "M01AE05",
        "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL277522",
    "molecule_properties": {
      "acd_logd": 0.32,
      "acd_logp": 3.12,
      "acd_most_apka": 4.55,
      "alogp": 3.4,
      "aromatic_rings": 2,
      "full_molformula": "C16H14O3",
      "full_mwt": 254.28,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "ACID",
      "mw_freebase": 254.28,
      "mw_monoisotopic": 254.0943,
      "psa": 54.37,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2",
      "standard_inchi": "InChI=1S/C16H14O3/c17-15(10-11-16(18)19)14-8-6-13(7-9-14)12-4-2-1-3-5-12/h1-9H,10-11H2,(H,18,19)",
      "standard_inchi_key": "ZPAKPRAICRBAOD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CL-82204"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fenbufen (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-bufen",
    "usan_stem_definition": "non-steroidal anti-inflammatory agents, fenbufen derivatives",
    "usan_stem_substem": "-bufen(-bufen)",
    "usan_year": 1973
  },
  {
    "atc_classification": {
      "drug": {
        "code": "D01AE10",
        "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (antifungal agent)",
    "molecule_chembl_id": "CHEMBL15841",
    "molecule_properties": {
      "acd_logd": 2.34,
      "acd_logp": 2.39,
      "acd_most_apka": 8.31,
      "alogp": 1.57,
      "aromatic_rings": 1,
      "full_molformula": "C9H10O3",
      "full_mwt": 166.18,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 12,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 166.18,
      "mw_monoisotopic": 166.063,
      "psa": 46.53,
      "qed_weighted": 0.68,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)c1ccc(O)cc1",
      "standard_inchi": "InChI=1S/C9H10O3/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6,10H,2H2,1H3",
      "standard_inchi_key": "NUVBSKCKDOMJSU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ethyl Parahydroxybenzoate (JAN)",
        "Ethylparaben (NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL279157",
    "molecule_properties": {
      "acd_logd": -0.93,
      "acd_logp": 1.08,
      "acd_most_apka": 13.96,
      "acd_most_bpka": 9.38,
      "alogp": 1.33,
      "aromatic_rings": 1,
      "full_molformula": "C10H15NO",
      "full_mwt": 165.24,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 12,
      "molecular_species": "BASE",
      "mw_freebase": 165.24,
      "mw_monoisotopic": 165.1154,
      "psa": 32.26,
      "qed_weighted": 0.71,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CNC(C)C(O)c1ccccc1",
      "standard_inchi": "InChI=1S/C10H15NO/c1-8(11-2)10(12)9-6-4-3-5-7-9/h3-8,10-12H,1-2H3",
      "standard_inchi_key": "KWGRBVOPPLSCSI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Racephedrine (BAN, INN)",
        "Racephedrine HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-drine",
    "usan_stem_definition": "sympathomimetics",
    "usan_stem_substem": "-drine(-drine)",
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Gilbert Laboratories",
        "Mallinckrodt Chemical Inc",
        "Novast Laboratories Ltd",
        "Mallinckrodt Inc",
        "Lannett Holdings Inc",
        "Forest Pharmaceuticals Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Wraser Pharmaceuticals Llc",
        "Exela Pharma Sciences Llc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06BC01",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Xanthine derivatives"
      }
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1948,
    "indication_class": "Stimulant (central)",
    "molecule_chembl_id": "CHEMBL113",
    "molecule_properties": {
      "acd_logd": -0.63,
      "acd_logp": -0.63,
      "acd_most_bpka": 0.52,
      "alogp": -1.03,
      "aromatic_rings": 2,
      "full_molformula": "C8H10N4O2",
      "full_mwt": 194.19,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 194.19,
      "mw_monoisotopic": 194.0804,
      "psa": 61.82,
      "qed_weighted": 0.54,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)N(C)c2ncn(C)c2C1=O",
      "standard_inchi": "InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",
      "standard_inchi_key": "RYYVLZVUVIJVGH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5972916,
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-5972916-A",
    "synonyms": {
      "value": [
        "Caffeine Citrate (FDA)",
        "Caffeine, Citrated (MI, NF)",
        "Caffeine (BAN, FDA, JAN, USP)",
        null
      ]
    },
    "topical": true
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "N02BE53",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilide"
        },
        {
          "code": "N02BE03",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilide"
        },
        {
          "code": "N02BE73",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Anilides"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL16073",
    "molecule_properties": {
      "acd_logd": 1.66,
      "acd_logp": 1.66,
      "acd_most_bpka": 1.42,
      "alogp": 2.04,
      "aromatic_rings": 1,
      "full_molformula": "C10H13NO2",
      "full_mwt": 179.22,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 13,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 179.22,
      "mw_monoisotopic": 179.0946,
      "psa": 38.33,
      "qed_weighted": 0.77,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCOc1ccc(NC(=O)C)cc1",
      "standard_inchi": "InChI=1S/C10H13NO2/c1-3-13-10-6-4-9(5-7-10)11-8(2)12/h4-7H,3H2,1-2H3,(H,11,12)",
      "standard_inchi_key": "CPJSUEIXXCENMM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Phenacetin (INN, JAN, USP)",
        null
      ]
    },
    "withdrawn_class": "Nephrotoxicity",
    "withdrawn_country": "United Kingdom; United States; Germany; Denmark",
    "withdrawn_reason": "Nephropathy",
    "withdrawn_year": 1980
  },
  {
    "applicants": {
      "value": [
        "Sun Pharmaceutical Industries Inc",
        "Wilshire Pharmaceuticals Inc",
        "Schering Corp Sub Schering Plough Corp",
        "Sandoz Inc",
        "New River Pharmaceuticals Inc",
        "Watson Laboratories Inc",
        "Par Pharmaceutical Inc",
        "Pharmaceutical Assoc Inc",
        "Ani Pharmaceuticals Inc",
        "Mylan Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AB03",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperazine structure"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1957,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL567",
    "molecule_properties": {
      "acd_logd": 3.6,
      "acd_logp": 3.94,
      "acd_most_bpka": 7.39,
      "alogp": 3.94,
      "aromatic_rings": 2,
      "full_molformula": "C21H26ClN3OS",
      "full_mwt": 403.98,
      "hba": 5,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 403.98,
      "mw_monoisotopic": 403.1485,
      "psa": 29.95,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "OCCN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1",
      "standard_inchi": "InChI=1S/C21H26ClN3OS/c22-17-6-7-21-19(16-17)25(18-4-1-2-5-20(18)27-21)9-3-8-23-10-12-24(13-11-23)14-15-26/h1-2,4-7,16,26H,3,8-15H2",
      "standard_inchi_key": "RGCVKNLCSQQDEP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Perphenazine (BAN, FDA, INN, JAN, USP)",
        "Perphenazine Fendizoate (JAN)",
        "Perphenazine Maleate (JAN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "American Therapeutics Inc",
        "Actavis Elizabeth Llc",
        "Sun Pharmaceutical Industries Inc",
        "Anda Repository Llc",
        "Sandoz Inc",
        "Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Watson Laboratories Inc",
        "Quantum Pharmics Ltd",
        "Parke Davis Div Warner Lambert Co",
        "Mylan Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05BA04",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1965,
    "indication_class": "Tranquilizer (minor)",
    "molecule_chembl_id": "CHEMBL568",
    "molecule_properties": {
      "acd_logd": 2.21,
      "acd_logp": 2.22,
      "acd_most_apka": 10.94,
      "acd_most_bpka": 1.17,
      "alogp": 2.45,
      "aromatic_rings": 2,
      "full_molformula": "C15H11ClN2O2",
      "full_mwt": 286.72,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 286.72,
      "mw_monoisotopic": 286.0509,
      "psa": 61.69,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "OC1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O",
      "standard_inchi": "InChI=1S/C15H11ClN2O2/c16-10-6-7-12-11(8-10)13(9-4-2-1-3-5-9)18-15(20)14(19)17-12/h1-8,15,20H,(H,17,19)",
      "standard_inchi_key": "ADIMAYPTOBDMTL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "WY-3498"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Oxazepam (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-azepam",
    "usan_stem_definition": "antianxiety agents (diazepam type)",
    "usan_stem_substem": "-azepam(-azepam)",
    "usan_year": 1965
  },
  {
    "applicants": {
      "value": [
        "Epic Pharma Llc",
        "Sun Pharmaceutical Industries Inc",
        "Merck Research Laboratories Div Merck Co Inc",
        "Sandoz Inc",
        "Watson Laboratories Inc",
        "Ani Pharmaceuticals Inc",
        "Mylan Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "M01AB02",
        "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1978,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL15770",
    "molecule_properties": {
      "acd_logd": -0.49,
      "acd_logp": 2.55,
      "acd_most_apka": 4.26,
      "alogp": 4.37,
      "aromatic_rings": 2,
      "full_molformula": "C20H17FO3S",
      "full_mwt": 356.42,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 356.42,
      "mw_monoisotopic": 356.0882,
      "psa": 54.37,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "C[S+]([O-])c1ccc(\\C=C/2\\C(=C(CC(=O)O)c3cc(F)ccc23)C)cc1",
      "standard_inchi": "InChI=1S/C20H17FO3S/c1-12-17(9-13-3-6-15(7-4-13)25(2)24)16-8-5-14(21)10-19(16)18(12)11-20(22)23/h3-10H,11H2,1-2H3,(H,22,23)/b17-9-",
      "standard_inchi_key": "MLKXDPUZXIRXEP-MFOYZWKCSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "prodrug": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulindac (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-ac",
    "usan_stem_definition": "anti-inflammatory agents (acetic acid derivatives)",
    "usan_stem_substem": "-ac(-ac)",
    "usan_year": 1975
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1978,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL15677",
    "molecule_properties": {
      "acd_logd": 1.41,
      "acd_logp": 4.59,
      "acd_most_apka": 4.08,
      "alogp": 4.41,
      "aromatic_rings": 2,
      "full_molformula": "C14H10Cl2O3",
      "full_mwt": 297.14,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "ACID",
      "mw_freebase": 297.14,
      "mw_monoisotopic": 296.0007,
      "psa": 46.53,
      "qed_weighted": 0.91,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)Cc1ccccc1Oc2ccc(Cl)cc2Cl",
      "standard_inchi": "InChI=1S/C14H10Cl2O3/c15-10-5-6-13(11(16)8-10)19-12-4-2-1-3-9(12)7-14(17)18/h1-6,8H,7H2,(H,17,18)",
      "standard_inchi_key": "IDKAXRLETRCXKS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "R-67408",
        "RX-67408"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fenclofenac (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ac",
    "usan_stem_definition": "anti-inflammatory agents (acetic acid derivatives)",
    "usan_stem_substem": "-ac(-ac)",
    "usan_year": 1978,
    "withdrawn_class": "Carcinogenicity; Dermatological toxicity",
    "withdrawn_country": "United Kingdom",
    "withdrawn_reason": "Cutaneous Reactions; Animal Carcinogenicity",
    "withdrawn_year": 1984
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "P03AB01",
          "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES: Chlorine containing product"
        },
        {
          "code": "P03AB51",
          "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES: Chlorine containing products"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL416898",
    "molecule_properties": {
      "acd_logd": 6.32,
      "acd_logp": 6.32,
      "alogp": 6.5,
      "aromatic_rings": 2,
      "full_molformula": "C14H9Cl5",
      "full_mwt": 354.49,
      "heavy_atoms": 19,
      "mw_freebase": 354.49,
      "mw_monoisotopic": 351.9147,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 0,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1ccc(cc1)C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl",
      "standard_inchi": "InChI=1S/C14H9Cl5/c15-11-5-1-9(2-6-11)13(14(17,18)19)10-3-7-12(16)8-4-10/h1-8,13H",
      "standard_inchi_key": "YVGGHNCTFXOJCH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Chlorophenothane (NF)",
        "Clofenotane (INN)",
        "Dicophane (BAN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL276520",
    "molecule_properties": {
      "acd_logd": 0.18,
      "acd_logp": 3.06,
      "acd_most_bpka": 10.69,
      "alogp": 3.1,
      "aromatic_rings": 2,
      "full_molformula": "C15H20N2",
      "full_mwt": 228.34,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "BASE",
      "mw_freebase": 228.34,
      "mw_monoisotopic": 228.1626,
      "psa": 27.82,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "C(Cc1c[nH]c2ccccc12)C3CCNCC3",
      "standard_inchi": "InChI=1S/C15H20N2/c1-2-4-15-14(3-1)13(11-17-15)6-5-12-7-9-16-10-8-12/h1-4,11-12,16-17H,5-10H2",
      "standard_inchi_key": "SADQVAVFGNTEOD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "LM-5008"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Indalpine (BAN, INN, MI)",
        null
      ]
    },
    "usan_stem": "-pin(e)",
    "usan_stem_definition": "tricyclic compounds",
    "usan_stem_substem": "-pin(e)(-pin(e))",
    "withdrawn_class": "Hematological toxicity",
    "withdrawn_country": "France",
    "withdrawn_reason": "Agranulocytosis",
    "withdrawn_year": 1985
  },
  {
    "applicants": {
      "value": [
        "Eastman Kodak Co",
        "Miles Laboratories Inc",
        "Bel Mar Laboratories Inc",
        "Pfizer Laboratories Div Pfizer Inc",
        "Gd Searle Llc",
        "Watson Laboratories Inc",
        "Hospira Inc",
        "Abraxis Pharmaceutical Products",
        "Lederle Laboratories Div American Cyanamid Co",
        "Elkins Sinn Div Ah Robins Co Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N01BA52",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Esters of aminobenzoic aci"
        },
        {
          "code": "S01HA05",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: LOCAL ANESTHETICS: Local anesthetic"
        },
        {
          "code": "N01BA02",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Esters of aminobenzoic aci"
        },
        {
          "code": "C05AD05",
          "description": "CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Local anesthetics"
        }
      ]
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1954,
    "indication_class": "Anesthetic (local)",
    "molecule_chembl_id": "CHEMBL569",
    "molecule_properties": {
      "acd_logd": 0.42,
      "acd_logp": 2.26,
      "acd_most_bpka": 9.24,
      "alogp": 1.77,
      "aromatic_rings": 1,
      "full_molformula": "C13H20N2O2",
      "full_mwt": 236.31,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "BASE",
      "mw_freebase": 236.31,
      "mw_monoisotopic": 236.1525,
      "psa": 55.56,
      "qed_weighted": 0.6,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCOC(=O)c1ccc(N)cc1",
      "standard_inchi": "InChI=1S/C13H20N2O2/c1-3-15(4-2)9-10-17-13(16)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3",
      "standard_inchi_key": "MFDFERRIHVXMIY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Procaine HCl (FDA, JAN, USP)",
        "Procaine (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-caine",
    "usan_stem_definition": "local anesthetics",
    "usan_stem_substem": "-caine(-caine)"
  },
  {
    "applicants": {
      "value": [
        "Apothecon Inc Div Bristol Myers Squibb",
        "Bristol Myers Squibb Co",
        "Apothecon Sub Bristol Myers Squibb Co"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AA05",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with aliphatic side-chain"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1957,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL570",
    "molecule_properties": {
      "acd_logd": 3.22,
      "acd_logp": 5.16,
      "acd_most_bpka": 9.4,
      "alogp": 5.26,
      "aromatic_rings": 2,
      "full_molformula": "C18H19F3N2S",
      "full_mwt": 352.43,
      "hba": 3,
      "hba_lipinski": 2,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 352.43,
      "mw_monoisotopic": 352.1221,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 6.48,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCCN1c2ccccc2Sc3ccc(cc13)C(F)(F)F",
      "standard_inchi": "InChI=1S/C18H19F3N2S/c1-22(2)10-5-11-23-14-6-3-4-7-16(14)24-17-9-8-13(12-15(17)23)18(19,20)21/h3-4,6-9,12H,5,10-11H2,1-2H3",
      "standard_inchi_key": "XSCGXQMFQXDFCW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "synonyms": {
      "value": [
        "Triflupromazine HCl (FDA, JAN, USP)",
        "Triflupromazine (BAN, FDA, INN, USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Aurolife Pharma Llc",
        "Actavis Laboratories Fl Inc",
        "Novartis Consumer Health Inc",
        "Bayer Healthcare Llc",
        "Heritage Pharmaceuticals Inc",
        "Wyeth Ayerst Laboratories",
        "L Perrigo Co",
        "Wyeth Consumer Healthcare",
        "Mylan Pharmaceuticals Inc",
        "Alkermes Gainesville Llc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "M01AE53",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivative"
        },
        {
          "code": "M01AE03",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivative"
        },
        {
          "code": "M02AA10",
          "description": "MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical use"
        }
      ]
    },
    "availability_type": 2,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1986,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL571",
    "molecule_properties": {
      "acd_logd": -0.16,
      "acd_logp": 2.91,
      "acd_most_apka": 4.23,
      "alogp": 3.11,
      "aromatic_rings": 2,
      "full_molformula": "C16H14O3",
      "full_mwt": 254.29,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "ACID",
      "mw_freebase": 254.29,
      "mw_monoisotopic": 254.0943,
      "psa": 54.37,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2",
      "standard_inchi": "InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)",
      "standard_inchi_key": "DKYWVDODHFEZIM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "R.P. 19583",
        "RP-19583"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ketoprofen (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-profen",
    "usan_stem_definition": "anti-inflammatory/analgesic agents (ibuprofen type)",
    "usan_stem_substem": "-profen(-profen)",
    "usan_year": 1972
  },
  {
    "applicants": {
      "value": [
        "Casper Pharma Llc",
        "Whiteworth Towne Paulsen Inc",
        "Sun Pharmaceutical Industries Inc",
        "Lannett Co Inc",
        "Actavis Laboratories Fl Inc",
        "Alvogen Malta Operations Ltd",
        "Sandoz Inc",
        "Nostrum Laboratories Inc",
        "Watson Laboratories Inc",
        "Ranbaxy Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "J01XE51",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Nitrofuran derivative"
        },
        {
          "code": "J01XE01",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Nitrofuran derivatives"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1953,
    "indication_class": "Antibacterial (urinary)",
    "molecule_chembl_id": "CHEMBL572",
    "molecule_properties": {
      "acd_logd": -0.7,
      "acd_logp": -0.47,
      "acd_most_apka": 7.55,
      "alogp": 0.07,
      "aromatic_rings": 1,
      "full_molformula": "C8H6N4O5",
      "full_mwt": 238.16,
      "hba": 6,
      "hba_lipinski": 9,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 238.16,
      "mw_monoisotopic": 238.0338,
      "psa": 118.05,
      "qed_weighted": 0.35,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "[O-][N+](=O)c1oc(\\C=N\\N2CC(=O)NC2=O)cc1",
      "standard_inchi": "InChI=1S/C8H6N4O5/c13-6-4-11(8(14)10-6)9-3-5-1-2-7(17-5)12(15)16/h1-3H,4H2,(H,10,13,14)/b9-3+",
      "standard_inchi_key": "NXFQHRVNIOXGAQ-YCRREMRBSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nitrofurantoin sodium (FDA)",
        "Nitrofurantoin (BAN, FDA, INN, JAN, USP)",
        "Nitrofurantoin Macrocrystalline (FDA)",
        null
      ]
    },
    "usan_stem": "-toin",
    "usan_stem_definition": "antiepileptics (hydantoin derivatives)",
    "usan_stem_substem": "-toin(-toin)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "M01AE10",
        "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1979,
    "indication_class": "Analgesic; Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL15870",
    "molecule_properties": {
      "acd_logd": -0.06,
      "acd_logp": 2.82,
      "acd_most_apka": 4.39,
      "acd_most_bpka": 0.35,
      "alogp": 3.04,
      "aromatic_rings": 2,
      "full_molformula": "C17H15NO3",
      "full_mwt": 281.31,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "ACID",
      "mw_freebase": 281.31,
      "mw_monoisotopic": 281.1052,
      "psa": 57.61,
      "qed_weighted": 0.94,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O",
      "standard_inchi": "InChI=1S/C17H15NO3/c1-11(17(20)21)12-6-8-14(9-7-12)18-10-13-4-2-3-5-15(13)16(18)19/h2-9,11H,10H2,1H3,(H,20,21)",
      "standard_inchi_key": "RJMIEHBSYVWVIN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "K-4277"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Indoprofen (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-profen",
    "usan_stem_definition": "anti-inflammatory/analgesic agents (ibuprofen type)",
    "usan_stem_substem": "-profen(-profen)",
    "usan_year": 1976,
    "withdrawn_class": "Carcinogenicity; Gastrotoxicity",
    "withdrawn_country": "United Kingdom; Spain; Germany",
    "withdrawn_reason": "Animal Carcinogenicity (rodent); Gastrointestinal Toxicity",
    "withdrawn_year": 1983
  },
  {
    "applicants": {
      "value": [
        "Sola Barnes Hind",
        "Reed And Carnrick Pharmaceuticals Div Block Drug Co Inc",
        "Wockhardt Eu Operations (Swiss) Ag",
        "Stiefel Laboratories Inc",
        "Olta Pharmaceuticals Corp"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "P03AB02",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES: Chlorine containing products"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1974,
    "indication_class": "Pediculicide; Scabicide",
    "molecule_chembl_id": "CHEMBL15891",
    "molecule_properties": {
      "acd_logd": 3.82,
      "acd_logp": 3.82,
      "alogp": 3.64,
      "full_molformula": "C6H6Cl6",
      "full_mwt": 290.83,
      "heavy_atoms": 12,
      "mw_freebase": 290.83,
      "mw_monoisotopic": 287.8601,
      "psa": 0,
      "qed_weighted": 0.6,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "Cl[C@@H]1[C@@H](Cl)[C@H](Cl)[C@H](Cl)[C@@H](Cl)[C@@H]1Cl",
      "standard_inchi": "InChI=1S/C6H6Cl6/c7-1-2(8)4(10)6(12)5(11)3(1)9/h1-6H/t1-,2-,3-,4+,5+,6+",
      "standard_inchi_key": "JLYXXMFPNIAWKQ-GNIYUCBRSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lindane (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1980
  },
  {
    "applicants": {
      "value": [
        "Everylife",
        "Mk Laboratories Inc",
        "Hikma Pharmaceuticals Llc",
        "Medpointe Pharmaceuticals Medpointe Healthcare Inc",
        "Lannett Co Inc",
        "Lupin Ltd",
        "Sanofi Aventis Us Llc",
        "Sandoz Inc",
        "Watson Laboratories Inc",
        "Avondale Pharmaceuticals Llc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "C04AC01",
          "description": "CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Nicotinic acid and derivative"
        },
        {
          "code": "C10AD02",
          "description": "CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Nicotinic acid and derivative"
        },
        {
          "code": "C10AD52",
          "description": "CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Nicotinic acid and derivatives"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Vitamin (enzyme co-factor); Antihyperlipidemic",
    "molecule_chembl_id": "CHEMBL573",
    "molecule_properties": {
      "acd_logd": -2.85,
      "acd_logp": 0.22,
      "acd_most_apka": 2.2,
      "acd_most_bpka": 4.8,
      "alogp": 0.78,
      "aromatic_rings": 1,
      "full_molformula": "C6H5NO2",
      "full_mwt": 123.11,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 9,
      "molecular_species": "ACID",
      "mw_freebase": 123.11,
      "mw_monoisotopic": 123.032,
      "psa": 50.19,
      "qed_weighted": 0.6,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)c1cccnc1",
      "standard_inchi": "InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)",
      "standard_inchi_key": "PVNIIMVLHYAWGP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6080428,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-6080428-A",
    "synonyms": {
      "value": [
        "Niacin (FDA, USP)",
        "Nicotinic Acid (INN, JAN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": "Apothecon Inc Div Bristol Myers Squibb"
    },
    "atc_classification": {
      "drug": {
        "code": "J01CF03",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase resistant penicillins"
      }
    },
    "availability_type": 0,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1982,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL575",
    "molecule_properties": {
      "acd_logd": -2.71,
      "acd_logp": 1.02,
      "acd_most_apka": 2.44,
      "alogp": 0.95,
      "aromatic_rings": 1,
      "full_molformula": "C17H20N2O6S",
      "full_mwt": 380.42,
      "hba": 6,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 380.42,
      "mw_monoisotopic": 380.1042,
      "psa": 105.17,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cccc(OC)c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O",
      "standard_inchi": "InChI=1S/C17H20N2O6S/c1-17(2)12(16(22)23)19-14(21)11(15(19)26-17)18-13(20)10-8(24-3)6-5-7-9(10)25-4/h5-7,11-12,15H,1-4H3,(H,18,20)(H,22,23)/t11-,12+,15-/m1/s1",
      "standard_inchi_key": "RJQXTJLFIWVMTO-TYNCELHUSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "BRL-1241",
        "SQ-16123",
        "X-1497"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Methicillin (BAN, BAN)",
        "Methicillin sodium (FDA, USAN, USP)",
        "Meticillin Sodium (JAN)",
        "Meticillin (INN)",
        null
      ]
    },
    "usan_stem": "-cillin",
    "usan_stem_definition": "penicillins",
    "usan_stem_substem": "-cillin(-cillin)",
    "usan_year": 1962
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL15721",
    "molecule_properties": {
      "acd_logd": 1.36,
      "acd_logp": 1.36,
      "acd_most_apka": 10.65,
      "alogp": 1,
      "aromatic_rings": 1,
      "full_molformula": "C5H4N2O4",
      "full_mwt": 156.1,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 11,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 156.1,
      "mw_monoisotopic": 156.0171,
      "psa": 88.87,
      "qed_weighted": 0.3,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "O\\N=C\\c1oc(cc1)[N+](=O)[O-]",
      "standard_inchi": "InChI=1S/C5H4N2O4/c8-6-3-4-1-2-5(11-4)7(9)10/h1-3,8H/b6-3+",
      "standard_inchi_key": "PTBKFATYSVLSSD-ZZXKWVIFSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nifuroxime (INN, MI, NF)",
        null
      ]
    },
    "usan_stem": "nifur-",
    "usan_stem_definition": "5-nitrofuran derivatives",
    "usan_stem_substem": "nifur-(nifur-)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL16080",
    "molecule_properties": {
      "acd_logd": 2.35,
      "acd_logp": 2.35,
      "alogp": 2.38,
      "full_molformula": "C2H3Cl3",
      "full_mwt": 133.41,
      "heavy_atoms": 5,
      "mw_freebase": 133.41,
      "mw_monoisotopic": 131.93,
      "psa": 0,
      "qed_weighted": 0.45,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CC(Cl)(Cl)Cl",
      "standard_inchi": "InChI=1S/C2H3Cl3/c1-2(3,4)5/h1H3",
      "standard_inchi_key": "UOCLXMDMGBRAIB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": "Trichloroethane"
    },
    "withdrawn_country": "United States"
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "N01BA05",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Esters of aminobenzoic aci"
        },
        {
          "code": "C05AD03",
          "description": "CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Local anesthetic"
        },
        {
          "code": "D04AB04",
          "description": "DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Anesthetics for topical us"
        },
        {
          "code": "R02AD01",
          "description": "RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Anesthetics, local"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Anesthetic (topical)",
    "molecule_chembl_id": "CHEMBL278172",
    "molecule_properties": {
      "acd_logd": 1.83,
      "acd_logp": 1.83,
      "acd_most_bpka": 2.51,
      "alogp": 1.45,
      "aromatic_rings": 1,
      "full_molformula": "C9H11NO2",
      "full_mwt": 165.19,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 12,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 165.19,
      "mw_monoisotopic": 165.079,
      "psa": 52.32,
      "qed_weighted": 0.53,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)c1ccc(N)cc1",
      "standard_inchi": "InChI=1S/C9H11NO2/c1-2-12-9(11)7-3-5-8(10)6-4-7/h3-6H,2,10H2,1H3",
      "standard_inchi_key": "BLFLLBZGZJTVJG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Benzocaine (BAN, INN, USP)",
        "Ethyl Aminobenzoate (JAN)",
        null
      ]
    },
    "usan_stem": "-caine",
    "usan_stem_definition": "local anesthetics",
    "usan_stem_substem": "-caine(-caine)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL576",
    "molecule_properties": {
      "acd_logd": -5.47,
      "acd_logp": -0.93,
      "acd_most_apka": 4.25,
      "alogp": -0.06,
      "full_molformula": "C4H6O4",
      "full_mwt": 118.09,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 8,
      "molecular_species": "ACID",
      "mw_freebase": 118.09,
      "mw_monoisotopic": 118.0266,
      "psa": 74.6,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CCC(=O)O",
      "standard_inchi": "InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)",
      "standard_inchi_key": "KDYFGRWQOYBRFD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Succinic Acid (NF)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Biovail Laboratories International Srl",
        "Hospira Inc",
        "Athenex Inc",
        "Hikma Farmaceutica (Portugal) Sa"
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1988,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL577",
    "molecule_properties": {
      "acd_logd": -0.27,
      "acd_logp": 3.63,
      "acd_most_apka": 2.2,
      "acd_most_bpka": 7.79,
      "alogp": 1.13,
      "aromatic_rings": 1,
      "full_molformula": "C18H24N2O5",
      "full_mwt": 348.4,
      "hba": 4,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 348.4,
      "mw_monoisotopic": 348.1685,
      "psa": 106.94,
      "qed_weighted": 0.65,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N2CCC[C@H]2C(=O)O",
      "standard_inchi": "InChI=1S/C18H24N2O5/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25)/t12-,14-,15-/m0/s1",
      "standard_inchi_key": "LZFZMUMEGBBDTC-QEJZJMRPSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "MK-422",
        "MK-421"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Enalaprilat (BAN, USAN, USP, BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-prilat",
    "usan_stem_substem": "-prilat(-prilat)",
    "usan_year": 1984
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (flavor)",
    "molecule_chembl_id": "CHEMBL15972",
    "molecule_properties": {
      "acd_logd": 1.45,
      "acd_logp": 1.45,
      "alogp": 1.5,
      "aromatic_rings": 1,
      "full_molformula": "C7H6O",
      "full_mwt": 106.12,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 8,
      "mw_freebase": 106.12,
      "mw_monoisotopic": 106.0419,
      "psa": 17.07,
      "qed_weighted": 0.5,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "O=Cc1ccccc1",
      "standard_inchi": "InChI=1S/C7H6O/c8-6-7-4-2-1-3-5-7/h1-6H",
      "standard_inchi_key": "HUMNYLRZRPPJDN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Benzaldehyde (NF)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Valeant International Barbados Srl",
        "Valeant Pharmaceuticals North America Llc",
        "Apotex Inc Etobicoke Site",
        "Krka Dd Novo Mesto",
        "Upsher-Smith Laboratories Llc",
        "Silvergate Pharmaceuticals Inc",
        "Apotex Inc",
        "Astrazeneca Pharmaceuticals Lp",
        "Biovail Laboratories Inc",
        "Apothecon Inc Div Bristol Myers Squibb"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C09AA02",
        "description": "CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ACE INHIBITORS, PLAIN: ACE inhibitors, plain"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1985,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL578",
    "molecule_properties": {
      "acd_logd": -0.32,
      "acd_logp": 3.25,
      "acd_most_apka": 3.15,
      "acd_most_bpka": 5.43,
      "alogp": 1.6,
      "aromatic_rings": 1,
      "full_molformula": "C20H28N2O5",
      "full_mwt": 376.45,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 27,
      "molecular_species": "ACID",
      "mw_freebase": 376.45,
      "mw_monoisotopic": 376.1998,
      "psa": 95.94,
      "qed_weighted": 0.64,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O",
      "standard_inchi": "InChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1",
      "standard_inchi_key": "GBXSMTUPTTWBMN-XIRDDKMYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8568747,
    "oral": true,
    "prodrug": true,
    "rule_of_five": true,
    "sc_patent": "US-8568747-B1",
    "synonyms": {
      "value": [
        "Enalapril (BAN, INN)",
        "Enalapril Maleate (FDA, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1981
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Enzyme Inhibitor (angiotensin-converting)",
    "molecule_chembl_id": "CHEMBL579",
    "molecule_properties": {
      "acd_logd": 2.24,
      "acd_logp": 6.26,
      "acd_most_apka": 2.19,
      "acd_most_bpka": 7.64,
      "alogp": 1.91,
      "aromatic_rings": 1,
      "full_molformula": "C20H26N2O5S2",
      "full_mwt": 438.57,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 29,
      "molecular_species": "ACID",
      "mw_freebase": 438.57,
      "mw_monoisotopic": 438.1283,
      "psa": 106.94,
      "qed_weighted": 0.57,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N2CC3(C[C@H]2C(=O)O)SCCS3",
      "standard_inchi": "InChI=1S/C20H26N2O5S2/c1-13(21-15(18(24)25)8-7-14-5-3-2-4-6-14)17(23)22-12-20(28-9-10-29-20)11-16(22)19(26)27/h2-6,13,15-16,21H,7-12H2,1H3,(H,24,25)(H,26,27)/t13-,15-,16-/m0/s1",
      "standard_inchi_key": "FMMDBLMCSDRUPA-BPUTZDHNSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SCH-33861"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Spiraprilat (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-pril",
    "usan_stem_definition": "antihypertensives (ACE inhibitors): diacid analogs",
    "usan_stem_substem": "-pril(-pril(-prilat))",
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": [
        "Sagent Agila Llc",
        "Anda Repository Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Hi-Tech Pharmacal Co Inc",
        "Dava Pharmaceuticals Inc",
        "Pharmaceutical Assoc Inc",
        "Halsey Drug Co Inc",
        "Hospira Inc",
        "Par Pharmaceutical Inc",
        "Bedford Laboratories Div Ben Venue Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N05BA56",
          "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivative"
        },
        {
          "code": "N05BA06",
          "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1977,
    "indication_class": "Tranquilizer (minor)",
    "molecule_chembl_id": "CHEMBL580",
    "molecule_properties": {
      "acd_logd": 2.38,
      "acd_logp": 2.38,
      "acd_most_apka": 10.8,
      "acd_most_bpka": 0.17,
      "alogp": 3.1,
      "aromatic_rings": 2,
      "full_molformula": "C15H10Cl2N2O2",
      "full_mwt": 321.16,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 321.16,
      "mw_monoisotopic": 320.0119,
      "psa": 61.69,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "OC1N=C(c2ccccc2Cl)c3cc(Cl)ccc3NC1=O",
      "standard_inchi": "InChI=1S/C15H10Cl2N2O2/c16-8-5-6-12-10(7-8)13(19-15(21)14(20)18-12)9-3-1-2-4-11(9)17/h1-7,15,21H,(H,18,20)",
      "standard_inchi_key": "DIWRORZWFLOCLC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "WY-4036"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lorazepam (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-azepam",
    "usan_stem_definition": "antianxiety agents (diazepam type)",
    "usan_stem_substem": "-azepam(-azepam)",
    "usan_year": 1969
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05BA08",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Tranquilizer (minor)",
    "molecule_chembl_id": "CHEMBL277062",
    "molecule_properties": {
      "acd_logd": 2.28,
      "acd_logp": 2.28,
      "acd_most_apka": 11.39,
      "acd_most_bpka": 2,
      "alogp": 2.63,
      "aromatic_rings": 2,
      "full_molformula": "C14H10BrN3O",
      "full_mwt": 316.16,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 316.16,
      "mw_monoisotopic": 315.0007,
      "psa": 54.35,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Brc1ccc2NC(=O)CN=C(c3ccccn3)c2c1",
      "standard_inchi": "InChI=1S/C14H10BrN3O/c15-9-4-5-11-10(7-9)14(17-8-13(19)18-11)12-3-1-2-6-16-12/h1-7H,8H2,(H,18,19)",
      "standard_inchi_key": "VMIYHDSEFNYJSL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "Ro-53350"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Bromazepam (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-azepam",
    "usan_stem_definition": "antianxiety agents (diazepam type)",
    "usan_stem_substem": "-azepam(-azepam)",
    "usan_year": 1969
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL581",
    "molecule_properties": {
      "acd_logd": -0.34,
      "acd_logp": 4.41,
      "acd_most_apka": 2.75,
      "alogp": 4.16,
      "aromatic_rings": 1,
      "full_molformula": "C23H34NO5P",
      "full_mwt": 435.5,
      "hba": 3,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 30,
      "molecular_species": "ACID",
      "mw_freebase": 435.5,
      "mw_monoisotopic": 435.2175,
      "psa": 94.91,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)[C@@H]1C[C@H](CN1C(=O)CP(=O)(O)CCCCc2ccccc2)C3CCCCC3",
      "standard_inchi": "InChI=1S/C23H34NO5P/c25-22(17-30(28,29)14-8-7-11-18-9-3-1-4-10-18)24-16-20(15-21(24)23(26)27)19-12-5-2-6-13-19/h1,3-4,9-10,19-21H,2,5-8,11-17H2,(H,26,27)(H,28,29)/t20-,21+/m1/s1",
      "standard_inchi_key": "WOIWWYDXDVSWAZ-RTWAWAEBSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SO-27519"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fosinoprilat (INN, USAN)",
        null
      ]
    },
    "usan_stem": "fos-; -prilat",
    "usan_stem_definition": "phosphoro-derivatives; antihypertensives (ACE inhibitors) (diacid analogs of the -pril entity)",
    "usan_stem_substem": "fos-(fos-); -prilat(-prilat)",
    "usan_year": 1990
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N01AB05",
        "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Halogenated hydrocarbons"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL279816",
    "molecule_properties": {
      "acd_logd": 2.56,
      "acd_logp": 2.56,
      "alogp": 2.5,
      "full_molformula": "C2HCl3",
      "full_mwt": 131.39,
      "heavy_atoms": 5,
      "mw_freebase": 131.39,
      "mw_monoisotopic": 129.9144,
      "psa": 0,
      "qed_weighted": 0.47,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "ClC=C(Cl)Cl",
      "standard_inchi": "InChI=1S/C2HCl3/c3-1-2(4)5/h1H",
      "standard_inchi_key": "XSTXAVWGXDQKEL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Trichloroethylene (INN, MI, NF)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "D01AC60",
          "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivative"
        },
        {
          "code": "D01AC10",
          "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivatives"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antifungal",
    "molecule_chembl_id": "CHEMBL277535",
    "molecule_properties": {
      "acd_logd": 4.63,
      "acd_logp": 4.69,
      "acd_most_bpka": 6.55,
      "alogp": 5.19,
      "aromatic_rings": 4,
      "full_molformula": "C22H18N2",
      "full_mwt": 310.4,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 310.4,
      "mw_monoisotopic": 310.147,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 17.82,
      "qed_weighted": 0.51,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "c1ccc(cc1)C(c2ccc(cc2)c3ccccc3)n4ccnc4",
      "standard_inchi": "InChI=1S/C22H18N2/c1-3-7-18(8-4-1)19-11-13-21(14-12-19)22(24-16-15-23-17-24)20-9-5-2-6-10-20/h1-17,22H",
      "standard_inchi_key": "OCAPBUJLXMYKEJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BAY-H-4502"
    },
    "synonyms": {
      "value": [
        "Bifonazole (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-fo-",
    "usan_stem_definition": "phosphoro-derivatives",
    "usan_stem_substem": "-fo-(-fo-)",
    "usan_year": 1981
  },
  {
    "applicants": {
      "value": [
        "Becton Dickinson And Co",
        "Professional Disposables Inc",
        "3M Health Care Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "D08AX05",
        "description": "DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Other antiseptics and disinfectants"
      }
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2000,
    "indication_class": "Anti-Infective, Topical; Pharmaceutic Aid (solvent)",
    "molecule_chembl_id": "CHEMBL582",
    "molecule_properties": {
      "acd_logd": 0.17,
      "acd_logp": 0.17,
      "alogp": 0.39,
      "full_molformula": "C3H8O",
      "full_mwt": 60.1,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 4,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 60.1,
      "mw_monoisotopic": 60.0575,
      "psa": 20.23,
      "qed_weighted": 0.43,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)O",
      "standard_inchi": "InChI=1S/C3H8O/c1-3(2)4/h3-4H,1-2H3",
      "standard_inchi_key": "KFZMGEQAYNKOFK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5690958,
    "rule_of_five": true,
    "sc_patent": "US-5690958-A",
    "synonyms": {
      "value": [
        "Isopropanol (JAN)",
        "Isopropyl alcohol (FDA, USP)",
        null
      ]
    },
    "topical": true
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N01AA01",
        "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Ethers"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Anesthetic (inhalation)",
    "molecule_chembl_id": "CHEMBL16264",
    "molecule_properties": {
      "acd_logd": 1.04,
      "acd_logp": 1.04,
      "alogp": 1.04,
      "full_molformula": "C4H10O",
      "full_mwt": 74.12,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 5,
      "mw_freebase": 74.12,
      "mw_monoisotopic": 74.0732,
      "psa": 9.23,
      "qed_weighted": 0.48,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCOCC",
      "standard_inchi": "InChI=1S/C4H10O/c1-3-5-4-2/h3-4H2,1-2H3",
      "standard_inchi_key": "RTZKZFJDLAIYFH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ether (JAN, USP)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL275835",
    "molecule_properties": {
      "acd_logd": 4.84,
      "acd_logp": 4.85,
      "acd_most_apka": 9.98,
      "alogp": 3.92,
      "aromatic_rings": 1,
      "full_molformula": "C18H24N2O2S",
      "full_mwt": 332.47,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 332.47,
      "mw_monoisotopic": 332.1558,
      "psa": 75.68,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)c1cc(\\C=C\\2/SC(=NC2=O)N)cc(c1O)C(C)(C)C",
      "standard_inchi": "InChI=1S/C18H24N2O2S/c1-17(2,3)11-7-10(8-12(14(11)21)18(4,5)6)9-13-15(22)20-16(19)23-13/h7-9,21H,1-6H3,(H2,19,20,22)/b13-9-",
      "standard_inchi_key": "AKTXOQVMWSFEBQ-LCYFTJDESA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CI-1004"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Darbufelone mesylate (USAN)",
        "Darbufelone (INN)",
        null
      ]
    },
    "usan_year": 1998
  },
  {
    "applicants": {
      "value": "Otsuka Pharmaceutical Co Ltd"
    },
    "atc_classification": {
      "drug": {
        "code": "J01MA11",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1997,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL583",
    "molecule_properties": {
      "acd_logd": 0.62,
      "acd_logp": 2.57,
      "acd_most_apka": 6.44,
      "acd_most_bpka": 8.74,
      "alogp": 2.28,
      "aromatic_rings": 2,
      "full_molformula": "C19H22FN3O3",
      "full_mwt": 359.4,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 359.4,
      "mw_monoisotopic": 359.1645,
      "psa": 74.57,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC1CN(CCN1)c2cc3N(C=C(C(=O)O)C(=O)c3c(C)c2F)C4CC4",
      "standard_inchi": "InChI=1S/C19H22FN3O3/c1-10-8-22(6-5-21-10)15-7-14-16(11(2)17(15)20)18(24)13(19(25)26)9-23(14)12-3-4-12/h7,9-10,12,21H,3-6,8H2,1-2H3,(H,25,26)",
      "standard_inchi_key": "AIJTTZAVMXIJGM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "OPC-17116"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Grepafloxacin (INN)",
        "Grepafloxacin HCl (BAN, FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1995,
    "withdrawn_class": "Cardiotoxicity",
    "withdrawn_country": "United States; United Kingdom; United States; Germany",
    "withdrawn_reason": "Cardiac repolarization; QTc interval prolongation",
    "withdrawn_year": 1999
  },
  {
    "applicants": {
      "value": [
        "Hoffmann La Roche Inc",
        "Hoffmann-La Roche Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J05AE01",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1995,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL114",
    "molecule_properties": {
      "acd_logd": 5.05,
      "acd_logp": 5.08,
      "acd_most_apka": 11.05,
      "acd_most_bpka": 6.29,
      "alogp": 3.09,
      "aromatic_rings": 3,
      "full_molformula": "C38H50N6O5",
      "full_mwt": 670.86,
      "hba": 7,
      "hba_lipinski": 11,
      "hbd": 5,
      "hbd_lipinski": 6,
      "heavy_atoms": 49,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 670.86,
      "mw_monoisotopic": 670.3843,
      "num_lipinski_ro5_violations": 3,
      "num_ro5_violations": 1,
      "psa": 166.75,
      "qed_weighted": 0.2,
      "ro3_pass": "N",
      "rtb": 12
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)NC(=O)[C@@H]1C[C@@H]2CCCC[C@@H]2CN1C[C@@H](O)[C@H](Cc3ccccc3)NC(=O)[C@H](CC(=O)N)NC(=O)c4ccc5ccccc5n4",
      "standard_inchi": "InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1",
      "standard_inchi_key": "QWAXKHKRTORLEM-UGJKXSETSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6352717,
    "oral": true,
    "research_codes": {
      "value": [
        "Ro-31-8959",
        "Ro-31-8959-003",
        "Ro-318959000",
        "Ro-318959003"
      ]
    },
    "sc_patent": "US-6352717-B2",
    "synonyms": {
      "value": [
        "Saquinavir (BAN, FDA, INN, USAN, USP)",
        "Saquinavir Mesylate (FDA, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-vir",
    "usan_stem_definition": "antivirals: HIV protease inhibitors (saquinavir type)",
    "usan_stem_substem": "-vir(-vir(-navir))",
    "usan_year": 1994
  },
  {
    "applicants": {
      "value": "Merck Sharp And Dohme Corp"
    },
    "atc_classification": {
      "drug": {
        "code": "J05AE02",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1996,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL115",
    "molecule_properties": {
      "acd_logd": 3.43,
      "acd_logp": 3.44,
      "acd_most_bpka": 5.19,
      "alogp": 2.87,
      "aromatic_rings": 3,
      "full_molformula": "C36H47N5O4",
      "full_mwt": 613.8,
      "hba": 7,
      "hba_lipinski": 9,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 45,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 613.8,
      "mw_monoisotopic": 613.3628,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 118.03,
      "qed_weighted": 0.26,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)NC(=O)[C@@H]1CN(Cc2cccnc2)CCN1C[C@@H](O)C[C@@H](Cc3ccccc3)C(=O)N[C@@H]4[C@H](O)Cc5ccccc45",
      "standard_inchi": "InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",
      "standard_inchi_key": "CBVCZFGXHXORBI-PXQQMZJSSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6645961,
    "oral": true,
    "research_codes": {
      "value": [
        "L-735524",
        "MK-639"
      ]
    },
    "sc_patent": "US-6645961-B1",
    "synonyms": {
      "value": [
        "Indinavir sulfate (FDA, USAN, USP)",
        "Indinavir (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-vir",
    "usan_stem_definition": "antivirals: HIV protease inhibitors (saquinavir type)",
    "usan_stem_substem": "-vir(-vir(-navir))",
    "usan_year": 1995
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL16134",
    "molecule_properties": {
      "acd_logd": 0.98,
      "acd_logp": 2.88,
      "acd_most_apka": 4.82,
      "acd_most_bpka": 1.39,
      "alogp": 2.32,
      "aromatic_rings": 2,
      "full_molformula": "C14H14N2O4S",
      "full_mwt": 306.34,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "ACID",
      "mw_freebase": 306.34,
      "mw_monoisotopic": 306.0674,
      "psa": 77.52,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)C(=O)Nc1nc(cs1)c2ccc(OC)cc2",
      "standard_inchi": "InChI=1S/C14H14N2O4S/c1-3-20-13(18)12(17)16-14-15-11(8-21-14)9-4-6-10(19-2)7-5-9/h4-8H,3H2,1-2H3,(H,15,16,17)",
      "standard_inchi_key": "ROVWYOFNUFLLNL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tioxamast (INN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics (not acting primarily as antihistamines,leukotriene biosynthesis inhibitors)",
    "usan_stem_substem": "-ast(-ast)"
  },
  {
    "applicants": {
      "value": "Agouron Pharmaceuticals Llc"
    },
    "atc_classification": {
      "drug": {
        "code": "J05AE04",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1997,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL584",
    "molecule_properties": {
      "acd_logd": 7.26,
      "acd_logp": 7.28,
      "acd_most_apka": 9.58,
      "acd_most_bpka": 6.21,
      "alogp": 4.75,
      "aromatic_rings": 2,
      "full_molformula": "C32H45N3O4S",
      "full_mwt": 567.8,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 40,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 567.8,
      "mw_monoisotopic": 567.3131,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 101.9,
      "qed_weighted": 0.33,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1c(O)cccc1C(=O)N[C@@H](CSc2ccccc2)[C@H](O)CN3C[C@H]4CCCC[C@H]4C[C@H]3C(=O)NC(C)(C)C",
      "standard_inchi": "InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",
      "standard_inchi_key": "QAGYKUNXZHXKMR-HKWSIXNMSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "AG-1343"
    },
    "synonyms": {
      "value": [
        "Nelfinavir mesylate (FDA, USAN)",
        "Nelfinavir (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-vir",
    "usan_stem_definition": "antivirals: HIV protease inhibitors (saquinavir type)",
    "usan_stem_substem": "-vir(-vir(-navir))",
    "usan_year": 1996
  },
  {
    "applicants": {
      "value": "Glaxosmithkline"
    },
    "atc_classification": {
      "drug": {
        "code": "J05AE05",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Protease inhibitors"
      }
    },
    "availability_type": 0,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1999,
    "molecule_chembl_id": "CHEMBL116",
    "molecule_properties": {
      "acd_logd": 2.68,
      "acd_logp": 2.68,
      "acd_most_apka": 11.54,
      "acd_most_bpka": 1.76,
      "alogp": 2.4,
      "aromatic_rings": 2,
      "full_molformula": "C25H35N3O6S",
      "full_mwt": 505.64,
      "hba": 7,
      "hba_lipinski": 9,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 35,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 505.64,
      "mw_monoisotopic": 505.2247,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 131.19,
      "qed_weighted": 0.4,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)CN(C[C@@H](O)[C@H](Cc1ccccc1)NC(=O)O[C@H]2CCOC2)S(=O)(=O)c3ccc(N)cc3",
      "standard_inchi": "InChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1",
      "standard_inchi_key": "YMARZQAQMVYCKC-OEMFJLHTSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6730679,
    "oral": true,
    "research_codes": {
      "value": [
        "VX-478",
        "KVX-478",
        "141 W94"
      ]
    },
    "sc_patent": "US-6730679-B1",
    "synonyms": {
      "value": [
        "Amprenavir (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-vir",
    "usan_stem_definition": "antivirals: HIV protease inhibitors (saquinavir type)",
    "usan_stem_substem": "-vir(-vir(-navir))",
    "usan_year": 1997
  },
  {
    "applicants": {
      "value": [
        "Vitarine Pharmaceuticals Inc",
        "American Therapeutics Inc",
        "Lannett Holdings Inc",
        "Apotex Inc",
        "Novartis Pharmaceuticals Corp",
        "Sandoz Inc",
        "Quantum Pharmics Ltd",
        "Watson Laboratories Inc",
        "Glaxosmithkline Llc",
        "Ani Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C03DB02",
        "description": "CARDIOVASCULAR SYSTEM: DIURETICS: POTASSIUM-SPARING AGENTS: Other potassium-sparing agents"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1964,
    "indication_class": "Diuretic",
    "molecule_chembl_id": "CHEMBL585",
    "molecule_properties": {
      "acd_logd": 1.12,
      "acd_logp": 1.16,
      "acd_most_bpka": 6.19,
      "alogp": 0.83,
      "aromatic_rings": 3,
      "full_molformula": "C12H11N7",
      "full_mwt": 253.27,
      "hba": 7,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 6,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 253.27,
      "mw_monoisotopic": 253.1076,
      "num_lipinski_ro5_violations": 1,
      "psa": 129.62,
      "qed_weighted": 0.59,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3",
      "standard_inchi": "InChI=1S/C12H11N7/c13-9-7(6-4-2-1-3-5-6)16-8-10(14)18-12(15)19-11(8)17-9/h1-5H,(H6,13,14,15,17,18,19)",
      "standard_inchi_key": "FNYLWPVRPXGIIP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "SK-8542",
        "SK&F-8542"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Triamterene (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1963
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Asthmatic; Suppressant (inflammatory bowel disease)",
    "molecule_chembl_id": "CHEMBL16596",
    "molecule_properties": {
      "acd_logd": 5.68,
      "acd_logp": 8.34,
      "acd_most_apka": 4.7,
      "acd_most_bpka": 3.81,
      "alogp": 9.01,
      "aromatic_rings": 5,
      "full_molformula": "C34H35ClN2O3S",
      "full_mwt": 587.19,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 41,
      "molecular_species": "ACID",
      "mw_freebase": 587.19,
      "mw_monoisotopic": 586.2057,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 64.35,
      "qed_weighted": 0.17,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)Sc1c(CC(C)(C)C(=O)O)n(Cc2ccc(Cl)cc2)c3ccc(OCc4ccc5ccccc5n4)cc13",
      "standard_inchi": "InChI=1S/C34H35ClN2O3S/c1-33(2,3)41-31-27-18-26(40-21-25-15-12-23-8-6-7-9-28(23)36-25)16-17-29(27)37(20-22-10-13-24(35)14-11-22)30(31)19-34(4,5)32(38)39/h6-18H,19-21H2,1-5H3,(H,38,39)",
      "standard_inchi_key": "NZOONKHCNQFYCI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "L-686708",
        "MK-591"
      ]
    },
    "synonyms": {
      "value": [
        "Quiflapon Sodium (USAN)",
        "Quiflapon (INN)",
        null
      ]
    },
    "usan_stem": "-flapon",
    "usan_stem_definition": "5-lipoxygenase-activating protein (FLAP) inhibitors",
    "usan_stem_substem": "-flapon(-flapon)",
    "usan_year": 1995
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL16699",
    "molecule_properties": {
      "acd_logd": 0.64,
      "acd_logp": 0.61,
      "acd_most_apka": 8.88,
      "alogp": 3.62,
      "aromatic_rings": 4,
      "full_molformula": "C18H17N2O+",
      "full_mwt": 277.35,
      "hba": 1,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 277.35,
      "mw_monoisotopic": 277.1335,
      "psa": 39.9,
      "qed_weighted": 0.47,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1c2cc[n+](C)cc2c(C)c3c4cc(O)ccc4[nH]c13",
      "standard_inchi": "InChI=1S/C18H16N2O/c1-10-15-9-20(3)7-6-13(15)11(2)18-17(10)14-8-12(21)4-5-16(14)19-18/h4-9,21H,1-3H3/p+1",
      "standard_inchi_key": "YZQRAQOSAPWELU-UHFFFAOYSA-O"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Elliptinium Acetate (BAN, INN, MI)",
        null
      ]
    },
    "usan_stem": "-ium",
    "usan_stem_definition": "quaternary ammonium derivatives",
    "usan_stem_substem": "-ium(-ium)"
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL16476",
    "molecule_properties": {
      "acd_logd": 0.85,
      "acd_logp": 2.77,
      "acd_most_apka": 13.91,
      "acd_most_bpka": 9.26,
      "alogp": 2.87,
      "aromatic_rings": 2,
      "full_molformula": "C15H19NO",
      "full_mwt": 229.32,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "BASE",
      "mw_freebase": 229.32,
      "mw_monoisotopic": 229.1467,
      "psa": 32.26,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)c1ccc2ccccc2c1",
      "standard_inchi": "InChI=1S/C15H19NO/c1-11(2)16-10-15(17)14-8-7-12-5-3-4-6-13(12)9-14/h3-9,11,15-17H,10H2,1-2H3",
      "standard_inchi_key": "HRSANNODOVBCST-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "ICI-38174 [As Hydrochloride]",
        "AY-6204 HCl",
        "GNF-Pf-2670"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pronetalol (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-alol",
    "usan_stem_definition": "combined alpha and beta receptors",
    "usan_stem_substem": "-alol(-alol)",
    "withdrawn_class": "Carcinogenicity",
    "withdrawn_country": "United Kingdom",
    "withdrawn_reason": "Animal carcinogenicity (rodent)",
    "withdrawn_year": 1965
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL17205",
    "molecule_properties": {
      "acd_logd": 3.95,
      "acd_logp": 3.96,
      "acd_most_apka": 9.22,
      "alogp": 4.34,
      "aromatic_rings": 2,
      "full_molformula": "C22H22O5",
      "full_mwt": 366.41,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 366.41,
      "mw_monoisotopic": 366.1467,
      "psa": 75.99,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(\\C=C\\2/CCC\\C(=C/c3ccc(O)c(OC)c3)\\C2=O)ccc1O",
      "standard_inchi": "InChI=1S/C22H22O5/c1-26-20-12-14(6-8-18(20)23)10-16-4-3-5-17(22(16)25)11-15-7-9-19(24)21(13-15)27-2/h6-13,23-24H,3-5H2,1-2H3/b16-10+,17-11+",
      "standard_inchi_key": "DHKKONBXGAAFTB-OTYYAQKOSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cyclovalone (INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL16503",
    "molecule_properties": {
      "acd_logd": -0.29,
      "acd_logp": 2.35,
      "acd_most_apka": 4.77,
      "alogp": 2.55,
      "aromatic_rings": 1,
      "full_molformula": "C15H21NO4",
      "full_mwt": 279.34,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 20,
      "molecular_species": "ACID",
      "mw_freebase": 279.34,
      "mw_monoisotopic": 279.1471,
      "psa": 86.63,
      "qed_weighted": 0.61,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CCCCCCCNC(=O)c1ccccc1O",
      "standard_inchi": "InChI=1S/C15H21NO4/c17-13-9-6-5-8-12(13)15(20)16-11-7-3-1-2-4-10-14(18)19/h5-6,8-9,17H,1-4,7,10-11H2,(H,16,20)(H,18,19)",
      "standard_inchi_key": "NJEKDCUDSORUJA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "E414",
        "SNAC"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Salcaprozate Sodium (USAN)",
        "Salcaprozic Acid (INN)",
        null
      ]
    },
    "usan_stem": "sal-",
    "usan_stem_definition": "anti-inflammatory agents (salicylic acid derivatives)",
    "usan_stem_substem": "sal-(sal-)",
    "usan_year": 2002
  },
  {
    "applicants": {
      "value": [
        "Lupin Ltd",
        "Macleods Pharmaceuticals Ltd",
        "Torrent Pharmaceuticals Ltd",
        "Apotex Inc",
        "Jubilant Generics Ltd",
        "Alembic Pharmaceuticals Ltd",
        "Teva Pharmaceuticals Usa Inc",
        "Gd Searle Llc",
        "Watson Laboratories Inc",
        "Mylan Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "L01XX33",
          "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agent"
        },
        {
          "code": "M01AH01",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Coxibs"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1998,
    "molecule_chembl_id": "CHEMBL118",
    "molecule_properties": {
      "acd_logd": 2.59,
      "acd_logp": 2.59,
      "acd_most_apka": 9.68,
      "alogp": 3.51,
      "aromatic_rings": 3,
      "full_molformula": "C17H14F3N3O2S",
      "full_mwt": 381.38,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 381.38,
      "mw_monoisotopic": 381.0759,
      "psa": 77.98,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F",
      "standard_inchi": "InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)",
      "standard_inchi_key": "RZEKVGVHFLEQIL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "SC-58635"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Celecoxib (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-coxib",
    "usan_stem_definition": "cyclooxygenase-2 inhibitors",
    "usan_stem_substem": "-coxib(-coxib)",
    "usan_year": 1998,
    "withdrawn_country": "European Union",
    "withdrawn_year": 2011
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL17045",
    "molecule_properties": {
      "acd_logd": -0.32,
      "acd_logp": 2.41,
      "acd_most_apka": 11.29,
      "acd_most_bpka": 10.46,
      "alogp": 3.51,
      "aromatic_rings": 2,
      "full_molformula": "C24H31N5O2",
      "full_mwt": 421.55,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 31,
      "molecular_species": "BASE",
      "mw_freebase": 421.55,
      "mw_monoisotopic": 421.2478,
      "psa": 68.78,
      "qed_weighted": 0.77,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CC1CCCCN1CC(=O)N2c3ccccc3C(=O)Nc4cccnc24",
      "standard_inchi": "InChI=1S/C24H31N5O2/c1-3-27(4-2)16-18-10-7-8-15-28(18)17-22(30)29-21-13-6-5-11-19(21)24(31)26-20-12-9-14-25-23(20)29/h5-6,9,11-14,18H,3-4,7-8,10,15-17H2,1-2H3,(H,26,31)",
      "standard_inchi_key": "UBRKDAVQCKZSPO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Otenzepad (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL17313",
    "molecule_properties": {
      "acd_logd": -0.88,
      "acd_logp": 1.46,
      "acd_most_apka": 6.83,
      "acd_most_bpka": 11.68,
      "alogp": 1.55,
      "aromatic_rings": 2,
      "full_molformula": "C24H27N5O5",
      "full_mwt": 465.51,
      "hba": 6,
      "hba_lipinski": 10,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 34,
      "molecular_species": "BASE",
      "mw_freebase": 465.51,
      "mw_monoisotopic": 465.2012,
      "psa": 154.68,
      "qed_weighted": 0.19,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)C[C@H](NC(=O)CN1C(=O)N[C@](C)(C1=O)c2ccc(cc2)C(=N)N)c3ccccc3",
      "standard_inchi": "InChI=1S/C24H27N5O5/c1-3-34-20(31)13-18(15-7-5-4-6-8-15)27-19(30)14-29-22(32)24(2,28-23(29)33)17-11-9-16(10-12-17)21(25)26/h4-12,18H,3,13-14H2,1-2H3,(H3,25,26)(H,27,30)(H,28,33)/t18-,24-/m0/s1",
      "standard_inchi_key": "SSGOEPXWNBXKPQ-UUOWRZLLSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Carafiban (INN)",
        null
      ]
    },
    "usan_stem": "-fiban",
    "usan_stem_definition": "fibrinogen receptor antagonists (glycoprotein IIb/IIIa receptor antagonists)",
    "usan_stem_substem": "-fiban(-fiban)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Cardiotonic",
    "molecule_chembl_id": "CHEMBL17125",
    "molecule_properties": {
      "acd_logd": 1.06,
      "acd_logp": 1.3,
      "acd_most_apka": 7.56,
      "acd_most_bpka": 5.07,
      "alogp": 0.96,
      "aromatic_rings": 2,
      "full_molformula": "C12H11N5O",
      "full_mwt": 241.25,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 241.25,
      "mw_monoisotopic": 241.0964,
      "psa": 94.46,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC1=NC(=O)C(=C(NCc2cccnc2)N1)C#N",
      "standard_inchi": "InChI=1S/C12H11N5O/c1-8-16-11(10(5-13)12(18)17-8)15-7-9-3-2-4-14-6-9/h2-4,6H,7H2,1H3,(H2,15,16,17,18)",
      "standard_inchi_key": "NZXHFDXOCVIYLO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AY-28768"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pelrinone HCl (USAN)",
        "Pelrinone (INN)",
        null
      ]
    },
    "usan_stem": "-rinone",
    "usan_stem_definition": "cardiotonics (amrinone type)",
    "usan_stem_substem": "-rinone(-rinone)",
    "usan_year": 1985
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Cardiotonic",
    "molecule_chembl_id": "CHEMBL17423",
    "molecule_properties": {
      "acd_logd": 0.97,
      "acd_logp": 0.97,
      "acd_most_bpka": 3.76,
      "alogp": 2.55,
      "aromatic_rings": 2,
      "full_molformula": "C22H25N3O4",
      "full_mwt": 395.46,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 395.46,
      "mw_monoisotopic": 395.1845,
      "psa": 71.11,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(cc1OC)C(=O)N2CCN(CC2)c3ccc4NC(=O)CCc4c3",
      "standard_inchi": "InChI=1S/C22H25N3O4/c1-28-19-7-3-16(14-20(19)29-2)22(27)25-11-9-24(10-12-25)17-5-6-18-15(13-17)4-8-21(26)23-18/h3,5-7,13-14H,4,8-12H2,1-2H3,(H,23,26)",
      "standard_inchi_key": "ZVNYJIZDIRKMBF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "OPC-8212"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Vesnarinone (INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-rinone",
    "usan_stem_definition": "cardiotonics (amrinone type)",
    "usan_stem_substem": "-rinone(-rinone)",
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": "Medimmune Oncology Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "P01AX07",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Other agents against amoebiasis and other protozoal diseases"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1993,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL119",
    "molecule_properties": {
      "acd_logd": 0.73,
      "acd_logp": 1.76,
      "acd_most_bpka": 8.09,
      "alogp": 2.74,
      "aromatic_rings": 3,
      "full_molformula": "C19H23N5O3",
      "full_mwt": 369.43,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 3,
      "hbd_lipinski": 5,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 369.43,
      "mw_monoisotopic": 369.1801,
      "psa": 117.54,
      "qed_weighted": 0.61,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(NCc2ccc3nc(N)nc(N)c3c2C)cc(OC)c1OC",
      "standard_inchi": "InChI=1S/C19H23N5O3/c1-10-11(5-6-13-16(10)18(20)24-19(21)23-13)9-22-12-7-14(25-2)17(27-4)15(8-12)26-3/h5-8,22H,9H2,1-4H3,(H4,20,21,23,24)",
      "standard_inchi_key": "NOYPYLRCIDNJJB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6017922,
    "parenteral": true,
    "research_codes": {
      "value": "CI-898"
    },
    "rule_of_five": true,
    "sc_patent": "US-6017922-A",
    "synonyms": {
      "value": [
        "Trimetrexate (BAN, INN, USAN)",
        "Trimetrexate Glucuronate (FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-trexate",
    "usan_stem_definition": "antimetabolites (folic acid derivatives)",
    "usan_stem_substem": "-trexate(-trexate)",
    "usan_year": 1981
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Anthelmintic",
    "molecule_chembl_id": "CHEMBL277775",
    "molecule_properties": {
      "acd_logd": -0.06,
      "acd_logp": 1.84,
      "acd_most_bpka": 9.99,
      "alogp": 2.15,
      "aromatic_rings": 1,
      "full_molformula": "C11H12N2S",
      "full_mwt": 204.3,
      "hba": 3,
      "hba_lipinski": 2,
      "heavy_atoms": 14,
      "molecular_species": "BASE",
      "mw_freebase": 204.3,
      "mw_monoisotopic": 204.0721,
      "psa": 15.6,
      "qed_weighted": 0.7,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "C1CN2CC(N=C2S1)c3ccccc3",
      "standard_inchi": "InChI=1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2",
      "standard_inchi_key": "HLFSDGLLUJUHTE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "R-8299",
        "MCN-JR-8299-11"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tetramisole HCl (USAN)",
        "Tetramisole (BAN, INN)",
        null
      ]
    },
    "usan_year": 1966
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL430150",
    "molecule_properties": {
      "acd_logd": 4.26,
      "acd_logp": 4.26,
      "acd_most_apka": 10.51,
      "acd_most_bpka": 2.98,
      "alogp": 4.78,
      "aromatic_rings": 3,
      "full_molformula": "C18H15F3N2O2",
      "full_mwt": 348.32,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 348.32,
      "mw_monoisotopic": 348.1086,
      "psa": 47.14,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(cc1)c2nc([nH]c2c3ccc(OC)cc3)C(F)(F)F",
      "standard_inchi": "InChI=1S/C18H15F3N2O2/c1-24-13-7-3-11(4-8-13)15-16(23-17(22-15)18(19,20)21)12-5-9-14(25-2)10-6-12/h3-10H,1-2H3,(H,22,23)",
      "standard_inchi_key": "OPYFPDBMMYUPME-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CP-22665"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Flumizole (INN, USAN)",
        null
      ]
    },
    "usan_year": 1974
  },
  {
    "applicants": {
      "value": [
        "Teva Parenteral Medicines Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Sandoz Inc",
        "Luitpold Pharmaceuticals Inc",
        "Hospira Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C01CA19",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1997,
    "indication_class": "Dopamine Agonist; Antihypertensive",
    "molecule_chembl_id": "CHEMBL588",
    "molecule_properties": {
      "acd_logd": 0.21,
      "acd_logp": 2.06,
      "acd_most_apka": 8.5,
      "acd_most_bpka": 9.49,
      "alogp": 2.73,
      "aromatic_rings": 2,
      "full_molformula": "C16H16ClNO3",
      "full_mwt": 305.76,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 305.76,
      "mw_monoisotopic": 305.0819,
      "psa": 72.72,
      "qed_weighted": 0.61,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1ccc(cc1)C2CNCCc3c(Cl)c(O)c(O)cc23",
      "standard_inchi": "InChI=1S/C16H16ClNO3/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21/h1-4,7,13,18-21H,5-6,8H2",
      "standard_inchi_key": "TVURRHSHRRELCG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "SK&F-82526",
        "SK-82526",
        "SK&F-82526J",
        "SK-82526-J"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fenoldopam mesylate (FDA, USAN, USP)",
        "Fenoldopam (BAN, INN)",
        null
      ]
    },
    "usan_year": 1984
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Epic Pharma Llc",
        "Actavis Elizabeth Llc",
        "Wockhardt Ltd",
        "Sandoz Inc",
        "Apotex Inc",
        "Alembic Pharmaceuticals Ltd",
        "Watson Laboratories Inc",
        "Glaxosmithkline Llc",
        "Glenmark Generics Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N04BC04",
        "description": "NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Dopamine agonists"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1997,
    "indication_class": "Antiparkinsonian (D2 receptor agonist)",
    "molecule_chembl_id": "CHEMBL589",
    "molecule_properties": {
      "acd_logd": 0.49,
      "acd_logp": 2.49,
      "acd_most_bpka": 9.45,
      "alogp": 2.85,
      "aromatic_rings": 1,
      "full_molformula": "C16H24N2O",
      "full_mwt": 260.38,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 260.38,
      "mw_monoisotopic": 260.1889,
      "psa": 32.34,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCCN(CCC)CCc1cccc2NC(=O)Cc12",
      "standard_inchi": "InChI=1S/C16H24N2O/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15/h5-7H,3-4,8-12H2,1-2H3,(H,17,19)",
      "standard_inchi_key": "UHSKFQJFRQCDBE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7927624,
    "oral": true,
    "research_codes": {
      "value": [
        "SK&F-101468",
        "SK&F-101468-A",
        "SK&F-101468A"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-7927624-B2",
    "synonyms": {
      "value": [
        "Ropinirole HCl (FDA, USAN)",
        "Ropinirole (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1993
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Asthmatic (leukotriene antagonist)",
    "molecule_chembl_id": "CHEMBL17344",
    "molecule_properties": {
      "acd_logd": 2.19,
      "acd_logp": 4.18,
      "acd_most_apka": 3.5,
      "acd_most_bpka": 3.89,
      "alogp": 4.08,
      "aromatic_rings": 3,
      "full_molformula": "C17H13F3N2O3S",
      "full_mwt": 382.36,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 382.36,
      "mw_monoisotopic": 382.0599,
      "psa": 68.29,
      "qed_weighted": 0.72,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "FC(F)(F)S(=O)(=O)Nc1cccc(OCc2ccc3ccccc3n2)c1",
      "standard_inchi": "InChI=1S/C17H13F3N2O3S/c18-17(19,20)26(23,24)22-13-5-3-6-15(10-13)25-11-14-9-8-12-4-1-2-7-16(12)21-14/h1-10,22H,11H2",
      "standard_inchi_key": "GOHUJGMYCZDYDF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "WY-48252"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ritolukast (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics: leukotriene receptor antagonists",
    "usan_stem_substem": "-ast(-ast(-lukast))",
    "usan_year": 1990
  },
  {
    "applicants": {
      "value": "Eli Lilly And Co"
    },
    "atc_classification": {
      "drug": {
        "code": "B02BA02",
        "description": "BLOOD AND BLOOD FORMING ORGANS: ANTIHEMORRHAGICS: VITAMIN K AND OTHER HEMOSTATICS: Vitamin K"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Vitamin (prothrombogenic)",
    "molecule_chembl_id": "CHEMBL590",
    "molecule_properties": {
      "acd_logd": 1.99,
      "acd_logp": 1.99,
      "alogp": 2.01,
      "aromatic_rings": 1,
      "full_molformula": "C11H8O2",
      "full_mwt": 172.18,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 13,
      "mw_freebase": 172.18,
      "mw_monoisotopic": 172.0524,
      "psa": 34.14,
      "qed_weighted": 0.6,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CC1=CC(=O)c2ccccc2C1=O",
      "standard_inchi": "InChI=1S/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H3",
      "standard_inchi_key": "MJVAVZPDRWSRRC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Menadione (BAN, FDA, USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Abbvie Inc",
        "Banner Pharmacaps Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05CM08",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedatives"
      }
    },
    "availability_type": 0,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1961,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL591",
    "molecule_properties": {
      "acd_logd": 1.19,
      "acd_logp": 1.19,
      "acd_most_apka": 12.06,
      "alogp": 1.51,
      "full_molformula": "C7H9ClO",
      "full_mwt": 144.6,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 9,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 144.6,
      "mw_monoisotopic": 144.0342,
      "psa": 20.23,
      "qed_weighted": 0.58,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(O)(\\C=C\\Cl)C#C",
      "standard_inchi": "InChI=1S/C7H9ClO/c1-3-7(9,4-2)5-6-8/h1,5-6,9H,4H2,2H3/b6-5+",
      "standard_inchi_key": "ZEHYJZXQEQOSON-AATRIKPKSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ethchlorvynol (BAN, FDA, INN, USP)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "R06AX12",
        "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1985,
    "indication_class": "Antihistaminic",
    "molecule_chembl_id": "CHEMBL17157",
    "molecule_properties": {
      "acd_logd": 3.6,
      "acd_logp": 5.62,
      "acd_most_apka": 13.32,
      "acd_most_bpka": 9.42,
      "alogp": 6.45,
      "aromatic_rings": 3,
      "full_molformula": "C32H41NO2",
      "full_mwt": 471.69,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 35,
      "molecular_species": "BASE",
      "mw_freebase": 471.69,
      "mw_monoisotopic": 471.3137,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 43.7,
      "qed_weighted": 0.4,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4",
      "standard_inchi": "InChI=1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3",
      "standard_inchi_key": "GUGOEEXESWIERI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "prodrug": true,
    "research_codes": {
      "value": "RMI-9918"
    },
    "synonyms": {
      "value": [
        "Terfenadine (BAN, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1975,
    "withdrawn_class": "Cardiotoxicity",
    "withdrawn_country": "United States; France; Oman; Saudi Arabia",
    "withdrawn_reason": "Prolonged QT interval; ventricular tachycardia",
    "withdrawn_year": 1998
  },
  {
    "applicants": {
      "value": [
        "Valeant Pharmaceuticals International",
        "Sentynl Therapeutics Inc"
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1991,
    "indication_class": "Analgesic (narcotic)",
    "molecule_chembl_id": "CHEMBL592",
    "molecule_properties": {
      "acd_logd": 1.71,
      "acd_logp": 3.25,
      "acd_most_apka": 10.07,
      "acd_most_bpka": 9.06,
      "alogp": 3.08,
      "aromatic_rings": 1,
      "full_molformula": "C17H23NO",
      "full_mwt": 257.38,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 257.38,
      "mw_monoisotopic": 257.178,
      "psa": 23.47,
      "qed_weighted": 0.77,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CC[C@]23CCCC[C@H]2[C@H]1Cc4ccc(O)cc34",
      "standard_inchi": "InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m0/s1",
      "standard_inchi_key": "JAQUASYNZVUNQP-USXIJHARSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Levorphanol (BAN, INN)",
        "Levorphanol Tartrate (FDA, USP)",
        null
      ]
    },
    "usan_stem": "-orphan-",
    "usan_stem_definition": "narcotic antagonists/agonists (morphinan derivatives)",
    "usan_stem_substem": "-orphan-(-orphan-)"
  },
  {
    "applicants": {
      "value": "Viiv Healthcare Co"
    },
    "atc_classification": {
      "drug": {
        "code": "J05AG02",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Non-nucleoside reverse transcriptase inhibitors"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1997,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL593",
    "molecule_properties": {
      "acd_logd": 1.77,
      "acd_logp": 3.53,
      "acd_most_apka": 9.02,
      "acd_most_bpka": 9.17,
      "alogp": 2.72,
      "aromatic_rings": 3,
      "full_molformula": "C22H28N6O3S",
      "full_mwt": 456.57,
      "hba": 6,
      "hba_lipinski": 9,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 32,
      "molecular_species": "BASE",
      "mw_freebase": 456.57,
      "mw_monoisotopic": 456.1944,
      "psa": 110.43,
      "qed_weighted": 0.53,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)Nc1cccnc1N2CCN(CC2)C(=O)c3cc4cc(NS(=O)(=O)C)ccc4[nH]3",
      "standard_inchi": "InChI=1S/C22H28N6O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20/h4-8,13-15,24-26H,9-12H2,1-3H3",
      "standard_inchi_key": "WHBIGIKBNXZKFE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6177101,
    "oral": true,
    "research_codes": {
      "value": [
        "U-90152T",
        "U-90152S",
        "U-90152"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6177101-B1",
    "synonyms": {
      "value": [
        "Delavirdine mesylate (FDA, USAN)",
        "Delavirdine (INN)",
        null
      ]
    },
    "usan_stem": "-vir-",
    "usan_stem_definition": "antivirals",
    "usan_stem_substem": "-vir-(-vir-)",
    "usan_year": 1994
  },
  {
    "applicants": {
      "value": "Novartis Pharmaceuticals Corp"
    },
    "atc_classification": {
      "drug": {
        "code": "S01GX06",
        "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergics"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1997,
    "indication_class": "Anti-Allergic; Antihistaminic, H1-Receptor; Asthma Prophylactic",
    "molecule_chembl_id": "CHEMBL594",
    "molecule_properties": {
      "acd_logd": 1.33,
      "acd_logp": 2.78,
      "acd_most_bpka": 8.86,
      "alogp": 2.21,
      "aromatic_rings": 2,
      "full_molformula": "C17H26N4O",
      "full_mwt": 302.42,
      "hba": 5,
      "hba_lipinski": 5,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 302.42,
      "mw_monoisotopic": 302.2107,
      "psa": 33.53,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCOCCn1c(nc2ccccc12)N3CCCN(C)CC3",
      "standard_inchi": "InChI=1S/C17H26N4O/c1-3-22-14-13-21-16-8-5-4-7-15(16)18-17(21)20-10-6-9-19(2)11-12-20/h4-5,7-8H,3,6,9-14H2,1-2H3",
      "standard_inchi_key": "KBUZBQVCBVDWKX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AL-3432A"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Emedastine Difumarate (FDA, JAN, USAN, USP)",
        "Emedastine (BAN, INN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-astine",
    "usan_stem_definition": "antihistaminics (histamine-H1 receptor antagonists)",
    "usan_stem_substem": "-astine(-astine)",
    "usan_year": 1996
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL17669",
    "molecule_properties": {
      "acd_logd": 3.27,
      "acd_logp": 4.32,
      "acd_most_apka": 6.33,
      "alogp": 3.52,
      "aromatic_rings": 2,
      "full_molformula": "C20H19NO3S",
      "full_mwt": 353.44,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 353.44,
      "mw_monoisotopic": 353.1086,
      "psa": 55.4,
      "qed_weighted": 0.91,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1NC(=O)C(Cc2ccc3O[C@@H](Cc4ccccc4)CCc3c2)S1",
      "standard_inchi": "InChI=1S/C20H19NO3S/c22-19-18(25-20(23)21-19)12-14-6-9-17-15(10-14)7-8-16(24-17)11-13-4-2-1-3-5-13/h1-6,9-10,16,18H,7-8,11-12H2,(H,21,22,23)/t16-,18?/m1/s1",
      "standard_inchi_key": "MVDXXGIBARMXSA-PYUWXLGESA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CP-72467-2"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Englitazone (INN)",
        "Englitazone Sodium (USAN)",
        null
      ]
    },
    "usan_stem": "-glitazone",
    "usan_stem_definition": "PPST agonists (thiazolidene derivatives)",
    "usan_stem_substem": "-glitazone(-glitazone)",
    "usan_year": 1993
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Teva Pharmaceuticals Usa",
        "Takeda Pharmaceuticals Usa Inc",
        "Lupin Ltd",
        "Macleods Pharmaceuticals Ltd",
        "Torrent Pharmaceuticals Ltd",
        "Sandoz Inc",
        "Breckenridge Pharmaceutical Inc",
        "Zydus Pharmaceuticals Usa Inc",
        "Dr Reddys Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A10BG03",
        "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Thiazolidinediones"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1999,
    "indication_class": "Antidiabetic",
    "molecule_chembl_id": "CHEMBL595",
    "molecule_properties": {
      "acd_logd": 2.45,
      "acd_logp": 3.5,
      "acd_most_apka": 6.35,
      "acd_most_bpka": 5.53,
      "alogp": 3.16,
      "aromatic_rings": 2,
      "full_molformula": "C19H20N2O3S",
      "full_mwt": 356.45,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 356.45,
      "mw_monoisotopic": 356.1195,
      "psa": 68.29,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCc1ccc(CCOc2ccc(CC3SC(=O)NC3=O)cc2)nc1",
      "standard_inchi": "InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",
      "standard_inchi_key": "HYAFETHFCAUJAY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6099859,
    "oral": true,
    "research_codes": {
      "value": "U-72107A"
    },
    "rule_of_five": true,
    "sc_patent": "US-6099859-A",
    "synonyms": {
      "value": [
        "Pioglitazone (BAN, INN)",
        "Pioglitazone HCl (FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-glitazone",
    "usan_stem_definition": "PPST agonists (thiazolidene derivatives)",
    "usan_stem_substem": "-glitazone(-glitazone)",
    "usan_year": 1989
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL17350",
    "molecule_properties": {
      "acd_logd": -0.16,
      "acd_logp": 1.57,
      "acd_most_apka": 9.99,
      "acd_most_bpka": 8.83,
      "alogp": 2.8,
      "aromatic_rings": 2,
      "full_molformula": "C20H25NO3",
      "full_mwt": 327.42,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 327.42,
      "mw_monoisotopic": 327.1834,
      "psa": 63.93,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@@H]([C@@H](O)c1ccc(O)cc1)N2CCC(O)(CC2)c3ccccc3",
      "standard_inchi": "InChI=1S/C20H25NO3/c1-15(19(23)16-7-9-18(22)10-8-16)21-13-11-20(24,12-14-21)17-5-3-2-4-6-17/h2-10,15,19,22-24H,11-14H2,1H3/t15-,19+/m0/s1",
      "standard_inchi_key": "QEMSVZNTSXPFJA-HNAYVOBHSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "CP-101606",
        "CP-101606-27"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Traxoprodil Mesylate (INN, USAN)",
        "Traxoprodil (INN)",
        null
      ]
    },
    "usan_stem": "-dil",
    "usan_stem_definition": "vasodilators (undefined group)",
    "usan_stem_substem": "-dil(-dil)",
    "usan_year": 2000
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Amino Acid",
    "molecule_chembl_id": "CHEMBL17962",
    "molecule_properties": {
      "acd_logd": -3.98,
      "acd_logp": -1.42,
      "acd_most_apka": 1.91,
      "acd_most_bpka": 9.46,
      "alogp": -0.64,
      "aromatic_rings": 1,
      "full_molformula": "C6H9N3O2",
      "full_mwt": 155.16,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 11,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 155.16,
      "mw_monoisotopic": 155.0695,
      "psa": 92,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "N[C@@H](Cc1c[nH]cn1)C(=O)O",
      "standard_inchi": "InChI=1S/C6H9N3O2/c7-5(6(10)11)1-4-2-8-3-9-4/h2-3,5H,1,7H2,(H,8,9)(H,10,11)/t5-/m0/s1",
      "standard_inchi_key": "HNDVDQJCIGZPNO-YFKPBYRVSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Histidine (INN, USAN, USP)",
        "Histidine Monohydrochloride (MI, NF)",
        null
      ]
    },
    "usan_stem": "-tidine",
    "usan_stem_definition": "H2-receptor antagonists (cimetidine type)",
    "usan_stem_substem": "-tidine(-tidine)",
    "usan_year": 1979
  },
  {
    "applicants": {
      "value": [
        "Mallinckrodt Inc",
        "Astrazeneca Lp",
        "West-Ward Pharmaceuticals International Ltd",
        "Hospira Inc",
        "Elefsee Pharmaceuticals International Ltd",
        "Par Pharmaceutical Inc",
        "Mayne Pharma Llc",
        "Akorn Inc",
        "The Medicines Co",
        "Biodelivery Sciences International Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N02AB03",
          "description": "NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Phenylpiperidine derivative"
        },
        {
          "code": "N01AH51",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Opioid anesthetic"
        },
        {
          "code": "N01AH01",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Opioid anesthetics"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1968,
    "indication_class": "Analgesic (narcotic)",
    "molecule_chembl_id": "CHEMBL596",
    "molecule_properties": {
      "acd_logd": 2.61,
      "acd_logp": 3.68,
      "acd_most_bpka": 8.92,
      "alogp": 4.14,
      "aromatic_rings": 2,
      "full_molformula": "C22H28N2O",
      "full_mwt": 336.48,
      "hba": 2,
      "hba_lipinski": 3,
      "heavy_atoms": 25,
      "molecular_species": "BASE",
      "mw_freebase": 336.48,
      "mw_monoisotopic": 336.2202,
      "psa": 23.55,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c3ccccc3",
      "standard_inchi": "InChI=1S/C22H28N2O/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19/h3-12,21H,2,13-18H2,1H3",
      "standard_inchi_key": "PJMPHNIQZUBGLI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5697896,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "R-4263",
        "MCN-JR-4263-49"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5697896-A",
    "synonyms": {
      "value": [
        "Fentanyl citrate (FDA, JAN, USAN, USP)",
        "Fentanyl HCl (FDA)",
        "Fentanyl (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1963
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Teva Pharmaceuticals Usa Inc",
        "Sb Pharmco Puerto Rico Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A10BG02",
        "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Thiazolidinediones"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1999,
    "indication_class": "Antidiabetic",
    "molecule_chembl_id": "CHEMBL121",
    "molecule_properties": {
      "acd_logd": 1.93,
      "acd_logp": 3.02,
      "acd_most_apka": 6.34,
      "acd_most_bpka": 6.5,
      "alogp": 2.49,
      "aromatic_rings": 2,
      "full_molformula": "C18H19N3O3S",
      "full_mwt": 357.44,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 357.44,
      "mw_monoisotopic": 357.1147,
      "psa": 71.53,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CN(CCOc1ccc(CC2SC(=O)NC2=O)cc1)c3ccccn3",
      "standard_inchi": "InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",
      "standard_inchi_key": "YASAKCUCGLMORW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6288095,
    "oral": true,
    "research_codes": {
      "value": [
        "BRL-49653-C",
        "BRL-49653C",
        "BRL-49653"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6288095-B1",
    "synonyms": {
      "value": [
        "Rosiglitazone maleate (FDA, USAN)",
        "Rosiglitazone (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-glitazone",
    "usan_stem_definition": "PPST agonists (thiazolidene derivatives)",
    "usan_stem_substem": "-glitazone(-glitazone)",
    "usan_year": 1997,
    "withdrawn_class": "Cardiotoxicity",
    "withdrawn_country": "European Union",
    "withdrawn_reason": "Increased risk of ischaemic heart disease",
    "withdrawn_year": 2010
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N07BC04",
        "description": "NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in opioid dependence"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL17860",
    "molecule_properties": {
      "acd_logd": 1.18,
      "acd_logp": 3.04,
      "acd_most_bpka": 9.8,
      "alogp": 2.76,
      "aromatic_rings": 1,
      "full_molformula": "C11H12Cl2N2O",
      "full_mwt": 259.14,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "BASE",
      "mw_freebase": 259.14,
      "mw_monoisotopic": 258.0327,
      "psa": 33.62,
      "qed_weighted": 0.91,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(Oc1c(Cl)cccc1Cl)C2=NCCN2",
      "standard_inchi": "InChI=1S/C11H12Cl2N2O/c1-7(11-14-5-6-15-11)16-10-8(12)3-2-4-9(10)13/h2-4,7H,5-6H2,1H3,(H,14,15)",
      "standard_inchi_key": "KSMAGQUYOIHWFS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MDL-14042"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lofexidine HCl (USAN)",
        "Lofexidine (BAN, INN)",
        null
      ]
    },
    "usan_year": 1986
  },
  {
    "applicants": {
      "value": [
        "West-Ward Pharmaceuticals International Ltd",
        "Novartis Pharmaceuticals Corp",
        "Septodont Holding Sas",
        "Precision Dose Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "C04AB01",
          "description": "CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Imidazoline derivative"
        },
        {
          "code": "V03AB36",
          "description": "VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1952,
    "indication_class": "Anti-Adrenergic",
    "molecule_chembl_id": "CHEMBL597",
    "molecule_properties": {
      "acd_logd": 2.13,
      "acd_logp": 4.08,
      "acd_most_apka": 9.52,
      "acd_most_bpka": 10.31,
      "alogp": 2.84,
      "aromatic_rings": 2,
      "full_molformula": "C17H19N3O",
      "full_mwt": 281.36,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 281.36,
      "mw_monoisotopic": 281.1528,
      "psa": 47.86,
      "qed_weighted": 0.91,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccc(cc1)N(CC2=NCCN2)c3cccc(O)c3",
      "standard_inchi": "InChI=1S/C17H19N3O/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15/h2-8,11,21H,9-10,12H2,1H3,(H,18,19)",
      "standard_inchi_key": "MRBDMNSDAVCSSF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6764678,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-6764678-B2",
    "synonyms": {
      "value": [
        "Phentolamine (BAN, INN)",
        "Phentolamine HCl (MI, USP)",
        "Phentolamine Mesilate (INN, JAN)",
        "Phentolamine Mesylate (FDA, USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": "Genzyme Corp"
    },
    "atc_classification": {
      "drug": {
        "code": "L03AX16",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSTIMULANTS: IMMUNOSTIMULANTS: Other immunostimulants"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 2008,
    "first_in_class": true,
    "molecule_chembl_id": "CHEMBL18442",
    "molecule_properties": {
      "acd_logd": -6.88,
      "acd_logp": -0.82,
      "acd_most_bpka": 10.6,
      "alogp": 0.42,
      "aromatic_rings": 1,
      "full_molformula": "C28H54N8",
      "full_mwt": 502.8,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 6,
      "hbd_lipinski": 6,
      "heavy_atoms": 36,
      "molecular_species": "BASE",
      "mw_freebase": 502.8,
      "mw_monoisotopic": 502.4471,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 78.66,
      "qed_weighted": 0.35,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "C(N1CCCNCCNCCCNCC1)c2ccc(CN3CCCNCCNCCCNCC3)cc2",
      "standard_inchi": "InChI=1S/C28H54N8/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36/h5-8,29-34H,1-4,9-26H2",
      "standard_inchi_key": "YIQPUIGJQJDJOS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6987102,
    "parenteral": true,
    "research_codes": {
      "value": "AMD-3100"
    },
    "sc_patent": "US-6987102-B2",
    "synonyms": {
      "value": [
        "Plerixafor (FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ixafor",
    "usan_stem_definition": "CXCR4 antagonists",
    "usan_stem_substem": "-ixafor(-ixafor)",
    "usan_year": 2004
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N06AG03",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Monoamine oxidase A inhibitors"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL18116",
    "molecule_properties": {
      "acd_logd": 1.53,
      "acd_logp": 1.53,
      "alogp": 1.31,
      "aromatic_rings": 1,
      "full_molformula": "C11H13NO3",
      "full_mwt": 207.23,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 207.23,
      "mw_monoisotopic": 207.0895,
      "psa": 49.77,
      "qed_weighted": 0.8,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cccc(c1)N2CC(CO)OC2=O",
      "standard_inchi": "InChI=1S/C11H13NO3/c1-8-3-2-4-9(5-8)12-6-10(7-13)15-11(12)14/h2-5,10,13H,6-7H2,1H3",
      "standard_inchi_key": "MXUNKHLAEDCYJL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Toloxatone (INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Stimulant (peristaltic); Anti-Emetic",
    "molecule_chembl_id": "CHEMBL18041",
    "molecule_properties": {
      "acd_logd": -0.33,
      "acd_logp": 1.7,
      "acd_most_apka": 13.56,
      "acd_most_bpka": 9.53,
      "alogp": 1.75,
      "aromatic_rings": 1,
      "full_molformula": "C15H20ClN3O2",
      "full_mwt": 309.8,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 309.8,
      "mw_monoisotopic": 309.1244,
      "psa": 67.59,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(N)c(Cl)cc1C(=O)NC2CN3CCC2CC3",
      "standard_inchi": "InChI=1S/C15H20ClN3O2/c1-21-14-7-12(17)11(16)6-10(14)15(20)18-13-8-19-4-2-9(13)3-5-19/h6-7,9,13H,2-5,8,17H2,1H3,(H,18,20)",
      "standard_inchi_key": "FEROPKNOYKURCJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AHR-11190-B"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Zacopride HCl (INN, USAN)",
        "Zacopride (INN)",
        null
      ]
    },
    "usan_stem": "-pride",
    "usan_stem_definition": "sulpiride derivatives",
    "usan_stem_substem": "-pride(-pride)",
    "usan_year": 1986
  },
  {
    "applicants": {
      "value": [
        "Anda Repository Llc",
        "Breckenridge Pharmaceutical Inc",
        "Strides Pharma Global Pte Ltd",
        "Aurobindo Pharma Ltd",
        "Taro Pharmaceutical Industries Ltd",
        "China Resources Double Crane Pharmaceutical Co Ltd",
        "Teva Pharmaceuticals Usa",
        "Yung Shin Pharmaceutical Industrial Co Ltd",
        "Roxane Laboratories Inc",
        "Sun Pharmaceutical Industries Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "M01AC06",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Oxicam"
        },
        {
          "code": "M01AC56",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Oxicams"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2000,
    "indication_class": "Anti-Inflammatory (nonsteroidal)",
    "molecule_chembl_id": "CHEMBL599",
    "molecule_properties": {
      "acd_logd": -0.22,
      "acd_logp": 2.66,
      "acd_most_apka": 4.5,
      "acd_most_bpka": 3.18,
      "alogp": 1.95,
      "aromatic_rings": 2,
      "full_molformula": "C14H13N3O4S2",
      "full_mwt": 351.41,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 351.41,
      "mw_monoisotopic": 351.0347,
      "psa": 99.6,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ncc(C)s3",
      "standard_inchi": "InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)",
      "standard_inchi_key": "ZRVUJXDFFKFLMG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6184220,
    "oral": true,
    "research_codes": {
      "value": "UH-AC 62XX"
    },
    "rule_of_five": true,
    "sc_patent": "US-6184220-B1",
    "synonyms": {
      "value": [
        "Meloxicam (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-icam",
    "usan_stem_definition": "anti-inflammatory agents (isoxicam type)",
    "usan_stem_substem": "-icam(-icam)",
    "usan_year": 1997
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL18197",
    "molecule_properties": {
      "acd_logd": 1.71,
      "acd_logp": 4.4,
      "acd_most_apka": 4.68,
      "acd_most_bpka": 4.33,
      "alogp": 4.83,
      "aromatic_rings": 3,
      "full_molformula": "C19H19Cl2N3O2",
      "full_mwt": 392.29,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 392.29,
      "mw_monoisotopic": 391.0854,
      "psa": 68.01,
      "qed_weighted": 0.65,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(CC(=O)O)Cc1nc2cc(Cl)cnc2n1Cc3ccc(Cl)cc3",
      "standard_inchi": "InChI=1S/C19H19Cl2N3O2/c1-19(2,9-17(25)26)8-16-23-15-7-14(21)10-22-18(15)24(16)11-12-3-5-13(20)6-4-12/h3-7,10H,8-9,11H2,1-2H3,(H,25,26)",
      "standard_inchi_key": "NJDYXRUUHUXUDU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mipitroban (INN)",
        null
      ]
    },
    "usan_stem": "-troban",
    "usan_stem_definition": "antithrombotics (thromboxane A2 receptor antagonists)",
    "usan_stem_substem": "-troban(-troban)"
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Fresenius Kabi Usa Llc",
        "Roxane Laboratories Inc",
        "Arbor Pharmaceuticals Llc",
        "Apothecon Inc Div Bristol Myers Squibb",
        "Mead Johnson And Co Sub Bristol Myers Co",
        "Luitpold Pharmaceuticals Inc",
        "Cumberland Pharmaceuticals Inc",
        "Dey Lp",
        "Alvogen Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "V03AB23",
          "description": "VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidote"
        },
        {
          "code": "S01XA08",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmological"
        },
        {
          "code": "R05CB01",
          "description": "RESPIRATORY SYSTEM: COUGH AND COLD PREPARATIONS: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS: Mucolytics"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1963,
    "indication_class": "Mucolytic",
    "molecule_chembl_id": "CHEMBL600",
    "molecule_properties": {
      "acd_logd": -4.39,
      "acd_logp": -0.7,
      "acd_most_apka": 3.25,
      "alogp": -0.49,
      "full_molformula": "C5H9NO3S",
      "full_mwt": 163.2,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 3,
      "hbd_lipinski": 2,
      "heavy_atoms": 10,
      "molecular_species": "ACID",
      "mw_freebase": 163.2,
      "mw_monoisotopic": 163.0303,
      "psa": 66.4,
      "qed_weighted": 0.49,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)N[C@@H](CS)C(=O)O",
      "standard_inchi": "InChI=1S/C5H9NO3S/c1-3(7)6-4(2-10)5(8)9/h4,10H,2H2,1H3,(H,6,7)(H,8,9)/t4-/m0/s1",
      "standard_inchi_key": "PWKSKIMOESPYIA-BYPYZUCNSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8148356,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": 5052
    },
    "rule_of_five": true,
    "sc_patent": "US-8148356-B2",
    "synonyms": {
      "value": [
        "Acetylcysteine (BAN, FDA, INN, JAN, USAN, USP)",
        "N-Acetyl-L-Cysteine (JAN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1963
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL18647",
    "molecule_properties": {
      "acd_logd": 3.25,
      "acd_logp": 3.99,
      "acd_most_apka": 6.72,
      "alogp": 4.65,
      "aromatic_rings": 3,
      "full_molformula": "C17H10F6N2O2S",
      "full_mwt": 420.33,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 420.33,
      "mw_monoisotopic": 420.0367,
      "psa": 62.82,
      "qed_weighted": 0.61,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "FC(F)C(F)(F)S(=O)(=O)c1nc(c2ccc(F)cc2)c([nH]1)c3ccc(F)cc3",
      "standard_inchi": "InChI=1S/C17H10F6N2O2S/c18-11-5-1-9(2-6-11)13-14(10-3-7-12(19)8-4-10)25-16(24-13)28(26,27)17(22,23)15(20)21/h1-8,15H,(H,24,25)",
      "standard_inchi_key": "XUOAKFNMJMYKBY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tiflamizole (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Biofrontera Bioscience Gmbh",
        "Dusa Pharmaceuticals Inc",
        "Nx Development Corp"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01XD04",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Sensitizers used in photodynamic/radiation therapy"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1999,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL601",
    "molecule_properties": {
      "acd_logd": -3.67,
      "acd_logp": -1.05,
      "acd_most_apka": 4.13,
      "acd_most_bpka": 7.37,
      "alogp": -0.62,
      "full_molformula": "C5H9NO3",
      "full_mwt": 131.13,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 9,
      "molecular_species": "ACID",
      "mw_freebase": 131.13,
      "mw_monoisotopic": 131.0582,
      "psa": 80.39,
      "qed_weighted": 0.53,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "NCC(=O)CCC(=O)O",
      "standard_inchi": "InChI=1S/C5H9NO3/c6-3-4(7)1-2-5(8)9/h1-3,6H2,(H,8,9)",
      "standard_inchi_key": "ZGXJTSGNIOSYLO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5954703,
    "rule_of_five": true,
    "sc_patent": "US-5954703-A",
    "synonyms": {
      "value": [
        "Aminolevulinic Acid HCl (FDA, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1997
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Fibrinogen Receptor Antagonist; Antithrombotic",
    "molecule_chembl_id": "CHEMBL18301",
    "molecule_properties": {
      "acd_logd": -1.07,
      "acd_logp": 0.92,
      "acd_most_apka": 10.63,
      "acd_most_bpka": 11.07,
      "alogp": 1.04,
      "aromatic_rings": 1,
      "full_molformula": "C21H29N5O6",
      "full_mwt": 447.49,
      "hba": 8,
      "hba_lipinski": 11,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 32,
      "molecular_species": "BASE",
      "mw_freebase": 447.49,
      "mw_monoisotopic": 447.2118,
      "num_lipinski_ro5_violations": 1,
      "psa": 165.19,
      "qed_weighted": 0.17,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCOC(=O)N[C@@H](CNC(=O)C[C@H]1CC(=NO1)c2ccc(cc2)C(=N)N)C(=O)OC",
      "standard_inchi": "InChI=1S/C21H29N5O6/c1-3-4-9-31-21(29)25-17(20(28)30-2)12-24-18(27)11-15-10-16(26-32-15)13-5-7-14(8-6-13)19(22)23/h5-8,15,17H,3-4,9-12H2,1-2H3,(H3,22,23)(H,24,27)(H,25,29)/t15-,17+/m1/s1",
      "standard_inchi_key": "IRAXRQFCCSHQDX-WBVHZDCISA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "DMP-754"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Roxifiban Acetate (USAN)",
        "Roxifiban (INN)",
        null
      ]
    },
    "usan_stem": "-fiban",
    "usan_stem_definition": "fibrinogen receptor antagonists (glycoprotein IIb/IIIa receptor antagonists)",
    "usan_stem_substem": "-fiban(-fiban)",
    "usan_year": 1997
  },
  {
    "applicants": {
      "value": [
        "Leadiant Biosciences Inc",
        "Mylan Pharmaceuticals Inc",
        "Horizon Pharma Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "A16AA04",
          "description": "ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Amino acids and derivative"
        },
        {
          "code": "S01XA21",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS: Other ophthalmologicals"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1994,
    "indication_class": "Anti-Urolithic (cystine calculi)",
    "molecule_chembl_id": "CHEMBL602",
    "molecule_properties": {
      "acd_logd": -1.3,
      "acd_logp": 0.22,
      "acd_most_apka": 8.32,
      "acd_most_bpka": 10.34,
      "alogp": -0.13,
      "full_molformula": "C2H7NS",
      "full_mwt": 77.15,
      "hba": 2,
      "hba_lipinski": 1,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 4,
      "molecular_species": "BASE",
      "mw_freebase": 77.15,
      "mw_monoisotopic": 77.0299,
      "psa": 26.02,
      "qed_weighted": 0.42,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "NCCS",
      "standard_inchi": "InChI=1S/C2H7NS/c3-1-2-4/h4H,1-3H2",
      "standard_inchi_key": "UFULAYFCSOUIOV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8026284,
    "oral": true,
    "research_codes": {
      "value": [
        "L-1573",
        "MEA",
        "CI-9148"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-8026284-B2",
    "synonyms": {
      "value": [
        "Cysteamine HCl (FDA, USAN)",
        "Cysteamine (USAN)",
        "Mercaptamine (BAN, DCF, INN)",
        "Cysteamine Bitartrate (FDA)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1990
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL18098",
    "molecule_properties": {
      "acd_logd": 1.28,
      "acd_logp": 1.28,
      "alogp": 2,
      "aromatic_rings": 1,
      "full_molformula": "C12H10O3",
      "full_mwt": 202.21,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 15,
      "mw_freebase": 202.21,
      "mw_monoisotopic": 202.063,
      "psa": 43.37,
      "qed_weighted": 0.65,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)c1ccc2OC3(CC3)C(=O)c2c1",
      "standard_inchi": "InChI=1S/C12H10O3/c1-7(13)8-2-3-10-9(6-8)11(14)12(15-10)4-5-12/h2-3,6H,4-5H2,1H3",
      "standard_inchi_key": "SETMGIIITGNLAS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AG-629"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Spizofurone (INN, JAN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Oxytocic; Antidepressant",
    "molecule_chembl_id": "CHEMBL18772",
    "molecule_properties": {
      "acd_logd": 0.68,
      "acd_logp": 2.04,
      "acd_most_bpka": 8.93,
      "alogp": 1.64,
      "aromatic_rings": 2,
      "full_molformula": "C13H15N3",
      "full_mwt": 213.28,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "BASE",
      "mw_freebase": 213.28,
      "mw_monoisotopic": 213.1266,
      "psa": 28.16,
      "qed_weighted": 0.78,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "C1CN(CCN1)c2ccc3ccccc3n2",
      "standard_inchi": "InChI=1S/C13H15N3/c1-2-4-12-11(3-1)5-6-13(15-12)16-9-7-14-8-10-16/h1-6,14H,7-10H2",
      "standard_inchi_key": "XRXDAJYKGWNHTQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Quipazine Maleate (USAN)",
        "Quipazine (INN)",
        null
      ]
    },
    "usan_year": 1966
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL276368",
    "molecule_properties": {
      "acd_logd": 3.93,
      "acd_logp": 4.87,
      "acd_most_bpka": 8.61,
      "alogp": 5.21,
      "aromatic_rings": 3,
      "full_molformula": "C20H23N5S",
      "full_mwt": 365.51,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "BASE",
      "mw_freebase": 365.51,
      "mw_monoisotopic": 365.1674,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 62.2,
      "qed_weighted": 0.49,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cc(N\\C(=N\\C2CCCCC2)\\Nc3nccs3)c4ccccc4n1",
      "standard_inchi": "InChI=1S/C20H23N5S/c1-14-13-18(16-9-5-6-10-17(16)22-14)24-19(25-20-21-11-12-26-20)23-15-7-3-2-4-8-15/h5-6,9-13,15H,2-4,7-8H2,1H3,(H2,21,22,23,24,25)",
      "standard_inchi_key": "SQVNITZYWXMWOG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Timegadine (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Tranquilizer",
    "molecule_chembl_id": "CHEMBL18331",
    "molecule_properties": {
      "acd_logd": 2.39,
      "acd_logp": 3.07,
      "acd_most_bpka": 7.91,
      "alogp": 3.28,
      "aromatic_rings": 3,
      "full_molformula": "C23H24FN3O2",
      "full_mwt": 393.46,
      "hba": 5,
      "hba_lipinski": 5,
      "heavy_atoms": 29,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 393.46,
      "mw_monoisotopic": 393.1853,
      "psa": 54.68,
      "qed_weighted": 0.62,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC1=C(CCN2CCC(CC2)C(=O)c3ccc(F)cc3)C(=O)N4C=CC=CC4=N1",
      "standard_inchi": "InChI=1S/C23H24FN3O2/c1-16-20(23(29)27-12-3-2-4-21(27)25-16)11-15-26-13-9-18(10-14-26)22(28)17-5-7-19(24)8-6-17/h2-8,12,18H,9-11,13-15H2,1H3",
      "standard_inchi_key": "HXCNRYXBZNHDNE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "R-47465"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pirenperone (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-perone",
    "usan_stem_definition": "antianxiety agents/neuroleptics (4-fluoro-4-piperidinobutyrophenone derivatives)",
    "usan_stem_substem": "-perone(-perone)",
    "usan_year": 1981
  },
  {
    "atc_classification": {
      "drug": {
        "code": "L01XD06",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Sensitizers used in photodynamic/radiation therapy"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL18901",
    "molecule_properties": {
      "acd_logd": -0.69,
      "acd_logp": 2.92,
      "acd_most_apka": 3.26,
      "acd_most_bpka": 0.76,
      "alogp": 3.73,
      "aromatic_rings": 2,
      "full_molformula": "C20H23NO4",
      "full_mwt": 341.41,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 341.41,
      "mw_monoisotopic": 341.1627,
      "psa": 75.63,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cc(C)cc(NC(=O)Cc2ccc(OC(C)(C)C(=O)O)cc2)c1",
      "standard_inchi": "InChI=1S/C20H23NO4/c1-13-9-14(2)11-16(10-13)21-18(22)12-15-5-7-17(8-6-15)25-20(3,4)19(23)24/h5-11H,12H2,1-4H3,(H,21,22)(H,23,24)",
      "standard_inchi_key": "BNFRJXLZYUTIII-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "RSR13",
        "RSR13 Sodium"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Efaproxiral (INN, USAN)",
        "Efaproxiral Sodium (USAN)",
        null
      ]
    },
    "usan_year": 2002
  },
  {
    "atc_classification": {
      "drug": {
        "code": "G04BX10",
        "description": "GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Other urologicals"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL275661",
    "molecule_properties": {
      "acd_logd": -1.18,
      "acd_logp": -1.17,
      "acd_most_apka": 9.62,
      "alogp": -0.58,
      "full_molformula": "C4H5NO2",
      "full_mwt": 99.09,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 7,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 99.09,
      "mw_monoisotopic": 99.032,
      "psa": 46.17,
      "qed_weighted": 0.41,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1CCC(=O)N1",
      "standard_inchi": "InChI=1S/C4H5NO2/c6-3-1-2-4(7)5-3/h1-2H2,(H,5,6,7)",
      "standard_inchi_key": "KZNICNPSHKQLFF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": "Succinimide"
    }
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Orexigen Therapeutics Inc",
        "Mallinckrodt Inc",
        "Pfizer Inc",
        "Sandoz Inc",
        "Apotex Inc",
        "Elite Laboratories Inc",
        "Barr Laboratories Inc",
        "Alkermes Inc",
        "Sun Pharma Global Fze"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N07BB04",
        "description": "NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in alcohol dependence"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1984,
    "indication_class": "Antagonist (to narcotics)",
    "molecule_chembl_id": "CHEMBL19019",
    "molecule_properties": {
      "acd_logd": 1.6,
      "acd_logp": 2.05,
      "acd_most_apka": 9.16,
      "acd_most_bpka": 7.5,
      "alogp": 1.53,
      "aromatic_rings": 1,
      "full_molformula": "C20H23NO4",
      "full_mwt": 341.41,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 341.41,
      "mw_monoisotopic": 341.1627,
      "psa": 70,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1ccc2C[C@H]3N(CC4CC4)CC[C@@]56[C@@H](Oc1c25)C(=O)CC[C@@]36O",
      "standard_inchi": "InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1",
      "standard_inchi_key": "DQCKKXVULJGBQN-XFWGSAIBSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5792477,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "EN-1639A [As Hydrochloride]",
        "EN-1639A"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5792477-A",
    "synonyms": {
      "value": [
        "Naltrexone HCl (FDA, USP)",
        "Naltrexone (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "nal-",
    "usan_stem_definition": "narcotic agonists/antagonists (normorphine type)",
    "usan_stem_substem": "nal-(nal-)",
    "usan_year": 1973
  },
  {
    "applicants": {
      "value": [
        "Dr Reddys Laboratories Ltd",
        "Par Pharmaceutical Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "R03DC01",
        "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Leukotriene receptor antagonists"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1996,
    "indication_class": "Anti-Asthmatic (leukotriene antagonist)",
    "molecule_chembl_id": "CHEMBL603",
    "molecule_properties": {
      "acd_logd": 3.17,
      "acd_logp": 5.04,
      "acd_most_apka": 4.94,
      "acd_most_bpka": 0.73,
      "alogp": 5.7,
      "aromatic_rings": 4,
      "full_molformula": "C31H33N3O6S",
      "full_mwt": 575.69,
      "hba": 7,
      "hba_lipinski": 9,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 41,
      "molecular_species": "ACID",
      "mw_freebase": 575.69,
      "mw_monoisotopic": 575.209,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 115.73,
      "qed_weighted": 0.28,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(ccc1Cc2cn(C)c3ccc(NC(=O)OC4CCCC4)cc23)C(=O)NS(=O)(=O)c5ccccc5C",
      "standard_inchi": "InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",
      "standard_inchi_key": "YEEZWCHGZNKEEK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "ICI-204219"
    },
    "synonyms": {
      "value": [
        "Zafirlukast (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics: leukotriene receptor antagonists",
    "usan_stem_substem": "-ast(-ast(-lukast))",
    "usan_year": 1995
  },
  {
    "applicants": {
      "value": "Merck Research Laboratories Div Merck Co Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "M01AH02",
        "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Coxibs"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1999,
    "molecule_chembl_id": "CHEMBL122",
    "molecule_properties": {
      "acd_logd": -0.34,
      "acd_logp": -0.34,
      "alogp": 2.56,
      "aromatic_rings": 2,
      "full_molformula": "C17H14O4S",
      "full_mwt": 314.36,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 22,
      "mw_freebase": 314.36,
      "mw_monoisotopic": 314.0613,
      "psa": 60.44,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3",
      "standard_inchi": "InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3",
      "standard_inchi_key": "RZJQGNCSTQAWON-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6063811,
    "oral": true,
    "research_codes": {
      "value": [
        "MK-966",
        "MK-0966"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6063811-A",
    "synonyms": {
      "value": [
        "Rofecoxib (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-coxib",
    "usan_stem_definition": "cyclooxygenase-2 inhibitors",
    "usan_stem_substem": "-coxib(-coxib)",
    "usan_year": 1998,
    "withdrawn_class": "Cardiotoxicity; Neurotoxicity",
    "withdrawn_country": "United States",
    "withdrawn_reason": "Risk for heart attack and stroke",
    "withdrawn_year": 2004
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C02AC05",
        "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Imidazoline receptor agonists"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL19236",
    "molecule_properties": {
      "acd_logd": 0.15,
      "acd_logp": 0.33,
      "acd_most_bpka": 7.11,
      "alogp": 0.82,
      "aromatic_rings": 1,
      "full_molformula": "C9H12ClN5O",
      "full_mwt": 241.68,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 241.68,
      "mw_monoisotopic": 241.073,
      "psa": 71.43,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "COc1nc(C)nc(Cl)c1NC2=NCCN2",
      "standard_inchi": "InChI=1S/C9H12ClN5O/c1-5-13-7(10)6(8(14-5)16-2)15-9-11-3-4-12-9/h3-4H2,1-2H3,(H2,11,12,15)",
      "standard_inchi_key": "WPNJAUFVNXKLIM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "BE5895",
        "BDF5896"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Moxonidine (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1998
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "A03AD01",
          "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Papaverine and derivative"
        },
        {
          "code": "G04BE52",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunctio"
        },
        {
          "code": "G04BE02",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunction"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Relaxant (smooth muscle)",
    "molecule_chembl_id": "CHEMBL19224",
    "molecule_properties": {
      "acd_logd": 2.9,
      "acd_logp": 2.93,
      "acd_most_bpka": 6.32,
      "alogp": 3.86,
      "aromatic_rings": 3,
      "full_molformula": "C20H21NO4",
      "full_mwt": 339.39,
      "hba": 5,
      "hba_lipinski": 5,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 339.39,
      "mw_monoisotopic": 339.1471,
      "psa": 49.81,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC",
      "standard_inchi": "InChI=1S/C20H21NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-8,10-12H,9H2,1-4H3",
      "standard_inchi_key": "XQYZDYMELSJDRZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Papaverine (BAN, BAN)",
        "Papaverine HCl (JAN, USP)",
        null
      ]
    },
    "usan_stem": "-verine",
    "usan_stem_definition": "spasmolytic agents (papaverine type)",
    "usan_stem_substem": "-verine(-verine)"
  },
  {
    "applicants": {
      "value": "Abraxis Pharmaceutical Products"
    },
    "atc_classification": {
      "drug": {
        "code": "V03AB20",
        "description": "VARIOUS: ALL OTHER THERAPEUTIC PRODUCTS: ALL OTHER THERAPEUTIC PRODUCTS: Antidotes"
      }
    },
    "availability_type": 0,
    "chirality": -1,
    "development_phase": 4,
    "drug_type": 10,
    "first_approval": 1987,
    "indication_class": "Antidote (to phosphorus)",
    "molecule_chembl_id": "CHEMBL604",
    "molecule_properties": {
      "full_molformula": "CuO4S",
      "full_mwt": 159.61,
      "mw_freebase": 159.61,
      "mw_monoisotopic": 158.8813
    },
    "molecule_structures": {
      "canonical_smiles": "[Cu+2].[O-]S(=O)(=O)[O-]",
      "standard_inchi": "InChI=1S/Cu.H2O4S/c;1-5(2,3)4/h;(H2,1,2,3,4)/q+2;/p-2",
      "standard_inchi_key": "ARUVKPQLZAKDPS-UHFFFAOYSA-L"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "synonyms": {
      "value": [
        "Cupric Sulfate (FDA, USP)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL19004",
    "molecule_properties": {
      "acd_logd": 2.48,
      "acd_logp": 2.48,
      "alogp": 3.96,
      "aromatic_rings": 3,
      "full_molformula": "C17H18N2O3S",
      "full_mwt": 330.41,
      "hba": 6,
      "hba_lipinski": 5,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 330.41,
      "mw_monoisotopic": 330.1038,
      "psa": 65.22,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)c1nnc(COc2ccc3C(=C(C)C(=O)Oc3c2)C)s1",
      "standard_inchi": "InChI=1S/C17H18N2O3S/c1-9(2)16-19-18-15(23-16)8-21-12-5-6-13-10(3)11(4)17(20)22-14(13)7-12/h5-7,9H,8H2,1-4H3",
      "standard_inchi_key": "HQTNJPCZUQAYAB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Atibeprone (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Bronchodilator (anti-allergic)",
    "molecule_chembl_id": "CHEMBL18531",
    "molecule_properties": {
      "acd_logd": 2.51,
      "acd_logp": 2.51,
      "acd_most_apka": 10.27,
      "acd_most_bpka": 2.23,
      "alogp": 2.67,
      "aromatic_rings": 2,
      "full_molformula": "C16H16ClN5O",
      "full_mwt": 329.79,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 329.79,
      "mw_monoisotopic": 329.1043,
      "psa": 64.59,
      "qed_weighted": 0.92,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)CN2C(=O)c3[nH]cnc3N(Cc4ccc(Cl)cc4)C2=N1",
      "standard_inchi": "InChI=1S/C16H16ClN5O/c1-16(2)8-22-14(23)12-13(19-9-18-12)21(15(22)20-16)7-10-3-5-11(17)6-4-10/h3-6,9H,7-8H2,1-2H3,(H,18,19)",
      "standard_inchi_key": "MXEAHCWVILOHDC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MJ-13401-1-3"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fenprinast (INN)",
        "Fenprinast HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics (not acting primarily as antihistamines,leukotriene biosynthesis inhibitors)",
    "usan_stem_substem": "-ast(-ast)",
    "usan_year": 1982
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL18504",
    "molecule_properties": {
      "acd_logd": 2.65,
      "acd_logp": 2.65,
      "alogp": 2.14,
      "aromatic_rings": 2,
      "full_molformula": "C13H14O5S",
      "full_mwt": 282.32,
      "hba": 5,
      "hba_lipinski": 5,
      "heavy_atoms": 19,
      "mw_freebase": 282.32,
      "mw_monoisotopic": 282.0562,
      "psa": 73.58,
      "qed_weighted": 0.64,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCS(=O)(=O)Oc1ccc2C(=C(C)C(=O)Oc2c1)C",
      "standard_inchi": "InChI=1S/C13H14O5S/c1-4-19(15,16)18-10-5-6-11-8(2)9(3)13(14)17-12(11)7-10/h5-7H,4H2,1-3H3",
      "standard_inchi_key": "CHDGAVDQRSPBTA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Esuprone (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antiparkinsonian",
    "molecule_chembl_id": "CHEMBL279390",
    "molecule_properties": {
      "acd_logd": -0.98,
      "acd_logp": 0.2,
      "acd_most_apka": 12.89,
      "acd_most_bpka": 8.49,
      "alogp": 0.42,
      "aromatic_rings": 1,
      "full_molformula": "C8H10ClN3O",
      "full_mwt": 199.64,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 13,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 199.64,
      "mw_monoisotopic": 199.0512,
      "psa": 68.01,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "NCCNC(=O)c1ccc(Cl)cn1",
      "standard_inchi": "InChI=1S/C8H10ClN3O/c9-6-1-2-7(12-5-6)8(13)11-4-3-10/h1-2,5H,3-4,10H2,(H,11,13)",
      "standard_inchi_key": "JZXRLKWWVNUZRB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "Ro-196327000",
        "Ro-196327",
        "Ro-196327001"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lazabemide (BAN, INN, USAN)",
        "Lazabemide HCl (USAN)",
        null
      ]
    },
    "usan_year": 1992
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Platelet Aggregation Inhibitor",
    "molecule_chembl_id": "CHEMBL277592",
    "molecule_properties": {
      "acd_logd": 4.88,
      "acd_logp": 4.88,
      "alogp": 5.51,
      "aromatic_rings": 3,
      "full_molformula": "C18H14F3NO2S",
      "full_mwt": 365.38,
      "hba": 4,
      "hba_lipinski": 3,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 365.38,
      "mw_monoisotopic": 365.0697,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 31.35,
      "qed_weighted": 0.61,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(cc1)c2nc(sc2c3ccc(OC)cc3)C(F)(F)F",
      "standard_inchi": "InChI=1S/C18H14F3NO2S/c1-23-13-7-3-11(4-8-13)15-16(25-17(22-15)18(19,20)21)12-5-9-14(24-2)10-6-12/h3-10H,1-2H3",
      "standard_inchi_key": "CIPBQTCSXVEDSG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "U-53059"
    },
    "synonyms": {
      "value": [
        "Itazigrel (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-grel",
    "usan_stem_definition": "platelet aggregation inhibitors",
    "usan_stem_substem": "-grel(-grel)",
    "usan_year": 1986
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Serotonin Inhibitor",
    "molecule_chembl_id": "CHEMBL18786",
    "molecule_properties": {
      "acd_logd": 1.33,
      "acd_logp": 3.33,
      "acd_most_apka": 13.46,
      "acd_most_bpka": 9.38,
      "alogp": 4.38,
      "aromatic_rings": 2,
      "full_molformula": "C20H24N2OS",
      "full_mwt": 340.49,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 340.49,
      "mw_monoisotopic": 340.1609,
      "psa": 32.34,
      "qed_weighted": 0.44,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCCSc1ccccc1NC(=O)\\C=C\\c2ccccc2",
      "standard_inchi": "InChI=1S/C20H24N2OS/c1-22(2)15-8-16-24-19-12-7-6-11-18(19)21-20(23)14-13-17-9-4-3-5-10-17/h3-7,9-14H,8,15-16H2,1-2H3,(H,21,23)/b14-13+",
      "standard_inchi_key": "RSUVYMGADVXGOU-BUHFOSPRSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SQ-10643"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cinanserin HCl (USAN)",
        "Cinanserin (INN)",
        null
      ]
    },
    "usan_stem": "-anserin",
    "usan_stem_definition": "serotonin 5-HT2 receptor antagonists",
    "usan_stem_substem": "-anserin(-anserin)",
    "usan_year": 1966
  },
  {
    "atc_classification": {
      "drug": {
        "code": "G02CB05",
        "description": "GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: OTHER GYNECOLOGICALS: Prolactine inhibitors"
      }
    },
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL19215",
    "molecule_properties": {
      "acd_logd": 3.12,
      "acd_logp": 3.8,
      "acd_most_apka": 12.45,
      "acd_most_bpka": 8.06,
      "alogp": 4.06,
      "aromatic_rings": 3,
      "full_molformula": "C25H29N3O2",
      "full_mwt": 403.53,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 30,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 403.53,
      "mw_monoisotopic": 403.226,
      "psa": 46.5,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C[C@H](CNC(=O)OCc2ccccc2)C[C@H]3[C@H]1Cc4cn(C)c5cccc3c45",
      "standard_inchi": "InChI=1S/C25H29N3O2/c1-27-14-18(13-26-25(29)30-16-17-7-4-3-5-8-17)11-21-20-9-6-10-22-24(20)19(12-23(21)27)15-28(22)2/h3-10,15,18,21,23H,11-14,16H2,1-2H3,(H,26,29)/t18-,21+,23+/m0/s1",
      "standard_inchi_key": "WZHJKEUHNJHDLS-QTGUNEKASA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "FI-6337",
        "MCE"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Metergoline (BAN, INN, MI)",
        null
      ]
    },
    "usan_stem": "-erg-",
    "usan_stem_definition": "ergot alkaloid derivatives",
    "usan_stem_substem": "-erg-(-erg-)"
  },
  {
    "applicants": {
      "value": [
        "Exela Holdings Inc",
        "Actavis Laboratories Fl Inc",
        "Sandoz Inc",
        "Gd Searle Llc",
        "Amneal Pharmaceuticals",
        "Novel Laboratories Inc",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "G02AD06",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: UTEROTONICS: Prostaglandin"
        },
        {
          "code": "A02BB01",
          "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR ACID RELATED DISORDERS: DRUGS FOR PEPTIC ULCER AND GASTRO-OESOPHAGEAL REFLUX DISEASE (GORD): Prostaglandins"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1988,
    "indication_class": "Anti-Ulcerative",
    "molecule_chembl_id": "CHEMBL606",
    "molecule_properties": {
      "acd_logd": 3.8,
      "acd_logp": 3.8,
      "acd_most_apka": 13.92,
      "alogp": 3.95,
      "full_molformula": "C22H38O5",
      "full_mwt": 382.54,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 382.54,
      "mw_monoisotopic": 382.2719,
      "psa": 83.83,
      "qed_weighted": 0.29,
      "ro3_pass": "N",
      "rtb": 13
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCC(C)(O)C\\C=C\\[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)OC",
      "standard_inchi": "InChI=1S/C22H38O5/c1-4-5-14-22(2,26)15-10-12-18-17(19(23)16-20(18)24)11-8-6-7-9-13-21(25)27-3/h10,12,17-18,20,24,26H,4-9,11,13-16H2,1-3H3/b12-10+/t17-,18-,20-,22?/m1/s1",
      "standard_inchi_key": "OJLOPKGSLYJEMD-URPKTTJQSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "prodrug": true,
    "research_codes": {
      "value": "SC-29333"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Misoprostol (BAN, FDA, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-prost-",
    "usan_stem_definition": "prostaglandins",
    "usan_stem_substem": "-prost-(-prost-)",
    "usan_year": 1981
  },
  {
    "atc_classification": {
      "drug": {
        "code": "V04CD06",
        "description": "VARIOUS: DIAGNOSTIC AGENTS: OTHER DIAGNOSTIC AGENTS: Tests for pituitary function"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2017,
    "first_in_class": true,
    "molecule_chembl_id": "CHEMBL278623",
    "molecule_properties": {
      "acd_logd": 0.52,
      "acd_logp": 1.42,
      "acd_most_bpka": 8.23,
      "alogp": 1.84,
      "aromatic_rings": 4,
      "full_molformula": "C26H30N6O3",
      "full_mwt": 474.57,
      "hba": 4,
      "hba_lipinski": 9,
      "hbd": 6,
      "hbd_lipinski": 7,
      "heavy_atoms": 35,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 474.57,
      "mw_monoisotopic": 474.2379,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 144.9,
      "qed_weighted": 0.15,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(N)C(=O)N[C@H](Cc1c[nH]c2ccccc12)C(=O)N[C@H](Cc3c[nH]c4ccccc34)NC=O",
      "standard_inchi": "InChI=1S/C26H30N6O3/c1-26(2,27)25(35)31-22(11-16-13-28-20-9-5-3-7-18(16)20)24(34)32-23(30-15-33)12-17-14-29-21-10-6-4-8-19(17)21/h3-10,13-15,22-23,28-29H,11-12,27H2,1-2H3,(H,30,33)(H,31,35)(H,32,34)/t22-,23-/m1/s1",
      "standard_inchi_key": "UJVDJAPJQWZRFR-DHIUTWEWSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "D-87575",
        "EP 1572",
        "ARD 07",
        "JMV-1843",
        "AEZS-130",
        "EP-01572"
      ]
    },
    "synonyms": {
      "value": [
        "Macimorelin (INN, USAN)",
        "Macimorelin Acetate (FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-relin",
    "usan_stem_definition": "prehormones or hormone-release stimulating peptides: growth hormone-release stimulating peptides",
    "usan_stem_substem": "-relin(-relin(-morelin))",
    "usan_year": 2013
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL278462",
    "molecule_properties": {
      "acd_logd": 2.94,
      "acd_logp": 3.53,
      "acd_most_bpka": 7.56,
      "alogp": 3.34,
      "aromatic_rings": 1,
      "full_molformula": "C14H20N2",
      "full_mwt": 216.33,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 216.33,
      "mw_monoisotopic": 216.1626,
      "psa": 28.68,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)CCC#C[C@@H]1C[C@H]1c2c[nH]cn2",
      "standard_inchi": "InChI=1S/C14H20N2/c1-14(2,3)7-5-4-6-11-8-12(11)13-9-15-10-16-13/h9-12H,5,7-8H2,1-3H3,(H,15,16)/t11-,12-/m1/s1",
      "standard_inchi_key": "CVKJAXCQPFOAIN-VXGBXAGGSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "GT-2331"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cipralisant Maleate (USAN)",
        "Cipralisant (INN)",
        null
      ]
    },
    "usan_stem": "-isant",
    "usan_stem_definition": "histamine H3 receptor antagonists",
    "usan_stem_substem": "-isant(-isant)",
    "usan_year": 2001
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL279960",
    "molecule_properties": {
      "acd_logd": 2.83,
      "acd_logp": 2.83,
      "acd_most_bpka": 1.66,
      "alogp": 3.35,
      "aromatic_rings": 3,
      "full_molformula": "C15H11ClN2O",
      "full_mwt": 270.72,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 270.72,
      "mw_monoisotopic": 270.056,
      "psa": 34.89,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC1=Nc2ccccc2C(=O)N1c3ccccc3Cl",
      "standard_inchi": "InChI=1S/C15H11ClN2O/c1-10-17-13-8-4-2-6-11(13)15(19)18(10)14-9-5-3-7-12(14)16/h2-9H,1H3",
      "standard_inchi_key": "SFITWQDBYUMAPS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "W-4744"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mecloqualone (INN, USAN)",
        null
      ]
    },
    "usan_year": 1968
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Anti-Anxiety Agent",
    "molecule_chembl_id": "CHEMBL18972",
    "molecule_properties": {
      "acd_logd": 1.95,
      "acd_logp": 3.54,
      "acd_most_bpka": 9.01,
      "alogp": 3.67,
      "aromatic_rings": 2,
      "full_molformula": "C20H25NO",
      "full_mwt": 295.43,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 295.43,
      "mw_monoisotopic": 295.1936,
      "psa": 23.47,
      "qed_weighted": 0.91,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "OC(C1CCN(CCc2ccccc2)CC1)c3ccccc3",
      "standard_inchi": "InChI=1S/C20H25NO/c22-20(18-9-5-2-6-10-18)19-12-15-21(16-13-19)14-11-17-7-3-1-4-8-17/h1-10,19-20,22H,11-16H2",
      "standard_inchi_key": "AXNGJCOYCMDPQG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MDL-11939"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Glemanserin (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-anserin",
    "usan_stem_definition": "serotonin 5-HT2 receptor antagonists",
    "usan_stem_substem": "-anserin(-anserin)",
    "usan_year": 1992
  },
  {
    "applicants": {
      "value": [
        "Icu Medical Inc",
        "Mallinckrodt Inc",
        "Sun Pharmaceutical Industries Inc",
        "Baxter Healthcare Corp Anesthesia And Critical Care",
        "West-Ward Pharmaceuticals International Ltd",
        "Us Pharmaceutical Holdings Ii Llc",
        "International Medication System",
        "Watson Laboratories Inc",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Vintage Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N02AB02",
          "description": "NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Phenylpiperidine derivative"
        },
        {
          "code": "N02AB72",
          "description": "NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Phenylpiperidine derivative"
        },
        {
          "code": "N02AB52",
          "description": "NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Phenylpiperidine derivatives"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1942,
    "indication_class": "Analgesic (narcotic)",
    "molecule_chembl_id": "CHEMBL607",
    "molecule_properties": {
      "acd_logd": 1.61,
      "acd_logp": 2.19,
      "acd_most_bpka": 7.84,
      "alogp": 2.21,
      "aromatic_rings": 1,
      "full_molformula": "C15H21NO2",
      "full_mwt": 247.34,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 247.34,
      "mw_monoisotopic": 247.1572,
      "psa": 29.54,
      "qed_weighted": 0.77,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)C1(CCN(C)CC1)c2ccccc2",
      "standard_inchi": "InChI=1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3",
      "standard_inchi_key": "XADCESSVHJOZHK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pethidine (BAN, INN)",
        "Meperidine HCl (FDA, USP)",
        "Pethidine HCl (JAN)",
        null
      ]
    },
    "usan_stem": "-eridine",
    "usan_stem_definition": "analgesics (meperidine type)",
    "usan_stem_substem": "-eridine(-eridine)"
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "N05CM01",
          "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedative"
        },
        {
          "code": "N05CX02",
          "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Hypnotics and sedatives in combination, excl. barbiturates"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL282052",
    "molecule_properties": {
      "acd_logd": 2.5,
      "acd_logp": 2.5,
      "acd_most_bpka": 2.96,
      "alogp": 3,
      "aromatic_rings": 3,
      "full_molformula": "C16H14N2O",
      "full_mwt": 250.3,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 250.3,
      "mw_monoisotopic": 250.1106,
      "psa": 34.89,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC1=Nc2ccccc2C(=O)N1c3ccccc3C",
      "standard_inchi": "InChI=1S/C16H14N2O/c1-11-7-3-6-10-15(11)18-12(2)17-14-9-5-4-8-13(14)16(18)19/h3-10H,1-2H3",
      "standard_inchi_key": "JEYCTXHKTXCGPB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "R-148",
        "CN-38703",
        "QZ-2",
        "TR-495",
        "CI-705"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Methaqualone (BAN, INN, USAN, USP)",
        "Methaqualone HCl (MI, USP)",
        null
      ]
    },
    "usan_year": 1962,
    "withdrawn_class": "Misuse",
    "withdrawn_country": "United States",
    "withdrawn_reason": "Overdose",
    "withdrawn_year": 1984
  },
  {
    "applicants": {
      "value": "Sanofi Aventis Us Llc"
    },
    "atc_classification": {
      "drug": {
        "code": "C10AX02",
        "description": "CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Other lipid modifying agents"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1977,
    "indication_class": "Antihyperlipidemic",
    "molecule_chembl_id": "CHEMBL608",
    "molecule_properties": {
      "acd_logd": 9,
      "acd_logp": 9,
      "acd_most_apka": 10.27,
      "alogp": 9.91,
      "aromatic_rings": 2,
      "full_molformula": "C31H48O2S2",
      "full_mwt": 516.86,
      "hba": 4,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 35,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 516.86,
      "mw_monoisotopic": 516.3096,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 40.46,
      "qed_weighted": 0.31,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)c1cc(SC(C)(C)Sc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C)cc(c1O)C(C)(C)C",
      "standard_inchi": "InChI=1S/C31H48O2S2/c1-27(2,3)21-15-19(16-22(25(21)32)28(4,5)6)34-31(13,14)35-20-17-23(29(7,8)9)26(33)24(18-20)30(10,11)12/h15-18,32-33H,1-14H3",
      "standard_inchi_key": "FYPMFJGVHOHGLL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "DH-581"
    },
    "synonyms": {
      "value": [
        "Probucol (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1970
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL19299",
    "molecule_properties": {
      "acd_logd": -1.24,
      "acd_logp": 1.69,
      "acd_most_apka": 4.39,
      "alogp": 2.79,
      "aromatic_rings": 1,
      "full_molformula": "C15H18O3",
      "full_mwt": 246.31,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 18,
      "molecular_species": "ACID",
      "mw_freebase": 246.31,
      "mw_monoisotopic": 246.1256,
      "psa": 54.37,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C(=O)O)c1ccc(CC2CCCC2=O)cc1",
      "standard_inchi": "InChI=1S/C15H18O3/c1-10(15(17)18)12-7-5-11(6-8-12)9-13-3-2-4-14(13)16/h5-8,10,13H,2-4,9H2,1H3,(H,17,18)",
      "standard_inchi_key": "YMBXTVYHTMGZDW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Loxoprofen (INN, MI)",
        "Loxoprofen Sodium (JAN)",
        null
      ]
    },
    "usan_stem": "-profen",
    "usan_stem_definition": "anti-inflammatory/analgesic agents (ibuprofen type)",
    "usan_stem_substem": "-profen(-profen)"
  },
  {
    "applicants": {
      "value": "Aton Pharma Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "A16AX12",
        "description": "ALIMENTARY TRACT AND METABOLISM: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS: Various alimentary tract and metabolism products"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1985,
    "indication_class": "Chelating Agent",
    "molecule_chembl_id": "CHEMBL609",
    "molecule_properties": {
      "acd_logd": -6.05,
      "acd_logp": -1.99,
      "acd_most_bpka": 10.05,
      "alogp": -1.92,
      "full_molformula": "C6H18N4",
      "full_mwt": 146.24,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 4,
      "hbd_lipinski": 6,
      "heavy_atoms": 10,
      "molecular_species": "BASE",
      "mw_freebase": 146.24,
      "mw_monoisotopic": 146.1531,
      "num_lipinski_ro5_violations": 1,
      "psa": 76.1,
      "qed_weighted": 0.32,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "NCCNCCNCCN",
      "standard_inchi": "InChI=1S/C6H18N4/c7-1-3-9-5-6-10-4-2-8/h9-10H,1-8H2",
      "standard_inchi_key": "VILCJCGEZXAXTO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "MK-0681"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Trientine (INN)",
        "Trientine Dihydrochloride (BAN)",
        "Trientine HCl (FDA, USAN, USP)",
        null
      ]
    },
    "usan_year": 1984
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL19892",
    "molecule_properties": {
      "acd_logd": -5.15,
      "acd_logp": -1.12,
      "acd_most_apka": 1.44,
      "acd_most_bpka": 2.8,
      "alogp": 0.68,
      "aromatic_rings": 2,
      "full_molformula": "C14H15F3N3O6P",
      "full_mwt": 409.26,
      "hba": 6,
      "hba_lipinski": 9,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 27,
      "molecular_species": "ACID",
      "mw_freebase": 409.26,
      "mw_monoisotopic": 409.0651,
      "psa": 124.86,
      "qed_weighted": 0.5,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "OP(=O)(O)CN1C(=O)C(=O)Nc2cc(c(cc12)N3CCOCC3)C(F)(F)F",
      "standard_inchi": "InChI=1S/C14H15F3N3O6P/c15-14(16,17)8-5-9-11(6-10(8)19-1-3-26-4-2-19)20(7-27(23,24)25)13(22)12(21)18-9/h5-6H,1-4,7H2,(H,18,21)(H2,23,24,25)",
      "standard_inchi_key": "WZMQMKNCWDCCMT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fanapanel (INN)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "M01AB04",
        "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1980,
    "indication_class": "Analgesic; Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL19490",
    "molecule_properties": {
      "acd_logd": 0.27,
      "acd_logp": 3.36,
      "acd_most_apka": 4.2,
      "alogp": 2.85,
      "aromatic_rings": 2,
      "full_molformula": "C15H14ClNO3",
      "full_mwt": 291.73,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "ACID",
      "mw_freebase": 291.73,
      "mw_monoisotopic": 291.0662,
      "psa": 59.3,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cc(CC(=O)O)n(C)c1C(=O)c2ccc(Cl)cc2",
      "standard_inchi": "InChI=1S/C15H14ClNO3/c1-9-7-12(8-13(18)19)17(2)14(9)15(20)10-3-5-11(16)6-4-10/h3-7H,8H2,1-2H3,(H,18,19)",
      "standard_inchi_key": "ZXVNMYWKKDOREA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MCN-2783-21-98"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Zomepirac (BAN, INN)",
        "Zomepirac Sodium (USAN, USP)",
        null
      ]
    },
    "usan_stem": "-ac",
    "usan_stem_definition": "anti-inflammatory agents (acetic acid derivatives)",
    "usan_stem_substem": "-ac(-ac)",
    "usan_year": 1978,
    "withdrawn_class": "Immune system toxicity",
    "withdrawn_country": "United States; United Kingdom; United States; Spain; Germany ",
    "withdrawn_reason": "Anaphylactic reactions and non_fatal allergic reactions",
    "withdrawn_year": 1983
  },
  {
    "applicants": {
      "value": [
        "Jubilant Cadista Pharmaceuticals Inc",
        "Apotex Inc",
        "Sandoz Inc",
        "Mylan Technologies Inc",
        "Ranbaxy Laboratories Ltd",
        "Abbott Laboratories Pharmaceutical Products Div",
        "Mylan Pharmaceuticals Inc",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa",
        "Teva Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "G04CA03",
        "description": "GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY: Alpha-adrenoreceptor antagonists"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1987,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL611",
    "molecule_properties": {
      "acd_logd": 0.74,
      "acd_logp": 0.8,
      "acd_most_bpka": 6.52,
      "alogp": 1.06,
      "aromatic_rings": 2,
      "full_molformula": "C19H25N5O4",
      "full_mwt": 387.44,
      "hba": 8,
      "hba_lipinski": 9,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 387.44,
      "mw_monoisotopic": 387.1907,
      "psa": 103.04,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4CCCO4",
      "standard_inchi": "InChI=1S/C19H25N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22)",
      "standard_inchi_key": "VCKUSRYTPJJLNI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "ABBOTT-45975"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Terazosin (BAN, INN)",
        "Terazosin HCl (FDA, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-azosin",
    "usan_stem_definition": "antihypertensives (prazosin type)",
    "usan_stem_substem": "-azosin(-azosin)",
    "usan_year": 1980
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL19633",
    "molecule_properties": {
      "acd_logd": 0.81,
      "acd_logp": 0.95,
      "acd_most_bpka": 6.97,
      "alogp": 1.25,
      "aromatic_rings": 2,
      "full_molformula": "C13H16N4O2",
      "full_mwt": 260.3,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 260.3,
      "mw_monoisotopic": 260.1273,
      "psa": 96.28,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(Cc2cnc(N)nc2N)cc1OC",
      "standard_inchi": "InChI=1S/C13H16N4O2/c1-18-10-4-3-8(6-11(10)19-2)5-9-7-16-13(15)17-12(9)14/h3-4,6-7H,5H2,1-2H3,(H4,14,15,16,17)",
      "standard_inchi_key": "LDBTVAXGKYIFHO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BW-49210"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Diaveridine (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-eridine",
    "usan_stem_definition": "analgesics (meperidine type)",
    "usan_stem_substem": "-eridine(-eridine)",
    "usan_year": 1962
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Anorexic",
    "molecule_chembl_id": "CHEMBL19393",
    "molecule_properties": {
      "acd_logd": -0.65,
      "acd_logp": 1.79,
      "acd_most_bpka": 9.94,
      "alogp": 1.58,
      "aromatic_rings": 1,
      "full_molformula": "C9H13N",
      "full_mwt": 135.21,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 10,
      "molecular_species": "BASE",
      "mw_freebase": 135.21,
      "mw_monoisotopic": 135.1048,
      "psa": 26.02,
      "qed_weighted": 0.65,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@@H](N)Cc1ccccc1",
      "standard_inchi": "InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m1/s1",
      "standard_inchi_key": "KWTSXDURSIMDCE-MRVPVSSYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Levamfetamine (BAN, INN)",
        "Levamfetamine Succinate (USAN)",
        null
      ]
    },
    "usan_stem": "-fetamin(e)",
    "usan_stem_definition": "amfetamine derivatives",
    "usan_stem_substem": "-fetamin(e)(-fetamin(e))",
    "usan_year": 1962
  },
  {
    "applicants": {
      "value": [
        "Mallinckrodt Inc",
        "Halsey Drug Co Inc",
        "Outlook Pharmaceuticals Inc",
        "Mayne Pharma Llc",
        "Teva Womens Health Inc",
        "Teva Pharmaceuticals Usa",
        "Shire Development Inc",
        "Shire Development Llc",
        "Sunrise Pharmaceutical Inc",
        "Epic Pharma Llc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06BA02",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1955,
    "indication_class": "Stimulant (central)",
    "molecule_chembl_id": "CHEMBL612",
    "molecule_properties": {
      "acd_logd": -0.65,
      "acd_logp": 1.79,
      "acd_most_bpka": 9.94,
      "alogp": 1.58,
      "aromatic_rings": 1,
      "full_molformula": "C9H13N",
      "full_mwt": 135.21,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 10,
      "molecular_species": "BASE",
      "mw_freebase": 135.21,
      "mw_monoisotopic": 135.1048,
      "psa": 26.02,
      "qed_weighted": 0.65,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H](N)Cc1ccccc1",
      "standard_inchi": "InChI=1S/C9H13N/c1-8(10)7-9-5-3-2-4-6-9/h2-6,8H,7,10H2,1H3/t8-/m0/s1",
      "standard_inchi_key": "KWTSXDURSIMDCE-QMMMGPOBSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6322819,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-6322819-B1",
    "synonyms": {
      "value": [
        "Dextroamphetamine Adipate (FDA)",
        "Dextroamphetamine sulfate (FDA, USP)",
        "Dexamfetamine (BAN, INN)",
        "Dexamphetamine (DCF)",
        "Dextroamphetamine (USAN)",
        "Dextroamphetamine resin complex (FDA)",
        "Dextroamphetamine Saccharate (FDA)",
        "Dextroamphetamine Phosphate (USP)",
        null
      ]
    },
    "usan_year": 1964
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C02KX03",
        "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: OTHER ANTIHYPERTENSIVES: Antihypertensives for pulmonary arterial hypertension"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2006,
    "molecule_chembl_id": "CHEMBL282724",
    "molecule_properties": {
      "acd_logd": 1.25,
      "acd_logp": 3.11,
      "acd_most_apka": 4.96,
      "alogp": 3.96,
      "aromatic_rings": 3,
      "full_molformula": "C18H15ClN2O6S2",
      "full_mwt": 454.91,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "ACID",
      "mw_freebase": 454.91,
      "mw_monoisotopic": 454.006,
      "psa": 107.73,
      "qed_weighted": 0.56,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cc2OCOc2cc1CC(=O)c3sccc3S(=O)(=O)Nc4onc(C)c4Cl",
      "standard_inchi": "InChI=1S/C18H15ClN2O6S2/c1-9-5-13-14(26-8-25-13)7-11(9)6-12(22)17-15(3-4-28-17)29(23,24)21-18-16(19)10(2)20-27-18/h3-5,7,21H,6,8H2,1-2H3",
      "standard_inchi_key": "PHWXUGHIIBDVKD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "TBC-11251NA",
        "TBC-11251Z"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sitaxentan Sodium (USAN)",
        "Sitaxentan (INN)",
        null
      ]
    },
    "usan_stem": "-entan",
    "usan_stem_definition": "endothelin receptor antagonists",
    "usan_stem_substem": "-entan(-entan)",
    "usan_year": 2011,
    "withdrawn_class": "Hepatotoxicity",
    "withdrawn_country": "European Union",
    "withdrawn_reason": "Liver toxicity",
    "withdrawn_year": 2010
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL279786",
    "molecule_properties": {
      "acd_logd": 3.29,
      "acd_logp": 3.3,
      "acd_most_apka": 9.04,
      "alogp": 3.1,
      "aromatic_rings": 2,
      "full_molformula": "C23H31N3O4S2",
      "full_mwt": 477.65,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 32,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 477.65,
      "mw_monoisotopic": 477.1756,
      "psa": 107.53,
      "qed_weighted": 0.21,
      "ro3_pass": "N",
      "rtb": 12
    },
    "molecule_structures": {
      "canonical_smiles": "CNC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(C)C)[C@H](CSc2cccs2)C(=O)NO",
      "standard_inchi": "InChI=1S/C23H31N3O4S2/c1-15(2)12-17(18(22(28)26-30)14-32-20-10-7-11-31-20)21(27)25-19(23(29)24-3)13-16-8-5-4-6-9-16/h4-11,15,17-19,30H,12-14H2,1-3H3,(H,24,29)(H,25,27)(H,26,28)/t17-,18+,19+/m1/s1",
      "standard_inchi_key": "XFILPEOLDIKJHX-QYZOEREBSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BB-94"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Batimastat (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors: matrix metalloprotease inhibitors",
    "usan_stem_substem": "-stat(-stat(-mastat))",
    "usan_year": 1994
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Antineoplastic (matrix metalloproteinase inhibitor)",
    "molecule_chembl_id": "CHEMBL279785",
    "molecule_properties": {
      "acd_logd": 1.31,
      "acd_logp": 1.31,
      "acd_most_apka": 9.44,
      "alogp": -0.21,
      "full_molformula": "C15H29N3O5",
      "full_mwt": 331.41,
      "hba": 5,
      "hba_lipinski": 8,
      "hbd": 5,
      "hbd_lipinski": 5,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 331.41,
      "mw_monoisotopic": 331.2107,
      "psa": 127.76,
      "qed_weighted": 0.33,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CNC(=O)[C@@H](NC(=O)[C@H](CC(C)C)[C@H](O)C(=O)NO)C(C)(C)C",
      "standard_inchi": "InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1",
      "standard_inchi_key": "OCSMOTCMPXTDND-OUAUKWLOSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BB-2516"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Marimastat (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors: matrix metalloprotease inhibitors",
    "usan_stem_substem": "-stat(-stat(-mastat))",
    "usan_year": 1996
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL279085",
    "molecule_properties": {
      "acd_logd": 1.79,
      "acd_logp": 1.98,
      "acd_most_bpka": 7.22,
      "alogp": 1.31,
      "aromatic_rings": 1,
      "full_molformula": "C10H15N3S",
      "full_mwt": 209.32,
      "hba": 4,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 209.32,
      "mw_monoisotopic": 209.0987,
      "psa": 42.15,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1nc2CCN(CC=C)CCc2s1",
      "standard_inchi": "InChI=1S/C10H15N3S/c1-2-5-13-6-3-8-9(4-7-13)14-10(11)12-8/h2H,1,3-7H2,(H2,11,12)",
      "standard_inchi_key": "DHSSDEDRBUKTQY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Talipexole (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL19611",
    "molecule_properties": {
      "acd_logd": 2.04,
      "acd_logp": 2.05,
      "acd_most_apka": 9.16,
      "alogp": 1.5,
      "aromatic_rings": 2,
      "full_molformula": "C20H28N4O4",
      "full_mwt": 388.47,
      "hba": 4,
      "hba_lipinski": 8,
      "hbd": 5,
      "hbd_lipinski": 5,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 388.47,
      "mw_monoisotopic": 388.2111,
      "psa": 123.32,
      "qed_weighted": 0.33,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)CC(=O)NO",
      "standard_inchi": "InChI=1S/C20H28N4O4/c1-12(2)8-13(10-18(25)24-28)19(26)23-17(20(27)21-3)9-14-11-22-16-7-5-4-6-15(14)16/h4-7,11-13,17,22,28H,8-10H2,1-3H3,(H,21,27)(H,23,26)(H,24,25)/t13-,17+/m1/s1",
      "standard_inchi_key": "NITYDPDXAAFEIT-DYVFJYSZSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ilomastat (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors: matrix metalloprotease inhibitors",
    "usan_stem_substem": "-stat(-stat(-mastat))",
    "usan_year": 1994
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL279890",
    "molecule_properties": {
      "acd_logd": 3.53,
      "acd_logp": 6.79,
      "acd_most_bpka": 10.32,
      "alogp": 5.64,
      "aromatic_rings": 4,
      "full_molformula": "C25H32N4O",
      "full_mwt": 404.56,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 30,
      "molecular_species": "BASE",
      "mw_freebase": 404.56,
      "mw_monoisotopic": 404.2576,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 53.18,
      "qed_weighted": 0.37,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCCNc1nccc2c(C)c3[nH]c4ccc(OC)cc4c3c(C)c12",
      "standard_inchi": "InChI=1S/C25H32N4O/c1-6-29(7-2)14-8-12-26-25-23-17(4)22-20-15-18(30-5)9-10-21(20)28-24(22)16(3)19(23)11-13-27-25/h9-11,13,15,28H,6-8,12,14H2,1-5H3,(H,26,27)",
      "standard_inchi_key": "PAVKBQLPQCDVNI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Retelliptine (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Sanofi Aventis Us Llc",
        "Dava Pharmaceuticals Inc",
        "Akorn Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J04AK01",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Other drugs for treatment of tuberculosis"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1971,
    "indication_class": "Antibacterial (tuberculostatic)",
    "molecule_chembl_id": "CHEMBL614",
    "molecule_properties": {
      "acd_logd": -0.71,
      "acd_logp": -0.71,
      "acd_most_apka": 13.91,
      "acd_most_bpka": 0.87,
      "alogp": -0.42,
      "aromatic_rings": 1,
      "full_molformula": "C5H5N3O",
      "full_mwt": 123.11,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 9,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 123.11,
      "mw_monoisotopic": 123.0433,
      "psa": 68.87,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=O)c1cnccn1",
      "standard_inchi": "InChI=1S/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9)",
      "standard_inchi_key": "IPEHBUMCGVEMRF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "prodrug": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pyrazinamide (BAN, FDA, INN, JAN, USP)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "R03DC04",
        "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Leukotriene receptor antagonists"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL19449",
    "molecule_properties": {
      "acd_logd": 2.44,
      "acd_logp": 2.44,
      "acd_most_bpka": 1.22,
      "alogp": 3.3,
      "aromatic_rings": 2,
      "full_molformula": "C14H18N2O",
      "full_mwt": 230.31,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 230.31,
      "mw_monoisotopic": 230.1419,
      "psa": 34.37,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)C(=O)c1c(nn2ccccc12)C(C)C",
      "standard_inchi": "InChI=1S/C14H18N2O/c1-9(2)13-12(14(17)10(3)4)11-7-5-6-8-16(11)15-13/h5-10H,1-4H3",
      "standard_inchi_key": "ZJVFLBOZORBYFE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "MN-166",
        "AV-411"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ibudilast (INN, JAN, MI)",
        null
      ]
    },
    "usan_stem": "-ast; -dil-",
    "usan_stem_definition": "antiasthmatics/antiallergics (not acting primarily as antihistamines,leukotriene biosynthesis inhibitors); vasodilators (undefined group)",
    "usan_stem_substem": "-ast(-ast); -dil-(-dil-)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": -1,
    "molecule_chembl_id": "CHEMBL263367",
    "molecule_properties": {
      "full_molformula": "C70H97Cl2NO38",
      "full_mwt": 1631.42,
      "mw_freebase": 1631.42,
      "mw_monoisotopic": 1629.5066
    },
    "molecule_structures": {
      "canonical_smiles": "COC[C@H]1O[C@@H](O[C@@H]2OC[C@@H]3O[C@@]4(OC[C@@H](OC(=O)c5c(C)cc(O)cc5O)[C@@H]6OCO[C@@H]46)O[C@H]3[C@H]2O)[C@@H](OC)[C@@H](O)[C@@H]1O[C@@H]7O[C@H](C)[C@H](OC)[C@H](O[C@@H]8O[C@H](C)[C@H]9O[C@]%10(C[C@@H](O)[C@H](O[C@H]%11C[C@@H](O[C@H]%12C[C@@](C)([C@@H](OC)[C@H](C)O%12)[N+](=O)[O-])[C@H](OC(=O)c%13c(C)c(Cl)c(O)c(Cl)c%13OC)[C@@H](C)O%11)[C@@H](C)O%10)O[C@]9(C)[C@@H]8O)[C@H]7O",
      "standard_inchi": "InChI=1S/C70H97Cl2NO38/c1-24-15-31(74)16-32(75)40(24)61(82)100-36-22-94-70(60-53(36)92-23-93-60)108-37-21-91-63(46(79)52(37)109-70)106-65-56(89-13)45(78)51(35(101-65)20-86-10)104-64-47(80)55(50(87-11)27(4)97-64)105-66-57(81)68(9)59(30(7)98-66)110-69(111-68)18-33(76)48(28(5)107-69)102-38-17-34(99-39-19-67(8,73(84)85)58(90-14)29(6)96-39)49(26(3)95-38)103-62(83)41-25(2)42(71)44(77)43(72)54(41)88-12/h15-16,26-30,33-39,45-53,55-60,63-66,74-81H,17-23H2,1-14H3/t26-,27-,28-,29+,30-,33-,34-,35-,36-,37+,38+,39+,45+,46-,47-,48-,49-,50+,51-,52-,53+,55-,56+,57-,58+,59-,60-,63+,64+,65+,66+,67+,68-,69-,70-/m1/s1",
      "standard_inchi_key": "UPADRKHAIMTUCC-OWALTSPQSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SCH-27899"
    },
    "synonyms": {
      "value": [
        "Evernimicin (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-micin",
    "usan_stem_definition": "antibiotics (Micromonospora strains)",
    "usan_stem_substem": "-micin(-micin)",
    "usan_year": 1999
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL428676",
    "molecule_properties": {
      "acd_logd": -0.83,
      "acd_logp": 0.61,
      "acd_most_bpka": 8.83,
      "alogp": 1.58,
      "aromatic_rings": 2,
      "full_molformula": "C16H17N3O2",
      "full_mwt": 283.33,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 283.33,
      "mw_monoisotopic": 283.1321,
      "psa": 66.64,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCN1C(=O)c2cccc3cc(N)cc(C1=O)c23",
      "standard_inchi": "InChI=1S/C16H17N3O2/c1-18(2)6-7-19-15(20)12-5-3-4-10-8-11(17)9-13(14(10)12)16(19)21/h3-5,8-9H,6-7,17H2,1-2H3",
      "standard_inchi_key": "UPALIKSFLSVKIS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "AS-1413",
        "XAN-02"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Amonafide (INN, USAN)",
        "Amonafide L-Malate (USAN)",
        null
      ]
    },
    "usan_year": 2011
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL20803",
    "molecule_properties": {
      "acd_logd": 1.71,
      "acd_logp": 3.25,
      "acd_most_apka": 10.07,
      "acd_most_bpka": 9.06,
      "alogp": 3.08,
      "aromatic_rings": 1,
      "full_molformula": "C17H23NO",
      "full_mwt": 257.38,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 257.38,
      "mw_monoisotopic": 257.178,
      "psa": 23.47,
      "qed_weighted": 0.77,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCC23CCCCC2C1Cc4ccc(O)cc34",
      "standard_inchi": "InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3",
      "standard_inchi_key": "JAQUASYNZVUNQP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Racemorphan (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-orphan",
    "usan_stem_definition": "narcotic antagonists/agonists (morphinan derivatives)",
    "usan_stem_substem": "-orphan(-orphan)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL278581",
    "molecule_properties": {
      "acd_logd": 1.51,
      "acd_logp": 3.49,
      "acd_most_bpka": 10.75,
      "alogp": 2.95,
      "aromatic_rings": 1,
      "full_molformula": "C12H13Cl2N3",
      "full_mwt": 270.16,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "BASE",
      "mw_freebase": 270.16,
      "mw_monoisotopic": 269.0487,
      "psa": 27.63,
      "qed_weighted": 0.86,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1cccc(Cl)c1N(CC=C)C2=NCCN2",
      "standard_inchi": "InChI=1S/C12H13Cl2N3/c1-2-8-17(12-15-6-7-16-12)11-9(13)4-3-5-10(11)14/h2-5H,1,6-8H2,(H,15,16)",
      "standard_inchi_key": "OXTYVEUAQHPPMV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "ST-567",
        "ST-567-BR [As Hydrobromide]"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Alinidine (BAN, INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL20634",
    "molecule_properties": {
      "acd_logd": -0.52,
      "acd_logp": 2.36,
      "acd_most_apka": 4.5,
      "acd_most_bpka": 2.7,
      "alogp": 1.64,
      "aromatic_rings": 2,
      "full_molformula": "C13H11N3O4S2",
      "full_mwt": 337.38,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "ACID",
      "mw_freebase": 337.38,
      "mw_monoisotopic": 337.0191,
      "psa": 99.6,
      "qed_weighted": 0.87,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3nccs3",
      "standard_inchi": "InChI=1S/C13H11N3O4S2/c1-16-10(12(18)15-13-14-6-7-21-13)11(17)8-4-2-3-5-9(8)22(16,19)20/h2-7,17H,1H3,(H,14,15,18)",
      "standard_inchi_key": "SYCHUQUJURZQMO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CP-15973"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sudoxicam (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-icam",
    "usan_stem_definition": "anti-inflammatory agents (isoxicam type)",
    "usan_stem_substem": "-icam(-icam)",
    "usan_year": 1972
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Platelet Activating Factor Antagonist",
    "molecule_chembl_id": "CHEMBL280164",
    "molecule_properties": {
      "acd_logd": 0.69,
      "acd_logp": 0.69,
      "acd_most_bpka": 2.36,
      "alogp": 3.43,
      "aromatic_rings": 3,
      "full_molformula": "C22H22ClN5O2S",
      "full_mwt": 455.97,
      "hba": 7,
      "hba_lipinski": 7,
      "heavy_atoms": 31,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 455.97,
      "mw_monoisotopic": 455.1183,
      "psa": 72.61,
      "qed_weighted": 0.6,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1nnc2CN=C(c3ccccc3Cl)c4cc(CCC(=O)N5CCOCC5)sc4n12",
      "standard_inchi": "InChI=1S/C22H22ClN5O2S/c1-14-25-26-19-13-24-21(16-4-2-3-5-18(16)23)17-12-15(31-22(17)28(14)19)6-7-20(29)27-8-10-30-11-9-27/h2-5,12H,6-11,13H2,1H3",
      "standard_inchi_key": "JGPJQFOROWSRRS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "WEB-2086",
        "WEB 2086 BS"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Apafant (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-pafant",
    "usan_stem_definition": "platelet-activating factor antagonists",
    "usan_stem_substem": "-pafant(-pafant)",
    "usan_year": 1997
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "L01BC03",
          "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogue"
        },
        {
          "code": "L01BC53",
          "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 7,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL20883",
    "molecule_properties": {
      "acd_logd": -0.8,
      "acd_logp": -0.6,
      "acd_most_apka": 7.63,
      "alogp": -0.02,
      "aromatic_rings": 1,
      "full_molformula": "C8H9FN2O3",
      "full_mwt": 200.17,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 200.17,
      "mw_monoisotopic": 200.0597,
      "psa": 64.09,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "FC1=CN(C2CCCO2)C(=O)NC1=O",
      "standard_inchi": "InChI=1S/C8H9FN2O3/c9-5-4-11(6-2-1-3-14-6)8(13)10-7(5)12/h4,6H,1-3H2,(H,10,12,13)",
      "standard_inchi_key": "WFWLQNSHRPWKFK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MJF-12264"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tegafur (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_year": 1979
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL281164",
    "molecule_properties": {
      "acd_logd": 4.42,
      "acd_logp": 4.42,
      "acd_most_bpka": 3.48,
      "alogp": 2.84,
      "aromatic_rings": 3,
      "full_molformula": "C17H17N3O2",
      "full_mwt": 295.34,
      "hba": 5,
      "hba_lipinski": 5,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 295.34,
      "mw_monoisotopic": 295.1321,
      "psa": 56.49,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCc1c(OC)nc2nc(cn2c1C)C(=O)c3ccccc3",
      "standard_inchi": "InChI=1S/C17H17N3O2/c1-4-13-11(2)20-10-14(18-17(20)19-16(13)22-3)15(21)12-8-6-5-7-9-12/h5-10H,4H2,1-3H3",
      "standard_inchi_key": "NRJVHCSYLGLURI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Divaplon (INN)",
        null
      ]
    },
    "usan_stem": "-plon",
    "usan_stem_definition": "non-benzodiazepine anxiolytics, sedatives, hypnotics",
    "usan_stem_substem": "-plon(-plon)"
  },
  {
    "applicants": {
      "value": [
        "Apothecon Inc Div Bristol Myers Squibb",
        "Dava Pharmaceuticals Inc",
        "Teva Pharmaceuticals Usa Inc",
        "Eli Lilly And Co",
        "Pfizer Laboratories Div Pfizer Inc",
        "Apothecon Sub Bristol Myers Squibb Co",
        "Bristol Laboratories Inc Div Bristol Myers Co",
        "Purepac Pharmaceutical Co",
        "Parke Davis Div Warner Lambert Co",
        "Aurobindo Pharma Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01CE02",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase sensitive penicillins"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1958,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL615",
    "molecule_properties": {
      "acd_logd": -1.79,
      "acd_logp": 1.94,
      "acd_most_apka": 2.44,
      "alogp": 0.7,
      "aromatic_rings": 1,
      "full_molformula": "C16H18N2O5S",
      "full_mwt": 350.4,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 24,
      "molecular_species": "ACID",
      "mw_freebase": 350.4,
      "mw_monoisotopic": 350.0936,
      "psa": 95.94,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O",
      "standard_inchi": "InChI=1S/C16H18N2O5S/c1-16(2)12(15(21)22)18-13(20)11(14(18)24-16)17-10(19)8-23-9-6-4-3-5-7-9/h3-7,11-12,14H,8H2,1-2H3,(H,17,19)(H,21,22)/t11-,12+,14-/m1/s1",
      "standard_inchi_key": "BPLBGHOLXOTWMN-MBNYWOFBSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Bicillin V2 (JAN)",
        "Penicillin V Benzathine (USAN, USP)",
        "Penicillin V Potassium (FDA, USAN, USP)",
        "Phenoxymethylpenicillin Potassium (JAN)",
        "Penicillin V (FDA, USAN, USP)",
        "Phenoxymethylpenicillin (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-cillin",
    "usan_stem_definition": "penicillins",
    "usan_stem_substem": "-cillin(-cillin)",
    "usan_year": 1975
  },
  {
    "availability_type": -1,
    "biotherapeutic": {
      "description": "INTERMEDINE",
      "helm_notation": "PEPTIDE1{[ac].S.Y.S.M.E.H.F.R.W.G.K.P.V.[am]}$$$$",
      "molecule_chembl_id": "CHEMBL214332"
    },
    "chirality": 1,
    "drug_type": 5,
    "helm_notation": "PEPTIDE1{[ac].S.Y.S.M.E.H.F.R.W.G.K.P.V.[am]}$$$$",
    "molecule_chembl_id": "CHEMBL214332",
    "molecule_properties": {
      "full_molformula": "C77H109N21O19S",
      "full_mwt": 1664.91,
      "mw_freebase": 1664.91,
      "mw_monoisotopic": 1663.7929
    },
    "molecule_structures": {
      "canonical_smiles": "CSCC[C@H](NC(=O)[C@H](CO)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](Cc4c[nH]c5ccccc45)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N6CCC[C@H]6C(=O)N[C@@H](C(C)C)C(=O)N",
      "standard_inchi": "InChI=1S/C77H109N21O19S/c1-42(2)64(65(79)106)97-75(116)61-20-13-30-98(61)76(117)54(18-10-11-28-78)88-62(103)38-85-66(107)57(34-46-36-84-50-17-9-8-16-49(46)50)94-67(108)51(19-12-29-83-77(80)81)89-70(111)55(32-44-14-6-5-7-15-44)92-72(113)58(35-47-37-82-41-86-47)95-68(109)52(25-26-63(104)105)90-69(110)53(27-31-118-4)91-74(115)60(40-100)96-71(112)56(33-45-21-23-48(102)24-22-45)93-73(114)59(39-99)87-43(3)101/h5-9,14-17,21-24,36-37,41-42,51-61,64,84,99-100,102H,10-13,18-20,25-35,38-40,78H2,1-4H3,(H2,79,106)(H,82,86)(H,85,107)(H,87,101)(H,88,103)(H,89,111)(H,90,110)(H,91,115)(H,92,113)(H,93,114)(H,94,108)(H,95,109)(H,96,112)(H,97,116)(H,104,105)(H4,80,81,83)/t51-,52-,53-,54-,55-,56-,57-,58-,59-,60-,61-,64-/m0/s1",
      "standard_inchi_key": "WHNFPRLDDSXQCL-UAZQEYIDSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Intermedine (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL20210",
    "molecule_properties": {
      "acd_logd": 2.64,
      "acd_logp": 2.64,
      "acd_most_apka": 12.16,
      "alogp": 2.82,
      "aromatic_rings": 2,
      "full_molformula": "C31H39FN4O7",
      "full_mwt": 598.67,
      "hba": 8,
      "hba_lipinski": 11,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 43,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 598.67,
      "mw_monoisotopic": 598.2803,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 1,
      "psa": 156.7,
      "qed_weighted": 0.21,
      "ro3_pass": "N",
      "rtb": 15
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)\\C=C\\[C@H](C[C@@H]1CCNC1=O)NC(=O)[C@@H](CC(=O)[C@@H](NC(=O)c2cc(C)on2)C(C)C)Cc3ccc(F)cc3",
      "standard_inchi": "InChI=1S/C31H39FN4O7/c1-5-42-27(38)11-10-24(16-21-12-13-33-29(21)39)34-30(40)22(15-20-6-8-23(32)9-7-20)17-26(37)28(18(2)3)35-31(41)25-14-19(4)43-36-25/h6-11,14,18,21-22,24,28H,5,12-13,15-17H2,1-4H3,(H,33,39)(H,34,40)(H,35,41)/b11-10+/t21-,22+,24+,28-/m0/s1",
      "standard_inchi_key": "CAYJBRBGZBCZKO-BHGBQCOSSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AG-7088"
    },
    "synonyms": {
      "value": [
        "Rupintrivir (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-vir",
    "usan_stem_definition": "antivirals",
    "usan_stem_substem": "-vir(-vir)",
    "usan_year": 2002
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL281594",
    "molecule_properties": {
      "acd_logd": 4.93,
      "acd_logp": 5.35,
      "acd_most_bpka": 7.55,
      "alogp": 5.32,
      "aromatic_rings": 3,
      "full_molformula": "C28H32F2N2O",
      "full_mwt": 450.57,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 33,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 450.57,
      "mw_monoisotopic": 450.2483,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 15.71,
      "qed_weighted": 0.42,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "Fc1ccc(cc1)C(OCCN2CCN(CCCc3ccccc3)CC2)c4ccc(F)cc4",
      "standard_inchi": "InChI=1S/C28H32F2N2O/c29-26-12-8-24(9-13-26)28(25-10-14-27(30)15-11-25)33-22-21-32-19-17-31(18-20-32)16-4-7-23-5-2-1-3-6-23/h1-3,5-6,8-15,28H,4,7,16-22H2",
      "standard_inchi_key": "NAUWTFJOPJWYOT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "GBR-12909"
    },
    "synonyms": {
      "value": [
        "Vanoxerine (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Eli Lilly And Co",
        "Bristol Laboratories Inc Div Bristol Myers Co",
        "Baxter Healthcare Corp",
        "International Medication Systems Ltd",
        "Abraxis Pharmaceutical Products",
        "Abbott Laboratories Pharmaceutical Products Div",
        "Glaxosmithkline"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01DB03",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: First-generation cephalosporins"
      }
    },
    "availability_type": 0,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1974,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL617",
    "molecule_properties": {
      "acd_logd": -3.62,
      "acd_logp": 0.09,
      "acd_most_apka": 2.68,
      "alogp": 0.59,
      "aromatic_rings": 1,
      "full_molformula": "C16H16N2O6S2",
      "full_mwt": 396.45,
      "hba": 7,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 396.45,
      "mw_monoisotopic": 396.045,
      "psa": 113.01,
      "qed_weighted": 0.53,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc3cccs3)C2=O)C(=O)O",
      "standard_inchi": "InChI=1S/C16H16N2O6S2/c1-8(19)24-6-9-7-26-15-12(14(21)18(15)13(9)16(22)23)17-11(20)5-10-3-2-4-25-10/h2-4,12,15H,5-7H2,1H3,(H,17,20)(H,22,23)/t12-,15-/m1/s1",
      "standard_inchi_key": "XIURVHNZVLADCM-IUODEOHRSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": 38253
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cefalotin Sodium (JAN)",
        "Cephalothin sodium (FDA, USAN, USP)",
        "Cefalotin (BAN, INN)",
        null
      ]
    },
    "usan_year": 1965
  },
  {
    "applicants": {
      "value": "Knight Therapeutics Usa Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "L01XX09",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2014,
    "first_in_class": true,
    "molecule_chembl_id": "CHEMBL125",
    "molecule_properties": {
      "acd_logd": 4.01,
      "acd_logp": 3.41,
      "acd_most_apka": 1.28,
      "alogp": 5.68,
      "full_molformula": "C21H46NO4P",
      "full_mwt": 407.58,
      "hba": 4,
      "hba_lipinski": 5,
      "heavy_atoms": 27,
      "molecular_species": "ACID",
      "mw_freebase": 407.58,
      "mw_monoisotopic": 407.3164,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 58.59,
      "qed_weighted": 0.15,
      "ro3_pass": "N",
      "rtb": 20
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCCCCCCCCCCOP(=O)([O-])OCC[N+](C)(C)C",
      "standard_inchi": "InChI=1S/C21H46NO4P/c1-5-6-7-8-9-10-11-12-13-14-15-16-17-18-20-25-27(23,24)26-21-19-22(2,3)4/h5-21H2,1-4H3",
      "standard_inchi_key": "PQLXHQMOHUQAKB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "HDPC",
        "D-18506"
      ]
    },
    "synonyms": {
      "value": [
        "Miltefosine (BAN, FDA, INN)",
        null
      ]
    },
    "usan_stem": "-fo-",
    "usan_stem_definition": "phosphoro-derivatives",
    "usan_stem_substem": "-fo-(-fo-)"
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL20734",
    "molecule_properties": {
      "acd_logd": 2.71,
      "acd_logp": 3.78,
      "acd_most_apka": 13.69,
      "acd_most_bpka": 8.36,
      "alogp": 3.78,
      "aromatic_rings": 2,
      "full_molformula": "C21H26ClN3O2",
      "full_mwt": 387.91,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 387.91,
      "mw_monoisotopic": 387.1714,
      "psa": 53.6,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CNc1cc(OC)c(cc1Cl)C(=O)NC2CCN(Cc3ccccc3)C2C",
      "standard_inchi": "InChI=1S/C21H26ClN3O2/c1-14-18(9-10-25(14)13-15-7-5-4-6-8-15)24-21(26)16-11-17(22)19(23-2)12-20(16)27-3/h4-8,11-12,14,18,23H,9-10,13H2,1-3H3,(H,24,26)",
      "standard_inchi_key": "KRVOJOCLBAAKSJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nemonapride (INN, JAN)",
        null
      ]
    },
    "usan_stem": "-pride",
    "usan_stem_definition": "sulpiride derivatives",
    "usan_stem_substem": "-pride(-pride)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL277465",
    "molecule_properties": {
      "acd_logd": 2.37,
      "acd_logp": 2.37,
      "alogp": 1.55,
      "aromatic_rings": 2,
      "full_molformula": "C16H24N4O3",
      "full_mwt": 320.39,
      "hba": 7,
      "hba_lipinski": 7,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 320.39,
      "mw_monoisotopic": 320.1848,
      "psa": 78.89,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCN1C(=O)N(CCCC)c2ncn(CC(=O)C)c2C1=O",
      "standard_inchi": "InChI=1S/C16H24N4O3/c1-4-6-8-19-14-13(18(11-17-14)10-12(3)21)15(22)20(16(19)23)9-7-5-2/h11H,4-10H2,1-3H3",
      "standard_inchi_key": "HJPRDDKCXVCFOH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BRL-30892"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Denbufylline (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-fylline",
    "usan_stem_definition": "theophylline derivatives",
    "usan_stem_substem": "-fylline(-fylline)"
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL20679",
    "molecule_properties": {
      "acd_logd": 2.46,
      "acd_logp": 3.88,
      "acd_most_bpka": 9.29,
      "alogp": 4.22,
      "aromatic_rings": 1,
      "full_molformula": "C16H22Cl2N2O",
      "full_mwt": 329.27,
      "hba": 2,
      "hba_lipinski": 3,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 329.27,
      "mw_monoisotopic": 328.1109,
      "psa": 23.55,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(=O)N(C1CCCC1N(C)C)c2ccc(Cl)c(Cl)c2",
      "standard_inchi": "InChI=1S/C16H22Cl2N2O/c1-4-16(21)20(11-8-9-12(17)13(18)10-11)15-7-5-6-14(15)19(2)3/h8-10,14-15H,4-7H2,1-3H3",
      "standard_inchi_key": "YCRFSKUCDBJWLX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "U-48753E"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Eclanamine (INN)",
        "Eclanamine Maleate (USAN)",
        null
      ]
    },
    "usan_year": 1986
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05AL02",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Benzamides"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL277945",
    "molecule_properties": {
      "acd_logd": -0.49,
      "acd_logp": 1.39,
      "acd_most_apka": 13.99,
      "acd_most_bpka": 8.97,
      "alogp": 1.7,
      "aromatic_rings": 1,
      "full_molformula": "C17H26N2O4S",
      "full_mwt": 354.47,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 354.47,
      "mw_monoisotopic": 354.1613,
      "psa": 75.71,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1CCCC1CNC(=O)c2cc(ccc2OC)S(=O)(=O)CC",
      "standard_inchi": "InChI=1S/C17H26N2O4S/c1-4-19-10-6-7-13(19)12-18-17(20)15-11-14(24(21,22)5-2)8-9-16(15)23-3/h8-9,11,13H,4-7,10,12H2,1-3H3,(H,18,20)",
      "standard_inchi_key": "UNRHXEPDKXPRTM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sultopride (DCF, INN, MI)",
        "Sultopride HCl (JAN)",
        null
      ]
    },
    "usan_stem": "-pride",
    "usan_stem_definition": "sulpiride derivatives",
    "usan_stem_substem": "-pride(-pride)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 7,
    "indication_class": "Bronchodilator",
    "molecule_chembl_id": "CHEMBL279898",
    "molecule_properties": {
      "acd_logd": 0.57,
      "acd_logp": 0.57,
      "acd_most_apka": 10.88,
      "acd_most_bpka": 1.77,
      "alogp": -0.18,
      "aromatic_rings": 2,
      "full_molformula": "C8H10N4O2",
      "full_mwt": 194.19,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 194.19,
      "mw_monoisotopic": 194.0804,
      "psa": 83.54,
      "qed_weighted": 0.7,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCCN1C(=O)NC(=O)c2[nH]cnc12",
      "standard_inchi": "InChI=1S/C8H10N4O2/c1-2-3-12-6-5(9-4-10-6)7(13)11-8(12)14/h4H,2-3H2,1H3,(H,9,10)(H,11,13,14)",
      "standard_inchi_key": "SIQPXVQCUCHWDI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "D-4028"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Enprofylline (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-fylline",
    "usan_stem_definition": "theophylline derivatives",
    "usan_stem_substem": "-fylline(-fylline)",
    "usan_year": 1985
  },
  {
    "applicants": {
      "value": [
        "Hq Specialty Pharma Corp",
        "Fresenius Kabi Usa Llc",
        "Nang Kuang Pharmaceutical Co Ltd",
        "Teva Pharmaceuticals Usa",
        "West-Ward Pharmaceuticals International Ltd",
        "Sandoz Inc",
        "Alembic Pharmaceuticals Ltd",
        "Hetero Labs Ltd Unit V",
        "Alkem Laboratories Ltd",
        "Glenmark Pharmaceuticals Sa"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01XX08",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Other antibacterials"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2000,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL126",
    "molecule_properties": {
      "acd_logd": 0.44,
      "acd_logp": 0.45,
      "acd_most_bpka": 5.75,
      "alogp": 1.12,
      "aromatic_rings": 1,
      "full_molformula": "C16H20FN3O4",
      "full_mwt": 337.35,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 337.35,
      "mw_monoisotopic": 337.1438,
      "psa": 71.11,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(N3CCOCC3)c(F)c2",
      "standard_inchi": "InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1",
      "standard_inchi_key": "TYZROVQLWOKYKF-ZDUSSCGKSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6514529,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "U-100766"
    },
    "rule_of_five": true,
    "sc_patent": "US-6514529-B2",
    "synonyms": {
      "value": [
        "Linezolid (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-zolid",
    "usan_stem_definition": "oxazolidinone antibacterials",
    "usan_stem_substem": "-zolid(-zolid)",
    "usan_year": 1997
  },
  {
    "applicants": {
      "value": [
        "Hoffmann La Roche Inc",
        "Valeant Pharmaceuticals North America Llc"
      ]
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Anticholinergic",
    "molecule_chembl_id": "CHEMBL620",
    "molecule_properties": {
      "acd_logd": -0.33,
      "acd_logp": -0.33,
      "acd_most_apka": 11.13,
      "alogp": 2.7,
      "aromatic_rings": 2,
      "full_molformula": "C22H26NO3+",
      "full_mwt": 352.45,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 352.45,
      "mw_monoisotopic": 352.1907,
      "psa": 46.53,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "C[N+]12CCC(CC1)C(C2)OC(=O)C(O)(c3ccccc3)c4ccccc4",
      "standard_inchi": "InChI=1S/C22H26NO3/c1-23-14-12-17(13-15-23)20(16-23)26-21(24)22(25,18-8-4-2-5-9-18)19-10-6-3-7-11-19/h2-11,17,20,25H,12-16H2,1H3/q+1",
      "standard_inchi_key": "HOOSGZJRQIVJSZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "Ro-23773"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clidinium Bromide (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-ium",
    "usan_stem_definition": "quaternary ammonium derivatives",
    "usan_stem_substem": "-ium(-ium)",
    "usan_year": 1961
  },
  {
    "applicants": {
      "value": [
        "Daewoong Pharmaceutical Co Ltd",
        "Pfizer Inc",
        "Sandoz Inc",
        "Par Sterile Products Llc",
        "Savior Lifetec Corp",
        "Rempex Pharmaceuticals A Wholly Owned Sub Of The Medicines Co",
        "Amneal Pharmaceuticals",
        "Hospira Inc",
        "B Braun Medical Inc",
        "Acs Dobfar Spa"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01DH02",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Carbapenems"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1996,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL127",
    "molecule_properties": {
      "acd_logd": -3.83,
      "acd_logp": -1.23,
      "acd_most_apka": 4.27,
      "acd_most_bpka": 8.31,
      "alogp": -0.31,
      "full_molformula": "C17H25N3O5S",
      "full_mwt": 383.47,
      "hba": 6,
      "hba_lipinski": 8,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 383.47,
      "mw_monoisotopic": 383.1515,
      "psa": 110.18,
      "qed_weighted": 0.56,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(N2C1=O)C(=O)O)S[C@@H]3CN[C@@H](C3)C(=O)N(C)C",
      "standard_inchi": "InChI=1S/C17H25N3O5S/c1-7-12-11(8(2)21)16(23)20(12)13(17(24)25)14(7)26-9-5-10(18-6-9)15(22)19(3)4/h7-12,18,21H,5-6H2,1-4H3,(H,24,25)/t7-,8-,9+,10+,11-,12-/m1/s1",
      "standard_inchi_key": "DMJNNHOOLUXYBV-PQTSNVLCSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8680136,
    "parenteral": true,
    "research_codes": {
      "value": [
        "ICI-194660",
        "SM-7338"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-8680136-B2",
    "synonyms": {
      "value": [
        "Meropenem (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-penem",
    "usan_stem_definition": "antibacterial antibiotics, carbapenem derivatives",
    "usan_stem_substem": "-penem(-penem)",
    "usan_year": 1992
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "American Therapeutics Inc",
        "Aurolife Pharma Llc",
        "Torrent Pharmaceuticals Ltd",
        "Sun Pharmaceutical Industries Inc",
        "Apotex Inc",
        "Sandoz Inc",
        "Teva Pharmaceuticals Usa Inc",
        "Quantum Pharmics Ltd",
        "Watson Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AX05",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1981,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL621",
    "molecule_properties": {
      "acd_logd": 2.58,
      "acd_logp": 2.76,
      "acd_most_bpka": 7.52,
      "alogp": 2.36,
      "aromatic_rings": 3,
      "full_molformula": "C19H22ClN5O",
      "full_mwt": 371.87,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 371.87,
      "mw_monoisotopic": 371.1513,
      "psa": 45.78,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1cccc(c1)N2CCN(CCCN3N=C4C=CC=CN4C3=O)CC2",
      "standard_inchi": "InChI=1S/C19H22ClN5O/c20-16-5-3-6-17(15-16)23-13-11-22(12-14-23)8-4-10-25-19(26)24-9-2-1-7-18(24)21-25/h1-3,5-7,9,15H,4,8,10-14H2",
      "standard_inchi_key": "PHLBKPHSAVXXEF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6607748,
    "oral": true,
    "research_codes": {
      "value": "AF-1161"
    },
    "rule_of_five": true,
    "sc_patent": "US-6607748-B1",
    "synonyms": {
      "value": [
        "Trazodone HCl (FDA, JAN, USAN, USP)",
        "Trazodone (BAN, INN)",
        null
      ]
    },
    "usan_year": 1970
  },
  {
    "applicants": {
      "value": [
        "Chartwell Molecules Llc",
        "Apotex Inc Etobicoke Site",
        "Actavis Elizabeth Llc",
        "Watson Laboratories Inc Florida",
        "Oxford Pharmaceuticals Llc",
        "Apotex Inc",
        "Sandoz Inc",
        "Eci Pharmaceuticals Llc",
        "Watson Laboratories Inc",
        "Ranbaxy Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "M01AB08",
        "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1991,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL622",
    "molecule_properties": {
      "acd_logd": 0.44,
      "acd_logp": 3.42,
      "acd_most_apka": 4.31,
      "alogp": 3.38,
      "aromatic_rings": 2,
      "full_molformula": "C17H21NO3",
      "full_mwt": 287.36,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "ACID",
      "mw_freebase": 287.36,
      "mw_monoisotopic": 287.1521,
      "psa": 62.32,
      "qed_weighted": 0.91,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCc1cccc2c3CCOC(CC)(CC(=O)O)c3[nH]c12",
      "standard_inchi": "InChI=1S/C17H21NO3/c1-3-11-6-5-7-12-13-8-9-21-17(4-2,10-14(19)20)16(13)18-15(11)12/h5-7,18H,3-4,8-10H2,1-2H3,(H,19,20)",
      "standard_inchi_key": "NNYBQONXHNTVIJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "AY-24236"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Etodolac (BAN, FDA, INN, USAN, USP)",
        "Etodolic Acid (INN)",
        null
      ]
    },
    "usan_stem": "-ac",
    "usan_stem_definition": "anti-inflammatory agents (acetic acid derivatives)",
    "usan_stem_substem": "-ac(-ac)",
    "usan_year": 1975
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "R06AB03",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamine"
        },
        {
          "code": "D04AA13",
          "description": "DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Antihistamines for topical use"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antihistaminic",
    "molecule_chembl_id": "CHEMBL22108",
    "molecule_properties": {
      "acd_logd": 1.71,
      "acd_logp": 3.85,
      "acd_most_bpka": 9.58,
      "alogp": 4.15,
      "aromatic_rings": 2,
      "full_molformula": "C20H24N2",
      "full_mwt": 292.43,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 292.43,
      "mw_monoisotopic": 292.1939,
      "psa": 16.13,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C1=C(CCN(C)C)Cc2ccccc12)c3ccccn3",
      "standard_inchi": "InChI=1S/C20H24N2/c1-15(19-10-6-7-12-21-19)20-17(11-13-22(2)3)14-16-8-4-5-9-18(16)20/h4-10,12,15H,11,13-14H2,1-3H3",
      "standard_inchi_key": "MVMQESMQSYOVGV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SU-6518"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dimetindene (BAN, INN)",
        "Dimethindene Maleate (USAN, USP)",
        "Dimetindene Maleate (JAN)",
        null
      ]
    },
    "usan_year": 1962
  },
  {
    "atc_classification": {
      "drug": {
        "code": "R03DC02",
        "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Leukotriene receptor antagonists"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL21333",
    "molecule_properties": {
      "acd_logd": 2.23,
      "acd_logp": 3.97,
      "acd_most_apka": 5.33,
      "acd_most_bpka": 1.4,
      "alogp": 4.63,
      "aromatic_rings": 5,
      "full_molformula": "C27H23N5O4",
      "full_mwt": 481.51,
      "hba": 7,
      "hba_lipinski": 9,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 36,
      "molecular_species": "ACID",
      "mw_freebase": 481.51,
      "mw_monoisotopic": 481.175,
      "psa": 123,
      "qed_weighted": 0.29,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "O=C(Nc1cccc2C(=O)C=C(Oc12)c3nn[nH]n3)c4ccc(OCCCCc5ccccc5)cc4",
      "standard_inchi": "InChI=1S/C27H23N5O4/c33-23-17-24(26-29-31-32-30-26)36-25-21(23)10-6-11-22(25)28-27(34)19-12-14-20(15-13-19)35-16-5-4-9-18-7-2-1-3-8-18/h1-3,6-8,10-15,17H,4-5,9,16H2,(H,28,34)(H,29,30,31,32)",
      "standard_inchi_key": "NBQKINXMPLXUET-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "ONO-1078",
        "SB-205312"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pranlukast (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics: leukotriene receptor antagonists",
    "usan_stem_substem": "-ast(-ast(-lukast))"
  },
  {
    "applicants": {
      "value": [
        "Roxane Laboratories Inc",
        "Bristol Myers Squibb Co Pharmaceutical Research Institute",
        "Sandoz Inc",
        "Watson Laboratories Inc",
        "Dr Reddys Laboratories Inc",
        "Idt Australia Ltd",
        "Mylan Pharmaceuticals Inc",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa",
        "Teva Pharmaceuticals Usa Inc",
        "Sun Pharmaceutical Industries Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AX06",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1994,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL623",
    "molecule_properties": {
      "acd_logd": 3.88,
      "acd_logp": 4.09,
      "acd_most_bpka": 7.65,
      "alogp": 3.55,
      "aromatic_rings": 3,
      "full_molformula": "C25H32ClN5O2",
      "full_mwt": 470.02,
      "hba": 7,
      "hba_lipinski": 7,
      "heavy_atoms": 33,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 470.02,
      "mw_monoisotopic": 469.2245,
      "psa": 55.53,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "CCC1=NN(CCCN2CCN(CC2)c3cccc(Cl)c3)C(=O)N1CCOc4ccccc4",
      "standard_inchi": "InChI=1S/C25H32ClN5O2/c1-2-24-27-31(25(32)30(24)18-19-33-23-10-4-3-5-11-23)13-7-12-28-14-16-29(17-15-28)22-9-6-8-21(26)20-22/h3-6,8-11,20H,2,7,12-19H2,1H3",
      "standard_inchi_key": "VRBKIVRKKCLPHA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "MJ-13754-1",
        "BMY-13754"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nefazodone HCl (FDA, USAN)",
        "Nefazodone (BAN, INN)",
        null
      ]
    },
    "usan_year": 1984
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Anti-Asthmatic (leukotriene antagonist)",
    "molecule_chembl_id": "CHEMBL278570",
    "molecule_properties": {
      "acd_logd": 1.77,
      "acd_logp": 6.35,
      "acd_most_apka": 4.29,
      "acd_most_bpka": 0.64,
      "alogp": 5.73,
      "aromatic_rings": 2,
      "full_molformula": "C25H36N4O3S",
      "full_mwt": 472.66,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 33,
      "molecular_species": "ACID",
      "mw_freebase": 472.66,
      "mw_monoisotopic": 472.2508,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 111.99,
      "qed_weighted": 0.2,
      "ro3_pass": "N",
      "rtb": 17
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCCC\\C=C/C=C/[C@@H](SCCC(=O)O)[C@@H](O)c1cccc(c1)c2nn[nH]n2",
      "standard_inchi": "InChI=1S/C25H36N4O3S/c1-2-3-4-5-6-7-8-9-10-11-12-16-22(33-18-17-23(30)31)24(32)20-14-13-15-21(19-20)25-26-28-29-27-25/h10-16,19,22,24,32H,2-9,17-18H2,1H3,(H,30,31)(H,26,27,28,29)/b11-10-,16-12+/t22-,24+/m1/s1",
      "standard_inchi_key": "YPHOSUPSOWQQCB-AFOLHBCXSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "LY-170680"
    },
    "synonyms": {
      "value": [
        "Sulukast (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics: leukotriene receptor antagonists",
    "usan_stem_substem": "-ast(-ast(-lukast))",
    "usan_year": 1990
  },
  {
    "applicants": {
      "value": "Merck Sharp And Dohme Corp"
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D01AC06",
          "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivative"
        },
        {
          "code": "P02CA02",
          "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Benzimidazole derivatives"
        }
      ]
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1967,
    "indication_class": "Anthelmintic",
    "molecule_chembl_id": "CHEMBL625",
    "molecule_properties": {
      "acd_logd": 2.47,
      "acd_logp": 2.47,
      "acd_most_apka": 10.53,
      "acd_most_bpka": 3.4,
      "alogp": 2.69,
      "aromatic_rings": 3,
      "full_molformula": "C10H7N3S",
      "full_mwt": 201.25,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 201.25,
      "mw_monoisotopic": 201.0361,
      "psa": 41.57,
      "qed_weighted": 0.66,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "c1ccc2[nH]c(nc2c1)c3cscn3",
      "standard_inchi": "InChI=1S/C10H7N3S/c1-2-4-8-7(3-1)12-10(13-8)9-5-14-6-11-9/h1-6H,(H,12,13)",
      "standard_inchi_key": "WJCNZQLZVWNLKY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "MK-360"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Thiabendazole (FDA, USAN, USP)",
        "Tiabendazole (BAN, INN, JAN)",
        null
      ]
    },
    "usan_stem": "-bendazole",
    "usan_stem_definition": "anthelmintics (tibendazole type)",
    "usan_stem_substem": "-bendazole(-bendazole)",
    "usan_year": 1962
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Asthmatic (leukotriene antagonist)",
    "molecule_chembl_id": "CHEMBL283754",
    "molecule_properties": {
      "acd_logd": 1.71,
      "acd_logp": 4.47,
      "acd_most_apka": 4.76,
      "acd_most_bpka": 2.74,
      "alogp": 5.8,
      "aromatic_rings": 2,
      "full_molformula": "C23H28N2O3S",
      "full_mwt": 412.56,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 29,
      "molecular_species": "ACID",
      "mw_freebase": 412.56,
      "mw_monoisotopic": 412.1821,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 79.29,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(CC)(CC(=O)Nc1cccc(\\C=C\\c2nc(cs2)C3CCC3)c1)C(=O)O",
      "standard_inchi": "InChI=1S/C23H28N2O3S/c1-3-23(4-2,22(27)28)14-20(26)24-18-10-5-7-16(13-18)11-12-21-25-19(15-29-21)17-8-6-9-17/h5,7,10-13,15,17H,3-4,6,8-9,14H2,1-2H3,(H,24,26)(H,27,28)/b12-11+",
      "standard_inchi_key": "BZMKNPGKXJAIDV-VAWYXSNFSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "Ro-24-5913",
        "Ro-245913"
      ]
    },
    "synonyms": {
      "value": [
        "Cinalukast (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics: leukotriene receptor antagonists",
    "usan_stem_substem": "-ast(-ast(-lukast))",
    "usan_year": 1993
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL22055",
    "molecule_properties": {
      "acd_logd": 5.82,
      "acd_logp": 5.94,
      "acd_most_apka": 13.2,
      "acd_most_bpka": 7.07,
      "alogp": 6.52,
      "aromatic_rings": 6,
      "full_molformula": "C36H31F2N5O4S",
      "full_mwt": 667.74,
      "hba": 8,
      "hba_lipinski": 9,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 48,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 667.74,
      "mw_monoisotopic": 667.2065,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 97.6,
      "qed_weighted": 0.16,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "CONC(=O)Nc1ccc(cc1)c2sc3N(Cc4c(F)cccc4F)C(=O)N(C(=O)c3c2CN(C)Cc5ccccc5)c6ccccc6",
      "standard_inchi": "InChI=1S/C36H31F2N5O4S/c1-41(20-23-10-5-3-6-11-23)21-28-31-33(44)43(26-12-7-4-8-13-26)36(46)42(22-27-29(37)14-9-15-30(27)38)34(31)48-32(28)24-16-18-25(19-17-24)39-35(45)40-47-2/h3-19H,20-22H2,1-2H3,(H2,39,40,45)",
      "standard_inchi_key": "UCQSBGOFELXYIN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "TAK-013"
    },
    "synonyms": {
      "value": [
        "Sufugolix (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-golix",
    "usan_stem_definition": "GnRH receptor antagonists (nonpeptide)",
    "usan_stem_substem": "-golix(-golix)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 1,
    "drug_type": 1,
    "indication_class": "Alzheimer's Disease Treatment (cholinergic agonist)",
    "molecule_chembl_id": "CHEMBL21536",
    "molecule_properties": {
      "acd_logd": 3.73,
      "acd_logp": 4.01,
      "acd_most_bpka": 7.34,
      "alogp": 3.22,
      "aromatic_rings": 1,
      "full_molformula": "C14H23N3OS",
      "full_mwt": 281.43,
      "hba": 5,
      "hba_lipinski": 4,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 281.43,
      "mw_monoisotopic": 281.1562,
      "psa": 38.25,
      "qed_weighted": 0.72,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCOc1nsnc1C2=CCCN(C)C2",
      "standard_inchi": "InChI=1S/C14H23N3OS/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3",
      "standard_inchi_key": "JOLJIIDDOBNFHW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Xanomeline (INN, USAN)",
        "Xanomeline Tartrate (USAN)",
        null
      ]
    },
    "usan_stem": "-meline",
    "usan_stem_definition": "cholinergic agonists (arecoline derivatives used in treatment of Alzheimer disease)",
    "usan_stem_substem": "-meline(-meline)",
    "usan_year": 1994
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Anti-Asthmatic (leukotriene antagonist)",
    "molecule_chembl_id": "CHEMBL22776",
    "molecule_properties": {
      "acd_logd": 1.04,
      "acd_logp": 5.79,
      "acd_most_apka": 3.4,
      "alogp": 5.51,
      "aromatic_rings": 2,
      "full_molformula": "C26H34O5S",
      "full_mwt": 458.62,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 32,
      "molecular_species": "ACID",
      "mw_freebase": 458.62,
      "mw_monoisotopic": 458.2127,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 94.83,
      "qed_weighted": 0.29,
      "ro3_pass": "N",
      "rtb": 16
    },
    "molecule_structures": {
      "canonical_smiles": "O[C@H]([C@H](SCCC(=O)O)c1ccccc1CCCCCCCCc2ccccc2)C(=O)O",
      "standard_inchi": "InChI=1S/C26H34O5S/c27-23(28)18-19-32-25(24(29)26(30)31)22-17-11-10-16-21(22)15-9-4-2-1-3-6-12-20-13-7-5-8-14-20/h5,7-8,10-11,13-14,16-17,24-25,29H,1-4,6,9,12,15,18-19H2,(H,27,28)(H,30,31)/t24-,25-/m1/s1",
      "standard_inchi_key": "PZIFPMYXXCAOCC-JWQCQUIFSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "SKF-104353",
        "SK&F-104353-Q"
      ]
    },
    "synonyms": {
      "value": [
        "Pobilukast (INN)",
        "Pobilukast Edamine (USAN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics: leukotriene receptor antagonists",
    "usan_stem_substem": "-ast(-ast(-lukast))",
    "usan_year": 1994
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Anti-Asthmatic (leukotriene antagonist)",
    "molecule_chembl_id": "CHEMBL22016",
    "molecule_properties": {
      "acd_logd": 1.03,
      "acd_logp": 4.71,
      "acd_most_apka": 2.92,
      "alogp": 5.16,
      "aromatic_rings": 2,
      "full_molformula": "C28H34O8",
      "full_mwt": 498.57,
      "hba": 7,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 36,
      "molecular_species": "ACID",
      "mw_freebase": 498.57,
      "mw_monoisotopic": 498.2254,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 119.36,
      "qed_weighted": 0.29,
      "ro3_pass": "N",
      "rtb": 13
    },
    "molecule_structures": {
      "canonical_smiles": "CCCc1c(O)c(ccc1OCCCCCOc2cc3OC(CCc3cc2C(=O)C)C(=O)O)C(=O)C",
      "standard_inchi": "InChI=1S/C28H34O8/c1-4-8-21-23(12-10-20(17(2)29)27(21)31)34-13-6-5-7-14-35-26-16-25-19(15-22(26)18(3)30)9-11-24(36-25)28(32)33/h10,12,15-16,24,31H,4-9,11,13-14H2,1-3H3,(H,32,33)",
      "standard_inchi_key": "FGGYJWZYDAROFF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "Ro-23-3544",
        "Ro-233544001",
        "Ro-233544000"
      ]
    },
    "synonyms": {
      "value": [
        "Ablukast (INN, USAN)",
        "Ablukast Sodium (USAN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics: leukotriene receptor antagonists",
    "usan_stem_substem": "-ast(-ast(-lukast))",
    "usan_year": 1989
  },
  {
    "applicants": {
      "value": [
        "Sebela Ireland Ltd",
        "Taro Pharmaceuticals Usa Inc",
        "Tolmar Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "D01AE22",
        "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1988,
    "indication_class": "Antifungal",
    "molecule_chembl_id": "CHEMBL626",
    "molecule_properties": {
      "acd_logd": 4.36,
      "acd_logp": 5.04,
      "acd_most_bpka": 7.99,
      "alogp": 4.99,
      "aromatic_rings": 3,
      "full_molformula": "C21H21N",
      "full_mwt": 287.41,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 287.41,
      "mw_monoisotopic": 287.1674,
      "psa": 3.24,
      "qed_weighted": 0.64,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C\\C=C\\c1ccccc1)Cc2cccc3ccccc23",
      "standard_inchi": "InChI=1S/C21H21N/c1-22(16-8-11-18-9-3-2-4-10-18)17-20-14-7-13-19-12-5-6-15-21(19)20/h2-15H,16-17H2,1H3/b11-8+",
      "standard_inchi_key": "OZGNYLLQHRPOBR-DHZHZOJOSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8778365,
    "research_codes": {
      "value": [
        "AW-105-843",
        "AW-105843"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-8778365-B1",
    "synonyms": {
      "value": [
        "Naftifine HCl (FDA, USAN, USP)",
        "Naftifine (BAN, INN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1981
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "S01EB08",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetic"
        },
        {
          "code": "S01EB58",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Cholinergic",
    "molecule_chembl_id": "CHEMBL20835",
    "molecule_properties": {
      "acd_logd": -1.54,
      "acd_logp": 0.26,
      "acd_most_bpka": 9.22,
      "alogp": 0.64,
      "full_molformula": "C9H15NO2",
      "full_mwt": 169.22,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 12,
      "molecular_species": "BASE",
      "mw_freebase": 169.22,
      "mw_monoisotopic": 169.1103,
      "psa": 29.54,
      "qed_weighted": 0.54,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)OC1CN2CCC1CC2",
      "standard_inchi": "InChI=1S/C9H15NO2/c1-7(11)12-9-6-10-4-2-8(9)3-5-10/h8-9H,2-6H2,1H3",
      "standard_inchi_key": "WRJPSSPFHGNBMG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Aceclidine (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-clidine",
    "usan_stem_definition": "muscarinic receptor agonists",
    "usan_stem_substem": "-clidine(-clidine)",
    "usan_year": 1967
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Antischistosomal",
    "molecule_chembl_id": "CHEMBL279014",
    "molecule_properties": {
      "acd_logd": 2.71,
      "acd_logp": 5.17,
      "acd_most_bpka": 10,
      "alogp": 4.48,
      "aromatic_rings": 3,
      "full_molformula": "C20H24N2OS",
      "full_mwt": 340.49,
      "hba": 4,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 340.49,
      "mw_monoisotopic": 340.1609,
      "psa": 32.34,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCNc1ccc(C)c2Sc3ccccc3C(=O)c12",
      "standard_inchi": "InChI=1S/C20H24N2OS/c1-4-22(5-2)13-12-21-16-11-10-14(3)20-18(16)19(23)15-8-6-7-9-17(15)24-20/h6-11,21H,4-5,12-13H2,1-3H3",
      "standard_inchi_key": "FBQPGGIHOFZRGH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "79 T61"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lucanthone HCl (USAN, USP)",
        "Lucanthone (BAN, INN)",
        null
      ]
    },
    "usan_year": 1962
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL280685",
    "molecule_properties": {
      "acd_logd": -0.23,
      "acd_logp": -0.23,
      "acd_most_apka": 11,
      "alogp": 2.03,
      "full_molformula": "C11H22N3O3P",
      "full_mwt": 275.29,
      "hba": 3,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 275.29,
      "mw_monoisotopic": 275.1399,
      "psa": 61.42,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)NP(=O)(N1CC1(C)C)N2CC2(C)C",
      "standard_inchi": "InChI=1S/C11H22N3O3P/c1-6-17-9(15)12-18(16,13-7-10(13,2)3)14-8-11(14,4)5/h6-8H2,1-5H3,(H,12,15,16)",
      "standard_inchi_key": "QTFKTBRIGWJQQL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AB-132"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Meturedepa (INN, USAN)",
        null
      ]
    },
    "usan_year": 1962
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antischistosomal",
    "molecule_chembl_id": "CHEMBL22077",
    "molecule_properties": {
      "acd_logd": 1.37,
      "acd_logp": 3.81,
      "acd_most_bpka": 9.99,
      "alogp": 3.66,
      "aromatic_rings": 3,
      "full_molformula": "C20H24N2O2S",
      "full_mwt": 356.49,
      "hba": 5,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 25,
      "molecular_species": "BASE",
      "mw_freebase": 356.49,
      "mw_monoisotopic": 356.1558,
      "psa": 52.57,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCNc1ccc(CO)c2Sc3ccccc3C(=O)c12",
      "standard_inchi": "InChI=1S/C20H24N2O2S/c1-3-22(4-2)12-11-21-16-10-9-14(13-23)20-18(16)19(24)15-7-5-6-8-17(15)25-20/h5-10,21,23H,3-4,11-13H2,1-2H3",
      "standard_inchi_key": "MFZWMTSUNYWVBU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "WIN-24933"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Hycanthone (INN, USAN)",
        "Hycanthone Mesylate (MI)",
        null
      ]
    },
    "usan_year": 1966
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "S02DA03",
          "description": "SENSORY ORGANS: OTOLOGICALS: OTHER OTOLOGICALS: Analgesics and anesthetic"
        },
        {
          "code": "N02BB51",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Pyrazolone"
        },
        {
          "code": "N02BB01",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Pyrazolone"
        },
        {
          "code": "N02BB71",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Pyrazolones"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Analgesic",
    "molecule_chembl_id": "CHEMBL277474",
    "molecule_properties": {
      "acd_logd": 0.44,
      "acd_logp": 0.44,
      "acd_most_bpka": 0.65,
      "alogp": 1.48,
      "aromatic_rings": 2,
      "full_molformula": "C11H12N2O",
      "full_mwt": 188.23,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 188.23,
      "mw_monoisotopic": 188.095,
      "psa": 26.93,
      "qed_weighted": 0.67,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1N(C(=O)C=C1C)c2ccccc2",
      "standard_inchi": "InChI=1S/C11H12N2O/c1-9-8-11(14)13(12(9)2)10-6-4-3-5-7-10/h3-8H,1-2H3",
      "standard_inchi_key": "VEQOALNAAJBPNY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Antipyrine (JAN, MI, USP)",
        "Phenazone (BAN, DCF, INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL627",
    "molecule_properties": {
      "acd_logd": 1.75,
      "acd_logp": 1.75,
      "acd_most_bpka": 4.63,
      "alogp": 4.18,
      "aromatic_rings": 2,
      "full_molformula": "C20H23NO",
      "full_mwt": 293.41,
      "hba": 1,
      "hba_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 293.41,
      "mw_monoisotopic": 293.178,
      "psa": 23.06,
      "qed_weighted": 0.61,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "C[N+](C)([O-])CCC=C1c2ccccc2CCc3ccccc13",
      "standard_inchi": "InChI=1S/C20H23NO/c1-21(2,22)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3",
      "standard_inchi_key": "ZPMKQFOGINQDAM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Amitriptylinoxide (INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL281398",
    "molecule_properties": {
      "acd_logd": 0.47,
      "acd_logp": 3.14,
      "acd_most_apka": 4.66,
      "acd_most_bpka": 5.16,
      "alogp": 4.41,
      "aromatic_rings": 2,
      "full_molformula": "C23H27N5O2",
      "full_mwt": 405.5,
      "hba": 4,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 30,
      "molecular_species": "ACID",
      "mw_freebase": 405.5,
      "mw_monoisotopic": 405.2165,
      "psa": 110.4,
      "qed_weighted": 0.21,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)\\N=C(/NC#N)\\Nc1cccc(c1)\\C(=C/CCCC(=O)O)\\c2cccnc2",
      "standard_inchi": "InChI=1S/C23H27N5O2/c1-23(2,3)28-22(26-16-24)27-19-10-6-8-17(14-19)20(11-4-5-12-21(29)30)18-9-7-13-25-15-18/h6-11,13-15H,4-5,12H2,1-3H3,(H,29,30)(H2,26,27,28)/b20-11+",
      "standard_inchi_key": "XUTLOCQNGLJNSA-RGVLZGJSSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BIBV-308-SE"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Terbogrel (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-grel",
    "usan_stem_definition": "platelet aggregation inhibitors",
    "usan_stem_substem": "-grel(-grel)",
    "usan_year": 1998
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL279676",
    "molecule_properties": {
      "acd_logd": 3.16,
      "acd_logp": 4.34,
      "acd_most_bpka": 8.56,
      "alogp": 4.39,
      "aromatic_rings": 1,
      "full_molformula": "C15H23NS",
      "full_mwt": 249.42,
      "hba": 2,
      "hba_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "BASE",
      "mw_freebase": 249.42,
      "mw_monoisotopic": 249.1551,
      "psa": 3.24,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C1CCN(CC1)C2(CCCCC2)c3cccs3",
      "standard_inchi": "InChI=1S/C15H23NS/c1-3-9-15(10-4-1,14-8-7-13-17-14)16-11-5-2-6-12-16/h7-8,13H,1-6,9-12H2",
      "standard_inchi_key": "JUZZEWSCNBCFRL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tenocyclidine (INN)",
        null
      ]
    },
    "usan_stem": "-clidine",
    "usan_stem_definition": "muscarinic receptor agonists",
    "usan_stem_substem": "-clidine(-clidine)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05CD06",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL22097",
    "molecule_properties": {
      "acd_logd": 2.35,
      "acd_logp": 2.35,
      "acd_most_apka": 11.6,
      "alogp": 3.13,
      "aromatic_rings": 2,
      "full_molformula": "C16H12Cl2N2O2",
      "full_mwt": 335.19,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 335.19,
      "mw_monoisotopic": 334.0276,
      "psa": 52.9,
      "qed_weighted": 0.87,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)C(O)N=C(c2ccccc2Cl)c3cc(Cl)ccc13",
      "standard_inchi": "InChI=1S/C16H12Cl2N2O2/c1-20-13-7-6-9(17)8-11(13)14(19-15(21)16(20)22)10-4-2-3-5-12(10)18/h2-8,15,21H,1H3",
      "standard_inchi_key": "FJIKWRGCXUCUIG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "WY-4082"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lormetazepam (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-azepam",
    "usan_stem_definition": "antianxiety agents (diazepam type)",
    "usan_stem_substem": "-azepam(-azepam)",
    "usan_year": 1980
  },
  {
    "applicants": {
      "value": [
        "Pliva Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Valeant Pharmaceuticals North America Llc",
        "Actavis Elizabeth Llc",
        "Upsher-Smith Laboratories Llc",
        "Apotex Inc",
        "Us Pharmaceutical Holdings Ii Llc",
        "Watson Laboratories Inc",
        "Heritage Pharmaceuticals Inc",
        "Mylan Pharmaceuticals Inc",
        "Impax Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C04AD03",
        "description": "CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Purine derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1984,
    "indication_class": "Vasodilator",
    "molecule_chembl_id": "CHEMBL628",
    "molecule_properties": {
      "acd_logd": -0.15,
      "acd_logp": -0.15,
      "acd_most_bpka": 0.5,
      "alogp": 0.19,
      "aromatic_rings": 2,
      "full_molformula": "C13H18N4O3",
      "full_mwt": 278.31,
      "hba": 7,
      "hba_lipinski": 7,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 278.31,
      "mw_monoisotopic": 278.1379,
      "psa": 78.89,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)N(CCCCC(=O)C)C(=O)c2c1ncn2C",
      "standard_inchi": "InChI=1S/C13H18N4O3/c1-9(18)6-4-5-7-17-12(19)10-11(14-8-15(10)2)16(3)13(17)20/h8H,4-7H2,1-3H3",
      "standard_inchi_key": "BYPFEZZEUUWMEJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "BL-191"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Oxpentifylline (BAN)",
        "Pentoxifylline (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-fylline",
    "usan_stem_definition": "theophylline derivatives",
    "usan_stem_substem": "-fylline(-fylline)",
    "usan_year": 1976
  },
  {
    "applicants": {
      "value": [
        "Copley Pharmaceutical Inc",
        "Anda Repository Llc",
        "Halsey Drug Co Inc",
        "Bristol Myers Squibb Co",
        "Pliva Inc",
        "Par Pharmaceutical Inc",
        "Vangard Laboratories Inc Div Midway Medical Co",
        "Hoffmann La Roche Inc",
        "Roxane Laboratories Inc",
        "Sun Pharmaceutical Industries Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AA09",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1961,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL629",
    "molecule_properties": {
      "acd_logd": 2.65,
      "acd_logp": 4.41,
      "acd_most_bpka": 9.18,
      "alogp": 4.17,
      "aromatic_rings": 2,
      "full_molformula": "C20H23N",
      "full_mwt": 277.41,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 277.41,
      "mw_monoisotopic": 277.183,
      "psa": 3.24,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCC=C1c2ccccc2CCc3ccccc13",
      "standard_inchi": "InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3",
      "standard_inchi_key": "KRMDCWKBEZIMAB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Amitriptyline HCl (FDA, JAN, USP)",
        "Amitriptyline (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-triptyline",
    "usan_stem_definition": "antidepressants (dibenzo[a,d]cycloheptane derivatives)",
    "usan_stem_substem": "-triptyline(-triptyline)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Disinfectant",
    "molecule_chembl_id": "CHEMBL21869",
    "molecule_properties": {
      "acd_logd": 4.88,
      "acd_logp": 5.19,
      "acd_most_apka": 7.57,
      "alogp": 4.17,
      "aromatic_rings": 2,
      "full_molformula": "C13H9Br2NO2",
      "full_mwt": 371.03,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 371.03,
      "mw_monoisotopic": 368.9,
      "psa": 49.33,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1ccc(Br)cc1C(=O)Nc2ccc(Br)cc2",
      "standard_inchi": "InChI=1S/C13H9Br2NO2/c14-8-1-4-10(5-2-8)16-13(18)11-7-9(15)3-6-12(11)17/h1-7,17H,(H,16,18)",
      "standard_inchi_key": "CTFFKFYWSOSIAA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dibromsalan (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-sal-",
    "usan_stem_definition": "anti-inflammatory agents (salicylic acid derivatives)",
    "usan_stem_substem": "-sal-(-sal-)",
    "usan_year": 1963,
    "withdrawn_country": "United States"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Disinfectant",
    "molecule_chembl_id": "CHEMBL24944",
    "molecule_properties": {
      "acd_logd": 4.86,
      "acd_logp": 6.17,
      "acd_most_apka": 6,
      "alogp": 4.93,
      "aromatic_rings": 2,
      "full_molformula": "C13H8Br3NO2",
      "full_mwt": 449.92,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "ACID",
      "mw_freebase": 449.92,
      "mw_monoisotopic": 446.8105,
      "psa": 49.33,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1c(Br)cc(Br)cc1C(=O)Nc2ccc(Br)cc2",
      "standard_inchi": "InChI=1S/C13H8Br3NO2/c14-7-1-3-9(4-2-7)17-13(19)10-5-8(15)6-11(16)12(10)18/h1-6,18H,(H,17,19)",
      "standard_inchi_key": "KVSKGMLNBAPGKH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "ET-394"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tribromsalan (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-sal-",
    "usan_stem_definition": "anti-inflammatory agents (salicylic acid derivatives)",
    "usan_stem_substem": "-sal-(-sal-)",
    "usan_year": 1963,
    "withdrawn_country": "United States"
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Sagent Agila Llc",
        "Teva Parenteral Medicines Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Injectalia Srl",
        "Aurobindo Pharma Ltd",
        "Par Pharmaceutical Inc",
        "Teva Pharmaceuticals Usa",
        "Roxane Laboratories Inc",
        "Endo Ventures Ltd Ireland"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N02CC01",
        "description": "NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Selective serotonin (5HT1) agonists"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1992,
    "indication_class": "Antimigraine",
    "molecule_chembl_id": "CHEMBL128",
    "molecule_properties": {
      "acd_logd": -1.45,
      "acd_logp": 0.44,
      "acd_most_apka": 11.31,
      "acd_most_bpka": 9.49,
      "alogp": 1.32,
      "aromatic_rings": 2,
      "full_molformula": "C14H21N3O2S",
      "full_mwt": 295.41,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 295.41,
      "mw_monoisotopic": 295.1354,
      "psa": 65.2,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CNS(=O)(=O)Cc1ccc2[nH]cc(CCN(C)C)c2c1",
      "standard_inchi": "InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3",
      "standard_inchi_key": "KQKPFRSPSRPDEB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5872145,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "GR-43175C"
    },
    "rule_of_five": true,
    "sc_patent": "US-5872145-A",
    "synonyms": {
      "value": [
        "Sumatriptan (BAN, FDA, INN, USP)",
        "Sumatriptan Succinate (FDA, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-triptan",
    "usan_stem_definition": "antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives",
    "usan_stem_substem": "-triptan(-triptan)",
    "usan_year": 1989
  },
  {
    "applicants": {
      "value": [
        "Watson Laboratories",
        "Sun Pharmaceutical Industries Inc",
        "Vintage Pharmaceuticals Inc",
        "Glenmark Pharmaceuticals Ltd",
        "Watson Laboratories Inc",
        "Glaxosmithkline Llc",
        "Nesher Pharmaceuticals Usa Llc",
        "Ani Pharmaceuticals Inc",
        "Par Pharmaceutical",
        "Mylan Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C01BC03",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ic"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1989,
    "indication_class": "Cardiac Depressant (anti-arrhythmic)",
    "molecule_chembl_id": "CHEMBL631",
    "molecule_properties": {
      "acd_logd": 1.37,
      "acd_logp": 3.35,
      "acd_most_apka": 13.82,
      "acd_most_bpka": 9.31,
      "alogp": 3.24,
      "aromatic_rings": 2,
      "full_molformula": "C21H27NO3",
      "full_mwt": 341.45,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 25,
      "molecular_species": "BASE",
      "mw_freebase": 341.45,
      "mw_monoisotopic": 341.1991,
      "psa": 58.56,
      "qed_weighted": 0.49,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CCCNCC(O)COc1ccccc1C(=O)CCc2ccccc2",
      "standard_inchi": "InChI=1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3",
      "standard_inchi_key": "JWHAUXFOSRPERK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "GNF-Pf-4594"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Propafenone HCl (FDA, JAN, USAN, USP)",
        "Propafenone (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-afenone",
    "usan_stem_definition": "antiarrhythmics (propafenone derivatives)",
    "usan_stem_substem": "-afenone(-afenone)",
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": [
        "Schering Corp Sub Schering Plough Corp",
        "Merck Sharp And Dohme Corp"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "A07EA04",
          "description": "ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locall"
        },
        {
          "code": "S02BA07",
          "description": "SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroid"
        },
        {
          "code": "S03BA03",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: CORTICOSTEROIDS: Corticosteroid"
        },
        {
          "code": "S01BA06",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plai"
        },
        {
          "code": "C05AA05",
          "description": "CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroid"
        },
        {
          "code": "R03BA04",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Glucocorticoid"
        },
        {
          "code": "S01CB04",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combinatio"
        },
        {
          "code": "D07AC01",
          "description": "DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, potent (group III"
        },
        {
          "code": "H02AB01",
          "description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoid"
        },
        {
          "code": "D07XC01",
          "description": "DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, potent, other combination"
        },
        {
          "code": "R01AD06",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroids"
        }
      ]
    },
    "availability_type": 0,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1961,
    "indication_class": "Glucocorticoid",
    "molecule_chembl_id": "CHEMBL632",
    "molecule_properties": {
      "acd_logd": 2.03,
      "acd_logp": 2.03,
      "acd_most_apka": 12.13,
      "alogp": 1.9,
      "full_molformula": "C22H29FO5",
      "full_mwt": 392.47,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 392.47,
      "mw_monoisotopic": 392.1999,
      "psa": 94.83,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO",
      "standard_inchi": "InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15-,16-,17-,19-,20-,21-,22-/m0/s1",
      "standard_inchi_key": "UREBDLICKHMUKA-DVTGEIKXSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "SCH-4831"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Betamethasone (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1962
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Murty Pharmaceuticals Inc",
        "Hospira Inc",
        "Mylan Institutional Llc",
        "Aurobindo Pharma Ltd",
        "Bedford Laboratories Div Ben Venue Laboratories Inc",
        "Taro Pharmaceutical Industries Ltd",
        "Akorn Inc",
        "Teva Pharmaceuticals Usa",
        "Zydus Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C01BD01",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class III"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1985,
    "molecule_chembl_id": "CHEMBL633",
    "molecule_properties": {
      "acd_logd": 5.87,
      "acd_logp": 7.82,
      "acd_most_bpka": 9.37,
      "alogp": 6.94,
      "aromatic_rings": 3,
      "full_molformula": "C25H29I2NO3",
      "full_mwt": 645.32,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 31,
      "molecular_species": "BASE",
      "mw_freebase": 645.32,
      "mw_monoisotopic": 645.0237,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 42.68,
      "qed_weighted": 0.17,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCc1oc2ccccc2c1C(=O)c3cc(I)c(OCCN(CC)CC)c(I)c3",
      "standard_inchi": "InChI=1S/C25H29I2NO3/c1-4-7-11-22-23(18-10-8-9-12-21(18)31-22)24(29)17-15-19(26)25(20(27)16-17)30-14-13-28(5-2)6-3/h8-10,12,15-16H,4-7,11,13-14H2,1-3H3",
      "standard_inchi_key": "IYIKLHRQXLHMJQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6869939,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "SKF-33134A",
        "SK&F-33134-A",
        "L-3428"
      ]
    },
    "sc_patent": "US-6869939-B2",
    "synonyms": {
      "value": [
        "Amiodarone (USAN, BAN, INN, USAN)",
        "Amiodarone HCl (FDA, JAN)",
        null
      ]
    },
    "usan_stem": "-arone",
    "usan_stem_definition": "antirrhythmics: indicates high iodine content",
    "usan_stem_substem": "-arone(-arone(-iodarone))",
    "usan_year": 1987
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Hospira Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N01AH02",
        "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Opioid anesthetics"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1986,
    "indication_class": "Analgesic (narcotic)",
    "molecule_chembl_id": "CHEMBL634",
    "molecule_properties": {
      "acd_logd": 1.81,
      "acd_logp": 2.16,
      "acd_most_bpka": 7.82,
      "alogp": 1.38,
      "aromatic_rings": 2,
      "full_molformula": "C21H32N6O3",
      "full_mwt": 416.53,
      "hba": 8,
      "hba_lipinski": 9,
      "heavy_atoms": 30,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 416.53,
      "mw_monoisotopic": 416.2536,
      "psa": 85.49,
      "qed_weighted": 0.61,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1N=NN(CCN2CCC(COC)(CC2)N(C(=O)CC)c3ccccc3)C1=O",
      "standard_inchi": "InChI=1S/C21H32N6O3/c1-4-19(28)27(18-9-7-6-8-10-18)21(17-30-3)11-13-24(14-12-21)15-16-26-20(29)25(5-2)22-23-26/h6-10H,4-5,11-17H2,1-3H3",
      "standard_inchi_key": "IDBPHNDTYPBSNI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "R-39209"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Alfentanil HCl (FDA, USAN, USP)",
        "Alfentanil (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-fentanil",
    "usan_stem_definition": "narcotic analgesics (fentanyl derivatives)",
    "usan_stem_substem": "-fentanil(-fentanil)",
    "usan_year": 1980
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL277689",
    "molecule_properties": {
      "acd_logd": 1.48,
      "acd_logp": 4.16,
      "acd_most_apka": 4.66,
      "acd_most_bpka": 5.1,
      "alogp": 4.94,
      "aromatic_rings": 3,
      "full_molformula": "C25H25ClN2O4S",
      "full_mwt": 485.01,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 33,
      "molecular_species": "ACID",
      "mw_freebase": 485.01,
      "mw_monoisotopic": 484.1224,
      "psa": 96.36,
      "qed_weighted": 0.38,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CCC\\C=C(/c1ccc(CCNS(=O)(=O)c2ccc(Cl)cc2)cc1)\\c3cccnc3",
      "standard_inchi": "InChI=1S/C25H25ClN2O4S/c26-22-11-13-23(14-12-22)33(31,32)28-17-15-19-7-9-20(10-8-19)24(5-1-2-6-25(29)30)21-4-3-16-27-18-21/h3-5,7-14,16,18,28H,1-2,6,15,17H2,(H,29,30)/b24-5+",
      "standard_inchi_key": "LGHLGTHRJNIRCA-ZXKDJJQISA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Samixogrel (INN)",
        null
      ]
    },
    "usan_stem": "-grel",
    "usan_stem_definition": "platelet aggregation inhibitors",
    "usan_stem_substem": "-grel(-grel)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Analgesic",
    "molecule_chembl_id": "CHEMBL430916",
    "molecule_properties": {
      "acd_logd": 1.74,
      "acd_logp": 4.74,
      "acd_most_apka": 4.31,
      "alogp": 4.6,
      "aromatic_rings": 3,
      "full_molformula": "C22H23NO3",
      "full_mwt": 349.43,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 349.43,
      "mw_monoisotopic": 349.1678,
      "psa": 62.32,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC[C@@]1(CC(=O)O)OC[C@H](Cc2ccccc2)c3c1[nH]c4ccccc34",
      "standard_inchi": "InChI=1S/C22H23NO3/c1-2-22(13-19(24)25)21-20(17-10-6-7-11-18(17)23-21)16(14-26-22)12-15-8-4-3-5-9-15/h3-11,16,23H,2,12-14H2,1H3,(H,24,25)/t16-,22-/m0/s1",
      "standard_inchi_key": "BUUODSZYUAZDIF-AOMKIAJQSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "WAY-PEM-420"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dexpemedolac (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ac",
    "usan_stem_definition": "anti-inflammatory agents (acetic acid derivatives)",
    "usan_stem_substem": "-ac(-ac)",
    "usan_year": 1994
  },
  {
    "applicants": {
      "value": [
        "Chartwell Rx Sciences Llc",
        "Upsher Smith Laboratories Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Panray Corp Sub Ormont Drug And Chemical Co Inc",
        "Halsey Drug Co Inc",
        "Contract Pharmacal Corp",
        "Kv Pharmaceutical Co",
        "Marshall Pharmacal Corp",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Elkins Sinn Div Ah Robins Co Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "H02AB07",
          "description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoid"
        },
        {
          "code": "A07EA03",
          "description": "ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locally"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1955,
    "indication_class": "Glucocorticoid",
    "molecule_chembl_id": "CHEMBL635",
    "molecule_properties": {
      "acd_logd": 1.57,
      "acd_logp": 1.57,
      "acd_most_apka": 12.36,
      "alogp": 1.77,
      "full_molformula": "C21H26O5",
      "full_mwt": 358.43,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 358.43,
      "mw_monoisotopic": 358.178,
      "psa": 91.67,
      "qed_weighted": 0.78,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@]12CC(=O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO",
      "standard_inchi": "InChI=1S/C21H26O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-15,18,22,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,18+,19-,20-,21-/m0/s1",
      "standard_inchi_key": "XOFYZVNMUHMLCC-ZPOLXVRWSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6488960,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-6488960-B1",
    "synonyms": {
      "value": [
        "Prednisone (BAN, FDA, INN, USP)",
        null
      ]
    },
    "usan_stem": "pred-",
    "usan_stem_definition": "prednisone and prednisolone derivatives",
    "usan_stem_substem": "pred-(pred-)"
  },
  {
    "applicants": {
      "value": [
        "Cadila Pharmaceuticals Ltd",
        "Macleods Pharmaceuticals Ltd",
        "Apotex Inc",
        "Alvogen Malta Operations Ltd",
        "Novartis Pharmaceuticals Corp",
        "Alembic Pharmaceuticals Ltd",
        "Orchid Healthcare",
        "Dr Reddys Laboratories Inc",
        "Watson Laboratories Inc",
        "Ajanta Pharma Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06DA03",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTI-DEMENTIA DRUGS: Anticholinesterases"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2000,
    "molecule_chembl_id": "CHEMBL636",
    "molecule_properties": {
      "acd_logd": 0.85,
      "acd_logp": 2.06,
      "acd_most_bpka": 8.62,
      "alogp": 2.76,
      "aromatic_rings": 1,
      "full_molformula": "C14H22N2O2",
      "full_mwt": 250.34,
      "hba": 3,
      "hba_lipinski": 4,
      "heavy_atoms": 18,
      "molecular_species": "BASE",
      "mw_freebase": 250.34,
      "mw_monoisotopic": 250.1681,
      "psa": 32.78,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(C)C(=O)Oc1cccc(c1)[C@H](C)N(C)C",
      "standard_inchi": "InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1",
      "standard_inchi_key": "XSVMFMHYUFZWBK-NSHDSACASA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6316023,
    "oral": true,
    "research_codes": {
      "value": [
        "SDZ-ENA-713",
        "ENA-713",
        "SDZ-212-713"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6316023-B1",
    "synonyms": {
      "value": [
        "Rivastigmine (BAN, FDA, INN, USAN)",
        "Rivastigmine Tartrate (FDA)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-stigmine",
    "usan_stem_definition": "cholinesterase inhibitors (physostigmine type)",
    "usan_stem_substem": "-stigmine(-stigmine)",
    "usan_year": 1997
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Vasodilator (coronary); Anti-Adrenergic (beta-receptor); Cardiac Depressant (anti-arrhythmic)",
    "molecule_chembl_id": "CHEMBL418192",
    "molecule_properties": {
      "acd_logd": 1.18,
      "acd_logp": 2.03,
      "acd_most_apka": 13.84,
      "acd_most_bpka": 8.09,
      "alogp": 1.5,
      "aromatic_rings": 2,
      "full_molformula": "C19H24N2O4",
      "full_mwt": 344.41,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 344.41,
      "mw_monoisotopic": 344.1736,
      "psa": 93.81,
      "qed_weighted": 0.57,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccccc1OCC(O)CNCCOc2ccc(cc2)C(=O)N",
      "standard_inchi": "InChI=1S/C19H24N2O4/c1-14-4-2-3-5-18(14)25-13-16(22)12-21-10-11-24-17-8-6-15(7-9-17)19(20)23/h2-9,16,21-22H,10-13H2,1H3,(H2,20,23)",
      "standard_inchi_key": "SKQDKFOTIPJUSV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tolamolol (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1973
  },
  {
    "applicants": {
      "value": [
        "Valeant Pharmaceuticals North America Llc",
        "Yaopharma Co Ltd",
        "Aurobindo Pharma Ltd",
        "Osmotica Pharmaceutical Corp",
        "Sun Pharmaceutical Industries Inc",
        "Alembic Pharmaceuticals Ltd",
        "Anchen Pharmaceuticals, Inc",
        "Torrent Pharmaceuticals Llc",
        "Zydus Pharmaceuticals Usa Inc",
        "Dr Reddys Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AX16",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1993,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL637",
    "molecule_properties": {
      "acd_logd": 0.76,
      "acd_logp": 2.48,
      "acd_most_bpka": 9.27,
      "alogp": 3.04,
      "aromatic_rings": 1,
      "full_molformula": "C17H27NO2",
      "full_mwt": 277.41,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 277.41,
      "mw_monoisotopic": 277.2042,
      "psa": 32.7,
      "qed_weighted": 0.9,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(cc1)C(CN(C)C)C2(O)CCCCC2",
      "standard_inchi": "InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3",
      "standard_inchi_key": "PNVNVHUZROJLTJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6274171,
    "oral": true,
    "research_codes": {
      "value": "WY-45030"
    },
    "rule_of_five": true,
    "sc_patent": "US-6274171-B1",
    "synonyms": {
      "value": [
        "Venlafaxine HCl (FDA, USAN)",
        "Venlafaxine (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-faxine",
    "usan_stem_definition": "antianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake",
    "usan_stem_substem": "-faxine(-faxine)",
    "usan_year": 1989
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Lupin Ltd",
        "Viiv Healthcare Co",
        "Hetero Labs Ltd Unit Iii",
        "West-Ward Pharmaceuticals International Ltd",
        "Hetero Labs Ltd Unit V",
        "Aurobindo Pharma Ltd Inc",
        "Pharmacare Ltd",
        "Luitpold Pharmaceuticals Inc",
        "Ranbaxy Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J05AF01",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1987,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL129",
    "molecule_properties": {
      "acd_logd": 0.05,
      "acd_logp": 0.05,
      "acd_most_apka": 9.55,
      "alogp": -0.2,
      "aromatic_rings": 1,
      "full_molformula": "C10H13N5O4",
      "full_mwt": 267.25,
      "hba": 6,
      "hba_lipinski": 9,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 267.25,
      "mw_monoisotopic": 267.0968,
      "psa": 133.08,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC1=CN([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)C(=O)NC1=O",
      "standard_inchi": "InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1",
      "standard_inchi_key": "HBOMLICNUCNMMY-XLPZGREQSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6294540,
    "oral": true,
    "parenteral": true,
    "prodrug": true,
    "research_codes": {
      "value": [
        "BW-A-509U",
        "AZT",
        "BW-A509U",
        "Compound S"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6294540-B1",
    "synonyms": {
      "value": [
        "Zidovudine (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-vudine",
    "usan_stem_definition": "antineoplastics,antivirals (zidovudine group) (exception: edoxudine)",
    "usan_stem_substem": "-vudine(-vudine)",
    "usan_year": 1987
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Teva Pharmaceuticals Usa",
        "Sandoz Inc",
        "Glenmark Pharmaceuticals Ltd",
        "Ajanta Pharma Ltd",
        "Xellia Pharmaceuticals Aps",
        "Prinston Pharmaceutical Inc",
        "Amneal Pharmaceuticals",
        "Alvogen Inc",
        "Zydus Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J02AC03",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Triazole derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2002,
    "molecule_chembl_id": "CHEMBL638",
    "molecule_properties": {
      "acd_logd": 1.21,
      "acd_logp": 1.21,
      "acd_most_apka": 11.54,
      "acd_most_bpka": 2.72,
      "alogp": 2.18,
      "aromatic_rings": 3,
      "full_molformula": "C16H14F3N5O",
      "full_mwt": 349.32,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 349.32,
      "mw_monoisotopic": 349.115,
      "psa": 76.72,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@@H](c1ncncc1F)[C@](O)(Cn2cncn2)c3ccc(F)cc3F",
      "standard_inchi": "InChI=1S/C16H14F3N5O/c1-10(15-14(19)5-20-7-22-15)16(25,6-24-9-21-8-23-24)12-3-2-11(17)4-13(12)18/h2-5,7-10,25H,6H2,1H3/t10-,16+/m0/s1",
      "standard_inchi_key": "BCEHBSKCWLPMDN-MGPLVRAMSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6632803,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "UK-109496"
    },
    "rule_of_five": true,
    "sc_patent": "US-6632803-B1",
    "synonyms": {
      "value": [
        "Voriconazole (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-conazole",
    "usan_stem_definition": "systemic antifungals (miconazole type)",
    "usan_stem_substem": "-conazole(-conazole)",
    "usan_year": 1999
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Apotex Inc Richmond Hill",
        "Mylan Specialty Lp",
        "Perrigo Israel Pharmaceuticals Ltd",
        "Amneal Pharmaceuticals Llc",
        "Upsher-Smith Laboratories Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Sandoz Inc",
        "Apotex Inc",
        "Sun Pharma Global Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01GX07",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergic"
        },
        {
          "code": "R06AX19",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic us"
        },
        {
          "code": "R01AC03",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Antiallergic agents, excl. corticosteroids"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1996,
    "indication_class": "Anti-Asthmatic; Anti-Allergic",
    "molecule_chembl_id": "CHEMBL639",
    "molecule_properties": {
      "acd_logd": 1.57,
      "acd_logp": 3.47,
      "acd_most_bpka": 9.15,
      "alogp": 4.3,
      "aromatic_rings": 3,
      "full_molformula": "C22H24ClN3O",
      "full_mwt": 381.91,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 27,
      "molecular_species": "BASE",
      "mw_freebase": 381.91,
      "mw_monoisotopic": 381.1608,
      "psa": 38.13,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCCC(CC1)N2N=C(Cc3ccc(Cl)cc3)c4ccccc4C2=O",
      "standard_inchi": "InChI=1S/C22H24ClN3O/c1-25-13-4-5-18(12-14-25)26-22(27)20-7-3-2-6-19(20)21(24-26)15-16-8-10-17(23)11-9-16/h2-3,6-11,18H,4-5,12-15H2,1H3",
      "standard_inchi_key": "MBUVEWMHONZEQD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8163723,
    "research_codes": {
      "value": [
        "W-2979M",
        "A-5610",
        "E-0659"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-8163723-B2",
    "synonyms": {
      "value": [
        "Azelastine HCl (FDA, JAN, USAN)",
        "Azelastine (BAN, INN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-astine",
    "usan_stem_definition": "antihistaminics (histamine-H1 receptor antagonists)",
    "usan_stem_substem": "-astine(-astine)",
    "usan_year": 1984
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Pharmafair Inc",
        "Parkedale Pharmaceuticals Inc",
        "John J Ferrante",
        "Allergan Pharmaceutical",
        "Parke-Davis",
        "Parke Davis Pharmaceutical Research Div Warner Lambert Co",
        "Altana Inc",
        "Optopics Laboratories Corp",
        "Armenpharm Ltd"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S03AA08",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: ANTIINFECTIVES: Antiinfective"
        },
        {
          "code": "D10AF03",
          "description": "DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Antiinfectives for treatment of acn"
        },
        {
          "code": "G01AA05",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Antibiotic"
        },
        {
          "code": "J01BA01",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: AMPHENICOLS: Amphenicol"
        },
        {
          "code": "S02AA01",
          "description": "SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfective"
        },
        {
          "code": "S01AA01",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antibiotic"
        },
        {
          "code": "D06AX02",
          "description": "DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Other antibiotics for topical use"
        }
      ]
    },
    "availability_type": -1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1950,
    "indication_class": "Antibacterial; Antirickettsial",
    "molecule_chembl_id": "CHEMBL130",
    "molecule_properties": {
      "acd_logd": 1.1,
      "acd_logp": 1.1,
      "acd_most_apka": 11.03,
      "alogp": 0.91,
      "aromatic_rings": 1,
      "full_molformula": "C11H12Cl2N2O5",
      "full_mwt": 323.13,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 323.13,
      "mw_monoisotopic": 322.0123,
      "psa": 112.7,
      "qed_weighted": 0.41,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+](=O)[O-]",
      "standard_inchi": "InChI=1S/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4,8-10,16-17H,5H2,(H,14,18)/t8-,9-/m1/s1",
      "standard_inchi_key": "WIIZWVCIJKGZOK-RKDXNWHRSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Chloramphenicol (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "topical": true,
    "withdrawn_class": "Hematological toxicity",
    "withdrawn_country": "United States",
    "withdrawn_reason": "Bone marrow depression (anemia, thrombocytopenia, and granulocytopenia temporally associated with treatment). Bone marrow toxicities may present as either reversible bone marrow depression, which was dose-related and responsive to drug withdrawal, or as aplastic anemia, which was not dose-related, irreversible, and associated with a high mortality",
    "withdrawn_year": 2012
  },
  {
    "applicants": {
      "value": [
        "Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc",
        "Nexus Pharmaceuticals Inc",
        "Smith And Nephew Solopak Div Smith And Nephew",
        "Pharmafair Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Parkedale Pharmaceuticals Inc",
        "International Medication System",
        "Panray Corp Sub Ormont Drug And Chemical Co Inc",
        "Hospira Inc",
        "Vangard Laboratories Inc Div Midway Medical Co"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C01BA02",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ia"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1950,
    "indication_class": "Cardiac Depressant (anti-arrhythmic)",
    "molecule_chembl_id": "CHEMBL640",
    "molecule_properties": {
      "acd_logd": -0.56,
      "acd_logp": 1.32,
      "acd_most_bpka": 9.09,
      "alogp": 1.34,
      "aromatic_rings": 1,
      "full_molformula": "C13H21N3O",
      "full_mwt": 235.33,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 17,
      "molecular_species": "BASE",
      "mw_freebase": 235.33,
      "mw_monoisotopic": 235.1685,
      "psa": 58.36,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCNC(=O)c1ccc(N)cc1",
      "standard_inchi": "InChI=1S/C13H21N3O/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17)",
      "standard_inchi_key": "REQCZEXYDRLIBE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Procainamide HCl (FDA, JAN, USP)",
        "Procainamide (BAN, INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Actavis Elizabeth Llc",
        "Sandoz Inc",
        "Eli Lilly And Co",
        "Apotex Inc",
        "Glenmark Pharmaceuticals Ltd",
        "Sun Pharma Global Inc",
        "Zydus Pharmaceuticals Usa Inc",
        "Mylan Pharmaceuticals Inc",
        "Aurobindo Pharma Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06BA09",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2002,
    "molecule_chembl_id": "CHEMBL641",
    "molecule_properties": {
      "acd_logd": 0.77,
      "acd_logp": 3.36,
      "acd_most_bpka": 10.15,
      "alogp": 3.72,
      "aromatic_rings": 2,
      "full_molformula": "C17H21NO",
      "full_mwt": 255.36,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 255.36,
      "mw_monoisotopic": 255.1623,
      "psa": 21.26,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CNCC[C@@H](Oc1ccccc1C)c2ccccc2",
      "standard_inchi": "InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1",
      "standard_inchi_key": "VHGCDTVCOLNTBX-QGZVFWFLSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5658590,
    "oral": true,
    "research_codes": {
      "value": "LY-139603"
    },
    "rule_of_five": true,
    "sc_patent": "US-5658590-A",
    "synonyms": {
      "value": [
        "Atomoxetine (BAN, INN)",
        "Atomoxetine HCl (FDA, USAN)",
        "Tomoxetine (INN)",
        null
      ]
    },
    "usan_stem": "-oxetine",
    "usan_stem_definition": "antidepressants (fluoxetine type)",
    "usan_stem_substem": "-oxetine(-oxetine)",
    "usan_year": 2001
  },
  {
    "applicants": {
      "value": [
        "Mylan Pharmaceuticals Inc",
        "Watson Laboratories Inc",
        "Amneal Pharmaceutical",
        "Promius Pharma Llc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C07AB04",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1984,
    "indication_class": "Anti-Adrenergic (beta-receptor)",
    "molecule_chembl_id": "CHEMBL642",
    "molecule_properties": {
      "acd_logd": -0.3,
      "acd_logp": 1.77,
      "acd_most_apka": 13.78,
      "acd_most_bpka": 9.4,
      "alogp": 2.37,
      "aromatic_rings": 1,
      "full_molformula": "C18H28N2O4",
      "full_mwt": 336.43,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 336.43,
      "mw_monoisotopic": 336.2049,
      "psa": 87.66,
      "qed_weighted": 0.57,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(=O)C",
      "standard_inchi": "InChI=1S/C18H28N2O4/c1-5-6-18(23)20-14-7-8-17(16(9-14)13(4)21)24-11-15(22)10-19-12(2)3/h7-9,12,15,19,22H,5-6,10-11H2,1-4H3,(H,20,23)",
      "standard_inchi_key": "GOEMGAFJFRBGGG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "M&B-17803A",
        "IL-17803A"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Acebutolol HCl (FDA, JAN, USP)",
        "Acebutolol (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1973
  },
  {
    "applicants": {
      "value": [
        "Marsam Pharmaceuticals Llc",
        "Hi-Tech Pharmacal Co Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Halsey Drug Co Inc",
        "Hospira Inc",
        "Kv Pharmaceutical Co",
        "Strides Pharma Global Pte Ltd",
        "Mylan Institutional Llc",
        "Mylan Pharmaceuticals Inc",
        "Akorn Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R06AD52",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Phenothiazine derivative"
        },
        {
          "code": "R06AD02",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Phenothiazine derivative"
        },
        {
          "code": "D04AA10",
          "description": "DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Antihistamines for topical use"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1951,
    "indication_class": "Antihistaminic; Anti-Emetic",
    "molecule_chembl_id": "CHEMBL643",
    "molecule_properties": {
      "acd_logd": 3.4,
      "acd_logp": 4.89,
      "acd_most_bpka": 8.98,
      "alogp": 4.24,
      "aromatic_rings": 2,
      "full_molformula": "C17H20N2S",
      "full_mwt": 284.43,
      "hba": 3,
      "hba_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 284.43,
      "mw_monoisotopic": 284.1347,
      "psa": 6.48,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(CN1c2ccccc2Sc3ccccc13)N(C)C",
      "standard_inchi": "InChI=1S/C17H20N2S/c1-13(18(2)3)12-19-14-8-4-6-10-16(14)20-17-11-7-5-9-15(17)19/h4-11,13H,12H2,1-3H3",
      "standard_inchi_key": "PWWVAXIEGOYWEE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Promethazine HCl (FDA, JAN, USP)",
        "Promethazine (BAN, INN)",
        null
      ]
    },
    "topical": true
  },
  {
    "applicants": {
      "value": [
        "Chartwell Rx Sciences Llc",
        "We Pharmaceuticals Inc",
        "Panray Corp Sub Ormont Drug And Chemical Co Inc",
        "Halsey Drug Co Inc",
        "Allergan Pharmaceutical",
        "Marshall Pharmacal Corp",
        "Elkins Sinn Div Ah Robins Co Inc",
        "Teva Pharmaceuticals Usa",
        "Ferndale Laboratories Inc",
        "Aurolife Pharma Llc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01BA04",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Corticosteroids, plai"
        },
        {
          "code": "D07AA03",
          "description": "DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, weak (group I"
        },
        {
          "code": "R01AD02",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroid"
        },
        {
          "code": "S02BA03",
          "description": "SENSORY ORGANS: OTOLOGICALS: CORTICOSTEROIDS: Corticosteroid"
        },
        {
          "code": "H02AB06",
          "description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoid"
        },
        {
          "code": "D07XA02",
          "description": "DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, OTHER COMBINATIONS: Corticosteroids, weak, other combination"
        },
        {
          "code": "R01AD52",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Corticosteroid"
        },
        {
          "code": "A07EA01",
          "description": "ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Corticosteroids acting locall"
        },
        {
          "code": "C05AA04",
          "description": "CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Corticosteroid"
        },
        {
          "code": "S01CB02",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION: Corticosteroids/antiinfectives/mydriatics in combinatio"
        },
        {
          "code": "S03BA02",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: CORTICOSTEROIDS: Corticosteroid"
        },
        {
          "code": "A01AC54",
          "description": "ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Corticosteroids for local oral treatment"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1955,
    "indication_class": "Glucocorticoid",
    "molecule_chembl_id": "CHEMBL131",
    "molecule_properties": {
      "acd_logd": 1.64,
      "acd_logp": 1.64,
      "acd_most_apka": 12.46,
      "alogp": 1.56,
      "full_molformula": "C21H28O5",
      "full_mwt": 360.45,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 360.45,
      "mw_monoisotopic": 360.1937,
      "psa": 94.83,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)C=C[C@]34C)[C@@H]1CC[C@]2(O)C(=O)CO",
      "standard_inchi": "InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",
      "standard_inchi_key": "OIGNJSKKLXVSLS-VWUMJDOOSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Prednisolone (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "pred-",
    "usan_stem_definition": "prednisone and prednisolone derivatives",
    "usan_stem_substem": "pred-(pred-)"
  },
  {
    "applicants": {
      "value": [
        "Elite Laboratories Inc",
        "Usl Pharma Inc",
        "Odyssey Pharmaceuticals Inc",
        "Crossmedika Sa"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AA06",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1979,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL644",
    "molecule_properties": {
      "acd_logd": 2.77,
      "acd_logp": 4.71,
      "acd_most_bpka": 9.38,
      "alogp": 4.12,
      "aromatic_rings": 2,
      "full_molformula": "C20H26N2",
      "full_mwt": 294.44,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 294.44,
      "mw_monoisotopic": 294.2096,
      "psa": 6.48,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(CN(C)C)CN1c2ccccc2CCc3ccccc13",
      "standard_inchi": "InChI=1S/C20H26N2/c1-16(14-21(2)3)15-22-19-10-6-4-8-17(19)12-13-18-9-5-7-11-20(18)22/h4-11,16H,12-15H2,1-3H3",
      "standard_inchi_key": "ZSCDBOWYZJWBIY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "IL-6001",
        "7162 RP"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Trimipramine Maleate (FDA, JAN, USAN)",
        "Trimipramine (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-pramine",
    "usan_stem_definition": "antidepressants (imipramine type)",
    "usan_stem_substem": "-pramine(-pramine)",
    "usan_year": 1966
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Orit Laboratories Llc",
        "Actavis Elizabeth Llc",
        "Teva Branded Pharmaceutical Products R And D Inc",
        "Anda Repository Llc",
        "Sandoz Inc",
        "Apothecon Inc Div Bristol Myers Squibb",
        "Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Teva Pharmaceuticals Usa Inc",
        "Unichem Pharmaceuticals (Usa) Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C07AB07",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1992,
    "indication_class": "Antihypertensive (beta-blocker)",
    "molecule_chembl_id": "CHEMBL645",
    "molecule_properties": {
      "acd_logd": -0.2,
      "acd_logp": 1.89,
      "acd_most_apka": 13.86,
      "acd_most_bpka": 9.42,
      "alogp": 2.37,
      "aromatic_rings": 1,
      "full_molformula": "C18H31NO4",
      "full_mwt": 325.45,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "BASE",
      "mw_freebase": 325.45,
      "mw_monoisotopic": 325.2253,
      "psa": 59.95,
      "qed_weighted": 0.58,
      "ro3_pass": "N",
      "rtb": 12
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)COc1ccc(COCCOC(C)C)cc1",
      "standard_inchi": "InChI=1S/C18H31NO4/c1-14(2)19-11-17(20)13-23-18-7-5-16(6-8-18)12-21-9-10-22-15(3)4/h5-8,14-15,17,19-20H,9-13H2,1-4H3",
      "standard_inchi_key": "VHYCDWMUTMEGQY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "EMD-33-512",
        "CL-297939",
        "EMD-33512"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Bisoprolol Fumarate (FDA, JAN, USAN, USP)",
        "Bisoprolol (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1987
  },
  {
    "applicants": {
      "value": [
        "Mylan Pharmaceuticals Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Watson Laboratories Inc",
        "Pharmacia And Upjohn Co"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05CD05",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1978,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL646",
    "molecule_properties": {
      "acd_logd": 2.08,
      "acd_logp": 2.08,
      "acd_most_bpka": 2.29,
      "alogp": 4.23,
      "aromatic_rings": 3,
      "full_molformula": "C17H12Cl2N4",
      "full_mwt": 343.22,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 343.22,
      "mw_monoisotopic": 342.0439,
      "psa": 43.07,
      "qed_weighted": 0.66,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1nnc2CN=C(c3ccccc3Cl)c4cc(Cl)ccc4n12",
      "standard_inchi": "InChI=1S/C17H12Cl2N4/c1-10-21-22-16-9-20-17(12-4-2-3-5-14(12)19)13-8-11(18)6-7-15(13)23(10)16/h2-8H,9H2,1H3",
      "standard_inchi_key": "JOFWLTCLBGQGBO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "U-33030"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Triazolam (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1973,
    "withdrawn_class": "Neurotoxicity; Psychiatric toxicity",
    "withdrawn_country": "United Kingdom; France; Netherlands; Finland; Argentina",
    "withdrawn_reason": "Psychiatric reaction and amnesia",
    "withdrawn_year": 1992
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Inhibitor (thromboxanesynthetase)",
    "molecule_chembl_id": "CHEMBL280728",
    "molecule_properties": {
      "acd_logd": 0.97,
      "acd_logp": 3.62,
      "acd_most_apka": 4.7,
      "acd_most_bpka": 2.94,
      "alogp": 4.12,
      "aromatic_rings": 2,
      "full_molformula": "C18H17F3N2O3",
      "full_mwt": 366.34,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 366.34,
      "mw_monoisotopic": 366.1191,
      "psa": 71.78,
      "qed_weighted": 0.43,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CCCCO\\N=C(\\c1cccnc1)/c2cccc(c2)C(F)(F)F",
      "standard_inchi": "InChI=1S/C18H17F3N2O3/c19-18(20,21)15-7-3-5-13(11-15)17(14-6-4-9-22-12-14)23-26-10-2-1-8-16(24)25/h3-7,9,11-12H,1-2,8,10H2,(H,24,25)/b23-17+",
      "standard_inchi_key": "GLLPUTYLZIKEGF-HAVVHWLPSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "R-68070"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ridogrel (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-grel",
    "usan_stem_definition": "platelet aggregation inhibitors",
    "usan_stem_substem": "-grel(-grel)",
    "usan_year": 1991
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Disinfectant",
    "molecule_chembl_id": "CHEMBL283552",
    "molecule_properties": {
      "acd_logd": 5.24,
      "acd_logp": 6.58,
      "acd_most_apka": 5.98,
      "alogp": 5.19,
      "aromatic_rings": 2,
      "full_molformula": "C14H8Br2F3NO2",
      "full_mwt": 439.02,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "ACID",
      "mw_freebase": 439.02,
      "mw_monoisotopic": 436.8874,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 49.33,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1c(Br)cc(Br)cc1C(=O)Nc2cccc(c2)C(F)(F)F",
      "standard_inchi": "InChI=1S/C14H8Br2F3NO2/c15-8-5-10(12(21)11(16)6-8)13(22)20-9-3-1-2-7(4-9)14(17,18)19/h1-6,21H,(H,20,22)",
      "standard_inchi_key": "VYKKDKFTDMVOBU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Fluorosalan (USAN)",
        "Flusalan (INN)",
        null
      ]
    },
    "usan_stem": "-sal-",
    "usan_stem_definition": "anti-inflammatory agents (salicylic acid derivatives)",
    "usan_stem_substem": "-sal-(-sal-)",
    "usan_year": 1966
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Novartis Pharmaceuticals Corp"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "S01EA03",
        "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Sympathomimetics in glaucoma therapy 1)"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1987,
    "indication_class": "Adrenergic (alpha12-agonist)",
    "molecule_chembl_id": "CHEMBL647",
    "molecule_properties": {
      "acd_logd": -0.76,
      "acd_logp": 0.87,
      "acd_most_bpka": 8.41,
      "alogp": 1.76,
      "aromatic_rings": 1,
      "full_molformula": "C9H10Cl2N4",
      "full_mwt": 245.11,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 245.11,
      "mw_monoisotopic": 244.0283,
      "psa": 62.44,
      "qed_weighted": 0.66,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1cc(Cl)c(N=C2NCCN2)c(Cl)c1",
      "standard_inchi": "InChI=1S/C9H10Cl2N4/c10-6-3-5(12)4-7(11)8(6)15-9-13-1-2-14-9/h3-4H,1-2,12H2,(H2,13,14,15)",
      "standard_inchi_key": "IEJXVRYNEISIKR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AL-02145"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Apraclonidine HCl (FDA, USAN, USP)",
        "Apraclonidine (BAN, INN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1988
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL281786",
    "molecule_properties": {
      "acd_logd": 0.65,
      "acd_logp": 1.55,
      "acd_most_apka": 9.44,
      "acd_most_bpka": 8.21,
      "alogp": 3.39,
      "aromatic_rings": 1,
      "full_molformula": "C26H35NO4",
      "full_mwt": 425.57,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 31,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 425.57,
      "mw_monoisotopic": 425.2566,
      "psa": 62.16,
      "qed_weighted": 0.77,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CO[C@]12CC[C@@]3(C[C@@H]1C(C)(C)O)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56",
      "standard_inchi": "InChI=1S/C26H35NO4/c1-23(2,29)18-13-24-8-9-26(18,30-3)22-25(24)10-11-27(14-15-4-5-15)19(24)12-16-6-7-17(28)21(31-22)20(16)25/h6-7,15,18-19,22,28-29H,4-5,8-14H2,1-3H3/t18-,19-,22-,24-,25+,26-/m1/s1",
      "standard_inchi_key": "OIJXLIIMXHRJJH-KNLIIKEYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Diprenorphine (BAN, INN, MI)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "R06AE04",
        "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Piperazine derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL22150",
    "molecule_properties": {
      "acd_logd": 2.87,
      "acd_logp": 3.24,
      "acd_most_bpka": 7.47,
      "alogp": 3.68,
      "aromatic_rings": 2,
      "full_molformula": "C18H21ClN2",
      "full_mwt": 300.83,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 300.83,
      "mw_monoisotopic": 300.1393,
      "psa": 6.48,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3",
      "standard_inchi": "InChI=1S/C18H21ClN2/c1-20-11-13-21(14-12-20)18(15-5-3-2-4-6-15)16-7-9-17(19)10-8-16/h2-10,18H,11-14H2,1H3",
      "standard_inchi_key": "WFNAKBGANONZEQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Chlorcyclizine HCl (MI, USP)",
        "Chlorcyclizine (BAN, INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": "Glaxosmithkline"
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R06AE53",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Piperazine derivative"
        },
        {
          "code": "R06AE03",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Piperazine derivatives"
        }
      ]
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Anti-Emetic,Antihistaminic,Antinauseant",
    "molecule_chembl_id": "CHEMBL648",
    "molecule_properties": {
      "acd_logd": 2.08,
      "acd_logp": 2.47,
      "acd_most_bpka": 7.5,
      "alogp": 3.02,
      "aromatic_rings": 2,
      "full_molformula": "C18H22N2",
      "full_mwt": 266.39,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 266.39,
      "mw_monoisotopic": 266.1783,
      "psa": 6.48,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN(CC1)C(c2ccccc2)c3ccccc3",
      "standard_inchi": "InChI=1S/C18H22N2/c1-19-12-14-20(15-13-19)18(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18H,12-15H2,1H3",
      "standard_inchi_key": "UVKZSORBKUEBAZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cyclizine (BAN, DCF, INN, USP)",
        "Cyclizine HCl (BAN, USP)",
        "Cyclizine Lactate (BAN, FDA, USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Amerigen Pharmaceuticals Ltd",
        "Glenmark Pharmaceuticals Ltd",
        "Indchemie Health Specialties Pvt Ltd",
        "Watson Laboratories Inc",
        "Forest Laboratories Inc",
        "Alkem Laboratories Ltd",
        "Forest Laboratories Llc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C07AB12",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2007,
    "indication_class": "Antihypertensive (beta-blocker)",
    "molecule_chembl_id": "CHEMBL434394",
    "molecule_properties": {
      "acd_logd": 2.75,
      "acd_logp": 4.08,
      "acd_most_bpka": 8.65,
      "alogp": 2.36,
      "aromatic_rings": 2,
      "full_molformula": "C22H25F2NO4",
      "full_mwt": 405.44,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 29,
      "molecular_species": "BASE",
      "mw_freebase": 405.44,
      "mw_monoisotopic": 405.1752,
      "psa": 70.95,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "OC(CNCC(O)C1CCc2cc(F)ccc2O1)C3CCc4cc(F)ccc4O3",
      "standard_inchi": "InChI=1S/C22H25F2NO4/c23-15-3-7-19-13(9-15)1-5-21(28-19)17(26)11-25-12-18(27)22-6-2-14-10-16(24)4-8-20(14)29-22/h3-4,7-10,17-18,21-22,25-27H,1-2,5-6,11-12H2",
      "standard_inchi_key": "KOHIRBRYDXPAMZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6545040,
    "oral": true,
    "research_codes": {
      "value": [
        "Ro-67555",
        "R-65824"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6545040-B1",
    "synonyms": {
      "value": [
        "Nebivolol HCl (FDA, USAN)",
        "Nebivolol (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Amneal Pharmaceuticals Co Gmbh",
        "Lupin Ltd",
        "Sandoz Inc",
        "Invagen Pharmaceuticals Inc",
        "Zydus Pharmaceuticals Usa Inc",
        "King Pharmaceuticals Llc",
        "Mylan Pharmaceuticals Inc",
        "Impax Laboratories Inc",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C07AA12",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1979,
    "indication_class": "Anti-Adrenergic (beta-receptor)",
    "molecule_chembl_id": "CHEMBL649",
    "molecule_properties": {
      "acd_logd": -1.54,
      "acd_logp": 0.56,
      "acd_most_apka": 13.91,
      "acd_most_bpka": 9.54,
      "alogp": 0.63,
      "aromatic_rings": 1,
      "full_molformula": "C17H27NO4",
      "full_mwt": 309.41,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 309.41,
      "mw_monoisotopic": 309.194,
      "psa": 81.95,
      "qed_weighted": 0.64,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12",
      "standard_inchi": "InChI=1S/C17H27NO4/c1-17(2,3)18-9-12(19)10-22-16-6-4-5-11-7-14(20)15(21)8-13(11)16/h4-6,12,14-15,18-21H,7-10H2,1-3H3/t12?,14-,15+/m1/s1",
      "standard_inchi_key": "VWPOSFSPZNDTMJ-UCWKZMIHSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "SQ-11725"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nadolol (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1976
  },
  {
    "applicants": {
      "value": [
        "Jubilant Cadista Pharmaceuticals Inc",
        "Sandoz Inc",
        "Vintage Pharmaceuticals Inc",
        "Watson Laboratories Inc",
        "Pharmacia And Upjohn Co",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Heather Drug Co Inc",
        "Par Pharmaceutical Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D07AA01",
          "description": "DERMATOLOGICALS: CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS: CORTICOSTEROIDS, PLAIN: Corticosteroids, weak (group I"
        },
        {
          "code": "H02BX01",
          "description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, COMBINATIONS: Corticosteroids for systemic use, combination"
        },
        {
          "code": "H02AB04",
          "description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: CORTICOSTEROIDS FOR SYSTEMIC USE: CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN: Glucocorticoid"
        },
        {
          "code": "D10AA02",
          "description": "DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Corticosteroids, combinations for treatment of acne"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1957,
    "indication_class": "Glucocorticoid",
    "molecule_chembl_id": "CHEMBL650",
    "molecule_properties": {
      "acd_logd": 2.17,
      "acd_logp": 2.17,
      "acd_most_apka": 12.46,
      "alogp": 1.8,
      "full_molformula": "C22H30O5",
      "full_mwt": 374.48,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 374.48,
      "mw_monoisotopic": 374.2093,
      "psa": 94.83,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H]1C[C@H]2[C@@H]3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)[C@@H]2[C@@]4(C)C=CC(=O)C=C14",
      "standard_inchi": "InChI=1S/C22H30O5/c1-12-8-14-15-5-7-22(27,18(26)11-23)21(15,3)10-17(25)19(14)20(2)6-4-13(24)9-16(12)20/h4,6,9,12,14-15,17,19,23,25,27H,5,7-8,10-11H2,1-3H3/t12-,14-,15-,17-,19+,20-,21-,22-/m0/s1",
      "standard_inchi_key": "VHRSUDSXCMQTMA-PJHHCJLFSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "U-67590A"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Methylprednisolone (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-pred-",
    "usan_stem_definition": "prednisone and prednisolone derivatives",
    "usan_stem_substem": "-pred-(-pred-)"
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Aurolife Pharma Llc",
        "Epic Pharma Llc",
        "Mallinckrodt Inc",
        "Roxane Laboratories Inc",
        "Mallinckrodt Chemical Inc",
        "Sandoz Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Vistapharm Inc",
        "Mylan Institutional Llc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N07BC02",
          "description": "NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: DRUGS USED IN ADDICTIVE DISORDERS: Drugs used in opioid dependenc"
        },
        {
          "code": "N02AC52",
          "description": "NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Diphenylpropylamine derivatives"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1947,
    "indication_class": "Analgesic (narcotic)",
    "molecule_chembl_id": "CHEMBL651",
    "molecule_properties": {
      "acd_logd": 2.29,
      "acd_logp": 3.93,
      "acd_most_bpka": 9.05,
      "alogp": 4.29,
      "aromatic_rings": 2,
      "full_molformula": "C21H27NO",
      "full_mwt": 309.45,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "BASE",
      "mw_freebase": 309.45,
      "mw_monoisotopic": 309.2093,
      "psa": 20.31,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c2ccccc2",
      "standard_inchi": "InChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3",
      "standard_inchi_key": "USSIQXCVUWKGNF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Methadone HCl (FDA, USP)",
        "Methadone (BAN, INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "County Line Pharmaceuticals Llc",
        "Apotex Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Idt Australia Ltd",
        "Ani Pharmaceuticals Inc",
        "Amneal Pharmaceutical",
        "Aurobindo Pharma Ltd",
        "Sun Pharmaceutical Industries Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C01BC04",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: ANTIARRHYTHMICS, CLASS I AND III: Antiarrhythmics, class Ic"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1985,
    "indication_class": "Cardiac Depressant (anti-arrhythmic)",
    "molecule_chembl_id": "CHEMBL652",
    "molecule_properties": {
      "acd_logd": 1.05,
      "acd_logp": 3.19,
      "acd_most_bpka": 9.69,
      "alogp": 3.44,
      "aromatic_rings": 1,
      "full_molformula": "C17H20F6N2O3",
      "full_mwt": 414.35,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 28,
      "molecular_species": "BASE",
      "mw_freebase": 414.35,
      "mw_monoisotopic": 414.1378,
      "psa": 59.59,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC2CCCCN2",
      "standard_inchi": "InChI=1S/C17H20F6N2O3/c18-16(19,20)9-27-12-4-5-14(28-10-17(21,22)23)13(7-12)15(26)25-8-11-3-1-2-6-24-11/h4-5,7,11,24H,1-3,6,8-10H2,(H,25,26)",
      "standard_inchi_key": "DJBNUMBKLMJRSA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Flecainide Acetate (FDA, JAN, USAN, USP)",
        "Flecainide (BAN, INN)",
        null
      ]
    },
    "usan_year": 1977
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Chartwell Molecules Llc",
        "Exela Pharma Sciences Llc",
        "Ajanta Pharma Ltd",
        "Boehringer Ingelheim",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Actavis Elizabeth Llc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Mylan Institutional Llc",
        "Mylan Pharmaceuticals Inc",
        "Par Pharmaceutical Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01EA04",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Sympathomimetics in glaucoma therapy 1"
        },
        {
          "code": "N02CX02",
          "description": "NERVOUS SYSTEM: ANALGESICS: ANTIMIGRAINE PREPARATIONS: Other antimigraine preparation"
        },
        {
          "code": "C02AC01",
          "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Imidazoline receptor agonists"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1974,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL134",
    "molecule_properties": {
      "acd_logd": 1.6,
      "acd_logp": 2.36,
      "acd_most_bpka": 8.1,
      "alogp": 2.36,
      "aromatic_rings": 1,
      "full_molformula": "C9H9Cl2N3",
      "full_mwt": 230.1,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 230.1,
      "mw_monoisotopic": 229.0174,
      "psa": 36.42,
      "qed_weighted": 0.78,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1cccc(Cl)c1NC2=NCCN2",
      "standard_inchi": "InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)",
      "standard_inchi_key": "GJSURZIOUXUGAL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "ST-155",
        "ST-155BS",
        "ST-155-BS"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clonidine HCl (BAN, FDA, JAN, USAN, USP)",
        "Clonidine (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1969
  },
  {
    "applicants": {
      "value": [
        "Apotex Inc Etobicoke Site",
        "Actavis Elizabeth Llc",
        "Roxane Laboratories Inc",
        "Sun Pharmaceutical Industries Inc",
        "Upsher-Smith Laboratories Llc",
        "Actavis Laboratories Fl Inc",
        "Teva Pharmaceuticals Usa Inc",
        "Watson Laboratories Inc",
        "Zydus Pharmaceuticals Usa Inc",
        "Organon Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AX11",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1996,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL654",
    "molecule_properties": {
      "acd_logd": 0.28,
      "acd_logp": 0.89,
      "acd_most_bpka": 8.1,
      "alogp": 2.48,
      "aromatic_rings": 2,
      "full_molformula": "C17H19N3",
      "full_mwt": 265.36,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 265.36,
      "mw_monoisotopic": 265.1579,
      "psa": 19.37,
      "qed_weighted": 0.73,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN2C(C1)c3ccccc3Cc4cccnc24",
      "standard_inchi": "InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3",
      "standard_inchi_key": "RONZAEMNMFQXRA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "ORG-3770"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mirtazapine (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-pin(e)",
    "usan_stem_definition": "tricyclic compounds",
    "usan_stem_substem": "-pin(e)(-pin(e))",
    "usan_year": 1989
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Sagent Agila Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Hospira Inc",
        "Bedford Laboratories Div Ben Venue Laboratories Inc",
        "Akorn Inc",
        "Hoffmann La Roche Inc",
        "Hlr Technology",
        "Apothecon Inc Div Bristol Myers Squibb",
        "Baxter Healthcare Corp"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05CD08",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1985,
    "indication_class": "Anesthetic (injectable),Anesthetic (intravenous)",
    "molecule_chembl_id": "CHEMBL655",
    "molecule_properties": {
      "acd_logd": 3.78,
      "acd_logp": 3.8,
      "acd_most_bpka": 6.03,
      "alogp": 4.32,
      "aromatic_rings": 3,
      "full_molformula": "C18H13ClFN3",
      "full_mwt": 325.77,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 325.77,
      "mw_monoisotopic": 325.0782,
      "psa": 30.18,
      "qed_weighted": 0.65,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ncc2CN=C(c3ccccc3F)c4cc(Cl)ccc4n12",
      "standard_inchi": "InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3",
      "standard_inchi_key": "DDLIGBOFAVUZHB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "Ro-213981-003",
        "Ro-213981003",
        "Ro-213981001"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Midazolam (JAN, BAN, INN, JAN)",
        "Midazolam HCl (FDA, USAN)",
        "Midazolam Maleate (USAN)",
        null
      ]
    },
    "usan_year": 1978
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05AL04",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Benzamides"
      }
    },
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1990,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL22242",
    "molecule_properties": {
      "acd_logd": 0.38,
      "acd_logp": 2.19,
      "acd_most_apka": 13.64,
      "acd_most_bpka": 8.97,
      "alogp": 2.68,
      "aromatic_rings": 1,
      "full_molformula": "C16H23BrN2O3",
      "full_mwt": 371.28,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 371.28,
      "mw_monoisotopic": 370.0892,
      "psa": 50.8,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1CCC[C@H]1CNC(=O)c2c(OC)ccc(Br)c2OC",
      "standard_inchi": "InChI=1S/C16H23BrN2O3/c1-4-19-9-5-6-11(19)10-18-16(20)14-13(21-2)8-7-12(17)15(14)22-3/h7-8,11H,4-6,9-10H2,1-3H3,(H,18,20)/t11-/m0/s1",
      "standard_inchi_key": "GUJRSXAPGDDABA-NSHDSACASA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "A-33547",
        "FLA-731(-)",
        "A-33547.HCL.H20",
        "FLA-731"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Remoxipride (BAN, INN, USAN)",
        "Remoxipride HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-pride",
    "usan_stem_definition": "sulpiride derivatives",
    "usan_stem_substem": "-pride(-pride)",
    "usan_year": 1985,
    "withdrawn_class": "Hematological toxicity",
    "withdrawn_country": "United Kingdom",
    "withdrawn_reason": "Aplastic anemia",
    "withdrawn_year": 1993
  },
  {
    "applicants": {
      "value": [
        "Wes Pharma Inc",
        "Mallinckrodt Inc",
        "Lannett Holdings Inc",
        "Mallinckrodt Chemical Inc",
        "Hi-Tech Pharmacal Co Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Halsey Drug Co Inc",
        "Purdue Pharma Lp",
        "Ken Lifescience",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N02AA05",
        "description": "NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Natural opium alkaloids"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1950,
    "indication_class": "Analgesic (narcotic)",
    "molecule_chembl_id": "CHEMBL656",
    "molecule_properties": {
      "acd_logd": 1.13,
      "acd_logp": 1.59,
      "acd_most_apka": 13.13,
      "acd_most_bpka": 7.57,
      "alogp": 1.05,
      "aromatic_rings": 1,
      "full_molformula": "C18H21NO4",
      "full_mwt": 315.37,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 315.37,
      "mw_monoisotopic": 315.1471,
      "psa": 59,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2C[C@H]3N(C)CC[C@@]45[C@@H](Oc1c24)C(=O)CC[C@@]35O",
      "standard_inchi": "InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1",
      "standard_inchi_key": "BRUQQQPBMZOVGD-XFKAJCMBSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6277384,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-6277384-B1",
    "synonyms": {
      "value": [
        "Oxycodone HCl (FDA, JAN, USAN, USP)",
        "Oxycodone (BAN, FDA, INN, USAN)",
        "Oxycodone terephthalate (FDA, USP)",
        null
      ]
    },
    "usan_year": 1963,
    "withdrawn_country": "United States"
  },
  {
    "applicants": {
      "value": [
        "Perrigo Pharma International Dac",
        "Lannett Holdings Inc",
        "Allergan Sales Llc",
        "Breckenridge Pharmaceutical Inc",
        "Bristol Myers Squibb Co",
        "Bayer Healthcare Pharmaceuticals Inc",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Mylan Pharmaceuticals Inc",
        "Mayne Pharma Llc",
        "Teva Pharmaceuticals Usa"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "G03CA03",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plai"
        },
        {
          "code": "G03CA53",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plain"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1975,
    "indication_class": "Estrogen",
    "molecule_chembl_id": "CHEMBL135",
    "molecule_properties": {
      "acd_logd": 4.14,
      "acd_logp": 4.15,
      "acd_most_apka": 10.27,
      "alogp": 3.61,
      "aromatic_rings": 1,
      "full_molformula": "C18H24O2",
      "full_mwt": 272.39,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 272.39,
      "mw_monoisotopic": 272.1776,
      "psa": 40.46,
      "qed_weighted": 0.76,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@H]2O",
      "standard_inchi": "InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",
      "standard_inchi_key": "VOXZDWNPVJITMN-ZBRFXRBCSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5891868,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-5891868-A",
    "synonyms": {
      "value": [
        "Estradiol (BAN, FDA, INN, USP)",
        "Estradiol Hemihydrate (FDA)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "estr-",
    "usan_stem_definition": "estrogens",
    "usan_stem_substem": "estr-(estr-)"
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Naska Pharmacal Co Inc Div Rugby Darby Group Cosmetics",
        "West-Ward Pharmaceuticals International Ltd",
        "International Medication System",
        "Halsey Drug Co Inc",
        "Hospira Inc",
        "Morton Grove Pharmaceuticals Inc",
        "Kv Pharmaceutical Co",
        "Strides Pharma Global Pte Ltd",
        "Hikma International Pharmaceuticals Llc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R06AA02",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Aminoalkyl ether"
        },
        {
          "code": "R06AA52",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Aminoalkyl ether"
        },
        {
          "code": "D04AA32",
          "description": "DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Antihistamines for topical use"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1946,
    "indication_class": "Antihistaminic",
    "molecule_chembl_id": "CHEMBL657",
    "molecule_properties": {
      "acd_logd": 1.63,
      "acd_logp": 3,
      "acd_most_bpka": 8.76,
      "alogp": 3.35,
      "aromatic_rings": 2,
      "full_molformula": "C17H21NO",
      "full_mwt": 255.36,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 255.36,
      "mw_monoisotopic": 255.1623,
      "psa": 12.47,
      "qed_weighted": 0.78,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCOC(c1ccccc1)c2ccccc2",
      "standard_inchi": "InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3",
      "standard_inchi_key": "ZZVUWRFHKOJYTH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8263647,
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-8263647-B2",
    "synonyms": {
      "value": [
        "Diphenhydramine (BAN, INN, JAN, JAN)",
        "Diphenhydramine HCl (BAN, FDA, JAN, USP)",
        "Diphenhydramine Citrate (FDA, USP)",
        "Diphenhydramine Laurylsulfate (JAN)",
        "Diphenhydramine Tannate (JAN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Hospira Inc",
        "Watson Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N01AH03",
        "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Opioid anesthetics"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1984,
    "indication_class": "Analgesic,Analgesic (narcotic)",
    "molecule_chembl_id": "CHEMBL658",
    "molecule_properties": {
      "acd_logd": 3.56,
      "acd_logp": 3.95,
      "acd_most_bpka": 7.89,
      "alogp": 4.21,
      "aromatic_rings": 2,
      "full_molformula": "C22H30N2O2S",
      "full_mwt": 386.56,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 386.56,
      "mw_monoisotopic": 386.2028,
      "psa": 32.78,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(=O)N(c1ccccc1)C2(COC)CCN(CCc3cccs3)CC2",
      "standard_inchi": "InChI=1S/C22H30N2O2S/c1-3-21(25)24(19-8-5-4-6-9-19)22(18-26-2)12-15-23(16-13-22)14-11-20-10-7-17-27-20/h4-10,17H,3,11-16,18H2,1-2H3",
      "standard_inchi_key": "GGCSSNBKKAUURC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "R-33800",
        "R-30730"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sufentanil (BAN, INN, USAN)",
        "Sufentanil Citrate (FDA, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-fentanil",
    "usan_stem_definition": "narcotic analgesics (fentanyl derivatives)",
    "usan_stem_substem": "-fentanil(-fentanil)",
    "usan_year": 1976
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Actavis Elizabeth Llc",
        "Yabao Pharmaceutical Co Ltd Beijing",
        "Sandoz Inc",
        "Apotex Inc.",
        "West-Ward Pharmaceuticals International Ltd",
        "Watson Laboratories Inc",
        "Aurobindo Pharma Limited",
        "Barr Laboratories Inc",
        "Zydus Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06DA04",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTI-DEMENTIA DRUGS: Anticholinesterases"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 2001,
    "molecule_chembl_id": "CHEMBL659",
    "molecule_properties": {
      "acd_logd": -0.69,
      "acd_logp": -0.05,
      "acd_most_apka": 13.93,
      "acd_most_bpka": 7.92,
      "alogp": 1.85,
      "aromatic_rings": 1,
      "full_molformula": "C17H21NO3",
      "full_mwt": 287.36,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 287.36,
      "mw_monoisotopic": 287.1521,
      "psa": 41.93,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2CN(C)CC[C@@]34C=C[C@H](O)C[C@@H]3Oc1c24",
      "standard_inchi": "InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1",
      "standard_inchi_key": "ASUTZQLVASHGKV-JDFRZJQESA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6099863,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-6099863-A",
    "synonyms": {
      "value": [
        "Galantamine hydrobromide (FDA, USAN)",
        "Galantamine (BAN, INN, MI, USAN)",
        null
      ]
    },
    "usan_year": 2000
  },
  {
    "applicants": {
      "value": [
        "Lannett Holdings Inc",
        "Strides Pharma Global Pte Ltd",
        "Cmp Pharma Inc",
        "Newgen Pharmaceuticals Llc",
        "Usl Pharma Llc",
        "Endo Pharmaceuticals Inc",
        "Teva Pharmaceuticals Usa",
        "Alembic Pharmaceuticals Ltd",
        "Wockhardt Eu Operations (Swiss) Ag",
        "Zydus Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N04BB01",
        "description": "NERVOUS SYSTEM: ANTI-PARKINSON DRUGS: DOPAMINERGIC AGENTS: Adamantane derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1968,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL660",
    "molecule_properties": {
      "acd_logd": -0.47,
      "acd_logp": 2.44,
      "acd_most_bpka": 10.76,
      "alogp": 1.91,
      "full_molformula": "C10H17N",
      "full_mwt": 151.25,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 11,
      "molecular_species": "BASE",
      "mw_freebase": 151.25,
      "mw_monoisotopic": 151.1361,
      "psa": 26.02,
      "qed_weighted": 0.56,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "NC12CC3CC(CC(C3)C1)C2",
      "standard_inchi": "InChI=1S/C10H17N/c11-10-4-7-1-8(5-10)3-9(2-7)6-10/h7-9H,1-6,11H2",
      "standard_inchi_key": "DKNWSYNQZKUICI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8389578,
    "oral": true,
    "research_codes": {
      "value": [
        "TCMDC-125869",
        "EXP-105-1"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-8389578-B2",
    "synonyms": {
      "value": [
        "Amantadine HCl (FDA, JAN, USAN, USP)",
        "Amantadine (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-mantadine",
    "usan_stem_definition": "antivirals/antiparkinsonians (adamantane derivatives)",
    "usan_stem_substem": "-mantadine(-mantadine)",
    "usan_year": 1964
  },
  {
    "applicants": {
      "value": [
        "West-Ward Pharmaceuticals International Ltd",
        "Actavis Elizabeth Llc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Par Pharmaceutical Inc",
        "Aurobindo Pharma Ltd",
        "Natco Pharma Ltd",
        "Roxane Laboratories Inc",
        "Amneal Pharmaceuticals Ny Llc",
        "Actavis Laboratories Fl Inc",
        "Anchen Pharmaceuticals, Inc",
        "Ucb Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05BA12",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1981,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL661",
    "molecule_properties": {
      "acd_logd": 1.92,
      "acd_logp": 1.92,
      "acd_most_bpka": 2.37,
      "alogp": 3.58,
      "aromatic_rings": 3,
      "full_molformula": "C17H13ClN4",
      "full_mwt": 308.77,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 308.77,
      "mw_monoisotopic": 308.0829,
      "psa": 43.07,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1nnc2CN=C(c3ccccc3)c4cc(Cl)ccc4n12",
      "standard_inchi": "InChI=1S/C17H13ClN4/c1-11-20-21-16-10-19-17(12-5-3-2-4-6-12)14-9-13(18)7-8-15(14)22(11)16/h2-9H,10H2,1H3",
      "standard_inchi_key": "VREFGVBLTWBCJP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6024981,
    "oral": true,
    "research_codes": {
      "value": "U-31889"
    },
    "rule_of_five": true,
    "sc_patent": "US-6024981-A",
    "synonyms": {
      "value": [
        "Alprazolam (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1973
  },
  {
    "applicants": {
      "value": [
        "American Therapeutics Inc",
        "Novartis Pharmaceuticals Corp",
        "Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Watson Laboratories Inc",
        "Mylan Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AA21",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1980,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL21731",
    "molecule_properties": {
      "acd_logd": 1.51,
      "acd_logp": 4.36,
      "acd_most_bpka": 10.62,
      "alogp": 4.21,
      "aromatic_rings": 2,
      "full_molformula": "C20H23N",
      "full_mwt": 277.41,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 277.41,
      "mw_monoisotopic": 277.183,
      "psa": 12.03,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CNCCCC12CCC(c3ccccc13)c4ccccc24",
      "standard_inchi": "InChI=1S/C20H23N/c1-21-14-6-12-20-13-11-15(16-7-2-4-9-18(16)20)17-8-3-5-10-19(17)20/h2-5,7-10,15,21H,6,11-14H2,1H3",
      "standard_inchi_key": "QSLMDECMDJKHMQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "BA-34276 [As Hydrochloride]"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Maprotiline (BAN, INN, USAN)",
        "Maprotiline HCl (FDA, JAN, USP)",
        null
      ]
    },
    "usan_year": 1971
  },
  {
    "applicants": {
      "value": [
        "Clinigen Healthcare Ltd",
        "Hospira Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J05AD01",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Phosphonic acid derivatives"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1991,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL666",
    "molecule_properties": {
      "acd_logd": -6.91,
      "acd_logp": -1.9,
      "acd_most_apka": 0.78,
      "alogp": -0.16,
      "full_molformula": "CH3O5P",
      "full_mwt": 126,
      "hba": 2,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 7,
      "molecular_species": "ACID",
      "mw_freebase": 126,
      "mw_monoisotopic": 125.9718,
      "psa": 94.83,
      "qed_weighted": 0.42,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)P(=O)(O)O",
      "standard_inchi": "InChI=1S/CH3O5P/c2-1(3)7(4,5)6/h(H,2,3)(H2,4,5,6)",
      "standard_inchi_key": "ZJAOAACCNHFJAH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "EHB-776"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Foscarnet Sodium (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "fos-",
    "usan_stem_definition": "phosphoro-derivatives",
    "usan_stem_substem": "fos-(fos-)",
    "usan_year": 1985
  },
  {
    "applicants": {
      "value": [
        "Novartis Pharmaceuticals Corp",
        "Bausch And Lomb Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "S01EB09",
        "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1973,
    "indication_class": "Vasodilator (peripheral); Cardiac Depressant; Miotic; Cholinergic",
    "molecule_chembl_id": "CHEMBL667",
    "molecule_properties": {
      "acd_logd": -3.4,
      "acd_logp": -3.4,
      "alogp": 0.26,
      "full_molformula": "C7H16NO2+",
      "full_mwt": 146.21,
      "hba": 2,
      "hba_lipinski": 3,
      "heavy_atoms": 10,
      "mw_freebase": 146.21,
      "mw_monoisotopic": 146.1176,
      "psa": 26.3,
      "qed_weighted": 0.42,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)OCC[N+](C)(C)C",
      "standard_inchi": "InChI=1S/C7H16NO2/c1-7(9)10-6-5-8(2,3)4/h5-6H2,1-4H3/q+1",
      "standard_inchi_key": "OIPILFWXSMYKGL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Acetylcholine chloride (BAN, FDA, INN, JAN, USP)",
        "Acetylcholine Chloride (JAN)",
        null
      ]
    },
    "topical": true
  },
  {
    "applicants": {
      "value": [
        "Cadila Pharmaceuticals Ltd",
        "Chartwell Molecules Llc",
        "Valeant Pharmaceuticals North America Llc",
        "Galderma Laboratories Lp",
        "West-Ward Pharmaceuticals International Ltd",
        "Gd Searle Llc",
        "Forest Laboratories Llc",
        "Halsey Drug Co Inc",
        "Hospira Inc",
        "Strides Pharma Global Pte Ltd"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "P01AB01",
          "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Nitroimidazole derivative"
        },
        {
          "code": "A01AB17",
          "description": "ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatmen"
        },
        {
          "code": "J01XD01",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER ANTIBACTERIALS: Imidazole derivative"
        },
        {
          "code": "G01AF01",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Imidazole derivative"
        },
        {
          "code": "P01AB51",
          "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Nitroimidazole derivative"
        },
        {
          "code": "D06BX01",
          "description": "DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Other chemotherapeutics"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1963,
    "indication_class": "Antibacterial,Antiprotozoal (trichomonas)",
    "molecule_chembl_id": "CHEMBL137",
    "molecule_properties": {
      "acd_logd": -0.14,
      "acd_logp": -0.14,
      "acd_most_bpka": 2.58,
      "alogp": 0.09,
      "aromatic_rings": 1,
      "full_molformula": "C6H9N3O3",
      "full_mwt": 171.16,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 12,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 171.16,
      "mw_monoisotopic": 171.0644,
      "psa": 81.19,
      "qed_weighted": 0.52,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ncc([N+](=O)[O-])n1CCO",
      "standard_inchi": "InChI=1S/C6H9N3O3/c1-5-7-4-6(9(11)12)8(5)2-3-10/h4,10H,2-3H2,1H3",
      "standard_inchi_key": "VAOCPAMSLUNLGC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6350468,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "RP-8823",
        "SC-32642",
        "BAY-5360",
        "BAYER-5360"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6350468-B1",
    "synonyms": {
      "value": [
        "Metronidazole HCl (FDA, USAN)",
        "Metronidazole (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-nidazole",
    "usan_stem_definition": "antiprotozoal substances (metronidazole type)",
    "usan_stem_substem": "-nidazole(-nidazole)",
    "usan_year": 1962
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL21799",
    "molecule_properties": {
      "acd_logd": 3.19,
      "acd_logp": 3.28,
      "acd_most_bpka": 6.79,
      "alogp": 3.18,
      "aromatic_rings": 2,
      "full_molformula": "C12H12Cl2N4",
      "full_mwt": 283.16,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 283.16,
      "mw_monoisotopic": 282.0439,
      "psa": 77.82,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCc1nc(N)nc(N)c1c2ccc(Cl)c(Cl)c2",
      "standard_inchi": "InChI=1S/C12H12Cl2N4/c1-2-9-10(11(15)18-12(16)17-9)6-3-4-7(13)8(14)5-6/h3-5H,2H2,1H3,(H4,15,16,17,18)",
      "standard_inchi_key": "PXLPCZJACKUXGP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Etoprine (USAN)",
        null
      ]
    },
    "usan_year": 1977
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Sandoz Inc",
        "Jubilant Generics Ltd",
        "Alembic Pharmaceuticals Ltd",
        "Alkem Laboratories Ltd",
        "Amneal Pharmaceuticals",
        "Zydus Pharmaceuticals Usa Inc",
        "Sebela Ireland Ltd",
        "Mylan Pharmaceuticals Inc",
        "Janssen Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J02AC02",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: ANTIMYCOTICS FOR SYSTEMIC USE: Triazole derivatives"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1992,
    "indication_class": "Antifungal",
    "molecule_chembl_id": "CHEMBL22587",
    "molecule_properties": {
      "acd_logd": 4.93,
      "acd_logp": 5,
      "acd_most_bpka": 6.47,
      "alogp": 5.58,
      "aromatic_rings": 5,
      "full_molformula": "C35H38Cl2N8O4",
      "full_mwt": 705.65,
      "hba": 12,
      "hba_lipinski": 12,
      "heavy_atoms": 49,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 705.65,
      "mw_monoisotopic": 704.2393,
      "num_lipinski_ro5_violations": 3,
      "num_ro5_violations": 3,
      "psa": 104.7,
      "qed_weighted": 0.17,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(C)N1N=CN(C1=O)c2ccc(cc2)N3CCN(CC3)c4ccc(OC[C@H]5CO[C@@](Cn6cncn6)(O5)c7ccc(Cl)cc7Cl)cc4",
      "standard_inchi": "InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/m0/s1",
      "standard_inchi_key": "VHVPQPYKVGDNFY-ZPGVKDDISA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6407079,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "R-51211"
    },
    "sc_patent": "US-6407079-B1",
    "synonyms": {
      "value": [
        "Itraconazole (BAN, FDA, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-conazole",
    "usan_stem_definition": "systemic antifungals (miconazole type)",
    "usan_stem_substem": "-conazole(-conazole)",
    "usan_year": 1984
  },
  {
    "applicants": {
      "value": [
        "Epic Pharma Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Sigmapharm Laboratories Llc",
        "Teva Womens Health Inc",
        "Odyssey Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AA11",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Non-selective monoamine reuptake inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1967,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL668",
    "molecule_properties": {
      "acd_logd": 1.51,
      "acd_logp": 4.36,
      "acd_most_bpka": 10.61,
      "alogp": 4.3,
      "aromatic_rings": 2,
      "full_molformula": "C19H21N",
      "full_mwt": 263.38,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 263.38,
      "mw_monoisotopic": 263.1674,
      "psa": 12.03,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CNCCCC1c2ccccc2C=Cc3ccccc13",
      "standard_inchi": "InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3",
      "standard_inchi_key": "BWPIARFWQZKAIA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "MK-240"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Protriptyline HCl (FDA, USAN, USP)",
        "Protriptyline (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-triptyline",
    "usan_stem_definition": "antidepressants (dibenzo[a,d]cycloheptane derivatives)",
    "usan_stem_substem": "-triptyline(-triptyline)",
    "usan_year": 1963
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL22498",
    "molecule_properties": {
      "acd_logd": -0.15,
      "acd_logp": 0.66,
      "acd_most_bpka": 8,
      "alogp": 1.08,
      "aromatic_rings": 1,
      "full_molformula": "C9H14N2",
      "full_mwt": 150.22,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 11,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 150.22,
      "mw_monoisotopic": 150.1157,
      "psa": 38.05,
      "qed_weighted": 0.5,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(Cc1ccccc1)NN",
      "standard_inchi": "InChI=1S/C9H14N2/c1-8(11-10)7-9-5-3-2-4-6-9/h2-6,8,11H,7,10H2,1H3",
      "standard_inchi_key": "VXTWEDPZMSVFEF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pheniprazine HCl (MI)",
        "Pheniprazine (BAN, INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Janssen Research And Development Llc",
        "Orit Laboratories Llc",
        "Jubilant Cadista Pharmaceuticals Inc",
        "Oxford Pharmaceuticals Llc",
        "Twi Pharmaceuticals Inc",
        "Rubicon Research Pvt Ltd",
        "Upsher-Smith Laboratories Llc",
        "Teva Pharmaceuticals International Gmbh",
        "Actavis Laboratories Fl Inc",
        "Invagen Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "M03BX08",
        "description": "MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Other centrally acting agents"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1977,
    "indication_class": "Relaxant (muscle)",
    "molecule_chembl_id": "CHEMBL669",
    "molecule_properties": {
      "acd_logd": 4.45,
      "acd_logp": 6.19,
      "acd_most_bpka": 9.15,
      "alogp": 4.55,
      "aromatic_rings": 2,
      "full_molformula": "C20H21N",
      "full_mwt": 275.4,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 275.4,
      "mw_monoisotopic": 275.1674,
      "psa": 3.24,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCC=C1c2ccccc2C=Cc3ccccc13",
      "standard_inchi": "InChI=1S/C20H21N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-14H,7,15H2,1-2H3",
      "standard_inchi_key": "JURKNVYFZMSNLP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7387793,
    "oral": true,
    "research_codes": {
      "value": [
        "MK-130 [As The Base]",
        "MK-130"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-7387793-B2",
    "synonyms": {
      "value": [
        "Cyclobenzaprine HCl (FDA, USAN, USP)",
        "Cyclobenzaprine (INN)",
        null
      ]
    },
    "usan_year": 1977
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL25336",
    "molecule_properties": {
      "acd_logd": -0.06,
      "acd_logp": 2.85,
      "acd_most_bpka": 9.76,
      "alogp": 1.76,
      "aromatic_rings": 3,
      "full_molformula": "C22H22N8",
      "full_mwt": 398.47,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 30,
      "molecular_species": "BASE",
      "mw_freebase": 398.47,
      "mw_monoisotopic": 398.1967,
      "psa": 97.56,
      "qed_weighted": 0.31,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "C1CN=C(N\\N=C\\c2c3ccccc3c(\\C=N\\NC4=NCCN4)c5ccccc25)N1",
      "standard_inchi": "InChI=1S/C22H22N8/c1-2-6-16-15(5-1)19(13-27-29-21-23-9-10-24-21)17-7-3-4-8-18(17)20(16)14-28-30-22-25-11-12-26-22/h1-8,13-14H,9-12H2,(H2,23,24,29)(H2,25,26,30)/b27-13+,28-14+",
      "standard_inchi_key": "NJSMWLQOCQIOPE-OCHFTUDZSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "CL-216942",
        "NSC-337766"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Bisantrene HCl (USAN)",
        "Bisantrene (INN)",
        null
      ]
    },
    "usan_year": 1981
  },
  {
    "applicants": {
      "value": [
        "Adienne Sa",
        "Fresenius Kabi Usa Llc",
        "Teva Parenteral Medicines Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Immunex Corp"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01AC01",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Ethylene imines"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1959,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL671",
    "molecule_properties": {
      "acd_logd": 0.53,
      "acd_logp": 0.53,
      "acd_most_bpka": 2.74,
      "alogp": 0.16,
      "full_molformula": "C6H12N3PS",
      "full_mwt": 189.22,
      "hba": 1,
      "hba_lipinski": 3,
      "heavy_atoms": 11,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 189.22,
      "mw_monoisotopic": 189.049,
      "psa": 9.03,
      "qed_weighted": 0.46,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "S=P(N1CC1)(N2CC2)N3CC3",
      "standard_inchi": "InChI=1S/C6H12N3PS/c11-10(7-1-2-7,8-3-4-8)9-5-6-9/h1-6H2",
      "standard_inchi_key": "FOCVUCIESVLUNU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Thiotepa (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "usan_stem": "-tepa",
    "usan_stem_definition": "antineoplastics (thiotepa derivatives)",
    "usan_stem_substem": "-tepa(-tepa)"
  },
  {
    "applicants": {
      "value": [
        "Cipla Ltd",
        "Lupin Ltd",
        "Valeant Pharmaceuticals North America Llc",
        "County Line Pharmaceuticals Llc",
        "Apotex Inc",
        "Glenmark Pharmaceuticals Ltd",
        "Lupin Atlantis Holdings Sa",
        "Invagen Pharmaceuticals Inc",
        "Skyepharma Ag",
        "Hetero Labs Ltd Unit Iii"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C10AB05",
        "description": "CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Fibrates"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1993,
    "molecule_chembl_id": "CHEMBL672",
    "molecule_properties": {
      "acd_logd": 5.8,
      "acd_logp": 5.8,
      "alogp": 4.68,
      "aromatic_rings": 2,
      "full_molformula": "C20H21ClO4",
      "full_mwt": 360.84,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 25,
      "mw_freebase": 360.84,
      "mw_monoisotopic": 360.1128,
      "psa": 52.6,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(Cl)cc2",
      "standard_inchi": "InChI=1S/C20H21ClO4/c1-13(2)24-19(23)20(3,4)25-17-11-7-15(8-12-17)18(22)14-5-9-16(21)10-6-14/h5-13H,1-4H3",
      "standard_inchi_key": "YMTINGFKWWXKFG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6074670,
    "oral": true,
    "prodrug": true,
    "rule_of_five": true,
    "sc_patent": "US-6074670-A",
    "synonyms": {
      "value": [
        "Fenofibrate (BAN, FDA, INN, MI)",
        null
      ]
    },
    "usan_stem": "-fibrate",
    "usan_stem_definition": "antihyperlipidemics (clofibrate type)",
    "usan_stem_substem": "-fibrate(-fibrate)"
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL24938",
    "molecule_properties": {
      "acd_logd": 3.17,
      "acd_logp": 6.04,
      "acd_most_apka": 4.47,
      "alogp": 5.17,
      "aromatic_rings": 1,
      "full_molformula": "C22H32Cl2N2O4",
      "full_mwt": 459.41,
      "hba": 3,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 30,
      "molecular_species": "ACID",
      "mw_freebase": 459.41,
      "mw_monoisotopic": 458.1739,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 86.71,
      "qed_weighted": 0.38,
      "ro3_pass": "N",
      "rtb": 14
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCN(CCCCC)C(=O)C(CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1",
      "standard_inchi": "InChI=1S/C22H32Cl2N2O4/c1-3-5-7-13-26(14-8-6-4-2)22(30)19(11-12-20(27)28)25-21(29)16-9-10-17(23)18(24)15-16/h9-10,15,19H,3-8,11-14H2,1-2H3,(H,25,29)(H,27,28)",
      "standard_inchi_key": "IEKOTSCYBBDIJC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CR-1409"
    },
    "synonyms": {
      "value": [
        "Lorglumide (INN)",
        null
      ]
    },
    "usan_stem": "-glumide",
    "usan_stem_definition": "CCK antagonists, antiulcer, anxiolytic agent",
    "usan_stem_substem": "-glumide(-glumide)"
  },
  {
    "applicants": {
      "value": "Abbott Laboratories Pharmaceutical Products Div"
    },
    "atc_classification": {
      "drug": {
        "code": "C02KC01",
        "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: OTHER ANTIHYPERTENSIVES: MAO inhibitors"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL673",
    "molecule_properties": {
      "acd_logd": 1.62,
      "acd_logp": 1.68,
      "acd_most_bpka": 6.5,
      "alogp": 1.75,
      "aromatic_rings": 1,
      "full_molformula": "C11H13N",
      "full_mwt": 159.23,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 12,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 159.23,
      "mw_monoisotopic": 159.1048,
      "psa": 3.24,
      "qed_weighted": 0.61,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CN(CC#C)Cc1ccccc1",
      "standard_inchi": "InChI=1S/C11H13N/c1-3-9-12(2)10-11-7-5-4-6-8-11/h1,4-8H,9-10H2,2H3",
      "standard_inchi_key": "DPWPWRLQFGFJFI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "MO-911",
        "A-19120"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pargyline (BAN, INN)",
        "Pargyline HCl (FDA, USAN, USP)",
        null
      ]
    },
    "usan_year": 1962
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "D08AC03",
          "description": "DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Biguanides and amidine"
        },
        {
          "code": "S01AX15",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Other antiinfectives"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL23013",
    "molecule_properties": {
      "acd_logd": -1.33,
      "acd_logp": 1.67,
      "acd_most_bpka": 12.45,
      "alogp": 2.1,
      "aromatic_rings": 2,
      "full_molformula": "C17H20N4O2",
      "full_mwt": 312.37,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 4,
      "hbd_lipinski": 6,
      "heavy_atoms": 23,
      "molecular_species": "BASE",
      "mw_freebase": 312.37,
      "mw_monoisotopic": 312.1586,
      "num_lipinski_ro5_violations": 1,
      "psa": 118.2,
      "qed_weighted": 0.34,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=N)c1ccc(OCCCOc2ccc(cc2)C(=N)N)cc1",
      "standard_inchi": "InChI=1S/C17H20N4O2/c18-16(19)12-2-6-14(7-3-12)22-10-1-11-23-15-8-4-13(5-9-15)17(20)21/h2-9H,1,10-11H2,(H3,18,19)(H3,20,21)",
      "standard_inchi_key": "WTFXJFJYEJZMFO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "M&B-782 [As Isethionate]",
        "GNF-Pf-3839"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Propamidine (BAN, DCF, INN, MI)",
        null
      ]
    },
    "usan_stem": "-amidine",
    "usan_stem_definition": "pentamidine derivatives/analogues",
    "usan_stem_substem": "-amidine(-amidine)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anticonvulsant",
    "molecule_chembl_id": "CHEMBL22916",
    "molecule_properties": {
      "acd_logd": 1.9,
      "acd_logp": 1.9,
      "acd_most_bpka": 2.58,
      "alogp": 3.14,
      "aromatic_rings": 2,
      "full_molformula": "C15H16N2O",
      "full_mwt": 240.31,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 240.31,
      "mw_monoisotopic": 240.1263,
      "psa": 55.12,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cccc(C)c1NC(=O)c2ccc(N)cc2",
      "standard_inchi": "InChI=1S/C15H16N2O/c1-10-4-3-5-11(2)14(10)17-15(18)12-6-8-13(16)9-7-12/h3-9H,16H2,1-2H3,(H,17,18)",
      "standard_inchi_key": "HZIWGOAXOBPQGY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ameltolide (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1990
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL278764",
    "molecule_properties": {
      "acd_logd": 1.74,
      "acd_logp": 1.74,
      "acd_most_bpka": 0.14,
      "alogp": 2.29,
      "aromatic_rings": 2,
      "full_molformula": "C10H10FN3S",
      "full_mwt": 223.28,
      "hba": 4,
      "hba_lipinski": 3,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 223.28,
      "mw_monoisotopic": 223.0579,
      "psa": 22.75,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1N=C(N(C)C1=S)c2cccc(F)c2",
      "standard_inchi": "InChI=1S/C10H10FN3S/c1-13-9(12-14(2)10(13)15)7-4-3-5-8(11)6-7/h3-6H,1-2H3",
      "standard_inchi_key": "IWDUZEHNLHFBRZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MDL-26479"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Suritozole (INN, USAN)",
        null
      ]
    },
    "usan_year": 1993
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "S01AX08",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Other antiinfective"
        },
        {
          "code": "R02AA18",
          "description": "RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Antiseptic"
        },
        {
          "code": "R01AX07",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Other nasal preparation"
        },
        {
          "code": "S03AA05",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: ANTIINFECTIVES: Antiinfective"
        },
        {
          "code": "D08AC04",
          "description": "DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Biguanides and amidines"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL25105",
    "molecule_properties": {
      "acd_logd": 0.36,
      "acd_logp": 3.36,
      "acd_most_bpka": 12.5,
      "alogp": 3.27,
      "aromatic_rings": 2,
      "full_molformula": "C20H26N4O2",
      "full_mwt": 354.45,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 4,
      "hbd_lipinski": 6,
      "heavy_atoms": 26,
      "molecular_species": "BASE",
      "mw_freebase": 354.45,
      "mw_monoisotopic": 354.2056,
      "num_lipinski_ro5_violations": 1,
      "psa": 118.2,
      "qed_weighted": 0.28,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=N)c1ccc(OCCCCCCOc2ccc(cc2)C(=N)N)cc1",
      "standard_inchi": "InChI=1S/C20H26N4O2/c21-19(22)15-5-9-17(10-6-15)25-13-3-1-2-4-14-26-18-11-7-16(8-12-18)20(23)24/h5-12H,1-4,13-14H2,(H3,21,22)(H3,23,24)",
      "standard_inchi_key": "OQLKNTOKMBVBKV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Hexamidine (BAN, DCF, INN, MI)",
        null
      ]
    },
    "usan_stem": "-amidine",
    "usan_stem_definition": "pentamidine derivatives/analogues",
    "usan_stem_substem": "-amidine(-amidine)"
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL22207",
    "molecule_properties": {
      "acd_logd": 2.17,
      "acd_logp": 3.89,
      "acd_most_bpka": 9.13,
      "alogp": 3.38,
      "aromatic_rings": 1,
      "full_molformula": "C18H25NO",
      "full_mwt": 271.4,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 271.4,
      "mw_monoisotopic": 271.1936,
      "psa": 12.47,
      "qed_weighted": 0.78,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2CC3C4CCCCC4(CCN3C)c2c1",
      "standard_inchi": "InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3",
      "standard_inchi_key": "MKXZASYAUGDDCJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Racemethorphan (BAN, DCF, INN, MI)",
        null
      ]
    },
    "usan_stem": "-orphan",
    "usan_stem_definition": "narcotic antagonists/agonists (morphinan derivatives)",
    "usan_stem_substem": "-orphan(-orphan)"
  },
  {
    "applicants": {
      "value": [
        "Deproco Inc",
        "Eastman Kodak Co",
        "Solvay Pharmaceuticals",
        "Dentsply Pharmaceutical",
        "Septodont Inc",
        "Belmora Llc"
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1960,
    "indication_class": "Adrenergic (vasoconstrictor)",
    "molecule_chembl_id": "CHEMBL677",
    "molecule_properties": {
      "acd_logd": -2.78,
      "acd_logp": -0.91,
      "acd_most_apka": 9.59,
      "acd_most_bpka": 8.4,
      "alogp": 0.48,
      "aromatic_rings": 1,
      "full_molformula": "C9H13NO3",
      "full_mwt": 183.21,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 13,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 183.21,
      "mw_monoisotopic": 183.0895,
      "psa": 86.71,
      "qed_weighted": 0.5,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H](N)[C@H](O)c1ccc(O)c(O)c1",
      "standard_inchi": "InChI=1S/C9H13NO3/c1-5(10)9(13)6-2-3-7(11)8(12)4-6/h2-5,9,11-13H,10H2,1H3/t5-,9-/m0/s1",
      "standard_inchi_key": "GEFQWZLICWMTKF-CDUCUWFYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Corbadrine (DCF, INN)",
        "Levonordefrin (FDA, USP)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL416557",
    "molecule_properties": {
      "acd_logd": -2.25,
      "acd_logp": -0.18,
      "acd_most_apka": 9.59,
      "acd_most_bpka": 9.48,
      "alogp": 0.74,
      "aromatic_rings": 1,
      "full_molformula": "C10H15NO3",
      "full_mwt": 197.23,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 14,
      "molecular_species": "BASE",
      "mw_freebase": 197.23,
      "mw_monoisotopic": 197.1052,
      "psa": 72.72,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CNC(C)C(O)c1ccc(O)c(O)c1",
      "standard_inchi": "InChI=1S/C10H15NO3/c1-6(11-2)10(14)7-3-4-8(12)9(13)5-7/h3-6,10-14H,1-2H3",
      "standard_inchi_key": "DDBFLXGTCAVAFD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dioxifedrine (INN)",
        null
      ]
    },
    "usan_stem": "-drine",
    "usan_stem_definition": "sympathomimetics",
    "usan_stem_substem": "-drine(-drine)"
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Adamis Pharmaceuticals Corp",
        "Astrazeneca Lp",
        "West-Ward Pharmaceuticals International Ltd",
        "Kaleo Inc",
        "International Medication System",
        "Hospira Inc",
        "Empi Inc",
        "Belcher Pharmaceuticals Llc",
        "Eastman Kodak Co"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "B02BC09",
          "description": "BLOOD AND BLOOD FORMING ORGANS: ANTIHEMORRHAGICS: VITAMIN K AND OTHER HEMOSTATICS: Local hemostatic"
        },
        {
          "code": "R03AK01",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergic"
        },
        {
          "code": "R01AA14",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, plai"
        },
        {
          "code": "S01EA51",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Sympathomimetics in glaucoma therapy 1"
        },
        {
          "code": "S01EA01",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Sympathomimetics in glaucoma therapy 1"
        },
        {
          "code": "R03AA01",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Alpha- and beta-adrenoreceptor agonist"
        },
        {
          "code": "C01CA24",
          "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agent"
        },
        {
          "code": "A01AD01",
          "description": "ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Other agents for local oral treatment"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1965,
    "indication_class": "Adrenergic (ophthalmic),Adrenergic (vasoconstrictor)",
    "molecule_chembl_id": "CHEMBL679",
    "molecule_properties": {
      "acd_logd": -2.37,
      "acd_logp": -0.54,
      "acd_most_apka": 9.6,
      "acd_most_bpka": 9.16,
      "alogp": 0.35,
      "aromatic_rings": 1,
      "full_molformula": "C9H13NO3",
      "full_mwt": 183.21,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 13,
      "molecular_species": "BASE",
      "mw_freebase": 183.21,
      "mw_monoisotopic": 183.0895,
      "psa": 72.72,
      "qed_weighted": 0.51,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CNC[C@H](O)c1ccc(O)c(O)c1",
      "standard_inchi": "InChI=1S/C9H13NO3/c1-10-5-9(13)6-2-3-7(11)8(12)4-6/h2-4,9-13H,5H2,1H3/t9-/m0/s1",
      "standard_inchi_key": "UCTWMZQNUQWSLP-VIFPVBQESA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6629968,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-6629968-B1",
    "synonyms": {
      "value": [
        "Epinephrine Bitartrate (FDA, JAN, USP)",
        "Adrenaline (BAN)",
        "Epinephrine (FDA, INN, JAN, USP)",
        "Epinephrine HCl (JAN)",
        null
      ]
    },
    "topical": true
  },
  {
    "applicants": {
      "value": [
        "Facta Farmaceutici Spa",
        "Yung Shin Pharmaceutical Industrial Co Ltd",
        "Eli Lilly And Co",
        "Dava Pharmaceuticals Inc",
        "World Gen Llc",
        "Ranbaxy Pharmaceuticals Inc",
        "Watson Laboratories Inc",
        "Ceph International Corp",
        "Ranbaxy Laboratories Ltd",
        "Hikma Pharmaceuticals"
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1979,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL680",
    "molecule_properties": {
      "acd_logd": -3.01,
      "acd_logp": 0.14,
      "acd_most_apka": 1.95,
      "acd_most_bpka": 6.84,
      "alogp": 0.62,
      "aromatic_rings": 1,
      "full_molformula": "C15H14ClN3O4S",
      "full_mwt": 367.81,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 24,
      "molecular_species": "ACID",
      "mw_freebase": 367.81,
      "mw_monoisotopic": 367.0394,
      "psa": 112.73,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "N[C@@H](C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)Cl)c3ccccc3",
      "standard_inchi": "InChI=1S/C15H14ClN3O4S/c16-8-6-24-14-10(13(21)19(14)11(8)15(22)23)18-12(20)9(17)7-4-2-1-3-5-7/h1-5,9-10,14H,6,17H2,(H,18,20)(H,22,23)/t9-,10-,14-/m1/s1",
      "standard_inchi_key": "QYIYFLOTGYLRGG-GPCCPHFNSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "Compound 99638"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cefaclor (BAN, FDA, INN, JAN, USAN, USP, BAN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "cef-",
    "usan_stem_definition": "cephalosporins",
    "usan_stem_substem": "cef-(cef-)",
    "usan_year": 1976
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Asthmatic; Inhibitor (mediator release)",
    "molecule_chembl_id": "CHEMBL23811",
    "molecule_properties": {
      "acd_logd": 2.47,
      "acd_logp": 2.47,
      "alogp": 2.82,
      "aromatic_rings": 3,
      "full_molformula": "C12H7ClN2O3",
      "full_mwt": 262.65,
      "hba": 5,
      "hba_lipinski": 5,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 262.65,
      "mw_monoisotopic": 262.0145,
      "psa": 65.22,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "COC(=O)c1oc2c(cc(Cl)c3cccnc23)n1",
      "standard_inchi": "InChI=1S/C12H7ClN2O3/c1-17-12(16)11-15-8-5-7(13)6-3-2-4-14-9(6)10(8)18-11/h2-5H,1H3",
      "standard_inchi_key": "ZCRBUWNCWCWRGL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "RHC-3988"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Quazolast (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics: benzoxazole derivatives",
    "usan_stem_substem": "-ast(-ast(-zolast))",
    "usan_year": 1986
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL265502",
    "molecule_properties": {
      "full_molformula": "C51H40N6O23S6",
      "full_mwt": 1297.3,
      "mw_freebase": 1297.3,
      "mw_monoisotopic": 1296.0469
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O",
      "standard_inchi": "InChI=1S/C51H40N6O23S6/c1-25-9-11-29(49(60)54-37-13-15-41(83(69,70)71)35-21-33(81(63,64)65)23-43(45(35)37)85(75,76)77)19-39(25)56-47(58)27-5-3-7-31(17-27)52-51(62)53-32-8-4-6-28(18-32)48(59)57-40-20-30(12-10-26(40)2)50(61)55-38-14-16-42(84(72,73)74)36-22-34(82(66,67)68)24-44(46(36)38)86(78,79)80/h3-24H,1-2H3,(H,54,60)(H,55,61)(H,56,58)(H,57,59)(H2,52,53,62)(H,63,64,65)(H,66,67,68)(H,69,70,71)(H,72,73,74)(H,75,76,77)(H,78,79,80)",
      "standard_inchi_key": "FIAFUQMPZJWCLV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CI-1003"
    },
    "synonyms": {
      "value": [
        "Suramin Hexasodium (USAN)",
        "Suramin sodium (INN)",
        null
      ]
    },
    "usan_year": 1997
  },
  {
    "applicants": {
      "value": [
        "Par Sterile Products Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Luitpold Pharmaceuticals Inc",
        "Zydus Pharmaceuticals Usa Inc",
        "Hospira Inc",
        "Emcure Pharmaceuticals Ltd",
        "Mylan Laboratories Ltd",
        "Hikma Farmaceutica Portugal Sa",
        "Aurobindo Pharma Ltd",
        "Gland Pharma Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N01AX07",
        "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Other general anesthetics"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL681",
    "molecule_properties": {
      "acd_logd": 3.05,
      "acd_logp": 3.05,
      "acd_most_bpka": 4.23,
      "alogp": 2.67,
      "aromatic_rings": 2,
      "full_molformula": "C14H16N2O2",
      "full_mwt": 244.29,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 244.29,
      "mw_monoisotopic": 244.1212,
      "psa": 44.12,
      "qed_weighted": 0.78,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)c1cncn1[C@H](C)c2ccccc2",
      "standard_inchi": "InChI=1S/C14H16N2O2/c1-3-18-14(17)13-9-15-10-16(13)11(2)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3/t11-/m1/s1",
      "standard_inchi_key": "NPUKDXXFDDZOKR-LLVKDONJSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Etomidate (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_year": 1975
  },
  {
    "applicants": {
      "value": "Parke Davis Div Warner Lambert Co"
    },
    "atc_classification": {
      "drug": {
        "code": "P01BA06",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Aminoquinolines"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Antimalarial,Antiprotozoal",
    "molecule_chembl_id": "CHEMBL682",
    "molecule_properties": {
      "acd_logd": 0.95,
      "acd_logp": 3.13,
      "acd_most_apka": 9.43,
      "acd_most_bpka": 5.62,
      "alogp": 5.18,
      "aromatic_rings": 3,
      "full_molformula": "C20H22ClN3O",
      "full_mwt": 355.87,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 355.87,
      "mw_monoisotopic": 355.1451,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 48.39,
      "qed_weighted": 0.6,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O",
      "standard_inchi": "InChI=1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23)",
      "standard_inchi_key": "OVCDSSHSILBFBN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "TCMDC-123932",
        "GNF-Pf-5648",
        "SJ000110703"
      ]
    },
    "synonyms": {
      "value": [
        "Amodiaquine HCl (FDA, USP)",
        "Amodiaquine (BAN, INN, USP)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Allergic",
    "molecule_chembl_id": "CHEMBL23771",
    "molecule_properties": {
      "acd_logd": -1.77,
      "acd_logp": 1.26,
      "acd_most_apka": 3.76,
      "alogp": 2.38,
      "aromatic_rings": 3,
      "full_molformula": "C15H10O5S",
      "full_mwt": 302.31,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "ACID",
      "mw_freebase": 302.31,
      "mw_monoisotopic": 302.0249,
      "psa": 84.58,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C[S+]([O-])c1ccc2Oc3ccc(cc3C(=O)c2c1)C(=O)O",
      "standard_inchi": "InChI=1S/C15H10O5S/c1-21(19)9-3-5-13-11(7-9)14(16)10-6-8(15(17)18)2-4-12(10)20-13/h2-7H,1H3,(H,17,18)",
      "standard_inchi_key": "PCVFKIXSNYJABV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "RS-7337"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tixanox (INN, USAN)",
        "Tixanoxum (INN)",
        null
      ]
    },
    "usan_stem": "-xanox",
    "usan_stem_definition": "antiallergic respiratory tract drugs (xanoxic acid derivatives)",
    "usan_stem_substem": "-xanox(-xanox)",
    "usan_year": 1976
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL683",
    "molecule_properties": {
      "acd_logd": -1.2,
      "acd_logp": 2.42,
      "acd_most_apka": 3.18,
      "alogp": 2.58,
      "aromatic_rings": 1,
      "full_molformula": "C10H11ClO3",
      "full_mwt": 214.65,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 14,
      "molecular_species": "ACID",
      "mw_freebase": 214.65,
      "mw_monoisotopic": 214.0397,
      "psa": 46.53,
      "qed_weighted": 0.84,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(Oc1ccc(Cl)cc1)C(=O)O",
      "standard_inchi": "InChI=1S/C10H11ClO3/c1-10(2,9(12)13)14-8-5-3-7(11)4-6-8/h3-6H,1-2H3,(H,12,13)",
      "standard_inchi_key": "TXCGAZHTZHNUAI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clofibric Acid (DCF, INN, MI)",
        "Calcium Clofibrate (INN)",
        "Magnesium Clofibrate (INN)",
        "Aluminium clofibrate (INN)",
        "Aluminum clofibrate (BAN, INN, JAN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": "Lederle Laboratories Div American Cyanamid Co"
    },
    "atc_classification": {
      "drug": {
        "code": "P02CB02",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Piperazine and derivatives"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1950,
    "indication_class": "Anthelmintic",
    "molecule_chembl_id": "CHEMBL684",
    "molecule_properties": {
      "acd_logd": 1.5,
      "acd_logp": 1.66,
      "acd_most_bpka": 7.15,
      "alogp": 0.7,
      "full_molformula": "C10H21N3O",
      "full_mwt": 199.3,
      "hba": 2,
      "hba_lipinski": 4,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 199.3,
      "mw_monoisotopic": 199.1685,
      "psa": 26.79,
      "qed_weighted": 0.65,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)C(=O)N1CCN(C)CC1",
      "standard_inchi": "InChI=1S/C10H21N3O/c1-4-12(5-2)10(14)13-8-6-11(3)7-9-13/h4-9H2,1-3H3",
      "standard_inchi_key": "RCKMWOKWVGPNJF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Diethylcarbamazine citrate (FDA, JAN, USP)",
        "Diethylcarbamazine (BAN, INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL280378",
    "molecule_properties": {
      "acd_logd": 3.2,
      "acd_logp": 3.31,
      "acd_most_bpka": 6.85,
      "alogp": 2.82,
      "aromatic_rings": 3,
      "full_molformula": "C19H23N5O2",
      "full_mwt": 353.43,
      "hba": 7,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 353.43,
      "mw_monoisotopic": 353.1852,
      "psa": 101.21,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCOc1cc(Cc2cnc(N)nc2N)cc(OCC)c1n3cccc3",
      "standard_inchi": "InChI=1S/C19H23N5O2/c1-3-25-15-10-13(9-14-12-22-19(21)23-18(14)20)11-16(26-4-2)17(15)24-7-5-6-8-24/h5-8,10-12H,3-4,9H2,1-2H3,(H4,20,21,22,23)",
      "standard_inchi_key": "NMARPFMJVCXSAV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "TCMDC-137295"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Epiroprim (INN)",
        null
      ]
    },
    "usan_stem": "-prim",
    "usan_stem_definition": "antibacterials (trimethoprim type)",
    "usan_stem_substem": "-prim(-prim)"
  },
  {
    "applicants": {
      "value": [
        "Impax Laboratories Inc",
        "Janssen Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "P02CA51",
          "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Benzimidazole derivative"
        },
        {
          "code": "P02CA01",
          "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Benzimidazole derivatives"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1974,
    "indication_class": "Anthelmintic",
    "molecule_chembl_id": "CHEMBL685",
    "molecule_properties": {
      "acd_logd": 2.83,
      "acd_logp": 2.83,
      "acd_most_apka": 10.52,
      "acd_most_bpka": 4.7,
      "alogp": 2.97,
      "aromatic_rings": 3,
      "full_molformula": "C16H13N3O3",
      "full_mwt": 295.3,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 295.3,
      "mw_monoisotopic": 295.0957,
      "psa": 84.08,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "COC(=O)Nc1nc2ccc(cc2[nH]1)C(=O)c3ccccc3",
      "standard_inchi": "InChI=1S/C16H13N3O3/c1-22-16(21)19-15-17-12-8-7-11(9-13(12)18-15)14(20)10-5-3-2-4-6-10/h2-9H,1H3,(H2,17,18,19,21)",
      "standard_inchi_key": "OPXLLQIJSORQAM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "R-17635"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mebendazole (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-bendazole",
    "usan_stem_definition": "anthelmintics (tibendazole type)",
    "usan_stem_substem": "-bendazole(-bendazole)",
    "usan_year": 1971
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL23330",
    "molecule_properties": {
      "acd_logd": 0.19,
      "acd_logp": 0.19,
      "alogp": 0.42,
      "aromatic_rings": 1,
      "full_molformula": "C9H8N4O5",
      "full_mwt": 252.19,
      "hba": 6,
      "hba_lipinski": 9,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 252.19,
      "mw_monoisotopic": 252.0495,
      "psa": 132.38,
      "qed_weighted": 0.47,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=O)c1cc(N2CC2)c(cc1[N+](=O)[O-])[N+](=O)[O-]",
      "standard_inchi": "InChI=1S/C9H8N4O5/c10-9(14)5-3-7(11-1-2-11)8(13(17)18)4-6(5)12(15)16/h3-4H,1-2H2,(H2,10,14)",
      "standard_inchi_key": "WOCXQMCIOTUMJV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CB-1954"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tretazicar (INN)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "M01AG03",
        "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Fenamates"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL23588",
    "molecule_properties": {
      "acd_logd": 2.17,
      "acd_logp": 5.22,
      "acd_most_apka": 3.67,
      "alogp": 4.15,
      "aromatic_rings": 2,
      "full_molformula": "C14H10F3NO2",
      "full_mwt": 281.23,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "ACID",
      "mw_freebase": 281.23,
      "mw_monoisotopic": 281.0664,
      "psa": 49.33,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)c1ccccc1Nc2cccc(c2)C(F)(F)F",
      "standard_inchi": "InChI=1S/C14H10F3NO2/c15-14(16,17)9-4-3-5-10(8-9)18-12-7-2-1-6-11(12)13(19)20/h1-8,18H,(H,19,20)",
      "standard_inchi_key": "LPEPZBJOKDYZAD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "INF-1837",
        "CI-440",
        "CN-27554"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Flufenamic Acid (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_year": 1962
  },
  {
    "applicants": {
      "value": [
        "Rising Pharmaceuticals Inc",
        "Dexcel Ltd",
        "Anda Repository Llc",
        "Glenmark Pharmaceuticals Ltd",
        "Gd Searle Llc",
        "Unique Pharmaceutical Laboratories A Division Of J.B. Chemicals And Pharmaceuticals Ltd",
        "Glaxosmithkline Consumer Healthcare",
        "Horizon Pharma Ireland Ltd",
        "Pliva Inc",
        "Allied Pharma Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01BC03",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFLAMMATORY AGENTS: Antiinflammatory agents, non-steroid"
        },
        {
          "code": "M02AA15",
          "description": "MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical us"
        },
        {
          "code": "D11AX18",
          "description": "DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatological"
        },
        {
          "code": "M01AB05",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substance"
        },
        {
          "code": "M01AB55",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Acetic acid derivatives and related substances"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1988,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL139",
    "molecule_properties": {
      "acd_logd": 1.44,
      "acd_logp": 4.55,
      "acd_most_apka": 4.18,
      "alogp": 4.36,
      "aromatic_rings": 2,
      "full_molformula": "C14H11Cl2NO2",
      "full_mwt": 296.15,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "ACID",
      "mw_freebase": 296.15,
      "mw_monoisotopic": 295.0167,
      "psa": 49.33,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl",
      "standard_inchi": "InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",
      "standard_inchi_key": "DCOPUUMXTXDBNB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5607690,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "GP-45840",
        "CGP-45840B"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5607690-A",
    "synonyms": {
      "value": [
        "Diclofenac Epolamine (FDA)",
        "Diclofenac Potassium (FDA, USAN)",
        "Diclofenac Sodium (FDA, JAN, USAN, USP)",
        "Diclofenac (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-ac",
    "usan_stem_definition": "anti-inflammatory agents (acetic acid derivatives)",
    "usan_stem_substem": "-ac(-ac)",
    "usan_year": 1973
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL279924",
    "molecule_properties": {
      "acd_logd": 1.04,
      "acd_logp": 3.65,
      "acd_most_bpka": 10.17,
      "alogp": 3.46,
      "aromatic_rings": 1,
      "full_molformula": "C14H21N",
      "full_mwt": 203.33,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 15,
      "molecular_species": "BASE",
      "mw_freebase": 203.33,
      "mw_monoisotopic": 203.1674,
      "psa": 12.03,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCNC1(CCCCC1)c2ccccc2",
      "standard_inchi": "InChI=1S/C14H21N/c1-2-15-14(11-7-4-8-12-14)13-9-5-3-6-10-13/h3,5-6,9-10,15H,2,4,7-8,11-12H2,1H3",
      "standard_inchi_key": "IFYLVUHLOOCYBG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Eticyclidine (INN)",
        null
      ]
    },
    "usan_stem": "-clidine",
    "usan_stem_definition": "muscarinic receptor agonists",
    "usan_stem_substem": "-clidine(-clidine)"
  },
  {
    "applicants": {
      "value": [
        "Viva Healthcare Fz Llc",
        "Lupin Ltd",
        "Shionogi Inc",
        "Breckenridge Pharmaceutical Inc",
        "Vintage Pharmaceuticals Llc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "M01AG01",
        "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Fenamates"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1967,
    "indication_class": "Anti-Inflammatory; Analgesic",
    "molecule_chembl_id": "CHEMBL686",
    "molecule_properties": {
      "acd_logd": 1.88,
      "acd_logp": 4.83,
      "acd_most_apka": 3.73,
      "alogp": 3.75,
      "aromatic_rings": 2,
      "full_molformula": "C15H15NO2",
      "full_mwt": 241.29,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 18,
      "molecular_species": "ACID",
      "mw_freebase": 241.29,
      "mw_monoisotopic": 241.1103,
      "psa": 49.33,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cccc(Nc2ccccc2C(=O)O)c1C",
      "standard_inchi": "InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18)",
      "standard_inchi_key": "HYYBABOKPJLUIN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "CN-35355",
        "INF-3355",
        "CI-473"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mefenamic acid (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1962
  },
  {
    "atc_classification": {
      "drug": {
        "code": "R06AX04",
        "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Other antihistamines for systemic use"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL278398",
    "molecule_properties": {
      "acd_logd": 2.69,
      "acd_logp": 3.81,
      "acd_most_bpka": 8.48,
      "alogp": 3.92,
      "aromatic_rings": 2,
      "full_molformula": "C19H19N",
      "full_mwt": 261.37,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 261.37,
      "mw_monoisotopic": 261.1517,
      "psa": 3.24,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCC2=C(C1)C(c3ccccc3)c4ccccc24",
      "standard_inchi": "InChI=1S/C19H19N/c1-20-12-11-16-15-9-5-6-10-17(15)19(18(16)13-20)14-7-3-2-4-8-14/h2-10,19H,11-13H2,1H3",
      "standard_inchi_key": "ISFHAYSTHMVOJR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Phenindamine (BAN, INN)",
        "Phenindamine Tartrate (USAN)",
        null
      ]
    },
    "usan_year": 1988
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL23115",
    "molecule_properties": {
      "acd_logd": 2.51,
      "acd_logp": 5.57,
      "acd_most_apka": 3.61,
      "alogp": 4.44,
      "aromatic_rings": 2,
      "full_molformula": "C13H9Cl2NO2",
      "full_mwt": 282.13,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 18,
      "molecular_species": "ACID",
      "mw_freebase": 282.13,
      "mw_monoisotopic": 281.001,
      "psa": 49.33,
      "qed_weighted": 0.87,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)c1ccccc1Nc2cccc(Cl)c2Cl",
      "standard_inchi": "InChI=1S/C13H9Cl2NO2/c14-9-5-3-7-11(12(9)15)16-10-6-2-1-4-8(10)13(17)18/h1-7,16H,(H,17,18)",
      "standard_inchi_key": "JONFYSWOLCTYFK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clofenamic Acid (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL22542",
    "molecule_properties": {
      "acd_logd": -2.35,
      "acd_logp": 0.48,
      "acd_most_apka": 4.37,
      "acd_most_bpka": 6.61,
      "alogp": 2.41,
      "aromatic_rings": 2,
      "full_molformula": "C13H12N2O2S",
      "full_mwt": 260.32,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 18,
      "molecular_species": "ACID",
      "mw_freebase": 260.32,
      "mw_monoisotopic": 260.0619,
      "psa": 55.12,
      "qed_weighted": 0.92,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)C1=Cc2sc(Cn3ccnc3)cc2CC1",
      "standard_inchi": "InChI=1S/C13H12N2O2S/c16-13(17)10-2-1-9-5-11(18-12(9)6-10)7-15-4-3-14-8-15/h3-6,8H,1-2,7H2,(H,16,17)",
      "standard_inchi_key": "KRBSZXUPPSXPAN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Imitrodast (INN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics: thromboxane A2 receptor antagonists",
    "usan_stem_substem": "-ast(-ast(-trodast))"
  },
  {
    "applicants": {
      "value": [
        "Pharmaxis Ltd",
        "Fresenius Kabi Usa Llc",
        "Icu Medical Inc",
        "Miles Laboratories Inc",
        "International Medication System",
        "Watson Laboratories Inc",
        "Luitpold Pharmaceuticals Inc",
        "Hospira Inc",
        "Baxter Healthcare Corp",
        "B Braun Medical Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "A06AD16",
          "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Osmotically acting laxative"
        },
        {
          "code": "R05CB16",
          "description": "RESPIRATORY SYSTEM: COUGH AND COLD PREPARATIONS: EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS: Mucolytic"
        },
        {
          "code": "B05BC01",
          "description": "BLOOD AND BLOOD FORMING ORGANS: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS: I.V. SOLUTIONS: Solutions producing osmotic diuresi"
        },
        {
          "code": "B05CX04",
          "description": "BLOOD AND BLOOD FORMING ORGANS: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS: IRRIGATING SOLUTIONS: Other irrigating solutions"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Diagnostic Aid (renal function determination); Diuretic",
    "molecule_chembl_id": "CHEMBL689",
    "molecule_properties": {
      "acd_logd": -3.26,
      "acd_logp": -3.26,
      "acd_most_apka": 13.13,
      "alogp": -3.59,
      "full_molformula": "C6H14O6",
      "full_mwt": 182.17,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 6,
      "hbd_lipinski": 6,
      "heavy_atoms": 12,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 182.17,
      "mw_monoisotopic": 182.079,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 121.38,
      "qed_weighted": 0.26,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO",
      "standard_inchi": "InChI=1S/C6H14O6/c7-1-3(9)5(11)6(12)4(10)2-8/h3-12H,1-2H2/t3-,4-,5-,6-/m1/s1",
      "standard_inchi_key": "FBPFZTCFMRRESA-KVTDHHQDSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "synonyms": {
      "value": [
        "D-Mannitol (JAN)",
        "Mannitol (FDA, USP)",
        null
      ]
    },
    "topical": true
  },
  {
    "availability_type": -1,
    "chirality": -1,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (surfactant)",
    "molecule_chembl_id": "CHEMBL23393",
    "molecule_properties": {
      "full_molformula": "C12H25NaO4S",
      "full_mwt": 288.38,
      "mw_freebase": 288.38,
      "mw_monoisotopic": 288.1371
    },
    "molecule_structures": {
      "canonical_smiles": "[Na+].CCCCCCCCCCCCOS(=O)(=O)[O-]",
      "standard_inchi": "InChI=1S/C12H26O4S.Na/c1-2-3-4-5-6-7-8-9-10-11-12-16-17(13,14)15;/h2-12H2,1H3,(H,13,14,15);/q;+1/p-1",
      "standard_inchi_key": "DBMJMQXJHONAFJ-UHFFFAOYSA-M"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Sodium Lauryl Sulfate (JAN, NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL23293",
    "molecule_properties": {
      "acd_logd": 3.93,
      "acd_logp": 7.01,
      "acd_most_apka": 3.5,
      "alogp": 6.9,
      "aromatic_rings": 1,
      "full_molformula": "C22H30O2S",
      "full_mwt": 358.55,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 358.55,
      "mw_monoisotopic": 358.1967,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 37.3,
      "qed_weighted": 0.37,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=CCC\\C(=C\\CC\\C(=C\\CSc1ccccc1C(=O)O)\\C)\\C)C",
      "standard_inchi": "InChI=1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6,9,11,13-15H,7-8,10,12,16H2,1-4H3,(H,23,24)/b18-11+,19-15+",
      "standard_inchi_key": "WUILNKCFCLNXOK-CFBAGHHKSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "FTS"
    },
    "synonyms": {
      "value": [
        "Salirasib (INN, USAN)",
        null
      ]
    },
    "usan_stem": "sal-",
    "usan_stem_definition": "anti-inflammatory agents (salicylic acid derivatives)",
    "usan_stem_substem": "sal-(sal-)",
    "usan_year": 2005
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL23261",
    "molecule_properties": {
      "acd_logd": -2.29,
      "acd_logp": 1.46,
      "acd_most_apka": 1.82,
      "acd_most_bpka": 0.41,
      "alogp": 2.92,
      "aromatic_rings": 3,
      "full_molformula": "C22H22N2O6",
      "full_mwt": 410.43,
      "hba": 7,
      "hba_lipinski": 8,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 30,
      "molecular_species": "ACID",
      "mw_freebase": 410.43,
      "mw_monoisotopic": 410.1478,
      "psa": 100,
      "qed_weighted": 0.57,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(OC)nc(O[C@H](C(=O)O)C(OC)(c2ccccc2)c3ccccc3)n1",
      "standard_inchi": "InChI=1S/C22H22N2O6/c1-27-17-14-18(28-2)24-21(23-17)30-19(20(25)26)22(29-3,15-10-6-4-7-11-15)16-12-8-5-9-13-16/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1",
      "standard_inchi_key": "FEJVSJIALLTFRP-LJQANCHMSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "LU-135252",
        "HMR-4005"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Darusentan (INN)",
        null
      ]
    },
    "usan_stem": "-entan",
    "usan_stem_definition": "endothelin receptor antagonists",
    "usan_stem_substem": "-entan(-entan)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "S01EB10",
        "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Parasympathomimetics"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL23838",
    "molecule_properties": {
      "acd_logd": 2.11,
      "acd_logp": 2.11,
      "alogp": 3.15,
      "aromatic_rings": 1,
      "full_molformula": "C10H14NO6P",
      "full_mwt": 275.2,
      "hba": 6,
      "hba_lipinski": 7,
      "heavy_atoms": 18,
      "mw_freebase": 275.2,
      "mw_monoisotopic": 275.0559,
      "psa": 87.9,
      "qed_weighted": 0.43,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCOP(=O)(OCC)Oc1ccc(cc1)[N+](=O)[O-]",
      "standard_inchi": "InChI=1S/C10H14NO6P/c1-3-15-18(14,16-4-2)17-10-7-5-9(6-8-10)11(12)13/h5-8H,3-4H2,1-2H3",
      "standard_inchi_key": "WYMSBXTXOHUIGT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": "Paraoxon"
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 7,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL23550",
    "molecule_properties": {
      "acd_logd": -4.43,
      "acd_logp": -2.1,
      "acd_most_apka": 3.11,
      "acd_most_bpka": 10.27,
      "alogp": -0.72,
      "aromatic_rings": 2,
      "full_molformula": "C11H15N5O3",
      "full_mwt": 265.27,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 19,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 265.27,
      "mw_monoisotopic": 265.1175,
      "psa": 130.31,
      "qed_weighted": 0.58,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1nc(O)c2ncn([C@@H]3C[C@H](CO)[C@H]3CO)c2n1",
      "standard_inchi": "InChI=1S/C11H15N5O3/c12-11-14-9-8(10(19)15-11)13-4-16(9)7-1-5(2-17)6(7)3-18/h4-7,17-18H,1-3H2,(H3,12,14,15,19)/t5-,6-,7-/m1/s1",
      "standard_inchi_key": "GWFOVSGRNGAGDL-FSDSQADBSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "SQ-34514",
        "BMS-180194"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lobucavir (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-vir",
    "usan_stem_definition": "antivirals: carbocyclic nucleosides",
    "usan_stem_substem": "-vir(-vir(-cavir))",
    "usan_year": 1994
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL283120",
    "molecule_properties": {
      "acd_logd": 2.35,
      "acd_logp": 2.35,
      "acd_most_apka": 13.26,
      "alogp": 2.41,
      "aromatic_rings": 2,
      "full_molformula": "C22H22O8",
      "full_mwt": 414.41,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 30,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 414.41,
      "mw_monoisotopic": 414.1315,
      "psa": 92.68,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(cc(OC)c1OC)[C@H]2[C@H]3[C@H](COC3=O)[C@@H](O)c4cc5OCOc5cc24",
      "standard_inchi": "InChI=1S/C22H22O8/c1-25-16-4-10(5-17(26-2)21(16)27-3)18-11-6-14-15(30-9-29-14)7-12(11)20(23)13-8-28-22(24)19(13)18/h4-7,13,18-20,23H,8-9H2,1-3H3/t13-,18+,19+,20-/m0/s1",
      "standard_inchi_key": "YJGVMLPVUAXIQN-HAEOHBJNSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AXL-1717"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": "AXL-1717"
    },
    "usan_stem": "-oxin",
    "usan_stem_definition": "fluoroquinolone derivatives, nonantibacterial indications (e.g., antineoplastic antibiotics)",
    "usan_stem_substem": "-oxin(-oxin)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL25931",
    "molecule_properties": {
      "acd_logd": 0.46,
      "acd_logp": 0.46,
      "acd_most_apka": 9.72,
      "acd_most_bpka": 4.13,
      "alogp": 2.85,
      "aromatic_rings": 3,
      "full_molformula": "C16H14N4O",
      "full_mwt": 278.31,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 278.31,
      "mw_monoisotopic": 278.1168,
      "psa": 70.67,
      "qed_weighted": 0.72,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)C(=O)Nc2cc3[nH]c(nc3cc12)c4ccncc4",
      "standard_inchi": "InChI=1S/C16H14N4O/c1-16(2)10-7-12-13(8-11(10)20-15(16)21)19-14(18-12)9-3-5-17-6-4-9/h3-8H,1-2H3,(H,18,19)(H,20,21)",
      "standard_inchi_key": "TVLQBBHUNDMTEC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Adibendan (INN)",
        null
      ]
    },
    "usan_stem": "-dan",
    "usan_stem_definition": "positive inotropic agents (pimobendan type)",
    "usan_stem_substem": "-dan(-dan)"
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Cardiac Depressant (anti-arrhythmic)",
    "molecule_chembl_id": "CHEMBL286259",
    "molecule_properties": {
      "acd_logd": 0.74,
      "acd_logp": 3.56,
      "acd_most_bpka": 10.51,
      "alogp": 4.25,
      "aromatic_rings": 1,
      "full_molformula": "C23H35N3O",
      "full_mwt": 369.55,
      "hba": 3,
      "hba_lipinski": 4,
      "heavy_atoms": 27,
      "molecular_species": "BASE",
      "mw_freebase": 369.55,
      "mw_monoisotopic": 369.278,
      "psa": 35.91,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)N(CCC1(C2CCCCN2C(=NC1=O)C)c3ccccc3)C(C)C",
      "standard_inchi": "InChI=1S/C23H35N3O/c1-17(2)25(18(3)4)16-14-23(20-11-7-6-8-12-20)21-13-9-10-15-26(21)19(5)24-22(23)27/h6-8,11-12,17-18,21H,9-10,13-16H2,1-5H3",
      "standard_inchi_key": "QAHRRCMLXFLZTF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SC-36602"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Actisomide (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-isomide",
    "usan_stem_definition": "antiarrhythmics (disopyramide derivatives)",
    "usan_stem_substem": "-isomide(-isomide)",
    "usan_year": 1989
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "C01DX52",
          "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Other vasodilators used in cardiac disease"
        },
        {
          "code": "C01DX02",
          "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Other vasodilators used in cardiac diseases"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Vasodilator (coronary)",
    "molecule_chembl_id": "CHEMBL24072",
    "molecule_properties": {
      "acd_logd": 3.06,
      "acd_logp": 5.62,
      "acd_most_bpka": 10.1,
      "alogp": 5.43,
      "aromatic_rings": 3,
      "full_molformula": "C24H27N",
      "full_mwt": 329.49,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "BASE",
      "mw_freebase": 329.49,
      "mw_monoisotopic": 329.2143,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 12.03,
      "qed_weighted": 0.58,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC(Cc1ccccc1)NCCC(c2ccccc2)c3ccccc3",
      "standard_inchi": "InChI=1S/C24H27N/c1-20(19-21-11-5-2-6-12-21)25-18-17-24(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,20,24-25H,17-19H2,1H3",
      "standard_inchi_key": "IFFPICMESYHZPQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "B-436"
    },
    "synonyms": {
      "value": [
        "Prenylamine (BAN, INN, USAN)",
        "Prenylamine Lactate (JAN)",
        null
      ]
    },
    "usan_year": 1962,
    "withdrawn_class": "Cardiotoxicity",
    "withdrawn_country": "United Kingdom; Germany; France; Malaysia",
    "withdrawn_reason": "Polymorphic Ventricular Tachycardia and Death",
    "withdrawn_year": 1988
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 5,
    "molecule_chembl_id": "CHEMBL25892",
    "molecule_properties": {
      "acd_logd": 3.65,
      "acd_logp": 3.65,
      "acd_most_apka": 12.43,
      "acd_most_bpka": 2.33,
      "alogp": 2.2,
      "aromatic_rings": 3,
      "full_molformula": "C23H28N6O4",
      "full_mwt": 452.52,
      "hba": 9,
      "hba_lipinski": 10,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 33,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 452.52,
      "mw_monoisotopic": 452.2172,
      "psa": 146,
      "qed_weighted": 0.52,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)C(NC(=O)CN1C(=O)C(=CN=C1c2ccccc2)N)C(=O)c3oc(nn3)C(C)(C)C",
      "standard_inchi": "InChI=1S/C23H28N6O4/c1-13(2)17(18(31)20-27-28-22(33-20)23(3,4)5)26-16(30)12-29-19(14-9-7-6-8-10-14)25-11-15(24)21(29)32/h6-11,13,17H,12,24H2,1-5H3,(H,26,30)",
      "standard_inchi_key": "YSIHYROEMJSOAS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "ONO-6818"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Freselestat (INN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors: elastase inhibitors",
    "usan_stem_substem": "-stat(-stat(-elestat))"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "D05BA03",
        "description": "DERMATOLOGICALS: ANTIPSORIATICS: ANTIPSORIATICS FOR SYSTEMIC USE: Psoralens for systemic use"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL24171",
    "molecule_properties": {
      "acd_logd": 2.04,
      "acd_logp": 2.04,
      "alogp": 2.55,
      "aromatic_rings": 3,
      "full_molformula": "C12H8O4",
      "full_mwt": 216.19,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 16,
      "mw_freebase": 216.19,
      "mw_monoisotopic": 216.0423,
      "psa": 52.58,
      "qed_weighted": 0.59,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "COc1c2C=CC(=O)Oc2cc3occc13",
      "standard_inchi": "InChI=1S/C12H8O4/c1-14-12-7-2-3-11(13)16-10(7)6-9-8(12)4-5-15-9/h2-6H,1H3",
      "standard_inchi_key": "BGEBZHIAGXMEMV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": "Bergapten"
    },
    "usan_stem": "-erg-",
    "usan_stem_definition": "ergot alkaloid derivatives",
    "usan_stem_substem": "-erg-(-erg-)"
  },
  {
    "applicants": {
      "value": [
        "Novast Laboratories Ltd",
        "Parke Davis Laboratories Div Warner Lambert Co",
        "Allergan Pharmaceuticals International Ltd",
        "Glenmark Pharmaceuticals Ltd",
        "Lupin Atlantis Holdings Sa",
        "Allergan Sales Llc",
        "Gd Searle Llc",
        "Watson Pharmaceuticals Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Bayer Healthcare Pharmaceuticals Inc",
        "Ortho Mcneil Janssen Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "G03CA01",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ESTROGENS: Natural and semisynthetic estrogens, plai"
        },
        {
          "code": "L02AA03",
          "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONES AND RELATED AGENTS: Estrogens"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 2001,
    "indication_class": "Estrogen",
    "molecule_chembl_id": "CHEMBL691",
    "molecule_properties": {
      "acd_logd": 4.11,
      "acd_logp": 4.11,
      "acd_most_apka": 10.24,
      "alogp": 3.61,
      "aromatic_rings": 1,
      "full_molformula": "C20H24O2",
      "full_mwt": 296.41,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 296.41,
      "mw_monoisotopic": 296.1776,
      "psa": 40.46,
      "qed_weighted": 0.72,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@@]2(O)C#C",
      "standard_inchi": "InChI=1S/C20H24O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,5,7,12,16-18,21-22H,4,6,8-11H2,2H3/t16-,17-,18+,19+,20+/m1/s1",
      "standard_inchi_key": "BFPYWIDHMRZLRN-SLHNCBLASA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5898032,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-5898032-A",
    "synonyms": {
      "value": [
        "Ethinylestradiol (FDA, USP, BAN, INN, JAN)",
        null
      ]
    },
    "topical": true
  },
  {
    "applicants": {
      "value": [
        "Acorda Therapeutics Inc",
        "Actavis Laboratories Fl Inc",
        "Aurobindo Pharma Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N07XX07",
        "description": "NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2010,
    "indication_class": "Multiple Sclerosis Symptomatic Treatment",
    "molecule_chembl_id": "CHEMBL284348",
    "molecule_properties": {
      "acd_logd": -1.43,
      "acd_logp": 0.34,
      "acd_most_bpka": 9.26,
      "alogp": 0.66,
      "aromatic_rings": 1,
      "full_molformula": "C5H6N2",
      "full_mwt": 94.12,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 7,
      "molecular_species": "BASE",
      "mw_freebase": 94.12,
      "mw_monoisotopic": 94.0531,
      "psa": 38.91,
      "qed_weighted": 0.51,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ccncc1",
      "standard_inchi": "InChI=1S/C5H6N2/c6-5-1-3-7-4-2-5/h1-4H,(H2,6,7)",
      "standard_inchi_key": "NUKYPUAOHBNCPY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5540938,
    "oral": true,
    "research_codes": {
      "value": "EL-970"
    },
    "rule_of_five": true,
    "sc_patent": "US-5540938-A",
    "synonyms": {
      "value": [
        "Dalfampridine (FDA, USAN)",
        "Fampridine (INN)",
        null
      ]
    },
    "usan_year": 1994
  },
  {
    "applicants": {
      "value": "B Braun Medical Inc"
    },
    "atc_classification": {
      "drug": [
        {
          "code": "A06AG04",
          "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Enema"
        },
        {
          "code": "A06AX01",
          "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR CONSTIPATION: DRUGS FOR CONSTIPATION: Other drugs for constipation"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Pharmaceutic Aid (solvent); Pharmaceutic Aid (humectant)",
    "molecule_chembl_id": "CHEMBL692",
    "molecule_properties": {
      "acd_logd": -1.85,
      "acd_logp": -1.85,
      "acd_most_apka": 13.68,
      "alogp": -1.67,
      "full_molformula": "C3H8O3",
      "full_mwt": 92.09,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 6,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 92.09,
      "mw_monoisotopic": 92.0473,
      "psa": 60.69,
      "qed_weighted": 0.38,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "OCC(O)CO",
      "standard_inchi": "InChI=1S/C3H8O3/c4-1-3(6)2-5/h3-6H,1-2H2",
      "standard_inchi_key": "PEDCQBHIVMGVHV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Glycerin (FDA, JAN, USP)",
        "Glycerol (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (antimicrobial preservative)",
    "molecule_chembl_id": "CHEMBL284127",
    "molecule_properties": {
      "acd_logd": -2.36,
      "acd_logp": -0.57,
      "acd_most_apka": 5.53,
      "alogp": 0.22,
      "full_molformula": "C8H8O4",
      "full_mwt": 168.15,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 12,
      "molecular_species": "ACID",
      "mw_freebase": 168.15,
      "mw_monoisotopic": 168.0423,
      "psa": 60.44,
      "qed_weighted": 0.41,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)C1C(=O)OC(=CC1=O)C",
      "standard_inchi": "InChI=1S/C8H8O4/c1-4-3-6(10)7(5(2)9)8(11)12-4/h3,7H,1-2H3",
      "standard_inchi_key": "PGRHXDWITVMQBC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sodium Dehydroacetate (NF)",
        "Dehydroacetic Acid (NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL287275",
    "molecule_properties": {
      "acd_logd": -5.13,
      "acd_logp": -0.21,
      "acd_most_apka": 1.06,
      "alogp": 0.86,
      "aromatic_rings": 1,
      "full_molformula": "C7H7O6P",
      "full_mwt": 218.1,
      "hba": 3,
      "hba_lipinski": 6,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 14,
      "molecular_species": "ACID",
      "mw_freebase": 218.1,
      "mw_monoisotopic": 217.998,
      "psa": 104.06,
      "qed_weighted": 0.65,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)c1ccccc1OP(=O)(O)O",
      "standard_inchi": "InChI=1S/C7H7O6P/c8-7(9)5-3-1-2-4-6(5)13-14(10,11)12/h1-4H,(H,8,9)(H2,10,11,12)",
      "standard_inchi_key": "FFKUDWZICMJVPA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fosfosal (INN, MI)",
        null
      ]
    },
    "usan_stem": "fos-; -sal",
    "usan_stem_definition": "phosphoro-derivatives; anti-inflammatory agents (salicylic acid derivatives)",
    "usan_stem_substem": "fos-(fos-); -sal(-sal)"
  },
  {
    "applicants": {
      "value": "Abbvie Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "N03AC02",
        "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Oxazolidine derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1946,
    "indication_class": "Anticonvulsant",
    "molecule_chembl_id": "CHEMBL695",
    "molecule_properties": {
      "acd_logd": 0.79,
      "acd_logp": 0.79,
      "alogp": 0.37,
      "full_molformula": "C6H9NO3",
      "full_mwt": 143.14,
      "hba": 3,
      "hba_lipinski": 4,
      "heavy_atoms": 10,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 143.14,
      "mw_monoisotopic": 143.0582,
      "psa": 46.61,
      "qed_weighted": 0.49,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)OC(C)(C)C1=O",
      "standard_inchi": "InChI=1S/C6H9NO3/c1-6(2)4(8)7(3)5(9)10-6/h1-3H3",
      "standard_inchi_key": "IRYJRGCIQBGHIV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "prodrug": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Trimethadione (BAN, FDA, INN, JAN, USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Akorn Inc",
        "Parke-Davis Division Of Pfizer Inc",
        "Parke Davis Div Warner Lambert Co",
        "Mikart Inc",
        "Bionpharma Inc",
        "Heritage Pharmaceuticals Inc",
        "Pharmaceutical Associates Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "N03AD01",
          "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Succinimide derivative"
        },
        {
          "code": "N03AD51",
          "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Succinimide derivatives"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1960,
    "indication_class": "Anticonvulsant",
    "molecule_chembl_id": "CHEMBL696",
    "molecule_properties": {
      "acd_logd": 0.25,
      "acd_logp": 0.25,
      "acd_most_apka": 9.7,
      "alogp": 0.45,
      "full_molformula": "C7H11NO2",
      "full_mwt": 141.17,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 10,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 141.17,
      "mw_monoisotopic": 141.079,
      "psa": 46.17,
      "qed_weighted": 0.54,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CCC1(C)CC(=O)NC1=O",
      "standard_inchi": "InChI=1S/C7H11NO2/c1-3-7(2)4-5(9)8-6(7)10/h3-4H2,1-2H3,(H,8,9,10)",
      "standard_inchi_key": "HAPOVYFOVVWLRS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "CN-10395",
        "CI-366",
        "PM-671"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ethosuximide (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1962
  },
  {
    "applicants": {
      "value": "Parke Davis Div Warner Lambert Co"
    },
    "atc_classification": {
      "drug": {
        "code": "N03AD03",
        "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Succinimide derivatives"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1957,
    "indication_class": "Anticonvulsant",
    "molecule_chembl_id": "CHEMBL697",
    "molecule_properties": {
      "acd_logd": 0.42,
      "acd_logp": 0.42,
      "alogp": 1.33,
      "aromatic_rings": 1,
      "full_molformula": "C12H13NO2",
      "full_mwt": 203.24,
      "hba": 2,
      "hba_lipinski": 3,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 203.24,
      "mw_monoisotopic": 203.0946,
      "psa": 37.38,
      "qed_weighted": 0.65,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)CC(C)(C1=O)c2ccccc2",
      "standard_inchi": "InChI=1S/C12H13NO2/c1-12(9-6-4-3-5-7-9)8-10(14)13(2)11(12)15/h3-7H,8H2,1-2H3",
      "standard_inchi_key": "AJXPJJZHWIXJCJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mesuximide (BAN, INN)",
        "Methsuximide (FDA, USP)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Cardiotonic",
    "molecule_chembl_id": "CHEMBL24646",
    "molecule_properties": {
      "acd_logd": 2.08,
      "acd_logp": 2.08,
      "acd_most_apka": 10.55,
      "acd_most_bpka": 4.43,
      "alogp": 3.1,
      "aromatic_rings": 3,
      "full_molformula": "C19H18N4O2",
      "full_mwt": 334.38,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 334.38,
      "mw_monoisotopic": 334.143,
      "psa": 79.37,
      "qed_weighted": 0.77,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(cc1)c2nc3cc(ccc3[nH]2)C4=NNC(=O)CC4C",
      "standard_inchi": "InChI=1S/C19H18N4O2/c1-11-9-17(24)22-23-18(11)13-5-8-15-16(10-13)21-19(20-15)12-3-6-14(25-2)7-4-12/h3-8,10-11H,9H2,1-2H3,(H,20,21)(H,22,24)",
      "standard_inchi_key": "GLBJJMFZWDBELO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "UDCG-115"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pimobendan (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-dan",
    "usan_stem_definition": "positive inotropic agents (pimobendan type)",
    "usan_stem_substem": "-dan(-dan)",
    "usan_year": 1990
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL24609",
    "molecule_properties": {
      "acd_logd": 5.67,
      "acd_logp": 5.67,
      "acd_most_apka": 13.7,
      "alogp": 4.15,
      "full_molformula": "C19H36O5",
      "full_mwt": 344.49,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 344.49,
      "mw_monoisotopic": 344.2563,
      "psa": 72.83,
      "qed_weighted": 0.34,
      "ro3_pass": "N",
      "rtb": 16
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC",
      "standard_inchi": "InChI=1S/C19H36O5/c1-3-5-7-9-11-13-18(21)23-16-17(15-20)24-19(22)14-12-10-8-6-4-2/h17,20H,3-16H2,1-2H3",
      "standard_inchi_key": "ZQBULZYTDGUSSK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": "Monoctanoin component C"
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL26505",
    "molecule_properties": {
      "acd_logd": 1.9,
      "acd_logp": 3.69,
      "acd_most_bpka": 9.2,
      "alogp": 3.88,
      "aromatic_rings": 2,
      "full_molformula": "C21H27NO2",
      "full_mwt": 325.45,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 325.45,
      "mw_monoisotopic": 325.2042,
      "psa": 29.54,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCOC(=O)C(C)(c1ccccc1)c2ccccc2",
      "standard_inchi": "InChI=1S/C21H27NO2/c1-4-22(5-2)16-17-24-20(23)21(3,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15H,4-5,16-17H2,1-3H3",
      "standard_inchi_key": "DIDYGLSKVUKRRP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Aprofene (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "St Renatus Llc",
        "Novartis Pharmaceuticals Corp",
        "Galen Specialty Pharma Us Llc",
        "Taro Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "C05AD02",
          "description": "CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Local anesthetic"
        },
        {
          "code": "S01HA03",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: LOCAL ANESTHETICS: Local anesthetic"
        },
        {
          "code": "N01BA03",
          "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, LOCAL: Esters of aminobenzoic aci"
        },
        {
          "code": "D04AB06",
          "description": "DERMATOLOGICALS: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC.: Anesthetics for topical use"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2005,
    "first_in_class": true,
    "indication_class": "Anesthetic (local),Anesthetic (topical)",
    "molecule_chembl_id": "CHEMBL698",
    "molecule_properties": {
      "acd_logd": 2.71,
      "acd_logp": 3.75,
      "acd_most_bpka": 8.24,
      "alogp": 2.62,
      "aromatic_rings": 1,
      "full_molformula": "C15H24N2O2",
      "full_mwt": 264.37,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 264.37,
      "mw_monoisotopic": 264.1838,
      "psa": 41.57,
      "qed_weighted": 0.58,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCNc1ccc(cc1)C(=O)OCCN(C)C",
      "standard_inchi": "InChI=1S/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H3",
      "standard_inchi_key": "GKCBAIGFKIBETG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6413499,
    "rule_of_five": true,
    "sc_patent": "US-6413499-B1",
    "synonyms": {
      "value": [
        "Amethocaine (BAN)",
        "Tetracaine (BAN, FDA, INN, USP)",
        "Amethocaine HCl (BAN)",
        "Tetracaine HCl (BAN, JAN, USP)",
        "Tetracaine hydrochloride (FDA)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-caine",
    "usan_stem_definition": "local anesthetics",
    "usan_stem_substem": "-caine(-caine)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL280527",
    "molecule_properties": {
      "acd_logd": 2.87,
      "acd_logp": 3.91,
      "acd_most_bpka": 9.76,
      "alogp": 2.97,
      "aromatic_rings": 3,
      "full_molformula": "C21H25N5O2",
      "full_mwt": 379.46,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 28,
      "molecular_species": "BASE",
      "mw_freebase": 379.46,
      "mw_monoisotopic": 379.2008,
      "psa": 73.49,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCNc1cccnc1N2CCN(CC2)C(=O)c3cc4cc(OC)ccc4[nH]3",
      "standard_inchi": "InChI=1S/C21H25N5O2/c1-3-22-18-5-4-8-23-20(18)25-9-11-26(12-10-25)21(27)19-14-15-13-16(28-2)6-7-17(15)24-19/h4-8,13-14,22,24H,3,9-12H2,1-2H3",
      "standard_inchi_key": "UCPOMLWZWRTIAA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "U-87201E",
        "U-87201"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Atevirdine (INN)",
        "Atevirdine mesylate (USAN)",
        null
      ]
    },
    "usan_stem": "-vir-",
    "usan_stem_definition": "antivirals",
    "usan_stem_substem": "-vir-(-vir-)",
    "usan_year": 1993
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL281764",
    "molecule_properties": {
      "acd_logd": 2.06,
      "acd_logp": 4.04,
      "acd_most_bpka": 9.48,
      "alogp": 3.71,
      "aromatic_rings": 3,
      "full_molformula": "C32H40N4O3",
      "full_mwt": 528.7,
      "hba": 4,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 39,
      "molecular_species": "BASE",
      "mw_freebase": 528.7,
      "mw_monoisotopic": 528.31,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 95.74,
      "qed_weighted": 0.37,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CNC(=O)[C@@H](Cc1ccccc1)N(C)C(=O)[C@@H](Cc2ccc3ccccc3c2)N(C)C(=O)\\C=C\\CC(C)(C)N",
      "standard_inchi": "InChI=1S/C32H40N4O3/c1-32(2,33)19-11-16-29(37)35(4)28(22-24-17-18-25-14-9-10-15-26(25)20-24)31(39)36(5)27(30(38)34-3)21-23-12-7-6-8-13-23/h6-18,20,27-28H,19,21-22,33H2,1-5H3,(H,34,38)/b16-11+/t27-,28-/m1/s1",
      "standard_inchi_key": "WURGZWOTGMLDJP-ZCYANPAGSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Tabimorelin (INN)",
        null
      ]
    },
    "usan_stem": "-relin",
    "usan_stem_definition": "prehormones or hormone-release stimulating peptides: growth hormone-release stimulating peptides",
    "usan_stem_substem": "-relin(-relin(-morelin))"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Neuroprotective",
    "molecule_chembl_id": "CHEMBL284237",
    "molecule_properties": {
      "acd_logd": 2.34,
      "acd_logp": 3,
      "acd_most_bpka": 7.96,
      "alogp": 3.15,
      "aromatic_rings": 2,
      "full_molformula": "C16H15N",
      "full_mwt": 221.3,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 221.3,
      "mw_monoisotopic": 221.1204,
      "psa": 12.03,
      "qed_weighted": 0.72,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@]12N[C@H](Cc3ccccc13)c4ccccc24",
      "standard_inchi": "InChI=1S/C16H15N/c1-16-13-8-4-2-6-11(13)10-15(17-16)12-7-3-5-9-14(12)16/h2-9,15,17H,10H2,1H3/t15-,16+/m1/s1",
      "standard_inchi_key": "LBOJYSIDWZQNJS-CVEARBPZSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MK-801"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dizocilpine (INN)",
        "Dizocilpine maleate (USAN)",
        null
      ]
    },
    "usan_stem": "-pin(e)",
    "usan_stem_definition": "tricyclic compounds",
    "usan_stem_substem": "-pin(e)(-pin(e))",
    "usan_year": 1989
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL24329",
    "molecule_properties": {
      "acd_logd": -2.11,
      "acd_logp": 1.07,
      "acd_most_apka": 7.41,
      "acd_most_bpka": 9.84,
      "alogp": 0.87,
      "aromatic_rings": 3,
      "full_molformula": "C21H25N5O4",
      "full_mwt": 411.46,
      "hba": 9,
      "hba_lipinski": 9,
      "hbd": 6,
      "hbd_lipinski": 6,
      "heavy_atoms": 30,
      "molecular_species": "BASE",
      "mw_freebase": 411.46,
      "mw_monoisotopic": 411.1907,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 131.67,
      "qed_weighted": 0.18,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CNCCNc1ccc2c3c(nn2CCNCCO)c4c(O)ccc(O)c4C(=O)c13",
      "standard_inchi": "InChI=1S/C21H25N5O4/c1-22-6-7-24-12-2-3-13-17-16(12)21(30)19-15(29)5-4-14(28)18(19)20(17)25-26(13)10-8-23-9-11-27/h2-5,22-24,27-29H,6-11H2,1H3",
      "standard_inchi_key": "XASBSYHEEHVCSJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "DUP-937"
    },
    "synonyms": {
      "value": [
        "Teloxantrone (INN)",
        "Teloxantrone HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-antrone",
    "usan_stem_definition": "antineoplastics, anthraquinone derivatives",
    "usan_stem_substem": "-antrone(-antrone)",
    "usan_year": 1992
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N07CA01",
        "description": "NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: ANTIVERTIGO PREPARATIONS: Antivertigo preparations"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Vasodilator",
    "molecule_chembl_id": "CHEMBL24441",
    "molecule_properties": {
      "acd_logd": -2.45,
      "acd_logp": -0.02,
      "acd_most_bpka": 9.75,
      "alogp": 0.84,
      "aromatic_rings": 1,
      "full_molformula": "C8H12N2",
      "full_mwt": 136.2,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 10,
      "molecular_species": "BASE",
      "mw_freebase": 136.2,
      "mw_monoisotopic": 136.1,
      "psa": 24.92,
      "qed_weighted": 0.67,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CNCCc1ccccn1",
      "standard_inchi": "InChI=1S/C8H12N2/c1-9-7-5-8-4-2-3-6-10-8/h2-4,6,9H,5,7H2,1H3",
      "standard_inchi_key": "UUQMNUMQCIQDMZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "PT-9"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Betahistine HCl (USAN, USP)",
        "Betahistine Mesilate (JAN)",
        "Betahistine (BAN, INN)",
        null
      ]
    },
    "usan_year": 1962
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL699",
    "molecule_properties": {
      "acd_logd": -0.91,
      "acd_logp": -0.91,
      "acd_most_bpka": 0.33,
      "alogp": -1.57,
      "aromatic_rings": 2,
      "full_molformula": "C9H12N4O3",
      "full_mwt": 224.22,
      "hba": 7,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 224.22,
      "mw_monoisotopic": 224.0909,
      "psa": 82.05,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)N(C)c2ncn(CCO)c2C1=O",
      "standard_inchi": "InChI=1S/C9H12N4O3/c1-11-7-6(8(15)12(2)9(11)16)13(3-4-14)5-10-7/h5,14H,3-4H2,1-2H3",
      "standard_inchi_key": "NWPRCRWQMGIBOT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Etofylline (BAN, INN, MI)",
        null
      ]
    },
    "usan_stem": "-fylline",
    "usan_stem_definition": "theophylline derivatives",
    "usan_stem_substem": "-fylline(-fylline)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL26291",
    "molecule_properties": {
      "acd_logd": 0.13,
      "acd_logp": 2.86,
      "acd_most_bpka": 9.44,
      "alogp": 3.66,
      "aromatic_rings": 3,
      "full_molformula": "C18H20N4O2",
      "full_mwt": 324.38,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 324.38,
      "mw_monoisotopic": 324.1586,
      "psa": 71.3,
      "qed_weighted": 0.32,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCCNc1c2ccccc2nc3cccc(c13)[N+](=O)[O-]",
      "standard_inchi": "InChI=1S/C18H20N4O2/c1-21(2)12-6-11-19-18-13-7-3-4-8-14(13)20-15-9-5-10-16(17(15)18)22(23)24/h3-5,7-10H,6,11-12H2,1-2H3,(H,19,20)",
      "standard_inchi_key": "YMVWGSQGCWCDGW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nitracrine (INN, MI)",
        null
      ]
    },
    "usan_stem": "-crine",
    "usan_stem_definition": "acridine derivatives",
    "usan_stem_substem": "-crine(-crine)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL279260",
    "molecule_properties": {
      "acd_logd": 0.72,
      "acd_logp": 3.23,
      "acd_most_apka": 3.3,
      "acd_most_bpka": 8.95,
      "alogp": 3.54,
      "aromatic_rings": 3,
      "full_molformula": "C21H23ClN2O4",
      "full_mwt": 402.88,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 28,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 402.88,
      "mw_monoisotopic": 402.1346,
      "psa": 94.58,
      "qed_weighted": 0.44,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H](Cc1c[nH]c2c(OCC(=O)O)cccc12)NC[C@H](O)c3cccc(Cl)c3",
      "standard_inchi": "InChI=1S/C21H23ClN2O4/c1-13(23-11-18(25)14-4-2-5-16(22)9-14)8-15-10-24-21-17(15)6-3-7-19(21)28-12-20(26)27/h2-7,9-10,13,18,23-25H,8,11-12H2,1H3,(H,26,27)/t13-,18+/m1/s1",
      "standard_inchi_key": "FHEYFIGWYQJVDR-ACJLOTCBSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "TAK-677",
        "AD-9677"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Rafabegron (INN)",
        null
      ]
    },
    "usan_stem": "-begron",
    "usan_stem_definition": "beta 3 adrenoreceptor agonist",
    "usan_stem_substem": "-begron(-begron)"
  },
  {
    "applicants": {
      "value": "Eli Lilly And Co"
    },
    "atc_classification": {
      "drug": {
        "code": "J01EB04",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Short-acting sulfonamides"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1939,
    "indication_class": "Suppressant (dermatitis herpetiformis)",
    "molecule_chembl_id": "CHEMBL700",
    "molecule_properties": {
      "acd_logd": 0.41,
      "acd_logp": 0.47,
      "acd_most_apka": 8.54,
      "acd_most_bpka": 2.13,
      "alogp": 1.46,
      "aromatic_rings": 2,
      "full_molformula": "C11H11N3O2S",
      "full_mwt": 249.3,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 249.3,
      "mw_monoisotopic": 249.0572,
      "psa": 85.08,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2",
      "standard_inchi": "InChI=1S/C11H11N3O2S/c12-9-4-6-10(7-5-9)17(15,16)14-11-3-1-2-8-13-11/h1-8H,12H2,(H,13,14)",
      "standard_inchi_key": "GECHUMIMRBOMGK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulfapyridine Sodium (MI, NF)",
        "Sulfapyridine (BAN, FDA, INN, USP)",
        null
      ]
    },
    "usan_stem": "sulfa-",
    "usan_stem_definition": "antimicrobials (sulfonamides derivatives)",
    "usan_stem_substem": "sulfa-(sulfa-)"
  },
  {
    "applicants": {
      "value": [
        "Northstar Healthcare Holdings Ltd",
        "Emerald International Ltd",
        "Sun Pharmaceutical Industries Inc",
        "Lannett Holdings Inc",
        "Oxford Pharmaceuticals Llc",
        "Rubicon Research Pvt Ltd",
        "Teva Pharmaceuticals Usa Inc",
        "Vintage Pharmaceuticals Inc",
        "Watson Laboratories Inc",
        "Novartis Pharmaceuticals Corp"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "M03BX01",
        "description": "MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, CENTRALLY ACTING AGENTS: Other centrally acting agents"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1977,
    "indication_class": "Relaxant (muscle)",
    "molecule_chembl_id": "CHEMBL701",
    "molecule_properties": {
      "acd_logd": -1.72,
      "acd_logp": 0.78,
      "acd_most_apka": 4.04,
      "acd_most_bpka": 10.33,
      "alogp": 1.86,
      "aromatic_rings": 1,
      "full_molformula": "C10H12ClNO2",
      "full_mwt": 213.66,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 14,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 213.66,
      "mw_monoisotopic": 213.0557,
      "psa": 63.32,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "NCC(CC(=O)O)c1ccc(Cl)cc1",
      "standard_inchi": "InChI=1S/C10H12ClNO2/c11-9-3-1-7(2-4-9)8(6-12)5-10(13)14/h1-4,8H,5-6,12H2,(H,13,14)",
      "standard_inchi_key": "KPYSYYIEGFHWSV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6024981,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "BA-34647"
    },
    "rule_of_five": true,
    "sc_patent": "US-6024981-A",
    "synonyms": {
      "value": [
        "Baclofen (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1971
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "D10AX02",
          "description": "DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Other anti-acne preparations for topical us"
        },
        {
          "code": "S01AX06",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Other antiinfectives"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Keratolytic",
    "molecule_chembl_id": "CHEMBL24147",
    "molecule_properties": {
      "acd_logd": 0.81,
      "acd_logp": 0.82,
      "acd_most_apka": 9.45,
      "alogp": 1.1,
      "aromatic_rings": 1,
      "full_molformula": "C6H6O2",
      "full_mwt": 110.11,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 8,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 110.11,
      "mw_monoisotopic": 110.0368,
      "psa": 40.46,
      "qed_weighted": 0.52,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1cccc(O)c1",
      "standard_inchi": "InChI=1S/C6H6O2/c7-5-2-1-3-6(8)4-5/h1-4,7-8H",
      "standard_inchi_key": "GHMLBKRAJCXXBS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Resorcin (JAN)",
        "Resorcinol (USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Wockhardt Bio Ag",
        "Istituto Biochimico Italiano Spa",
        "Sandoz Inc",
        "Apollo Pharmaceuticals Inc",
        "Hospira Inc",
        "Mylan Laboratories Ltd",
        "Aurobindo Pharma Ltd",
        "Wyeth Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01CA12",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Penicillins with extended spectrum"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1981,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL702",
    "molecule_properties": {
      "acd_logd": -2.73,
      "acd_logp": 1,
      "acd_most_apka": 2.44,
      "alogp": -0.24,
      "aromatic_rings": 1,
      "full_molformula": "C23H27N5O7S",
      "full_mwt": 517.56,
      "hba": 7,
      "hba_lipinski": 12,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 36,
      "molecular_species": "ACID",
      "mw_freebase": 517.56,
      "mw_monoisotopic": 517.1631,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 1,
      "psa": 156.43,
      "qed_weighted": 0.34,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1CCN(C(=O)N[C@@H](C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4ccccc4)C(=O)C1=O",
      "standard_inchi": "InChI=1S/C23H27N5O7S/c1-4-26-10-11-27(19(32)18(26)31)22(35)25-13(12-8-6-5-7-9-12)16(29)24-14-17(30)28-15(21(33)34)23(2,3)36-20(14)28/h5-9,13-15,20H,4,10-11H2,1-3H3,(H,24,29)(H,25,35)(H,33,34)/t13-,14-,15+,20-/m1/s1",
      "standard_inchi_key": "IVBHGBMCVLDMKU-GXNBUGAJSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6207661,
    "parenteral": true,
    "research_codes": {
      "value": [
        "CL-227193",
        "T-1220"
      ]
    },
    "sc_patent": "US-6207661-B1",
    "synonyms": {
      "value": [
        "Piperacillin (USP, BAN, INN, USP)",
        "Piperacillin Sodium (FDA, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-cillin",
    "usan_stem_definition": "penicillins",
    "usan_stem_substem": "-cillin(-cillin)",
    "usan_year": 1977
  },
  {
    "applicants": {
      "value": [
        "Apothecon Inc Div Bristol Myers Squibb",
        "Sandoz Inc",
        "Hospira Inc",
        "International Medication Systems Ltd",
        "Organon Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "M03AB01",
        "description": "MUSCULO-SKELETAL SYSTEM: MUSCLE RELAXANTS: MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS: Choline derivatives"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1952,
    "indication_class": "Neuromuscular Blocking Agent",
    "molecule_chembl_id": "CHEMBL703",
    "molecule_properties": {
      "acd_logd": -5,
      "acd_logp": -5,
      "alogp": 0.27,
      "full_molformula": "C14H30N2O4+2",
      "full_mwt": 290.4,
      "hba": 4,
      "hba_lipinski": 6,
      "heavy_atoms": 20,
      "mw_freebase": 290.4,
      "mw_monoisotopic": 290.2195,
      "psa": 52.6,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "C[N+](C)(C)CCOC(=O)CCC(=O)OCC[N+](C)(C)C",
      "standard_inchi": "InChI=1S/C14H30N2O4/c1-15(2,3)9-11-19-13(17)7-8-14(18)20-12-10-16(4,5)6/h7-12H2,1-6H3/q+2",
      "standard_inchi_key": "AXOIZCJOOAYSMI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Succinylcholine chloride (FDA, USP)",
        "Suxamethonium Chloride (BAN, DCF, INN, JAN)",
        "Suxamethonium Bromide (BAN)",
        null
      ]
    },
    "usan_stem": "-ium",
    "usan_stem_definition": "quaternary ammonium derivatives",
    "usan_stem_substem": "-ium(-ium)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (emulsifying agent); Pharmaceutic Aid (emulsion adjunct)",
    "molecule_chembl_id": "CHEMBL24640",
    "molecule_properties": {
      "acd_logd": 7.97,
      "acd_logp": 7.97,
      "alogp": 6.24,
      "full_molformula": "C18H38O",
      "full_mwt": 270.5,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 270.5,
      "mw_monoisotopic": 270.2923,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 20.23,
      "qed_weighted": 0.33,
      "ro3_pass": "N",
      "rtb": 16
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCCCCCCCCCCCCO",
      "standard_inchi": "InChI=1S/C18H38O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19/h19H,2-18H2,1H3",
      "standard_inchi_key": "GLDOVTGHNKAZLK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Cetostearyl alcohol (NF)",
        "Stearyl Alcohol (JAN, NF)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Shire Development Inc",
        "Perrigo Israel Pharmaceuticals Ltd",
        "Mylan Specialty Lp",
        "Allergan Pharmaceuticals International Ltd",
        "Forest Laboratories Llc",
        "G And W Laboratories Inc",
        "Zydus Pharmaceuticals Usa Inc",
        "Valeant Pharmaceuticals International",
        "Mylan Pharmaceuticals Inc",
        "Meda Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A07EC02",
        "description": "ALIMENTARY TRACT AND METABOLISM: ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS: INTESTINAL ANTIINFLAMMATORY AGENTS: Aminosalicylic acid and similar agents"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1987,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL704",
    "molecule_properties": {
      "acd_logd": -2.39,
      "acd_logp": 0.74,
      "acd_most_apka": 1.9,
      "acd_most_bpka": 5.43,
      "alogp": 0.67,
      "aromatic_rings": 1,
      "full_molformula": "C7H7NO3",
      "full_mwt": 153.14,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 11,
      "molecular_species": "ACID",
      "mw_freebase": 153.14,
      "mw_monoisotopic": 153.0426,
      "psa": 83.55,
      "qed_weighted": 0.41,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ccc(O)c(c1)C(=O)O",
      "standard_inchi": "InChI=1S/C7H7NO3/c8-4-1-2-6(9)5(3-4)7(10)11/h1-3,9H,8H2,(H,10,11)",
      "standard_inchi_key": "KBOPZPXVLCULAV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6551620,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-6551620-B2",
    "synonyms": {
      "value": [
        "Mesalamine (FDA, USAN, USP)",
        "Mesalazine (BAN, INN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-sal-",
    "usan_stem_definition": "anti-inflammatory agents (salicylic acid derivatives)",
    "usan_stem_substem": "-sal-(-sal-)",
    "usan_year": 1986
  },
  {
    "applicants": {
      "value": "Eisai Inc"
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D11AH04",
          "description": "DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Agents for dermatitis, excluding corticosteroid"
        },
        {
          "code": "L01XX22",
          "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1999,
    "molecule_chembl_id": "CHEMBL705",
    "molecule_properties": {
      "acd_logd": 3.62,
      "acd_logp": 6.26,
      "acd_most_apka": 4.73,
      "alogp": 5.6,
      "full_molformula": "C20H28O2",
      "full_mwt": 300.44,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "ACID",
      "mw_freebase": 300.44,
      "mw_monoisotopic": 300.2089,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 37.3,
      "qed_weighted": 0.53,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "C\\C(=C\\C=C\\C(=C\\C(=O)O)\\C)\\C=C\\C1=C(C)CCCC1(C)C",
      "standard_inchi": "InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8-,16-14+",
      "standard_inchi_key": "SHGAZHPCJJPHSC-ZVCIMWCZSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5932622,
    "research_codes": {
      "value": [
        "LG100057",
        "ALRT1057",
        "AGN-192013",
        "LGD1057",
        "LG-100057",
        "LGD-1057",
        "ALRT-1057"
      ]
    },
    "sc_patent": "US-5932622-A",
    "synonyms": {
      "value": [
        "Alitretinoin (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-retin-",
    "usan_stem_definition": "retinol derivatives",
    "usan_stem_substem": "-retin-(-retin-)",
    "usan_year": 1998
  },
  {
    "applicants": {
      "value": "Glaxosmithkline"
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1990,
    "indication_class": "Pharmaceutic Aid (emulsifying and stiffening agent)",
    "molecule_chembl_id": "CHEMBL706",
    "molecule_properties": {
      "acd_logd": 6.95,
      "acd_logp": 6.95,
      "alogp": 5.46,
      "full_molformula": "C16H34O",
      "full_mwt": 242.45,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 242.45,
      "mw_monoisotopic": 242.261,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 20.23,
      "qed_weighted": 0.4,
      "ro3_pass": "N",
      "rtb": 14
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCCCCCCCCCCO",
      "standard_inchi": "InChI=1S/C16H34O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17/h17H,2-16H2,1H3",
      "standard_inchi_key": "BXWNKGSJHAJOGX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "synonyms": {
      "value": [
        "Cetanol (JAN)",
        "Cetyl alcohol (FDA, NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (stiffening agent)",
    "molecule_chembl_id": "CHEMBL24022",
    "molecule_properties": {
      "acd_logd": 5.93,
      "acd_logp": 5.93,
      "alogp": 4.68,
      "full_molformula": "C14H30O",
      "full_mwt": 214.39,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 214.39,
      "mw_monoisotopic": 214.2297,
      "psa": 20.23,
      "qed_weighted": 0.47,
      "ro3_pass": "N",
      "rtb": 12
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCCCCCCCCO",
      "standard_inchi": "InChI=1S/C14H30O/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15/h15H,2-14H2,1H3",
      "standard_inchi_key": "HLZKNKRTKFSKGZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Myristyl alcohol (NF)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Sandoz Inc",
        "Allergan Sales Llc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "G04CA04",
        "description": "GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY: Alpha-adrenoreceptor antagonists"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2008,
    "molecule_chembl_id": "CHEMBL24778",
    "molecule_properties": {
      "acd_logd": 1.59,
      "acd_logp": 3.04,
      "acd_most_bpka": 8.78,
      "alogp": 3.07,
      "aromatic_rings": 2,
      "full_molformula": "C25H32F3N3O4",
      "full_mwt": 495.54,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 35,
      "molecular_species": "BASE",
      "mw_freebase": 495.54,
      "mw_monoisotopic": 495.2345,
      "psa": 97.05,
      "qed_weighted": 0.37,
      "ro3_pass": "N",
      "rtb": 13
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H](Cc1cc2CCN(CCCO)c2c(c1)C(=O)N)NCCOc3ccccc3OCC(F)(F)F",
      "standard_inchi": "InChI=1S/C25H32F3N3O4/c1-17(30-8-12-34-21-5-2-3-6-22(21)35-16-25(26,27)28)13-18-14-19-7-10-31(9-4-11-32)23(19)20(15-18)24(29)33/h2-3,5-6,14-15,17,30,32H,4,7-13,16H2,1H3,(H2,29,33)/t17-/m1/s1",
      "standard_inchi_key": "PNCPYILNMDWPEY-QGZVFWFLSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5387603,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-5387603-A",
    "synonyms": {
      "value": [
        "Silodosin (FDA, INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Univ Texas Md Anderson Cancer Center",
        "Ucsf Radiopharmaceutical Facility",
        "Washington Univ School Medicine",
        "Mayo Clinic Pet Radiochemistry Facility",
        "Global Isotopes Llc Dba Zevacor Molecular"
      ]
    },
    "availability_type": 1,
    "chirality": -1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2012,
    "molecule_chembl_id": "CHEMBL282468",
    "molecule_properties": {
      "full_molformula": "C5H14ClNO",
      "full_mwt": 139.63,
      "mw_freebase": 139.63,
      "mw_monoisotopic": 139.0764
    },
    "molecule_structures": {
      "canonical_smiles": "[Cl-].C[N+](C)(C)CCO",
      "standard_inchi": "InChI=1S/C5H14NO.ClH/c1-6(2,3)4-5-7;/h7H,4-5H2,1-3H3;1H/q+1;/p-1",
      "standard_inchi_key": "SGMZJAMFUVOLNK-UHFFFAOYSA-M"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "synonyms": {
      "value": [
        "Choline Chloride (INN, MI, USP)",
        "Choline (11C) (FDA)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Actavis Elizabeth Llc",
        "Genpharm Inc",
        "Pfizer Inc",
        "Apotex Inc",
        "Dava Pharmaceuticals Inc",
        "Sandoz Inc",
        "Pfizer Laboratories Div Pfizer Inc",
        "Nesher Pharmaceuticals Usa Llc",
        "Watson Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C02CA04",
        "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING: Alpha-adrenoreceptor antagonists"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1990,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL707",
    "molecule_properties": {
      "acd_logd": 2.79,
      "acd_logp": 2.85,
      "acd_most_bpka": 6.52,
      "alogp": 1.72,
      "aromatic_rings": 3,
      "full_molformula": "C23H25N5O5",
      "full_mwt": 451.48,
      "hba": 9,
      "hba_lipinski": 10,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 33,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 451.48,
      "mw_monoisotopic": 451.1856,
      "psa": 112.27,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)C4COc5ccccc5O4",
      "standard_inchi": "InChI=1S/C23H25N5O5/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26)",
      "standard_inchi_key": "RUZYUOTYCVRMRZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "UK-33274-27",
        "UK-3327427"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Doxazosin Mesilate (JAN)",
        "Doxazosin Mesylate (FDA, USAN)",
        "Doxazosin (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-azosin",
    "usan_stem_definition": "antihypertensives (prazosin type)",
    "usan_stem_substem": "-azosin(-azosin)",
    "usan_year": 1981
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Immunoregulator",
    "molecule_chembl_id": "CHEMBL25422",
    "molecule_properties": {
      "acd_logd": 2.71,
      "acd_logp": 2.71,
      "alogp": 2.52,
      "aromatic_rings": 2,
      "full_molformula": "C14H12N4",
      "full_mwt": 236.28,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 236.28,
      "mw_monoisotopic": 236.1062,
      "psa": 34.58,
      "qed_weighted": 0.72,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C1=CC(=Nn2cccc2)C=CC1=Nn3cccc3",
      "standard_inchi": "InChI=1S/C14H12N4/c1-2-10-17(9-1)15-13-5-7-14(8-6-13)16-18-11-3-4-12-18/h1-12H/b15-13-,16-14-",
      "standard_inchi_key": "VQKVZNAYFUDTTE-VMNXYWKNSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "WIN-38770"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Azarole (USAN)",
        null
      ]
    },
    "usan_year": 1979
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C02CA02",
        "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING: Alpha-adrenoreceptor antagonists"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL279516",
    "molecule_properties": {
      "acd_logd": 1.5,
      "acd_logp": 2.87,
      "acd_most_bpka": 8.88,
      "alogp": 3.6,
      "aromatic_rings": 3,
      "full_molformula": "C22H25N3O",
      "full_mwt": 347.46,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "BASE",
      "mw_freebase": 347.46,
      "mw_monoisotopic": 347.1998,
      "psa": 48.13,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "O=C(NC1CCN(CCc2c[nH]c3ccccc23)CC1)c4ccccc4",
      "standard_inchi": "InChI=1S/C22H25N3O/c26-22(17-6-2-1-3-7-17)24-19-11-14-25(15-12-19)13-10-18-16-23-21-9-5-4-8-20(18)21/h1-9,16,19,23H,10-15H2,(H,24,26)",
      "standard_inchi_key": "JXZZEXZZKAWDSP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "WY-21901",
        "WY-21901 HCl"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Indoramin HCl (BAN, USAN)",
        "Indoramin (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1971
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C02CA06",
        "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING: Alpha-adrenoreceptor antagonists"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL279229",
    "molecule_properties": {
      "acd_logd": 1.23,
      "acd_logp": 1.64,
      "acd_most_bpka": 7.79,
      "alogp": 0.72,
      "aromatic_rings": 2,
      "full_molformula": "C20H29N5O3",
      "full_mwt": 387.48,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 387.48,
      "mw_monoisotopic": 387.227,
      "psa": 71.74,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccccc1N2CCN(CCCNC3=CC(=O)N(C)C(=O)N3C)CC2",
      "standard_inchi": "InChI=1S/C20H29N5O3/c1-22-18(15-19(26)23(2)20(22)27)21-9-6-10-24-11-13-25(14-12-24)16-7-4-5-8-17(16)28-3/h4-5,7-8,15,21H,6,9-14H2,1-3H3",
      "standard_inchi_key": "ICMGLRUYEQNHPF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Urapidil (BAN, INN, JAN, MI)",
        null
      ]
    },
    "usan_stem": "-dil",
    "usan_stem_definition": "vasodilators (undefined group)",
    "usan_stem_substem": "-dil(-dil)"
  },
  {
    "applicants": {
      "value": "Genzyme Corp"
    },
    "atc_classification": {
      "drug": {
        "code": "L01XE12",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Protein kinase inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2011,
    "molecule_chembl_id": "CHEMBL24828",
    "molecule_properties": {
      "acd_logd": 2.5,
      "acd_logp": 4,
      "acd_most_bpka": 8.92,
      "alogp": 5,
      "aromatic_rings": 3,
      "full_molformula": "C22H24BrFN4O2",
      "full_mwt": 475.36,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 30,
      "molecular_species": "BASE",
      "mw_freebase": 475.36,
      "mw_monoisotopic": 474.1067,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 59.51,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC4CCN(C)CC4",
      "standard_inchi": "InChI=1S/C22H24BrFN4O2/c1-28-7-5-14(6-8-28)12-30-21-11-19-16(10-20(21)29-2)22(26-13-25-19)27-18-4-3-15(23)9-17(18)24/h3-4,9-11,13-14H,5-8,12H2,1-2H3,(H,25,26,27)",
      "standard_inchi_key": "UHTHHESEBZOYNR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": "RE42353",
    "oral": true,
    "research_codes": {
      "value": [
        "ZD-64",
        "ZD-6474",
        "TCMDC-123476",
        "GNF-Pf-2188"
      ]
    },
    "sc_patent": "US-RE42353-E1",
    "synonyms": {
      "value": [
        "Vandetanib (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-anib",
    "usan_stem_definition": "angiogenesis inhibitors",
    "usan_stem_substem": "-anib(-anib)",
    "usan_year": 2006
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N06AX07",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antidepressant,Psychotropic",
    "molecule_chembl_id": "CHEMBL278819",
    "molecule_properties": {
      "acd_logd": 1.92,
      "acd_logp": 2.04,
      "acd_most_bpka": 6.79,
      "alogp": 2.2,
      "aromatic_rings": 2,
      "full_molformula": "C17H22N4O",
      "full_mwt": 298.39,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 298.39,
      "mw_monoisotopic": 298.1794,
      "psa": 50.28,
      "qed_weighted": 0.92,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cc(nnc1NCCN2CCOCC2)c3ccccc3",
      "standard_inchi": "InChI=1S/C17H22N4O/c1-14-13-16(15-5-3-2-4-6-15)19-20-17(14)18-7-8-21-9-11-22-12-10-21/h2-6,13H,7-12H2,1H3,(H,18,20)",
      "standard_inchi_key": "LDMWSLGGVTVJPG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "CB-30038",
        "AGR-1240",
        "30038CB"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Minaprine (BAN, INN, USAN)",
        "Minaprine HCl (USAN)",
        null
      ]
    },
    "usan_year": 1986,
    "withdrawn_class": "Neurotoxicity",
    "withdrawn_country": "France",
    "withdrawn_reason": "Convulsions",
    "withdrawn_year": 1996
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL25202",
    "molecule_properties": {
      "acd_logd": 2.48,
      "acd_logp": 5.52,
      "acd_most_apka": 3.83,
      "alogp": 4.99,
      "aromatic_rings": 2,
      "full_molformula": "C22H25NO3",
      "full_mwt": 351.45,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 351.45,
      "mw_monoisotopic": 351.1834,
      "psa": 66.4,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)CCC(C)(C)c2cc(NC(=O)c3ccc(cc3)C(=O)O)ccc12",
      "standard_inchi": "InChI=1S/C22H25NO3/c1-21(2)11-12-22(3,4)18-13-16(9-10-17(18)21)23-19(24)14-5-7-15(8-6-14)20(25)26/h5-10,13H,11-12H2,1-4H3,(H,23,24)(H,25,26)",
      "standard_inchi_key": "MUTNCGKQJGXKEM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tamibarotene (INN)",
        null
      ]
    },
    "usan_stem": "-arotene",
    "usan_stem_definition": "arotinoid derivatives",
    "usan_stem_substem": "-arotene(-arotene)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL281872",
    "molecule_properties": {
      "acd_logd": 3.25,
      "acd_logp": 3.25,
      "acd_most_bpka": 5.29,
      "alogp": 3.95,
      "aromatic_rings": 4,
      "full_molformula": "C19H16BrFN6O2",
      "full_mwt": 459.28,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 459.28,
      "mw_monoisotopic": 458.0502,
      "psa": 86.98,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn4ccnn4",
      "standard_inchi": "InChI=1S/C19H16BrFN6O2/c1-28-17-9-13-16(10-18(17)29-7-6-27-5-4-24-26-27)22-11-23-19(13)25-15-3-2-12(20)8-14(15)21/h2-5,8-11H,6-7H2,1H3,(H,22,23,25)",
      "standard_inchi_key": "YBTGTVGEKMZEQX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "ZD-4190"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": "ZD-4190"
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL278865",
    "molecule_properties": {
      "acd_logd": 4.08,
      "acd_logp": 4.41,
      "acd_most_bpka": 7.49,
      "alogp": 4.72,
      "aromatic_rings": 4,
      "full_molformula": "C31H33N3O4",
      "full_mwt": 511.62,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 38,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 511.62,
      "mw_monoisotopic": 511.2471,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 75.02,
      "qed_weighted": 0.35,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccccc1N2CCN(CCCNC(=O)c3cccc4C(=O)C(=C(Oc34)c5ccccc5)C)CC2",
      "standard_inchi": "InChI=1S/C31H33N3O4/c1-22-28(35)24-12-8-13-25(30(24)38-29(22)23-10-4-3-5-11-23)31(36)32-16-9-17-33-18-20-34(21-19-33)26-14-6-7-15-27(26)37-2/h3-8,10-15H,9,16-21H2,1-2H3,(H,32,36)",
      "standard_inchi_key": "DUCNHKDCVVSJLG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Upidosin (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Macleods Pharmaceuticals Ltd",
        "Wockhardt Ltd",
        "Pfizer Inc",
        "Apotex Inc",
        "Sandoz Inc",
        "Dr Reddys Laboratories Inc",
        "Zydus Pharmaceuticals Usa Inc",
        "Mylan Pharmaceuticals Inc",
        "Lupin Pharmaceuticals Inc",
        "Aurobindo Pharma Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AE04",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Indole derivatives"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2001,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL708",
    "molecule_properties": {
      "acd_logd": 2.17,
      "acd_logp": 2.97,
      "acd_most_apka": 13.34,
      "acd_most_bpka": 8.41,
      "alogp": 3.81,
      "aromatic_rings": 3,
      "full_molformula": "C21H21ClN4OS",
      "full_mwt": 412.95,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 412.95,
      "mw_monoisotopic": 412.1125,
      "psa": 48.47,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1cc2NC(=O)Cc2cc1CCN3CCN(CC3)c4nsc5ccccc45",
      "standard_inchi": "InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)",
      "standard_inchi_key": "MVWVFYHBGMAFLY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6110918,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "CP-88059",
        "CP-8805927",
        "CP-880591",
        "CP-88059-1",
        "CP-88059-27"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6110918-A",
    "synonyms": {
      "value": [
        "Ziprasidone (BAN, INN)",
        "Ziprasidone HCl (FDA, USAN)",
        "Ziprasidone Mesylate (FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-sidone",
    "usan_stem_definition": "antipsychotic with binding activity on serotonin (5HT2A) and dopamine (D2) receptors",
    "usan_stem_substem": "-sidone(-sidone)",
    "usan_year": 1994
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Wockhardt Ltd",
        "Apotex Inc",
        "Invagen Pharmaceuticals Inc",
        "Sun Pharma Global Inc",
        "Concordia Pharmaceuticals Inc",
        "Unichem Laboratories Ltd",
        "Mylan Pharmaceuticals Inc",
        "Torrent Pharmaceuticals Ltd.",
        "Aurobindo Pharma Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "G04CA01",
        "description": "GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY: Alpha-adrenoreceptor antagonists"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2003,
    "indication_class": "Antihypertensive (alpha-blocker)",
    "molecule_chembl_id": "CHEMBL709",
    "molecule_properties": {
      "acd_logd": 0.35,
      "acd_logp": 1.26,
      "acd_most_bpka": 8.06,
      "alogp": 1.35,
      "aromatic_rings": 2,
      "full_molformula": "C19H27N5O4",
      "full_mwt": 389.46,
      "hba": 8,
      "hba_lipinski": 9,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 389.46,
      "mw_monoisotopic": 389.2063,
      "psa": 111.83,
      "qed_weighted": 0.65,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc2nc(nc(N)c2cc1OC)N(C)CCCNC(=O)C3CCCO3",
      "standard_inchi": "InChI=1S/C19H27N5O4/c1-24(8-5-7-21-18(25)14-6-4-9-28-14)19-22-13-11-16(27-3)15(26-2)10-12(13)17(20)23-19/h10-11,14H,4-9H2,1-3H3,(H,21,25)(H2,20,22,23)",
      "standard_inchi_key": "WNMJYKCGWZFFKR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6149940,
    "oral": true,
    "research_codes": {
      "value": [
        "SL-77499-10",
        "SL-7749910"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6149940-A",
    "synonyms": {
      "value": [
        "Alfuzosin (BAN, INN)",
        "Alfuzosin HCl (FDA, USAN)",
        null
      ]
    },
    "usan_year": 1984
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Merck Research Laboratories Div Merck Co Inc",
        "Actavis Totowa Llc",
        "Hetero Labs Ltd Unit Iii",
        "Gedeon Richter Usa Inc",
        "Teva Pharmaceuticals Usa Inc",
        "Merck And Co Inc",
        "Alkem Laboratories Ltd",
        "Dr Reddys Laboratories Inc",
        "Zydus Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "G04CB01",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY: Testosterone-5-alpha reductase inhibitor"
        },
        {
          "code": "D11AX10",
          "description": "DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatologicals"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1992,
    "indication_class": "Inhibitor (alpha reductase)",
    "molecule_chembl_id": "CHEMBL710",
    "molecule_properties": {
      "acd_logd": 3.83,
      "acd_logp": 3.83,
      "alogp": 3.81,
      "full_molformula": "C23H36N2O2",
      "full_mwt": 372.55,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 372.55,
      "mw_monoisotopic": 372.2777,
      "psa": 58.2,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)NC(=O)[C@H]1CC[C@H]2[C@@H]3CC[C@H]4NC(=O)C=C[C@]4(C)[C@H]3CC[C@]12C",
      "standard_inchi": "InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1",
      "standard_inchi_key": "DBEPLOCGEIEOCV-WSBQPABSSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5942519,
    "oral": true,
    "research_codes": {
      "value": "MK-906"
    },
    "rule_of_five": true,
    "sc_patent": "US-5942519-A",
    "synonyms": {
      "value": [
        "Finasteride (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-steride",
    "usan_stem_definition": "testosterone reductase inhibitors",
    "usan_stem_substem": "-steride(-steride)",
    "usan_year": 1989
  },
  {
    "applicants": {
      "value": "Sanofi Aventis Us Llc"
    },
    "atc_classification": {
      "drug": {
        "code": "B01AA02",
        "description": "BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Vitamin K antagonists"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "molecule_chembl_id": "CHEMBL711",
    "molecule_properties": {
      "acd_logd": 2.96,
      "acd_logp": 3.13,
      "acd_most_apka": 7.72,
      "alogp": 2.85,
      "aromatic_rings": 2,
      "full_molformula": "C15H10O2",
      "full_mwt": 222.24,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 222.24,
      "mw_monoisotopic": 222.0681,
      "psa": 34.14,
      "qed_weighted": 0.7,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1C(C(=O)c2ccccc12)c3ccccc3",
      "standard_inchi": "InChI=1S/C15H10O2/c16-14-11-8-4-5-9-12(11)15(17)13(14)10-6-2-1-3-7-10/h1-9,13H",
      "standard_inchi_key": "NFBAXHOPROOJAW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Phenindione (BAN, FDA, INN, USP)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "B01AA09",
        "description": "BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Vitamin K antagonists"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL278519",
    "molecule_properties": {
      "acd_logd": 3.31,
      "acd_logp": 3.9,
      "acd_most_apka": 6.94,
      "alogp": 3.5,
      "aromatic_rings": 2,
      "full_molformula": "C15H9ClO2",
      "full_mwt": 256.69,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 256.69,
      "mw_monoisotopic": 256.0291,
      "psa": 34.14,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1ccc(cc1)C2C(=O)c3ccccc3C2=O",
      "standard_inchi": "InChI=1S/C15H9ClO2/c16-10-7-5-9(6-8-10)13-14(17)11-3-1-2-4-12(11)15(13)18/h1-8,13H",
      "standard_inchi_key": "NJDUWAXIURWWLN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "G-25766"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clorindione (BAN, INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL24038",
    "molecule_properties": {
      "acd_logd": 0.63,
      "acd_logp": 4.1,
      "acd_most_apka": 3.61,
      "acd_most_bpka": 1.11,
      "alogp": 5.04,
      "aromatic_rings": 3,
      "full_molformula": "C25H25NO5",
      "full_mwt": 419.48,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 31,
      "molecular_species": "ACID",
      "mw_freebase": 419.48,
      "mw_monoisotopic": 419.1733,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 68.23,
      "qed_weighted": 0.52,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CCO[C@@H](Cc1ccc(OCCN2c3ccccc3Oc4ccccc24)cc1)C(=O)O",
      "standard_inchi": "InChI=1S/C25H25NO5/c1-2-29-24(25(27)28)17-18-11-13-19(14-12-18)30-16-15-26-20-7-3-5-9-22(20)31-23-10-6-4-8-21(23)26/h3-14,24H,2,15-17H2,1H3,(H,27,28)/t24-/m0/s1",
      "standard_inchi_key": "WMUIIGVAWPWQAW-DEOSSOPVSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Ragaglitazar (INN)",
        null
      ]
    },
    "usan_stem": "-glitazar",
    "usan_stem_definition": "PPAR agonists (not thiazolidene derivatives)",
    "usan_stem_substem": "-glitazar(-glitazar)"
  },
  {
    "applicants": {
      "value": "Schering Corp Sub Schering Plough Corp"
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1957,
    "molecule_chembl_id": "CHEMBL712",
    "molecule_properties": {
      "acd_logd": 3.24,
      "acd_logp": 3.27,
      "acd_most_apka": 8.64,
      "alogp": 2.86,
      "aromatic_rings": 2,
      "full_molformula": "C16H12O3",
      "full_mwt": 252.27,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 252.27,
      "mw_monoisotopic": 252.0786,
      "psa": 43.37,
      "qed_weighted": 0.77,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(cc1)C2C(=O)c3ccccc3C2=O",
      "standard_inchi": "InChI=1S/C16H12O3/c1-19-11-8-6-10(7-9-11)14-15(17)12-4-2-3-5-13(12)16(14)18/h2-9,14H,1H3",
      "standard_inchi_key": "XRCFXMGQEVUZFC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Anisindione (BAN, FDA, INN, MI, NF)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "B01AA12",
        "description": "BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Vitamin K antagonists"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL24924",
    "molecule_properties": {
      "acd_logd": 3.12,
      "acd_logp": 3.42,
      "acd_most_apka": 7.42,
      "alogp": 2.99,
      "aromatic_rings": 2,
      "full_molformula": "C15H9FO2",
      "full_mwt": 240.23,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 240.23,
      "mw_monoisotopic": 240.0587,
      "psa": 34.14,
      "qed_weighted": 0.72,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Fc1ccc(cc1)C2C(=O)c3ccccc3C2=O",
      "standard_inchi": "InChI=1S/C15H9FO2/c16-10-7-5-9(6-8-10)13-14(17)11-3-1-2-4-12(11)15(13)18/h1-8,13H",
      "standard_inchi_key": "NASXCEITKQITLD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fluindione (INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL282686",
    "molecule_properties": {
      "acd_logd": -1.92,
      "acd_logp": 1.55,
      "acd_most_apka": 3.62,
      "alogp": 2.68,
      "aromatic_rings": 2,
      "full_molformula": "C20H24O7S",
      "full_mwt": 408.47,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 28,
      "molecular_species": "ACID",
      "mw_freebase": 408.47,
      "mw_monoisotopic": 408.1243,
      "psa": 99.13,
      "qed_weighted": 0.57,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CCO[C@@H](Cc1ccc(OCCc2ccc(OS(=O)(=O)C)cc2)cc1)C(=O)O",
      "standard_inchi": "InChI=1S/C20H24O7S/c1-3-25-19(20(21)22)14-16-6-8-17(9-7-16)26-13-12-15-4-10-18(11-5-15)27-28(2,23)24/h4-11,19H,3,12-14H2,1-2H3,(H,21,22)/t19-/m0/s1",
      "standard_inchi_key": "CXGTZJYQWSUFET-IBGZPJMESA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "AR-H039242XX",
        "BR-44608"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tesaglitazar (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-glitazar",
    "usan_stem_definition": "PPAR agonists (not thiazolidene derivatives)",
    "usan_stem_substem": "-glitazar(-glitazar)",
    "usan_year": 2004
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL25141",
    "molecule_properties": {
      "acd_logd": 1.88,
      "acd_logp": 1.88,
      "alogp": 3.21,
      "aromatic_rings": 1,
      "full_molformula": "C13H12O",
      "full_mwt": 184.24,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 14,
      "mw_freebase": 184.24,
      "mw_monoisotopic": 184.0888,
      "psa": 17.07,
      "qed_weighted": 0.6,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1C2=C(CCCC2)c3ccccc13",
      "standard_inchi": "InChI=1S/C13H12O/c14-13-11-7-3-1-5-9(11)10-6-2-4-8-12(10)13/h1,3,5,7H,2,4,6,8H2",
      "standard_inchi_key": "PWTXAEYNCISTMB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Phentydrone (MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL24955",
    "molecule_properties": {
      "acd_logd": 3.33,
      "acd_logp": 3.33,
      "alogp": 2.99,
      "aromatic_rings": 1,
      "full_molformula": "C14H16ClNO",
      "full_mwt": 249.74,
      "hba": 1,
      "hba_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 249.74,
      "mw_monoisotopic": 249.092,
      "psa": 20.31,
      "qed_weighted": 0.69,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1[C@@H]2CCc3cc(Cl)ccc3[C@H]2CCC1=O",
      "standard_inchi": "InChI=1S/C14H16ClNO/c1-16-13-6-2-9-8-10(15)3-4-11(9)12(13)5-7-14(16)17/h3-4,8,12-13H,2,5-7H2,1H3/t12-,13-/m1/s1",
      "standard_inchi_key": "WQBIOEFDDDEARX-CHWSQXEVSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "LY-191704"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Bexlosteride (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-steride",
    "usan_stem_definition": "testosterone reductase inhibitors",
    "usan_stem_substem": "-steride(-steride)",
    "usan_year": 1998
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Teva Pharmaceuticals Usa",
        "Bristol Myers Squibb",
        "Sandoz Inc",
        "Hetero Labs Ltd Unit V",
        "Par Pharmaceutical Inc",
        "Prinston Pharmaceutical Inc",
        "Zydus Pharmaceuticals Usa Inc",
        "Amneal Pharmaceuticals",
        "Cipla Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J05AF10",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 2005,
    "molecule_chembl_id": "CHEMBL713",
    "molecule_properties": {
      "acd_logd": -1.98,
      "acd_logp": -1.97,
      "acd_most_apka": 9.64,
      "acd_most_bpka": 2.64,
      "alogp": -0.83,
      "aromatic_rings": 2,
      "full_molformula": "C12H15N5O3",
      "full_mwt": 277.28,
      "hba": 7,
      "hba_lipinski": 8,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 277.28,
      "mw_monoisotopic": 277.1175,
      "psa": 130.05,
      "qed_weighted": 0.53,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NC1=Nc2c(ncn2[C@H]3C[C@H](O)[C@@H](CO)C3=C)C(=O)N1",
      "standard_inchi": "InChI=1S/C12H15N5O3/c1-5-6(3-18)8(19)2-7(5)17-4-14-9-10(17)15-12(13)16-11(9)20/h4,6-8,18-19H,1-3H2,(H3,13,15,16,20)/t6-,7-,8-/m0/s1",
      "standard_inchi_key": "QDGZDCVAUDNJFG-FXQIFTODSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "prodrug": true,
    "research_codes": {
      "value": [
        "SQ-34676",
        "BMS-200475-01"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Entecavir (FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-vir",
    "usan_stem_definition": "antivirals: carbocyclic nucleosides",
    "usan_stem_substem": "-vir(-vir(-cavir))",
    "usan_year": 1999
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Lupin Ltd",
        "Silarx Pharmaceuticals Inc",
        "Viiv Healthcare Co",
        "Hetero Labs Ltd Unit Iii",
        "Apotex Inc",
        "Hetero Labs Ltd Unit V",
        "Eci Pharmaceuticals Llc",
        "Pharmacare Ltd",
        "Strides Pharma Global Pte Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J05AF05",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleoside and nucleotide reverse transcriptase inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1995,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL141",
    "molecule_properties": {
      "acd_logd": -0.51,
      "acd_logp": -0.51,
      "acd_most_apka": 13.83,
      "acd_most_bpka": 4.18,
      "alogp": -0.59,
      "aromatic_rings": 1,
      "full_molformula": "C8H11N3O3S",
      "full_mwt": 229.26,
      "hba": 7,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 229.26,
      "mw_monoisotopic": 229.0521,
      "psa": 90.37,
      "qed_weighted": 0.7,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NC1=NC(=O)N(C=C1)[C@@H]2CS[C@H](CO)O2",
      "standard_inchi": "InChI=1S/C8H11N3O3S/c9-5-1-2-11(8(13)10-5)6-4-15-7(3-12)14-6/h1-2,6-7,12H,3-4H2,(H2,9,10,13)/t6-,7+/m0/s1",
      "standard_inchi_key": "JTEGQNOMFQHVDC-NKWVEPMBSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6004968,
    "oral": true,
    "research_codes": {
      "value": "GR-109714X"
    },
    "rule_of_five": true,
    "sc_patent": "US-6004968-A",
    "synonyms": {
      "value": [
        "Lamivudine (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-vudine",
    "usan_stem_definition": "antineoplastics,antivirals (zidovudine group) (exception: edoxudine)",
    "usan_stem_substem": "-vudine(-vudine)",
    "usan_year": 1992
  },
  {
    "applicants": {
      "value": [
        "Copley Pharmaceutical Inc",
        "Genpharm Inc",
        "The Ritedose Corp",
        "Dava Pharmaceuticals Inc",
        "Pliva Inc",
        "Aurobindo Pharma Ltd",
        "Mylan Pharmaceuticals Inc",
        "Teva Pharmaceuticals Usa",
        "Roxane Laboratories Inc",
        "Sun Pharmaceutical Industries Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R03CC02",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS FOR SYSTEMIC USE: Selective beta-2-adrenoreceptor agonist"
        },
        {
          "code": "R03AC02",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Selective beta-2-adrenoreceptor agonists"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1981,
    "indication_class": "Bronchodilator",
    "molecule_chembl_id": "CHEMBL714",
    "molecule_properties": {
      "acd_logd": -1.44,
      "acd_logp": 0.69,
      "acd_most_apka": 9.99,
      "acd_most_bpka": 9.62,
      "alogp": 1.31,
      "aromatic_rings": 1,
      "full_molformula": "C13H21NO3",
      "full_mwt": 239.31,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 17,
      "molecular_species": "BASE",
      "mw_freebase": 239.31,
      "mw_monoisotopic": 239.1521,
      "psa": 72.72,
      "qed_weighted": 0.64,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)NCC(O)c1ccc(O)c(CO)c1",
      "standard_inchi": "InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3",
      "standard_inchi_key": "NDAUXUAQIAJITI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5964416,
    "oral": true,
    "research_codes": {
      "value": [
        "SCH-13949W Sulfate",
        "SCH-13949W"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5964416-A",
    "synonyms": {
      "value": [
        "Albuterol (FDA, USAN, USP)",
        "Salbutamol (BAN, DCF, INN)",
        "Albuterol Sulfate (FDA, USAN, USP)",
        "Salbutamol Sulfate (JAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-terol",
    "usan_stem_definition": "bronchodilators (phenethylamine derivatives)",
    "usan_stem_substem": "-terol(-terol)",
    "usan_year": 1971
  },
  {
    "applicants": {
      "value": [
        "Torrent Pharmaceuticals Ltd",
        "Jubilant Generics Ltd",
        "Eli Lilly And Co",
        "Ajanta Pharma Ltd",
        "Invagen Pharmaceuticals Inc",
        "Aurobindo Pharma Ltd",
        "Par Pharmaceutical Inc",
        "Teva Pharmaceuticals Usa",
        "Torrent Pharmaceuticals Llc",
        "Alkem Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AH03",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1996,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL715",
    "molecule_properties": {
      "acd_logd": 2.35,
      "acd_logp": 3.08,
      "acd_most_bpka": 7.78,
      "alogp": 3.44,
      "aromatic_rings": 2,
      "full_molformula": "C17H20N4S",
      "full_mwt": 312.44,
      "hba": 5,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 312.44,
      "mw_monoisotopic": 312.1409,
      "psa": 30.87,
      "qed_weighted": 0.81,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN(CC1)C2=Nc3ccccc3Nc4sc(C)cc24",
      "standard_inchi": "InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3",
      "standard_inchi_key": "KVWDHTXUZHCGIO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5945416,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": "LY-170053"
    },
    "rule_of_five": true,
    "sc_patent": "US-5945416-A",
    "synonyms": {
      "value": [
        "Olanzapine (BAN, FDA, INN, USAN)",
        "Olanzapine Pamoate (FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-pin(e)",
    "usan_stem_definition": "tricyclic compounds",
    "usan_stem_substem": "-pin(e)(-pin(e))",
    "usan_year": 1992
  },
  {
    "applicants": {
      "value": [
        "Novast Laboratories Ltd",
        "Torrent Pharmaceuticals Ltd",
        "Jubilant Generics Ltd",
        "West-Ward Pharmaceuticals International Ltd",
        "Par Pharmaceutical Inc",
        "Aurobindo Pharma Ltd",
        "Teva Pharmaceuticals Usa",
        "Lupin Ltd",
        "Intellipharmaceutics Corp",
        "Astrazeneca Pharmaceuticals Lp"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AH04",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Diazepines, oxazepines, thiazepines and oxepines"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1997,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL716",
    "molecule_properties": {
      "acd_logd": 2.51,
      "acd_logp": 2.6,
      "acd_most_bpka": 6.74,
      "alogp": 2.86,
      "aromatic_rings": 2,
      "full_molformula": "C21H25N3O2S",
      "full_mwt": 383.52,
      "hba": 6,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 383.52,
      "mw_monoisotopic": 383.1667,
      "psa": 48.3,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "OCCOCCN1CCN(CC1)C2=Nc3ccccc3Sc4ccccc24",
      "standard_inchi": "InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2",
      "standard_inchi_key": "URKOMYMAXPYINW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5948437,
    "oral": true,
    "research_codes": {
      "value": [
        "ICI-204636",
        "ZM-204636",
        "ZD-5077"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5948437-A",
    "synonyms": {
      "value": [
        "Quetiapine (BAN, INN)",
        "Quetiapine Fumarate (FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-tiapine",
    "usan_stem_definition": "antipsychotics (dibenzothiazepine derivatives)",
    "usan_stem_substem": "-tiapine(-tiapine)",
    "usan_year": 1996
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05AX11",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Other antipsychotics"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL285802",
    "molecule_properties": {
      "acd_logd": 4.1,
      "acd_logp": 5.43,
      "acd_most_bpka": 8.72,
      "alogp": 4.88,
      "aromatic_rings": 2,
      "full_molformula": "C18H18ClNOS",
      "full_mwt": 331.87,
      "hba": 3,
      "hba_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 331.87,
      "mw_monoisotopic": 331.0798,
      "psa": 12.47,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCOC1=Cc2ccccc2Sc3ccc(Cl)cc13",
      "standard_inchi": "InChI=1S/C18H18ClNOS/c1-20(2)9-10-21-16-11-13-5-3-4-6-17(13)22-18-8-7-14(19)12-15(16)18/h3-8,11-12H,9-10H2,1-2H3",
      "standard_inchi_key": "HDOZVRUNCMBHFH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Zotepine (BAN, INN, JAN, MI)",
        null
      ]
    },
    "usan_stem": "-pin(e)",
    "usan_stem_definition": "tricyclic compounds",
    "usan_stem_substem": "-pin(e)(-pin(e))"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05BA03",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANXIOLYTICS: Benzodiazepine derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Tranquilizer (minor)",
    "molecule_chembl_id": "CHEMBL28333",
    "molecule_properties": {
      "acd_logd": 3.88,
      "acd_logp": 3.89,
      "acd_most_bpka": 6.18,
      "alogp": 3.63,
      "aromatic_rings": 2,
      "full_molformula": "C16H15ClN2",
      "full_mwt": 270.76,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 270.76,
      "mw_monoisotopic": 270.0924,
      "psa": 15.6,
      "qed_weighted": 0.77,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN=C(c2ccccc2)c3cc(Cl)ccc13",
      "standard_inchi": "InChI=1S/C16H15ClN2/c1-19-10-9-18-16(12-5-3-2-4-6-12)14-11-13(17)7-8-15(14)19/h2-8,11H,9-10H2,1H3",
      "standard_inchi_key": "YLCXGBZIZBEVPZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "Ro-54556"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Medazepam (JAN, BAN, INN, JAN)",
        "Medazepam HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-azepam",
    "usan_stem_definition": "antianxiety agents (diazepam type)",
    "usan_stem_substem": "-azepam(-azepam)",
    "usan_year": 1968
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL27926",
    "molecule_properties": {
      "acd_logd": 3.06,
      "acd_logp": 5.18,
      "acd_most_bpka": 9.56,
      "alogp": 4.32,
      "aromatic_rings": 2,
      "full_molformula": "C22H25NO2",
      "full_mwt": 335.45,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 25,
      "molecular_species": "BASE",
      "mw_freebase": 335.45,
      "mw_monoisotopic": 335.1885,
      "psa": 21.7,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "C(C1CCCc2c3OCOc3ccc12)N4CCC(C4)c5ccccc5",
      "standard_inchi": "InChI=1S/C22H25NO2/c1-2-5-16(6-3-1)17-11-12-23(13-17)14-18-7-4-8-20-19(18)9-10-21-22(20)25-15-24-21/h1-3,5-6,9-10,17-18H,4,7-8,11-15H2",
      "standard_inchi_key": "HAEPGZUGYMHCJE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "A-75200 Mesylate"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Napitane (INN)",
        "Napitane Mesylate (USAN)",
        null
      ]
    },
    "usan_year": 1996
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL283639",
    "molecule_properties": {
      "acd_logd": 4.75,
      "acd_logp": 4.75,
      "acd_most_bpka": 5.18,
      "alogp": 4.33,
      "aromatic_rings": 2,
      "full_molformula": "C20H26N2O3",
      "full_mwt": 342.44,
      "hba": 5,
      "hba_lipinski": 5,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 342.44,
      "mw_monoisotopic": 342.1943,
      "psa": 56.85,
      "qed_weighted": 0.6,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cc(CCCCCCCOc2ccc(cc2)C3=NCCO3)on1",
      "standard_inchi": "InChI=1S/C20H26N2O3/c1-16-15-19(25-22-16)7-5-3-2-4-6-13-23-18-10-8-17(9-11-18)20-21-12-14-24-20/h8-11,15H,2-7,12-14H2,1H3",
      "standard_inchi_key": "FKLJPTJMIBLJAV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "WIN-51711"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Disoxaril (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-aril",
    "usan_stem_definition": "antiviral (arildone derivatives)",
    "usan_stem_substem": "-aril(-aril)",
    "usan_year": 1987
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Estrogen",
    "molecule_chembl_id": "CHEMBL28211",
    "molecule_properties": {
      "acd_logd": 3.45,
      "acd_logp": 5.63,
      "acd_most_bpka": 9.63,
      "alogp": 6.08,
      "aromatic_rings": 3,
      "full_molformula": "C29H31NO2",
      "full_mwt": 425.57,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 32,
      "molecular_species": "BASE",
      "mw_freebase": 425.57,
      "mw_monoisotopic": 425.2355,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 21.7,
      "qed_weighted": 0.46,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2C(=C(CCc2c1)c3ccccc3)c4ccc(OCCN5CCCC5)cc4",
      "standard_inchi": "InChI=1S/C29H31NO2/c1-31-26-14-16-28-24(21-26)11-15-27(22-7-3-2-4-8-22)29(28)23-9-12-25(13-10-23)32-20-19-30-17-5-6-18-30/h2-4,7-10,12-14,16,21H,5-6,11,15,17-20H2,1H3",
      "standard_inchi_key": "JEYWNNAZDLFBFF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "U-11100A",
        "U-11000A"
      ]
    },
    "synonyms": {
      "value": [
        "Nafoxidine (INN)",
        "Nafoxidine HCl (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-fo-",
    "usan_stem_definition": "phosphoro-derivatives",
    "usan_stem_substem": "-fo-(-fo-)",
    "usan_year": 1965
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Solvay Pharmaceuticals",
        "Sandoz Inc",
        "Teva Pharmaceuticals Usa Inc",
        "Pharmacia And Upjohn Co",
        "Pharmacia And Upjohn Sub Pfizer Inc",
        "Amarin Pharmaceuticals Inc",
        "Barr Laboratories Inc",
        "Amphastar Pharmaceuticals Inc",
        "Esi Pharmacal"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "L02AB02",
          "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONES AND RELATED AGENTS: Progestogen"
        },
        {
          "code": "G03DA02",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: PROGESTOGENS: Pregnen (4) derivative"
        },
        {
          "code": "G03AC06",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: HORMONAL CONTRACEPTIVES FOR SYSTEMIC USE: Progestogens"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1959,
    "indication_class": "Progestin",
    "molecule_chembl_id": "CHEMBL717",
    "molecule_properties": {
      "acd_logd": 4.17,
      "acd_logp": 4.17,
      "alogp": 4.66,
      "full_molformula": "C24H34O4",
      "full_mwt": 386.53,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 28,
      "mw_freebase": 386.53,
      "mw_monoisotopic": 386.2457,
      "psa": 60.44,
      "qed_weighted": 0.65,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H]1C[C@@H]2[C@H](CC[C@@]3(C)[C@H]2CC[C@]3(OC(=O)C)C(=O)C)[C@@]4(C)CCC(=O)C=C14",
      "standard_inchi": "InChI=1S/C24H34O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h13-14,18-20H,6-12H2,1-5H3/t14-,18+,19-,20-,22+,23-,24-/m0/s1",
      "standard_inchi_key": "PSGAAPLEWMOORI-PEINSRQWSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6495534,
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-6495534-B2",
    "synonyms": {
      "value": [
        "Medroxyprogesterone (BAN, INN)",
        "Medroxyprogesterone acetate (FDA, JAN, USP)",
        null
      ]
    },
    "usan_stem": "-gest-",
    "usan_stem_definition": "progestins",
    "usan_stem_substem": "-gest-(-gest-)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL27114",
    "molecule_properties": {
      "acd_logd": 2.15,
      "acd_logp": 2.16,
      "acd_most_apka": 10.53,
      "acd_most_bpka": 5.58,
      "alogp": 2.02,
      "full_molformula": "C14H23Cl2N3O2",
      "full_mwt": 336.26,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 336.26,
      "mw_monoisotopic": 335.1167,
      "psa": 52.65,
      "qed_weighted": 0.57,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "ClCCN(CCCl)CCN1C(=O)NC2(CCCCC2)C1=O",
      "standard_inchi": "InChI=1S/C14H23Cl2N3O2/c15-6-8-18(9-7-16)10-11-19-12(20)14(17-13(19)21)4-2-1-3-5-14/h1-11H2,(H,17,21)",
      "standard_inchi_key": "QNKJFXARIMSDBR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Spiromustine (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-mustine",
    "usan_stem_definition": "antineoplastics (chloroethylamine derivatives)",
    "usan_stem_substem": "-mustine(-mustine)",
    "usan_year": 1981
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C02AB02",
        "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Methyldopa"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL718",
    "molecule_properties": {
      "acd_logd": -3.26,
      "acd_logp": -0.74,
      "acd_most_apka": 2.28,
      "acd_most_bpka": 8.85,
      "alogp": 0.44,
      "aromatic_rings": 1,
      "full_molformula": "C10H13NO4",
      "full_mwt": 211.22,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 15,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 211.22,
      "mw_monoisotopic": 211.0845,
      "psa": 103.78,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(N)(Cc1ccc(O)c(O)c1)C(=O)O",
      "standard_inchi": "InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)",
      "standard_inchi_key": "CJCSPKMFHVPWAR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": "Methyldopa (racemic)"
    },
    "usan_stem": "-dopa",
    "usan_stem_definition": "dopamine receptor agonists",
    "usan_stem_substem": "-dopa(-dopa)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL25146",
    "molecule_properties": {
      "acd_logd": -1.9,
      "acd_logp": 1.14,
      "acd_most_apka": 4.09,
      "alogp": 2.13,
      "aromatic_rings": 2,
      "full_molformula": "C15H13NO3",
      "full_mwt": 255.27,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 19,
      "molecular_species": "ACID",
      "mw_freebase": 255.27,
      "mw_monoisotopic": 255.0895,
      "psa": 80.39,
      "qed_weighted": 0.65,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1c(CC(=O)O)cccc1C(=O)c2ccccc2",
      "standard_inchi": "InChI=1S/C15H13NO3/c16-14-11(9-13(17)18)7-4-8-12(14)15(19)10-5-2-1-3-6-10/h1-8H,9,16H2,(H,17,18)",
      "standard_inchi_key": "SOYCMDCMZDHQFP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "AHR-5850D"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Amfenac (BAN, INN)",
        "Amfenac Sodium (JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-ac",
    "usan_stem_definition": "anti-inflammatory agents (acetic acid derivatives)",
    "usan_stem_substem": "-ac(-ac)",
    "usan_year": 1977
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Radioactive Agent",
    "molecule_chembl_id": "CHEMBL24132",
    "molecule_properties": {
      "acd_logd": 0.92,
      "acd_logp": 0.92,
      "alogp": 2.09,
      "aromatic_rings": 2,
      "full_molformula": "C11H11IN2O",
      "full_mwt": 314.13,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 314.13,
      "mw_monoisotopic": 313.9916,
      "psa": 26.93,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1N(C(=O)C(=C1C)I)c2ccccc2",
      "standard_inchi": "InChI=1S/C11H11IN2O/c1-8-10(12)11(15)14(13(8)2)9-6-4-3-5-7-9/h3-7H,1-2H3",
      "standard_inchi_key": "ZZOBLCHCPLOXCE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Iodoantipyrine I 131 (USAN)",
        null
      ]
    },
    "usan_stem": "io-",
    "usan_stem_definition": "iodine-containing contrast media",
    "usan_stem_substem": "io-(io-)",
    "usan_year": 1963
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "A14AA01",
          "description": "ALIMENTARY TRACT AND METABOLISM: ANABOLIC AGENTS FOR SYSTEMIC USE: ANABOLIC STEROIDS: Androstan derivative"
        },
        {
          "code": "G03BB02",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM: ANDROGENS: 5-androstanon (3) derivatives"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL27769",
    "molecule_properties": {
      "acd_logd": 3.93,
      "acd_logp": 3.93,
      "alogp": 3.96,
      "full_molformula": "C19H30O2",
      "full_mwt": 290.45,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 290.45,
      "mw_monoisotopic": 290.2246,
      "psa": 37.3,
      "qed_weighted": 0.73,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@]12CC[C@H]3[C@@H](CC[C@H]4CC(=O)CC[C@]34C)[C@@H]1CC[C@@H]2O",
      "standard_inchi": "InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1",
      "standard_inchi_key": "NVKAWKQGWWIWPM-ABEVXSGRSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Androstanolone (BAN, INN)",
        "Stanolone (MI)",
        null
      ]
    },
    "usan_stem": "-olone",
    "usan_stem_definition": "steroids (not prednisolone derivatives)",
    "usan_stem_substem": "-olone(-olone)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05AD06",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Butyrophenone derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL28218",
    "molecule_properties": {
      "acd_logd": 3.2,
      "acd_logp": 4.03,
      "acd_most_apka": 13.86,
      "acd_most_bpka": 8.04,
      "alogp": 4.53,
      "aromatic_rings": 2,
      "full_molformula": "C21H23BrFNO2",
      "full_mwt": 420.32,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 420.32,
      "mw_monoisotopic": 419.0896,
      "psa": 40.54,
      "qed_weighted": 0.7,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Br)cc3",
      "standard_inchi": "InChI=1S/C21H23BrFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",
      "standard_inchi_key": "RKLNONIVDFXQRX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "R-11333"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Bromperidol (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-peridol",
    "usan_stem_definition": "antipsychotics (haloperidol type)",
    "usan_stem_substem": "-peridol(-peridol)",
    "usan_year": 1975
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anesthetic (local)",
    "molecule_chembl_id": "CHEMBL280802",
    "molecule_properties": {
      "acd_logd": 0.75,
      "acd_logp": 0.75,
      "acd_most_apka": 9.93,
      "alogp": 0.88,
      "aromatic_rings": 1,
      "full_molformula": "C7H8O2",
      "full_mwt": 124.14,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 9,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 124.14,
      "mw_monoisotopic": 124.0524,
      "psa": 40.46,
      "qed_weighted": 0.58,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "OCc1ccccc1O",
      "standard_inchi": "InChI=1S/C7H8O2/c8-5-6-3-1-2-4-7(6)9/h1-4,8-9H,5H2",
      "standard_inchi_key": "CQRYARSYNCAZFO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Salicyl alcohol (USAN)",
        null
      ]
    },
    "usan_stem": "sal-",
    "usan_stem_definition": "anti-inflammatory agents (salicylic acid derivatives)",
    "usan_stem_substem": "sal-(sal-)",
    "usan_year": 1979
  },
  {
    "applicants": {
      "value": [
        "Taro Pharmaceuticals Usa Inc",
        "Perrigo New York Inc",
        "Fougera Pharmaceuticals Inc",
        "Glenmark Pharmaceuticals Inc Usa",
        "Teva Pharmaceuticals Usa Inc",
        "Glaxosmithkline"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D06AX09",
          "description": "DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: ANTIBIOTICS FOR TOPICAL USE: Other antibiotics for topical us"
        },
        {
          "code": "R01AX06",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Other nasal preparations"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1987,
    "indication_class": "Antibacterial (topical)",
    "molecule_chembl_id": "CHEMBL719",
    "molecule_properties": {
      "acd_logd": -0.36,
      "acd_logp": 2.24,
      "acd_most_apka": 4.78,
      "alogp": 2.59,
      "full_molformula": "C26H44O9",
      "full_mwt": 500.63,
      "hba": 8,
      "hba_lipinski": 9,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 35,
      "molecular_species": "ACID",
      "mw_freebase": 500.63,
      "mw_monoisotopic": 500.2985,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 146.05,
      "qed_weighted": 0.11,
      "ro3_pass": "N",
      "rtb": 16
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@H]2CO[C@@H](C\\C(=C\\C(=O)OCCCCCCCCC(=O)O)\\C)[C@H](O)[C@@H]2O",
      "standard_inchi": "InChI=1S/C26H44O9/c1-16(13-23(30)33-11-9-7-5-4-6-8-10-22(28)29)12-20-25(32)24(31)19(15-34-20)14-21-26(35-21)17(2)18(3)27/h13,17-21,24-27,31-32H,4-12,14-15H2,1-3H3,(H,28,29)/b16-13+/t17-,18-,19-,20-,21-,24+,25-,26-/m0/s1",
      "standard_inchi_key": "MINDHVHHQZYEEK-HBBNESRFSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6013657,
    "research_codes": {
      "value": [
        "BRL-4910A",
        "BRL-4910F"
      ]
    },
    "sc_patent": "US-6013657-A",
    "synonyms": {
      "value": [
        "Mupirocin (BAN, FDA, INN, USAN, USP)",
        "Mupirocin Calcium (FDA, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-rocin",
    "usan_stem_definition": "t-RNA synthetase inhibitors",
    "usan_stem_substem": "-rocin(-rocin)",
    "usan_year": 1986
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Synergist (non-specific)",
    "molecule_chembl_id": "CHEMBL282567",
    "molecule_properties": {
      "acd_logd": 2.92,
      "acd_logp": 4.71,
      "acd_most_bpka": 9.2,
      "alogp": 4.66,
      "aromatic_rings": 2,
      "full_molformula": "C23H31NO2",
      "full_mwt": 353.51,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 26,
      "molecular_species": "BASE",
      "mw_freebase": 353.51,
      "mw_monoisotopic": 353.2355,
      "psa": 29.54,
      "qed_weighted": 0.58,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c2ccccc2",
      "standard_inchi": "InChI=1S/C23H31NO2/c1-4-17-23(20-13-9-7-10-14-20,21-15-11-8-12-16-21)22(25)26-19-18-24(5-2)6-3/h7-16H,4-6,17-19H2,1-3H3",
      "standard_inchi_key": "SNTQPLDRUZOSDP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "RP-5171",
        "SK&F-525A"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Proadifen HCl (USAN)",
        "Proadifen (INN)",
        null
      ]
    },
    "usan_year": 1964
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "N02BA55",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Salicylic acid and derivative"
        },
        {
          "code": "N02BA75",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Salicylic acid and derivative"
        },
        {
          "code": "N02BA05",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Salicylic acid and derivatives"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Analgesic",
    "molecule_chembl_id": "CHEMBL27577",
    "molecule_properties": {
      "acd_logd": 1.3,
      "acd_logp": 1.35,
      "acd_most_apka": 8.37,
      "alogp": 0.49,
      "aromatic_rings": 1,
      "full_molformula": "C7H7NO2",
      "full_mwt": 137.14,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 10,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 137.14,
      "mw_monoisotopic": 137.0477,
      "psa": 63.32,
      "qed_weighted": 0.59,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=O)c1ccccc1O",
      "standard_inchi": "InChI=1S/C7H7NO2/c8-7(10)5-3-1-2-4-6(5)9/h1-4,9H,(H2,8,10)",
      "standard_inchi_key": "SKZKKFZAGNVIMN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Salicylamide (BAN, INN, JAN, USP)",
        null
      ]
    },
    "usan_stem": "sal-",
    "usan_stem_definition": "anti-inflammatory agents (salicylic acid derivatives)",
    "usan_stem_substem": "sal-(sal-)"
  },
  {
    "applicants": {
      "value": "Shionogi Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "P03AX06",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES, INSECTICIDES AND REPELLENTS: ECTOPARASITICIDES, INCL. SCABICIDES: Other ectoparasiticides, incl. scabicides"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2009,
    "indication_class": "Pharmaceutic Aid (antimicrobial agent)",
    "molecule_chembl_id": "CHEMBL720",
    "molecule_properties": {
      "acd_logd": 1.05,
      "acd_logp": 1.05,
      "alogp": 1.18,
      "aromatic_rings": 1,
      "full_molformula": "C7H8O",
      "full_mwt": 108.14,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 8,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 108.14,
      "mw_monoisotopic": 108.0575,
      "psa": 20.23,
      "qed_weighted": 0.57,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "OCc1ccccc1",
      "standard_inchi": "InChI=1S/C7H8O/c8-6-7-4-2-1-3-5-7/h1-5,8H,6H2",
      "standard_inchi_key": "WVDDGKGOMKODPV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5858383,
    "rule_of_five": true,
    "sc_patent": "US-5858383-A",
    "synonyms": {
      "value": [
        "Benzyl alcohol (FDA, INN, JAN, NF)",
        null
      ]
    },
    "topical": true
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "N02BB74",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Pyrazolone"
        },
        {
          "code": "N02BB54",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Pyrazolone"
        },
        {
          "code": "N02BB04",
          "description": "NERVOUS SYSTEM: ANALGESICS: OTHER ANALGESICS AND ANTIPYRETICS: Pyrazolones"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL28318",
    "molecule_properties": {
      "acd_logd": 1.72,
      "acd_logp": 1.72,
      "acd_most_bpka": 1.46,
      "alogp": 2.61,
      "aromatic_rings": 2,
      "full_molformula": "C14H18N2O",
      "full_mwt": 230.31,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 230.31,
      "mw_monoisotopic": 230.1419,
      "psa": 26.93,
      "qed_weighted": 0.78,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)C1=C(C)N(C)N(C1=O)c2ccccc2",
      "standard_inchi": "InChI=1S/C14H18N2O/c1-10(2)13-11(3)15(4)16(14(13)17)12-8-6-5-7-9-12/h5-10H,1-4H3",
      "standard_inchi_key": "PXWLVJLKJGVOKE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Isopropylantipyrine (JAN)",
        "Propyphenazone (BAN, DCF, INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL282614",
    "molecule_properties": {
      "acd_logd": -0.37,
      "acd_logp": 0.86,
      "acd_most_bpka": 8.91,
      "alogp": 0.87,
      "aromatic_rings": 1,
      "full_molformula": "C12H16N2O2",
      "full_mwt": 220.27,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "BASE",
      "mw_freebase": 220.27,
      "mw_monoisotopic": 220.1212,
      "psa": 33.73,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "C1CN(CCN1)c2cccc3OCCOc23",
      "standard_inchi": "InChI=1S/C12H16N2O2/c1-2-10(14-6-4-13-5-7-14)12-11(3-1)15-8-9-16-12/h1-3,13H,4-9H2",
      "standard_inchi_key": "WVLHGCRWEHCIOT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "DU-28853"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Eltoprazine (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Inhibitor (thromboxanesynthetase)",
    "molecule_chembl_id": "CHEMBL283656",
    "molecule_properties": {
      "acd_logd": -1.02,
      "acd_logp": 1.67,
      "acd_most_apka": 4.57,
      "acd_most_bpka": 6.92,
      "alogp": 2.67,
      "aromatic_rings": 3,
      "full_molformula": "C16H17N3O2",
      "full_mwt": 283.33,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "ACID",
      "mw_freebase": 283.33,
      "mw_monoisotopic": 283.1321,
      "psa": 60.05,
      "qed_weighted": 0.78,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1c(Cn2ccnc2)c3ccccc3n1CCC(=O)O",
      "standard_inchi": "InChI=1S/C16H17N3O2/c1-12-14(10-18-9-7-17-11-18)13-4-2-3-5-15(13)19(12)8-6-16(20)21/h2-5,7,9,11H,6,8,10H2,1H3,(H,20,21)",
      "standard_inchi_key": "DEQLGSOHGTZKFB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "UK-38485"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dazmegrel (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-grel",
    "usan_stem_definition": "platelet aggregation inhibitors",
    "usan_stem_substem": "-grel(-grel)",
    "usan_year": 1984
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL26479",
    "molecule_properties": {
      "acd_logd": 2.07,
      "acd_logp": 4.2,
      "acd_most_bpka": 9.57,
      "alogp": 3.45,
      "aromatic_rings": 2,
      "full_molformula": "C20H23NO2",
      "full_mwt": 309.41,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 23,
      "molecular_species": "BASE",
      "mw_freebase": 309.41,
      "mw_monoisotopic": 309.1729,
      "psa": 30.49,
      "qed_weighted": 0.94,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "C1CCC(NC1)C2COC(O2)(c3ccccc3)c4ccccc4",
      "standard_inchi": "InChI=1S/C20H23NO2/c1-3-9-16(10-4-1)20(17-11-5-2-6-12-17)22-15-19(23-20)18-13-7-8-14-21-18/h1-6,9-12,18-19,21H,7-8,13-15H2",
      "standard_inchi_key": "HGKAMARNFGKMLC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CL-639C"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dioxadrol (INN)",
        "Dioxadrol HCl (USAN)",
        null
      ]
    },
    "usan_year": 1962
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL26424",
    "molecule_properties": {
      "acd_logd": 2.21,
      "acd_logp": 4.4,
      "acd_most_bpka": 9.64,
      "alogp": 4,
      "aromatic_rings": 2,
      "full_molformula": "C19H25NO",
      "full_mwt": 283.41,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 283.41,
      "mw_monoisotopic": 283.1936,
      "psa": 12.47,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCOc1ccc(Cc2ccccc2)cc1",
      "standard_inchi": "InChI=1S/C19H25NO/c1-3-20(4-2)14-15-21-19-12-10-18(11-13-19)16-17-8-6-5-7-9-17/h5-13H,3-4,14-16H2,1-2H3",
      "standard_inchi_key": "NFIXBCVWIPOYCD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "BMY-33419",
        "DPPE",
        "BMS-217380-01"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tesmilifene (INN)",
        "Tesmilifene HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-ifene",
    "usan_stem_definition": "antiestrogens of the clomifene and tamoxifen groups",
    "usan_stem_substem": "-ifene(-ifene)",
    "usan_year": 1998
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL27507",
    "molecule_properties": {
      "acd_logd": 4.68,
      "acd_logp": 5.55,
      "acd_most_bpka": 8.21,
      "alogp": 5.23,
      "aromatic_rings": 3,
      "full_molformula": "C27H29NO3",
      "full_mwt": 415.53,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 31,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 415.53,
      "mw_monoisotopic": 415.2147,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 30.93,
      "qed_weighted": 0.53,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "C(Cc1ccc2OCOc2c1)N3CCC[C@H](C3)OC(c4ccccc4)c5ccccc5",
      "standard_inchi": "InChI=1S/C27H29NO3/c1-3-8-22(9-4-1)27(23-10-5-2-6-11-23)31-24-12-7-16-28(19-24)17-15-21-13-14-25-26(18-21)30-20-29-25/h1-6,8-11,13-14,18,24,27H,7,12,15-17,19-20H2/t24-/m1/s1",
      "standard_inchi_key": "BDNFQGRSKSQXRI-XMMPIXPASA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "UK-766542 [As Fumarate]"
    },
    "synonyms": {
      "value": [
        "Zamifenacin (INN)",
        null
      ]
    },
    "usan_stem": "-fenacin",
    "usan_stem_definition": "muscarinic receptor antagonists",
    "usan_stem_substem": "-fenacin(-fenacin)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL27759",
    "molecule_properties": {
      "acd_logd": 3.37,
      "acd_logp": 3.37,
      "acd_most_apka": 11.32,
      "acd_most_bpka": 4.32,
      "alogp": 3.34,
      "aromatic_rings": 3,
      "full_molformula": "C21H20N4O3",
      "full_mwt": 376.42,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 376.42,
      "mw_monoisotopic": 376.1535,
      "psa": 106.34,
      "qed_weighted": 0.57,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ccccc1NC(=O)c2ccc(CNC(=O)OCc3cccnc3)cc2",
      "standard_inchi": "InChI=1S/C21H20N4O3/c22-18-5-1-2-6-19(18)25-20(26)17-9-7-15(8-10-17)13-24-21(27)28-14-16-4-3-11-23-12-16/h1-12H,13-14,22H2,(H,24,27)(H,25,26)",
      "standard_inchi_key": "INVTYAOGFAGBOE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "SNDX-275",
        "MS-275"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Entinostat (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors: inhibitors of histone deacetylase",
    "usan_stem_substem": "-stat(-stat(-inostat))",
    "usan_year": 2008
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Coccidiostat",
    "molecule_chembl_id": "CHEMBL27999",
    "molecule_properties": {
      "acd_logd": 3.48,
      "acd_logp": 4.44,
      "acd_most_apka": 6.45,
      "alogp": 3.34,
      "aromatic_rings": 3,
      "full_molformula": "C17H14ClN3O2S",
      "full_mwt": 359.84,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "ACID",
      "mw_freebase": 359.84,
      "mw_monoisotopic": 359.0495,
      "psa": 67.75,
      "qed_weighted": 0.78,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cc(cc(C)c1Sc2ccc(Cl)cc2)N3N=CC(=O)NC3=O",
      "standard_inchi": "InChI=1S/C17H14ClN3O2S/c1-10-7-13(21-17(23)20-15(22)9-19-21)8-11(2)16(10)24-14-5-3-12(18)4-6-14/h3-9H,1-2H3,(H,20,22,23)",
      "standard_inchi_key": "YLEMUUWGEWKCGK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CP-25673"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tiazuril (INN, USAN)",
        null
      ]
    },
    "usan_year": 1972
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL27077",
    "molecule_properties": {
      "acd_logd": 0.56,
      "acd_logp": 2.62,
      "acd_most_apka": 13.76,
      "acd_most_bpka": 9.39,
      "alogp": 2.21,
      "aromatic_rings": 2,
      "full_molformula": "C16H22N2O2",
      "full_mwt": 274.36,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 274.36,
      "mw_monoisotopic": 274.1681,
      "psa": 46.42,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)COc1ccccc1n2cccc2",
      "standard_inchi": "InChI=1S/C16H22N2O2/c1-13(2)17-11-14(19)12-20-16-8-4-3-7-15(16)18-9-5-6-10-18/h3-10,13-14,17,19H,11-12H2,1-2H3",
      "standard_inchi_key": "XVTVPGKWYHWYAD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Isamoltan (INN)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C07AB08",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Anti-Adrenergic (beta-receptor)",
    "molecule_chembl_id": "CHEMBL27810",
    "molecule_properties": {
      "acd_logd": -0.22,
      "acd_logp": 1.92,
      "acd_most_apka": 13.81,
      "acd_most_bpka": 9.5,
      "alogp": 2.89,
      "aromatic_rings": 1,
      "full_molformula": "C20H33N3O4",
      "full_mwt": 379.5,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 27,
      "molecular_species": "BASE",
      "mw_freebase": 379.5,
      "mw_monoisotopic": 379.2471,
      "psa": 90.9,
      "qed_weighted": 0.57,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)C(=O)Nc1ccc(OCC(O)CNC(C)(C)C)c(c1)C(=O)C",
      "standard_inchi": "InChI=1S/C20H33N3O4/c1-7-23(8-2)19(26)22-15-9-10-18(17(11-15)14(3)24)27-13-16(25)12-21-20(4,5)6/h9-11,16,21,25H,7-8,12-13H2,1-6H3,(H,22,26)",
      "standard_inchi_key": "JOATXPAWOHTVSZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Celiprolol (BAN, INN)",
        "Celiprolol HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1981
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL26984",
    "molecule_properties": {
      "acd_logd": -0.4,
      "acd_logp": 1.71,
      "acd_most_apka": 13.78,
      "acd_most_bpka": 9.74,
      "alogp": 2.72,
      "aromatic_rings": 2,
      "full_molformula": "C20H29N5O3",
      "full_mwt": 387.48,
      "hba": 6,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 28,
      "molecular_species": "BASE",
      "mw_freebase": 387.48,
      "mw_monoisotopic": 387.227,
      "psa": 88.61,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCNC(=O)NC1CCN(CC1)c2ncnc3cc(OC)c(OC)cc23",
      "standard_inchi": "InChI=1S/C20H29N5O3/c1-4-5-8-21-20(26)24-14-6-9-25(10-7-14)19-15-11-17(27-2)18(28-3)12-16(15)22-13-23-19/h11-14H,4-10H2,1-3H3,(H2,21,24,26)",
      "standard_inchi_key": "CPZHDDGPHQRMEJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Buquineran (BAN, INN)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C07AA16",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, non-selective"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL434200",
    "molecule_properties": {
      "acd_logd": -1.04,
      "acd_logp": 1.03,
      "acd_most_apka": 13.84,
      "acd_most_bpka": 9.52,
      "alogp": 2.85,
      "aromatic_rings": 1,
      "full_molformula": "C16H25NO2S",
      "full_mwt": 295.45,
      "hba": 4,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 295.45,
      "mw_monoisotopic": 295.1606,
      "psa": 41.49,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)NCC(O)COc1cccc2CCCSc12",
      "standard_inchi": "InChI=1S/C16H25NO2S/c1-16(2,3)17-10-13(18)11-19-14-8-4-6-12-7-5-9-20-15(12)14/h4,6,8,13,17-18H,5,7,9-11H2,1-3H3",
      "standard_inchi_key": "HTWFXPCUFWKXOP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "S-2395"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tertatolol (BAN, INN, MI)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)"
  },
  {
    "applicants": {
      "value": [
        "Pliva Hrvatska Doo",
        "Lupin Ltd",
        "Apotex Inc Etobicoke Site",
        "Sun Pharmaceutical Industries Inc",
        "Wockhardt Ltd",
        "Sandoz Inc",
        "Smithkline Beecham (Cork) Ltd Ireland",
        "Glenmark Generics Ltd",
        "Teva Pharmaceuticals Usa Inc",
        "Caraco Pharmaceutical Laboratories Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C07AG02",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Alpha and beta blocking agents"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1995,
    "indication_class": "Antihypertensive; Anti-Anginal",
    "molecule_chembl_id": "CHEMBL723",
    "molecule_properties": {
      "acd_logd": 3.06,
      "acd_logp": 4.07,
      "acd_most_apka": 13.9,
      "acd_most_bpka": 8.24,
      "alogp": 3.74,
      "aromatic_rings": 4,
      "full_molformula": "C24H26N2O4",
      "full_mwt": 406.48,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 30,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 406.48,
      "mw_monoisotopic": 406.1893,
      "psa": 75.74,
      "qed_weighted": 0.35,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccccc1OCCNCC(O)COc2cccc3[nH]c4ccccc4c23",
      "standard_inchi": "InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",
      "standard_inchi_key": "OGHNVEJMJSYVRP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7268156,
    "oral": true,
    "research_codes": {
      "value": [
        "BM-14-190",
        "SK&F-105517-D",
        "BM-14.190",
        "BM 14.190"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-7268156-B2",
    "synonyms": {
      "value": [
        "Carvedilol (BAN, FDA, INN, JAN, USAN)",
        "Carvedilol Phosphate (FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-dil-",
    "usan_stem_definition": "vasodilators (undefined group)",
    "usan_stem_substem": "-dil-(-dil-)",
    "usan_year": 1988
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Lannett Holdings Inc",
        "Apothecon Inc Div Bristol Myers Squibb",
        "Sandoz Inc",
        "Schering Corp Sub Schering Plough Corp",
        "Watson Laboratories Inc",
        "Ani Pharmaceuticals Inc",
        "Mylan Pharmaceuticals Inc",
        "Pharmaceutical Associates Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AB02",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperazine structure"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1959,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL726",
    "molecule_properties": {
      "acd_logd": 3.58,
      "acd_logp": 3.92,
      "acd_most_bpka": 7.39,
      "alogp": 4.31,
      "aromatic_rings": 2,
      "full_molformula": "C22H26F3N3OS",
      "full_mwt": 437.53,
      "hba": 5,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 30,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 437.53,
      "mw_monoisotopic": 437.1749,
      "psa": 29.95,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1",
      "standard_inchi": "InChI=1S/C22H26F3N3OS/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29/h1-2,4-7,16,29H,3,8-15H2",
      "standard_inchi_key": "PLDUPXSUYLZYBN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fluphenazine HCl (BAN, FDA, JAN, USP)",
        "Fluphenazine (BAN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": "Aspen Global Inc"
    },
    "atc_classification": {
      "drug": {
        "code": "L01BB03",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Purine analogues"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1966,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL727",
    "molecule_properties": {
      "acd_logd": -1.5,
      "acd_logp": -0.54,
      "acd_most_apka": 6.79,
      "acd_most_bpka": 2.45,
      "alogp": 0.6,
      "aromatic_rings": 2,
      "full_molformula": "C5H5N5S",
      "full_mwt": 167.2,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 11,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 167.2,
      "mw_monoisotopic": 167.0266,
      "psa": 83.38,
      "qed_weighted": 0.5,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "NC1=Nc2[nH]cnc2C(=S)N1",
      "standard_inchi": "InChI=1S/C5H5N5S/c6-5-9-3-2(4(11)10-5)7-1-8-3/h1H,(H4,6,7,8,9,10,11)",
      "standard_inchi_key": "WYWHKKSPHMUBEB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Thioguanine (FDA, USAN, USP)",
        "Tioguanine (BAN, INN)",
        null
      ]
    },
    "usan_year": 1965
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL26630",
    "molecule_properties": {
      "acd_logd": -0.08,
      "acd_logp": 1,
      "acd_most_apka": 5.93,
      "acd_most_bpka": 1.4,
      "alogp": 1.67,
      "aromatic_rings": 2,
      "full_molformula": "C11H13N3O3S",
      "full_mwt": 267.31,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 18,
      "molecular_species": "ACID",
      "mw_freebase": 267.31,
      "mw_monoisotopic": 267.0678,
      "psa": 98.22,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1onc(NS(=O)(=O)c2ccc(N)cc2)c1C",
      "standard_inchi": "InChI=1S/C11H13N3O3S/c1-7-8(2)17-13-11(7)14-18(15,16)10-5-3-9(12)4-6-10/h3-6H,12H2,1-2H3,(H,13,14)",
      "standard_inchi_key": "DAUFGBIKKGOPJA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulfatroxazole (BAN, INN)",
        null
      ]
    },
    "usan_stem": "sulfa-",
    "usan_stem_definition": "antimicrobials (sulfonamides derivatives)",
    "usan_stem_substem": "sulfa-(sulfa-)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL26319",
    "molecule_properties": {
      "acd_logd": 5.69,
      "acd_logp": 5.69,
      "acd_most_apka": 10.39,
      "alogp": 5.25,
      "aromatic_rings": 1,
      "full_molformula": "C20H29ClO4",
      "full_mwt": 368.9,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 368.9,
      "mw_monoisotopic": 368.1754,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 52.6,
      "qed_weighted": 0.35,
      "ro3_pass": "N",
      "rtb": 13
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(=O)C(CCCCCCOc1ccc(OC)cc1Cl)C(=O)CC",
      "standard_inchi": "InChI=1S/C20H29ClO4/c1-4-18(22)16(19(23)5-2)10-8-6-7-9-13-25-20-12-11-15(24-3)14-17(20)21/h11-12,14,16H,4-10,13H2,1-3H3",
      "standard_inchi_key": "DIXRMZGIJNJUGL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "WIN-38020"
    },
    "synonyms": {
      "value": [
        "Arildone (INN, USAN)",
        null
      ]
    },
    "usan_stem": "aril-",
    "usan_stem_definition": "antiviral (arildone derivatives)",
    "usan_stem_substem": "aril-(aril-)",
    "usan_year": 1977
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N03AG05",
        "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Fatty acid derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Relaxant (muscle); Anticonvulsant",
    "molecule_chembl_id": "CHEMBL287631",
    "molecule_properties": {
      "acd_logd": 2.96,
      "acd_logp": 2.97,
      "acd_most_bpka": 10.32,
      "alogp": 3.29,
      "aromatic_rings": 2,
      "full_molformula": "C17H16ClFN2O2",
      "full_mwt": 334.78,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 23,
      "molecular_species": "BASE",
      "mw_freebase": 334.78,
      "mw_monoisotopic": 334.0884,
      "psa": 75.68,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=O)CCC\\N=C(/c1ccc(Cl)cc1)\\c2cc(F)ccc2O",
      "standard_inchi": "InChI=1S/C17H16ClFN2O2/c18-12-5-3-11(4-6-12)17(21-9-1-2-16(20)23)14-10-13(19)7-8-15(14)22/h3-8,10,22H,1-2,9H2,(H2,20,23)/b21-17+",
      "standard_inchi_key": "IBALRBWGSVJPAP-HEHNFIMWSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SL-76002"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Progabide (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-gab-",
    "usan_stem_definition": "gabamimetics",
    "usan_stem_substem": "-gab-(-gab-)",
    "usan_year": 1984
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL286738",
    "molecule_properties": {
      "acd_logd": 2.42,
      "acd_logp": 2.47,
      "acd_most_apka": 8.26,
      "alogp": 1.64,
      "aromatic_rings": 2,
      "full_molformula": "C14H15NO5S",
      "full_mwt": 309.34,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 309.34,
      "mw_monoisotopic": 309.0671,
      "psa": 99.6,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NS(=O)(=O)Oc1ccc2C3=C(CCCCC3)C(=O)Oc2c1",
      "standard_inchi": "InChI=1S/C14H15NO5S/c15-21(17,18)20-9-6-7-11-10-4-2-1-3-5-12(10)14(16)19-13(11)8-9/h6-8H,1-5H2,(H2,15,17,18)",
      "standard_inchi_key": "DSLPMJSGSBLWRE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "STX64",
        "BN-83495",
        "STX-64",
        "667 Coumate"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Irosustat (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-stat",
    "usan_stem_definition": "enzyme inhibitors",
    "usan_stem_substem": "-stat(-stat)",
    "usan_year": 2010
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL27289",
    "molecule_properties": {
      "acd_logd": 4.37,
      "acd_logp": 4.41,
      "acd_most_bpka": 6.29,
      "alogp": 4.63,
      "aromatic_rings": 3,
      "full_molformula": "C18H15ClN2O",
      "full_mwt": 310.78,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 310.78,
      "mw_monoisotopic": 310.0873,
      "psa": 27.05,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1cccc(COc2ccccc2C(=C)n3ccnc3)c1",
      "standard_inchi": "InChI=1S/C18H15ClN2O/c1-14(21-10-9-20-13-21)17-7-2-3-8-18(17)22-12-15-5-4-6-16(19)11-15/h2-11,13H,1,12H2",
      "standard_inchi_key": "WHPAGCJNPTUGGD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Croconazole (INN)",
        "Croconazole HCl (JAN)",
        null
      ]
    },
    "usan_stem": "-conazole",
    "usan_stem_definition": "systemic antifungals (miconazole type)",
    "usan_stem_substem": "-conazole(-conazole)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1990,
    "indication_class": "Anti-Adrenergic (beta-receptor); Antihypertensive",
    "molecule_chembl_id": "CHEMBL27193",
    "molecule_properties": {
      "acd_logd": 0.83,
      "acd_logp": 2.72,
      "acd_most_apka": 8.21,
      "acd_most_bpka": 9.3,
      "alogp": 2.14,
      "aromatic_rings": 2,
      "full_molformula": "C19H24N2O3",
      "full_mwt": 328.41,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 328.41,
      "mw_monoisotopic": 328.1787,
      "psa": 95.58,
      "qed_weighted": 0.6,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H](CCc1ccccc1)NC[C@H](O)c2ccc(O)c(c2)C(=O)N",
      "standard_inchi": "InChI=1S/C19H24N2O3/c1-13(7-8-14-5-3-2-4-6-14)21-12-18(23)15-9-10-17(22)16(11-15)19(20)24/h2-6,9-11,13,18,21-23H,7-8,12H2,1H3,(H2,20,24)/t13-,18+/m1/s1",
      "standard_inchi_key": "SGUAFYQXFOLMHL-ACJLOTCBSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SCH-19927"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dilevalol (BAN, INN)",
        "Dilevalol HCl (JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-alol",
    "usan_stem_definition": "combined alpha and beta receptors",
    "usan_stem_substem": "-alol(-alol)",
    "usan_year": 1984,
    "withdrawn_class": "Hepatotoxicity",
    "withdrawn_country": "United Kingdom",
    "withdrawn_reason": "Hepatotoxicity",
    "withdrawn_year": 1990
  },
  {
    "applicants": {
      "value": [
        "Marsam Pharmaceuticals Llc",
        "Teva Parenteral Medicines Inc",
        "Smith And Nephew Solopak Div Smith And Nephew",
        "West-Ward Pharmaceuticals International Ltd",
        "Hospira Inc",
        "Morton Grove Pharmaceuticals Inc",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Teva Pharmaceuticals Usa",
        "Able Laboratories Inc",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05AB04",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with piperazine structure"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1956,
    "indication_class": "Anti-Emetic,Anti-Emetic; Antipsychotic,Antipsychotic; Anti-Emetic",
    "molecule_chembl_id": "CHEMBL728",
    "molecule_properties": {
      "acd_logd": 4.04,
      "acd_logp": 4.65,
      "acd_most_bpka": 7.66,
      "alogp": 4.58,
      "aromatic_rings": 2,
      "full_molformula": "C20H24ClN3S",
      "full_mwt": 373.95,
      "hba": 4,
      "hba_lipinski": 3,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 373.95,
      "mw_monoisotopic": 373.1379,
      "psa": 9.72,
      "qed_weighted": 0.78,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1",
      "standard_inchi": "InChI=1S/C20H24ClN3S/c1-22-11-13-23(14-12-22)9-4-10-24-17-5-2-3-6-19(17)25-20-8-7-16(21)15-18(20)24/h2-3,5-8,15H,4,9-14H2,1H3",
      "standard_inchi_key": "WIKYUJGCLQQFNW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Prochlorperazine Maleate (FDA, JAN, USP)",
        "Prochlorperazine edisylate (FDA, USP)",
        "Prochlorperazine (BAN, FDA, INN, JAN, USP)",
        "Prochlorperazine Mesilate (JAN)",
        null
      ]
    },
    "topical": true
  },
  {
    "applicants": {
      "value": [
        "Abbvie Inc",
        "Silarx Pharmaceuticals Inc"
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2000,
    "molecule_chembl_id": "CHEMBL729",
    "molecule_properties": {
      "acd_logd": 5.42,
      "acd_logp": 5.42,
      "acd_most_apka": 13.89,
      "alogp": 4.33,
      "aromatic_rings": 3,
      "full_molformula": "C37H48N4O5",
      "full_mwt": 628.81,
      "hba": 5,
      "hba_lipinski": 9,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 46,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 628.81,
      "mw_monoisotopic": 628.3625,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 120,
      "qed_weighted": 0.2,
      "ro3_pass": "N",
      "rtb": 15
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)[C@H](N1CCCNC1=O)C(=O)N[C@H](C[C@H](O)[C@H](Cc2ccccc2)NC(=O)COc3c(C)cccc3C)Cc4ccccc4",
      "standard_inchi": "InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1",
      "standard_inchi_key": "KJHKTHWMRKYKJE-SUGCFTRWSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6232333,
    "oral": true,
    "research_codes": {
      "value": [
        "ABT-378",
        "A-157378.0",
        "A-157378-0"
      ]
    },
    "sc_patent": "US-6232333-B1",
    "synonyms": {
      "value": [
        "Lopinavir (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-vir",
    "usan_stem_definition": "antivirals: HIV protease inhibitors (saquinavir type)",
    "usan_stem_substem": "-vir(-vir(-navir))",
    "usan_year": 1998
  },
  {
    "applicants": {
      "value": [
        "Valeant Pharmaceuticals North America Llc",
        "Smith And Nephew Solopak Div Smith And Nephew",
        "Sanofi Aventis Us Llc",
        "G Pohl Boskamp Gmbh And Co Kg",
        "Glenmark Pharmaceuticals Ltd",
        "Hercon Pharmaceutical Llc",
        "Hospira Inc",
        "Actavis Laboratories Fl Inc",
        "Luitpold Pharmaceuticals Inc",
        "Uspharma Ltd"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "C01DA52",
          "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Organic nitrate"
        },
        {
          "code": "C05AE01",
          "description": "CARDIOVASCULAR SYSTEM: VASOPROTECTIVES: AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE: Muscle relaxant"
        },
        {
          "code": "C01DA02",
          "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Organic nitrates"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1981,
    "indication_class": "Vasodilator (coronary)",
    "molecule_chembl_id": "CHEMBL730",
    "molecule_properties": {
      "acd_logd": 2.15,
      "acd_logp": 2.15,
      "alogp": -1.02,
      "full_molformula": "C3H5N3O9",
      "full_mwt": 227.09,
      "hba": 9,
      "hba_lipinski": 12,
      "heavy_atoms": 15,
      "mw_freebase": 227.09,
      "mw_monoisotopic": 227.0026,
      "num_lipinski_ro5_violations": 1,
      "psa": 157.11,
      "qed_weighted": 0.37,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "[O-][N+](=O)OCC(CO[N+](=O)[O-])O[N+](=O)[O-]",
      "standard_inchi": "InChI=1S/C3H5N3O9/c7-4(8)13-1-3(15-6(11)12)2-14-5(9)10/h3H,1-2H2",
      "standard_inchi_key": "SNIOPGDIGTZGOP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6500456,
    "parenteral": true,
    "rule_of_five": true,
    "sc_patent": "US-6500456-B1",
    "synonyms": {
      "value": [
        "Glyceryl Trinitrate (BAN)",
        "Nitroglycerin (FDA, JAN, USP)",
        null
      ]
    },
    "topical": true
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL285815",
    "molecule_properties": {
      "acd_logd": 4.89,
      "acd_logp": 4.89,
      "alogp": 5.1,
      "full_molformula": "C20H34O2",
      "full_mwt": 306.49,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 306.49,
      "mw_monoisotopic": 306.2559,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 40.46,
      "qed_weighted": 0.52,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=CCC\\C(=C\\CC\\C(=C\\CC\\C(=C\\CO)\\C)\\CO)\\C)C",
      "standard_inchi": "InChI=1S/C20H34O2/c1-17(2)8-5-9-18(3)10-6-12-20(16-22)13-7-11-19(4)14-15-21/h8,10,13-14,21-22H,5-7,9,11-12,15-16H2,1-4H3/b18-10+,19-14+,20-13-",
      "standard_inchi_key": "SUWYPNNPLSRNPS-UNTSEYQFSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Plaunotol (INN, JAN, MI)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "J01MB04",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Other quinolones"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL30116",
    "molecule_properties": {
      "acd_logd": -2.75,
      "acd_logp": -0.19,
      "acd_most_apka": 3.27,
      "acd_most_bpka": 8.51,
      "alogp": -0.08,
      "aromatic_rings": 2,
      "full_molformula": "C14H17N5O3",
      "full_mwt": 303.32,
      "hba": 7,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 303.32,
      "mw_monoisotopic": 303.1331,
      "psa": 100.35,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1C=C(C(=O)O)C(=O)c2cnc(nc12)N3CCNCC3",
      "standard_inchi": "InChI=1S/C14H17N5O3/c1-2-18-8-10(13(21)22)11(20)9-7-16-14(17-12(9)18)19-5-3-15-4-6-19/h7-8,15H,2-6H2,1H3,(H,21,22)",
      "standard_inchi_key": "JOHZPMXAZQZXHR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pipemidic Acid (BAN, DCF, INN, MI)",
        "Pipemidic Acid Trihydrate (JAN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL27129",
    "molecule_properties": {
      "acd_logd": 2.01,
      "acd_logp": 2.01,
      "alogp": 0.69,
      "aromatic_rings": 1,
      "full_molformula": "C10H10N2O5",
      "full_mwt": 238.2,
      "hba": 5,
      "hba_lipinski": 7,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 238.2,
      "mw_monoisotopic": 238.059,
      "psa": 81.91,
      "qed_weighted": 0.57,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "[O-][N+](=O)OCCN1COc2ccccc2C1=O",
      "standard_inchi": "InChI=1S/C10H10N2O5/c13-10-8-3-1-2-4-9(8)16-7-11(10)5-6-17-12(14)15/h1-4H,5-7H2",
      "standard_inchi_key": "POVFCWQCRHXYAB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sinitrodil (INN)",
        null
      ]
    },
    "usan_stem": "-dil",
    "usan_stem_definition": "vasodilators (undefined group)",
    "usan_stem_substem": "-dil(-dil)"
  },
  {
    "applicants": {
      "value": "Mission Pharmacal Co"
    },
    "atc_classification": {
      "drug": {
        "code": "G04BX03",
        "description": "GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Other urologicals"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1983,
    "indication_class": "Enzyme Inhibitor (urease)",
    "molecule_chembl_id": "CHEMBL734",
    "molecule_properties": {
      "acd_logd": -0.24,
      "acd_logp": -0.23,
      "acd_most_apka": 9.26,
      "alogp": -0.49,
      "full_molformula": "C2H5NO2",
      "full_mwt": 75.07,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 5,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 75.07,
      "mw_monoisotopic": 75.032,
      "psa": 49.33,
      "qed_weighted": 0.3,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)NO",
      "standard_inchi": "InChI=1S/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4)",
      "standard_inchi_key": "RRUDCFGSUDOHDG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Acetohydroxamic acid (FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1984
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C01DX16",
        "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: VASODILATORS USED IN CARDIAC DISEASES: Other vasodilators used in cardiac diseases"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Vasodilator (coronary)",
    "molecule_chembl_id": "CHEMBL284906",
    "molecule_properties": {
      "acd_logd": 0.74,
      "acd_logp": 0.74,
      "acd_most_apka": 12.7,
      "acd_most_bpka": 3.49,
      "alogp": 0.02,
      "aromatic_rings": 1,
      "full_molformula": "C8H9N3O4",
      "full_mwt": 211.18,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 211.18,
      "mw_monoisotopic": 211.0593,
      "psa": 94.36,
      "qed_weighted": 0.42,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "[O-][N+](=O)OCCNC(=O)c1cccnc1",
      "standard_inchi": "InChI=1S/C8H9N3O4/c12-8(7-2-1-3-9-6-7)10-4-5-15-11(13)14/h1-3,6H,4-5H2,(H,10,12)",
      "standard_inchi_key": "LBHIOVVIQHSOQN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SG-75"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nicorandil (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-dil",
    "usan_stem_definition": "vasodilators (undefined group)",
    "usan_stem_substem": "-dil(-dil)",
    "usan_year": 1981
  },
  {
    "atc_classification": {
      "drug": {
        "code": "A03AA04",
        "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: Synthetic anticholinergics, esters with tertiary amino group"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Relaxant (smooth muscle)",
    "molecule_chembl_id": "CHEMBL282121",
    "molecule_properties": {
      "acd_logd": 3.7,
      "acd_logp": 5.77,
      "acd_most_bpka": 9.51,
      "alogp": 4.6,
      "aromatic_rings": 2,
      "full_molformula": "C25H35NO5",
      "full_mwt": 429.56,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 31,
      "molecular_species": "BASE",
      "mw_freebase": 429.56,
      "mw_monoisotopic": 429.2515,
      "psa": 57.23,
      "qed_weighted": 0.34,
      "ro3_pass": "N",
      "rtb": 13
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc2ccc(OC)cc2",
      "standard_inchi": "InChI=1S/C25H35NO5/c1-6-26(19(2)17-20-9-12-22(28-3)13-10-20)15-7-8-16-31-25(27)21-11-14-23(29-4)24(18-21)30-5/h9-14,18-19H,6-8,15-17H2,1-5H3",
      "standard_inchi_key": "VYVKHNNGDFVQGA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CSAG-144"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mebeverine HCl (USAN)",
        "Mebeverine (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-verine",
    "usan_stem_definition": "spasmolytic agents (papaverine type)",
    "usan_stem_substem": "-verine(-verine)",
    "usan_year": 1966
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "D08AC01",
          "description": "DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Biguanides and amidine"
        },
        {
          "code": "S01AX14",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Other antiinfectives"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL30044",
    "molecule_properties": {
      "acd_logd": 0.14,
      "acd_logp": 3.14,
      "acd_most_bpka": 11.59,
      "alogp": 3.63,
      "aromatic_rings": 2,
      "full_molformula": "C17H18Br2N4O2",
      "full_mwt": 470.17,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 4,
      "hbd_lipinski": 6,
      "heavy_atoms": 25,
      "molecular_species": "BASE",
      "mw_freebase": 470.17,
      "mw_monoisotopic": 467.9797,
      "num_lipinski_ro5_violations": 1,
      "psa": 118.2,
      "qed_weighted": 0.27,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=N)c1ccc(OCCCOc2ccc(cc2Br)C(=N)N)c(Br)c1",
      "standard_inchi": "InChI=1S/C17H18Br2N4O2/c18-12-8-10(16(20)21)2-4-14(12)24-6-1-7-25-15-5-3-11(17(22)23)9-13(15)19/h2-5,8-9H,1,6-7H2,(H3,20,21)(H3,22,23)",
      "standard_inchi_key": "GMJFVGRUYJHMCO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dibrompropamidine (BAN, INN, MI)",
        null
      ]
    },
    "usan_stem": "-amidine",
    "usan_stem_definition": "pentamidine derivatives/analogues",
    "usan_stem_substem": "-amidine(-amidine)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (stabilizer)",
    "molecule_chembl_id": "CHEMBL29411",
    "molecule_properties": {
      "acd_logd": 3.25,
      "acd_logp": 3.25,
      "acd_most_apka": 10.59,
      "alogp": 2.82,
      "aromatic_rings": 1,
      "full_molformula": "C10H14O",
      "full_mwt": 150.22,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 11,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 150.22,
      "mw_monoisotopic": 150.1045,
      "psa": 20.23,
      "qed_weighted": 0.65,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)c1ccc(C)cc1O",
      "standard_inchi": "InChI=1S/C10H14O/c1-7(2)9-5-4-8(3)6-10(9)11/h4-7,11H,1-3H3",
      "standard_inchi_key": "MGSRCZKZVOBKFT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Thymol (JAN, NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (antioxidant)",
    "molecule_chembl_id": "CHEMBL146",
    "molecule_properties": {
      "acd_logd": 5.17,
      "acd_logp": 5.17,
      "acd_most_apka": 12.76,
      "alogp": 4.3,
      "aromatic_rings": 1,
      "full_molformula": "C15H24O",
      "full_mwt": 220.36,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 220.36,
      "mw_monoisotopic": 220.1827,
      "psa": 20.23,
      "qed_weighted": 0.69,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C",
      "standard_inchi": "InChI=1S/C15H24O/c1-10-8-11(14(2,3)4)13(16)12(9-10)15(5,6)7/h8-9,16H,1-7H3",
      "standard_inchi_key": "NLZUEZXRPGMBCV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Butylated Hydroxytoluene (BAN, NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL287419",
    "molecule_properties": {
      "acd_logd": 2.88,
      "acd_logp": 2.88,
      "acd_most_bpka": 4.87,
      "alogp": 5.28,
      "aromatic_rings": 4,
      "full_molformula": "C27H22F4N4O3S",
      "full_mwt": 558.56,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 39,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 558.56,
      "mw_monoisotopic": 558.1349,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 82.61,
      "qed_weighted": 0.34,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "Fc1ccc(cc1)S(=O)(=O)N2CCN(CC2)C(=O)c3ccc(Nc4ccnc5cc(ccc45)C(F)(F)F)cc3",
      "standard_inchi": "InChI=1S/C27H22F4N4O3S/c28-20-4-8-22(9-5-20)39(37,38)35-15-13-34(14-16-35)26(36)18-1-6-21(7-2-18)33-24-11-12-32-25-17-19(27(29,30)31)3-10-23(24)25/h1-12,17H,13-16H2,(H,32,33)",
      "standard_inchi_key": "SYJKIRZBDWNJSB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "U-54669F"
    },
    "synonyms": {
      "value": [
        "Losulazine HCl (USAN)",
        "Losulazine (INN)",
        null
      ]
    },
    "usan_year": 1984
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL29741",
    "molecule_properties": {
      "acd_logd": 1.93,
      "acd_logp": 3.12,
      "acd_most_bpka": 8.57,
      "alogp": 3.34,
      "aromatic_rings": 3,
      "full_molformula": "C18H19N3O2",
      "full_mwt": 309.37,
      "hba": 5,
      "hba_lipinski": 5,
      "heavy_atoms": 23,
      "molecular_species": "BASE",
      "mw_freebase": 309.37,
      "mw_monoisotopic": 309.1477,
      "psa": 51.39,
      "qed_weighted": 0.7,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCOc1ccccc1c2onc(n2)c3ccccc3",
      "standard_inchi": "InChI=1S/C18H19N3O2/c1-21(2)12-13-22-16-11-7-6-10-15(16)18-19-17(20-23-18)14-8-4-3-5-9-14/h3-11H,12-13H2,1-2H3",
      "standard_inchi_key": "QZULPCPLWGCGSL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "BIIR-561",
        "BIIR-561 Cl"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Irampanel (INN)",
        null
      ]
    },
    "usan_stem": "-ampa",
    "usan_stem_definition": "ionotropic non-NMDA glutamate receptors (AMPA and/or KA receptors): antagonists",
    "usan_stem_substem": "-ampa(-ampa(-ampanel))"
  },
  {
    "applicants": {
      "value": [
        "Torrent Pharmaceuticals Ltd",
        "Jubilant Generics Ltd",
        "Glenmark Pharmaceuticals Ltd",
        "Actavis Totowa Llc",
        "Actavis Elizabeth Llc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Aurobindo Pharma Ltd",
        "Par Pharmaceutical Inc",
        "Taro Pharmaceutical Industries Ltd",
        "Lupin Ltd",
        "Roxane Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N03AX09",
        "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1994,
    "indication_class": "Anticonvulsant",
    "molecule_chembl_id": "CHEMBL741",
    "molecule_properties": {
      "acd_logd": 1.24,
      "acd_logp": 1.24,
      "acd_most_bpka": 5.39,
      "alogp": 2.01,
      "aromatic_rings": 2,
      "full_molformula": "C9H7Cl2N5",
      "full_mwt": 256.1,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 256.1,
      "mw_monoisotopic": 255.0079,
      "psa": 90.71,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1nnc(c(N)n1)c2cccc(Cl)c2Cl",
      "standard_inchi": "InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)",
      "standard_inchi_key": "PYZRQGJRPPTADH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7919115,
    "oral": true,
    "research_codes": {
      "value": "BW-430C"
    },
    "rule_of_five": true,
    "sc_patent": "US-7919115-B2",
    "synonyms": {
      "value": [
        "Lamotrigine (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_year": 1985
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL29919",
    "molecule_properties": {
      "acd_logd": 2.71,
      "acd_logp": 2.71,
      "acd_most_bpka": 2.24,
      "alogp": 3.27,
      "aromatic_rings": 2,
      "full_molformula": "C10H7Cl3N4",
      "full_mwt": 289.55,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 289.55,
      "mw_monoisotopic": 287.9736,
      "psa": 77.82,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1cnc(c(N)n1)c2cc(Cl)cc(Cl)c2Cl",
      "standard_inchi": "InChI=1S/C10H7Cl3N4/c11-4-1-5(8(13)6(12)2-4)9-10(15)17-7(14)3-16-9/h1-3H,(H4,14,15,17)",
      "standard_inchi_key": "NNXUYJFHOVCRSM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "JZP-4"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Elpetrigine (INN, USAN)",
        null
      ]
    },
    "usan_year": 2009
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N07CA03",
        "description": "NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: ANTIVERTIGO PREPARATIONS: Antivertigo preparations"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Vasodilator",
    "molecule_chembl_id": "CHEMBL30008",
    "molecule_properties": {
      "acd_logd": 5.44,
      "acd_logp": 5.59,
      "acd_most_bpka": 6.99,
      "alogp": 5.39,
      "aromatic_rings": 3,
      "full_molformula": "C26H26F2N2",
      "full_mwt": 404.5,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 30,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 404.5,
      "mw_monoisotopic": 404.2064,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 6.48,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "Fc1ccc(cc1)C(N2CCN(C\\C=C\\c3ccccc3)CC2)c4ccc(F)cc4",
      "standard_inchi": "InChI=1S/C26H26F2N2/c27-24-12-8-22(9-13-24)26(23-10-14-25(28)15-11-23)30-19-17-29(18-20-30)16-4-7-21-5-2-1-3-6-21/h1-15,26H,16-20H2/b7-4+",
      "standard_inchi_key": "SMANXXCATUTDDT-QPJJXVBHSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "R-14950"
    },
    "synonyms": {
      "value": [
        "Flunarizine HCl (JAN, USAN)",
        "Flunarizine (BAN, INN)",
        null
      ]
    },
    "usan_year": 1970
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Cardiotonic (vasodilator); Cardiotonic (positive inotropic)",
    "molecule_chembl_id": "CHEMBL29798",
    "molecule_properties": {
      "acd_logd": 1.18,
      "acd_logp": 1.18,
      "acd_most_apka": 11.03,
      "acd_most_bpka": 1.01,
      "alogp": 1.25,
      "aromatic_rings": 2,
      "full_molformula": "C11H12N2O3",
      "full_mwt": 220.23,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 220.23,
      "mw_monoisotopic": 220.0848,
      "psa": 64.21,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2NC(=O)N=C(C)c2c1OC",
      "standard_inchi": "InChI=1S/C11H12N2O3/c1-6-9-7(13-11(14)12-6)4-5-8(15-2)10(9)16-3/h4-5H,1-3H3,(H,12,13,14)",
      "standard_inchi_key": "WVNXGAOAWSQPAL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "ORF-16600",
        "RWJ-16600"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Bemarinone (INN)",
        "Bemarinone HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-rinone",
    "usan_stem_definition": "cardiotonics (amrinone type)",
    "usan_stem_substem": "-rinone(-rinone)",
    "usan_year": 1987
  },
  {
    "applicants": {
      "value": [
        "West-Ward Pharmaceuticals International Ltd",
        "Par Sterile Products Llc",
        "Hospira Inc",
        "Mylan Institutional Llc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N01AX03",
        "description": "NERVOUS SYSTEM: ANESTHETICS: ANESTHETICS, GENERAL: Other general anesthetics"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1970,
    "indication_class": "Anesthetic",
    "molecule_chembl_id": "CHEMBL742",
    "molecule_properties": {
      "acd_logd": 2.96,
      "acd_logp": 3.01,
      "acd_most_bpka": 6.46,
      "alogp": 2.9,
      "aromatic_rings": 1,
      "full_molformula": "C13H16ClNO",
      "full_mwt": 237.73,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 237.73,
      "mw_monoisotopic": 237.092,
      "psa": 29.1,
      "qed_weighted": 0.86,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CNC1(CCCCC1=O)c2ccccc2Cl",
      "standard_inchi": "InChI=1S/C13H16ClNO/c1-15-13(9-5-4-8-12(13)16)10-6-2-3-7-11(10)14/h2-3,6-7,15H,4-5,8-9H2,1H3",
      "standard_inchi_key": "YQEZLKZALYSWHR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "CI-581",
        "CN-52372-2",
        "CL-369"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ketamine HCl (FDA, JAN, USAN, USP)",
        "Ketamine (BAN, INN)",
        null
      ]
    },
    "usan_year": 1966
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Anticonvulsant (neuroprotective)",
    "molecule_chembl_id": "CHEMBL25843",
    "molecule_properties": {
      "acd_logd": 2.05,
      "acd_logp": 2.23,
      "acd_most_bpka": 7.76,
      "alogp": 2.22,
      "aromatic_rings": 2,
      "full_molformula": "C17H20N2O",
      "full_mwt": 268.36,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 268.36,
      "mw_monoisotopic": 268.1576,
      "psa": 55.12,
      "qed_weighted": 0.87,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC(Cc1ccccc1)(NC(=O)CN)c2ccccc2",
      "standard_inchi": "InChI=1S/C17H20N2O/c1-17(19-16(20)13-18,15-10-6-3-7-11-15)12-14-8-4-2-5-9-14/h2-11H,12-13,18H2,1H3,(H,19,20)",
      "standard_inchi_key": "YSGASDXSLKIKOD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "PR-934423A",
        "FPL-12924AA"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Remacemide HCl (USAN)",
        "Remacemide (INN)",
        null
      ]
    },
    "usan_year": 1990
  },
  {
    "atc_classification": {
      "drug": {
        "code": "J01MB05",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Other quinolones"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL416755",
    "molecule_properties": {
      "acd_logd": -1.86,
      "acd_logp": -0.38,
      "acd_most_apka": 5.94,
      "alogp": 1.45,
      "aromatic_rings": 2,
      "full_molformula": "C13H11NO5",
      "full_mwt": 261.23,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "ACID",
      "mw_freebase": 261.23,
      "mw_monoisotopic": 261.0637,
      "psa": 77.76,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1C=C(C(=O)O)C(=O)c2cc3OCOc3cc12",
      "standard_inchi": "InChI=1S/C13H11NO5/c1-2-14-5-8(13(16)17)12(15)7-3-10-11(4-9(7)14)19-6-18-10/h3-5H,2,6H2,1H3,(H,16,17)",
      "standard_inchi_key": "KYGZCKSPAKDVKC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "W-4565"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Oxolinic Acid (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1968
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL29404",
    "molecule_properties": {
      "acd_logd": 2.13,
      "acd_logp": 4.39,
      "acd_most_bpka": 9.72,
      "alogp": 4.63,
      "aromatic_rings": 2,
      "full_molformula": "C21H28FN3O",
      "full_mwt": 357.47,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 26,
      "molecular_species": "BASE",
      "mw_freebase": 357.47,
      "mw_monoisotopic": 357.2216,
      "psa": 38.25,
      "qed_weighted": 0.65,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1nc(OCCCCCN2CCCCC2)cc(n1)c3ccc(F)cc3",
      "standard_inchi": "InChI=1S/C21H28FN3O/c1-17-23-20(18-8-10-19(22)11-9-18)16-21(24-17)26-15-7-3-6-14-25-12-4-2-5-13-25/h8-11,16H,2-7,12-15H2,1H3",
      "standard_inchi_key": "SZSHJTJCJOWMHM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Enecadin (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Apotex Corp",
        "Glenmark Pharmaceuticals Ltd",
        "Alkem Laboratories Ltd",
        "Covis Pharma Bv",
        "Mylan Pharmaceuticals Inc",
        "Impax Laboratories Inc",
        "Sun Pharmaceutical Industries Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N07XX02",
        "description": "NERVOUS SYSTEM: OTHER NERVOUS SYSTEM DRUGS: OTHER NERVOUS SYSTEM DRUGS: Other nervous system drugs"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1995,
    "indication_class": "Amyotrophic Lateral Sclerosis Treatment",
    "molecule_chembl_id": "CHEMBL744",
    "molecule_properties": {
      "acd_logd": 2.92,
      "acd_logp": 2.92,
      "acd_most_bpka": 2.96,
      "alogp": 2.78,
      "aromatic_rings": 2,
      "full_molformula": "C8H5F3N2OS",
      "full_mwt": 234.2,
      "hba": 4,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 234.2,
      "mw_monoisotopic": 234.0075,
      "psa": 48.14,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1nc2ccc(OC(F)(F)F)cc2s1",
      "standard_inchi": "InChI=1S/C8H5F3N2OS/c9-8(10,11)14-4-1-2-5-6(3-4)15-7(12)13-5/h1-3H,(H2,12,13)",
      "standard_inchi_key": "FTALBRSUTCGOEG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "RP-54274"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Riluzole (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_year": 1995
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL28636",
    "molecule_properties": {
      "acd_logd": 2.37,
      "acd_logp": 2.37,
      "acd_most_apka": 9.69,
      "alogp": 3.27,
      "aromatic_rings": 3,
      "full_molformula": "C17H14F3N3O3S",
      "full_mwt": 397.38,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 397.38,
      "mw_monoisotopic": 397.0708,
      "psa": 87.21,
      "qed_weighted": 0.72,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(cc1F)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)F",
      "standard_inchi": "InChI=1S/C17H14F3N3O3S/c1-26-16-7-2-10(8-13(16)18)15-9-14(17(19)20)22-23(15)11-3-5-12(6-4-11)27(21,24)25/h2-9,17H,1H3,(H2,21,24,25)",
      "standard_inchi_key": "WAZQAZKAZLXFMK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SC-59046"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Deracoxib (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-coxib",
    "usan_stem_definition": "cyclooxygenase-2 inhibitors",
    "usan_stem_substem": "-coxib(-coxib)",
    "usan_year": 1998
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL28527",
    "molecule_properties": {
      "acd_logd": 1.98,
      "acd_logp": 1.98,
      "acd_most_apka": 9.67,
      "alogp": 3.34,
      "aromatic_rings": 3,
      "full_molformula": "C16H11F4N3O2S",
      "full_mwt": 385.34,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 385.34,
      "mw_monoisotopic": 385.0508,
      "psa": 77.98,
      "qed_weighted": 0.7,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "NS(=O)(=O)c1ccc(cc1)n2nc(cc2c3ccc(F)cc3)C(F)(F)F",
      "standard_inchi": "InChI=1S/C16H11F4N3O2S/c17-11-3-1-10(2-4-11)14-9-15(16(18,19)20)22-23(14)12-5-7-13(8-6-12)26(21,24)25/h1-9H,(H2,21,24,25)",
      "standard_inchi_key": "TTZNQDOUNXBMJV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "PHA-739521"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mavacoxib (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-coxib",
    "usan_stem_definition": "cyclooxygenase-2 inhibitors",
    "usan_stem_substem": "-coxib(-coxib)",
    "usan_year": 2005
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL29188",
    "molecule_properties": {
      "acd_logd": 3.23,
      "acd_logp": 3.26,
      "acd_most_bpka": 6.17,
      "alogp": 4.9,
      "aromatic_rings": 3,
      "full_molformula": "C27H30F2N2O3",
      "full_mwt": 468.54,
      "hba": 5,
      "hba_lipinski": 5,
      "heavy_atoms": 34,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 468.54,
      "mw_monoisotopic": 468.2224,
      "psa": 34.17,
      "qed_weighted": 0.47,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(CN2CCN(CC2)C(c3ccc(F)cc3)c4ccc(F)cc4)c(OC)c1OC",
      "standard_inchi": "InChI=1S/C27H30F2N2O3/c1-32-24-13-8-21(26(33-2)27(24)34-3)18-30-14-16-31(17-15-30)25(19-4-9-22(28)10-5-19)20-6-11-23(29)12-7-20/h4-13,25H,14-18H2,1-3H3",
      "standard_inchi_key": "JQSAYKKFZOSZGJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lomerizine (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Sanofi Aventis Us Llc",
        "Allergan Inc",
        "King Pharmaceuticals Llc",
        "Akorn Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R01AC07",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Antiallergic agents, excl. corticosteroid"
        },
        {
          "code": "S01GX04",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Other antiallergic"
        },
        {
          "code": "R03BC03",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS: Antiallergic agents, excl. corticosteroids"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1992,
    "indication_class": "Anti-Allergic (prophylactic)",
    "molecule_chembl_id": "CHEMBL746",
    "molecule_properties": {
      "acd_logd": -3.45,
      "acd_logp": 1.3,
      "acd_most_apka": 2.19,
      "alogp": 2.48,
      "aromatic_rings": 3,
      "full_molformula": "C19H17NO7",
      "full_mwt": 371.35,
      "hba": 6,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 27,
      "molecular_species": "ACID",
      "mw_freebase": 371.35,
      "mw_monoisotopic": 371.1005,
      "psa": 126.81,
      "qed_weighted": 0.66,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCCc1c2OC(=CC(=O)c2cc3C(=O)C=C(N(CC)c13)C(=O)O)C(=O)O",
      "standard_inchi": "InChI=1S/C19H17NO7/c1-3-5-9-16-10(13(21)7-12(18(23)24)20(16)4-2)6-11-14(22)8-15(19(25)26)27-17(9)11/h6-8H,3-5H2,1-2H3,(H,23,24)(H,25,26)",
      "standard_inchi_key": "RQTOOFIXOKYGAN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "FPL-59002",
        "FPL-59002KC",
        "FPL-59002KP"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nedocromil sodium (FDA, USAN)",
        "Nedocromil (BAN, INN, USAN)",
        "Nedocromil Calcium (USAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-cromil",
    "usan_stem_definition": "antiallergics (cromoglicic acid derivatives)",
    "usan_stem_substem": "-cromil(-cromil)",
    "usan_year": 1985
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Stroke Treatment",
    "molecule_chembl_id": "CHEMBL281724",
    "molecule_properties": {
      "acd_logd": 3.56,
      "acd_logp": 4.15,
      "acd_most_apka": 13.89,
      "acd_most_bpka": 8,
      "alogp": 3.92,
      "aromatic_rings": 3,
      "full_molformula": "C22H25F2N3O2S",
      "full_mwt": 433.52,
      "hba": 6,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 30,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 433.52,
      "mw_monoisotopic": 433.1636,
      "psa": 48.83,
      "qed_weighted": 0.61,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C1CCN(C[C@H](O)COc2ccc(F)c(F)c2)CC1)c3nc4ccccc4s3",
      "standard_inchi": "InChI=1S/C22H25F2N3O2S/c1-26(22-25-20-4-2-3-5-21(20)30-22)15-8-10-27(11-9-15)13-16(28)14-29-17-6-7-18(23)19(24)12-17/h2-7,12,15-16,28H,8-11,13-14H2,1H3/t16-/m0/s1",
      "standard_inchi_key": "OZFSWVOEXHGDES-INIZCTEOSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "R-87926"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lubeluzole (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1997
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antimalarial",
    "molecule_chembl_id": "CHEMBL747",
    "molecule_properties": {
      "acd_logd": -0.69,
      "acd_logp": 0.94,
      "acd_most_bpka": 9.27,
      "alogp": 1.53,
      "aromatic_rings": 1,
      "full_molformula": "C11H14ClN5",
      "full_mwt": 251.72,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 17,
      "molecular_species": "BASE",
      "mw_freebase": 251.72,
      "mw_monoisotopic": 251.0938,
      "psa": 80,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)N=C(N)N=C(N)N1c2ccc(Cl)cc2",
      "standard_inchi": "InChI=1S/C11H14ClN5/c1-11(2)16-9(13)15-10(14)17(11)8-5-3-7(12)4-6-8/h3-6H,1-2H3,(H4,13,14,15,16)",
      "standard_inchi_key": "QMNFFXRFOJIOKZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "GNF-Pf-2519",
        "CI-501",
        "TCMDC-125837",
        "PAM-MR-807-23A",
        "CN-14329-23A"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cycloguanil Embonate (BAN, INN)",
        "Cycloguanil Pamoate (USAN)",
        null
      ]
    },
    "usan_year": 1964
  },
  {
    "atc_classification": {
      "drug": {
        "code": "J05AX06",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Other antivirals"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL29609",
    "molecule_properties": {
      "acd_logd": 3.99,
      "acd_logp": 3.99,
      "alogp": 4.68,
      "aromatic_rings": 3,
      "full_molformula": "C18H18F3N3O3",
      "full_mwt": 381.35,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 381.35,
      "mw_monoisotopic": 381.13,
      "psa": 74.18,
      "qed_weighted": 0.58,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cc(CCCOc2c(C)cc(cc2C)c3noc(n3)C(F)(F)F)on1",
      "standard_inchi": "InChI=1S/C18H18F3N3O3/c1-10-7-13(16-22-17(27-24-16)18(19,20)21)8-11(2)15(10)25-6-4-5-14-9-12(3)23-26-14/h7-9H,4-6H2,1-3H3",
      "standard_inchi_key": "KQOXLKOJHVFTRN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "WIN-63843",
        "VP-63843"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pleconaril (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-aril",
    "usan_stem_definition": "antiviral (arildone derivatives)",
    "usan_stem_substem": "-aril(-aril)",
    "usan_year": 1997
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Alzheimer's Disease Treatment (cognition enhancer)",
    "molecule_chembl_id": "CHEMBL29835",
    "molecule_properties": {
      "acd_logd": 3.67,
      "acd_logp": 4.31,
      "acd_most_bpka": 7.94,
      "alogp": 3.72,
      "aromatic_rings": 3,
      "full_molformula": "C16H17N3",
      "full_mwt": 251.33,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 251.33,
      "mw_monoisotopic": 251.1422,
      "psa": 21.06,
      "qed_weighted": 0.7,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCCN(c1ccncc1)n2ccc3ccccc23",
      "standard_inchi": "InChI=1S/C16H17N3/c1-2-12-18(15-7-10-17-11-8-15)19-13-9-14-5-3-4-6-16(14)19/h3-11,13H,2,12H2,1H3",
      "standard_inchi_key": "OTPPJICEBWOCKD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "HP-749"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Besipirdine (INN)",
        "Besipirdine HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-pirdine",
    "usan_stem_definition": "5-HT6 inhibitors",
    "usan_stem_substem": "-pirdine(-pirdine)",
    "usan_year": 1994
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL282575",
    "molecule_properties": {
      "acd_logd": 5.09,
      "acd_logp": 5.09,
      "alogp": 5.12,
      "aromatic_rings": 2,
      "full_molformula": "C25H28O3",
      "full_mwt": 376.5,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 28,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 376.5,
      "mw_monoisotopic": 376.2038,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 46.53,
      "qed_weighted": 0.58,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)c5ccccc5)ccc34)[C@@H]1CC[C@@H]2O",
      "standard_inchi": "InChI=1S/C25H28O3/c1-25-14-13-20-19-10-8-18(28-24(27)16-5-3-2-4-6-16)15-17(19)7-9-21(20)22(25)11-12-23(25)26/h2-6,8,10,15,20-23,26H,7,9,11-14H2,1H3/t20-,21-,22+,23+,25+/m1/s1",
      "standard_inchi_key": "UYIFTLBWAOGQBI-BZDYCCQFSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Estradiol Benzoate (BAN, INN, JAN, MI, USP)",
        null
      ]
    },
    "usan_stem": "estr-",
    "usan_stem_definition": "estrogens",
    "usan_stem_substem": "estr-(estr-)"
  },
  {
    "applicants": {
      "value": [
        "Glenmark Generics Inc Usa",
        "Epic Pharma Llc",
        "Sunovion Pharmaceuticals Inc",
        "Sun Pharmaceutical Industries Inc",
        "Apotex Inc Etobicoke Site",
        "Roxane Laboratories Inc",
        "Upsher-Smith Laboratories Llc",
        "Wockhardt Ltd",
        "Invagen Pharmaceuticals Inc",
        "Watson Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N03AX15",
        "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Other antiepileptics"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2000,
    "indication_class": "Anticonvulsant",
    "molecule_chembl_id": "CHEMBL750",
    "molecule_properties": {
      "acd_logp": 0.72,
      "alogp": 1.85,
      "aromatic_rings": 2,
      "full_molformula": "C8H8N2O3S",
      "full_mwt": 212.23,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 14,
      "mw_freebase": 212.23,
      "mw_monoisotopic": 212.0256,
      "psa": 87.18,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "OS(=N)(=O)Cc1noc2ccccc12",
      "standard_inchi": "InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)",
      "standard_inchi_key": "UBQNRHZMVUUOMG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "PD-110843",
        "CI-912",
        "AD-810"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Zonisamide (BAN, FDA, INN, JAN, USAN)",
        null
      ]
    },
    "usan_year": 1985
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL28196",
    "molecule_properties": {
      "acd_logd": 0.78,
      "acd_logp": 3.43,
      "acd_most_apka": 4.7,
      "acd_most_bpka": 5.11,
      "alogp": 4.16,
      "aromatic_rings": 2,
      "full_molformula": "C18H19NO2",
      "full_mwt": 281.36,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 21,
      "molecular_species": "ACID",
      "mw_freebase": 281.36,
      "mw_monoisotopic": 281.1416,
      "psa": 50.19,
      "qed_weighted": 0.78,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CCCC\\C=C(\\c1ccccc1)/c2cccnc2",
      "standard_inchi": "InChI=1S/C18H19NO2/c20-18(21)12-6-2-5-11-17(15-8-3-1-4-9-15)16-10-7-13-19-14-16/h1,3-4,7-11,13-14H,2,5-6,12H2,(H,20,21)/b17-11-",
      "standard_inchi_key": "UWPBQLKEHGGKKD-BOPFTXTBSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Isbogrel (INN)",
        null
      ]
    },
    "usan_stem": "-grel",
    "usan_stem_definition": "platelet aggregation inhibitors",
    "usan_stem_substem": "-grel(-grel)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL28854",
    "molecule_properties": {
      "acd_logd": 1.14,
      "acd_logp": 1.37,
      "acd_most_bpka": 7.25,
      "alogp": 3.44,
      "aromatic_rings": 2,
      "full_molformula": "C15H16Cl3N5",
      "full_mwt": 372.69,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 372.69,
      "mw_monoisotopic": 371.0471,
      "psa": 58.28,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CCN(CC1)c2ncc(c(N)n2)c3cc(Cl)cc(Cl)c3Cl",
      "standard_inchi": "InChI=1S/C15H16Cl3N5/c1-22-2-4-23(5-3-22)15-20-8-11(14(19)21-15)10-6-9(16)7-12(17)13(10)18/h6-8H,2-5H2,1H3,(H2,19,20,21)",
      "standard_inchi_key": "PDOCBJADCWMDGL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "619C89"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sipatrigine (BAN, INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL28509",
    "molecule_properties": {
      "acd_logd": 4.85,
      "acd_logp": 4.25,
      "acd_most_apka": 1.2,
      "alogp": 6.49,
      "full_molformula": "C27H58NO6P",
      "full_mwt": 523.74,
      "hba": 6,
      "hba_lipinski": 7,
      "heavy_atoms": 35,
      "molecular_species": "ACID",
      "mw_freebase": 523.74,
      "mw_monoisotopic": 523.4002,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 77.05,
      "qed_weighted": 0.07,
      "ro3_pass": "N",
      "rtb": 27
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCCCCCCCCCCCCOCC(COP(=O)([O-])OCC[N+](C)(C)C)OC",
      "standard_inchi": "InChI=1S/C27H58NO6P/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-20-21-23-32-25-27(31-5)26-34-35(29,30)33-24-22-28(2,3)4/h27H,6-26H2,1-5H3",
      "standard_inchi_key": "MHFRGQHAERHWKZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Edelfosine (INN)",
        null
      ]
    },
    "usan_stem": "-fo-",
    "usan_stem_definition": "phosphoro-derivatives",
    "usan_stem_substem": "-fo-(-fo-)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL28079",
    "molecule_properties": {
      "acd_logd": 1.31,
      "acd_logp": 2.35,
      "acd_most_apka": 6.92,
      "acd_most_bpka": 1.51,
      "alogp": 1.5,
      "aromatic_rings": 3,
      "full_molformula": "C13H13N5O2",
      "full_mwt": 271.28,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 271.28,
      "mw_monoisotopic": 271.1069,
      "psa": 96.55,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCCOc1ccccc1C2=Nc3nn[nH]c3C(=O)N2",
      "standard_inchi": "InChI=1S/C13H13N5O2/c1-2-7-20-9-6-4-3-5-8(9)11-14-12-10(13(19)15-11)16-18-17-12/h3-6H,2,7H2,1H3,(H2,14,15,16,17,18,19)",
      "standard_inchi_key": "REZGGXNDEMKIQB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "M&B-22948"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Zaprinast (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics (not acting primarily as antihistamines,leukotriene biosynthesis inhibitors)",
    "usan_stem_substem": "-ast(-ast)"
  },
  {
    "applicants": {
      "value": "Eli Lilly And Co"
    },
    "atc_classification": {
      "drug": {
        "code": "H04AA01",
        "description": "SYSTEMIC HORMONAL PREPARATIONS, EXCL. SEX HORMONES AND INSULINS: PANCREATIC HORMONES: GLYCOGENOLYTIC HORMONES: Glycogenolytic hormones"
      }
    },
    "availability_type": 1,
    "biotherapeutic": {
      "description": "GLUCAGON",
      "helm_notation": "PEPTIDE1{H.S.Q.G.T.F.T.S.D.Y.S.K.Y.L.D.S.R.R.A.Q.D.F.V.Q.W.L.M.N.T}$$$$",
      "molecule_chembl_id": "CHEMBL266481"
    },
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 5,
    "first_approval": 1998,
    "helm_notation": "PEPTIDE1{H.S.Q.G.T.F.T.S.D.Y.S.K.Y.L.D.S.R.R.A.Q.D.F.V.Q.W.L.M.N.T}$$$$",
    "indication_class": "Antidiabetic",
    "molecule_chembl_id": "CHEMBL266481",
    "molecule_properties": {
      "full_molformula": "C153H225N43O49S",
      "full_mwt": 3482.8,
      "mw_freebase": 3482.8,
      "mw_monoisotopic": 3480.6157
    },
    "molecule_structures": {
      "canonical_smiles": "CSCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H](NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc4ccc(O)cc4)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](Cc5ccc(O)cc5)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc6ccccc6)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)NC(=O)[C@@H](N)Cc7c[nH]cn7)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H]([C@@H](C)O)C(=O)O",
      "standard_inchi": "InChI=1S/C153H225N43O49S/c1-72(2)52-97(133(226)176-96(47-51-246-11)132(225)184-104(60-115(159)209)143(236)196-123(78(10)203)151(244)245)179-137(230)103(58-83-64-167-89-29-19-18-28-87(83)89)183-131(224)95(43-46-114(158)208)177-148(241)120(74(5)6)194-141(234)101(54-79-24-14-12-15-25-79)182-138(231)105(61-117(211)212)185-130(223)94(42-45-113(157)207)171-124(217)75(7)170-127(220)91(31-22-49-165-152(160)161)172-128(221)92(32-23-50-166-153(162)163)174-146(239)110(69-199)191-140(233)107(63-119(215)216)186-134(227)98(53-73(3)4)178-135(228)99(56-81-33-37-85(204)38-34-81)180-129(222)90(30-20-21-48-154)173-145(238)109(68-198)190-136(229)100(57-82-35-39-86(205)40-36-82)181-139(232)106(62-118(213)214)187-147(240)111(70-200)192-150(243)122(77(9)202)195-142(235)102(55-80-26-16-13-17-27-80)188-149(242)121(76(8)201)193-116(210)66-168-126(219)93(41-44-112(156)206)175-144(237)108(67-197)189-125(218)88(155)59-84-65-164-71-169-84/h12-19,24-29,33-40,64-65,71-78,88,90-111,120-123,167,197-205H,20-23,30-32,41-63,66-70,154-155H2,1-11H3,(H2,156,206)(H2,157,207)(H2,158,208)(H2,159,209)(H,164,169)(H,168,219)(H,170,220)(H,171,217)(H,172,221)(H,173,238)(H,174,239)(H,175,237)(H,176,226)(H,177,241)(H,178,228)(H,179,230)(H,180,222)(H,181,232)(H,182,231)(H,183,224)(H,184,225)(H,185,223)(H,186,227)(H,187,240)(H,188,242)(H,189,218)(H,190,229)(H,191,233)(H,192,243)(H,193,210)(H,194,234)(H,195,235)(H,196,236)(H,211,212)(H,213,214)(H,215,216)(H,244,245)(H4,160,161,165)(H4,162,163,166)/t75-,76+,77+,78+,88-,90-,91-,92-,93-,94-,95-,96-,97-,98-,99-,100-,101-,102-,103-,104-,105-,106-,107-,108-,109-,110-,111-,120-,121-,122-,123-/m0/s1",
      "standard_inchi_key": "MASNOZXLGMXCHN-ZLPAWPGGSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "synonyms": {
      "value": [
        "Glucagon (BAN, INN, JAN, USP)",
        "Glucagon Recombinant (FDA)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL28979",
    "molecule_properties": {
      "acd_logd": -0.48,
      "acd_logp": 0.96,
      "acd_most_bpka": 9.03,
      "alogp": 2.19,
      "aromatic_rings": 2,
      "full_molformula": "C18H23N3O",
      "full_mwt": 297.4,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 297.4,
      "mw_monoisotopic": 297.1841,
      "psa": 59.22,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(CC(C(=O)N)(c1ccccc1)c2ccccn2)N(C)C",
      "standard_inchi": "InChI=1S/C18H23N3O/c1-14(21(2)3)13-18(17(19)22,15-9-5-4-6-10-15)16-11-7-8-12-20-16/h4-12,14H,13H2,1-3H3,(H2,19,22)",
      "standard_inchi_key": "BWNLUIXQIHPUGO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Vamicamide (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL29292",
    "molecule_properties": {
      "acd_logd": -1.71,
      "acd_logp": 0.99,
      "acd_most_apka": 3.28,
      "acd_most_bpka": 6.87,
      "alogp": 0.53,
      "aromatic_rings": 1,
      "full_molformula": "C16H24N2O4",
      "full_mwt": 308.38,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 22,
      "molecular_species": "ACID",
      "mw_freebase": 308.38,
      "mw_monoisotopic": 308.1736,
      "psa": 112.65,
      "qed_weighted": 0.56,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O",
      "standard_inchi": "InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1",
      "standard_inchi_key": "VGGGPCQERPFHOB-RDBSUJKOSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ubenimex (INN, JAN, MI)",
        null
      ]
    },
    "usan_stem": "-imex",
    "usan_stem_definition": "immunostimulants",
    "usan_stem_substem": "-imex(-imex)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL280531",
    "molecule_properties": {
      "acd_logd": -4.93,
      "acd_logp": -2.47,
      "acd_most_apka": 3.1,
      "acd_most_bpka": 10.17,
      "alogp": -1.29,
      "aromatic_rings": 2,
      "full_molformula": "C9H13N5O3",
      "full_mwt": 239.24,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 17,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 239.24,
      "mw_monoisotopic": 239.1018,
      "psa": 130.31,
      "qed_weighted": 0.52,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1nc(O)c2ncn(CC(CO)CO)c2n1",
      "standard_inchi": "InChI=1S/C9H13N5O3/c10-9-12-7-6(8(17)13-9)11-4-14(7)1-5(2-15)3-16/h4-5,15-16H,1-3H2,(H3,10,12,13,17)",
      "standard_inchi_key": "ANFNNSIOGODJDN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tiviciclovir (INN)",
        null
      ]
    },
    "usan_stem": "-vir",
    "usan_stem_definition": "antivirals: antivirals (acyclovir type)",
    "usan_stem_substem": "-vir(-vir(-ciclovir))"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "indication_class": "Nutrient",
    "molecule_chembl_id": "CHEMBL752",
    "molecule_properties": {
      "acd_logd": -7.44,
      "acd_logp": -3.19,
      "acd_most_apka": 1.86,
      "acd_most_bpka": 3.82,
      "alogp": -1.86,
      "aromatic_rings": 2,
      "full_molformula": "C10H14N5O7P",
      "full_mwt": 347.22,
      "hba": 10,
      "hba_lipinski": 12,
      "hbd": 5,
      "hbd_lipinski": 6,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 347.22,
      "mw_monoisotopic": 347.0631,
      "num_lipinski_ro5_violations": 2,
      "psa": 186.07,
      "qed_weighted": 0.39,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1ncnc2c1ncn2[C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O",
      "standard_inchi": "InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",
      "standard_inchi_key": "UDMBCSSLTHHNCD-KQYNXXCUSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "A-5MP"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Adenosine Phosphate (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1963,
    "withdrawn_country": "United States"
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL28564",
    "molecule_properties": {
      "acd_logd": 3.73,
      "acd_logp": 4.71,
      "acd_most_apka": 13.99,
      "acd_most_bpka": 8.41,
      "alogp": 4.47,
      "aromatic_rings": 2,
      "full_molformula": "C20H23ClFNO",
      "full_mwt": 347.86,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 347.86,
      "mw_monoisotopic": 347.1452,
      "psa": 23.47,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "OC(CN1CCC(Cc2ccc(F)cc2)CC1)c3ccc(Cl)cc3",
      "standard_inchi": "InChI=1S/C20H23ClFNO/c21-18-5-3-17(4-6-18)20(24)14-23-11-9-16(10-12-23)13-15-1-7-19(22)8-2-15/h1-8,16,20,24H,9-14H2",
      "standard_inchi_key": "GGUSQTSTQSHJAH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Eliprodil (INN)",
        null
      ]
    },
    "usan_stem": "-dil",
    "usan_stem_definition": "vasodilators (undefined group)",
    "usan_stem_substem": "-dil(-dil)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL286020",
    "molecule_properties": {
      "acd_logd": -0.9,
      "acd_logp": -0.83,
      "acd_most_bpka": 6.64,
      "alogp": 2.32,
      "aromatic_rings": 1,
      "full_molformula": "C14H13N3O2S",
      "full_mwt": 287.34,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 287.34,
      "mw_monoisotopic": 287.0728,
      "psa": 67.87,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(ccc1c2nc3ccc[nH]c3n2)[S+](C)[O-]",
      "standard_inchi": "InChI=1S/C14H13N3O2S/c1-19-12-8-9(20(2)18)5-6-10(12)13-16-11-4-3-7-15-14(11)17-13/h3-8H,1-2H3,(H,15,16,17)",
      "standard_inchi_key": "XMFCOYRWYYXZMY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sulmazole (INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL28930",
    "molecule_properties": {
      "acd_logd": 4.76,
      "acd_logp": 4.16,
      "acd_most_apka": 1.23,
      "alogp": 6.67,
      "full_molformula": "C26H56NO5PS",
      "full_mwt": 525.78,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 34,
      "molecular_species": "ACID",
      "mw_freebase": 525.78,
      "mw_monoisotopic": 525.3617,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 67.82,
      "qed_weighted": 0.07,
      "ro3_pass": "N",
      "rtb": 26
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCCCCCCCCCCSCC(COC)COP(=O)([O-])OCC[N+](C)(C)C",
      "standard_inchi": "InChI=1S/C26H56NO5PS/c1-6-7-8-9-10-11-12-13-14-15-16-17-18-19-22-34-25-26(23-30-5)24-32-33(28,29)31-21-20-27(2,3)4/h26H,6-25H2,1-5H3",
      "standard_inchi_key": "ODEDPKNSRBCSDO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BM 41.440"
    },
    "synonyms": {
      "value": [
        "Ilmofosine (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-fo-",
    "usan_stem_definition": "phosphoro-derivatives",
    "usan_stem_substem": "-fo-(-fo-)",
    "usan_year": 1990
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL31882",
    "molecule_properties": {
      "acd_logd": 1.22,
      "acd_logp": 1.22,
      "acd_most_apka": 9.7,
      "acd_most_bpka": 4.18,
      "alogp": -0.17,
      "aromatic_rings": 2,
      "full_molformula": "C6H6N4O",
      "full_mwt": 150.14,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 11,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 150.14,
      "mw_monoisotopic": 150.0542,
      "psa": 87.56,
      "qed_weighted": 0.49,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "NC1=Cc2[nH]cnc2C(=O)N1",
      "standard_inchi": "InChI=1S/C6H6N4O/c7-4-1-3-5(6(11)10-4)9-2-8-3/h1-2H,(H,8,9)(H3,7,10,11)",
      "standard_inchi_key": "KXBCLNRMQPRVTP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "CI-908",
        "CI-908 Mesylate",
        "PD-9069573"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dezaguanine (INN, USAN)",
        "Dezaguanine Mesylate (USAN)",
        null
      ]
    },
    "usan_year": 1984
  },
  {
    "applicants": {
      "value": [
        "Concordia Pharmaceuticals Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Par Pharmaceutical Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C04AX02",
        "description": "CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Other peripheral vasodilators"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1953,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL753",
    "molecule_properties": {
      "acd_logd": 3.62,
      "acd_logp": 3.69,
      "acd_most_bpka": 6.58,
      "alogp": 4.19,
      "aromatic_rings": 2,
      "full_molformula": "C18H22ClNO",
      "full_mwt": 303.83,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 303.83,
      "mw_monoisotopic": 303.139,
      "psa": 12.47,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CC(COc1ccccc1)N(CCCl)Cc2ccccc2",
      "standard_inchi": "InChI=1S/C18H22ClNO/c1-16(15-21-18-10-6-3-7-11-18)20(13-12-19)14-17-8-4-2-5-9-17/h2-11,16H,12-15H2,1H3",
      "standard_inchi_key": "QZVCTJOXCFMACW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Phenoxybenzamine HCl (FDA, USP)",
        "Phenoxybenzamine (BAN, INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL283403",
    "molecule_properties": {
      "acd_logd": 3.1,
      "acd_logp": 3.1,
      "acd_most_apka": 9.85,
      "acd_most_bpka": 1.73,
      "alogp": 2.43,
      "aromatic_rings": 3,
      "full_molformula": "C17H18N4O3S",
      "full_mwt": 358.42,
      "hba": 7,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 358.42,
      "mw_monoisotopic": 358.11,
      "psa": 110.57,
      "qed_weighted": 0.42,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)S(=O)(=O)n1c(N)nc2ccc(cc12)\\C(=N\\O)\\c3ccccc3",
      "standard_inchi": "InChI=1S/C17H18N4O3S/c1-11(2)25(23,24)21-15-10-13(8-9-14(15)19-17(21)18)16(20-22)12-6-4-3-5-7-12/h3-11,22H,1-2H3,(H2,18,19)/b20-16+",
      "standard_inchi_key": "IWKXBHQELWQLHF-CAPFRKAQSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Enviroxime (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-vir-",
    "usan_stem_definition": "antivirals",
    "usan_stem_substem": "-vir-(-vir-)",
    "usan_year": 1980
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 1,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL284642",
    "molecule_properties": {
      "acd_logd": 9.15,
      "acd_logp": 9.15,
      "acd_most_apka": 10.06,
      "acd_most_bpka": 0.47,
      "alogp": 9.25,
      "aromatic_rings": 8,
      "full_molformula": "C43H36Cl2N8O5",
      "full_mwt": 815.72,
      "hba": 5,
      "hba_lipinski": 13,
      "hbd": 8,
      "hbd_lipinski": 8,
      "heavy_atoms": 58,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 815.72,
      "mw_monoisotopic": 814.2186,
      "num_lipinski_ro5_violations": 4,
      "num_ro5_violations": 3,
      "psa": 185.37,
      "qed_weighted": 0.08,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1c[nH]c2c(O)cc3N(C[C@@H](CCl)c3c12)C(=O)c4cc5cc(NC(=O)Nc6ccc7[nH]c(cc7c6)C(=O)N8C[C@@H](CCl)c9c8cc(O)c%10[nH]cc(C)c9%10)ccc5[nH]4",
      "standard_inchi": "InChI=1S/C43H36Cl2N8O5/c1-19-15-46-39-33(54)11-31-37(35(19)39)23(13-44)17-52(31)41(56)29-9-21-7-25(3-5-27(21)50-29)48-43(58)49-26-4-6-28-22(8-26)10-30(51-28)42(57)53-18-24(14-45)38-32(53)12-34(55)40-36(38)20(2)16-47-40/h3-12,15-16,23-24,46-47,50-51,54-55H,13-14,17-18H2,1-2H3,(H2,48,49,58)/t23-,24-/m1/s1",
      "standard_inchi_key": "FONKWHRXTPJODV-DNQXCXABSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "U-77779"
    },
    "synonyms": {
      "value": [
        "Bizelesin (INN, USAN)",
        null
      ]
    },
    "usan_year": 1992
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antihyperlipoproteinemic",
    "molecule_chembl_id": "CHEMBL31907",
    "molecule_properties": {
      "acd_logd": 6.7,
      "acd_logp": 9.15,
      "acd_most_apka": 4.76,
      "acd_most_bpka": 2.54,
      "alogp": 7.28,
      "aromatic_rings": 1,
      "full_molformula": "C23H39NO2",
      "full_mwt": 361.57,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 361.57,
      "mw_monoisotopic": 361.2981,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 49.33,
      "qed_weighted": 0.29,
      "ro3_pass": "N",
      "rtb": 17
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCCCCCCCCCCNc1ccc(cc1)C(=O)O",
      "standard_inchi": "InChI=1S/C23H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-20-24-22-18-16-21(17-19-22)23(25)26/h16-19,24H,2-15,20H2,1H3,(H,25,26)",
      "standard_inchi_key": "QXWKHSSBFQDQPR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CL-203821"
    },
    "synonyms": {
      "value": [
        "Cetaben (INN)",
        "Cetaben sodium (USAN)",
        null
      ]
    },
    "usan_year": 1978
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL31965",
    "molecule_properties": {
      "acd_logd": 0.96,
      "acd_logp": 1.1,
      "acd_most_apka": 12.09,
      "acd_most_bpka": 6.99,
      "alogp": 4.39,
      "aromatic_rings": 3,
      "full_molformula": "C24H25ClFN5O3",
      "full_mwt": 485.95,
      "hba": 7,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 34,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 485.95,
      "mw_monoisotopic": 485.163,
      "psa": 88.61,
      "qed_weighted": 0.34,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl",
      "standard_inchi": "InChI=1S/C24H25ClFN5O3/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29)",
      "standard_inchi_key": "OMZCMEYTWSXEPZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "PD-183805",
        "SN-26606",
        "PD-0183805",
        "CI-1033"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Canertinib Dihydrochloride (USAN)",
        "Canertinib (INN)",
        null
      ]
    },
    "usan_stem": "-tinib",
    "usan_stem_definition": "tyrosine kinase inhibitors",
    "usan_stem_substem": "-tinib(-tinib)",
    "usan_year": 2002
  },
  {
    "availability_type": -1,
    "biotherapeutic": {
      "description": "TEPROTIDE",
      "helm_notation": "PEPTIDE1{[Glp].W.P.R.P.Q.I.P.P}$$$$",
      "molecule_chembl_id": "CHEMBL408983"
    },
    "chirality": 1,
    "drug_type": 5,
    "helm_notation": "PEPTIDE1{[Glp].W.P.R.P.Q.I.P.P}$$$$",
    "indication_class": "Enzyme Inhibitor (angiotensin-converting)",
    "molecule_chembl_id": "CHEMBL408983",
    "molecule_properties": {
      "full_molformula": "C53H76N14O12",
      "full_mwt": 1101.28,
      "mw_freebase": 1101.28,
      "mw_monoisotopic": 1100.5767
    },
    "molecule_structures": {
      "canonical_smiles": "CC[C@H](C)[C@H](NC(=O)[C@H](CCC(=O)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc3c[nH]c4ccccc34)NC(=O)[C@@H]5CCC(=O)N5)C(=O)N6CCC[C@H]6C(=O)N7CCC[C@H]7C(=O)O",
      "standard_inchi": "InChI=1S/C53H76N14O12/c1-3-29(2)43(51(77)66-25-9-16-39(66)50(76)67-26-10-17-40(67)52(78)79)63-45(71)34(18-20-41(54)68)60-46(72)37-14-7-23-64(37)48(74)35(13-6-22-57-53(55)56)61-47(73)38-15-8-24-65(38)49(75)36(62-44(70)33-19-21-42(69)59-33)27-30-28-58-32-12-5-4-11-31(30)32/h4-5,11-12,28-29,33-40,43,58H,3,6-10,13-27H2,1-2H3,(H2,54,68)(H,59,69)(H,60,72)(H,61,73)(H,62,70)(H,63,71)(H,78,79)(H4,55,56,57)/t29-,33-,34-,35-,36-,37-,38-,39-,40-,43-/m0/s1",
      "standard_inchi_key": "UUUHXMGGBIUAPW-CSCXCSGISA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "SO-20881",
        "SQ-20881"
      ]
    },
    "synonyms": {
      "value": [
        "Teprotide (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-tide",
    "usan_stem_definition": "peptides",
    "usan_stem_substem": "-tide(-tide)",
    "usan_year": 1976
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL435951",
    "molecule_properties": {
      "acd_logd": -0.47,
      "acd_logp": -0.47,
      "alogp": -1.38,
      "aromatic_rings": 2,
      "full_molformula": "C7H7ClN6O2",
      "full_mwt": 242.63,
      "hba": 7,
      "hba_lipinski": 8,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 242.63,
      "mw_monoisotopic": 242.0319,
      "psa": 108.17,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=O)c1ncn2C(=O)N(CCCl)N=Nc12",
      "standard_inchi": "InChI=1S/C7H7ClN6O2/c8-1-2-14-7(16)13-3-10-4(5(9)15)6(13)11-12-14/h3H,1-2H2,(H2,9,15)",
      "standard_inchi_key": "QXYYYPFGTSJXNS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mitozolomide (BAN, INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Shire Development Llc",
        "Roxane Laboratories Inc",
        "Torrent Pharmaceuticals Ltd",
        "Upsher-Smith Laboratories Llc",
        "Barr Laboratories Inc",
        "Mylan Pharmaceuticals Inc",
        "Impax Laboratories Inc",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa",
        "Watson Laboratories"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01XX35",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: OTHER ANTINEOPLASTIC AGENTS: Other antineoplastic agents"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1997,
    "indication_class": "Antithrombotic",
    "molecule_chembl_id": "CHEMBL760",
    "molecule_properties": {
      "acd_logd": 2.13,
      "acd_logp": 2.13,
      "acd_most_apka": 11.79,
      "alogp": 1.93,
      "aromatic_rings": 1,
      "full_molformula": "C10H7Cl2N3O",
      "full_mwt": 256.09,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 256.09,
      "mw_monoisotopic": 254.9966,
      "psa": 44.7,
      "qed_weighted": 0.77,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1ccc2N=C3NC(=O)CN3Cc2c1Cl",
      "standard_inchi": "InChI=1S/C10H7Cl2N3O/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7/h1-2H,3-4H2,(H,13,14,16)",
      "standard_inchi_key": "OTBXOEAOVRKTNQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "BL-4162a"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Anagrelide (BAN, INN)",
        "Anagrelide HCl (FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-grel-",
    "usan_stem_definition": "platelet aggregation inhibitors",
    "usan_stem_substem": "-grel-(-grel-)",
    "usan_year": 1979
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL31400",
    "molecule_properties": {
      "acd_logd": 0.29,
      "acd_logp": 3.5,
      "acd_most_bpka": 9.69,
      "alogp": 3.45,
      "aromatic_rings": 4,
      "full_molformula": "C31H28N4O4",
      "full_mwt": 520.59,
      "hba": 6,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 39,
      "molecular_species": "BASE",
      "mw_freebase": 520.59,
      "mw_monoisotopic": 520.2111,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 98.82,
      "qed_weighted": 0.25,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1N(CCNCCCNCCN2C(=O)c3cccc4cccc(C2=O)c34)C(=O)c5cccc6cccc1c56",
      "standard_inchi": "InChI=1S/C31H28N4O4/c36-28-22-10-1-6-20-7-2-11-23(26(20)22)29(37)34(28)18-16-32-14-5-15-33-17-19-35-30(38)24-12-3-8-21-9-4-13-25(27(21)24)31(35)39/h1-4,6-13,32-33H,5,14-19H2",
      "standard_inchi_key": "QUNOQBDEVTWCTA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "LU-79553"
    },
    "synonyms": {
      "value": [
        "Elinafide (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Akorn Inc",
        "Pharmafair Inc",
        "Allergan Inc",
        "Novartis Pharmaceuticals Corp",
        "Alcon Laboratories Inc",
        "Johnson And Johnson Consumer Inc",
        "Altaire Pharmaceuticals Inc",
        "Bausch And Lomb Pharmaceuticals Inc",
        "Bausch And Lomb Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R01AB02",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, combinations excl. corticosteroid"
        },
        {
          "code": "S01GA01",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Sympathomimetics used as decongestant"
        },
        {
          "code": "R01AA08",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, plai"
        },
        {
          "code": "S01GA51",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Sympathomimetics used as decongestants"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1971,
    "indication_class": "Adrenergic (vasoconstrictor)",
    "molecule_chembl_id": "CHEMBL761",
    "molecule_properties": {
      "acd_logd": 1.04,
      "acd_logp": 2.99,
      "acd_most_bpka": 10.27,
      "alogp": 2.38,
      "aromatic_rings": 2,
      "full_molformula": "C14H14N2",
      "full_mwt": 210.28,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "BASE",
      "mw_freebase": 210.28,
      "mw_monoisotopic": 210.1157,
      "psa": 24.39,
      "qed_weighted": 0.81,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C(C1=NCCN1)c2cccc3ccccc23",
      "standard_inchi": "InChI=1S/C14H14N2/c1-2-7-13-11(4-1)5-3-6-12(13)10-14-15-8-9-16-14/h1-7H,8-10H2,(H,15,16)",
      "standard_inchi_key": "CNIIGCLFLJGOGP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Naphazoline HCl (FDA, JAN, USP)",
        "Naphazoline Nitrate (JAN)",
        "Naphazoline (BAN, INN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-azoline",
    "usan_stem_definition": "antihistamines/local vasoconstrictors (antazoline type)",
    "usan_stem_substem": "-azoline(-azoline)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "J05AB15",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
      }
    },
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 1,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL31634",
    "molecule_properties": {
      "acd_logd": 0.24,
      "acd_logp": 0.29,
      "acd_most_apka": 8.37,
      "alogp": -0.46,
      "aromatic_rings": 1,
      "full_molformula": "C11H13BrN2O5",
      "full_mwt": 333.14,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 333.14,
      "mw_monoisotopic": 332.0008,
      "psa": 104.55,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(\\C=C\\Br)C(=O)NC2=O",
      "standard_inchi": "InChI=1S/C11H13BrN2O5/c12-2-1-6-4-14(11(18)13-10(6)17)9-3-7(16)8(5-15)19-9/h1-2,4,7-9,15-16H,3,5H2,(H,13,17,18)/b2-1+/t7-,8+,9+/m0/s1",
      "standard_inchi_key": "ODZBBRURCPAEIQ-PIXDULNESA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Brivudine (INN)",
        null
      ]
    },
    "usan_stem": "-vudine",
    "usan_stem_definition": "antineoplastics,antivirals (zidovudine group) (exception: edoxudine)",
    "usan_stem_substem": "-vudine(-vudine)"
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL31836",
    "molecule_properties": {
      "acd_logd": 2.04,
      "acd_logp": 3.25,
      "acd_most_bpka": 8.59,
      "alogp": 2.31,
      "aromatic_rings": 1,
      "full_molformula": "C14H19NO2",
      "full_mwt": 233.31,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 17,
      "molecular_species": "BASE",
      "mw_freebase": 233.31,
      "mw_monoisotopic": 233.1416,
      "psa": 21.7,
      "qed_weighted": 0.78,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C(C1COc2ccccc2O1)N3CCCCC3",
      "standard_inchi": "InChI=1S/C14H19NO2/c1-4-8-15(9-5-1)10-12-11-16-13-6-2-3-7-14(13)17-12/h2-3,6-7,12H,1,4-5,8-11H2",
      "standard_inchi_key": "LYKMMUBOEFYJQG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Piperoxan (BAN, INN, MI)",
        null
      ]
    },
    "usan_stem": "-oxan(e)",
    "usan_stem_definition": "alpha-adrenoceptor antagonists (benzodioxane derivatives)",
    "usan_stem_substem": "-oxan(e)(-oxan(e))"
  },
  {
    "applicants": {
      "value": [
        "Bayer Healthcare Llc",
        "St Renatus Llc",
        "Allergan Inc",
        "Johnson And Johnson Consumer Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "S01GA04",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Sympathomimetics used as decongestant"
        },
        {
          "code": "R01AA05",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, plai"
        },
        {
          "code": "R01AB07",
          "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, combinations excl. corticosteroids"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1986,
    "indication_class": "Adrenergic (vasoconstrictor)",
    "molecule_chembl_id": "CHEMBL762",
    "molecule_properties": {
      "acd_logd": 1.79,
      "acd_logp": 3.76,
      "acd_most_apka": 11.93,
      "acd_most_bpka": 10.61,
      "alogp": 2.85,
      "aromatic_rings": 1,
      "full_molformula": "C16H24N2O",
      "full_mwt": 260.38,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 260.38,
      "mw_monoisotopic": 260.1889,
      "psa": 44.62,
      "qed_weighted": 0.86,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cc(c(O)c(C)c1CC2=NCCN2)C(C)(C)C",
      "standard_inchi": "InChI=1S/C16H24N2O/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14/h8,19H,6-7,9H2,1-5H3,(H,17,18)",
      "standard_inchi_key": "WYWIFABBXFUGLM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6413499,
    "research_codes": {
      "value": "SCH-9384"
    },
    "rule_of_five": true,
    "sc_patent": "US-6413499-B1",
    "synonyms": {
      "value": [
        "Oxymetazoline (BAN, INN)",
        "Oxymetazoline HCl (FDA, JAN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-azoline",
    "usan_stem_definition": "antihistamines/local vasoconstrictors (antazoline type)",
    "usan_stem_substem": "-azoline(-azoline)",
    "usan_year": 1963
  },
  {
    "atc_classification": {
      "drug": {
        "code": "J01EA02",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: SULFONAMIDES AND TRIMETHOPRIM: Trimethoprim and derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL31891",
    "molecule_properties": {
      "acd_logd": 2.18,
      "acd_logp": 2.29,
      "acd_most_bpka": 6.85,
      "alogp": 2.01,
      "aromatic_rings": 2,
      "full_molformula": "C13H15BrN4O2",
      "full_mwt": 339.19,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 339.19,
      "mw_monoisotopic": 338.0378,
      "psa": 96.28,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(Cc2cnc(N)nc2N)cc(OC)c1Br",
      "standard_inchi": "InChI=1S/C13H15BrN4O2/c1-19-9-4-7(5-10(20-2)11(9)14)3-8-6-17-13(16)18-12(8)15/h4-6H,3H2,1-2H3,(H4,15,16,17,18)",
      "standard_inchi_key": "BFCRRLMMHNLSCP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Brodimoprim (INN, MI)",
        null
      ]
    },
    "usan_stem": "-prim",
    "usan_stem_definition": "antibacterials (trimethoprim type)",
    "usan_stem_substem": "-prim(-prim)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL32039",
    "molecule_properties": {
      "acd_logd": 0.17,
      "acd_logp": 0.29,
      "acd_most_bpka": 6.9,
      "alogp": 1.27,
      "aromatic_rings": 2,
      "full_molformula": "C16H22N4O4",
      "full_mwt": 334.38,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 334.38,
      "mw_monoisotopic": 334.1641,
      "psa": 114.74,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "COCCOc1c(OC)cc(Cc2cnc(N)nc2N)cc1OC",
      "standard_inchi": "InChI=1S/C16H22N4O4/c1-21-4-5-24-14-12(22-2)7-10(8-13(14)23-3)6-11-9-19-16(18)20-15(11)17/h7-9H,4-6H2,1-3H3,(H4,17,18,19,20)",
      "standard_inchi_key": "WSWJIZXMAUYHOE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tetroxoprim (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-prim",
    "usan_stem_definition": "antibacterials (trimethoprim type)",
    "usan_stem_substem": "-prim(-prim)",
    "usan_year": 1978
  },
  {
    "atc_classification": {
      "drug": {
        "code": "R01AA09",
        "description": "RESPIRATORY SYSTEM: NASAL PREPARATIONS: DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE: Sympathomimetics, plain"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Adrenergic",
    "molecule_chembl_id": "CHEMBL32573",
    "molecule_properties": {
      "acd_logd": 1.19,
      "acd_logp": 2.78,
      "acd_most_bpka": 9.01,
      "alogp": 1.94,
      "aromatic_rings": 1,
      "full_molformula": "C13H17N3",
      "full_mwt": 215.3,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 16,
      "molecular_species": "BASE",
      "mw_freebase": 215.3,
      "mw_monoisotopic": 215.1422,
      "psa": 36.42,
      "qed_weighted": 0.75,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "C1CCc2c(C1)cccc2NC3=NCCN3",
      "standard_inchi": "InChI=1S/C13H17N3/c1-2-6-11-10(4-1)5-3-7-12(11)16-13-14-8-9-15-13/h3,5,7H,1-2,4,6,8-9H2,(H2,14,15,16)",
      "standard_inchi_key": "QQJLHRRUATVHED-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tramazoline HCl (JAN, USAN)",
        "Tramazoline (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-azoline",
    "usan_stem_definition": "antihistamines/local vasoconstrictors (antazoline type)",
    "usan_stem_substem": "-azoline(-azoline)",
    "usan_year": 1970
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL31422",
    "molecule_properties": {
      "acd_logd": 0.03,
      "acd_logp": 0.07,
      "acd_most_apka": 8.4,
      "alogp": 0.65,
      "aromatic_rings": 1,
      "full_molformula": "C6H6O3",
      "full_mwt": 126.11,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 9,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 126.11,
      "mw_monoisotopic": 126.0317,
      "psa": 50.44,
      "qed_weighted": 0.55,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CC1=C(O)C(=O)C=CO1",
      "standard_inchi": "InChI=1S/C6H6O3/c1-4-6(8)5(7)2-3-9-4/h2-3,8H,1H3",
      "standard_inchi_key": "XPCTZQVDEJYUGT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Maltol (NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL440283",
    "molecule_properties": {
      "acd_logd": 3.95,
      "acd_logp": 3.95,
      "alogp": 3.67,
      "full_molformula": "C19H30O2",
      "full_mwt": 290.45,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 290.45,
      "mw_monoisotopic": 290.2246,
      "psa": 40.46,
      "qed_weighted": 0.67,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC[C@@H]2O",
      "standard_inchi": "InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-17,20-21H,4-11H2,1-2H3/t13-,14-,15-,16-,17-,18-,19-/m0/s1",
      "standard_inchi_key": "QADHLRWLCPCEKT-LOVVWNRFSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Androstenediol (JAN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (humectant); Pharmaceutic Aid (solvent); Pharmaceutic Aid (suspending agent)",
    "molecule_chembl_id": "CHEMBL286398",
    "molecule_properties": {
      "acd_logd": -1.01,
      "acd_logp": -1.01,
      "alogp": -0.64,
      "full_molformula": "C3H8O2",
      "full_mwt": 76.09,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 5,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 76.09,
      "mw_monoisotopic": 76.0524,
      "psa": 40.46,
      "qed_weighted": 0.44,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC(O)CO",
      "standard_inchi": "InChI=1S/C3H8O2/c1-3(5)2-4/h3-5H,2H2,1H3",
      "standard_inchi_key": "DNIAPMSPPWPWGF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Propylene Glycol (JAN, USP)",
        "Propylene Glycol Cefatrizine (JAN)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C09XA01",
        "description": "CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: OTHER AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: Renin-inhibitors"
      }
    },
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL31601",
    "molecule_properties": {
      "acd_logd": 3.66,
      "acd_logp": 3.81,
      "acd_most_apka": 13.68,
      "acd_most_bpka": 6.7,
      "alogp": 3.1,
      "aromatic_rings": 2,
      "full_molformula": "C33H50N4O6S",
      "full_mwt": 630.85,
      "hba": 7,
      "hba_lipinski": 10,
      "hbd": 5,
      "hbd_lipinski": 5,
      "heavy_atoms": 44,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 630.85,
      "mw_monoisotopic": 630.3451,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 161.48,
      "qed_weighted": 0.2,
      "ro3_pass": "N",
      "rtb": 15
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(C)S(=O)(=O)C[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc2cnc[nH]2)C(=O)N[C@@H](CC3CCCCC3)[C@@H](O)[C@@H](O)C4CC4",
      "standard_inchi": "InChI=1S/C33H50N4O6S/c1-33(2,3)44(42,43)20-25(16-22-10-6-4-7-11-22)31(40)37-28(18-26-19-34-21-35-26)32(41)36-27(17-23-12-8-5-9-13-23)30(39)29(38)24-14-15-24/h4,6-7,10-11,19,21,23-25,27-30,38-39H,5,8-9,12-18,20H2,1-3H3,(H,34,35)(H,36,41)(H,37,40)/t25-,27+,28+,29+,30-/m1/s1",
      "standard_inchi_key": "UXIGZRQVLGFTOU-VQXQMPIVSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Remikiren (INN)",
        null
      ]
    },
    "usan_stem": "-kiren",
    "usan_stem_definition": "renin inhibitors",
    "usan_stem_substem": "-kiren(-kiren)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Pharmaceutic Aid (alcohol denaturant)",
    "molecule_chembl_id": "CHEMBL285323",
    "molecule_properties": {
      "acd_logd": 1.33,
      "acd_logp": 1.33,
      "alogp": 1.62,
      "full_molformula": "C6H12O",
      "full_mwt": 100.16,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 7,
      "mw_freebase": 100.16,
      "mw_monoisotopic": 100.0888,
      "psa": 17.07,
      "qed_weighted": 0.52,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)CC(=O)C",
      "standard_inchi": "InChI=1S/C6H12O/c1-5(2)4-6(3)7/h5H,4H2,1-3H3",
      "standard_inchi_key": "NTIZESTWPVYFNL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Methyl isobutyl ketone (NF)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL764",
    "molecule_properties": {
      "acd_logd": -2.78,
      "acd_logp": -0.91,
      "acd_most_apka": 9.59,
      "acd_most_bpka": 8.4,
      "alogp": 0.48,
      "aromatic_rings": 1,
      "full_molformula": "C9H13NO3",
      "full_mwt": 183.21,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 13,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 183.21,
      "mw_monoisotopic": 183.0895,
      "psa": 86.71,
      "qed_weighted": 0.5,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(N)C(O)c1ccc(O)c(O)c1",
      "standard_inchi": "InChI=1S/C9H13NO3/c1-5(10)9(13)6-2-3-7(11)8(12)4-6/h2-5,9,11-13H,10H2,1H3",
      "standard_inchi_key": "GEFQWZLICWMTKF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nordefrin HCl (MI, NF)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Novartis Pharmaceuticals Corp",
        "Watson Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "C02CC02",
          "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, PERIPHERALLY ACTING: Guanidine derivative"
        },
        {
          "code": "S01EX01",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIGLAUCOMA PREPARATIONS AND MIOTICS: Other antiglaucoma preparations"
        }
      ]
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1960,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL765",
    "molecule_properties": {
      "acd_logd": -2.48,
      "acd_logp": 1.1,
      "acd_most_bpka": 13.36,
      "alogp": 0.74,
      "full_molformula": "C10H22N4",
      "full_mwt": 198.31,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 14,
      "molecular_species": "BASE",
      "mw_freebase": 198.31,
      "mw_monoisotopic": 198.1844,
      "psa": 65.14,
      "qed_weighted": 0.46,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=N)NCCN1CCCCCCC1",
      "standard_inchi": "InChI=1S/C10H22N4/c11-10(12)13-6-9-14-7-4-2-1-3-5-8-14/h1-9H2,(H4,11,12,13)",
      "standard_inchi_key": "ACGDKVXYNVEAGU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "SU-5864"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Guanethidine (BAN, INN)",
        "Guanethidine Sulfate (JAN, USAN, USP)",
        "Guanethidine monosulfate (FDA, USAN, USP)",
        null
      ]
    },
    "usan_stem": "guan-",
    "usan_stem_definition": "antihypertensives (guanidine derivatives)",
    "usan_stem_substem": "guan-(guan-)",
    "usan_year": 1963
  },
  {
    "applicants": {
      "value": [
        "Merck And Co Inc",
        "Hospira Inc",
        "Acs Dobfar Spa"
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1985,
    "indication_class": "Enzyme Inhibitor",
    "molecule_chembl_id": "CHEMBL766",
    "molecule_properties": {
      "acd_logd": -2.79,
      "acd_logp": 0.74,
      "acd_most_apka": 2.09,
      "acd_most_bpka": 8.83,
      "alogp": 1.43,
      "full_molformula": "C16H26N2O5S",
      "full_mwt": 358.46,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 24,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 358.46,
      "mw_monoisotopic": 358.1562,
      "psa": 129.72,
      "qed_weighted": 0.32,
      "ro3_pass": "N",
      "rtb": 11
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)C[C@@H]1C(=O)N\\C(=C/CCCCSC[C@H](N)C(=O)O)\\C(=O)O",
      "standard_inchi": "InChI=1S/C16H26N2O5S/c1-16(2)8-10(16)13(19)18-12(15(22)23)6-4-3-5-7-24-9-11(17)14(20)21/h6,10-11H,3-5,7-9,17H2,1-2H3,(H,18,19)(H,20,21)(H,22,23)/b12-6-/t10-,11+/m1/s1",
      "standard_inchi_key": "DHSUYTOATWAVLW-WFVMDLQDSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "MK-791"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cilastatin Sodium (FDA, JAN, USAN, USP)",
        "Cilastatin (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-stat-",
    "usan_stem_definition": "enzyme inhibitors",
    "usan_stem_substem": "-stat-(-stat-)",
    "usan_year": 1984
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Hq Specialty Pharma Corp",
        "Baxter Healthcare Corp Anesthesia Critical Care",
        "West-Ward Pharmaceuticals International Ltd",
        "Luitpold Pharmaceuticals Inc",
        "Baxter Healthcare Corp",
        "Mylan Institutional Llc",
        "Aurobindo Pharma Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C07AB09",
        "description": "CARDIOVASCULAR SYSTEM: BETA BLOCKING AGENTS: BETA BLOCKING AGENTS: Beta blocking agents, selective"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1986,
    "indication_class": "Anti-Adrenergic (beta-receptor)",
    "molecule_chembl_id": "CHEMBL768",
    "molecule_properties": {
      "acd_logd": -0.18,
      "acd_logp": 1.92,
      "acd_most_apka": 13.88,
      "acd_most_bpka": 9.43,
      "alogp": 1.53,
      "aromatic_rings": 1,
      "full_molformula": "C16H25NO4",
      "full_mwt": 295.38,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 295.38,
      "mw_monoisotopic": 295.1784,
      "psa": 67.79,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "COC(=O)CCc1ccc(OCC(O)CNC(C)C)cc1",
      "standard_inchi": "InChI=1S/C16H25NO4/c1-12(2)17-10-14(18)11-21-15-7-4-13(5-8-15)6-9-16(19)20-3/h4-5,7-8,12,14,17-18H,6,9-11H2,1-3H3",
      "standard_inchi_key": "AQNDDEOPVVGCPG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6310094,
    "parenteral": true,
    "research_codes": {
      "value": "ASL-8052"
    },
    "rule_of_five": true,
    "sc_patent": "US-6310094-B1",
    "synonyms": {
      "value": [
        "Esmolol HCl (FDA, USAN)",
        "Esmolol (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-olol",
    "usan_stem_definition": "beta-blockers (propranolol type)",
    "usan_stem_substem": "-olol(-olol)",
    "usan_year": 1983,
    "withdrawn_country": "United States",
    "withdrawn_reason": "Increased risk of medication errors resulting in serious adverse events, including deaths",
    "withdrawn_year": 2007
  },
  {
    "applicants": {
      "value": "Novartis Pharmaceuticals Corp"
    },
    "atc_classification": {
      "drug": [
        {
          "code": "C04AB02",
          "description": "CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Imidazoline derivative"
        },
        {
          "code": "M02AX02",
          "description": "MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Other topical products for joint and muscular pain"
        }
      ]
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1985,
    "indication_class": "Vasodilator (peripheral)",
    "molecule_chembl_id": "CHEMBL770",
    "molecule_properties": {
      "acd_logd": -0.18,
      "acd_logp": 1.8,
      "acd_most_bpka": 10.9,
      "alogp": 1.23,
      "aromatic_rings": 1,
      "full_molformula": "C10H12N2",
      "full_mwt": 160.22,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 12,
      "molecular_species": "BASE",
      "mw_freebase": 160.22,
      "mw_monoisotopic": 160.1,
      "psa": 24.39,
      "qed_weighted": 0.69,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C(C1=NCCN1)c2ccccc2",
      "standard_inchi": "InChI=1S/C10H12N2/c1-2-4-9(5-3-1)8-10-11-6-7-12-10/h1-5H,6-8H2,(H,11,12)",
      "standard_inchi_key": "JIVZKJJQOZQXQB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "TCMDC-125842"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tolazoline HCl (FDA, JAN, USP)",
        "Tolazoline (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-azoline",
    "usan_stem_definition": "antihistamines/local vasoconstrictors (antazoline type)",
    "usan_stem_substem": "-azoline(-azoline)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "J01DH05",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: OTHER BETA-LACTAM ANTIBACTERIALS: Carbapenems"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 1,
    "drug_type": 7,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL285347",
    "molecule_properties": {
      "acd_logd": -5.54,
      "acd_logp": -6.14,
      "acd_most_apka": 4.25,
      "alogp": -1.89,
      "aromatic_rings": 1,
      "full_molformula": "C15H18N4O4S",
      "full_mwt": 350.4,
      "hba": 7,
      "hba_lipinski": 8,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "ACID",
      "mw_freebase": 350.4,
      "mw_monoisotopic": 350.1049,
      "psa": 102.37,
      "qed_weighted": 0.5,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@@H](O)[C@@H]1[C@H]2[C@@H](C)C(=C(N2C1=O)C(=O)[O-])SC3C[n+]4cncn4C3",
      "standard_inchi": "InChI=1S/C15H18N4O4S/c1-7-11-10(8(2)20)14(21)19(11)12(15(22)23)13(7)24-9-3-17-5-16-6-18(17)4-9/h5-11,20H,3-4H2,1-2H3/t7-,8-,10-,11-/m1/s1",
      "standard_inchi_key": "MRMBZHPJVKCOMA-YJFSRANCSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "L-627",
        "CL-186815",
        "LJ-C10627"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Biapenem (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-penem",
    "usan_stem_definition": "antibacterial antibiotics, carbapenem derivatives",
    "usan_stem_substem": "-penem(-penem)",
    "usan_year": 1993
  },
  {
    "applicants": {
      "value": "Purdue Gmp Center Llc Dba The Chao Center Industrial Pharmacy"
    },
    "atc_classification": {
      "drug": {
        "code": "J04AB01",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIMYCOBACTERIALS: DRUGS FOR TREATMENT OF TUBERCULOSIS: Antibiotics"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1964,
    "indication_class": "Antibacterial (tuberculostatic)",
    "molecule_chembl_id": "CHEMBL771",
    "molecule_properties": {
      "acd_logd": -3,
      "acd_logp": -2.99,
      "acd_most_bpka": 5.93,
      "alogp": -1.62,
      "full_molformula": "C3H6N2O2",
      "full_mwt": 102.09,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 7,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 102.09,
      "mw_monoisotopic": 102.0429,
      "psa": 64.35,
      "qed_weighted": 0.39,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "N[C@@H]1CONC1=O",
      "standard_inchi": "InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6)/t2-/m1/s1",
      "standard_inchi_key": "DYDCUQKUCUHJBH-UWTATZPHSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cycloserine (BAN, FDA, INN, JAN, USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Acs Dobfar Spa",
        "Merck And Co Inc",
        "Hospira Inc"
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1985,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL148",
    "molecule_properties": {
      "acd_logd": -5.45,
      "acd_logp": -2.95,
      "acd_most_apka": 4.29,
      "acd_most_bpka": 10.62,
      "alogp": -0.18,
      "full_molformula": "C12H17N3O4S",
      "full_mwt": 299.35,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 20,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 299.35,
      "mw_monoisotopic": 299.094,
      "psa": 113.72,
      "qed_weighted": 0.22,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@@H](O)[C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCNC=N",
      "standard_inchi": "InChI=1S/C12H17N3O4S/c1-6(16)9-7-4-8(20-3-2-14-5-13)10(12(18)19)15(7)11(9)17/h5-7,9,16H,2-4H2,1H3,(H2,13,14)(H,18,19)/t6-,7-,9-/m1/s1",
      "standard_inchi_key": "ZSKVGTPCRGIANV-ZXFLCMHBSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "MK-0787"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Imipenem (BAN, FDA, INN, JAN, USAN, USP, BAN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-penem",
    "usan_stem_definition": "antibacterial antibiotics, carbapenem derivatives",
    "usan_stem_substem": "-penem(-penem)",
    "usan_year": 1983
  },
  {
    "applicants": {
      "value": [
        "Chartwell Rx Sciences Llc",
        "Sanofi Aventis Us Llc",
        "Eli Lilly And Co",
        "Panray Corp Sub Ormont Drug And Chemical Co Inc",
        "Halsey Drug Co Inc",
        "Bristol Myers Squibb Co",
        "Marshall Pharmacal Corp",
        "Merck And Co Inc",
        "Hikma International Pharmaceuticals Llc",
        "Elkins Sinn Div Ah Robins Co Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "C02AA52",
          "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Rauwolfia alkaloid"
        },
        {
          "code": "C02AA02",
          "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ANTIADRENERGIC AGENTS, CENTRALLY ACTING: Rauwolfia alkaloids"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1960,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL772",
    "molecule_properties": {
      "acd_logd": 4.21,
      "acd_logp": 4.45,
      "acd_most_bpka": 7.25,
      "alogp": 4.17,
      "aromatic_rings": 3,
      "full_molformula": "C33H40N2O9",
      "full_mwt": 608.69,
      "hba": 10,
      "hba_lipinski": 11,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 44,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 608.69,
      "mw_monoisotopic": 608.2734,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 1,
      "psa": 117.78,
      "qed_weighted": 0.37,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6",
      "standard_inchi": "InChI=1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1",
      "standard_inchi_key": "QEVHRUUCFGRFIF-MDEJGZGSSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "synonyms": {
      "value": [
        "Reserpine (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "usan_stem": "-serpine",
    "usan_stem_definition": "Rauwolfia alkaloid derivatives",
    "usan_stem_substem": "-serpine(-serpine)",
    "withdrawn_country": "United States"
  },
  {
    "applicants": {
      "value": [
        "Hospira Inc",
        "Icu Medical Inc",
        "Baxter Healthcare Corp",
        "B Braun Medical Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "B05CX03",
        "description": "BLOOD AND BLOOD FORMING ORGANS: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS: IRRIGATING SOLUTIONS: Other irrigating solutions"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL773",
    "molecule_properties": {
      "acd_logd": -3.43,
      "acd_logp": -0.93,
      "acd_most_apka": 2.43,
      "acd_most_bpka": 9.64,
      "alogp": -0.97,
      "full_molformula": "C2H5NO2",
      "full_mwt": 75.07,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 5,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 75.07,
      "mw_monoisotopic": 75.032,
      "psa": 63.32,
      "qed_weighted": 0.42,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "NCC(=O)O",
      "standard_inchi": "InChI=1S/C2H5NO2/c3-1-2(4)5/h1,3H2,(H,4,5)",
      "standard_inchi_key": "DHMQDGOQFOQNFH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Aminoacetic Acid (JAN)",
        "Glycine (FDA, INN, USP)",
        null
      ]
    },
    "usan_stem": "-ium",
    "usan_stem_definition": "quaternary ammonium derivatives",
    "usan_stem_substem": "-ium(-ium)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL283820",
    "molecule_properties": {
      "acd_logd": 1.33,
      "acd_logp": 4.21,
      "acd_most_apka": 4.47,
      "alogp": 4.14,
      "aromatic_rings": 1,
      "full_molformula": "C21H26Cl2N2O4",
      "full_mwt": 441.36,
      "hba": 3,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 29,
      "molecular_species": "ACID",
      "mw_freebase": 441.36,
      "mw_monoisotopic": 440.127,
      "psa": 86.71,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CC[C@@H](NC(=O)c1cc(Cl)cc(Cl)c1)C(=O)N2CCC3(CCCC3)CC2",
      "standard_inchi": "InChI=1S/C21H26Cl2N2O4/c22-15-11-14(12-16(23)13-15)19(28)24-17(3-4-18(26)27)20(29)25-9-7-21(8-10-25)5-1-2-6-21/h11-13,17H,1-10H2,(H,24,28)(H,26,27)/t17-/m1/s1",
      "standard_inchi_key": "FJCZHMXAGBYXHJ-QGZVFWFLSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CR-2194"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Spiroglumide (INN)",
        null
      ]
    },
    "usan_stem": "-glumide",
    "usan_stem_definition": "CCK antagonists, antiulcer, anxiolytic agent",
    "usan_stem_substem": "-glumide(-glumide)"
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL30400",
    "molecule_properties": {
      "acd_logd": -1.72,
      "acd_logp": 0.48,
      "acd_most_apka": 9.97,
      "acd_most_bpka": 9.62,
      "alogp": 1.03,
      "aromatic_rings": 1,
      "full_molformula": "C10H15NO2",
      "full_mwt": 181.24,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 13,
      "molecular_species": "BASE",
      "mw_freebase": 181.24,
      "mw_monoisotopic": 181.1103,
      "psa": 52.49,
      "qed_weighted": 0.65,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CNC(C)C(O)c1ccc(O)cc1",
      "standard_inchi": "InChI=1S/C10H15NO2/c1-7(11-2)10(13)8-3-5-9(12)6-4-8/h3-7,10-13H,1-2H3",
      "standard_inchi_key": "OXFGTKPPFSCSMA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Oxilofrine (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Bronchodilator",
    "molecule_chembl_id": "CHEMBL30746",
    "molecule_properties": {
      "acd_logd": -1.57,
      "acd_logp": 0.28,
      "acd_most_apka": 8.57,
      "acd_most_bpka": 9.29,
      "alogp": 0.8,
      "aromatic_rings": 1,
      "full_molformula": "C12H20N2O4S",
      "full_mwt": 288.37,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 288.37,
      "mw_monoisotopic": 288.1144,
      "psa": 98.66,
      "qed_weighted": 0.58,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)c1ccc(O)c(NS(=O)(=O)C)c1",
      "standard_inchi": "InChI=1S/C12H20N2O4S/c1-8(2)13-7-12(16)9-4-5-11(15)10(6-9)14-19(3,17)18/h4-6,8,12-16H,7H2,1-3H3",
      "standard_inchi_key": "HHRNQOGXBRYCHF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MJ-1992"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Soterenol (INN)",
        "Soterenol HCl (USAN)",
        null
      ]
    },
    "usan_year": 1968
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL284377",
    "molecule_properties": {
      "acd_logd": -7.7,
      "acd_logp": -3.26,
      "acd_most_apka": 1.71,
      "acd_most_bpka": 11.8,
      "alogp": -1.49,
      "full_molformula": "C3H8NO6P",
      "full_mwt": 185.07,
      "hba": 4,
      "hba_lipinski": 7,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 11,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 185.07,
      "mw_monoisotopic": 185.0089,
      "psa": 130.08,
      "qed_weighted": 0.39,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "N[C@@H](COP(=O)(O)O)C(=O)O",
      "standard_inchi": "InChI=1S/C3H8NO6P/c4-2(3(5)6)1-10-11(7,8)9/h2H,1,4H2,(H,5,6)(H2,7,8,9)/t2-/m0/s1",
      "standard_inchi_key": "BZQFBWGGLXLEPQ-REOHCLBHSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "GNF-Pf-1028"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dexfosfoserine (INN)",
        null
      ]
    },
    "usan_stem": "-fo-",
    "usan_stem_definition": "phosphoro-derivatives",
    "usan_stem_substem": "-fo-(-fo-)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL284907",
    "molecule_properties": {
      "acd_logd": 0.3,
      "acd_logp": 0.3,
      "acd_most_apka": 10.27,
      "alogp": -0.09,
      "full_molformula": "C5H10ClN3O3",
      "full_mwt": 195.61,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 12,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 195.61,
      "mw_monoisotopic": 195.0411,
      "psa": 82,
      "qed_weighted": 0.37,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "OCCNC(=O)N(CCCl)N=O",
      "standard_inchi": "InChI=1S/C5H10ClN3O3/c6-1-3-9(8-12)5(11)7-2-4-10/h10H,1-4H2,(H,7,11)",
      "standard_inchi_key": "YJZJEQBSODVMTH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Elmustine (INN)",
        null
      ]
    },
    "usan_stem": "-mustine",
    "usan_stem_definition": "antineoplastics (chloroethylamine derivatives)",
    "usan_stem_substem": "-mustine(-mustine)"
  },
  {
    "applicants": {
      "value": [
        "American Therapeutics Inc",
        "Mylan Specialty Lp",
        "Apotex Inc",
        "Astrazeneca Lp",
        "Teva Pharmaceuticals Usa Inc",
        "Watson Laboratories Inc",
        "Wockhardt Eu Operations (Swiss) Ag",
        "Dey Lp",
        "G And W Laboratories Inc",
        "Morton Grove Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R03AB03",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Non-selective beta-adrenoreceptor agonist"
        },
        {
          "code": "R03CB03",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS FOR SYSTEMIC USE: Non-selective beta-adrenoreceptor agonists"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1973,
    "indication_class": "Bronchodilator",
    "molecule_chembl_id": "CHEMBL776",
    "molecule_properties": {
      "acd_logd": -1.61,
      "acd_logp": 0.28,
      "acd_most_apka": 9.11,
      "acd_most_bpka": 9.3,
      "alogp": 1.13,
      "aromatic_rings": 1,
      "full_molformula": "C11H17NO3",
      "full_mwt": 211.26,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 15,
      "molecular_species": "BASE",
      "mw_freebase": 211.26,
      "mw_monoisotopic": 211.1208,
      "psa": 72.72,
      "qed_weighted": 0.6,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)NCC(O)c1cc(O)cc(O)c1",
      "standard_inchi": "InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-9(13)5-10(14)4-8/h3-5,7,11-15H,6H2,1-2H3",
      "standard_inchi_key": "LMOINURANNBYCM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "TH-152"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Metaproterenol Sulfate (FDA, USAN, USP)",
        "Orciprenaline Sulfate (JAN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1964
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "S01GA06",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Sympathomimetics used as decongestant"
        },
        {
          "code": "S01GA56",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: DECONGESTANTS AND ANTIALLERGICS: Sympathomimetics used as decongestant"
        },
        {
          "code": "C01CA08",
          "description": "CARDIOVASCULAR SYSTEM: CARDIAC THERAPY: CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES: Adrenergic and dopaminergic agents"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL33720",
    "molecule_properties": {
      "acd_logd": -1.9,
      "acd_logp": 0.13,
      "acd_most_apka": 9.98,
      "acd_most_bpka": 9.37,
      "alogp": 0.64,
      "aromatic_rings": 1,
      "full_molformula": "C9H13NO2",
      "full_mwt": 167.21,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 12,
      "molecular_species": "BASE",
      "mw_freebase": 167.21,
      "mw_monoisotopic": 167.0946,
      "psa": 52.49,
      "qed_weighted": 0.62,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CNCC(O)c1ccc(O)cc1",
      "standard_inchi": "InChI=1S/C9H13NO2/c1-10-6-9(12)7-2-4-8(11)5-3-7/h2-5,9-12H,6H2,1H3",
      "standard_inchi_key": "YRCWQPVGYLYSOX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Oxedrine (BAN)",
        null
      ]
    },
    "usan_stem": "-drine",
    "usan_stem_definition": "sympathomimetics",
    "usan_stem_substem": "-drine(-drine)"
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL31159",
    "molecule_properties": {
      "acd_logd": -2.33,
      "acd_logp": -0.4,
      "acd_most_apka": 9.59,
      "acd_most_bpka": 8.46,
      "alogp": 0.87,
      "aromatic_rings": 1,
      "full_molformula": "C10H15NO3",
      "full_mwt": 197.23,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 197.23,
      "mw_monoisotopic": 197.1052,
      "psa": 86.71,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCC(N)C(O)c1ccc(O)c(O)c1",
      "standard_inchi": "InChI=1S/C10H15NO3/c1-2-7(11)10(14)6-3-4-8(12)9(13)5-6/h3-5,7,10,12-14H,2,11H2,1H3",
      "standard_inchi_key": "LENNRXOJHWNHSD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ethylnorepinephrine HCl (USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Sandoz Inc",
        "Teva Pharmaceuticals Usa Inc",
        "Apotex Inc",
        "Micro Labs Ltd India",
        "Dr Reddys Laboratories Inc",
        "Wockhardt Eu Operations (Swiss) Ag",
        "Glaxosmithkline",
        "Hikma Pharmaceuticals",
        "Wockhardt Eu Operations Swiss Ag",
        "Aurobindo Pharma Ltd"
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1984,
    "indication_class": "Inhibitor (beta-lactamase)",
    "molecule_chembl_id": "CHEMBL777",
    "molecule_properties": {
      "acd_logd": -3.73,
      "acd_logp": -0.32,
      "acd_most_apka": 3.68,
      "alogp": -1.1,
      "full_molformula": "C8H9NO5",
      "full_mwt": 199.16,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 14,
      "molecular_species": "ACID",
      "mw_freebase": 199.16,
      "mw_monoisotopic": 199.0481,
      "psa": 87.07,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "OC\\C=C\\1/O[C@@H]2CC(=O)N2[C@H]1C(=O)O",
      "standard_inchi": "InChI=1S/C8H9NO5/c10-2-1-4-7(8(12)13)9-5(11)3-6(9)14-4/h1,6-7,10H,2-3H2,(H,12,13)/b4-1-/t6-,7-/m1/s1",
      "standard_inchi_key": "HZZVJAQRINQKSD-PBFISZAISA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6746692,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "BRL-14151K",
        "BRL-14151"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6746692-B2",
    "synonyms": {
      "value": [
        "Clavulanate potassium (FDA, JAN, USAN, USP)",
        "Clavulanic Acid (BAN, INN, MI)",
        null
      ]
    },
    "usan_year": 1986
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL285855",
    "molecule_properties": {
      "acd_logd": 3.63,
      "acd_logp": 5.06,
      "acd_most_bpka": 8.82,
      "alogp": 5.86,
      "aromatic_rings": 4,
      "full_molformula": "C31H38N2O5S",
      "full_mwt": 550.72,
      "hba": 7,
      "hba_lipinski": 7,
      "heavy_atoms": 39,
      "molecular_species": "BASE",
      "mw_freebase": 550.72,
      "mw_monoisotopic": 550.2501,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 69.48,
      "qed_weighted": 0.19,
      "ro3_pass": "N",
      "rtb": 13
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(CCN(C)CCCOc2ccc(cc2)S(=O)(=O)c3c(cn4ccccc34)C(C)C)cc1OC",
      "standard_inchi": "InChI=1S/C31H38N2O5S/c1-23(2)27-22-33-18-7-6-9-28(33)31(27)39(34,35)26-13-11-25(12-14-26)38-20-8-17-32(3)19-16-24-10-15-29(36-4)30(21-24)37-5/h6-7,9-15,18,21-23H,8,16-17,19-20H2,1-5H3",
      "standard_inchi_key": "ITAMRBIZWGDOHW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SR-33557"
    },
    "synonyms": {
      "value": [
        "Fantofarone (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-arone",
    "usan_stem_definition": "antirrhythmics",
    "usan_stem_substem": "-arone(-arone)"
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Akorn Inc",
        "Fresenius Kabi Usa Llc",
        "Teva Pharmaceuticals Usa",
        "Hq Specialty Pharma Corp",
        "Sun Pharmaceutical Industries Inc",
        "Jiangsu Hengrui Medicine Co Ltd",
        "Par Sterile Products Llc",
        "Sandoz Inc",
        "West-Ward Pharmaceuticals International Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05CM18",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Other hypnotics and sedatives"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1999,
    "indication_class": "Tranquilizer",
    "molecule_chembl_id": "CHEMBL778",
    "molecule_properties": {
      "acd_logd": 2.66,
      "acd_logp": 2.79,
      "acd_most_bpka": 6.65,
      "alogp": 3.18,
      "aromatic_rings": 2,
      "full_molformula": "C13H16N2",
      "full_mwt": 200.28,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 200.28,
      "mw_monoisotopic": 200.1313,
      "psa": 28.68,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H](c1c[nH]cn1)c2cccc(C)c2C",
      "standard_inchi": "InChI=1S/C13H16N2/c1-9-5-4-6-12(10(9)2)11(3)13-7-14-8-15-13/h4-8,11H,1-3H3,(H,14,15)/t11-/m0/s1",
      "standard_inchi_key": "CUHVIMMYOGQXCV-NSHDSACASA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6716867,
    "parenteral": true,
    "research_codes": {
      "value": "MPV-1440"
    },
    "rule_of_five": true,
    "sc_patent": "US-6716867-B1",
    "synonyms": {
      "value": [
        "Dexmedetomidine HCl (FDA, USAN)",
        "Dexmedetomidine (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1989
  },
  {
    "applicants": {
      "value": [
        "Eli Lilly Co",
        "Eli Lilly And Co"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "G04BE08",
        "description": "GENITO URINARY SYSTEM AND SEX HORMONES: UROLOGICALS: UROLOGICALS: Drugs used in erectile dysfunction"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2003,
    "molecule_chembl_id": "CHEMBL779",
    "molecule_properties": {
      "acd_logd": 2.71,
      "acd_logp": 2.71,
      "alogp": 2.21,
      "aromatic_rings": 3,
      "full_molformula": "C22H19N3O4",
      "full_mwt": 389.41,
      "hba": 4,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 29,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 389.41,
      "mw_monoisotopic": 389.1376,
      "psa": 74.87,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1CC(=O)N2[C@H](Cc3c([nH]c4ccccc34)[C@H]2c5ccc6OCOc6c5)C1=O",
      "standard_inchi": "InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1",
      "standard_inchi_key": "WOXKDUGGOYFFRN-IIBYNOLFSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5859006,
    "oral": true,
    "research_codes": {
      "value": [
        "IC351",
        "IC-351"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5859006-A",
    "synonyms": {
      "value": [
        "Tadalafil (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-afil",
    "usan_stem_definition": "PDE5 inhibitors",
    "usan_stem_substem": "-afil(-afil)",
    "usan_year": 2001
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL416578",
    "molecule_properties": {
      "acd_logd": 1.96,
      "acd_logp": 1.96,
      "acd_most_apka": 12.13,
      "acd_most_bpka": 0.39,
      "alogp": 2.35,
      "aromatic_rings": 1,
      "full_molformula": "C15H18F3NO5",
      "full_mwt": 349.31,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 349.31,
      "mw_monoisotopic": 349.1137,
      "psa": 68.23,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "COC[C@H]1CN(C(=O)O1)c2ccc(OCC[C@@H](O)C(F)(F)F)cc2",
      "standard_inchi": "InChI=1S/C15H18F3NO5/c1-22-9-12-8-19(14(21)24-12)10-2-4-11(5-3-10)23-7-6-13(20)15(16,17)18/h2-5,12-13,20H,6-9H2,1H3/t12-,13-/m1/s1",
      "standard_inchi_key": "IALVDLPLCLFBCF-CHWSQXEVSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Befloxatone (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Bristol Myers Squibb Co Pharmaceutical Research Institute",
        "Apothecon Inc Div Bristol Myers Squibb",
        "West-Ward Pharmaceuticals International Ltd",
        "Apotex Inc",
        "Hospira Inc",
        "Baxter Healthcare Corp",
        "Hikma Farmaceutica Sa",
        "Hikma Farmaceutica (Portugal) Sa",
        "Mylan Pharmaceuticals Inc",
        "Hospira Worldwide, Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N02AF01",
        "description": "NERVOUS SYSTEM: ANALGESICS: OPIOIDS: Morphinan derivatives"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1978,
    "indication_class": "Analgesic; Antitussive",
    "molecule_chembl_id": "CHEMBL33986",
    "molecule_properties": {
      "acd_logd": 2.77,
      "acd_logp": 3.54,
      "acd_most_apka": 10.06,
      "acd_most_bpka": 7.97,
      "alogp": 3.37,
      "aromatic_rings": 1,
      "full_molformula": "C21H29NO2",
      "full_mwt": 327.47,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 327.47,
      "mw_monoisotopic": 327.2198,
      "psa": 43.7,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1ccc2C[C@H]3N(CC4CCC4)CC[C@@]5(CCCC[C@@]35O)c2c1",
      "standard_inchi": "InChI=1S/C21H29NO2/c23-17-7-6-16-12-19-21(24)9-2-1-8-20(21,18(16)13-17)10-11-22(19)14-15-4-3-5-15/h6-7,13,15,19,23-24H,1-5,8-12,14H2/t19-,20+,21-/m1/s1",
      "standard_inchi_key": "IFKLAQQSCNILHL-QHAWAJNXSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "LEVO-BC-2627 Tartrate",
        "LEVO-BC-2627"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Butorphanol Tartrate (BAN, FDA, JAN, USAN, USP)",
        "Butorphanol (BAN, INN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-orphan-",
    "usan_stem_definition": "narcotic antagonists/agonists (morphinan derivatives)",
    "usan_stem_substem": "-orphan-(-orphan-)",
    "usan_year": 1974
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL34234",
    "molecule_properties": {
      "acd_logd": 2.21,
      "acd_logp": 2.21,
      "acd_most_apka": 11.51,
      "alogp": 5.34,
      "aromatic_rings": 2,
      "full_molformula": "C19H20BrN2O4P",
      "full_mwt": 451.26,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 451.26,
      "mw_monoisotopic": 450.0344,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 88.42,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CCOP(=O)(Cc1ccc(cc1)C(=O)Nc2ccc(Br)cc2C#N)OCC",
      "standard_inchi": "InChI=1S/C19H20BrN2O4P/c1-3-25-27(24,26-4-2)13-14-5-7-15(8-6-14)19(23)22-18-10-9-17(20)11-16(18)12-21/h5-11H,3-4,13H2,1-2H3,(H,22,23)",
      "standard_inchi_key": "KPRTURMJVWXURQ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "OPF-009",
        "NO-1886"
      ]
    },
    "synonyms": {
      "value": [
        "Ibrolipim (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-lipim",
    "usan_stem_definition": "lipoprotein lipase activators",
    "usan_stem_substem": "-lipim(-lipim)",
    "usan_year": 2002
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL433041",
    "molecule_properties": {
      "acd_logd": 3.58,
      "acd_logp": 4.33,
      "acd_most_apka": 12.29,
      "acd_most_bpka": 8.37,
      "alogp": 4.11,
      "aromatic_rings": 1,
      "full_molformula": "C21H33N3O2",
      "full_mwt": 359.51,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 359.51,
      "mw_monoisotopic": 359.2573,
      "psa": 44.81,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1",
      "standard_inchi": "InChI=1S/C21H33N3O2/c1-5-6-7-8-9-13-22-20(25)26-16-10-11-18-17(15-16)21(2)12-14-23(3)19(21)24(18)4/h10-11,15,19H,5-9,12-14H2,1-4H3,(H,22,25)/t19-,21+/m1/s1",
      "standard_inchi_key": "RRGMXBQMCUKRLH-CTNGQTDRSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Eptastigmine (INN)",
        null
      ]
    },
    "usan_stem": "-stigmine",
    "usan_stem_definition": "cholinesterase inhibitors (physostigmine type)",
    "usan_stem_substem": "-stigmine(-stigmine)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anti-Inflammatory",
    "molecule_chembl_id": "CHEMBL33211",
    "molecule_properties": {
      "acd_logd": -0.95,
      "acd_logp": 2.11,
      "acd_most_apka": 4.24,
      "alogp": 2.44,
      "aromatic_rings": 2,
      "full_molformula": "C16H12O4",
      "full_mwt": 268.27,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "ACID",
      "mw_freebase": 268.27,
      "mw_monoisotopic": 268.0736,
      "psa": 63.6,
      "qed_weighted": 0.91,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)Cc1ccc2OCc3ccccc3C(=O)c2c1",
      "standard_inchi": "InChI=1S/C16H12O4/c17-15(18)8-10-5-6-14-13(7-10)16(19)12-4-2-1-3-11(12)9-20-14/h1-7H,8-9H2,(H,17,18)",
      "standard_inchi_key": "QFGMXJOBTNZHEL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "HP-549",
        "P-720549"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Isoxepac (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-ac",
    "usan_stem_definition": "anti-inflammatory agents (acetic acid derivatives)",
    "usan_stem_substem": "-ac(-ac)",
    "usan_year": 1977
  },
  {
    "applicants": {
      "value": "Hameln Pharma Plus Gmbh"
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2004,
    "indication_class": "Chelating Agent (plutonium),Diagnostic Aid",
    "molecule_chembl_id": "CHEMBL780",
    "molecule_properties": {
      "acd_logd": -7.36,
      "acd_logp": -1.36,
      "acd_most_apka": 1.48,
      "acd_most_bpka": 11.24,
      "alogp": -2.68,
      "full_molformula": "C14H23N3O10",
      "full_mwt": 393.35,
      "hba": 8,
      "hba_lipinski": 13,
      "hbd": 5,
      "hbd_lipinski": 5,
      "heavy_atoms": 27,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 393.35,
      "mw_monoisotopic": 393.1383,
      "num_lipinski_ro5_violations": 1,
      "psa": 196.22,
      "qed_weighted": 0.18,
      "ro3_pass": "N",
      "rtb": 16
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CN(CCN(CC(=O)O)CC(=O)O)CCN(CC(=O)O)CC(=O)O",
      "standard_inchi": "InChI=1S/C14H23N3O10/c18-10(19)5-15(1-3-16(6-11(20)21)7-12(22)23)2-4-17(8-13(24)25)9-14(26)27/h1-9H2,(H,18,19)(H,20,21)(H,22,23)(H,24,25)(H,26,27)",
      "standard_inchi_key": "QPCDCPDFJACHGM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "DTPA"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pentetate Zinc Trisodium (FDA)",
        "Calcium Trisodium Pentetate (BAN, INN)",
        "Pentetate Calcium Trisodium (FDA, USAN)",
        "Pentetic Acid (BAN, INN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1964
  },
  {
    "applicants": {
      "value": [
        "Novartis Pharmaceuticals Corp",
        "Wyeth Ayerst Laboratories"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A08AA05",
        "description": "ALIMENTARY TRACT AND METABOLISM: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: ANTIOBESITY PREPARATIONS, EXCL. DIET PRODUCTS: Centrally acting antiobesity products"
      }
    },
    "availability_type": 0,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1973,
    "indication_class": "Anorexic",
    "molecule_chembl_id": "CHEMBL781",
    "molecule_properties": {
      "acd_logd": 0.36,
      "acd_logp": 2.36,
      "acd_most_apka": 9.82,
      "acd_most_bpka": 12.86,
      "alogp": 2.61,
      "aromatic_rings": 2,
      "full_molformula": "C16H13ClN2O",
      "full_mwt": 284.75,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 284.75,
      "mw_monoisotopic": 284.0716,
      "psa": 35.83,
      "qed_weighted": 0.87,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "OC1(N2CCN=C2c3ccccc13)c4ccc(Cl)cc4",
      "standard_inchi": "InChI=1S/C16H13ClN2O/c17-12-7-5-11(6-8-12)16(20)14-4-2-1-3-13(14)15-18-9-10-19(15)16/h1-8,20H,9-10H2",
      "standard_inchi_key": "ZPXSCAKFGYXMGA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "42-548"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mazindol (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1970
  },
  {
    "atc_classification": {
      "drug": {
        "code": "P02DX02",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTICESTODALS: Other anticestodals"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL33845",
    "molecule_properties": {
      "acd_logd": 4.34,
      "acd_logp": 4.35,
      "acd_most_apka": 9.15,
      "alogp": 4,
      "aromatic_rings": 2,
      "full_molformula": "C13H10Cl2O2",
      "full_mwt": 269.13,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 269.13,
      "mw_monoisotopic": 268.0058,
      "psa": 40.46,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1ccc(Cl)cc1Cc2cc(Cl)ccc2O",
      "standard_inchi": "InChI=1S/C13H10Cl2O2/c14-10-1-3-12(16)8(6-10)5-9-7-11(15)2-4-13(9)17/h1-4,6-7,16-17H,5H2",
      "standard_inchi_key": "MDNWOSOZYLHTCG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "G-4"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dichlorophen (BAN, DCF, INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL32227",
    "molecule_properties": {
      "acd_logd": 3.81,
      "acd_logp": 3.81,
      "alogp": 4.49,
      "aromatic_rings": 3,
      "full_molformula": "C21H21NO4",
      "full_mwt": 351.4,
      "hba": 5,
      "hba_lipinski": 5,
      "heavy_atoms": 26,
      "mw_freebase": 351.4,
      "mw_monoisotopic": 351.1471,
      "psa": 57.53,
      "qed_weighted": 0.51,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCn1c(c(C)c2cc(OC(=O)C)ccc12)c3ccc(OC(=O)C)cc3",
      "standard_inchi": "InChI=1S/C21H21NO4/c1-5-22-20-11-10-18(26-15(4)24)12-19(20)13(2)21(22)16-6-8-17(9-7-16)25-14(3)23/h6-12H,5H2,1-4H3",
      "standard_inchi_key": "KSZGVNZSUJHOJA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Zindoxifene (INN)",
        null
      ]
    },
    "usan_stem": "-ifene",
    "usan_stem_definition": "antiestrogens of the clomifene and tamoxifen groups",
    "usan_stem_substem": "-ifene(-ifene)"
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "P02BX01",
          "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTITREMATODALS: Other antitrematodal agent"
        },
        {
          "code": "D10AB01",
          "description": "DERMATOLOGICALS: ANTI-ACNE PREPARATIONS: ANTI-ACNE PREPARATIONS FOR TOPICAL USE: Preparations containing sulfur"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Anti-Infective, Topical",
    "molecule_chembl_id": "CHEMBL290106",
    "molecule_properties": {
      "acd_logd": 3.37,
      "acd_logp": 5.05,
      "acd_most_apka": 6.25,
      "alogp": 5.86,
      "aromatic_rings": 2,
      "full_molformula": "C12H6Cl4O2S",
      "full_mwt": 356.06,
      "hba": 3,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "ACID",
      "mw_freebase": 356.06,
      "mw_monoisotopic": 353.8843,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 40.46,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1c(Cl)cc(Cl)cc1Sc2cc(Cl)cc(Cl)c2O",
      "standard_inchi": "InChI=1S/C12H6Cl4O2S/c13-5-1-7(15)11(17)9(3-5)19-10-4-6(14)2-8(16)12(10)18/h1-4,17-18H",
      "standard_inchi_key": "JFIOVJDNOJYLKP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Bithionolate Sodium (USAN)",
        "Sodium Bitionolate (INN)",
        "Bithionol (BAN, INN, JAN, MI, NF)",
        null
      ]
    },
    "usan_year": 1962,
    "withdrawn_class": "Dermatological toxicity",
    "withdrawn_country": "United States",
    "withdrawn_reason": "Dermatologic Toxicity",
    "withdrawn_year": 1967
  },
  {
    "applicants": {
      "value": [
        "Ascot Hosp Pharmaceuticals Inc Div Travenol Laboratories Inc",
        "Dava Pharmaceuticals Inc",
        "Sandoz Inc",
        "Superpharm Corp",
        "Watson Laboratories Inc",
        "Ivax Pharmaceuticals Inc",
        "Parke Davis Div Warner Lambert Co",
        "Pharmacia And Upjohn Co",
        "Barr Laboratories Inc",
        "Purepac Pharmaceutical Co"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "A10BB03",
          "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Sulfonylurea"
        },
        {
          "code": "V04CA01",
          "description": "VARIOUS: DIAGNOSTIC AGENTS: OTHER DIAGNOSTIC AGENTS: Tests for diabetes"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1961,
    "indication_class": "Antidiabetic,Diagnostic Aid (diabetes)",
    "molecule_chembl_id": "CHEMBL782",
    "molecule_properties": {
      "acd_logd": 0.47,
      "acd_logp": 2.36,
      "acd_most_apka": 5.25,
      "alogp": 1.78,
      "aromatic_rings": 1,
      "full_molformula": "C12H18N2O3S",
      "full_mwt": 270.35,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 18,
      "molecular_species": "ACID",
      "mw_freebase": 270.35,
      "mw_monoisotopic": 270.1038,
      "psa": 75.27,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1",
      "standard_inchi": "InChI=1S/C12H18N2O3S/c1-3-4-9-13-12(15)14-18(16,17)11-7-5-10(2)6-8-11/h5-8H,3-4,9H2,1-2H3,(H2,13,14,15)",
      "standard_inchi_key": "JLRGJRBPOGGCBT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tolbutamide (BAN, FDA, INN, JAN, USP)",
        "Tolbutamide Sodium (FDA)",
        "Tolbutamide Sodium, Sterile (USP)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Alvogen Malta Operations Ltd",
        "Novartis Pharmaceuticals Corp",
        "Watson Laboratories Inc",
        "Zydus Pharmaceuticals Usa Inc",
        "Dr Reddys Laboratories Ltd",
        "Par Pharmaceutical Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A10BX03",
        "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Other blood glucose lowering drugs, excl. insulins"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2000,
    "molecule_chembl_id": "CHEMBL783",
    "molecule_properties": {
      "acd_logd": -1.25,
      "acd_logp": 2.35,
      "acd_most_apka": 3.61,
      "alogp": 3.26,
      "aromatic_rings": 1,
      "full_molformula": "C19H27NO3",
      "full_mwt": 317.43,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 317.43,
      "mw_monoisotopic": 317.1991,
      "psa": 66.4,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)[C@@H]1CC[C@H](CC1)C(=O)N[C@H](Cc2ccccc2)C(=O)O",
      "standard_inchi": "InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15-,16-,17-/m1/s1",
      "standard_inchi_key": "OELFLUMRDSZNSF-BRWVUGGUSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6559188,
    "oral": true,
    "research_codes": {
      "value": [
        "DJN-608",
        "A-4166",
        "SDZ DJN 608",
        "AY-4166",
        "SDZ-DJN-608"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6559188-B1",
    "synonyms": {
      "value": [
        "Nateglinide (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-glinide",
    "usan_stem_definition": "antidiabetic, SGLT2 inhibitors, not phlorozin derivatives",
    "usan_stem_substem": "-glinide(-glinide)",
    "usan_year": 2000
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Anti-Atherosclerotic",
    "molecule_chembl_id": "CHEMBL284768",
    "molecule_properties": {
      "acd_logd": 0.3,
      "acd_logp": 0.3,
      "alogp": 4.24,
      "aromatic_rings": 1,
      "full_molformula": "C11H17ClO7P2",
      "full_mwt": 358.65,
      "hba": 7,
      "hba_lipinski": 7,
      "heavy_atoms": 21,
      "mw_freebase": 358.65,
      "mw_monoisotopic": 358.0138,
      "psa": 80.29,
      "qed_weighted": 0.64,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "COP(=O)(OC)OC(c1ccc(Cl)cc1)P(=O)(OC)OC",
      "standard_inchi": "InChI=1S/C11H17ClO7P2/c1-15-20(13,16-2)11(19-21(14,17-3)18-4)9-5-7-10(12)8-6-9/h5-8,11H,1-4H3",
      "standard_inchi_key": "VQHUQHAPWMNBLP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SR-202"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mifobate (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-fo-",
    "usan_stem_definition": "phosphoro-derivatives",
    "usan_stem_substem": "-fo-(-fo-)",
    "usan_year": 1984
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL33864",
    "molecule_properties": {
      "acd_logd": -0.09,
      "acd_logp": 2.53,
      "acd_most_apka": 4.75,
      "alogp": 2.79,
      "full_molformula": "C8H14O2S2",
      "full_mwt": 206.33,
      "hba": 3,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 12,
      "molecular_species": "ACID",
      "mw_freebase": 206.33,
      "mw_monoisotopic": 206.0435,
      "psa": 37.3,
      "qed_weighted": 0.55,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CCCCC1CCSS1",
      "standard_inchi": "InChI=1S/C8H14O2S2/c9-8(10)4-2-1-3-7-5-6-11-12-7/h7H,1-6H2,(H,9,10)",
      "standard_inchi_key": "AGBQKNBQESQNJD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lipoic acid, alpha (NF)",
        "Thioctic Acid (JAN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL32350",
    "molecule_properties": {
      "acd_logd": 0.83,
      "acd_logp": 3.62,
      "acd_most_bpka": 10.47,
      "alogp": 2.93,
      "aromatic_rings": 2,
      "full_molformula": "C15H18N2",
      "full_mwt": 226.32,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "BASE",
      "mw_freebase": 226.32,
      "mw_monoisotopic": 226.147,
      "psa": 16.96,
      "qed_weighted": 0.73,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccc2c(c1)c3CCCC4NCCn2c34",
      "standard_inchi": "InChI=1S/C15H18N2/c1-10-5-6-14-12(9-10)11-3-2-4-13-15(11)17(14)8-7-16-13/h5-6,9,13,16H,2-4,7-8H2,1H3",
      "standard_inchi_key": "IWVRVEIKCBFZNF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pirlindole (INN)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05CD09",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL32479",
    "molecule_properties": {
      "acd_logd": 2.46,
      "acd_logp": 2.46,
      "acd_most_bpka": 2.01,
      "alogp": 4.4,
      "aromatic_rings": 3,
      "full_molformula": "C15H10BrClN4S",
      "full_mwt": 393.7,
      "hba": 5,
      "hba_lipinski": 4,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 393.7,
      "mw_monoisotopic": 391.9498,
      "psa": 43.07,
      "qed_weighted": 0.61,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1nnc2CN=C(c3ccccc3Cl)c4cc(Br)sc4n12",
      "standard_inchi": "InChI=1S/C15H10BrClN4S/c1-8-19-20-13-7-18-14(9-4-2-3-5-11(9)17)10-6-12(16)22-15(10)21(8)13/h2-6H,7H2,1H3",
      "standard_inchi_key": "UMSGKTJDUHERQW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "WE-941"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Brotizolam (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_year": 1983
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL417675",
    "molecule_properties": {
      "acd_logd": 5.8,
      "acd_logp": 5.8,
      "alogp": 4.58,
      "full_molformula": "C18H37NO2",
      "full_mwt": 299.5,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 299.5,
      "mw_monoisotopic": 299.2824,
      "psa": 49.33,
      "qed_weighted": 0.41,
      "ro3_pass": "N",
      "rtb": 16
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCCCCCCCCCC(=O)NCCO",
      "standard_inchi": "InChI=1S/C18H37NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)19-16-17-20/h20H,2-17H2,1H3,(H,19,21)",
      "standard_inchi_key": "HXYVTAGFYLMHSO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Palmidrol (INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL285852",
    "molecule_properties": {
      "acd_logd": 3.85,
      "acd_logp": 3.85,
      "alogp": 3.88,
      "aromatic_rings": 3,
      "full_molformula": "C20H19NO3",
      "full_mwt": 321.38,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 321.38,
      "mw_monoisotopic": 321.1365,
      "psa": 40.46,
      "qed_weighted": 0.64,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc2OC(C)(C)C=Cc2c3N(C)c4ccccc4C(=O)c13",
      "standard_inchi": "InChI=1S/C20H19NO3/c1-20(2)10-9-13-15(24-20)11-16(23-4)17-18(13)21(3)14-8-6-5-7-12(14)19(17)22/h5-11H,1-4H3",
      "standard_inchi_key": "SMPZPKRDRQOOHT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "Compound 42339"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Acronine (INN, USAN)",
        null
      ]
    },
    "usan_year": 1969
  },
  {
    "applicants": {
      "value": [
        "Unimark Remedies Ltd",
        "Anbison Laboratory Co Ltd",
        "Torrent Pharmaceuticals Ltd",
        "Merck Research Laboratories Div Merck Co Inc",
        "Jubilant Generics Ltd",
        "West-Ward Pharmaceuticals International Ltd",
        "Ajanta Pharma Ltd",
        "Aurobindo Pharma Ltd",
        "Teva Pharmaceuticals Usa",
        "Hetero Labs Ltd Unit V"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R03DC03",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Leukotriene receptor antagonist"
        },
        {
          "code": "R03DC53",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Leukotriene receptor antagonists"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1998,
    "indication_class": "Anti-Asthmatic (leukotriene antagonist)",
    "molecule_chembl_id": "CHEMBL787",
    "molecule_properties": {
      "acd_logd": 3.2,
      "acd_logp": 5.81,
      "acd_most_apka": 4.76,
      "acd_most_bpka": 2.22,
      "alogp": 8.95,
      "aromatic_rings": 4,
      "full_molformula": "C35H36ClNO3S",
      "full_mwt": 586.2,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 41,
      "molecular_species": "ACID",
      "mw_freebase": 586.2,
      "mw_monoisotopic": 585.2104,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 70.42,
      "qed_weighted": 0.17,
      "ro3_pass": "N",
      "rtb": 12
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(O)c1ccccc1CC[C@@H](SCC2(CC(=O)O)CC2)c3cccc(\\C=C\\c4ccc5ccc(Cl)cc5n4)c3",
      "standard_inchi": "InChI=1S/C35H36ClNO3S/c1-34(2,40)30-9-4-3-7-25(30)13-17-32(41-23-35(18-19-35)22-33(38)39)27-8-5-6-24(20-27)10-15-29-16-12-26-11-14-28(36)21-31(26)37-29/h3-12,14-16,20-21,32,40H,13,17-19,22-23H2,1-2H3,(H,38,39)/b15-10+/t32-/m1/s1",
      "standard_inchi_key": "UCHDWCPVSPXUMX-TZIWLTJVSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8007830,
    "oral": true,
    "research_codes": {
      "value": "MK-476"
    },
    "sc_patent": "US-8007830-B2",
    "synonyms": {
      "value": [
        "Montelukast Sodium (FDA, USAN)",
        "Montelukast (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-ast",
    "usan_stem_definition": "antiasthmatics/antiallergics: leukotriene receptor antagonists",
    "usan_stem_substem": "-ast(-ast(-lukast))",
    "usan_year": 1995
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL32778",
    "molecule_properties": {
      "acd_logd": -2.68,
      "acd_logp": -3.2,
      "acd_most_apka": 7.73,
      "alogp": 0.97,
      "aromatic_rings": 2,
      "full_molformula": "C15H18N4O2+2",
      "full_mwt": 286.33,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 286.33,
      "mw_monoisotopic": 286.1419,
      "psa": 72.94,
      "qed_weighted": 0.36,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "O\\N=C\\c1cc[n+](CCC[n+]2ccc(\\C=N\\O)cc2)cc1",
      "standard_inchi": "InChI=1S/C15H16N4O2/c20-16-12-14-2-8-18(9-3-14)6-1-7-19-10-4-15(5-11-19)13-17-21/h2-5,8-13H,1,6-7H2/p+2",
      "standard_inchi_key": "LJYGXPCCGGSATE-UHFFFAOYSA-P"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "C-434",
        "TMB-4"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Trimedoxime Bromide (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL32911",
    "molecule_properties": {
      "acd_logd": 8,
      "acd_logp": 8.01,
      "acd_most_apka": 12.96,
      "acd_most_bpka": 5.42,
      "alogp": 9.4,
      "aromatic_rings": 7,
      "full_molformula": "C41H37ClN6O5",
      "full_mwt": 729.24,
      "hba": 6,
      "hba_lipinski": 11,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 53,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 729.24,
      "mw_monoisotopic": 728.2514,
      "num_lipinski_ro5_violations": 3,
      "num_ro5_violations": 2,
      "psa": 135.7,
      "qed_weighted": 0.11,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)c1ccc2cc(oc2c1)C(=O)Nc3ccc4[nH]c(cc4c3)C(=O)N5C[C@@H](CCl)c6c5cc(OC(=O)Nc7ccccc7)c8[nH]cc(C)c68",
      "standard_inchi": "InChI=1S/C41H37ClN6O5/c1-4-47(5-2)29-13-11-24-17-35(52-33(24)18-29)39(49)44-28-12-14-30-25(15-28)16-31(46-30)40(50)48-22-26(20-42)37-32(48)19-34(38-36(37)23(3)21-43-38)53-41(51)45-27-9-7-6-8-10-27/h6-19,21,26,43,46H,4-5,20,22H2,1-3H3,(H,44,49)(H,45,51)/t26-/m1/s1",
      "standard_inchi_key": "BBZDXMBRAFTCAA-AREMUKBSSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "U-80244"
    },
    "synonyms": {
      "value": [
        "Carzelesin (INN, USAN)",
        null
      ]
    },
    "usan_year": 1992
  },
  {
    "applicants": {
      "value": [
        "Alcon Laboratories Inc",
        "Allergan Pharmaceutical",
        "Glaxosmithkline"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "J05AB02",
          "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitor"
        },
        {
          "code": "D06BB01",
          "description": "DERMATOLOGICALS: ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE: CHEMOTHERAPEUTICS FOR TOPICAL USE: Antiviral"
        },
        {
          "code": "S01AD01",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Antivirals"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1963,
    "indication_class": "Antiviral (ophthalmic)",
    "molecule_chembl_id": "CHEMBL788",
    "molecule_properties": {
      "acd_logd": -0.71,
      "acd_logp": -0.59,
      "acd_most_apka": 7.94,
      "alogp": -1.22,
      "aromatic_rings": 1,
      "full_molformula": "C9H11IN2O5",
      "full_mwt": 354.1,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 354.1,
      "mw_monoisotopic": 353.9713,
      "psa": 104.55,
      "qed_weighted": 0.58,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "OC[C@H]1O[C@H](C[C@@H]1O)N2C=C(I)C(=O)NC2=O",
      "standard_inchi": "InChI=1S/C9H11IN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1",
      "standard_inchi_key": "XQFRJNBWHJMXHO-RRKCRQDMSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "Allergan 211",
        "5IUDR",
        "IDU",
        "SK&F-14287"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Idoxuridine (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-uridine",
    "usan_stem_definition": "antivirals, antineoplastics (uridine derivatives)",
    "usan_stem_substem": "-uridine(-uridine)",
    "usan_year": 1962
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL36015",
    "molecule_properties": {
      "acd_logd": 4.36,
      "acd_logp": 4.46,
      "acd_most_bpka": 6.84,
      "alogp": 4.66,
      "aromatic_rings": 4,
      "full_molformula": "C32H36BrN5O8",
      "full_mwt": 698.57,
      "hba": 9,
      "hba_lipinski": 13,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 46,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 698.57,
      "mw_monoisotopic": 697.1747,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 1,
      "psa": 138.66,
      "qed_weighted": 0.21,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "COC(=O)c1c(C)[nH]c2c(OC(=O)N3CCN(C)CC3)cc4N(C[C@@H](CBr)c4c12)C(=O)c5cc6cc(OC)c(OC)c(OC)c6[nH]5",
      "standard_inchi": "InChI=1S/C32H36BrN5O8/c1-16-23(31(40)45-6)25-24-18(14-33)15-38(20(24)13-21(27(25)34-16)46-32(41)37-9-7-36(2)8-10-37)30(39)19-11-17-12-22(42-3)28(43-4)29(44-5)26(17)35-19/h11-13,18,34-35H,7-10,14-15H2,1-6H3/t18-/m1/s1",
      "standard_inchi_key": "QRMNENFZDDYDEF-GOSISDBHSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "KW-2189"
    },
    "synonyms": {
      "value": [
        "Pibrozelesin (INN)",
        "Pibrozelesin Hydrobromide (USAN)",
        null
      ]
    },
    "usan_year": 1998
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL789",
    "molecule_properties": {
      "acd_logd": 1.32,
      "acd_logp": 3.91,
      "acd_most_apka": 2.13,
      "acd_most_bpka": 8.27,
      "alogp": 3.95,
      "aromatic_rings": 2,
      "full_molformula": "C15H12I3NO4",
      "full_mwt": 650.98,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 650.98,
      "mw_monoisotopic": 650.7901,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 92.78,
      "qed_weighted": 0.43,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "NC(Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O",
      "standard_inchi": "InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)",
      "standard_inchi_key": "AUYYCJSJGJYCDS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Rathyronine (DCF, INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL35493",
    "molecule_properties": {
      "acd_logd": 2.53,
      "acd_logp": 2.53,
      "acd_most_apka": 12.93,
      "acd_most_bpka": 3.35,
      "alogp": 5.3,
      "aromatic_rings": 5,
      "full_molformula": "C30H22N4O4",
      "full_mwt": 502.53,
      "hba": 4,
      "hba_lipinski": 8,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 38,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 502.53,
      "mw_monoisotopic": 502.1641,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 111.2,
      "qed_weighted": 0.31,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1c[nH]c2C(=O)C=C3N(C[C@H]4C[C@@]34c12)C(=O)c5cc6cc(NC(=O)c7oc8ccccc8c7)ccc6[nH]5",
      "standard_inchi": "InChI=1S/C30H22N4O4/c1-15-13-31-27-22(35)11-25-30(26(15)27)12-18(30)14-34(25)29(37)21-9-17-8-19(6-7-20(17)33-21)32-28(36)24-10-16-4-2-3-5-23(16)38-24/h2-11,13,18,31,33H,12,14H2,1H3,(H,32,36)/t18-,30+/m1/s1",
      "standard_inchi_key": "BYRVKDUQDLJUBX-JJCDCTGGSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "U-73975"
    },
    "synonyms": {
      "value": [
        "Adozelesin (INN, USAN)",
        null
      ]
    },
    "usan_year": 1990
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anthelmintic",
    "molecule_chembl_id": "CHEMBL287542",
    "molecule_properties": {
      "acd_logd": 7.79,
      "acd_logp": 9.07,
      "acd_most_apka": 6.04,
      "alogp": 6.95,
      "aromatic_rings": 3,
      "full_molformula": "C19H11Cl2I2NO3",
      "full_mwt": 626.02,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 27,
      "molecular_species": "ACID",
      "mw_freebase": 626.02,
      "mw_monoisotopic": 624.8205,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 58.56,
      "qed_weighted": 0.31,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Oc1c(I)cc(I)cc1C(=O)Nc2ccc(Oc3ccc(Cl)cc3)c(Cl)c2",
      "standard_inchi": "InChI=1S/C19H11Cl2I2NO3/c20-10-1-4-13(5-2-10)27-17-6-3-12(9-15(17)21)24-19(26)14-7-11(22)8-16(23)18(14)25/h1-9,25H,(H,24,26)",
      "standard_inchi_key": "NEMNPWINWMHUMR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Rafoxanide (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-oxanide",
    "usan_stem_definition": "antiparasitics (salicylanilide derivatives)",
    "usan_stem_substem": "-oxanide(-oxanide)",
    "usan_year": 1970
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL285913",
    "molecule_properties": {
      "acd_logd": 2.66,
      "acd_logp": 4.12,
      "acd_most_bpka": 8.99,
      "alogp": 3.58,
      "aromatic_rings": 3,
      "full_molformula": "C24H27N3O3",
      "full_mwt": 405.5,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 30,
      "molecular_species": "BASE",
      "mw_freebase": 405.5,
      "mw_monoisotopic": 405.2052,
      "psa": 57.75,
      "qed_weighted": 0.67,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc2CCN3C(=O)N(C)\\C(=N\\c4c(C)cc(C)cc4C)\\C=C3c2cc1OC",
      "standard_inchi": "InChI=1S/C24H27N3O3/c1-14-9-15(2)23(16(3)10-14)25-22-13-19-18-12-21(30-6)20(29-5)11-17(18)7-8-27(19)24(28)26(22)4/h9-13H,7-8H2,1-6H3/b25-22+",
      "standard_inchi_key": "MCMSJVMUSBZUCN-YYDJUVGSSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Trequinsin (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Stimulant (central)",
    "molecule_chembl_id": "CHEMBL35337",
    "molecule_properties": {
      "acd_logd": -0.17,
      "acd_logp": 1.38,
      "acd_most_apka": 3.5,
      "alogp": 2.71,
      "aromatic_rings": 3,
      "full_molformula": "C18H16N2O3",
      "full_mwt": 308.34,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 308.34,
      "mw_monoisotopic": 308.1161,
      "psa": 72.19,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1C=C(C(=O)O)C(=O)c2ccc(Cc3ccccc3)nc12",
      "standard_inchi": "InChI=1S/C18H16N2O3/c1-2-20-11-15(18(22)23)16(21)14-9-8-13(19-17(14)20)10-12-6-4-3-5-7-12/h3-9,11H,2,10H2,1H3,(H,22,23)",
      "standard_inchi_key": "WHHHJDGNBVQNAU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "WIN-25978"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Amfonelic Acid (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-fo-",
    "usan_stem_definition": "phosphoro-derivatives",
    "usan_stem_substem": "-fo-(-fo-)",
    "usan_year": 1967
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL287257",
    "molecule_properties": {
      "acd_logd": 3.09,
      "acd_logp": 3.69,
      "acd_most_bpka": 7.87,
      "alogp": 4.58,
      "aromatic_rings": 2,
      "full_molformula": "C17H17Cl2NO",
      "full_mwt": 322.24,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 322.24,
      "mw_monoisotopic": 321.0687,
      "psa": 12.47,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2C(CN(C)Cc2c1)c3ccc(Cl)c(Cl)c3",
      "standard_inchi": "InChI=1S/C17H17Cl2NO/c1-20-9-12-7-13(21-2)4-5-14(12)15(10-20)11-3-6-16(18)17(19)8-11/h3-8,15H,9-10H2,1-2H3",
      "standard_inchi_key": "ZJDCGVDEEHWEIG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Diclofensine (INN)",
        null
      ]
    },
    "usan_stem": "-fensine",
    "usan_stem_definition": "norepinephrine, serotonin, dopamine reuptake inhibitor",
    "usan_stem_substem": "-fensine(-fensine)"
  },
  {
    "applicants": {
      "value": "Pharmacia And Upjohn Co"
    },
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1964,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL36506",
    "molecule_properties": {
      "acd_logd": 1.01,
      "acd_logp": 3.74,
      "acd_most_apka": 4.5,
      "alogp": 3.63,
      "aromatic_rings": 3,
      "full_molformula": "C31H36N2O11",
      "full_mwt": 612.63,
      "hba": 11,
      "hba_lipinski": 13,
      "hbd": 5,
      "hbd_lipinski": 6,
      "heavy_atoms": 44,
      "molecular_species": "ACID",
      "mw_freebase": 612.63,
      "mw_monoisotopic": 612.2319,
      "num_lipinski_ro5_violations": 3,
      "num_ro5_violations": 2,
      "psa": 200.01,
      "qed_weighted": 0.18,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CO[C@@H]1[C@@H](OC(=O)N)[C@@H](O)[C@H](Oc2ccc3C(=C(NC(=O)c4ccc(O)c(CC=C(C)C)c4)C(=O)Oc3c2C)O)OC1(C)C",
      "standard_inchi": "InChI=1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1",
      "standard_inchi_key": "YJQPYGGHQPGBLI-KGSXXDOSSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "synonyms": {
      "value": [
        "Novobiocin (BAN, INN)",
        "Novobiocin Calcium (USP)",
        "Novobiocin sodium (FDA, USP)",
        null
      ]
    },
    "withdrawn_class": "Dermatological toxicity; Hematological toxicity; Hepatotoxicity",
    "withdrawn_country": "United States",
    "withdrawn_reason": "Relatively common skin reactions; Jaundice; Hepatic failure; Blood dyscrasias (neutropenia, anemia, and thrombocytopenia)",
    "withdrawn_year": 2009
  },
  {
    "applicants": {
      "value": [
        "Gilead Sciences Inc",
        "Mylan Institutional Llc",
        "Emcure Pharmaceuticals Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J05AB12",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIVIRALS FOR SYSTEMIC USE: DIRECT ACTING ANTIVIRALS: Nucleosides and nucleotides excl. reverse transcriptase inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1996,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL152",
    "molecule_properties": {
      "acd_logd": -5.41,
      "acd_logp": -1.47,
      "acd_most_apka": 1.56,
      "acd_most_bpka": 4.42,
      "alogp": -1.66,
      "aromatic_rings": 1,
      "full_molformula": "C8H14N3O6P",
      "full_mwt": 279.19,
      "hba": 7,
      "hba_lipinski": 9,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 18,
      "molecular_species": "ACID",
      "mw_freebase": 279.19,
      "mw_monoisotopic": 279.062,
      "psa": 147.9,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "NC1=NC(=O)N(C[C@@H](CO)OCP(=O)(O)O)C=C1",
      "standard_inchi": "InChI=1S/C8H14N3O6P/c9-7-1-2-11(8(13)10-7)3-6(4-12)17-5-18(14,15)16/h1-2,6,12H,3-5H2,(H2,9,10,13)(H2,14,15,16)/t6-/m0/s1",
      "standard_inchi_key": "VWFCHDSQECPREK-LURJTMIESA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": "GS-0504"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cidofovir (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-vir",
    "usan_stem_definition": "antivirals",
    "usan_stem_substem": "-vir(-vir)",
    "usan_year": 1994
  },
  {
    "applicants": {
      "value": [
        "Bajaj Mecical Llc",
        "Matrix Medical Corp",
        "Professional Disposables Inc",
        "Lyne Laboratories Inc",
        "Becton Dickinson And Co",
        "Kw Griffen Co",
        "Johnson And Johnson Medical Inc",
        "Sage Products Inc",
        "Xttrium Laboratories Inc",
        "Ecolab Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "A01AB03",
          "description": "ALIMENTARY TRACT AND METABOLISM: STOMATOLOGICAL PREPARATIONS: STOMATOLOGICAL PREPARATIONS: Antiinfectives and antiseptics for local oral treatmen"
        },
        {
          "code": "D08AC02",
          "description": "DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Biguanides and amidine"
        },
        {
          "code": "S02AA09",
          "description": "SENSORY ORGANS: OTOLOGICALS: ANTIINFECTIVES: Antiinfective"
        },
        {
          "code": "S01AX09",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICALS: ANTIINFECTIVES: Other antiinfective"
        },
        {
          "code": "R02AA05",
          "description": "RESPIRATORY SYSTEM: THROAT PREPARATIONS: THROAT PREPARATIONS: Antiseptic"
        },
        {
          "code": "D09AA12",
          "description": "DERMATOLOGICALS: MEDICATED DRESSINGS: MEDICATED DRESSINGS: Medicated dressings with antiinfective"
        },
        {
          "code": "S03AA04",
          "description": "SENSORY ORGANS: OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS: ANTIINFECTIVES: Antiinfective"
        },
        {
          "code": "D08AC52",
          "description": "DERMATOLOGICALS: ANTISEPTICS AND DISINFECTANTS: ANTISEPTICS AND DISINFECTANTS: Biguanides and amidine"
        },
        {
          "code": "B05CA02",
          "description": "BLOOD AND BLOOD FORMING ORGANS: BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS: IRRIGATING SOLUTIONS: Antiinfectives"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1976,
    "indication_class": "Anti-Infective, Topical,Antibacterial,Antimicrobial",
    "molecule_chembl_id": "CHEMBL790",
    "molecule_properties": {
      "acd_logd": 1.58,
      "acd_logp": 4.58,
      "acd_most_bpka": 11.51,
      "alogp": 4.18,
      "aromatic_rings": 2,
      "full_molformula": "C22H30Cl2N10",
      "full_mwt": 505.46,
      "hba": 4,
      "hba_lipinski": 10,
      "hbd": 10,
      "hbd_lipinski": 10,
      "heavy_atoms": 34,
      "molecular_species": "BASE",
      "mw_freebase": 505.46,
      "mw_monoisotopic": 504.2032,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 167.58,
      "qed_weighted": 0.14,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc2ccc(Cl)cc2)cc1",
      "standard_inchi": "InChI=1S/C22H30Cl2N10/c23-15-5-9-17(10-6-15)31-21(27)33-19(25)29-13-3-1-2-4-14-30-20(26)34-22(28)32-18-11-7-16(24)8-12-18/h5-12H,1-4,13-14H2,(H5,25,27,29,31,33)(H5,26,28,30,32,34)",
      "standard_inchi_key": "GHXZTYHSJHQHIJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5690958,
    "research_codes": {
      "value": [
        "BMY-30120",
        "CHP",
        "AY-5312",
        "WP-973"
      ]
    },
    "sc_patent": "US-5690958-A",
    "synonyms": {
      "value": [
        "Chlorhexidine HCl (BAN, JAN, USAN)",
        "Chlorhexidine (BAN, INN)",
        "Chlorhexidine gluconate (FDA, JAN, USAN, USP)",
        "Chlorhexidine Phosphanilate (USAN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1963,
    "withdrawn_country": "United States"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "P01AX10",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES: Other agents against amoebiasis and other protozoal diseases"
      }
    },
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL32838",
    "molecule_properties": {
      "acd_logd": -0.78,
      "acd_logp": 2.26,
      "acd_most_apka": 4.27,
      "alogp": 3.92,
      "full_molformula": "C26H34O7",
      "full_mwt": 458.55,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 33,
      "molecular_species": "ACID",
      "mw_freebase": 458.55,
      "mw_monoisotopic": 458.2305,
      "psa": 97.89,
      "qed_weighted": 0.17,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "CO[C@@H]1[C@@H](CC[C@]2(CO2)[C@H]1[C@@]3(C)O[C@@H]3CC=C(C)C)OC(=O)\\C=C\\C=C\\C=C\\C=C\\C(=O)O",
      "standard_inchi": "InChI=1S/C26H34O7/c1-18(2)13-14-20-25(3,33-20)24-23(30-4)19(15-16-26(24)17-31-26)32-22(29)12-10-8-6-5-7-9-11-21(27)28/h5-13,19-20,23-24H,14-17H2,1-4H3,(H,27,28)/b7-5+,8-6+,11-9+,12-10+/t19-,20-,23-,24-,25+,26+/m1/s1",
      "standard_inchi_key": "NGGMYCMLYOUNGM-CSDLUJIJSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fumagillin (BAN, DCF, INN, MI)",
        null
      ]
    },
    "usan_stem": "-gillin",
    "usan_stem_definition": "antibiotics (Aspergillus strains)",
    "usan_stem_substem": "-gillin(-gillin)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL286452",
    "molecule_properties": {
      "acd_logd": 4.14,
      "acd_logp": 4.15,
      "acd_most_apka": 10.27,
      "alogp": 3.61,
      "aromatic_rings": 1,
      "full_molformula": "C18H24O2",
      "full_mwt": 272.39,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 272.39,
      "mw_monoisotopic": 272.1776,
      "psa": 40.46,
      "qed_weighted": 0.76,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]1CC[C@H]2O",
      "standard_inchi": "InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17-,18+/m1/s1",
      "standard_inchi_key": "VOXZDWNPVJITMN-SFFUCWETSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Alfatradiol (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL35241",
    "molecule_properties": {
      "acd_logd": -1.2,
      "acd_logp": 1.8,
      "acd_most_bpka": 11.84,
      "alogp": 2.37,
      "aromatic_rings": 2,
      "full_molformula": "C14H15N7",
      "full_mwt": 281.32,
      "hba": 4,
      "hba_lipinski": 7,
      "hbd": 5,
      "hbd_lipinski": 7,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 281.32,
      "mw_monoisotopic": 281.1389,
      "num_lipinski_ro5_violations": 1,
      "psa": 136.49,
      "qed_weighted": 0.25,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=N)c1ccc(NN=Nc2ccc(cc2)C(=N)N)cc1",
      "standard_inchi": "InChI=1S/C14H15N7/c15-13(16)9-1-5-11(6-2-9)19-21-20-12-7-3-10(4-8-12)14(17)18/h1-8H,(H3,15,16)(H3,17,18)(H,19,20)",
      "standard_inchi_key": "XNYZHCFCZNMTFY-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Diminazene (BAN, INN, MI)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": [
        {
          "code": "R03AC04",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS, INHALANTS: Selective beta-2-adrenoreceptor agonist"
        },
        {
          "code": "R03CC04",
          "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: ADRENERGICS FOR SYSTEMIC USE: Selective beta-2-adrenoreceptor agonist"
        },
        {
          "code": "G02CA03",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: OTHER GYNECOLOGICALS: Sympathomimetics, labour repressants"
        }
      ]
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Bronchodilator",
    "molecule_chembl_id": "CHEMBL32800",
    "molecule_properties": {
      "acd_logd": -0.33,
      "acd_logp": 1.33,
      "acd_most_apka": 9.25,
      "acd_most_bpka": 9.06,
      "alogp": 2.06,
      "aromatic_rings": 2,
      "full_molformula": "C17H21NO4",
      "full_mwt": 303.36,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 5,
      "hbd_lipinski": 5,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 303.36,
      "mw_monoisotopic": 303.1471,
      "psa": 92.95,
      "qed_weighted": 0.56,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC(Cc1ccc(O)cc1)NCC(O)c2cc(O)cc(O)c2",
      "standard_inchi": "InChI=1S/C17H21NO4/c1-11(6-12-2-4-14(19)5-3-12)18-10-17(22)13-7-15(20)9-16(21)8-13/h2-5,7-9,11,17-22H,6,10H2,1H3",
      "standard_inchi_key": "LSLYOANBFKQKPT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "TH-1165A [As Hydrobromide Salt]"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fenoterol (BAN, INN, USAN)",
        "Fenoterol Hydrobromide (JAN)",
        null
      ]
    },
    "usan_stem": "-terol",
    "usan_stem_definition": "bronchodilators (phenethylamine derivatives)",
    "usan_stem_substem": "-terol(-terol)",
    "usan_year": 1971,
    "withdrawn_class": "Respiratory toxicity",
    "withdrawn_country": "New Zealand",
    "withdrawn_reason": "Asthma Mortality",
    "withdrawn_year": 1990
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 1,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL284121",
    "molecule_properties": {
      "acd_logd": 5.1,
      "acd_logp": 5.1,
      "acd_most_apka": 13.12,
      "alogp": 4.85,
      "full_molformula": "C27H38O3",
      "full_mwt": 410.6,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 30,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 410.6,
      "mw_monoisotopic": 410.2821,
      "psa": 60.69,
      "qed_weighted": 0.46,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@H](CC#CC(C)(C)O)C1=CC[C@H]2\\C(=C\\C=C/3\\C[C@@H](O)C[C@H](O)C3=C)\\CCC[C@]12C",
      "standard_inchi": "InChI=1S/C27H38O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-12,18,22,24-25,28-30H,2,7-9,13,15-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,24+,25+,27-/m1/s1",
      "standard_inchi_key": "JKFZMIQMKFWJAY-RQJQXFIZSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "BXL-353",
        "ILX-7553",
        "Ro-23-7553"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": "ILX23-7553"
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL34246",
    "molecule_properties": {
      "acd_logd": 2.57,
      "acd_logp": 2.64,
      "acd_most_bpka": 6.84,
      "alogp": 2.42,
      "aromatic_rings": 1,
      "full_molformula": "C13H22ClN5S",
      "full_mwt": 315.87,
      "hba": 6,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 315.87,
      "mw_monoisotopic": 315.1284,
      "psa": 44.29,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CSc1c(Cl)nc(NC(C)C)nc1N2CCN(C)CC2",
      "standard_inchi": "InChI=1S/C13H22ClN5S/c1-9(2)15-13-16-11(14)10(20-4)12(17-13)19-7-5-18(3)6-8-19/h9H,5-8H2,1-4H3,(H,15,16,17)",
      "standard_inchi_key": "UMMYPDFDLDVDCZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Iprozilamine (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL34722",
    "molecule_properties": {
      "acd_logd": 0.3,
      "acd_logp": 0.32,
      "acd_most_apka": 8.83,
      "acd_most_bpka": 2.31,
      "alogp": 0.73,
      "aromatic_rings": 3,
      "full_molformula": "C9H8N8O2S",
      "full_mwt": 292.28,
      "hba": 9,
      "hba_lipinski": 10,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 20,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 292.28,
      "mw_monoisotopic": 292.0491,
      "psa": 141.44,
      "qed_weighted": 0.41,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cn1cnc(c1Sc2nc(N)nc3nc[nH]c23)[N+](=O)[O-]",
      "standard_inchi": "InChI=1S/C9H8N8O2S/c1-16-3-13-6(17(18)19)8(16)20-7-4-5(12-2-11-4)14-9(10)15-7/h2-3H,1H3,(H3,10,11,12,14,15)",
      "standard_inchi_key": "YFTWHEBLORWGNI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BW-57323"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Thiamiprine (USAN)",
        "Tiamiprine (INN)",
        null
      ]
    },
    "usan_year": 1964
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL35033",
    "molecule_properties": {
      "acd_logd": 3.57,
      "acd_logp": 3.57,
      "acd_most_apka": 9.46,
      "alogp": 2.24,
      "aromatic_rings": 2,
      "full_molformula": "C17H22N2O3",
      "full_mwt": 302.37,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 302.37,
      "mw_monoisotopic": 302.163,
      "psa": 64.09,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCOCN1C(=O)NC(=O)C(=C1Cc2ccccc2)C(C)C",
      "standard_inchi": "InChI=1S/C17H22N2O3/c1-4-22-11-19-14(10-13-8-6-5-7-9-13)15(12(2)3)16(20)18-17(19)21/h5-9,12H,4,10-11H2,1-3H3,(H,18,20,21)",
      "standard_inchi_key": "MLILORUFDVLTSP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "MKC-442"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Emivirine (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-virine",
    "usan_stem_definition": "antivirals: non-nucleoside reverse transcriptase inhibitors, not benzoxazinone derivatives",
    "usan_stem_substem": "-virine(-virine)",
    "usan_year": 1999
  },
  {
    "applicants": {
      "value": [
        "Mallinckrodt Inc",
        "Breckenridge Pharmaceutical Inc",
        "Abhai Inc",
        "Mayne Pharma Llc",
        "Teva Pharmaceuticals Usa",
        "Sun Pharmaceutical Industries Inc",
        "Pfizer Inc",
        "Actavis Laboratories Fl Inc",
        "Nextwave Pharmaceuticals Inc",
        "Ucb Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06BA04",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1955,
    "indication_class": "Stimulant (central)",
    "molecule_chembl_id": "CHEMBL796",
    "molecule_properties": {
      "acd_logd": 0.23,
      "acd_logp": 2.31,
      "acd_most_bpka": 9.51,
      "alogp": 2.09,
      "aromatic_rings": 1,
      "full_molformula": "C14H19NO2",
      "full_mwt": 233.31,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "BASE",
      "mw_freebase": 233.31,
      "mw_monoisotopic": 233.1416,
      "psa": 38.33,
      "qed_weighted": 0.81,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "COC(=O)C(C1CCCCN1)c2ccccc2",
      "standard_inchi": "InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3",
      "standard_inchi_key": "DUGOZIWVEXMGBE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6210705,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-6210705-B1",
    "synonyms": {
      "value": [
        "Methylphenidate HCl (FDA, JAN, USP)",
        "Methylphenidate (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 2003
  },
  {
    "applicants": {
      "value": [
        "Abbott Laboratories Pharmaceutical Products Div",
        "Par Pharmaceutical Inc",
        "Watson Laboratories Inc",
        "Mayne Pharma Llc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N05CD04",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: HYPNOTICS AND SEDATIVES: Benzodiazepine derivatives"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1990,
    "indication_class": "Sedative-Hypnotic",
    "molecule_chembl_id": "CHEMBL285674",
    "molecule_properties": {
      "acd_logd": 2.52,
      "acd_logp": 2.52,
      "acd_most_bpka": 1.99,
      "alogp": 3.27,
      "aromatic_rings": 3,
      "full_molformula": "C16H11ClN4",
      "full_mwt": 294.75,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 294.75,
      "mw_monoisotopic": 294.0672,
      "psa": 43.07,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1ccc2c(c1)C(=NCc3nncn23)c4ccccc4",
      "standard_inchi": "InChI=1S/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2",
      "standard_inchi_key": "CDCHDCWJMGXXRH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "ABBOTT-47631"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Estazolam (FDA, INN, JAN, USAN)",
        null
      ]
    },
    "usan_year": 1990
  },
  {
    "applicants": {
      "value": "Parke Davis Div Warner Lambert Co"
    },
    "atc_classification": {
      "drug": {
        "code": "N03AD02",
        "description": "NERVOUS SYSTEM: ANTIEPILEPTICS: ANTIEPILEPTICS: Succinimide derivatives"
      }
    },
    "availability_type": 0,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Anticonvulsant",
    "molecule_chembl_id": "CHEMBL797",
    "molecule_properties": {
      "acd_logd": 0.04,
      "acd_logp": 0.04,
      "alogp": 1.16,
      "aromatic_rings": 1,
      "full_molformula": "C11H11NO2",
      "full_mwt": 189.21,
      "hba": 2,
      "hba_lipinski": 3,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 189.21,
      "mw_monoisotopic": 189.079,
      "psa": 37.38,
      "qed_weighted": 0.62,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)CC(C1=O)c2ccccc2",
      "standard_inchi": "InChI=1S/C11H11NO2/c1-12-10(13)7-9(11(12)14)8-5-3-2-4-6-8/h2-6,9H,7H2,1H3",
      "standard_inchi_key": "WLWFNJKHKGIJNW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Phensuximide (BAN, FDA, INN, USP)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Tranquilizer (minor)",
    "molecule_chembl_id": "CHEMBL36565",
    "molecule_properties": {
      "acd_logd": 1.14,
      "acd_logp": 1.31,
      "acd_most_apka": 13.45,
      "acd_most_bpka": 7.63,
      "alogp": 2.26,
      "aromatic_rings": 2,
      "full_molformula": "C18H17Cl2N3O3",
      "full_mwt": 394.26,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 394.26,
      "mw_monoisotopic": 393.0647,
      "psa": 92.5,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C(=O)CNC(=O)CN)c1ccc(Cl)cc1C(=O)c2ccccc2Cl",
      "standard_inchi": "InChI=1S/C18H17Cl2N3O3/c1-23(17(25)10-22-16(24)9-21)15-7-6-11(19)8-13(15)18(26)12-4-2-3-5-14(12)20/h2-8H,9-10,21H2,1H3,(H,22,24)",
      "standard_inchi_key": "RCPMGOCZIHMTRD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lorzafone (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-fo-",
    "usan_stem_definition": "phosphoro-derivatives",
    "usan_stem_substem": "-fo-(-fo-)",
    "usan_year": 1983
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Dava Pharmaceuticals Inc",
        "Pharmachemie Bv",
        "Hospira Inc",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Bristol Myers Co",
        "Medac Pharma Inc",
        "Norbrook Laboratories Ltd",
        "Antares Pharma Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "L04AX03",
          "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: IMMUNOSUPPRESSANTS: IMMUNOSUPPRESSANTS: Other immunosuppressant"
        },
        {
          "code": "L01BA01",
          "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Folic acid analogues"
        }
      ]
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1953,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL34259",
    "molecule_properties": {
      "acd_logd": -5.1,
      "acd_logp": -0.45,
      "acd_most_apka": 3.47,
      "acd_most_bpka": 5.55,
      "alogp": 0.27,
      "aromatic_rings": 3,
      "full_molformula": "C20H22N8O5",
      "full_mwt": 454.45,
      "hba": 10,
      "hba_lipinski": 13,
      "hbd": 5,
      "hbd_lipinski": 7,
      "heavy_atoms": 33,
      "molecular_species": "ACID",
      "mw_freebase": 454.45,
      "mw_monoisotopic": 454.1713,
      "num_lipinski_ro5_violations": 2,
      "psa": 210.54,
      "qed_weighted": 0.29,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CN(Cc1cnc2nc(N)nc(N)c2n1)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O",
      "standard_inchi": "InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1",
      "standard_inchi_key": "FBOZXECLQNJBKD-ZDUSSCGKSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6746429,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "TCMDC-125858",
        "TCMDC-125488",
        "CL-14377",
        "TCMDC-123832"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6746429-B2",
    "synonyms": {
      "value": [
        "Methotrexate Sodium (FDA)",
        "Methotrexate (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-trexate",
    "usan_stem_definition": "antimetabolites (folic acid derivatives)",
    "usan_stem_substem": "-trexate(-trexate)",
    "usan_year": 1961
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL34412",
    "molecule_properties": {
      "acd_logd": -2.26,
      "acd_logp": 1.23,
      "acd_most_apka": 3.6,
      "acd_most_bpka": 9.51,
      "alogp": 0.62,
      "aromatic_rings": 2,
      "full_molformula": "C21H25N5O6",
      "full_mwt": 443.46,
      "hba": 7,
      "hba_lipinski": 11,
      "hbd": 6,
      "hbd_lipinski": 7,
      "heavy_atoms": 32,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 443.46,
      "mw_monoisotopic": 443.1805,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 1,
      "psa": 187.5,
      "qed_weighted": 0.32,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "NC1=NC2=C(C[C@@H](CCc3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)CN2)C(=O)N1",
      "standard_inchi": "InChI=1S/C21H25N5O6/c22-21-25-17-14(19(30)26-21)9-12(10-23-17)2-1-11-3-5-13(6-4-11)18(29)24-15(20(31)32)7-8-16(27)28/h3-6,12,15H,1-2,7-10H2,(H,24,29)(H,27,28)(H,31,32)(H4,22,23,25,26,30)/t12-,15+/m1/s1",
      "standard_inchi_key": "ZUQBAQVRAURMCL-DOMZBBRYSA-N"
    },
    "molecule_synonyms": [],
    "synonyms": {
      "value": [
        "Lometrexol (BAN, INN)",
        "Lometrexol Sodium (USAN)",
        null
      ]
    },
    "usan_year": 1990
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL36503",
    "molecule_properties": {
      "acd_logd": -1.71,
      "acd_logp": 1.79,
      "acd_most_apka": 2.56,
      "acd_most_bpka": 10.41,
      "alogp": 2.78,
      "aromatic_rings": 1,
      "full_molformula": "C21H33N2O6P",
      "full_mwt": 440.48,
      "hba": 5,
      "hba_lipinski": 8,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 30,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 440.48,
      "mw_monoisotopic": 440.2076,
      "psa": 130.16,
      "qed_weighted": 0.32,
      "ro3_pass": "N",
      "rtb": 13
    },
    "molecule_structures": {
      "canonical_smiles": "NCCCC[C@H](OP(=O)(O)CCCCc1ccccc1)C(=O)N2CCC[C@H]2C(=O)O",
      "standard_inchi": "InChI=1S/C21H33N2O6P/c22-14-6-4-13-19(20(24)23-15-8-12-18(23)21(25)26)29-30(27,28)16-7-5-11-17-9-2-1-3-10-17/h1-3,9-10,18-19H,4-8,11-16,22H2,(H,25,26)(H,27,28)/t18-,19-/m0/s1",
      "standard_inchi_key": "IFYLTXNCFVRALQ-OALUTQOASA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "SQ-29852"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ceronapril (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-pril",
    "usan_stem_definition": "antihypertensives (ACE inhibitors)",
    "usan_stem_substem": "-pril(-pril)",
    "usan_year": 1990
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N06AX19",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Other antidepressants"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 2,
    "drug_type": 1,
    "indication_class": "Tranquilizer",
    "molecule_chembl_id": "CHEMBL284092",
    "molecule_properties": {
      "acd_logd": 0.7,
      "acd_logp": 1.06,
      "acd_most_bpka": 7.71,
      "alogp": 1.55,
      "aromatic_rings": 1,
      "full_molformula": "C19H29N5O2",
      "full_mwt": 359.47,
      "hba": 6,
      "hba_lipinski": 7,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 359.47,
      "mw_monoisotopic": 359.2321,
      "psa": 69.64,
      "qed_weighted": 0.57,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)CC(=O)N(CCCCN2CCN(CC2)c3ncccn3)C(=O)C1",
      "standard_inchi": "InChI=1S/C19H29N5O2/c1-19(2)14-16(25)24(17(26)15-19)9-4-3-8-22-10-12-23(13-11-22)18-20-6-5-7-21-18/h5-7H,3-4,8-15H2,1-2H3",
      "standard_inchi_key": "QOIGKGMMAGJZNZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "BMY-13805",
        "ORG-13011",
        "BMY-13805-1"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Gepirone HCl (USAN)",
        "Gepirone (INN)",
        null
      ]
    },
    "usan_year": 1985
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL34431",
    "molecule_properties": {
      "acd_logd": 1.87,
      "acd_logp": 3.69,
      "acd_most_apka": 0.51,
      "acd_most_bpka": 9.73,
      "alogp": 3.89,
      "aromatic_rings": 2,
      "full_molformula": "C20H26N2O3",
      "full_mwt": 342.44,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 342.44,
      "mw_monoisotopic": 342.1943,
      "psa": 62.66,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C1CCCCC1)C(=O)CCCOc2ccc3nc(O)ccc3c2",
      "standard_inchi": "InChI=1S/C20H26N2O3/c1-22(16-6-3-2-4-7-16)20(24)8-5-13-25-17-10-11-18-15(14-17)9-12-19(23)21-18/h9-12,14,16H,2-8,13H2,1H3,(H,21,23)",
      "standard_inchi_key": "UIAYVIIHMORPSJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cilostamide (INN)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Chartwell Rx Sciences Llc",
        "Pliva Hrvatska Doo",
        "Epic Pharma Llc",
        "Apotex Inc Etobicoke Site",
        "Actavis Elizabeth Llc",
        "Otsuka Pharmaceutical Co Ltd",
        "Sandoz Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Breckenridge Pharmaceutical Inc",
        "Ivax Pharmaceuticals Inc Sub Teva Pharmaceuticals Usa"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "B01AC23",
        "description": "BLOOD AND BLOOD FORMING ORGANS: ANTITHROMBOTIC AGENTS: ANTITHROMBOTIC AGENTS: Platelet aggregation inhibitors excl. heparin"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1999,
    "indication_class": "Inhibitor (platelet); Vasodilator; Antithrombotic",
    "molecule_chembl_id": "CHEMBL799",
    "molecule_properties": {
      "acd_logd": 3.36,
      "acd_logp": 3.36,
      "acd_most_bpka": 2.19,
      "alogp": 3.46,
      "aromatic_rings": 2,
      "full_molformula": "C20H27N5O2",
      "full_mwt": 369.47,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 27,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 369.47,
      "mw_monoisotopic": 369.2165,
      "psa": 81.93,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1CCc2cc(OCCCCc3nnnn3C4CCCCC4)ccc2N1",
      "standard_inchi": "InChI=1S/C20H27N5O2/c26-20-12-9-15-14-17(10-11-18(15)21-20)27-13-5-4-8-19-22-23-24-25(19)16-6-2-1-3-7-16/h10-11,14,16H,1-9,12-13H2,(H,21,26)",
      "standard_inchi_key": "RRGUKTPIGVIEKM-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "OPC-13013",
        "OPC-21"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cilostazol (BAN, FDA, INN, JAN, USAN)",
        null
      ]
    },
    "usan_year": 1997
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL33958",
    "molecule_properties": {
      "acd_logd": 4.88,
      "acd_logp": 4.88,
      "alogp": 3.85,
      "aromatic_rings": 1,
      "full_molformula": "C14H15ClO2",
      "full_mwt": 250.72,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 17,
      "mw_freebase": 250.72,
      "mw_monoisotopic": 250.0761,
      "psa": 26.3,
      "qed_weighted": 0.56,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1cc2CC(=O)Oc2cc1C3CCCCC3",
      "standard_inchi": "InChI=1S/C14H15ClO2/c15-12-6-10-7-14(16)17-13(10)8-11(12)9-4-2-1-3-5-9/h6,8-9H,1-5,7H2",
      "standard_inchi_key": "FFPGKSCPXZYKFO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Clofurac (INN)",
        null
      ]
    },
    "usan_stem": "-ac",
    "usan_stem_definition": "anti-inflammatory agents (acetic acid derivatives)",
    "usan_stem_substem": "-ac(-ac)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL36016",
    "molecule_properties": {
      "acd_logd": -0.44,
      "acd_logp": -0.02,
      "acd_most_apka": 7.15,
      "alogp": -0.32,
      "full_molformula": "C16H20N4O6",
      "full_mwt": 364.36,
      "hba": 8,
      "hba_lipinski": 10,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 364.36,
      "mw_monoisotopic": 364.1383,
      "psa": 116.82,
      "qed_weighted": 0.49,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)NC1=C(N2CC2)C(=O)C(=C(N3CC3)C1=O)NC(=O)OCC",
      "standard_inchi": "InChI=1S/C16H20N4O6/c1-3-25-15(23)17-9-11(19-5-6-19)14(22)10(18-16(24)26-4-2)12(13(9)21)20-7-8-20/h3-8H2,1-2H3,(H,17,23)(H,18,24)",
      "standard_inchi_key": "WVYXNIXAMZOZFK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "AZQ",
        "CI-904"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Diaziquone (INN, USAN)",
        null
      ]
    },
    "usan_year": 1981
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL35802",
    "molecule_properties": {
      "acd_logd": 0.88,
      "acd_logp": 3.78,
      "acd_most_bpka": 10.72,
      "alogp": 3.82,
      "aromatic_rings": 2,
      "full_molformula": "C18H27N3O",
      "full_mwt": 301.43,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 301.43,
      "mw_monoisotopic": 301.2154,
      "psa": 46.18,
      "qed_weighted": 0.69,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc(NCCCCCNC(C)C)c2ncccc2c1",
      "standard_inchi": "InChI=1S/C18H27N3O/c1-14(2)19-9-5-4-6-10-20-17-13-16(22-3)12-15-8-7-11-21-18(15)17/h7-8,11-14,19-20H,4-6,9-10H2,1-3H3",
      "standard_inchi_key": "VKXQZROIIKPELG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pentaquine Phosphate (USP)",
        "Pentaquine (BAN, INN)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C04AX32",
        "description": "CARDIOVASCULAR SYSTEM: PERIPHERAL VASODILATORS: PERIPHERAL VASODILATORS: Other peripheral vasodilators"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL38380",
    "molecule_properties": {
      "acd_logd": -0.54,
      "acd_logp": 1.72,
      "acd_most_bpka": 9.73,
      "alogp": 1.22,
      "aromatic_rings": 2,
      "full_molformula": "C14H17N3O2S",
      "full_mwt": 291.38,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 291.38,
      "mw_monoisotopic": 291.1041,
      "psa": 62.3,
      "qed_weighted": 0.9,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "O=S(=O)(N1CCCNCC1)c2cccc3cnccc23",
      "standard_inchi": "InChI=1S/C14H17N3O2S/c18-20(19,17-9-2-6-15-8-10-17)14-4-1-3-12-11-16-7-5-13(12)14/h1,3-5,7,11,15H,2,6,8-10H2",
      "standard_inchi_key": "NGOGFTYYXHNFQH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "ZK-258594",
        "HA-1077",
        "AT-877"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fasudil (INN)",
        null
      ]
    },
    "usan_stem": "-dil",
    "usan_stem_definition": "vasodilators (undefined group)",
    "usan_stem_substem": "-dil(-dil)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C02DB01",
        "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON: Hydrazinophthalazine derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL35505",
    "molecule_properties": {
      "acd_logd": 1.29,
      "acd_logp": 1.32,
      "acd_most_bpka": 6.62,
      "alogp": 0.2,
      "aromatic_rings": 2,
      "full_molformula": "C8H10N6",
      "full_mwt": 190.21,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 4,
      "hbd_lipinski": 6,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 190.21,
      "mw_monoisotopic": 190.0967,
      "num_lipinski_ro5_violations": 1,
      "psa": 101.88,
      "qed_weighted": 0.4,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NNc1nnc(NN)c2ccccc12",
      "standard_inchi": "InChI=1S/C8H10N6/c9-11-7-5-3-1-2-4-6(5)8(12-10)14-13-7/h1-4H,9-10H2,(H,11,13)(H,12,14)",
      "standard_inchi_key": "VQKLRVZQQYVIJW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dihydralazine (BAN, INN)",
        "Dihydralazine Sulfate (MI)",
        null
      ]
    },
    "usan_stem": "-dralazine",
    "usan_stem_definition": "antihypertensives (hydrazine-phthalazines)",
    "usan_stem_substem": "-dralazine(-dralazine)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL432481",
    "molecule_properties": {
      "acd_logd": -0.58,
      "acd_logp": 2.88,
      "acd_most_apka": 1.01,
      "acd_most_bpka": 5.77,
      "alogp": 1.43,
      "aromatic_rings": 1,
      "full_molformula": "C11H11NO4S",
      "full_mwt": 253.28,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 3,
      "heavy_atoms": 17,
      "molecular_species": "ACID",
      "mw_freebase": 253.28,
      "mw_monoisotopic": 253.0409,
      "psa": 90.12,
      "qed_weighted": 0.74,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "C[C@@]1(CSC(=N1)c2ccc(O)cc2O)C(=O)O",
      "standard_inchi": "InChI=1S/C11H11NO4S/c1-11(10(15)16)5-17-9(12-11)7-3-2-6(13)4-8(7)14/h2-4,13-14H,5H2,1H3,(H,15,16)/t11-/m1/s1",
      "standard_inchi_key": "OEUUFNIKLCFNLN-LLVKDONJSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "GT56-252"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Deferitrin (INN, USAN)",
        null
      ]
    },
    "usan_year": 2005
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Cardiotonic",
    "molecule_chembl_id": "CHEMBL38224",
    "molecule_properties": {
      "acd_logd": -0.57,
      "acd_logp": -0.57,
      "acd_most_apka": 13.56,
      "acd_most_bpka": 1.12,
      "alogp": 1.53,
      "aromatic_rings": 1,
      "full_molformula": "C14H15N3O2",
      "full_mwt": 257.29,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 257.29,
      "mw_monoisotopic": 257.1164,
      "psa": 70.56,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CC1(C)C(=O)Nc2ccc(cc12)C3=NNC(=O)CC3",
      "standard_inchi": "InChI=1S/C14H15N3O2/c1-14(2)9-7-8(3-4-11(9)15-13(14)19)10-5-6-12(18)17-16-10/h3-4,7H,5-6H2,1-2H3,(H,15,19)(H,17,18)",
      "standard_inchi_key": "LZCQFJKUAIWHRW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Indolidan (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-dan",
    "usan_stem_definition": "positive inotropic agents (pimobendan type)",
    "usan_stem_substem": "-dan(-dan)",
    "usan_year": 1987
  },
  {
    "availability_type": -1,
    "chirality": -1,
    "drug_type": 1,
    "first_in_class": true,
    "molecule_chembl_id": "CHEMBL35228",
    "molecule_properties": {
      "acd_logd": 1.15,
      "acd_logp": 4.86,
      "acd_most_apka": 8.2,
      "acd_most_bpka": 10.21,
      "alogp": 6.09,
      "aromatic_rings": 4,
      "full_molformula": "C29H32ClN5O2",
      "full_mwt": 518.06,
      "hba": 7,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 37,
      "molecular_species": "BASE",
      "mw_freebase": 518.06,
      "mw_monoisotopic": 517.2245,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 73.75,
      "qed_weighted": 0.23,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2nc3cc(Cl)ccc3c(Nc4cc(CN5CCCC5)c(O)c(CN6CCCC6)c4)c2n1",
      "standard_inchi": "InChI=1S/C29H32ClN5O2/c1-37-26-9-8-24-28(33-26)27(23-7-6-21(30)16-25(23)32-24)31-22-14-19(17-34-10-2-3-11-34)29(36)20(15-22)18-35-12-4-5-13-35/h6-9,14-16,36H,2-5,10-13,17-18H2,1H3,(H,31,32)",
      "standard_inchi_key": "DJUFPMUQJKWIJB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "prodrug": true,
    "synonyms": {
      "value": "Pyronaridine"
    }
  },
  {
    "applicants": {
      "value": [
        "Copley Pharmaceutical Inc",
        "Avacor Products Llc",
        "Par Pharmaceutical Inc",
        "Sun Pharmaceutical Industries Inc",
        "Quantum Pharmics Ltd",
        "Wockhardt Eu Operations (Swiss) Ag",
        "Sight Pharmaceuticals Inc",
        "Johnson And Johnson Group Consumer Companies",
        "Perrigo New York Inc",
        "Teva Pharmaceuticals Usa Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D11AX01",
          "description": "DERMATOLOGICALS: OTHER DERMATOLOGICAL PREPARATIONS: OTHER DERMATOLOGICAL PREPARATIONS: Other dermatological"
        },
        {
          "code": "C02DC01",
          "description": "CARDIOVASCULAR SYSTEM: ANTIHYPERTENSIVES: ARTERIOLAR SMOOTH MUSCLE, AGENTS ACTING ON: Pyrimidine derivatives"
        }
      ]
    },
    "availability_type": 2,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1979,
    "indication_class": "Hair Growth Stimulant (topical); Antihypertensive",
    "molecule_chembl_id": "CHEMBL802",
    "molecule_properties": {
      "acd_logd": 1.61,
      "acd_logp": 1.62,
      "acd_most_bpka": 5.54,
      "alogp": -0.13,
      "aromatic_rings": 1,
      "full_molformula": "C9H15N5O",
      "full_mwt": 209.25,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 209.25,
      "mw_monoisotopic": 209.1277,
      "psa": 95.11,
      "qed_weighted": 0.5,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1cc(nc(N)[n+]1[O-])N2CCCCC2",
      "standard_inchi": "InChI=1S/C9H15N5O/c10-7-6-8(12-9(11)14(7)15)13-4-2-1-3-5-13/h6H,1-5,10H2,(H2,11,12)",
      "standard_inchi_key": "ZFMITUMMTDLWHR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6946120,
    "oral": true,
    "prodrug": true,
    "research_codes": {
      "value": "U-10858"
    },
    "rule_of_five": true,
    "sc_patent": "US-6946120-B2",
    "synonyms": {
      "value": [
        "Minoxidil (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-dil",
    "usan_stem_definition": "vasodilators (undefined group)",
    "usan_stem_substem": "-dil(-dil)",
    "usan_year": 1970
  },
  {
    "applicants": {
      "value": [
        "Marksans Pharma Ltd",
        "Chartwell Molecules Llc",
        "Hamilton Pharmaceuticals Ltd",
        "Dava Pharmaceuticals Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Glenmark Pharmaceuticals Ltd",
        "Invagen Pharmaceuticals Inc",
        "Bayer Healthcare Llc",
        "Contract Pharmacal Corp",
        "Hikma International Pharmaceuticals Llc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "G02CC02",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: OTHER GYNECOLOGICALS: Antiinflammatory products for vaginal administratio"
        },
        {
          "code": "M02AA12",
          "description": "MUSCULO-SKELETAL SYSTEM: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN: Antiinflammatory preparations, non-steroids for topical us"
        },
        {
          "code": "M01AE02",
          "description": "MUSCULO-SKELETAL SYSTEM: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS: ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS: Propionic acid derivatives"
        }
      ]
    },
    "availability_type": 2,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1976,
    "indication_class": "Anti-Inflammatory; Antipyretic; Analgesic,Antipyretic; Anti-Inflammatory; Analgesic",
    "molecule_chembl_id": "CHEMBL154",
    "molecule_properties": {
      "acd_logd": 0.35,
      "acd_logp": 2.88,
      "acd_most_apka": 4.84,
      "alogp": 3.04,
      "aromatic_rings": 2,
      "full_molformula": "C14H14O3",
      "full_mwt": 230.26,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "ACID",
      "mw_freebase": 230.26,
      "mw_monoisotopic": 230.0943,
      "psa": 46.53,
      "qed_weighted": 0.88,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc2cc(ccc2c1)[C@H](C)C(=O)O",
      "standard_inchi": "InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1",
      "standard_inchi_key": "CMWTZPSULFXXJA-VIFPVBQESA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5872145,
    "oral": true,
    "research_codes": {
      "value": [
        "RS-3650",
        "RS-3540"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5872145-A",
    "synonyms": {
      "value": [
        "Naproxen (BAN, FDA, INN, JAN, USAN, USP)",
        "Naproxen Sodium (FDA, USAN, USP)",
        null
      ]
    },
    "usan_year": 1970
  },
  {
    "applicants": {
      "value": [
        "Hoffmann La Roche Inc",
        "United States Army Walter Reed Army Institute Research",
        "Sandoz Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Barr Laboratories Inc",
        "Hikma International Pharmaceuticals Llc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "P01BC02",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: ANTIMALARIALS: Methanolquinolines"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1989,
    "indication_class": "Antimalarial",
    "molecule_chembl_id": "CHEMBL416956",
    "molecule_properties": {
      "acd_logd": 0.5,
      "acd_logp": 2.2,
      "acd_most_apka": 12.81,
      "acd_most_bpka": 9.24,
      "alogp": 4.45,
      "aromatic_rings": 2,
      "full_molformula": "C17H16F6N2O",
      "full_mwt": 378.32,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "BASE",
      "mw_freebase": 378.32,
      "mw_monoisotopic": 378.1167,
      "psa": 45.15,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "OC(C1CCCCN1)c2cc(nc3c(cccc23)C(F)(F)F)C(F)(F)F",
      "standard_inchi": "InChI=1S/C17H16F6N2O/c18-16(19,20)11-5-3-4-9-10(15(26)12-6-1-2-7-24-12)8-13(17(21,22)23)25-14(9)11/h3-5,8,12,15,24,26H,1-2,6-7H2",
      "standard_inchi_key": "XEEQGYMUWCZPDN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "GNF-Pf-5544",
        "Ro-215998",
        "Ro-215998001",
        "WR-142490"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Mefloquine HCl (FDA, USAN, USP)",
        "Mefloquine (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1975
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Pacira Pharmaceuticals Inc",
        "Teva Parenteral Medicines Inc",
        "Teva Pharmaceuticals Usa",
        "Celator Pharmaceuticals Inc",
        "West-Ward Pharmaceuticals International Ltd",
        "Hospira Inc",
        "Hong Kong King-Friend Industrial Co Ltd",
        "Mylan Laboratories Ltd",
        "Mylan Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01BC01",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ANTIMETABOLITES: Pyrimidine analogues"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1969,
    "indication_class": "Antiviral,Antiviral; Antineoplastic",
    "molecule_chembl_id": "CHEMBL803",
    "molecule_properties": {
      "acd_logd": -1.81,
      "acd_logp": -1.81,
      "acd_most_apka": 13.48,
      "acd_most_bpka": 4.26,
      "alogp": -2.56,
      "aromatic_rings": 1,
      "full_molformula": "C9H13N3O5",
      "full_mwt": 243.22,
      "hba": 8,
      "hba_lipinski": 8,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 243.22,
      "mw_monoisotopic": 243.0855,
      "psa": 130.83,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NC1=NC(=O)N(C=C1)[C@@H]2O[C@H](CO)[C@@H](O)[C@@H]2O",
      "standard_inchi": "InChI=1S/C9H13N3O5/c10-5-1-2-12(9(16)11-5)8-7(15)6(14)4(3-13)17-8/h1-2,4,6-8,13-15H,3H2,(H2,10,11,16)/t4-,6-,7+,8-/m1/s1",
      "standard_inchi_key": "UHDGCWIWMRVCDJ-CCXZUQQUSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7850990,
    "parenteral": true,
    "research_codes": {
      "value": [
        "U-19920",
        "U-19920A"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-7850990-B2",
    "synonyms": {
      "value": [
        "Cytarabine HCl (USAN)",
        "Cytarabine (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-arabine",
    "usan_stem_definition": "antineoplastics (arabinofuranosyl derivatives)",
    "usan_stem_substem": "-arabine(-arabine)",
    "usan_year": 1964
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antipsychotic",
    "molecule_chembl_id": "CHEMBL35057",
    "molecule_properties": {
      "acd_logd": 2.8,
      "acd_logp": 3.67,
      "acd_most_bpka": 8.41,
      "alogp": 3.91,
      "aromatic_rings": 2,
      "full_molformula": "C24H32N4O2S",
      "full_mwt": 440.61,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 31,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 440.61,
      "mw_monoisotopic": 440.2246,
      "psa": 56.75,
      "qed_weighted": 0.5,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4nsc5ccccc45",
      "standard_inchi": "InChI=1S/C24H32N4O2S/c29-21-17-24(9-3-4-10-24)18-22(30)28(21)12-6-5-11-26-13-15-27(16-14-26)23-19-7-1-2-8-20(19)31-25-23/h1-2,7-8H,3-6,9-18H2",
      "standard_inchi_key": "ZFZPJDFBJFHYIV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "BMY-13859",
        "BMY-13859-1"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tiospirone HCl (USAN)",
        "Tiospirone (INN)",
        null
      ]
    },
    "usan_stem": "-spirone",
    "usan_stem_definition": "anxiolytics (buspirone type)",
    "usan_stem_substem": "-spirone(-spirone)",
    "usan_year": 1987
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Coccidiostat (for poultry)",
    "molecule_chembl_id": "CHEMBL284733",
    "molecule_properties": {
      "acd_logd": 2.09,
      "acd_logp": 3.49,
      "acd_most_apka": 5.89,
      "alogp": 3.54,
      "aromatic_rings": 3,
      "full_molformula": "C17H9Cl3N4O2",
      "full_mwt": 407.64,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 26,
      "molecular_species": "ACID",
      "mw_freebase": 407.64,
      "mw_monoisotopic": 405.9791,
      "psa": 91.54,
      "qed_weighted": 0.72,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1ccc(cc1)C(C#N)c2c(Cl)cc(cc2Cl)N3N=CC(=O)NC3=O",
      "standard_inchi": "InChI=1S/C17H9Cl3N4O2/c18-10-3-1-9(2-4-10)12(7-21)16-13(19)5-11(6-14(16)20)24-17(26)23-15(25)8-22-24/h1-6,8,12H,(H,23,25,26)",
      "standard_inchi_key": "ZSZFUDFOPOMEET-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "R-64433"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Diclazuril (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1988
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Coccidiostat (for poultry)",
    "molecule_chembl_id": "CHEMBL416230",
    "molecule_properties": {
      "acd_logd": 4.73,
      "acd_logp": 7.19,
      "acd_most_apka": 2.6,
      "acd_most_bpka": 9.81,
      "alogp": 6.04,
      "aromatic_rings": 2,
      "full_molformula": "C24H35NO5",
      "full_mwt": 417.55,
      "hba": 6,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 30,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 417.55,
      "mw_monoisotopic": 417.2515,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 77.88,
      "qed_weighted": 0.3,
      "ro3_pass": "N",
      "rtb": 14
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCCCCCCCOc1cc2c(O)c(cnc2cc1OCC)C(=O)OCC",
      "standard_inchi": "InChI=1S/C24H35NO5/c1-4-7-8-9-10-11-12-13-14-30-21-15-18-20(16-22(21)28-5-2)25-17-19(23(18)26)24(27)29-6-3/h15-17H,4-14H2,1-3H3,(H,25,26)",
      "standard_inchi_key": "JHAYEQICABJSTP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "M&B-15497",
        "HC-1528"
      ]
    },
    "synonyms": {
      "value": [
        "Decoquinate (BAN, INN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1968
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anthelmintic",
    "molecule_chembl_id": "CHEMBL290578",
    "molecule_properties": {
      "acd_logd": 3.07,
      "acd_logp": 3.07,
      "acd_most_apka": 10.13,
      "acd_most_bpka": 3.58,
      "alogp": 3.64,
      "aromatic_rings": 3,
      "full_molformula": "C14H14N4O2S",
      "full_mwt": 302.36,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 302.36,
      "mw_monoisotopic": 302.0837,
      "psa": 79.9,
      "qed_weighted": 0.77,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)OC(=O)Nc1ccc2[nH]c(nc2c1)c3cscn3",
      "standard_inchi": "InChI=1S/C14H14N4O2S/c1-8(2)20-14(19)16-9-3-4-10-11(5-9)18-13(17-10)12-6-21-7-15-12/h3-8H,1-2H3,(H,16,19)(H,17,18)",
      "standard_inchi_key": "QZWHWHNCPFEXLL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Cambendazole (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-bendazole",
    "usan_stem_definition": "anthelmintics (tibendazole type)",
    "usan_stem_substem": "-bendazole(-bendazole)",
    "usan_year": 1970
  },
  {
    "atc_classification": {
      "drug": {
        "code": "P02CA06",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTHELMINTICS: ANTINEMATODAL AGENTS: Benzimidazole derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Anthelmintic",
    "molecule_chembl_id": "CHEMBL37161",
    "molecule_properties": {
      "acd_logd": 2.45,
      "acd_logp": 2.46,
      "acd_most_apka": 10.51,
      "acd_most_bpka": 5.25,
      "alogp": 3.89,
      "aromatic_rings": 3,
      "full_molformula": "C15H13N3O2S",
      "full_mwt": 299.36,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 299.36,
      "mw_monoisotopic": 299.0728,
      "psa": 67.01,
      "qed_weighted": 0.77,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1",
      "standard_inchi": "InChI=1S/C15H13N3O2S/c1-20-15(19)18-14-16-12-8-7-11(9-13(12)17-14)21-10-5-3-2-4-6-10/h2-9H,1H3,(H2,16,17,18,19)",
      "standard_inchi_key": "HDDSHPAODJUKPD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "HOE-881Y"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Fenbendazole (BAN, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-bendazole",
    "usan_stem_definition": "anthelmintics (tibendazole type)",
    "usan_stem_substem": "-bendazole(-bendazole)",
    "usan_year": 1975
  },
  {
    "applicants": {
      "value": [
        "Actavis Laboratories Fl Inc",
        "Schering Corp Sub Schering Plough Corp",
        "Sandoz Inc",
        "Mylan Pharmaceuticals Inc",
        "Cipla Ltd",
        "Par Pharmaceutical Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L02BB01",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ENDOCRINE THERAPY: HORMONE ANTAGONISTS AND RELATED AGENTS: Anti-androgens"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1989,
    "molecule_chembl_id": "CHEMBL806",
    "molecule_properties": {
      "acd_logd": 3.52,
      "acd_logp": 3.52,
      "acd_most_apka": 13.12,
      "alogp": 3.21,
      "aromatic_rings": 1,
      "full_molformula": "C11H11F3N2O3",
      "full_mwt": 276.21,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 276.21,
      "mw_monoisotopic": 276.0722,
      "psa": 72.24,
      "qed_weighted": 0.68,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)C(=O)Nc1ccc(c(c1)C(F)(F)F)[N+](=O)[O-]",
      "standard_inchi": "InChI=1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)",
      "standard_inchi_key": "MKXKFYHWDHIYRV-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "prodrug": true,
    "research_codes": {
      "value": "SCH-13521"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Flutamide (BAN, FDA, INN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-lutamide",
    "usan_stem_definition": "non-steroid antiandrogens",
    "usan_stem_substem": "-lutamide(-lutamide)",
    "usan_year": 1975
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL290352",
    "molecule_properties": {
      "acd_logd": 6.52,
      "acd_logp": 6.52,
      "acd_most_apka": 11.94,
      "alogp": 6.16,
      "aromatic_rings": 5,
      "full_molformula": "C33H33N3O5S2",
      "full_mwt": 615.78,
      "hba": 9,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 43,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 615.78,
      "mw_monoisotopic": 615.1862,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 94.72,
      "qed_weighted": 0.21,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCSCc1ccc2c(c1)c3c4CNC(=O)c4c5c6cc(CSCC)ccc6n7[C@H]8C[C@](O)(C(=O)OC)[C@](C)(O8)n2c3c57",
      "standard_inchi": "InChI=1S/C33H33N3O5S2/c1-5-42-15-17-7-9-22-19(11-17)26-27-21(14-34-30(27)37)25-20-12-18(16-43-6-2)8-10-23(20)36-29(25)28(26)35(22)24-13-33(39,31(38)40-4)32(36,3)41-24/h7-12,24,39H,5-6,13-16H2,1-4H3,(H,34,37)/t24-,32+,33+/m1/s1",
      "standard_inchi_key": "SCMLRESZJCKCTC-KMYQRJGFSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "CEP-1347",
        "KT-1575"
      ]
    },
    "synonyms": {
      "value": "CEP-1347"
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL35084",
    "molecule_properties": {
      "acd_logd": 0.76,
      "acd_logp": 3.28,
      "acd_most_apka": 4.84,
      "alogp": 4.07,
      "aromatic_rings": 1,
      "full_molformula": "C29H41NO7",
      "full_mwt": 515.65,
      "hba": 6,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 37,
      "molecular_species": "ACID",
      "mw_freebase": 515.65,
      "mw_monoisotopic": 515.2883,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 111.16,
      "qed_weighted": 0.25,
      "ro3_pass": "N",
      "rtb": 12
    },
    "molecule_structures": {
      "canonical_smiles": "COCCOC[C@H](CC1(CCCC1)C(=O)N[C@@H]2CC[C@@H](CC2)C(=O)O)C(=O)Oc3ccc4CCCc4c3",
      "standard_inchi": "InChI=1S/C29H41NO7/c1-35-15-16-36-19-23(27(33)37-25-12-9-20-5-4-6-22(20)17-25)18-29(13-2-3-14-29)28(34)30-24-10-7-21(8-11-24)26(31)32/h9,12,17,21,23-24H,2-8,10-11,13-16,18-19H2,1H3,(H,30,34)(H,31,32)/t21-,23-,24+/m0/s1",
      "standard_inchi_key": "ZTWZVMIYIIVABD-OEMFJLHTSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "UK-79300"
    },
    "synonyms": {
      "value": [
        "Candoxatril (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-tril",
    "usan_stem_definition": "endopeptidase inhibitors",
    "usan_stem_substem": "-tril(-tril)",
    "usan_year": 1993
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL37935",
    "molecule_properties": {
      "acd_logd": 1.78,
      "acd_logp": 1.82,
      "acd_most_apka": 12.02,
      "acd_most_bpka": 6.35,
      "alogp": 2.88,
      "aromatic_rings": 2,
      "full_molformula": "C19H23N3O3",
      "full_mwt": 341.41,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 341.41,
      "mw_monoisotopic": 341.1739,
      "psa": 75.44,
      "qed_weighted": 0.93,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1oc2nc3CCCCc3c(NC(=O)CN4CCCC4=O)c2c1C",
      "standard_inchi": "InChI=1S/C19H23N3O3/c1-11-12(2)25-19-17(11)18(13-6-3-4-7-14(13)20-19)21-15(23)10-22-9-5-8-16(22)24/h3-10H2,1-2H3,(H,20,21,23)",
      "standard_inchi_key": "PSPGQHXMUKWNDI-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Coluracetam (INN)",
        null
      ]
    },
    "usan_stem": "-racetam",
    "usan_stem_definition": "nootropes (piracetam type)",
    "usan_stem_substem": "-racetam(-racetam)"
  },
  {
    "applicants": {
      "value": [
        "Torrent Pharmaceuticals Ltd",
        "Jubilant Generics Ltd",
        "Ajanta Pharma Ltd",
        "Forest Laboratories Llc",
        "Strides Pharma Global Pte Ltd",
        "Aurobindo Pharma Ltd",
        "Bio-Pharm Inc",
        "Teva Pharmaceuticals Usa",
        "Lupin Ltd",
        "Alembic Pharmaceuticals Ltd"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06DX01",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTI-DEMENTIA DRUGS: Other anti-dementia drugs"
      }
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2003,
    "molecule_chembl_id": "CHEMBL807",
    "molecule_properties": {
      "acd_logd": 0.08,
      "acd_logp": 3,
      "acd_most_bpka": 10.79,
      "alogp": 2.69,
      "full_molformula": "C12H21N",
      "full_mwt": 179.31,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 13,
      "molecular_species": "BASE",
      "mw_freebase": 179.31,
      "mw_monoisotopic": 179.1674,
      "psa": 26.02,
      "qed_weighted": 0.61,
      "ro3_pass": "Y"
    },
    "molecule_structures": {
      "canonical_smiles": "CC12CC3CC(C)(C1)CC(N)(C3)C2",
      "standard_inchi": "InChI=1S/C12H21N/c1-10-3-9-4-11(2,6-10)8-12(13,5-9)7-10/h9H,3-8,13H2,1-2H3",
      "standard_inchi_key": "BUGYDGFZZOZRHP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 8039009,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-8039009-B2",
    "synonyms": {
      "value": [
        "Memantine HCl (FDA, USAN)",
        "Memantine (BAN, INN, MI)",
        null
      ]
    },
    "usan_stem": "-mantine",
    "usan_stem_definition": "antivirals/antiparkinsonians (adamantane derivatives)",
    "usan_stem_substem": "-mantine(-mantine)",
    "usan_year": 2003
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 1,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL37676",
    "molecule_properties": {
      "acd_logd": 3.79,
      "acd_logp": 3.79,
      "acd_most_apka": 11.41,
      "alogp": 3.42,
      "aromatic_rings": 1,
      "full_molformula": "C14H20O2",
      "full_mwt": 220.31,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 220.31,
      "mw_monoisotopic": 220.1463,
      "psa": 29.46,
      "qed_weighted": 0.73,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1c(C)c2OC(C)(C)CCc2c(C)c1O",
      "standard_inchi": "InChI=1S/C14H20O2/c1-8-9(2)13-11(10(3)12(8)15)6-7-14(4,5)16-13/h15H,6-7H2,1-5H3",
      "standard_inchi_key": "SEBPXHSZHLFWRL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": "APC-100"
    }
  },
  {
    "applicants": {
      "value": [
        "Alvogen Malta Operations Ltd",
        "Teligent Pharma Inc",
        "Taro Pharmaceuticals Usa Inc",
        "Perrigo New York Inc",
        "Fougera Pharmaceuticals Inc",
        "Chemo Research Sl"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D01AC03",
          "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Imidazole and triazole derivative"
        },
        {
          "code": "G01AF05",
          "description": "GENITO URINARY SYSTEM AND SEX HORMONES: GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS: ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS: Imidazole derivatives"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Antifungal",
    "molecule_chembl_id": "CHEMBL808",
    "molecule_properties": {
      "acd_logd": 4.41,
      "acd_logp": 4.48,
      "acd_most_bpka": 6.68,
      "alogp": 5.8,
      "aromatic_rings": 3,
      "full_molformula": "C18H15Cl3N2O",
      "full_mwt": 381.69,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 381.69,
      "mw_monoisotopic": 380.025,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 27.05,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)cc1",
      "standard_inchi": "InChI=1S/C18H15Cl3N2O/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21/h1-9,12,18H,10-11H2",
      "standard_inchi_key": "LEZWWPYKPKIXLL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5993830,
    "research_codes": {
      "value": [
        "SQ-13050",
        "R-14827"
      ]
    },
    "sc_patent": "US-5993830-A",
    "synonyms": {
      "value": [
        "Econazole Nitrate (BAN, FDA, JAN, USAN, USP)",
        "Econazole (BAN, INN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-conazole",
    "usan_stem_definition": "systemic antifungals (miconazole type)",
    "usan_stem_substem": "-conazole(-conazole)",
    "usan_year": 1972
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antipsoriatic",
    "molecule_chembl_id": "CHEMBL36648",
    "molecule_properties": {
      "acd_logd": 3.07,
      "acd_logp": 3.07,
      "alogp": 3.36,
      "aromatic_rings": 2,
      "full_molformula": "C16H15ClO6",
      "full_mwt": 338.74,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 23,
      "mw_freebase": 338.74,
      "mw_monoisotopic": 338.0557,
      "psa": 71.06,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "COc1c(OC)c(OC(=O)C)c2cc(Cl)ccc2c1OC(=O)C",
      "standard_inchi": "InChI=1S/C16H15ClO6/c1-8(18)22-13-11-6-5-10(17)7-12(11)14(23-9(2)19)16(21-4)15(13)20-3/h5-7H,1-4H3",
      "standard_inchi_key": "IFWMVQUGSGWCRP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "RS-43179"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Lonapalene (INN, USAN)",
        null
      ]
    },
    "usan_year": 1986
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N06AB07",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Selective serotonin reuptake inhibitors"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL36591",
    "molecule_properties": {
      "acd_logd": 2.56,
      "acd_logp": 3.07,
      "acd_most_bpka": 7.76,
      "alogp": 2.55,
      "aromatic_rings": 1,
      "full_molformula": "C13H18ClNO2",
      "full_mwt": 255.75,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 255.75,
      "mw_monoisotopic": 255.1026,
      "psa": 52.32,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1",
      "standard_inchi": "InChI=1S/C13H18ClNO2/c1-9(15)12(16)17-13(2,3)8-10-4-6-11(14)7-5-10/h4-7,9H,8,15H2,1-3H3",
      "standard_inchi_key": "FZSPJBYOKQPKCD-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "GEA-654"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Alaproclate (INN, USAN)",
        null
      ]
    },
    "usan_year": 1981
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL287064",
    "molecule_properties": {
      "acd_logd": 1.38,
      "acd_logp": 2.45,
      "acd_most_bpka": 8.49,
      "alogp": 3.5,
      "aromatic_rings": 2,
      "full_molformula": "C15H15BrN2",
      "full_mwt": 303.2,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 18,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 303.2,
      "mw_monoisotopic": 302.0419,
      "psa": 24.92,
      "qed_weighted": 0.93,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CNC\\C=C(\\c1ccc(Br)cc1)/c2cccnc2",
      "standard_inchi": "InChI=1S/C15H15BrN2/c1-17-10-8-15(13-3-2-9-18-11-13)12-4-6-14(16)7-5-12/h2-9,11,17H,10H2,1H3/b15-8-",
      "standard_inchi_key": "AZFZKANGXPSDEA-NVNXTCNLSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nomelidine (INN)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N06BX11",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Other psychostimulants and nootropics"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Mental Performance Enhancer",
    "molecule_chembl_id": "CHEMBL36994",
    "molecule_properties": {
      "acd_logd": 1.35,
      "acd_logp": 1.35,
      "alogp": 1.46,
      "aromatic_rings": 1,
      "full_molformula": "C12H13NO3",
      "full_mwt": 219.24,
      "hba": 3,
      "hba_lipinski": 4,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 219.24,
      "mw_monoisotopic": 219.0895,
      "psa": 46.61,
      "qed_weighted": 0.71,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(cc1)C(=O)N2CCCC2=O",
      "standard_inchi": "InChI=1S/C12H13NO3/c1-16-10-6-4-9(5-7-10)12(15)13-8-2-3-11(13)14/h4-7H,2-3,8H2,1H3",
      "standard_inchi_key": "ZXNRTKGTQJPIJK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "Ro-135057"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Aniracetam (INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-racetam",
    "usan_stem_definition": "nootropes (piracetam type)",
    "usan_stem_substem": "-racetam(-racetam)",
    "usan_year": 1981
  },
  {
    "applicants": {
      "value": [
        "Torrent Pharmaceuticals Ltd",
        "Anda Repository Llc",
        "Invagen Pharmaceuticals Inc",
        "Aurobindo Pharma Ltd",
        "Allied Pharma Inc",
        "Lupin Ltd",
        "Oxford Pharmaceuticals Llc",
        "Zydus Pharmaceuticals Usa Inc",
        "Dr Reddys Laboratories Ltd",
        "Hikma Pharmaceuticals"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AB06",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Selective serotonin reuptake inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1991,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL809",
    "molecule_properties": {
      "acd_logd": 3.04,
      "acd_logp": 5.08,
      "acd_most_bpka": 9.47,
      "alogp": 5.18,
      "aromatic_rings": 2,
      "full_molformula": "C17H17Cl2N",
      "full_mwt": 306.24,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 20,
      "molecular_species": "BASE",
      "mw_freebase": 306.24,
      "mw_monoisotopic": 305.0738,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 12.03,
      "qed_weighted": 0.81,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN[C@H]1CC[C@@H](c2ccc(Cl)c(Cl)c2)c3ccccc13",
      "standard_inchi": "InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1",
      "standard_inchi_key": "VGKDLMBJGBXTGI-SJCJKPOMSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6727283,
    "oral": true,
    "research_codes": {
      "value": [
        "CP-519741",
        "CP-51974-1"
      ]
    },
    "sc_patent": "US-6727283-B2",
    "synonyms": {
      "value": [
        "Sertraline HCl (FDA, USAN)",
        "Sertraline (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-traline",
    "usan_stem_definition": "selective serotonin reuptake inhibitors (SSRI)",
    "usan_stem_substem": "-traline(-traline)",
    "usan_year": 1983
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N06BX03",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Other psychostimulants and nootropics"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Cognition Adjuvant",
    "molecule_chembl_id": "CHEMBL36715",
    "molecule_properties": {
      "acd_logd": -1.75,
      "acd_logp": -1.75,
      "alogp": -0.91,
      "full_molformula": "C6H10N2O2",
      "full_mwt": 142.16,
      "hba": 2,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 10,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 142.16,
      "mw_monoisotopic": 142.0742,
      "psa": 63.4,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=O)CN1CCCC1=O",
      "standard_inchi": "InChI=1S/C6H10N2O2/c7-5(9)4-8-3-1-2-6(8)10/h1-4H2,(H2,7,9)",
      "standard_inchi_key": "GMZVRMREEHBGGF-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CL-871"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Piracetam (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-racetam",
    "usan_stem_definition": "nootropes (piracetam type)",
    "usan_stem_substem": "-racetam(-racetam)",
    "usan_year": 1980
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N06BX07",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Other psychostimulants and nootropics"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL36633",
    "molecule_properties": {
      "acd_logd": -2.48,
      "acd_logp": -2.48,
      "acd_most_apka": 13.77,
      "alogp": -1.94,
      "full_molformula": "C6H10N2O3",
      "full_mwt": 158.16,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 11,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 158.16,
      "mw_monoisotopic": 158.0691,
      "psa": 83.63,
      "qed_weighted": 0.49,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=O)CN1CC(O)CC1=O",
      "standard_inchi": "InChI=1S/C6H10N2O3/c7-5(10)3-8-2-4(9)1-6(8)11/h4,9H,1-3H2,(H2,7,10)",
      "standard_inchi_key": "IHLAQQPQKRMGSS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "CGP-21690E",
        "GNF-Pf-1005"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Oxiracetam (BAN, INN, MI)",
        null
      ]
    },
    "usan_stem": "-racetam",
    "usan_stem_definition": "nootropes (piracetam type)",
    "usan_stem_substem": "-racetam(-racetam)"
  },
  {
    "applicants": {
      "value": [
        "Accord Healthcare Inc",
        "Rising Pharmaceuticals Inc",
        "Chemi Spa",
        "Lannett Holdings Inc",
        "Amerigen Pharmaceuticals Ltd",
        "Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Idt Australia Ltd",
        "Barr Laboratories Inc",
        "Zydus Pharmaceuticals Usa Inc",
        "Deva Holding As"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01AX03",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Other alkylating agents"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1999,
    "molecule_chembl_id": "CHEMBL810",
    "molecule_properties": {
      "acd_logd": -1.27,
      "acd_logp": -1.27,
      "alogp": -2.08,
      "aromatic_rings": 2,
      "full_molformula": "C6H6N6O2",
      "full_mwt": 194.15,
      "hba": 7,
      "hba_lipinski": 8,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 194.15,
      "mw_monoisotopic": 194.0552,
      "psa": 108.17,
      "qed_weighted": 0.56,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "CN1N=Nc2c(ncn2C1=O)C(=O)N",
      "standard_inchi": "InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)",
      "standard_inchi_key": "BPEGJWRSRHCHSN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6987108,
    "oral": true,
    "parenteral": true,
    "prodrug": true,
    "research_codes": {
      "value": [
        "M&B-39831",
        "SCH-52365",
        "M-39831",
        "CCRG-81045"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-6987108-B2",
    "synonyms": {
      "value": [
        "Temozolomide (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_year": 1999
  },
  {
    "atc_classification": {
      "drug": {
        "code": "R03DA03",
        "description": "RESPIRATORY SYSTEM: DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: OTHER SYSTEMIC DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES: Xanthines"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL37390",
    "molecule_properties": {
      "acd_logd": -0.56,
      "acd_logp": -0.56,
      "acd_most_bpka": 0.49,
      "alogp": -1.19,
      "aromatic_rings": 2,
      "full_molformula": "C10H14N4O3",
      "full_mwt": 238.25,
      "hba": 7,
      "hba_lipinski": 7,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 238.25,
      "mw_monoisotopic": 238.1066,
      "psa": 82.05,
      "qed_weighted": 0.71,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CC(O)Cn1cnc2N(C)C(=O)N(C)C(=O)c12",
      "standard_inchi": "InChI=1S/C10H14N4O3/c1-6(15)4-14-5-11-8-7(14)9(16)13(3)10(17)12(8)2/h5-6,15H,4H2,1-3H3",
      "standard_inchi_key": "KYHQZNGJUGFTGR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Proxyphylline (BAN, INN, JAN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antiviral; Antineoplastic",
    "molecule_chembl_id": "CHEMBL37387",
    "molecule_properties": {
      "acd_logd": 0.71,
      "acd_logp": 2.14,
      "acd_most_bpka": 7.59,
      "alogp": 2.19,
      "aromatic_rings": 2,
      "full_molformula": "C10H8BrN3O",
      "full_mwt": 266.1,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 15,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 266.1,
      "mw_monoisotopic": 264.9851,
      "psa": 72.03,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Nc1nc(O)c(Br)c(n1)c2ccccc2",
      "standard_inchi": "InChI=1S/C10H8BrN3O/c11-7-8(6-4-2-1-3-5-6)13-10(12)14-9(7)15/h1-5H,(H3,12,13,14,15)",
      "standard_inchi_key": "CIUUIPMOFZIWIZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "U-54461"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Bropirimine (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1986
  },
  {
    "applicants": {
      "value": [
        "Copley Pharmaceutical Inc",
        "Morton Grove Pharmaceuticals Inc",
        "Kv Pharmaceutical Co",
        "Acella Pharmaceuticals Llc",
        "Par Pharmaceutical Inc",
        "Taro Pharmaceutical Industries Ltd",
        "Newtron Pharmaceuticals Inc",
        "Wockhardt Eu Operations (Swiss) Ag",
        "Vintage Pharmaceuticals",
        "Ah Robins Co"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "R06AB51",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamine"
        },
        {
          "code": "R06AB01",
          "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Substituted alkylamines"
        }
      ]
    },
    "availability_type": 1,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1957,
    "indication_class": "Antihistaminic",
    "molecule_chembl_id": "CHEMBL811",
    "molecule_properties": {
      "acd_logd": 1.3,
      "acd_logp": 3.24,
      "acd_most_bpka": 9.33,
      "alogp": 3.93,
      "aromatic_rings": 2,
      "full_molformula": "C16H19BrN2",
      "full_mwt": 319.25,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 319.25,
      "mw_monoisotopic": 318.0732,
      "psa": 16.13,
      "qed_weighted": 0.83,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCC(c1ccc(Br)cc1)c2ccccn2",
      "standard_inchi": "InChI=1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3",
      "standard_inchi_key": "ZDIGNSYAACHWNL-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Brompheniramine (BAN, INN)",
        "Brompheniramine Maleate (FDA, USP)",
        null
      ]
    }
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N06AB02",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Selective serotonin reuptake inhibitors"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL37744",
    "molecule_properties": {
      "acd_logd": 2.44,
      "acd_logp": 3.07,
      "acd_most_bpka": 7.91,
      "alogp": 3.84,
      "aromatic_rings": 2,
      "full_molformula": "C16H17BrN2",
      "full_mwt": 317.23,
      "hba": 2,
      "hba_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 317.23,
      "mw_monoisotopic": 316.0575,
      "psa": 16.13,
      "qed_weighted": 0.85,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)C\\C=C(\\c1ccc(Br)cc1)/c2cccnc2",
      "standard_inchi": "InChI=1S/C16H17BrN2/c1-19(2)11-9-16(14-4-3-10-18-12-14)13-5-7-15(17)8-6-13/h3-10,12H,11H2,1-2H3/b16-9-",
      "standard_inchi_key": "OYPPVKRFBIWMSX-SXGWCWSVSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "H 102/09 HCl"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Zimeldine HCl (USAN)",
        "Zimeldine (BAN, INN)",
        null
      ]
    },
    "usan_year": 1977,
    "withdrawn_class": "Hepatotoxicity",
    "withdrawn_country": "United Kingdom, Germany",
    "withdrawn_reason": "Guillan-Barre Syndrome, hepatotoxicity",
    "withdrawn_year": 1983
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL34913",
    "molecule_properties": {
      "acd_logd": 3.21,
      "acd_logp": 3.21,
      "acd_most_apka": 9.43,
      "acd_most_bpka": 1.38,
      "alogp": 3.48,
      "aromatic_rings": 2,
      "full_molformula": "C16H19FN2O3S",
      "full_mwt": 338.4,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 338.4,
      "mw_monoisotopic": 338.11,
      "psa": 86.19,
      "qed_weighted": 0.93,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1oc(c2ccc(c(F)c2)S(=O)(=O)N)c(n1)C3CCCCC3",
      "standard_inchi": "InChI=1S/C16H19FN2O3S/c1-10-19-15(11-5-3-2-4-6-11)16(22-10)12-7-8-14(13(17)9-12)23(18,20)21/h7-9,11H,2-6H2,1H3,(H2,18,20,21)",
      "standard_inchi_key": "MIMJSJSRRDZIPW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "JTE-522",
        "RWJ-57504",
        "JTP-19605"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tilmacoxib (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-coxib",
    "usan_stem_definition": "cyclooxygenase-2 inhibitors",
    "usan_stem_substem": "-coxib(-coxib)",
    "usan_year": 2002
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL285517",
    "molecule_properties": {
      "acd_logd": 2.99,
      "acd_logp": 4.15,
      "acd_most_bpka": 8.54,
      "alogp": 3.83,
      "aromatic_rings": 2,
      "full_molformula": "C22H27NO2",
      "full_mwt": 337.46,
      "hba": 3,
      "hba_lipinski": 3,
      "heavy_atoms": 25,
      "molecular_species": "BASE",
      "mw_freebase": 337.46,
      "mw_monoisotopic": 337.2042,
      "psa": 29.54,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "CCOC(=O)C1(CCN(CCc2ccccc2)CC1)c3ccccc3",
      "standard_inchi": "InChI=1S/C22H27NO2/c1-2-25-21(24)22(20-11-7-4-8-12-20)14-17-23(18-15-22)16-13-19-9-5-3-6-10-19/h3-12H,2,13-18H2,1H3",
      "standard_inchi_key": "IUNKCJPURQMGKG-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pheneridine (INN)",
        null
      ]
    },
    "usan_stem": "-eridine",
    "usan_stem_definition": "analgesics (meperidine type)",
    "usan_stem_substem": "-eridine(-eridine)"
  },
  {
    "applicants": {
      "value": [
        "Abbvie Inc",
        "Mylan Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "C09CA02",
        "description": "CARDIOVASCULAR SYSTEM: AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM: ANGIOTENSIN II ANTAGONISTS, PLAIN: Angiotensin II antagonists, plain"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1997,
    "indication_class": "Antihypertensive",
    "molecule_chembl_id": "CHEMBL813",
    "molecule_properties": {
      "acd_logd": -0.63,
      "acd_logp": 2.96,
      "acd_most_apka": 3.63,
      "acd_most_bpka": 8.31,
      "alogp": 4.74,
      "aromatic_rings": 3,
      "full_molformula": "C23H24N2O4S",
      "full_mwt": 424.52,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 30,
      "molecular_species": "ACID",
      "mw_freebase": 424.52,
      "mw_monoisotopic": 424.1457,
      "psa": 92.42,
      "qed_weighted": 0.46,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCc1ncc(\\C=C(/Cc2cccs2)\\C(=O)O)n1Cc3ccc(cc3)C(=O)O",
      "standard_inchi": "InChI=1S/C23H24N2O4S/c1-2-3-6-21-24-14-19(12-18(23(28)29)13-20-5-4-11-30-20)25(21)15-16-7-9-17(10-8-16)22(26)27/h4-5,7-12,14H,2-3,6,13,15H2,1H3,(H,26,27)(H,28,29)/b18-12+",
      "standard_inchi_key": "OROAFUQRIXKEMV-LDADJPATSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "SK&F-108566J",
        "SK-108566",
        "SK&F-108566-J",
        "SK&F-108566"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Eprosartan (BAN, INN, USAN)",
        "Eprosartan Mesylate (BAN, FDA, USAN)",
        null
      ]
    },
    "usan_stem": "-sartan",
    "usan_stem_definition": "angiotensin II receptor antagonists",
    "usan_stem_substem": "-sartan(-sartan)",
    "usan_year": 1994
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL40124",
    "molecule_properties": {
      "acd_logd": 1.37,
      "acd_logp": 4.36,
      "acd_most_bpka": 10.31,
      "alogp": 4.72,
      "aromatic_rings": 4,
      "full_molformula": "C22H27N5",
      "full_mwt": 361.49,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 27,
      "molecular_species": "BASE",
      "mw_freebase": 361.49,
      "mw_monoisotopic": 361.2266,
      "psa": 56.84,
      "qed_weighted": 0.47,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCCNc1nccc2c(C)c3[nH]c4ccncc4c3cc12",
      "standard_inchi": "InChI=1S/C22H27N5/c1-4-27(5-2)12-6-9-24-22-18-13-17-19-14-23-10-8-20(19)26-21(17)15(3)16(18)7-11-25-22/h7-8,10-11,13-14,26H,4-6,9,12H2,1-3H3,(H,24,25)",
      "standard_inchi_key": "LPHSYQSMAGVYNT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Pazelliptine (INN)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Antidepressant",
    "molecule_chembl_id": "CHEMBL38120",
    "molecule_properties": {
      "acd_logd": 1.56,
      "acd_logp": 3.7,
      "acd_most_bpka": 9.59,
      "alogp": 3.87,
      "aromatic_rings": 2,
      "full_molformula": "C17H19N",
      "full_mwt": 237.35,
      "hba": 1,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 18,
      "molecular_species": "BASE",
      "mw_freebase": 237.35,
      "mw_monoisotopic": 237.1517,
      "psa": 12.03,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN[C@@H]1CC[C@@H](c2ccccc2)c3ccccc13",
      "standard_inchi": "InChI=1S/C17H19N/c1-18-17-12-11-14(13-7-3-2-4-8-13)15-9-5-6-10-16(15)17/h2-10,14,17-18H,11-12H2,1H3/t14-,17+/m0/s1",
      "standard_inchi_key": "NVXPZMLRGBVYQV-WMLDXEAASA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CP-24441-1"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tametraline HCl (USAN)",
        "Tametraline (INN)",
        null
      ]
    },
    "usan_stem": "-traline",
    "usan_stem_definition": "selective serotonin reuptake inhibitors (SSRI)",
    "usan_stem_substem": "-traline(-traline)",
    "usan_year": 1981
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL36584",
    "molecule_properties": {
      "acd_logd": 3.42,
      "acd_logp": 3.42,
      "alogp": 3.61,
      "aromatic_rings": 2,
      "full_molformula": "C18H18O4",
      "full_mwt": 298.34,
      "hba": 4,
      "hba_lipinski": 4,
      "heavy_atoms": 22,
      "mw_freebase": 298.34,
      "mw_monoisotopic": 298.1205,
      "psa": 44.76,
      "qed_weighted": 0.6,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "COc1ccc(\\C=C\\C(=O)c2ccc(OC)cc2OC)cc1",
      "standard_inchi": "InChI=1S/C18H18O4/c1-20-14-7-4-13(5-8-14)6-11-17(19)16-10-9-15(21-2)12-18(16)22-3/h4-12H,1-3H3/b11-6+",
      "standard_inchi_key": "HVAKUYCEWDPRCA-IZZDOVSWSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Metochalcone (DCF, INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL39999",
    "molecule_properties": {
      "acd_logd": 2.2,
      "acd_logp": 2.2,
      "acd_most_apka": 11.14,
      "acd_most_bpka": 5.33,
      "alogp": 2.77,
      "aromatic_rings": 2,
      "full_molformula": "C13H13BrN4S",
      "full_mwt": 337.25,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 337.25,
      "mw_monoisotopic": 336.0044,
      "psa": 49.84,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Brc1ccc(NC(=S)NCCc2ccccn2)nc1",
      "standard_inchi": "InChI=1S/C13H13BrN4S/c14-10-4-5-12(17-9-10)18-13(19)16-8-6-11-3-1-2-7-15-11/h1-5,7,9H,6,8H2,(H2,16,17,18,19)",
      "standard_inchi_key": "HOCFDYZWQYGULA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "LY-300046"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Trovirdine (INN)",
        null
      ]
    },
    "usan_stem": "-vir-",
    "usan_stem_definition": "antivirals",
    "usan_stem_substem": "-vir-(-vir-)"
  },
  {
    "applicants": {
      "value": [
        "Fresenius Kabi Usa Llc",
        "Sagent Agila Llc",
        "West-Ward Pharmaceuticals International Ltd",
        "Aurobindo Pharma Ltd",
        "Taro Pharmaceutical Industries Ltd",
        "Natco Pharma Ltd",
        "Teva Pharmaceuticals Usa",
        "Hoffmann La Roche Inc",
        "Akorn Inc",
        "Epic Pharma Llc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A04AA02",
        "description": "ALIMENTARY TRACT AND METABOLISM: ANTIEMETICS AND ANTINAUSEANTS: ANTIEMETICS AND ANTINAUSEANTS: Serotonin (5HT3) antagonists"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1993,
    "indication_class": "Anti-Emetic",
    "molecule_chembl_id": "CHEMBL289469",
    "molecule_properties": {
      "acd_logd": 0.02,
      "acd_logp": 2.91,
      "acd_most_apka": 12.34,
      "acd_most_bpka": 10.5,
      "alogp": 2.32,
      "aromatic_rings": 2,
      "full_molformula": "C18H24N4O",
      "full_mwt": 312.42,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 23,
      "molecular_species": "BASE",
      "mw_freebase": 312.42,
      "mw_monoisotopic": 312.195,
      "psa": 50.16,
      "qed_weighted": 0.93,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C2CCCC1CC(C2)NC(=O)c3nn(C)c4ccccc34",
      "standard_inchi": "InChI=1S/C18H24N4O/c1-21-13-6-5-7-14(21)11-12(10-13)19-18(23)17-15-8-3-4-9-16(15)22(2)20-17/h3-4,8-9,12-14H,5-7,10-11H2,1-2H3,(H,19,23)",
      "standard_inchi_key": "MFWNKCLOYSRHCJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 5952340,
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "LY-278584",
        "BRL-43694",
        "BRL-43694A"
      ]
    },
    "rule_of_five": true,
    "sc_patent": "US-5952340-A",
    "synonyms": {
      "value": [
        "Granisetron (BAN, FDA, INN, USAN)",
        "Granisetron HCl (FDA, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_stem": "-setron",
    "usan_stem_definition": "serotonin 5-HT3 antagonists",
    "usan_stem_substem": "-setron(-setron)",
    "usan_year": 1991
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Nmda Antagonist",
    "molecule_chembl_id": "CHEMBL39664",
    "molecule_properties": {
      "acd_logd": -4.67,
      "acd_logp": -1.05,
      "acd_most_apka": 2.22,
      "acd_most_bpka": 13.2,
      "alogp": -0.38,
      "full_molformula": "C7H14NO5P",
      "full_mwt": 223.16,
      "hba": 3,
      "hba_lipinski": 6,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 14,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 223.16,
      "mw_monoisotopic": 223.061,
      "psa": 106.86,
      "qed_weighted": 0.49,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)[C@@H]1C[C@H](CP(=O)(O)O)CCN1",
      "standard_inchi": "InChI=1S/C7H14NO5P/c9-7(10)6-3-5(1-2-8-6)4-14(11,12)13/h5-6,8H,1-4H2,(H,9,10)(H2,11,12,13)/t5-,6+/m1/s1",
      "standard_inchi_key": "LPMRCCNDNGONCD-RITPCOANSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "CGS-19755",
        "GNF-Pf-157"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Selfotel (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-fo-",
    "usan_stem_definition": "phosphoro-derivatives",
    "usan_stem_substem": "-fo-(-fo-)",
    "usan_year": 1993
  },
  {
    "applicants": {
      "value": [
        "Solvay Pharmaceuticals",
        "Torrent Pharmaceuticals Ltd",
        "Actavis Elizabeth Llc",
        "Sun Pharmaceutical Industries Inc",
        "Upsher-Smith Laboratories Llc",
        "Anchen Pharmaceuticals Inc",
        "Apotex Inc",
        "Synthon Pharmaceuticals Ltd",
        "Eci Pharmaceuticals Llc",
        "Watson Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06AB08",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: ANTIDEPRESSANTS: Selective serotonin reuptake inhibitors"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1994,
    "indication_class": "Antiobsessional Agent",
    "molecule_chembl_id": "CHEMBL814",
    "molecule_properties": {
      "acd_logd": 1.75,
      "acd_logp": 3.71,
      "acd_most_bpka": 9.39,
      "alogp": 3.2,
      "aromatic_rings": 1,
      "full_molformula": "C15H21F3N2O2",
      "full_mwt": 318.34,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 22,
      "molecular_species": "BASE",
      "mw_freebase": 318.34,
      "mw_monoisotopic": 318.1555,
      "psa": 56.84,
      "qed_weighted": 0.43,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "COCCCC\\C(=N/OCCN)\\c1ccc(cc1)C(F)(F)F",
      "standard_inchi": "InChI=1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+",
      "standard_inchi_key": "CJOFXWAVKWHTFT-XSFVSMFZSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 7465462,
    "oral": true,
    "research_codes": {
      "value": "DU-23000"
    },
    "rule_of_five": true,
    "sc_patent": "US-7465462-B1",
    "synonyms": {
      "value": [
        "Fluvoxamine Maleate (FDA, USAN, USP)",
        "Fluvoxamine (BAN, INN)",
        null
      ]
    },
    "usan_year": 1995
  },
  {
    "applicants": {
      "value": "Pharmacia And Upjohn Co"
    },
    "atc_classification": {
      "drug": {
        "code": "G02AD01",
        "description": "GENITO URINARY SYSTEM AND SEX HORMONES: OTHER GYNECOLOGICALS: UTEROTONICS: Prostaglandins"
      }
    },
    "availability_type": 0,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1982,
    "indication_class": "Oxytocic; Prostaglandin",
    "molecule_chembl_id": "CHEMBL815",
    "molecule_properties": {
      "acd_logd": -0.02,
      "acd_logp": 2.59,
      "acd_most_apka": 4.76,
      "alogp": 3.04,
      "full_molformula": "C20H34O5",
      "full_mwt": 354.49,
      "hba": 4,
      "hba_lipinski": 5,
      "hbd": 4,
      "hbd_lipinski": 4,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 354.49,
      "mw_monoisotopic": 354.2406,
      "psa": 97.99,
      "qed_weighted": 0.32,
      "ro3_pass": "N",
      "rtb": 12
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCC[C@H](O)\\C=C\\[C@H]1[C@H](O)C[C@H](O)[C@@H]1C\\C=C/CCCC(=O)O",
      "standard_inchi": "InChI=1S/C20H34O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,15-19,21-23H,2-3,5-6,8-11,14H2,1H3,(H,24,25)/b7-4-,13-12+/t15-,16+,17+,18-,19+/m0/s1",
      "standard_inchi_key": "PXGPLTODNUVGFL-YNNPMVKQSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "research_codes": {
      "value": [
        "U-14583E",
        "U-14583",
        "PGF2ALPHA-THAM"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dinoprost Trometamol (BAN)",
        "Dinoprost Tromethamine (FDA, JAN, USAN, USP)",
        "Dinoprost (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-prost",
    "usan_stem_definition": "prostaglandins",
    "usan_stem_substem": "-prost(-prost)",
    "usan_year": 1971
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL290507",
    "molecule_properties": {
      "acd_logd": 4.2,
      "acd_logp": 4.2,
      "acd_most_bpka": 2.51,
      "alogp": 3.66,
      "aromatic_rings": 3,
      "full_molformula": "C19H21N3O2S",
      "full_mwt": 355.46,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 25,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 355.46,
      "mw_monoisotopic": 355.1354,
      "psa": 77.98,
      "qed_weighted": 0.77,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "C\\C=C(/c1ccccc1)\\c2ccc3nc(N)n(c3c2)S(=O)(=O)C(C)C",
      "standard_inchi": "InChI=1S/C19H21N3O2S/c1-4-16(14-8-6-5-7-9-14)15-10-11-17-18(12-15)22(19(20)21-17)25(23,24)13(2)3/h4-13H,1-3H3,(H2,20,21)/b16-4+",
      "standard_inchi_key": "BFPYUXIFGJJYHU-AYSLTRBKSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Enviradene (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-vir-",
    "usan_stem_definition": "antivirals",
    "usan_stem_substem": "-vir-(-vir-)",
    "usan_year": 1983
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 7,
    "indication_class": "Antikeratinizing Agent",
    "molecule_chembl_id": "CHEMBL39861",
    "molecule_properties": {
      "acd_logd": 4.41,
      "acd_logp": 7.26,
      "acd_most_apka": 4.24,
      "alogp": 6.43,
      "aromatic_rings": 1,
      "full_molformula": "C23H28O2",
      "full_mwt": 336.48,
      "hba": 1,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 336.48,
      "mw_monoisotopic": 336.2089,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 37.3,
      "qed_weighted": 0.63,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "C\\C(=C/C=C/c1ccc(cc1)C(=O)O)\\C=C\\C2=C(C)CCCC2(C)C",
      "standard_inchi": "InChI=1S/C23H28O2/c1-17(10-15-21-18(2)8-6-16-23(21,3)4)7-5-9-19-11-13-20(14-12-19)22(24)25/h5,7,9-15H,6,8,16H2,1-4H3,(H,24,25)/b9-5+,15-10+,17-7+",
      "standard_inchi_key": "YRNAHKPMDMVFMV-GMICYETFSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "BASF-43915",
        "ORF-18704",
        "RWJ-18704"
      ]
    },
    "synonyms": {
      "value": [
        "Pelretin (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-retin",
    "usan_stem_definition": "retinol derivatives",
    "usan_stem_substem": "-retin(-retin)",
    "usan_year": 1989
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL816",
    "molecule_properties": {
      "acd_logd": -4.55,
      "acd_logp": -2.06,
      "acd_most_bpka": 9.89,
      "alogp": -1.1,
      "full_molformula": "C2H8N2",
      "full_mwt": 60.1,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 2,
      "hbd_lipinski": 4,
      "heavy_atoms": 4,
      "molecular_species": "BASE",
      "mw_freebase": 60.1,
      "mw_monoisotopic": 60.0687,
      "psa": 52.04,
      "qed_weighted": 0.4,
      "ro3_pass": "Y",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "NCCN",
      "standard_inchi": "InChI=1S/C2H8N2/c3-1-2-4/h1-4H2",
      "standard_inchi_key": "PIICEJLVQHRZGT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Edamine (INN)",
        "Ethylenediamine (JAN, USP)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Vasodilator (calcium channel blocker)",
    "molecule_chembl_id": "CHEMBL39516",
    "molecule_properties": {
      "acd_logd": 3.55,
      "acd_logp": 3.55,
      "acd_most_bpka": 0.75,
      "alogp": 5.73,
      "aromatic_rings": 3,
      "full_molformula": "C18H20NO3PS",
      "full_mwt": 361.4,
      "hba": 5,
      "hba_lipinski": 4,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 361.4,
      "mw_monoisotopic": 361.0902,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 48.42,
      "qed_weighted": 0.5,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CCOP(=O)(Cc1ccc(cc1)c2nc3ccccc3s2)OCC",
      "standard_inchi": "InChI=1S/C18H20NO3PS/c1-3-21-23(20,22-4-2)13-14-9-11-15(12-10-14)18-19-16-7-5-6-8-17(16)24-18/h5-12H,3-4,13H2,1-2H3",
      "standard_inchi_key": "FVYRUSCZCWSFLT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "A-53986",
        "KB-944"
      ]
    },
    "synonyms": {
      "value": [
        "Fostedil (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-dil; fos-",
    "usan_stem_definition": "vasodilators (undefined group); phosphoro-derivatives",
    "usan_stem_substem": "-dil(-dil); fos-(fos-)",
    "usan_year": 1984
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL288149",
    "molecule_properties": {
      "acd_logd": 1.24,
      "acd_logp": 1.25,
      "acd_most_bpka": 5.75,
      "alogp": 1.84,
      "aromatic_rings": 1,
      "full_molformula": "C16H20FN3O3S",
      "full_mwt": 353.42,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 24,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 353.42,
      "mw_monoisotopic": 353.1209,
      "psa": 61.88,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)NC[C@H]1CN(C(=O)O1)c2ccc(N3CCSCC3)c(F)c2",
      "standard_inchi": "InChI=1S/C16H20FN3O3S/c1-11(21)18-9-13-10-20(16(22)23-13)12-2-3-15(14(17)8-12)19-4-6-24-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1",
      "standard_inchi_key": "FNDDDNOJWPQCBZ-ZDUSSCGKSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "PNU-100480",
        "U-100480"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sutezolid (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-zolid",
    "usan_stem_definition": "oxazolidinone antibacterials",
    "usan_stem_substem": "-zolid(-zolid)",
    "usan_year": 2011
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL39373",
    "molecule_properties": {
      "acd_logd": 0.21,
      "acd_logp": 0.21,
      "acd_most_apka": 9.87,
      "acd_most_bpka": 1.54,
      "alogp": 0.58,
      "aromatic_rings": 1,
      "full_molformula": "C16H17N3O4",
      "full_mwt": 315.33,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 4,
      "hbd_lipinski": 5,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 315.33,
      "mw_monoisotopic": 315.1219,
      "psa": 115.89,
      "qed_weighted": 0.47,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccc2C(=O)N3C=C(CC3C(O)Nc2c1O)\\C=C\\C(=O)N",
      "standard_inchi": "InChI=1S/C16H17N3O4/c1-8-2-4-10-13(14(8)21)18-15(22)11-6-9(3-5-12(17)20)7-19(11)16(10)23/h2-5,7,11,15,18,21-22H,6H2,1H3,(H2,17,20)/b5-3+",
      "standard_inchi_key": "VGQOVCHZGQWAOI-HWKANZROSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Anthramycin (USAN)",
        "Antramycin (INN)",
        null
      ]
    },
    "usan_stem": "-mycin",
    "usan_stem_definition": "antibiotics (Streptomyces strains)",
    "usan_stem_substem": "-mycin(-mycin)",
    "usan_year": 1966
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antiviral",
    "molecule_chembl_id": "CHEMBL37624",
    "molecule_properties": {
      "acd_logd": 3.91,
      "acd_logp": 3.91,
      "alogp": 4.14,
      "aromatic_rings": 2,
      "full_molformula": "C17H16Cl2N2O2",
      "full_mwt": 351.23,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 23,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 351.23,
      "mw_monoisotopic": 350.0589,
      "psa": 72.19,
      "qed_weighted": 0.8,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CC(=O)c1ccc(C)cc1NC(C(=O)N)c2c(Cl)cccc2Cl",
      "standard_inchi": "InChI=1S/C17H16Cl2N2O2/c1-9-6-7-11(10(2)22)14(8-9)21-16(17(20)23)15-12(18)4-3-5-13(15)19/h3-8,16,21H,1-2H3,(H2,20,23)",
      "standard_inchi_key": "CJPLEFFCVDQQFZ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "R-89439"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Loviride (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-vir-",
    "usan_stem_definition": "antivirals",
    "usan_stem_substem": "-vir-(-vir-)",
    "usan_year": 1997
  },
  {
    "atc_classification": {
      "drug": {
        "code": "A10BA03",
        "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Biguanides"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antidiabetic",
    "molecule_chembl_id": "CHEMBL39736",
    "molecule_properties": {
      "acd_logd": -1.4,
      "acd_logp": 0.6,
      "acd_most_bpka": 13.2,
      "alogp": -0.63,
      "full_molformula": "C6H15N5",
      "full_mwt": 157.22,
      "hba": 1,
      "hba_lipinski": 5,
      "hbd": 3,
      "hbd_lipinski": 6,
      "heavy_atoms": 11,
      "molecular_species": "BASE",
      "mw_freebase": 157.22,
      "mw_monoisotopic": 157.1327,
      "num_lipinski_ro5_violations": 1,
      "psa": 102.78,
      "qed_weighted": 0.29,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCCC\\N=C(\\N)/N=C(N)N",
      "standard_inchi": "InChI=1S/C6H15N5/c1-2-3-4-10-6(9)11-5(7)8/h2-4H2,1H3,(H6,7,8,9,10,11)",
      "standard_inchi_key": "XSEUMFJMFFMCIU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "W 37",
        "DBV"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Buformin (INN, USAN)",
        "Buformin HCl (JAN)",
        null
      ]
    },
    "usan_stem": "-formin",
    "usan_stem_definition": "hypoglycemics (phenformin type)",
    "usan_stem_substem": "-formin(-formin)",
    "usan_year": 1965,
    "withdrawn_class": "Metabolism toxicity",
    "withdrawn_country": "Germany",
    "withdrawn_reason": "Metabolic toxicity",
    "withdrawn_year": 1978
  },
  {
    "applicants": {
      "value": "Novartis Pharmaceuticals Corp"
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2009,
    "molecule_chembl_id": "CHEMBL38827",
    "molecule_properties": {
      "acd_logd": 7.42,
      "acd_logp": 8.67,
      "acd_most_apka": 13.44,
      "acd_most_bpka": 8.71,
      "alogp": 9.15,
      "aromatic_rings": 3,
      "full_molformula": "C30H32Cl3NO",
      "full_mwt": 528.95,
      "hba": 2,
      "hba_lipinski": 2,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 35,
      "molecular_species": "BASE",
      "mw_freebase": 528.95,
      "mw_monoisotopic": 527.1549,
      "num_lipinski_ro5_violations": 2,
      "num_ro5_violations": 2,
      "psa": 23.47,
      "qed_weighted": 0.22,
      "ro3_pass": "N",
      "rtb": 10
    },
    "molecule_structures": {
      "canonical_smiles": "CCCCN(CCCC)CC(O)c1cc(Cl)cc2\\C(=C/c3ccc(Cl)cc3)\\c4cc(Cl)ccc4c12",
      "standard_inchi": "InChI=1S/C30H32Cl3NO/c1-3-5-13-34(14-6-4-2)19-29(35)28-18-23(33)17-27-25(15-20-7-9-21(31)10-8-20)26-16-22(32)11-12-24(26)30(27)28/h7-12,15-18,29,35H,3-6,13-14,19H2,1-2H3/b25-15-",
      "standard_inchi_key": "DYLGFOYVTXJFJP-MYYYXRDXSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "synonyms": {
      "value": [
        "Lumefantrine (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "usan_year": 2008
  },
  {
    "applicants": {
      "value": [
        "Sun Pharmaceutical Industries Inc",
        "Sandoz Inc",
        "Superpharm Corp",
        "Par Pharmaceutical Inc",
        "Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc",
        "Watson Laboratories Inc",
        "Barr Laboratories Inc",
        "G And W Laboratories Inc",
        "Usl Pharma Inc",
        "Pharmacia And Upjohn Co"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "A10BB05",
        "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS USED IN DIABETES: BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS: Sulfonylureas"
      }
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1966,
    "indication_class": "Antidiabetic",
    "molecule_chembl_id": "CHEMBL817",
    "molecule_properties": {
      "acd_logd": -0.3,
      "acd_logp": 1.54,
      "acd_most_apka": 6.07,
      "acd_most_bpka": 3.26,
      "alogp": 1.77,
      "aromatic_rings": 1,
      "full_molformula": "C14H21N3O3S",
      "full_mwt": 311.41,
      "hba": 4,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "ACID",
      "mw_freebase": 311.41,
      "mw_monoisotopic": 311.1304,
      "psa": 78.51,
      "qed_weighted": 0.89,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2",
      "standard_inchi": "InChI=1S/C14H21N3O3S/c1-12-6-8-13(9-7-12)21(19,20)16-14(18)15-17-10-4-2-3-5-11-17/h6-9H,2-5,10-11H2,1H3,(H2,15,16,18)",
      "standard_inchi_key": "OUDSBRTVNLOZBN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": "U-17835"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Tolazamide (BAN, FDA, INN, JAN, USAN, USP)",
        null
      ]
    },
    "usan_year": 1964
  },
  {
    "applicants": {
      "value": [
        "Pharmalucence Inc",
        "Ge Healthcare"
      ]
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1994,
    "indication_class": "Diagnostic Aid (radioactive, adrenomedullary disorders and neuroendocrine tumors); Radioactive Agent,Radioactive Agent,Radioactive Agent; Diagnostic Aid",
    "molecule_chembl_id": "CHEMBL818",
    "molecule_properties": {
      "acd_logd": 0.27,
      "acd_logp": 2.27,
      "acd_most_bpka": 12.13,
      "alogp": 1.27,
      "aromatic_rings": 1,
      "full_molformula": "C8H10IN3",
      "full_mwt": 275.09,
      "hba": 1,
      "hba_lipinski": 3,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 12,
      "molecular_species": "BASE",
      "mw_freebase": 275.09,
      "mw_monoisotopic": 274.9919,
      "psa": 61.9,
      "qed_weighted": 0.43,
      "ro3_pass": "N",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=N)NCc1cccc(I)c1",
      "standard_inchi": "InChI=1S/C8H10IN3/c9-7-3-1-2-6(4-7)5-12-8(10)11/h1-4H,5H2,(H4,10,11,12)",
      "standard_inchi_key": "PDWUPXJEEYOOTR-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Iobenguane (123I) (INN, USP)",
        "Iobenguane (131I) (INN, USAN, USP)",
        "Iobenguane Sulfate (131I) (USAN, FDA)",
        "Iobenguane Sulfate (123I) (USAN, FDA)",
        null
      ]
    },
    "usan_stem": "io-",
    "usan_stem_definition": "iodine-containing contrast media",
    "usan_stem_substem": "io-(io-)",
    "usan_year": 1994
  },
  {
    "applicants": {
      "value": [
        "Wockhardt Bio Ag",
        "Apothecon Inc Div Bristol Myers Squibb",
        "Sandoz Inc",
        "Renaissance Ssa Llc",
        "Istituto Biochimico Italiano Spa",
        "Apothecon Sub Bristol Myers Squibb Co",
        "Watson Laboratories Inc",
        "Ani Pharmaceuticals Inc",
        "Hospira Inc",
        "Baxter Healthcare Corp"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "J01CF04",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: BETA-LACTAM ANTIBACTERIALS, PENICILLINS: Beta-lactamase resistant penicillins"
      }
    },
    "availability_type": 1,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 7,
    "first_approval": 1971,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL819",
    "molecule_properties": {
      "acd_logd": -1.18,
      "acd_logp": 2.55,
      "acd_most_apka": 2.44,
      "alogp": 1.9,
      "aromatic_rings": 2,
      "full_molformula": "C19H19N3O5S",
      "full_mwt": 401.44,
      "hba": 6,
      "hba_lipinski": 8,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 28,
      "molecular_species": "ACID",
      "mw_freebase": 401.44,
      "mw_monoisotopic": 401.1045,
      "psa": 112.74,
      "qed_weighted": 0.75,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1onc(c2ccccc2)c1C(=O)N[C@H]3[C@H]4SC(C)(C)[C@@H](N4C3=O)C(=O)O",
      "standard_inchi": "InChI=1S/C19H19N3O5S/c1-9-11(12(21-27-9)10-7-5-4-6-8-10)15(23)20-13-16(24)22-14(18(25)26)19(2,3)28-17(13)22/h4-8,13-14,17H,1-3H3,(H,20,23)(H,25,26)/t13-,14+,17-/m1/s1",
      "standard_inchi_key": "UWYHMGVUTGAWSP-JKIFEVAISA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "research_codes": {
      "value": [
        "P-12",
        "SO 16423",
        "SQ-16423"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Oxacillin (BAN, INN)",
        "Oxacillin sodium (FDA, JAN, USAN, USP)",
        null
      ]
    },
    "usan_stem": "-cillin",
    "usan_stem_definition": "penicillins",
    "usan_stem_substem": "-cillin(-cillin)",
    "usan_year": 1962
  },
  {
    "atc_classification": {
      "drug": {
        "code": "P01CC01",
        "description": "ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS: ANTIPROTOZOALS: AGENTS AGAINST LEISHMANIASIS AND TRYPANOSOMIASIS: Nitrofuran derivatives"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL290960",
    "molecule_properties": {
      "acd_logd": 0.72,
      "acd_logp": 0.72,
      "alogp": 0.64,
      "aromatic_rings": 1,
      "full_molformula": "C10H13N3O5S",
      "full_mwt": 287.3,
      "hba": 7,
      "hba_lipinski": 8,
      "heavy_atoms": 19,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 287.3,
      "mw_monoisotopic": 287.0576,
      "psa": 106.02,
      "qed_weighted": 0.46,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CC1CS(=O)(=O)CCN1\\N=C\\c2oc(cc2)[N+](=O)[O-]",
      "standard_inchi": "InChI=1S/C10H13N3O5S/c1-8-7-19(16,17)5-4-12(8)11-6-9-2-3-10(18-9)13(14)15/h2-3,6,8H,4-5,7H2,1H3/b11-6+",
      "standard_inchi_key": "ARFHIAQFJWUCFH-IZZDOVSWSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "BAY-A2502",
        "DNDI1613515",
        "BAYER-2502",
        "BAY-2502"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nifurtimox (BAN, INN, MI, USAN)",
        null
      ]
    },
    "usan_stem": "nifur-",
    "usan_stem_definition": "5-nitrofuran derivatives",
    "usan_stem_substem": "nifur-(nifur-)",
    "usan_year": 2015
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic (DNA topoisomerase II inhibitor)",
    "molecule_chembl_id": "CHEMBL38458",
    "molecule_properties": {
      "acd_logd": 0.18,
      "acd_logp": 3.79,
      "acd_most_apka": 8.35,
      "acd_most_bpka": 9.73,
      "alogp": 3.82,
      "aromatic_rings": 4,
      "full_molformula": "C21H27N5OS",
      "full_mwt": 397.55,
      "hba": 7,
      "hba_lipinski": 6,
      "hbd": 3,
      "hbd_lipinski": 4,
      "heavy_atoms": 28,
      "molecular_species": "BASE",
      "mw_freebase": 397.55,
      "mw_monoisotopic": 397.1936,
      "psa": 79.34,
      "qed_weighted": 0.39,
      "ro3_pass": "N",
      "rtb": 8
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCn1nc2c3ccc(O)cc3Sc4c(NCCN)ccc1c24",
      "standard_inchi": "InChI=1S/C21H27N5OS/c1-3-25(4-2)11-12-26-17-8-7-16(23-10-9-22)21-19(17)20(24-26)15-6-5-14(27)13-18(15)28-21/h5-8,13,23,27H,3-4,9-12,22H2,1-2H3",
      "standard_inchi_key": "HPCHDLLMIWHKBW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CI-958"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ledoxantrone Trihydrochloride (USAN)",
        null
      ]
    },
    "usan_stem": "-antrone",
    "usan_stem_definition": "antineoplastics, anthraquinone derivatives",
    "usan_stem_substem": "-antrone(-antrone)",
    "usan_year": 1996
  },
  {
    "applicants": {
      "value": [
        "Actavis Llc An Indirect Wholly-Owned Sub Of Teva Pharmaceuticals Usa Inc",
        "Sandoz Inc",
        "Otsuka Pharmaceutical Co Ltd",
        "Pharmascience Inc",
        "Aspen Global Inc",
        "Luitpold Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "L01AB01",
        "description": "ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS: ANTINEOPLASTIC AGENTS: ALKYLATING AGENTS: Alkyl sulfonates"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1954,
    "molecule_chembl_id": "CHEMBL820",
    "molecule_properties": {
      "acd_logd": -0.56,
      "acd_logp": -0.56,
      "alogp": -0.28,
      "full_molformula": "C6H14O6S2",
      "full_mwt": 246.31,
      "hba": 6,
      "hba_lipinski": 6,
      "heavy_atoms": 14,
      "mw_freebase": 246.31,
      "mw_monoisotopic": 246.0232,
      "psa": 86.74,
      "qed_weighted": 0.45,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CS(=O)(=O)OCCCCOS(=O)(=O)C",
      "standard_inchi": "InChI=1S/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3",
      "standard_inchi_key": "COVZYZSDYWQREU-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "parenteral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Busulfan (BAN, FDA, INN, JAN, USP)",
        null
      ]
    },
    "usan_stem": "-sulfan",
    "usan_stem_definition": "antineoplastics, alkylating agents (methanesulfonate derivatives)",
    "usan_stem_substem": "-sulfan(-sulfan)"
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL289228",
    "molecule_properties": {
      "acd_logd": 3.63,
      "acd_logp": 4.01,
      "acd_most_bpka": 7.2,
      "alogp": 5.5,
      "aromatic_rings": 5,
      "full_molformula": "C27H22Cl2N4O",
      "full_mwt": 489.41,
      "hba": 5,
      "hba_lipinski": 5,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 34,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 489.41,
      "mw_monoisotopic": 488.1171,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 65.84,
      "qed_weighted": 0.36,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN1C(=O)C=C(c2cccc(Cl)c2)c3cc(ccc13)[C@](N)(c4ccc(Cl)cc4)c5cncn5C",
      "standard_inchi": "InChI=1S/C27H22Cl2N4O/c1-32-16-31-15-25(32)27(30,18-6-9-20(28)10-7-18)19-8-11-24-23(13-19)22(14-26(34)33(24)2)17-4-3-5-21(29)12-17/h3-16H,30H2,1-2H3/t27-/m1/s1",
      "standard_inchi_key": "PLHJCIYEEKOWNM-HHHXNRCGSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": [
        "R-11577",
        "R-115777"
      ]
    },
    "synonyms": {
      "value": [
        "Tipifarnib (INN, USAN)",
        null
      ]
    },
    "usan_stem": "-farnib",
    "usan_stem_definition": "farnesyl transferase inhibitor",
    "usan_stem_substem": "-farnib(-farnib)",
    "usan_year": 2002
  },
  {
    "applicants": {
      "value": "Merck Sharp And Dohme Corp"
    },
    "availability_type": 1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1939,
    "molecule_chembl_id": "CHEMBL821",
    "molecule_properties": {
      "acd_logd": -3.25,
      "acd_logp": -1.25,
      "acd_most_bpka": 13.27,
      "alogp": -1.16,
      "full_molformula": "CH5N3",
      "full_mwt": 59.07,
      "hba": 1,
      "hba_lipinski": 3,
      "hbd": 3,
      "hbd_lipinski": 5,
      "heavy_atoms": 4,
      "molecular_species": "BASE",
      "mw_freebase": 59.07,
      "mw_monoisotopic": 59.0483,
      "psa": 75.89,
      "qed_weighted": 0.24,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "NC(=N)N",
      "standard_inchi": "InChI=1S/CH5N3/c2-1(3)4/h(H5,2,3,4)",
      "standard_inchi_key": "ZRALSGWEFCBTJO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Guanidine HCl (FDA)",
        null
      ]
    },
    "usan_stem": "guan-",
    "usan_stem_definition": "antihypertensives (guanidine derivatives)",
    "usan_stem_substem": "guan-(guan-)"
  },
  {
    "applicants": {
      "value": [
        "Roxane Laboratories Inc",
        "Harris Pharmaceutical Inc",
        "Apotex Corp",
        "Wockhardt Ltd",
        "Teva Pharmaceuticals Usa Inc",
        "Novartis Pharmaceuticals Corp",
        "Gedeon Richter Usa Inc",
        "Glenmark Generics Ltd",
        "Invagen Pharmaceuticals Inc",
        "Dr Reddys Laboratories Inc"
      ]
    },
    "atc_classification": {
      "drug": [
        {
          "code": "D01BA02",
          "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR SYSTEMIC USE: Antifungals for systemic us"
        },
        {
          "code": "D01AE15",
          "description": "DERMATOLOGICALS: ANTIFUNGALS FOR DERMATOLOGICAL USE: ANTIFUNGALS FOR TOPICAL USE: Other antifungals for topical use"
        }
      ]
    },
    "availability_type": 2,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1992,
    "indication_class": "Antifungal",
    "molecule_chembl_id": "CHEMBL822",
    "molecule_properties": {
      "acd_logd": 5.46,
      "acd_logp": 5.58,
      "acd_most_bpka": 6.92,
      "alogp": 4.88,
      "aromatic_rings": 2,
      "full_molformula": "C21H25N",
      "full_mwt": 291.44,
      "hba": 1,
      "hba_lipinski": 1,
      "heavy_atoms": 22,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 291.44,
      "mw_monoisotopic": 291.1987,
      "psa": 3.24,
      "qed_weighted": 0.73,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C\\C=C\\C#CC(C)(C)C)Cc1cccc2ccccc12",
      "standard_inchi": "InChI=1S/C21H25N/c1-21(2,3)15-8-5-9-16-22(4)17-19-13-10-12-18-11-6-7-14-20(18)19/h5-7,9-14H,16-17H2,1-4H3/b9-5+",
      "standard_inchi_key": "DOMXUEMWDBAQBQ-WEVVVXLNSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "SF-86-327",
        "SF-86327"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Terbinafine HCl (FDA, JAN, JAN)",
        "Terbinafine (BAN, FDA, INN, USAN)",
        null
      ]
    },
    "topical": true,
    "usan_year": 1987
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL37683",
    "molecule_properties": {
      "acd_logd": 0.01,
      "acd_logp": 2.17,
      "acd_most_apka": 6.04,
      "acd_most_bpka": 8.84,
      "alogp": 0.79,
      "aromatic_rings": 2,
      "full_molformula": "C15H17FN4O3",
      "full_mwt": 320.32,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 23,
      "molecular_species": "ZWITTERION",
      "mw_freebase": 320.32,
      "mw_monoisotopic": 320.1285,
      "psa": 101.45,
      "qed_weighted": 0.87,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1C=C(C(=O)O)C(=O)c2cc(F)c(nc12)N3CCC(N)C3",
      "standard_inchi": "InChI=1S/C15H17FN4O3/c1-2-19-7-10(15(22)23)12(21)9-5-11(16)14(18-13(9)19)20-4-3-8(17)6-20/h5,7-8H,2-4,6,17H2,1H3,(H,22,23)",
      "standard_inchi_key": "BQDVLIDLHOSQHC-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Esafloxacin (INN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antiprotozoal",
    "molecule_chembl_id": "CHEMBL290299",
    "molecule_properties": {
      "acd_logd": -0.11,
      "acd_logp": -0.11,
      "acd_most_apka": 12.99,
      "acd_most_bpka": 1.32,
      "alogp": -0.08,
      "aromatic_rings": 1,
      "full_molformula": "C6H8N4O4",
      "full_mwt": 200.15,
      "hba": 6,
      "hba_lipinski": 8,
      "hbd": 1,
      "hbd_lipinski": 2,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 200.15,
      "mw_monoisotopic": 200.0546,
      "psa": 113.28,
      "qed_weighted": 0.54,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cn1c(COC(=O)N)ncc1[N+](=O)[O-]",
      "standard_inchi": "InChI=1S/C6H8N4O4/c1-9-4(3-14-6(7)11)8-2-5(9)10(12)13/h2H,3H2,1H3,(H2,7,11)",
      "standard_inchi_key": "PQFRTXSWDXZRRS-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Ronidazole (BAN, INN, USAN)",
        null
      ]
    },
    "usan_stem": "-nidazole",
    "usan_stem_definition": "antiprotozoal substances (metronidazole type)",
    "usan_stem_substem": "-nidazole(-nidazole)",
    "usan_year": 1967
  },
  {
    "applicants": {
      "value": "Sanofi Aventis Us Llc"
    },
    "atc_classification": {
      "drug": {
        "code": "J01MA04",
        "description": "ANTIINFECTIVES FOR SYSTEMIC USE: ANTIBACTERIALS FOR SYSTEMIC USE: QUINOLONE ANTIBACTERIALS: Fluoroquinolones"
      }
    },
    "availability_type": 0,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1991,
    "indication_class": "Antibacterial",
    "molecule_chembl_id": "CHEMBL826",
    "molecule_properties": {
      "acd_logd": -0.62,
      "acd_logp": 1.59,
      "acd_most_apka": 6.04,
      "acd_most_bpka": 8.19,
      "alogp": 0.66,
      "aromatic_rings": 2,
      "full_molformula": "C15H17FN4O3",
      "full_mwt": 320.32,
      "hba": 6,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "ACID",
      "mw_freebase": 320.32,
      "mw_monoisotopic": 320.1285,
      "psa": 87.46,
      "qed_weighted": 0.86,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "CCN1C=C(C(=O)O)C(=O)c2cc(F)c(nc12)N3CCNCC3",
      "standard_inchi": "InChI=1S/C15H17FN4O3/c1-2-19-8-10(15(22)23)12(21)9-7-11(16)14(18-13(9)19)20-5-3-17-4-6-20/h7-8,17H,2-6H2,1H3,(H,22,23)",
      "standard_inchi_key": "IDYZIJYBMGIQMJ-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "research_codes": {
      "value": [
        "CI-919",
        "AT-2266",
        "PD-107779"
      ]
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Enoxacin (BAN, FDA, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-oxacin",
    "usan_stem_definition": "antibacterials (quinolone derivatives)",
    "usan_stem_substem": "-oxacin(-oxacin)",
    "usan_year": 1984
  },
  {
    "atc_classification": {
      "drug": {
        "code": "A03FA05",
        "description": "ALIMENTARY TRACT AND METABOLISM: DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS: PROPULSIVES: Propulsives"
      }
    },
    "availability_type": -1,
    "chirality": 0,
    "development_phase": 3,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL290194",
    "molecule_properties": {
      "acd_logd": -0.32,
      "acd_logp": 1.4,
      "acd_most_apka": 7.89,
      "acd_most_bpka": 9.01,
      "alogp": 1.35,
      "aromatic_rings": 2,
      "full_molformula": "C16H21N5O2",
      "full_mwt": 315.38,
      "hba": 5,
      "hba_lipinski": 7,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 23,
      "molecular_species": "BASE",
      "mw_freebase": 315.38,
      "mw_monoisotopic": 315.1695,
      "psa": 83.14,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "COc1cc2[nH]nnc2cc1C(=O)NCC3CCCN3CC=C",
      "standard_inchi": "InChI=1S/C16H21N5O2/c1-3-6-21-7-4-5-11(21)10-17-16(22)12-8-13-14(19-20-18-13)9-15(12)23-2/h3,8-9,11H,1,4-7,10H2,2H3,(H,17,22)(H,18,19,20)",
      "standard_inchi_key": "KSEYRUGYKHXGFW-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Alizapride (INN, MI)",
        null
      ]
    },
    "usan_stem": "-pride",
    "usan_stem_definition": "sulpiride derivatives",
    "usan_stem_substem": "-pride(-pride)"
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL38434",
    "molecule_properties": {
      "acd_logd": 3.71,
      "acd_logp": 6.85,
      "acd_most_apka": 0.71,
      "acd_most_bpka": 3.96,
      "alogp": 5.85,
      "aromatic_rings": 4,
      "full_molformula": "C23H15F2NO2",
      "full_mwt": 375.37,
      "hba": 2,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 28,
      "molecular_species": "ACID",
      "mw_freebase": 375.37,
      "mw_monoisotopic": 375.1071,
      "num_lipinski_ro5_violations": 1,
      "num_ro5_violations": 1,
      "psa": 50.19,
      "qed_weighted": 0.49,
      "ro3_pass": "N",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1c(C(=O)O)c2cc(F)ccc2nc1c3ccc(cc3)c4ccccc4F",
      "standard_inchi": "InChI=1S/C23H15F2NO2/c1-13-21(23(27)28)18-12-16(24)10-11-20(18)26-22(13)15-8-6-14(7-9-15)17-4-2-3-5-19(17)25/h2-12H,1H3,(H,27,28)",
      "standard_inchi_key": "PHEZJEYUWHETKO-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "DUP-785"
    },
    "synonyms": {
      "value": [
        "Brequinar sodium (USAN)",
        "Brequinar (INN)",
        null
      ]
    },
    "usan_year": 1987
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL37681",
    "molecule_properties": {
      "acd_logd": -9.1,
      "acd_logp": -2.94,
      "acd_most_apka": 1.66,
      "alogp": -1.79,
      "full_molformula": "C6H10NO8P",
      "full_mwt": 255.12,
      "hba": 4,
      "hba_lipinski": 9,
      "hbd": 5,
      "hbd_lipinski": 5,
      "heavy_atoms": 16,
      "molecular_species": "ACID",
      "mw_freebase": 255.12,
      "mw_monoisotopic": 255.0144,
      "psa": 161.23,
      "qed_weighted": 0.35,
      "ro3_pass": "N",
      "rtb": 6
    },
    "molecule_structures": {
      "canonical_smiles": "OC(=O)CC(NC(=O)CP(=O)(O)O)C(=O)O",
      "standard_inchi": "InChI=1S/C6H10NO8P/c8-4(2-16(13,14)15)7-3(6(11)12)1-5(9)10/h3H,1-2H2,(H,7,8)(H,9,10)(H,11,12)(H2,13,14,15)",
      "standard_inchi_key": "ZZKNRXZVGOYGJT-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "CI-882"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Sparfosic Acid (INN)",
        "Sparfosate Sodium (USAN)",
        null
      ]
    },
    "usan_stem": "-fo-",
    "usan_stem_definition": "phosphoro-derivatives",
    "usan_stem_substem": "-fo-(-fo-)",
    "usan_year": 1981
  },
  {
    "availability_type": -1,
    "chirality": 1,
    "drug_type": 7,
    "molecule_chembl_id": "CHEMBL38992",
    "molecule_properties": {
      "acd_logd": 2.53,
      "acd_logp": 3.02,
      "acd_most_apka": 11.46,
      "acd_most_bpka": 7.32,
      "alogp": 2.06,
      "aromatic_rings": 2,
      "full_molformula": "C19H28N4O2S",
      "full_mwt": 376.53,
      "hba": 3,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 26,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 376.53,
      "mw_monoisotopic": 376.1933,
      "psa": 68.44,
      "qed_weighted": 0.84,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)S(=O)(=O)N[C@H]1C[C@H]2[C@@H](Cc3c[nH]c4cccc2c34)N(C)C1",
      "standard_inchi": "InChI=1S/C19H28N4O2S/c1-4-23(5-2)26(24,25)21-14-10-16-15-7-6-8-17-19(15)13(11-20-17)9-18(16)22(3)12-14/h6-8,11,14,16,18,20-21H,4-5,9-10,12H2,1-3H3/t14-,16+,18+/m0/s1",
      "standard_inchi_key": "YHEIHLVIKSTGJE-YXJHDRRASA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Etisulergine (INN)",
        null
      ]
    },
    "usan_stem": "-erg-",
    "usan_stem_definition": "ergot alkaloid derivatives",
    "usan_stem_substem": "-erg-(-erg-)"
  },
  {
    "atc_classification": {
      "drug": {
        "code": "N05AA04",
        "description": "NERVOUS SYSTEM: PSYCHOLEPTICS: ANTIPSYCHOTICS: Phenothiazines with aliphatic side-chain"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "indication_class": "Sedative (veterinary)",
    "molecule_chembl_id": "CHEMBL39560",
    "molecule_properties": {
      "acd_logd": 2.13,
      "acd_logp": 4.08,
      "acd_most_bpka": 9.41,
      "alogp": 4.44,
      "aromatic_rings": 2,
      "full_molformula": "C19H22N2OS",
      "full_mwt": 326.47,
      "hba": 4,
      "hba_lipinski": 3,
      "heavy_atoms": 23,
      "molecular_species": "BASE",
      "mw_freebase": 326.47,
      "mw_monoisotopic": 326.1453,
      "psa": 23.55,
      "qed_weighted": 0.76,
      "ro3_pass": "N",
      "rtb": 5
    },
    "molecule_structures": {
      "canonical_smiles": "CN(C)CCCN1c2ccccc2Sc3ccc(cc13)C(=O)C",
      "standard_inchi": "InChI=1S/C19H22N2OS/c1-14(22)15-9-10-19-17(13-15)21(12-6-11-20(2)3)16-7-4-5-8-18(16)23-19/h4-5,7-10,13H,6,11-12H2,1-3H3",
      "standard_inchi_key": "NOSIYYJFMPDDSA-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Acepromazine Maleate (USAN, USP)",
        "Acepromazine (BAN, INN)",
        null
      ]
    },
    "usan_year": 1973
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Anti-Emetic",
    "molecule_chembl_id": "CHEMBL38594",
    "molecule_properties": {
      "acd_logd": -0.33,
      "acd_logp": 1.53,
      "acd_most_apka": 13.74,
      "acd_most_bpka": 9.08,
      "alogp": 2.35,
      "aromatic_rings": 1,
      "full_molformula": "C17H26ClN3O3",
      "full_mwt": 355.87,
      "hba": 5,
      "hba_lipinski": 6,
      "hbd": 2,
      "hbd_lipinski": 3,
      "heavy_atoms": 24,
      "molecular_species": "BASE",
      "mw_freebase": 355.87,
      "mw_monoisotopic": 355.1663,
      "psa": 84.66,
      "qed_weighted": 0.66,
      "ro3_pass": "N",
      "rtb": 9
    },
    "molecule_structures": {
      "canonical_smiles": "CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC(C)C(=O)C",
      "standard_inchi": "InChI=1S/C17H26ClN3O3/c1-5-21(6-2)8-7-20-17(23)13-9-14(18)15(19)10-16(13)24-12(4)11(3)22/h9-10,12H,5-8,19H2,1-4H3,(H,20,23)",
      "standard_inchi_key": "ZYOJXUNLLOBURP-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BMY-25801-01"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Batanopride (INN)",
        "Batanopride HCl (USAN)",
        null
      ]
    },
    "usan_stem": "-pride",
    "usan_stem_definition": "sulpiride derivatives",
    "usan_stem_substem": "-pride(-pride)",
    "usan_year": 1990
  },
  {
    "applicants": {
      "value": [
        "Teva Pharmaceuticals Usa",
        "Sun Pharmaceutical Industries Inc",
        "Lannett Co Inc",
        "Intellipharmaceutics Corp",
        "Novartis Pharmaceuticals Corp",
        "Abhai Inc",
        "Novel Laboratories Inc",
        "Rhodes Pharmaceuticals Lp",
        "Tris Pharma Inc",
        "Mylan Pharmaceuticals Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "N06BA11",
        "description": "NERVOUS SYSTEM: PSYCHOANALEPTICS: PSYCHOSTIMULANTS, AGENTS USED FOR ADHD AND NOOTROPICS: Centrally acting sympathomimetics"
      }
    },
    "availability_type": 1,
    "black_box": true,
    "chirality": 1,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 2001,
    "molecule_chembl_id": "CHEMBL827",
    "molecule_properties": {
      "acd_logd": 0.23,
      "acd_logp": 2.31,
      "acd_most_bpka": 9.51,
      "alogp": 2.09,
      "aromatic_rings": 1,
      "full_molformula": "C14H19NO2",
      "full_mwt": 233.31,
      "hba": 3,
      "hba_lipinski": 3,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 17,
      "molecular_species": "BASE",
      "mw_freebase": 233.31,
      "mw_monoisotopic": 233.1416,
      "psa": 38.33,
      "qed_weighted": 0.81,
      "ro3_pass": "Y",
      "rtb": 3
    },
    "molecule_structures": {
      "canonical_smiles": "COC(=O)[C@@H]([C@H]1CCCCN1)c2ccccc2",
      "standard_inchi": "InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1",
      "standard_inchi_key": "DUGOZIWVEXMGBE-CHWSQXEVSA-N"
    },
    "molecule_synonyms": [],
    "ob_patent": 6228398,
    "oral": true,
    "rule_of_five": true,
    "sc_patent": "US-6228398-B1",
    "synonyms": {
      "value": [
        "Dexmethylphenidate HCl (FDA, USAN)",
        "Dexmethylphenidate (INN)",
        null
      ]
    },
    "usan_year": 2002
  },
  {
    "availability_type": -1,
    "chirality": 0,
    "drug_type": 1,
    "indication_class": "Antineoplastic",
    "molecule_chembl_id": "CHEMBL289116",
    "molecule_properties": {
      "acd_logd": 0.78,
      "acd_logp": 0.78,
      "acd_most_apka": 10.88,
      "acd_most_bpka": 4.96,
      "alogp": 1.17,
      "aromatic_rings": 1,
      "full_molformula": "C12H14N2O2",
      "full_mwt": 218.26,
      "hba": 3,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 16,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 218.26,
      "mw_monoisotopic": 218.1055,
      "psa": 59.06,
      "qed_weighted": 0.76,
      "ro3_pass": "Y",
      "rtb": 2
    },
    "molecule_structures": {
      "canonical_smiles": "CCC1(CCC(=O)NC1=O)c2ccncc2",
      "standard_inchi": "InChI=1S/C12H14N2O2/c1-2-12(9-4-7-13-8-5-9)6-3-10(15)14-11(12)16/h4-5,7-8H,2-3,6H2,1H3,(H,14,15,16)",
      "standard_inchi_key": "QXKJWHWUDVQATH-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Rogletimide (BAN, INN, USAN)",
        null
      ]
    },
    "usan_year": 1991
  },
  {
    "atc_classification": {
      "drug": {
        "code": "C10AB02",
        "description": "CARDIOVASCULAR SYSTEM: LIPID MODIFYING AGENTS: LIPID MODIFYING AGENTS, PLAIN: Fibrates"
      }
    },
    "availability_type": -1,
    "chirality": 2,
    "development_phase": 4,
    "drug_type": 1,
    "indication_class": "Antihyperlipoproteinemic",
    "molecule_chembl_id": "CHEMBL264374",
    "molecule_properties": {
      "acd_logd": -1.09,
      "acd_logp": 2.5,
      "acd_most_apka": 3.29,
      "alogp": 3.55,
      "aromatic_rings": 2,
      "full_molformula": "C19H20ClNO4",
      "full_mwt": 361.83,
      "hba": 3,
      "hba_lipinski": 5,
      "hbd": 2,
      "hbd_lipinski": 2,
      "heavy_atoms": 25,
      "molecular_species": "ACID",
      "mw_freebase": 361.83,
      "mw_monoisotopic": 361.1081,
      "psa": 75.63,
      "qed_weighted": 0.79,
      "ro3_pass": "N",
      "rtb": 7
    },
    "molecule_structures": {
      "canonical_smiles": "CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O",
      "standard_inchi": "InChI=1S/C19H20ClNO4/c1-19(2,18(23)24)25-16-9-3-13(4-10-16)11-12-21-17(22)14-5-7-15(20)8-6-14/h3-10H,11-12H2,1-2H3,(H,21,22)(H,23,24)",
      "standard_inchi_key": "IIBYAHWJQTYFKB-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "BM 15.075"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Bezafibrate (BAN, INN, JAN, USAN)",
        null
      ]
    },
    "usan_stem": "-fibrate",
    "usan_stem_definition": "antihyperlipidemics (clofibrate type)",
    "usan_stem_substem": "-fibrate(-fibrate)",
    "usan_year": 1978
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL828",
    "molecule_properties": {
      "acd_logd": 4.15,
      "acd_logp": 4.15,
      "alogp": 3.89,
      "aromatic_rings": 2,
      "full_molformula": "C12H9NS",
      "full_mwt": 199.28,
      "hba": 2,
      "hba_lipinski": 1,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 14,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 199.28,
      "mw_monoisotopic": 199.0456,
      "psa": 12.03,
      "qed_weighted": 0.59,
      "ro3_pass": "N"
    },
    "molecule_structures": {
      "canonical_smiles": "N1c2ccccc2Sc3ccccc13",
      "standard_inchi": "InChI=1S/C12H9NS/c1-3-7-11-9(5-1)13-10-6-2-4-8-12(10)14-11/h1-8,13H",
      "standard_inchi_key": "WJFKNYWRSNBZNX-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Phenothiazine (INN, MI, NF)",
        null
      ]
    }
  },
  {
    "applicants": {
      "value": [
        "Morton Grove Pharmaceuticals Inc",
        "Alpharma Us Pharmaceuticals Division",
        "Allergan Herbert Skin Care Div Allergan Inc"
      ]
    },
    "atc_classification": {
      "drug": {
        "code": "R06AD01",
        "description": "RESPIRATORY SYSTEM: ANTIHISTAMINES FOR SYSTEMIC USE: ANTIHISTAMINES FOR SYSTEMIC USE: Phenothiazine derivatives"
      }
    },
    "availability_type": 0,
    "chirality": 0,
    "development_phase": 4,
    "drug_type": 1,
    "first_approval": 1982,
    "indication_class": "Antipruritic",
    "molecule_chembl_id": "CHEMBL829",
    "molecule_properties": {
      "acd_logd": 3.14,
      "acd_logp": 5.04,
      "acd_most_bpka": 9.34,
      "alogp": 4.49,
      "aromatic_rings": 2,
      "full_molformula": "C18H22N2S",
      "full_mwt": 298.45,
      "hba": 3,
      "hba_lipinski": 2,
      "heavy_atoms": 21,
      "molecular_species": "BASE",
      "mw_freebase": 298.45,
      "mw_monoisotopic": 298.1504,
      "psa": 6.48,
      "qed_weighted": 0.82,
      "ro3_pass": "N",
      "rtb": 4
    },
    "molecule_structures": {
      "canonical_smiles": "CC(CN(C)C)CN1c2ccccc2Sc3ccccc13",
      "standard_inchi": "InChI=1S/C18H22N2S/c1-14(12-19(2)3)13-20-15-8-4-6-10-17(15)21-18-11-7-5-9-16(18)20/h4-11,14H,12-13H2,1-3H3",
      "standard_inchi_key": "ZZHLYYDVIOPZBE-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "oral": true,
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Alimemazine (BAN, INN)",
        "Alimemazine Tartrate (JAN)",
        "Trimeprazine Tartrate (FDA, USP)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL38938",
    "molecule_properties": {
      "acd_logd": 0.1,
      "acd_logp": 0.1,
      "acd_most_bpka": 2.81,
      "alogp": 0.64,
      "aromatic_rings": 1,
      "full_molformula": "C5H7N3O2",
      "full_mwt": 141.13,
      "hba": 4,
      "hba_lipinski": 5,
      "heavy_atoms": 10,
      "molecular_species": "NEUTRAL",
      "mw_freebase": 141.13,
      "mw_monoisotopic": 141.0538,
      "psa": 60.96,
      "qed_weighted": 0.43,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1ncc([N+](=O)[O-])n1C",
      "standard_inchi": "InChI=1S/C5H7N3O2/c1-4-6-3-5(7(4)2)8(9)10/h3H,1-2H3",
      "standard_inchi_key": "IBXPYPUJPLLOIN-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "RP-8595"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Dimetridazole (BAN, INN, MI)",
        null
      ]
    }
  },
  {
    "availability_type": -1,
    "chirality": 2,
    "drug_type": 1,
    "molecule_chembl_id": "CHEMBL37971",
    "molecule_properties": {
      "acd_logd": 4.18,
      "acd_logp": 4.22,
      "acd_most_bpka": 9.25,
      "alogp": 3.05,
      "aromatic_rings": 3,
      "full_molformula": "C15H15N3O",
      "full_mwt": 253.31,
      "hba": 4,
      "hba_lipinski": 4,
      "hbd": 1,
      "hbd_lipinski": 1,
      "heavy_atoms": 19,
      "molecular_species": "BASE",
      "mw_freebase": 253.31,
      "mw_monoisotopic": 253.1215,
      "psa": 50.94,
      "qed_weighted": 0.72,
      "ro3_pass": "N",
      "rtb": 1
    },
    "molecule_structures": {
      "canonical_smiles": "Cc1cn(c(C)n1)c2cc(C)c3nc(O)ccc3c2",
      "standard_inchi": "InChI=1S/C15H15N3O/c1-9-6-13(18-8-10(2)16-11(18)3)7-12-4-5-14(19)17-15(9)12/h4-8H,1-3H3,(H,17,19)",
      "standard_inchi_key": "NMNXBEXPAHSXOK-UHFFFAOYSA-N"
    },
    "molecule_synonyms": [],
    "research_codes": {
      "value": "UK-61260-27"
    },
    "rule_of_five": true,
    "synonyms": {
      "value": [
        "Nanterinone (BAN, INN)",
        null
      ]
    },
    "usan_stem": "-rinone",
    "usan_stem_definition": "cardiotonics (amrinone type)",
    "usan_stem_substem": "-rinone(-rinone)"
  }
]